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made are identified in a schedule in appendix K of the 
guide. The changes do not include all those that might 
be considered necessary if the guide were subjected to a 
comprehensive review and revision.
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Notice to Readers
This AICPA Audit and Accounting Guide has been prepared by the AICPA 
Health Care Committee to assist preparers of financial statements in preparing 
financial statements in conformity with generally accepted accounting princi­
ples (GAAP) and to assist auditors in auditing and reporting on such financial 
statements in accordance with generally accepted auditing standards.
Descriptions of accounting principles and financial reporting practices in Au­
dit and Accounting Guides are approved by the affirmative vote of at least 
two-thirds of the members of the Accounting Standards Executive Committee, 
which is the senior technical body of the AICPA authorized to speak for the 
AICPA in the areas of financial accounting and reporting. AU section 411, The 
Meaning o f  Present Fairly in Conformity With Generally Accepted Account­
ing Principles (AICPA, Professional Standards, vol. 1), identifies AICPA Audit 
and Accounting Guides that have been cleared by the Financial Accounting 
Standards Board (FASB) (for financial statements of entities other than gov­
ernmental entities) or Governmental Accounting Standards Board (GASB) (for 
financial statements of governmental entities) as sources of accounting prin­
ciples in category b of the hierarchy of GAAP that it establishes. This Audit 
and Accounting Guide has been cleared by FASB and GASB. AICPA members 
should consider the accounting principles described in this Audit and Account­
ing Guide if the accounting treatment of a transaction or event is not specified by 
a pronouncement covered by Rule 203, Accounting Principles, of AICPA Code of 
Professional Conduct (AICPA, Professional Standards, vol. 2, ET section 203). 
In such circumstances, the accounting treatments specified by this Audit and 
Accounting Guide should be used, or the member should be prepared to justify 
another treatment, as discussed in paragraph .07 of AU section 411.*
* In May 2008, the Financial Accounting Standards Board (FASB) issued FASB Statement No. 
162, The Hierarchy o f Generally Accepted Accounting Principles, which identifies the sources of ac­
counting principles and the framework for selecting the principles used in the preparation of financial 
statements of nongovernmental entities that are presented in conformity with generally accepted 
accounting principles (GAAP) in the United States (the GAAP hierarchy). FASB concluded that the 
GAAP hierarchy should reside in the accounting literature established by FASB rather than in the 
auditing literature established by the AICPA (for non-Securities and Exchange Commission [SEC] 
registrants) or the Public Company Accounting Oversight Board (PCAOB) (for SEC registrants).
FASB Statement No. 162 carries forward the GAAP hierarchy as set forth in the AICPA's State­
ments on Auditing Standards (SAS) No. 69, The Meaning of Present Fairly in Conformity With Gen­
erally Accepted Accounting Principles (AICPA, Professional Standards, vol. 1, AU sec. 411), subject 
to certain modifications that the FASB does not expect to result in changes to current practice. The 
modifications include, among other changes, the expansion of category (a) accounting principles to 
include, with one exception, all sources of accounting principles that are issued after being subject 
to the FASB's due process (including, but not limited to, FASB Staff Positions and FASB Statement 
133 Implementation Issues, which are currently not addressed in AU section 411). Although certain 
consensus positions of the FASB Emerging Issues Task Force (EITF) have been issued after being 
subjected to the FASB's due process, the FASB decided to carry forward the categorization of EITF 
consensuses as presented in SAS No. 69, which is category (c).
FASB Statement No. 162 does not carry forward the exception permitted in ET section 203, Ac­
counting Principles (AICPA, Professional Standards, vol. 2), that allows departures from the GAAP 
hierarchy if the member can demonstrate that, due to unusual circumstances, the financial state­
ments would otherwise have been misleading. Therefore, an entity cannot represent that its financial 
statements are presented in accordance with GAAP if its selection of accounting principles departs 
from the GAAP hierarchy set forth in FASB Statement No. 162, and that departure has a material 
effect on its financial statements.
FASB Statement No. 162 is effective 60 days following the approval by the SEC of the con­
forming amendments included in PCAOB Auditing Standard No. 6, Evaluating Consistency o f Fi­
nancial Statements (AICPA, PCAOB Standards and Related Rules, Rules of the Board, "Stan­
dards"), and conforming amendments adopted by the PCAOB on January 29, 2008. Among other 
(continued)
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Auditing guidance is included in this AICPA Audit and Accounting Guide, 
which is an interpretive publication pursuant to AU section 150, Generally 
Accepted Auditing Standards (AICPA, Professional Standards, vol. 1). Inter­
pretive publications are recommendations on the application of Statements 
on Auditing Standards (SASs) in specific circumstances, including engage­
ments for entities in specialized industries. An interpretive publication is is­
sued under the authority of the Auditing Standards Board (ASB) after all 
ASB members have been provided an opportunity to consider and comment 
on whether the proposed interpretive publication is consistent with the SASs. 
The members of the ASB have found this guide to be consistent with existing 
SASs.
The auditor should be aware of and consider interpretive publications appli­
cable to his or her audit. If an auditor does not apply the auditing guidance 
included in an applicable interpretive publication, the auditor should be pre­
pared to explain how he or she complied with the SAS provisions addressed by 
such auditing guidance.
FASB Accounting Standards Codification™
On January 15, 2008, FASB launched the 1-year verification phase of the 
FASB Accounting Standards Codification™ (codification). After the verifica­
tion period, during which constituents are encouraged to provide feedback on 
whether the codification content accurately reflects existing U.S. GAAP for 
nongovernmental entities, FASB is expected to formally approve the codifi­
cation as the single source of authoritative U.S. GAAP, other than guidance 
issued by the Securities and Exchange Commission (SEC). The codification in­
cludes all accounting standards issued by a standard-setter within levels A-D 
of the current U.S. GAAP hierarchy, including FASB, AICPA, Emerging Issues 
Task Force (EITF), and related literature. The codification does not change 
GAAP; instead it reorganizes the thousands of U.S. GAAP pronouncements into 
roughly 90 accounting topics and displays all topics using a consistent struc­
ture. The SEC guidance will follow a similar topical structure in separate SEC 
sections.
This edition of the guide has not been conformed to the new codification. AICPA 
Audit and Accounting Guides, as well as other AICPA literature, will be con­
formed to reflect the codification after the verification phase and upon formal 
approval by FASB.
Defining Professional Requirements
AU section 120, Defining Professional Requirements in Statements on Au­
diting Standards, and AT section 20, Defining Professional Requirements in
(footnote continued)
significant provisions, the conforming amendments remove the GAAP hierarchy from the PCAOB's 
interim Auditing Standards.
In response to FASB's release of the exposure draft of Statement No. 162 in April 2005, the 
AICPA issued an exposure draft of a proposed SAS, Amendment to Statement on Auditing Standards 
No. 69, The Meaning of Present Fairly in Conformity with Generally Accepted Accounting Principles, 
for Nongovernmental Entities, in May 2005 that deletes the GAAP hierarchy for nongovernmental 
entities from SAS No. 69. The effective dates of the AICPA, FASB, and PCAOB standards will 
coincide. For more information, please visit the FASB Web site at www.fasb.org.
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Standards, vol. 1), which were issued in December 2005, set forth the mean­
ing of certain terms used in SASs and Standards for Attestation Engagements 
(SSAEs), respectively, issued by the ASB in describing the professional require­
ments imposed on auditors and practitioners. The specific terms used to define 
professional requirements in these sections are not intended to apply to inter­
pretive publications issued under the authority of the ASB because interpretive 
publications are not auditing or attestation standards. It is the ASB's intention 
to make conforming changes to the interpretive publications over the next sev­
eral years to remove any language that would imply a professional requirement 
where none exists.
In December 2007, the Accounting and Review Services Committee (ARSC) 
also issued AR section 20, Defining Professional Requirements in Statements 
on Standards for Accounting and Review Services (AICPA, Professional Stan­
dards, vol. 2), which sets forth the meaning of certain terms used in Statements 
on Standards for Accounting and Review Services (SSARS) issued by the ARSC 
in describing the professional requirements imposed on accountants perform­
ing a compilation or review of a nonissuer. The specific terms used to define 
professional requirements in this section are not intended to apply to interpre­
tive publications issued under the authority of the ARSC because interpretive 
publications are not SSARSs. It is the ARSC's intention to make conforming 
changes to the interpretive publications to remove any language that would 
imply a professional requirement where none exists.
AU section 120, AT section 20, and AR section 20, which were effective upon is­
suance, define the terminology that the ASB and ARSC will use going forward 
to describe the degree of responsibility that the requirements impose on the 
auditor, practitioner, or accountant in engagements performed for nonissuers. 
SASs, SSAEs, and SSARSs will use the words must or is required to indicate 
an unconditional requirement, with which the auditor, practitioner, or accoun­
tant is required to comply. SASs, SSAEs, and SSARSs will use the word should 
to indicate a presumptively mandatory requirement. The auditor, practitioner, 
or accountant is required to comply with a presumptively mandatory require­
ment in all cases in which the circumstances exist to which the presumptively 
mandatory requirement applies; however, in rare circumstances, the auditor, 
practitioner, or accountant may depart from a presumptively mandatory re­
quirement provided he or she documents the justification for the departure and 
how the alternative procedures performed in the circumstances were sufficient 
to achieve the objectives of the presumptively mandatory requirement. If a SAS, 
SSAE, or SSARS provides that a procedure or action is one that the auditor, 
practitioner, and accountant "should consider," the consideration of the proce­
dure or action is presumptively required, whereas carrying out the procedure 
or action is not.
This guide has been updated as applicable for AU section 120, AT section 20, 
and AR section 20. Refer to the schedule of changes (appendix K) for additional 
information.
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Guidance Considered in This Edition
This guide has been modified by the AICPA staff to include certain changes 
necessary due to the issuance of authoritative pronouncements since the guide 
was originally issued. Relevant guidance contained in official pronouncements 
issued through May 1, 2008, has been considered in the development of this 
edition of the guide. This includes relevant guidance issued up to and including 
the following:
• FASB Statement No. 161, Disclosures about Derivative Instru­
ments and Hedging Activities—an amendment o f FASB Statement 
No. 133
• Revised FASB statements issued through May 1, 2008, including 
FASB Statement No. 141(R), Business Combinations
• FASB Interpretation No. 48, Accounting for Uncertainty in Income 
Taxes—an interpretation o f FASB Statement No. 109
• FASB Technical Bulletin 01-1, Effective Date for Certain Financial 
Institutions o f Certain Provisions o f Statement 140 Related to the 
Isolation o f Transferred Financial Assets
• FASB EITF consensus ratified by FASB through May 1, 2008
• FASB Staff Positions issued through May 1, 2008
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• FASB Derivatives Implementation Group Statement 133 Imple­
mentation Issues cleared by FASB through May 1, 2008
• GASB Statement No. 52, Land and Other Real Estate Held as 
Investments by Endowments
• GASB Interpretation No. 6, Recognition and Measurement o f Cer­
tain Liabilities and Expenditures in Governmental Fund Finan­
cial Statements—an interpretation o f  NCGA Statements 1, 4, and 
5; NCGA Interpretation 8; and GASB Statements No. 10, 16, and 
18
• GASB Technical Bulletin 2006-1, Accounting and Financial Re­
porting by Employers and OPEB Plans for Payments from the Fed­
eral Government Pursuant to the Retiree Drug Subsidy Provisions 
o f Medicare Part D
• GASB 2007-2008 Comprehensive Implementation Guide as of 
June 30, 2007
• AICPA Statement of Position (SOP) 07-1, Clarification o f  the Scope 
o f the Audit and Accounting Guide Investment Companies and 
Accounting by Parent Companies and Equity Method Investors for 
Investments in Investment Companies (AICPA, Technical Practice 
Aids, ACC sec. 10,930)
• AICPA Practice Bulletin (PB) No. 15, Accounting by the Issuer o f  
Surplus Notes (AICPA, Technical Practice Aids, PB sec. 12,150)
• AICPA SAS No. 114, The Auditor's Communication With Those 
Charged With Governance (AICPA, Professional Standards, vol. 
1, AU sec. 380)
• Auditing Interpretation No. 1, "Communicating Deficiencies in In­
ternal Control Over Compliance in an Office of Management and 
Budget (OMB) Circular A-133 Audit" of AU section 325, Commu­
nicating Internal Control Related Matters Identified in an Audit 
(AICPA, Professional Standards, vol. 1, AU sec. 9325 par. .01-.04)
• SOP 07-2, Attestation Engagements That Address Specified Com­
pliance Control Objectives and Related Controls at Entities That 
Provide Services to Investment Companies, Investment Advisers, 
or Other Service Providers (AICPA, Technical Practice Aids, AUD 
sec. 14,430)
• SSAE No. 14, SSAE Hierarchy (AICPA, Professional Standards, 
vol. 1, AT sec. 50)
• Auditing Interpretation No. 6, "Reporting on Attestation Engage­
ments Performed in Accordance With Government Auditing Stan­
dards" of AT section 101, Attest Engagements (AICPA, Professional 
Standards, vol. 1, AT sec. 9101 par. .56-.58)
• SSARS No. 17, Omnibus Statement on Standards for Account­
ing and Review Services—2008 (AICPA, Professional Standards, 
vol. 2)
• Accounting and Review Services Interpretation No. 29, "Report­
ing on an Uncertainty, Including an Uncertainty About an Entity's 
Ability to Continue as a Going Concern" of AR section 100, Compi­
lation and Review o f Financial Statements (AICPA, Professional 
Standards, vol. 2, AR sec. 9100 par. .120-.129)
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• PCAOB Auditing Standard No. 5, An Audit o f Internal Control 
Over Financial Reporting That Is Integrated with An Audit o f  
Financial Statements (AICPA, PCAOB Standards and Related 
Rules, Rules of the Board, "Standards")
Users of this guide should consider pronouncements issued subsequent to those 
listed above to determine their effect on entities covered by this guide. In de­
termining the applicability of a pronouncement, its effective date should also 
be considered.
The changes made to this edition of the guide are identified in appendix K. The 
changes do not include all those that might be considered necessary if the guide 
were subjected to a comprehensive review and revision.
This edition includes SOP 98-2, Accounting for Costs o f  Activities o f Not-for- 
Profit Organizations and State and Local Governmental Entities That Include 
Fund Raising (appendix C); SOP 99-1, Guidance to Practitioners in Conduct­
ing and Reporting on an Agreed-Upon Procedures Engagement to Assist Man­
agement in Evaluating the Effectiveness o f Its Corporate Compliance Program 
(appendix D); SOP 00-1, Auditing Health Care Third-Party Revenues and Re­
lated Receivables (appendix E); and SOP 02-2, Accounting for Derivative Instru­
ments and Hedging Activities by Not-for-Profit Health Care Organizations, and 
Clarification o f the Performance Indicator (appendix F). In using this guide, 
readers should refer to the material in these SOPs.
Auditing Guidance Included in This Guide
Risk Assessment Standards
In March 2006, the ASB issued SAS Nos. 104-111 (the risk assessment stan­
dards). Collectively, the risk assessment standards establish standards and 
provide guidance concerning the auditor's assessment of the risks of material 
misstatement (whether caused by fraud or error) in a nonissuer financial state­
ment audit; design and performance of tailored audit procedures to address 
assessed risks; audit risk and materiality; planning and supervision; and audit 
evidence. The most significant changes to existing practice that the auditor will 
be required to perform are as follows:
• Obtain a more in-depth understanding of the audited entity and 
its environment, including its internal control
• Perform a more rigorous assessment of the risks of where and how 
the financial statements could be materially misstated (defaulting 
to a maximum control risk is not acceptable)
• Provide a linkage between the auditor's assessed risks and the na­
ture, timing, and extent of audit procedures performed in response 
to those risks
The statements are effective for audits of financial statements for periods be­
ginning on or after December 15, 2006. Early adoption is permitted. See appen­
dix J in this guide for a more detailed comparison between the risk assessment 
standards and the existing standards. This guide has been conformed to the 
new risk assessment standards.
For additional guidance on the risk assessment standards, please refer to the 
AICPA Audit Guide Assessing and Responding to Risk in a Financial Statement
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Audit (product no. 012456) and the AICPA Audit Risk Alert Understanding the 
New Auditing Standards Related to Risk Assessment (product no. 022526).
Defining Professional Requirements
As previously stated, this guide has been conformed, as applicable, to the stan­
dards found in AU section 120, AT section 20, and AR section 20, which were 
effective upon issuance (December 2005, except for AR section 20, which was 
issued in December 2007). These new standards define the terminology that 
the ASB and ARSC will use going forward to describe the degree of responsi­
bility that the requirements impose on the auditor, practitioner, or accountant 
in engagements performed for nonissuers. Refer to the schedule of changes, 
appendix K, for additional information.
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Preface
Purpose
This guide has been prepared to assist providers of health care services in 
preparing financial statements in conformity with generally accepted account­
ing principles (GAAP) and to assist independent auditors1 in auditing and re­
porting on those financial statements.
Applicability
This guide applies to health care organizations that are either (a) investor- 
owned businesses or (6) not-for-profit enterprises that have no ownership in­
terest and are essentially self-sustaining from fees charged for goods and ser­
vices, as defined in Financial Accounting Standards Board (FASB) Statement of 
Financial Accounting Concepts No. 4, Objectives o f Financial Reporting by Non­
business Organizations, paragraph 8,1 2 or (c) governmental. This guide applies 
to organizations whose principal operations consist of providing or agreeing to 
provide health care services and that derive all or almost all of their revenues 
from the sale of goods or services; it also applies to organizations whose primary 
activities are the planning, organization, and oversight of such organizations, 
such as parent or holding companies of health care providers.
This guide applies to the following types of health care organizations:
• Clinics, medical group practices, individual practice associations, 
individual practitioners, emergency care facilities, laboratories, 
surgery centers, and other ambulatory care organizations
• Continuing care retirement communities
• Health maintenance organizations and similar prepaid health 
care plans
• Home health agencies
• Hospitals
• Nursing homes that provide skilled, intermediate, and less inten­
sive levels of health care
• Drug and alcohol rehabilitation centers and other rehabilitation 
facilities
This guide also applies to integrated delivery systems that include one or more 
of the above types of organizations.
This guide does not apply to voluntary health and welfare organizations, as 
defined in FASB Statement No. 117, Financial Statements o f Not-for-Profit Or­
ganizations. These organizations should follow the AICPA Audit and Account­
ing Guide Not-for-Profit Organizations. Related fund-raising foundations that 
meet the definition of a not-for-profit organization given in FASB Statement
1 A member performing an attest engagement must be independent pursuant to Rule 101, In­
dependence (AICPA, Professional Standards, vol. 2, ET sec. 101), of the AICPA Code of Professional 
Conduct. Other applicable independence rules and regulations may also apply to members and ac­
countants while performing attest engagements (for example, Securities and Exchange Commission 
(SEC), Public Company Accounting Oversight Board (PCAOB), Government Accountability Office, 
and state licensing boards).
2 See paragraph 1.03 of this guide.
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No. 117 also should follow the AICPA Audit and Accounting Guide Not-for- 
Profit Organizations.
When separate financial statements are issued for a state or local governmental 
health care organization that uses enterprise fund accounting and reporting, 
the accounting, reporting, and disclosure requirements set forth in this guide 
and by pronouncements of the Governmental Accounting Standards Board 
(GASB) apply. (See chapter 1 for a discussion of the application of GAAP.) GASB 
Statement No. 34, Basic Financial Statements—and Management's Discussion 
and Analysis—for State and Local Governments, replaces the previous defini­
tion with a new definition of enterprise funds. Based on paragraph 67 of GASB 
Statement No. 34, as amended, any activity that charges a fee to external users 
for goods or services may be reported as an enterprise fund. In addition, para­
graph 67 requires governments to report activities in enterprise funds if any 
one of the following three criteria, as summarized below, is met:
(а) The activity is financed with debt that is secured solely by a pledge 
of the net revenues from fees and charges of the activity.
(b) Laws or regulations require the activity's costs of providing ser­
vices, including capital costs, to be recovered with fees and charges 
rather than with taxes or similar revenues.
(c) The pricing policies of the activity establish fees and charges that 
are designed to recover the activity's costs of providing services, 
including capital costs.
The primary focus of these criteria is on fees charged to external users. Also, 
paragraph 67 of GASB Statement No. 34 requires that these criteria should be 
applied in the context of the activity's principal revenue sources.
This guide is not the only industry-specific AICPA Audit and Accounting Guide 
that auditors should consider when performing an audit of a governmental 
health care entity. The Audit and Accounting Guide State and Local Govern­
ments, includes governmental health care entities in its scope and was cleared 
by the GASB. Therefore, certain accounting and financial reporting guidance 
in that guide constitutes category (6) guidance for governmental health care 
entities, and the auditing guidance in that guide should also be considered dur­
ing an audit of a governmental health care entity that is included in the scope 
of this guide. In practice, auditors of governmental health care entities that 
issue separate financial statements using enterprise fund accounting and re­
porting may use this guide as the primary source of guidance because this guide 
addresses transactions that are unique to or prevalent in the health care indus­
try. The Audit and Accounting Guide State and Local Governments, however, 
contains information about governmental accounting and financial reporting 
standards and other matters that are unique to or prevalent in government 
and not included in this guide.3
Many governmental health care entities are considered to be special-purpose 
governments as defined in GASB Statement No. 34, paragraph 134.4 Special- 
purpose governments are legally separate entities, as that term is described in
3 See paragraphs 1.21 and 12.11-.13 in the Audit and Accounting Guide State and Local Gov­
ernments.
4 Governmental Accounting Standards Board (GASB) Statement No. 34, Basic Financial 
Statements—and Management's Discussion and Analysis—for State and Local Governments, does 
not provide guidance on separate reporting by individual enterprise funds of a government. Although 
this discussion of the guidance in GASB Statement No. 34 is written in terms of special-purpose
(continued)
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paragraph 15 of GASB Statement No. 14, The Financial Reporting Entity. They 
may be component units of another governmental entity or they may be other 
stand-alone governments. (Both terms component units and other stand-alone 
governments are also defined by GASB Statement No. 14.) Because GASB State­
ment No. 34 is written from the perspective of general-purpose governments, 
paragraph 138 of GASB Statement No. 34 discusses how those requirements 
apply to special-purpose governments engaged only in business-type activities, 
such as certain governmental health care entities. Governmental health care 
entities that are special-purpose governments engaged only in business-type 
activities should present only the financial statements required for enterprise 
funds. These financial statements are discussed further in paragraph 1.13 of 
this guide.
Limitations
This guide does not discuss the application of all GAAP and all generally ac­
cepted auditing standards (GAAS) that are relevant to the preparation and au­
dit of financial statements of health care organizations. The guide is directed 
primarily to those aspects of the preparation and audit of health care organiza­
tions' financial statements that may be unique to those organizations or areas 
considered particularly significant to them.
Public Accounting Firms Registered With the Public Company 
Accounting Oversight Board
Subject to the Securities and Exchange Commission (SEC) oversight, Section 
103 of the Sarbanes-Oxley Act o f  2002 authorizes the Public Company Account­
ing Oversight Board (PCAOB) to establish auditing and related attestation, 
quality control, ethics, and independence standards to be used by registered 
public accounting firms in the preparation and issuance of audit reports as re­
quired by the act or the rules of the SEC. Accordingly, public accounting firms 
registered with the PCAOB are required to adhere to all PCAOB standards in 
the audits of issuers, as defined by the act, and other entities when prescribed 
by the rules of the SEC.
References to Professional Standards
In citing the professional standards, references are made to the AICPA Pro­
fessional Standards publication. In those sections of the guide where specific 
PCAOB Auditing Standards are referred to, references are made to the AICPA's 
PCAOB Standards and Related Rules publication. Please refer to appendix I 
of this guide for a summary of major existing differences between AICPA 
standards and PCAOB standards. Additionally, when referencing professional 
standards, this guide cites section numbers and not the original statement 
number, as appropriate. For example, Statement on Auditing Standards (SAS) 
No. 54 is referred to as AU section 317.
(footnote continued)
business-type activities that are governmental health care entities, the accounting, financial re­
porting, and auditing considerations are usually equally applicable when the health care activity is 
conducted as a function or program of a general-purpose government and reported in an enterprise 
fund. See footnote 7 to the section heading "Specific Guidance for Special-Purpose Governments" in 
chapter 12 of the Audit and Accounting Guide State and Local Governments. Reporting guidance 
on separate reporting by individual enterprise funds of a government is provided in the Audit and 
Accounting Guide State and Local Governments.
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Other Literature
This guide incorporates certain provisions of FASB Statements No. 116, Ac­
counting for Contributions Received and Contributions Made, No. 117, Finan­
cial Statements o f Not-for-Profit Organizations, No. 124, Accounting for Certain 
Investments Held by a Not-for-Profit Organizations, No. 136, Transfers o f As­
sets to a Not-for-Profit Organization or Charitable Trust That Raises or Holds 
Contributions for Others, GASB Statement No. 33, Accounting and Financial 
Reporting for Nonexchange Transactions, as amended, and GASB Statement 
No. 34 and related pronouncements. Not all guidance included in those state­
ments, however, is incorporated, repeated, or summarized in this guide. Ac­
cordingly, those statements, and all authoritative guidance,5 should be read in 
conjunction with this guide.
This guide supersedes the AICPA Audit and Accounting Guide Audits o f  
Providers o f Health Care Services. This guide also incorporates and supersedes 
AICPA Statements of Position (SOP) 89-5, Financial Accounting and Reporting 
by Providers o f  Prepaid Health Care Services, 90-8, Financial Accounting and 
Reporting by Continuing Care Retirement Communities, and 94-2, The Appli­
cation o f  the Requirements o f Accounting Research Bulletins, Opinions o f the 
Accounting Principles Board, and Statements and Interpretations o f the Finan­
cial Accounting Standards Board to Not-for-Profit Organizations.
Office of Management and Budget (OMB) Circular A-133, Audits o f States, Lo­
cal Governments, and Non-Profit Organizations, sets forth audit requirements 
for health care organizations expending federal awards. Institutions covered 
by OMB Circular A-133 include not-for-profit hospitals, public hospitals, and 
institutions of higher education, and their affiliated hospitals, voluntary health 
and welfare organizations, and other community-based organizations.6 Audi­
tors of health care organizations that are subject to the audit requirements 
of OMB Circular A-133 should refer to the Audit Guide Government Auditing 
Standards and Circular A-133 Audits.
Effective Date and Transition
The provisions of this guide, other than those included in paragraphs 1.41-.52, 
which are discussed below, are effective for financial statements for periods 
beginning after June 1 5 , 1996.7 Earlier application is permitted.
The provisions included in paragraphs 1.41-.52 are effective for financial state­
ments issued for fiscal years beginning after December 15, 1994, except for
5 Other professional literature and authoritative guidance includes statements issued by the 
AICPA Accounting Standards Executive Committee (AcSEC) and the Financial Accounting Stan­
dards Board (FASB), including its Emerging Issues Task Force (EITF). Authoritative literature for 
governmental health care entities includes GASB pronouncements, FASB and AICPA pronounce­
ments specifically made applicable to state and local governmental entities by the GASB, and AICPA 
Audit and Accounting Guides, Industry Audit Guides, Statements of Position, and Practice Bulletins 
made applicable to governmental entities and cleared by the GASB.
6 The Codification of Office of Management and Budget (OMB) Circular A-133 by the U.S. De­
partment of Health and Human Services (HHS) also includes audit requirements for commercial 
organizations (including for-profit hospitals) that receive federal awards under HHS programs. Gen­
erally, the organization has two options regarding audits: (1)a  financial-related audit of a particular 
award in accordance with Government Auditing Standards, or (2) an audit that meets the require­
ments of OMB Circular A-133. See Title 45, Public Welfare, of the Code of Federal Regulations Section 
74.26(d) for further information.
7 This guide does not defer the effective date of any pronouncements that cover not-for-profit 
organizations.
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organizations with less than $5 million in total assets and less than $1 million 
in annual expenses. For those organizations, the effective date is fiscal years 
beginning after December 1 5 , 1995. Earlier application is permitted.
Unless the provisions of this guide, other than those included in paragraphs 
1.41-.52, are applied retroactively under the provisions of the following para­
graph, the effect of initially applying this guide shall be reported as the effect of 
a change in accounting principle, in a manner similar to the cumulative effect of 
a change in accounting principle (Accounting Principles Board [APB] Opinion 
No. 20, Accounting Changes, paragraph 19). The amount of the cumulative ef­
fect should be based on a retroactive computation. A not-for-profit organization 
should report the cumulative effect of a change in accounting on each class of net 
assets in the statement of activities between the captions extraordinary items, 
if any, and change in unrestricted net assets, change in temporarily restricted 
net assets, and change in permanently restricted net assets. The cumulative ef­
fect on temporary and permanently restricted net assets should be reflected 
in the statement of changes in net assets. An investor-owned business should 
report the amount of the cumulative effect in the income statement between 
the captions extraordinary items and net income (APB Opinion No. 20 para­
graph 20).
This guide, other than the guidance in paragraphs 1.41-.52, may be applied 
retroactively by restating the opening net assets for the earliest year presented 
or for the year this guide is first applied if no prior years are presented. In the 
period in which this guide is first applied, that organization should disclose the 
nature of any restatement and its effect on the change in net assets for each 
period presented. An investor-owned business should account for any restate­
ment as a change in accounting principle applied retroactively (APB Opinion 
No. 20 paragraphs 27-28).
In implementing the guidance in paragraphs 1.41-.52, which incorporates the 
provisions of SOP 94-2 into this guide, the transition rules of the APB Opin­
ions and FASB statements adopted, other than their effective dates, should be 
followed. However, if there is more than one change in accounting principle as 
a result of applying the guidance in paragraphs 1.41-.52, organizations have 
the option of including the cumulative effect of adopting those accounting prin­
ciples in the statement of activity or similar statement in the year this guide 
is adopted, regardless of the transition rules of the APB Opinions and FASB 
statements adopted,8 and the financial statements should disclose the nature 
of the cumulative adjustment. (Paragraphs 19-20 of APB Opinion No. 20 dis­
cuss reporting the cumulative effects of changes in accounting principles.) In 
circumstances in which there is more than one change in accounting principle 
resulting from applying this guide and the cumulative effect of adopting those 
accounting principles is included in the statement of activity or similar state­
ment in the year the guidance in paragraphs 1.41-.52 is adopted, this guide 
does not require the pro forma disclosures required by paragraphs 19(d) and 
21 of APB Opinion No. 20.
8 Organizations that adopt the guidance in paragraphs 1.41-.52 of this guide in the same year in 
which they adopt FASB Statement No. 116, Accounting for Contributions Received and Contributions 
Made, are permitted to apply the provisions of paragraph 17 of that statement, concerning recognition 
of expirations of restrictions, prospectively, as specified in that statement, regardless of whether they 
report the cumulative effect of adopting other accounting principles as a result of applying the guidance 
in paragraphs 1.41-.52 of this guide.
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Applicability of Requirements of the Sarbanes-Oxley Act of 2002
Publicly held companies and other issuers (see definition below) are subject to 
the provisions of the Sarbanes-Oxley Act of 2002 and related SEC regulations 
implementing the act. Their outside auditors are also subject to the provisions 
of the act and to the rules and standards issued by the PCAOB.
Presented below is a summary of certain key areas addressed by the act, 
the SEC, and the PCAOB that are particularly relevant to the preparation 
and issuance of an issuer's financial statements and the preparation and is­
suance of an audit report on those financial statements. However, the provi­
sions of the act, the regulations of the SEC, and the rules and standards of 
the PCAOB are numerous and are not all addressed in this section or in this 
guide.
Definition o f an issuer. The act states that the term issuer means an issuer (as 
defined in Section 3 of the Securities Exchange Act of 1934 (15 U.S.C. 78c)), 
the securities of which are registered under Section 12 of that act (15 U.S.C. 
781), or that is required to file reports under Section 15(d) (15 U.S.C. 78o(d)), or 
that files or has filed a registration statement that has not yet become effective 
under the Securities Act of 1933 (15 U.S.C. 77a et seq.), and that it has not 
withdrawn.
Issuers, as defined by the act, and other entities when prescribed by the rules 
of the SEC (collectively referred to in this guide as issuers or issuer) and their 
public accounting firms (who must be registered with the PCAOB) are subject 
to the provisions of the act, implementing SEC regulations, and the rules and 
standards of the PCAOB, as appropriate.
Nonissuers are those entities not subject to the act or the rules of the SEC.
Guidance for Issuers
Management Assessment of Internal Control
As directed by Section 404 of the act, the SEC adopted final rules requiring 
companies subject to the reporting requirements of the Securities Exchange Act 
of 1934, other than registered investment companies and certain other entities, 
to include in their annual reports a report of management on the company's 
internal control over financial reporting.
Companies that are large accelerated filers or accelerated filers, as defined in 
Securities Exchange Act of 1934 Rule 12b-2, were required to comply with these 
rules for fiscal years ending on or after November 15, 2004. Foreign private 
issuers that are large accelerated filers or accelerated filers and that file their 
annual reports on Form 20-F or 40-F must comply with the rules for the first 
fiscal year ending on or after July 15, 2006. Nonaccelerated filers, including 
foreign private issuers that are not accelerated filers, are required to comply 
with the rules for the first fiscal year ending on or after December 15, 2007. See 
the SEC Web site at www.sec.gov for further information.
The SEC rules clarify that management's assessment and report is limited to 
internal control over financial reporting. The SEC's definition of internal con­
trol encompasses the Committee of Sponsoring Organizations of the Treadway 
Commission (COSO) definition but the SEC does not mandate that the entity 
use COSO as its criteria for judging effectiveness.
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The auditor's attestation on the effectiveness of the internal control over finan­
cial reporting is currently required for large accelerated filers and accelerated 
filers. For nonaccelerated filers, the auditor's attestation is required for annual 
reports for fiscal years ending on or after December 15, 2009.*
Select SEC Developments
The SEC posted an Interpretive Release, Commission Guidance Regarding 
Management's Report on Internal Control Over Financial Reporting Under Sec­
tion 13(a) or 15(d) o f the Securities Exchange Act o f 1934, on June 20, 2007, to 
provide guidance for management regarding its evaluation and assessment of 
internal control over financial reporting. This guidance is organized around 
2 broad principles. The first principle is that management should evaluate 
whether it has implemented controls that adequately address the risk that a 
material misstatement of the financial statements would not be prevented or 
detected in a timely manner. This guidance describes a top-down, risk-based ap­
proach to this principle. The second principle is that management's evaluation 
of evidence about the operation of its controls should be based on its assessment 
of risk. This guidance provides an approach for making risk-based judgments 
about the evidence needed for the evaluation.
The SEC also posted a Final Rule, Amendments to Rules Regarding Manage­
ment's Report on Internal Control Over Financial Reporting, on June 20, 2007, 
that provides, among other significant provisions, that a company performing 
an evaluation in accordance with the aforementioned interpretive guidance 
also satisfies the annual evaluation required by Securities Exchange Act of 
1934 Rules 13a-15 and 15d-15. Among other rule changes, the SEC defined the 
term material weakness and revised the requirements regarding the auditor's 
attestation report on the effectiveness of internal control over financial report­
ing to require the auditor to express an opinion directly on the effectiveness of 
internal control over financial reporting and not on management's evaluation 
process.
In a subsequent Final Rule, Definition o f the Term Significant Deficiency, posted 
August 3 , 2007, the SEC defined the term significant deficiency for the purpose 
of implementing Section 302 and Section 404 of the act. By including a definition 
of significant deficiency in SEC rules, in addition to the definition of material 
weakness, the SEC has enabled management to refer to its rules and guidance 
for information on the meaning of these terms rather than referring to the 
auditing standards. Readers should refer to the SEC Web site at www.sec.gov 
for more information.
Guidance for Auditors
The act mandates a number of requirements concerning auditors of issuers, 
including mandatory registration with the PCAOB, the setting of auditing 
standards, inspections, investigations, disciplinary proceedings, prohibited
* On February 1, 2008, the SEC issued Proposed Rule 33-8889 that, if adopted, would amend SEC 
Release No. 33-8760 by deferring for 1 year the auditor attestation requirement for nonaccelerated 
filers required by Section 404(b) of the Sarbanes-Oxley Act of 2002. Under the proposed amendments, 
a nonaccelerated filer would be required to provide the auditor's attestation report on internal control 
over financial reporting in an annual report filed for fiscal years ending on or after December 15, 2009. 
Until then, all nonaccelerated filers would be required to complete only management's assessment 
of internal control over financial reporting. Refer to the SEC Web site at www.sec.gov for further 
developments on this issue.
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Applicability of GAAS and PCAOB Standards
The act authorizes the PCAOB to establish auditing and related attestation, 
quality control, ethics, and independence standards to be used by registered 
public accounting firms in the preparation and issuance of audit reports for en­
tities subject to the act or the rules of the SEC. Accordingly, public accounting 
firms registered with the PCAOB are required to adhere to all PCAOB stan­
dards in the audits of issuers, as defined by the act, and other entities when 
prescribed by the rules of the SEC.
For those entities not subject to the act or the rules of the SEC, the prepara­
tion and issuance of audit reports remain governed by GAAS as issued by the 
Auditing Standards Board.
Select PCAOB Developments
On May 24, 2007, the PCAOB adopted Auditing Standard No. 5, An Audit o f  
Internal Control Over Financial Reporting That Is Integrated with An Audit 
o f Financial Statements (AICPA, PCAOB Standards and Related Rules, Rules 
of the Board, "Standards"), and an independence rule relating to the audi­
tor's provision of internal control-related nonaudit services. Auditing Standard 
No. 5 supersedes PCAOB Auditing Standard No. 2, An Audit o f Internal Control 
Over Financial Reporting Performed in Conjunction With an Audit o f Finan­
cial Statements. The SEC approved the standard on July 25, 2007, and it is 
effective for audits of internal control over financial reporting required by the 
act for fiscal years ending on or after November 15, 2007. Earlier adoption is 
permitted at any point after SEC approval.
Auditing Standard No. 5 is principles-based and is designed to increase the 
likelihood that material weaknesses in internal control will be found before they 
result in material misstatement of a company's financial statements and, at the 
same time, eliminate procedures that are unnecessary. It focuses the auditor on 
the procedures necessary to perform a high quality audit and makes the audit 
scalable so it can change to fit the size and complexity of any company. Readers 
should refer to the PCAOB Web site at www.pcaob.org for more information.
Major Existing Differences Between GAAS and
PCAOB Standards
The major differences between GAAS and PCAOB standards are described in 
both part I of volume one of the AICPA Professional Standards and in part I 
of the AICPA publication titled PCAOB Standards and Related Rules. Please 
refer to appendix I of this guide for a summary of major existing differences 
between AICPA standards and PCAOB standards.
activities, partner rotation, and reports to audit committees, among others. The
PCAOB continues to establish rules and standards implementing provisions of
the act concerning the auditors of issuers.
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Unique Considerations of Health Care Organizations 1
Chapter 1
Unique Considerations o f Health 
Care Organizations
Note: This guide presents auditing guidance to help you implement auditing 
standards included in both AICPA professional standards and in Public Com­
pany Accounting Oversight Board (PCAOB) professional standards. In citing 
the professional standards, references are made to the AICPA's Professional 
Standards publication and the AICPA's PCAOB Standards and Related 
Rules publication, depending upon the applicable professional standards. 
Additionally, when referencing professional standards, this guide cites sec­
tion numbers and not the original statement number, as appropriate. For 
example, Statement on Auditing Standards (SAS) No. 54 is referred to as 
AU section 317.
Overview
1.01 Financial statements of health care organizations should be prepared 
in conformity with generally accepted accounting principles (GAAP). AU sec­
tion 411, The Meaning o f  Present Fairly in Conformity With Generally Ac­
cepted Accounting Principles (AICPA, Professional Standards, vol. 1), provides 
the GAAP hierarchy summary for both nongovernmental and governmental 
organizations.*,1
* In May 2008, the Financial Accounting Standards Board (FASB) issued FASB Statement No. 
162, The Hierarchy of Generally Accepted Accounting Principles, which identifies the sources of ac­
counting principles and the framework for selecting the principles used in the preparation of financial 
statements of nongovernmental entities that are presented in conformity with generally accepted ac­
counting principles (GAAP) in the United States (the GAAP hierarchy). The FASB concluded that the 
GAAP hierarchy should reside in the accounting literature established by the FASB rather than in 
the auditing literature established by the AICPA (for non-Securities and Exchange Commission [SEC] 
registrants) or the Public Company Accounting Oversight Board (PCAOB) (for SEC registrants).
FASB Statement No. 162 carries forward the GAAP hierarchy as set forth in the AICPA's State­
ment on Auditing Standards (SAS) No. 69, The Meaning of Present Fairly in Conformity With Gen­
erally Accepted Accounting Principles (AICPA, Professional Standards, vol. 1, AU sec. 411), subject 
to certain modifications that the FASB does not expect to result in changes to current practice. The 
modifications include, among other changes, the expansion of category (a) accounting principles to 
include, with one exception, all sources of accounting principles that are issued after being subject to 
the FASB's due process (including, but not limited to, FASB Staff Positions and FASB Statement 133 
Implementation Issues, which are currently not addressed in SAS No. 69.) Although certain consensus 
positions of the FASB Emerging Issues Task Force (EITF) have been issued after being subjected to 
the FASB's due process, the FASB decided to carry forward the categorization of EITF consensuses 
as presented in SAS No. 69, which is category (c).
FASB Statement No. 162 does not carry forward the exception permitted in Rule 203, Accounting 
Principles (AICPA, Professional Standards, vol. 2, ET sec. 203), of the AICPA's Code of Professional 
Conduct, that allows departures from the GAAP hierarchy if the member can demonstrate that, due 
to unusual circumstances, the financial statements would otherwise have been misleading. Therefore, 
an entity cannot represent that its financial statements are presented in accordance with GAAP if 
its selection of accounting principles departs from the GAAP hierarchy set forth in FASB Statement 
No. 162, and that departure has a material effect on its financial statements.FASB Statement No. 
162 is effective 60 days following the approval by the SEC of the conforming amendments included in 
PCAOB Auditing Standard No. 6, Evaluating Consistency of Financial Statements, and conforming 
amendments adopted by the PCAOB on January 29, 2008. Among other significant provisions, the 
conforming amendments remove the GAAP hierarchy from the PCAOB's interim Auditing Standards.
In response to the FASB's release of the exposure draft of Statement No. 162 in April 2005, the 
AICPA issued an exposure draft of a proposed SAS, Amendment to Statement on Auditing Standards 
(continued)
AAG-HCO 1.01
2Classification of Health Care Organizations
1.02 Health care enterprises usually can be classified into the following 
categories on the basis of their operating characteristics:
a. Investor-owned health care enterprises. These are owned by in­
vestors or others with a private equity interest and provide goods 
or services with the objective of making a profit.
b. Not-for-profit, business-oriented organizations. These are character­
ized by no ownership interests and essentially are self-sustaining 
from fees charged for goods and services. The fees charged by such 
organizations generally are intended to help the organization main­
tain its self-sustaining status rather than to maximize profits for 
the owner's benefit. Such organizations often are exempt from fed­
eral income taxes and may receive contributions of relatively small 
amounts from resource providers that do not expect commensurate 
or proportionate pecuniary return.
c. Governmental health care organizations. These are public 
corporations* 12 and bodies corporate and politic. Other organizations
Health Care Organizations
(footnote continued)
No. 69, The Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles, 
for Nongovernmental Entities, in May 2005, which deletes the GAAP hierarchy for nongovernmental 
entities from SAS No. 69. The effective dates of the AICPA, FASB, and PCAOB standards will 
coincide.
For more information, please visit the FASB Web site at www.fasb.org and the PCAOB Web site 
at www.pcaob.org.
1 Governmental health care entities only. Governmental Accounting Standards Board (GASB) 
Statement No. 34, Basic Financial Statements—and Management's Discussion and Analysis—for 
State and Local Governments, paragraphs 93-95, indefinitely extend the provisions of GASB State­
ment No. 20, Accounting and Financial Reporting for Proprietary Funds and Other Governmental 
Entities That Use Proprietary Fund Accounting. GASB Statement No. 20 paragraph 6, as amended, 
requires that proprietary funds should apply all applicable GASB pronouncements as well as any 
FASB statements and interpretations, Accounting Principles Board (APB) opinions, and Accounting 
Research Bulletins (ARBs) issued on or before November 30, 1989, that do not conflict with or con­
tradict GASB pronouncements. Furthermore, paragraph 7, as amended, of GASB Statement No. 20 
provides that governmental enterprise funds and activities reported using enterprise fund accounting 
and financial reporting may apply all FASB statements and interpretations issued after November 
3 0 , 1989, that do not conflict with or contradict GASB pronouncements. Entities that choose to apply 
these new FASB pronouncements must apply them on an "all or none" basis (that is, they may not 
select which pronouncements to apply). In addition, GASB Statement No. 29, The Use of Not-for-Profit 
Accounting and Financial Reporting Principles by Governmental Entities, provides that governmen­
tal enterprise funds and activities reported using enterprise fund accounting and financial reporting 
that apply the provisions of paragraph 7, as amended, of GASB Statement No. 20 should apply only 
those FASB statements and interpretations issued after November 30, 1989, that are developed for 
business enterprises (see paragraph 1.54 in this guide). They should not apply FASB statements and 
interpretations whose provisions are limited to not-for-profit organizations, such as FASB Statement 
No. 117, Financial Statements of Not-for-Profit Organizations, or address issues concerning primarily 
such organizations, such as FASB Statement No. 116, Accounting for Contributions Received and Con­
tributions Made. The requirements set forth in this guide for governmental health care enterprises 
generally apply to such enterprises that apply paragraph 7, as amended, of GASB Statement No. 20.
2 Black's Law Dictionary defines a public corporation as: "An artificial person (e.g., [a] munici­
pality or a governmental corporation) created for the administration of public affairs. Unlike a private 
corporation it has no protection against legislative acts altering or even repealing its charter. Instru­
mentalities created by [the] state, formed and owned by it in [the] public interest, supported in whole 
or part by public funds, and governed by managers deriving their authority from [the] state." Sharon 
Realty Co. v. Westlake, Ohio Com.Pl., 188 N.E.2d 318,323,25, O.O.2d 322. "A public corporation is an 
instrumentality of the state, founded and owned in the public interest, supported by public funds and 
governed by those deriving their authority from the state." York County Fair Ass'n v. South Carolina
Tax Commission, 249 S.C. 337, 154 S.E.2d 361, 362.
AAG-HCO 1.02
3
are governmental organizations if they have one or more of the fol­
lowing characteristics:
• Popular election of officers or appointment (or approval) of 
a controlling majority of the members of the organization's 
governing body by officials of one or more state or local 
governments;
• The potential for unilateral dissolution by a government 
with the net assets reverting to a government; or
• The power to enact and enforce a tax levy.
Furthermore, organizations are presumed to be governmental if 
they have the ability to issue directly (rather than through a state 
or municipal authority) debt that pays interest exempt from federal 
taxation. However, organizations possessing only that ability (to is­
sue tax-exempt debt) and none of the other governmental charac­
teristics may rebut the presumption that they are governmental if 
their determination is supported by compelling, relevant evidence.
d. Not-for-profit, nonbusiness-oriented organizations. These are vol­
untary health and welfare organizations (see the glossary) as de­
fined in FASB Statement No. 117, Financial Statements ofNot-for- 
Profit Organizations. Such organizations are within the scope of 
the AICPA Audit and Accounting Guide Not-for-Profit Organiza­
tions rather than this guide.
Unique Considerations of Health Care Organizations
Financial Reporting of Nongovernmental Health
Care Organizations
1.03 The nature of the organization and its operating structure have a 
significant effect on the needs of financial statement users. According to FASB 
Statement of Financial Accounting Concepts (Concepts Statement) No. 4, Ob­
jectives o f Financial Reporting by Nonbusiness Organizations, paragraph 8:
Some organizations have no ownership interests but are essentially 
self-sustaining from fees they charge for goods and services. Examples 
are those private nonprofit hospitals . . . that may receive relatively 
small amounts of contributions and grants but finance their capital 
needs largely from the proceeds of debt issues and their operating 
needs largely from service charges rather than from private philan­
thropy or governmental grants. As a result, assessment of amounts, 
timing, and uncertainty of cash flows becomes the dominant interest of 
their creditors and other resource providers and profitability becomes 
an important indicator of performance. Consequently, the objectives 
of FASB Concepts Statement No. 1, Objectives o f Financial Reporting 
by Business Enterprises, may be more appropriate for those organiza­
tions. [Footnote reference omitted.]
1.04 The financial reporting for not-for-profit, business-oriented organi­
zations and investor-owned health care enterprises generally is consistent ex­
cept for transactions that clearly are not applicable. For example, not-for-profit, 
business organizations would have nothing to report for shareholders' equity. 
On the other hand, investor-owned health care enterprises typically would not 
have anything to report for contributions.
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1.05 The basic financial statements of health care organizations generally 
consist of a balance sheet, a statement of operations, a statement of changes 
in equity (or net assets), a statement of cash flows, and notes to the finan­
cial statements.3 The statement of operations for not-for-profit organizations 
should report a performance indicator (see paragraph 10.20) as well as all other 
changes in unrestricted net assets for the period. The statement of operations 
may be combined with the statement of changes in equity (net assets). Illustra­
tive financial statements are included in appendix A of this guide.
1.06 FASB Statement No. 117 requires not-for-profit organizations to pro­
vide information about the liquidity of assets and liabilities in the balance 
sheet. Health care organizations should classify assets and liabilities as current 
and noncurrent. However, rather than presenting a classified balance sheet, a 
continuing care retirement community (CCRC) instead may sequence assets 
according to their nearness of conversion to cash and may sequence liabilities 
according to the nearness of the maturity and resulting use of cash.
1.07 FASB Statement No. 95, Statement o f Cash Flows, established stan­
dards for cash flow reporting for investor-owned organizations. FASB State­
ment No. 95 was amended by FASB Statement No. 117 to include not-for-profit 
organizations. The statement of cash flows may be prepared using the direct or 
indirect method of reporting cash flows.
1.08 A health care organization may be a part of another organization, 
such as a medical school or a university, or a subsidiary of a corporation. The 
recommendations in this guide apply to the separate financial statements of 
these organizations as defined above.
Financial Reporting of Governmental Health
Care Organizations
1.09 This section of the guide discusses the financial reporting require­
ments applicable to governmental health care entities within the scope of 
this guide, including the financial reporting requirements of Governmen­
tal Accounting Standards Board (GASB) Statement No. 34, Basic Financial 
Statements—and Management's Discussion and Analysis—for State and Lo­
cal Governments, as amended, and GASB Statement No. 38, Certain Financial 
Statement Note Disclosures.†
Health Care Organizations
3 The terms balance sheet and statement of operations indicate the content and purpose of the 
respective statements and serve as possible titles for those statements. Other appropriately descrip­
tive titles may also be used. For example, a statement reporting financial position could be called 
a statement o f financial position as well as a balance sheet. Current practice and purpose suggest, 
however, that a statement of cash flows only be titled "Statement of Cash Flows."
† GASB Statement No. 51, Accounting and Financial Reporting for Intangible Assets, was issued 
in June 2007. The requirements of this statement are effective for financial statements for periods 
beginning after June 15, 2009.
This statement requires that all intangible assets not specifically excluded by its scope provisions 
be classified as capital assets. Accordingly, existing authoritative guidance related to the accounting 
and financial reporting for capital assets should be applied to theses intangible assets, as applicable. 
This statements also provides authoritative guidance that specifically addresses the nature of these 
intangible assets.
GASB Statement No. 52, Land and Other Real Estate held as Investments by Endowments, was 
issued in November 2007. The requirements of this statement are effective for financial statements 
for periods beginning after June 15, 2008.
This statements establishes consistent standards for the reporting of land and other real estate 
held as investments by essentially similar entities. It requires endowments to report their land and 
other real estate investments at fair value.
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1.10 A health care organization may be a part of another organization, 
such as a general-purpose-government or medical school or a university. The 
recommendations in this guide apply to the separate financial statements of 
these organizations. Therefore, when separate financial statements are pre­
pared for a governmental health care organization that uses enterprise fund 
accounting and reporting, the accounting and disclosure requirements set forth 
by GASB pronouncements and this guide apply. The requirements in this guide 
presume that governmental health care organizations apply paragraph 7 of 
GASB Statement No. 20, Accounting and Financial Reporting for Proprietary 
Funds and Other Governmental Entities That Use Proprietary Fund Accounting 
(see footnote 1 to this chapter).
1.11 This guide makes various references to implementation guides pub­
lished by the GASB staff. Those implementation guides are category (d) guid­
ance in the hierarchy of GAAP applicable to state and local governments, as 
discussed in AU section 411 and in paragraph 1.62 in this chapter. References 
to the guidance in GASB staff implementation guides in this guide do not ele­
vate that guidance to category (b) guidance. Similarly, references in this guide 
to discussions or examples in the nonauthoritative appendixes of GASB pro­
nouncements or its staff’s implementation guides do not elevate that guidance 
from "other accounting literature."
1.12 GASB issued Technical Bulletin 2006-1, Recognition and Measure­
ment o f Asbestos-Related Cleanup Costs, in June 2006. This technical bulletin 
is effective immediately, except for portions of answers pertaining specifically 
to measurement, recognition, or required supplementary information require­
ments of GASB Statement No. 43 or No. 45. Those provisions should be applied 
simultaneously with the implementation of GASB Statement No. 43 or No. 45. 
This technical bulletin clarifies the application of existing standards of account­
ing and financial reporting to payments that an employer or a defined benefit 
other postemployment benefit (OPEB) plan receives from the federal govern­
ment pursuant to the retiree drug subsidy provisions o f Medicare Part D, as 
established in the Medicare Prescription Drug, Improvement, and Moderniza­
tion Act of 2003.
GASB Statement No. 34 and Related Pronouncements
1.13 GASB Statement No. 34 and related pronouncements require that 
the separately issued financial reports of governmental health care entities 
that are special-purpose governments engaged only in business-type activities:
• Present a management's discussion and analysis (MD&A) before 
the basic financial statements as required supplementary infor­
mation (RSI).
• Present a classified statement of net assets/balance sheet.
• Report three categories of net assets—(a) net assets invested in 
capital assets net of related debt, (b) restricted net assets, and (c) 
unrestricted net assets.
• Apply the definition of restricted provided in GASB Statement No. 
34 in determining restricted assets and restricted net assets.
Unique Considerations of Health Care Organizations
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• Present a statement of revenues, expenses, and changes in net 
assets/equity that reports on changes in net assets, including per­
manent endowments. The focus of this statement is to present all 
changes in net assets.
• Report transfers as interfund transfers after nonoperating rev­
enues and expenses. Under GASB Statement No. 34, there is no 
distinction as to the type of transfer.
• Report revenues by major source and separately identify revenue 
used as security for revenue bonds.
• Distinguish between operating and nonoperating revenues and 
expenses and provide an intermediate total for operating income 
or loss.
• Separately report capital contributions and contributions to term 
and permanent endowments as components of the all-inclusive 
statement of revenues, expenses, and changes in net assets/equity.
• Separately report special items and extraordinary items at the 
bottom of the statement of revenues, expenses, and changes in net 
assets/equity.
• Report operating cash flows using the direct method in the state­
ment of cash flows,
• Present certain note disclosures, including the entity's policy for 
defining operating revenues and expenses, policy regarding the 
use of restricted resources, schedules of changes in capital as­
sets and long term liabilities, disaggregated information about 
accounts receivable and payable, and short-term debt activity dur­
ing the year. (Disclosure of disaggregated information about ac­
counts receivable and payable is required by GASB Statement 
No. 38.)
• If the entity has segments, present segment information based on 
the definition of a segment in GASB Statement No. 34.
The requirements in this paragraph do not apply to health care units that are 
not legally separate entities.
1.14 GASB Statement No. 34 requires governmental health care entities 
that are special-purpose governments engaged only in business-type activities 
to present three basic financial statements, notes to the financial statements, 
and RSI:4
a. MD&A as RSI.
b. A statement of net assets or balance sheet.
Health Care Organizations
4 GASB Statement No. 34 does not provide guidance on separate reporting by individual enter­
prise funds of a government. Although this discussion of the guidance in GASB Statement No. 34 is 
written in terms of special-purpose business-type activities that are governmental health care enti­
ties, the accounting, financial reporting, and auditing considerations are usually equally applicable 
when the health care activity is conducted as a function or program of a general-purpose govern­
ment and reported in an enterprise fund. See footnote 7 to the section heading "Specific Guidance for 
Special-Purpose Governments" in chapter 12 of the Audit and Accounting Guide State and Local Gov­
ernments. Reporting guidance on separate reporting by individual enterprise funds of a government 
is provided in the Audit and Accounting Guide State and Local Governments.
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c. A statement of revenues, expenses, and changes in net as- 
sets/equity.
d. A statement of cash flows.
e. Notes to financial statements.
f. RSI other than MD&A, as established by GAAP, such as GASB 
Statement No. 27, Accounting for Pensions by State and Local Gov­
ernmental Employers.
Unique Considerations of Health Care Organizations
Management's Discussion and Analysis
1.15 GASB Statement No. 34, paragraphs 8-11, as amended, establish 
eight required elements of MD&A for general-purpose governments. However, 
certain of those elements are not applicable to governmental health care enti­
ties that are special-purpose governments engaged only in business-type activ­
ities. These governmental health care entities should limit their discussion in 
MD&A to the elements that are applicable to their entity. Because it is RSI, no 
additional information should be presented within MD&A.
1.16 Many health care entities that are special-purpose governments 
engaged only in business-type activities present comparative financial state­
ments. When comparative financial statements are presented, MD&A should 
present an analysis of both current- and prior-year net assets and changes 
in them, as discussed in the GASB staff document, Comprehensive Imple­
mentation Guide—2007 (GASB Q&A—2007 Edition), item 7.5.4. (See para­
graph 1.11 in this chapter regarding references in this guide to discussions in 
GASB staff implementation guides.) Two completely separate MD&As are not 
required. When comparative financial statements are presented, the MD&A 
should present the current year, prior year, and preceding year financial in­
formation summarized in the MD&A, and discuss the fluctuations. If com­
parative financial data is presented, as distinguished from a complete set of 
comparative statements, notes, and RSI, the requirements for MD&A in para­
graph 11 of GASB Statement No. 34 should be met for the current year with 
comparisons to the prior year, as discussed in the GASB Q&A—2007 Edition, 
item 7.5.6.
Measurement Focus and Basis of Accounting
1.17 GASB Statement No. 34, paragraph 92, requires activities reported 
using enterprise fund accounting and reporting to use the accrual basis of ac­
counting and the economic resources measurement focus. GASB Statement 
No. 34, paragraphs 93-95, indefinitely extend the provisions of GASB State­
ment No. 20, Accounting and Financial Reporting for Proprietary Funds and 
Other Governmental Entities That Use Proprietary Fund Accounting (see foot­
note 1 to paragraph 1.01 in this chapter). GASB Statement No. 20, as amended, 
requires governmental health care entities that use enterprise fund account­
ing and reporting to apply all GASB pronouncements as well as FASB pro­
nouncements issued on or before November 30, 1989 that do not conflict 
with or contradict GASB pronouncements. In addition, those entities may 
also apply to all FASB statements and interpretations issued after Novem­
ber 30, 1989, except for those that conflict with or contradict GASB pro­
nouncements. Only those FASB statements and interpretations issued after
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November 30, 1989 that are developed for business enterprises should be 
applied, as discussed in GASB Statement No. 29, The Use o f  Not-for-Profit 
Accounting and Financial Reporting Principles by Governmental Entities, para­
graph 7, as amended. GASB Statement No. 34, paragraph 115, requires disclo­
sure in the summary of significant accounting policies of the policy for apply­
ing FASB pronouncements issued after November 30, 1989, to business-type 
activities and to enterprise funds. The requirements in this guide presume 
that governmental health care entities apply paragraph 7 of GASB Statement 
No. 20.
Health Care Organizations
Statement of Net Assets or Balance Sheet
1.18 GASB Statement No. 34, paragraphs 97-99, provide guidance on the 
statement o f net assets or balance sheet. Governmental health care entities 
that are special-purpose governments engaged only in business-type activi­
ties may use either a balance sheet format—assets equal liabilities plus net 
assets/equity—or a net assets format—assets less liabilities equal net as- 
sets/equity. Assets and liabilities are required to be presented in a classified 
format.5
1.19 Either term net assets or equity may be used to refer to the differ­
ence between assets and liabilities. Regardless of the label, net assets/equity 
is required to be reported in three broad components: (a) invested in capital 
assets, net of related debt; (b) restricted, and (c) unrestricted. When permanent 
endowments are reported in restricted net assets, two additional components— 
expendable and nonexpendable are required, as discussed in paragraph 35 of 
GASB Statement No. 34.
1.20 The term restricted is defined by GASB Statement No. 34, paragraph 
34, as amended, and paragraph 99. A restriction is a constraint placed on the 
use of assets or net assets that is either externally imposed (such as by creditors 
through debt covenants) or imposed by law through constitutional provisions or 
enabling legislation. Internally designated net assets should be reported as un­
restricted net assets and should not be displayed separately in the net assets 
section of the statement of net assets/balance sheet, as discussed in paragraph 
37 of GASB Statement No. 34. (Designated assets, however, may be reported 
in the statement of net assets/balance sheet, as discussed in paragraph 3.01 in 
this guide.)
Statement of Revenues, Expenses, and Changes
in Net Assets/Equity
1.21 The operating statement of governmental health care entities that 
are special-purpose governments engaged only in business-type activities is the 
statement o f revenues, expenses, and changes in net assets/equity. Changes in 
both restricted and unrestricted net assets should be reported in this statement 
using an all inclusive format, illustrated in GASB Statement No. 34, paragraph 
101:
5 Guidance regarding the classification of certain specific assets or liabilities can be found in 
the chapters of the guide. For example, see paragraph 4.25 in this guide regarding the reporting of 
securities as current and noncurrent.
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Operating revenues (detailed)
Total operating revenues 
Operating expenses (detailed)
Total operating expenses 
Operating income (loss)
Nonoperating revenues and expenses (detailed)
Income before other revenues, expenses, gains, losses, and transfers
Capital contributions (grant, developer, and other), additions to permanent
and term
endowments, special and extraordinary items (detailed) and transfers
Increase (decrease) in net assets
Net assets—beginning of period
Net assets—end of period
In a change in net assets approach, the increase or decrease in net assets for 
the period and net income are not necessarily the same amount (for example, 
because of capital contributions), as noted in GASB Statement No. 34, para­
graph 433. However, GASB Statement No. 34, paragraph 434, indicates that 
this required format does not preclude governments from presenting differ­
ent subtotals before the comprehensive performance measure—increase (de­
crease) in net assets. (See paragraph 1.11 in this chapter regarding references 
in this guide to discussions in the nonauthoritative appendixes in GASB pro­
nouncements.) The subtotals required by GASB Statement No. 34 must be 
presented.
1.22 As discussed in paragraph 100 and footnote 41 in GASB Statement 
No. 34, governmental health care entities are required to report revenues (net 
of discounts and allowances) by major source and separately identify revenues 
that provide security for revenue bonds. (See further discussion in chapter 10 
of this guide.) As illustrated in paragraph 1.21 of this guide, separate subtotals 
are required for operating revenues, operating expenses and operating income 
(loss). Governmental health care entities are required by GASB Statement No. 
34 paragraph 102 to establish a policy that defines operating revenues and 
expenses that is appropriate to the nature of the activity being reported and to 
disclose that policy in the notes to the financial statements. Factors that may 
be considered in establishing that policy are discussed in chapter 10 of this 
guide.
1.23 Revenues from capital contributions as well as contributions to the 
principal of permanent and term endowments should be reported after nonop­
erating revenues and expenses, as discussed in GASB Statement No. 34, para­
graph 100. Income from permanent or term endowments should be recorded 
as nonoperating revenue, as discussed in the GASB Q&A—2007 Edition, item 
7.74.3. (See paragraph 1.11 in this chapter regarding references in this guide 
to discussions in GASB staff implementation guides.)
1.24 Governmental health care entities that apply paragraph 7 of GASB 
Statement No. 20 should be aware that FASB Statement No. 130, Report­
ing Comprehensive Income, conflicts with the all-inclusive format required by
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GASB Statement No. 34, as discussed in the GASB Q&A—2007 Edition, item 
7.72.1. (See paragraph 1.11 in this chapter regarding references in this guide 
to discussions in GASB staff implementation guides.)
Health Care Organizations
Statement of Cash Flows
1.25 GASB Statement No. 9, Reporting Cash Flows o f Proprietary and 
Nonexpendable Trust Funds and Governmental Entities, established standards 
for cash flow reporting for governmental entities. GASB Statement No. 34, para­
graph 105, requires governmental health care entities that are special-purpose 
governments engaged only in business-type activities to present a statement of 
cash flows using the direct method, discussed in GASB Statement No. 9, para­
graph 31, as amended. A reconciliation of operating income (loss) to operating 
cash flows also should be presented.
Revenue From Health Care Services
1.26 In general, gross service revenue is recorded in the accounting records 
on an accrual basis at the provider's established rates, regardless of whether 
the health care organization expects to collect that amount. Provisions recog­
nizing contractual adjustments and other adjustments (see examples in para­
graph 5.02) are recorded on an accrual basis and deducted from gross service 
revenue to determine net service revenue. For financial reporting purposes, 
gross revenue does not include charity care (see discussion in paragraph 10.03) 
and service revenue is reported net of contractual and other adjustments in 
the statement of operations. Accounting and auditing issues related to re­
ceivables and revenue from health care services are discussed in chapters 5 
and 10.
1.27 In many cases, revenues are generated as a result of an agreement 
to provide health care services rather than from the actual provision of ser­
vices. For example, an integrated delivery system may agree to provide all 
health-related services for a specified group residing within its primary ser­
vice area for an agreed-upon amount per member per month (PMPM). These 
revenues are premium revenues, not patient service revenues, since they are 
earned by agreeing to provide care, regardless of whether services actually are 
rendered.
Third-Party Payor Considerations
1.28 Some third-party payors retrospectively determine final amounts re­
imbursable for services rendered to their beneficiaries based on allowable costs. 
These payors reimburse the health care organization on the basis of interim 
payment rates until the retrospective determination of allowable costs can be 
made. In most instances, the accumulation and allocation of allowable costs 
and other factors result in final settlements different from the interim pay­
ment rates. Final settlements are determined after the close of the fiscal pe­
riods to which they apply and may affect materially the health care organiza­
tion’s financial position and results of operations. Consequently, a reasonable 
estimate of the amount receivable from or payable to these payors should be 
made in the same period that the related services are rendered. Accounting
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chapter 5.
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Classification and Reporting of Net Assets
1.29 Currently, many not-for-profit health care organizations use fund ac­
counting for purposes of internal recordkeeping and managerial control. Many 
individual funds may be established by an organization to help in monitoring 
compliance with donor or grantor restrictions due to the fiduciary accountabil­
ity associated with these resources. Each fund consists of a self-balancing group 
of accounts composed of assets, liabilities, and net assets. Consistent with FASB 
Concepts Statement No. 6, Elements o f Financial Statements, FASB Statement 
No. 117 concluded that although some not-for-profit organizations may choose to 
classify assets and liabilities into fund groups, information about those group­
ings is not a necessary part of general-purpose external financial reporting. 
Although FASB Statement No. 117 does not preclude not-for-profit organiza­
tions from using fund accounting for internal recordkeeping and reporting, for 
purposes of external financial reporting each of the individual internal funds 
must be classified into one or more of the three broad classes of net assets: 
unrestricted net assets, temporarily restricted net assets, and permanently re­
stricted net assets. These classifications are related to the existence or absence 
of donor-imposed restrictions and are discussed in more detail in paragraphs 
1.30-.34 and also chapter 9.
1.30 Unrestricted Net Assets. These represent the part of net assets that 
have not been externally restricted for identified purposes by donors and 
grantors. Unrestricted net assets also include assets whose use is contractu­
ally limited, such as—
• Proceeds of debt issues and funds of the health care organization 
deposited with a trustee and limited to use in accordance with 
the requirements of an indenture or a similar agreement. (See 
paragraph 7.19.)
• Other assets limited to use for identified purposes through an 
agreement between the health care organization and an outside 
party other than a donor or grantor. Examples include assets 
set aside under debt agreements, assets set aside under self- 
insurance (risk-retention) funding arrangements, and assets set 
aside to meet statutory reserve requirements (such as those re­
quired under state law for many health maintenance organiza­
tions [HMOs]). (See paragraph 8.21.)
1.31 Information about significant contractual limits (for example, debt 
covenants and self-insurance trusts) generally is disclosed in the notes to the 
financial statements. Similarly, internally designated funds should be reported 
separately from externally designated funds either on the face of the balance 
sheet or in the notes to the financial statements.
1.32 Temporarily Restricted and Permanently Restricted Net Assets. FASB 
Statement No. 117 defines two classes of donor-restricted net assets: temporar­
ily restricted and permanently restricted. The distinction between these two 
types of restricted net assets is based on the nature of the donor's restriction.
AAG-HCO 1.32
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Temporarily restricted net assets are those donor-restricted net assets that can 
be used by the not-for-profit organization for their specified purpose once the 
donor's restriction is met. Generally, these restrictions are met either by the 
passage of time or by actions taken by the entity, such as use of the funds 
for the purpose intended. Permanently restricted net assets (for example, en­
dowment funds) are those with donor restrictions that do not expire with the 
passage of time and cannot be removed by any actions taken by the entity. All 
donor-restricted net assets must be classified into one of these two broad cate­
gories for external reporting. Not-for-profit organizations may want to further 
classify temporarily and permanently restricted net assets into distinct groups 
that distinguish the nature or purpose of the donor's restriction. Accounting 
and reporting considerations pertaining to gifts and grants that are externally 
restricted for identified purposes by donors and grantors are discussed in para­
graphs 9.04—.06 and 10.08-.15.
1.33 It should be noted that donor restrictions generally relate to limita­
tions on the use of net assets rather than the use of specific assets. According 
to FASB Concepts Statement No. 6, paragraphs 101 and 102:
Restrictions impose responsibilities on management to ensure that 
the organization uses donated resources in the manner stipulated by 
resource providers. Sometimes donor-imposed restrictions limit an or­
ganization's ability to sell or exchange the particular asset received. 
For example, a donor may give a painting to a museum stipulating 
that it must be publicly displayed, properly maintained, and never 
sold.
More commonly, donors' stipulations permit the organization to pool 
the donated assets with other assets and to sell or exchange the do­
nated assets for other suitable assets as long as the economic ben­
efits of the donated assets are not consumed or used for a purpose 
that does not comply with the stipulation. For example, a donor may 
contribute 100 shares o f Security A to an organization's endowment, 
thereby requiring that the amount of the gift be retained permanently 
but not requiring that the specified shares be held indefinitely. Thus, 
permanently restricted net assets and temporarily restricted net as­
sets generally refer to amounts of net assets that are restricted by 
donor-imposed limits, not to specific assets.
1.34 A not-for-profit organization can report separate line items within 
any of the three classes of net assets either on the face of the balance sheet 
or in the notes to the financial statements to further distinguish the nature 
of donor restrictions within that category of net assets. For example, a health 
care organization may want to disclose the amount of temporarily restricted net 
assets restricted for a specific purpose such as indigent care. Further examples 
are provided in paragraph 15 of FASB Statement No. 117. An organization's 
internal fund accounting can be used to account for these different types of 
resources within a specific class of net assets.
Health Care Organizations
Health Care Contracting
1.35 Contracts between a health care provider and a payor based on any­
thing other than full charges require the provider to accept some financial risk.
AAG-HCO 1.33
13
The nature and degree of risk for the provider varies depending on the contract 
terms (for example, the definition of the unit of service or the basis for pay­
ment). In planning the audit of the health care provider, the auditor considers 
the audit risk associated with the entity's health care contracts. For example, 
contracts with payments for services based on a discount from the provider's 
established rates may have different risks than contracts with payments for 
services based on a capitated arrangement.
1.36 Generally, capitation payments are made at the beginning of each 
month and obligate the provider to render covered services during the month. 
Revenue is earned as a result of agreeing to provide services to quali­
fied beneficiaries and not as a result of actually providing the care. If the 
provider's accounting system records patient charges and establishes patient 
receivables as services are rendered, appropriate valuation allowances or 
adjustments should be recorded so only the amount of contract revenue is 
recorded.
1.37 A capitation contract may obligate the provider to assume the risk of 
physician referrals and other outside services. In this case, a liability for unpaid 
claims, including incurred but not reported claims, should be established. A lag 
analysis may be helpful in estimating the liability.
1.38 In addition to the capitation payments, the amount of contract rev­
enue may be affected by factors such as reinsurance recoveries, deductibles, 
coinsurance, and risk pool adjustments. Risk pool adjustments may be based 
on factors such as utilization or cost targets.
1.39 Sometimes health care providers enter preferred provider arrange­
ments with self-insured employers whereby the provider guarantees that the 
employer's health care cost will not increase over a specified amount or per­
centage. In substance, these providers may have provided aggregate stop- 
loss insurance to the self-insured employer, and a material liability to the 
provider may exist. FASB Statement No. 5, Accounting for Contingencies, pro­
vides guidance on accounting for these contingencies. GASB Statement No. 10, 
Accounting and Financial Reporting for Risk Financing and Related Insur­
ance Issues, provides guidance on accounting for contingencies by governmental 
enterprises.
GAAP Hierarchy for Not-for-Profit Organizations*
1.40 AU section 411 states that the guidance provided by FASB statements 
and interpretations, opinions of the Accounting Principles Board (APB), and ac­
counting research bulletins (ARBs) shall be considered established accounting 
principles pursuant to Rule 203, Accounting Principles (AICPA, Professional 
Standards, vol. 2, ET sec. 203), o f the AICPA's Code of Professional Conduct. 
Appendix G (paragraph 1.62) of this chapter discusses AU section 411 and the 
hierarchy of sources of GAAP.
1.41 Not-for-profit organizations should follow the guidance in effective 
provisions of ARBs, APB opinions, and FASB statements and interpretations 
unless the specific pronouncement explicitly exempts not-for-profit organiza­
tions or their subject matter precludes such applicability. As noted in para­
graphs 1.46-.47, not-for-profit organizations should follow the guidance in
Unique Considerations of Health Care Organizations
* See footnote * in paragraph 1.01.
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FASB Statement Nos. 116, Accounting for Contributions Received and Con­
tributions Made; 117; 124, Accounting for Certain Investments Held by Not-for- 
Profit Organizations; 136, Transfers o f Assets to a Not-for-Profit Organization 
or Charitable Trust That Raises or Holds Contributions for Others; and this 
guide in applying the guidance in pronouncements listed in appendixes C and 
D (paragraphs 1.58-.59) of this chapter.
1.42 The appendixes (paragraphs 1.56-.62) of this chapter are aids to the 
implementation of the guidance in this chapter.
1.43 Pronouncements issued by the FASB subsequent to this guide's ef­
fective date apply to not-for-profit organizations unless those pronouncements 
explicitly exempt not-for-profit organizations or their subject matter precludes 
such applicability.6
1.44 Not-for-profit organizations may follow and are not prohibited from 
following the guidance in effective provisions of the APB opinions and the FASB 
statements and interpretations listed in appendix A (paragraph 1.56) of this 
chapter, which specifically exempt not-for-profit organizations from their ap­
plication, unless FASB Statement Nos. 116 or 117 or this guide provide dif­
ferent guidance. (However, the guidance included in the effective provisions of 
pronouncements listed in appendix A [paragraph 1.56] applies to all for-profit 
entities owned, whether owned all or in part, by not-for-profit entities.) The 
discussion in paragraphs 1.46-.52 should be considered in determining the hi­
erarchy of such guidance and of guidance issued by the AICPA.
1.45 Certain financial reporting guidance listed in appendix B (paragraph
1.57) of this chapter, such as that concerning common stock and convertible 
debt, generally does not apply to the kinds of not-for-profit entities covered by 
this guide because such entities do not enter into the kinds of transactions 
covered by that guidance. However, the guidance included in the effective pro­
visions of pronouncements included in appendix B (paragraph 1.57) applies to 
all for-profit entities owned, whether owned all or in part, by not-for-profit en­
tities. Also, not-for-profit organizations should follow the effective provisions of 
pronouncements in appendix B (paragraph 1.57) if they enter into the kinds of 
transactions covered by that guidance.
1.46 Other pronouncements, which are listed in appendix C (paragraph
1.58) of this chapter (ARB No. 51, Consolidated Financial Statements,‡ and APB
Health Care Organizations
6 The guidance in paragraphs 1.40-.52 addresses only the pronouncements listed in paragraph 
1.41. However, not-for-profit organizations are also subject to other pronouncements included in cat­
egories (b)—(d) of paragraph .05 of AU section 411, The Meaning o f Present Fairly in Conformity 
With Generally Accepted Accounting Principles (AICPA, Professional Standards, vol. 1), and should 
apply AICPA Audit and Accounting Guides, Statements of Position (SOPs), and Practice Bulletins 
and FASB Technical Bulletins and the consensus positions of the FASB Emerging Issues Task Force 
(EITF) that apply to them. Appendix G (paragraph 1.62) of this chapter discusses AU section 411 and 
the GAAP hierarchy. Readers should be alert to the issuance of a final FASB statement that would 
move responsibility for the GAAP hierarchy for nongovernmental entities from SAS No. 69 to FASB 
literature, and a final SAS that would delete the GAAP hierarchy for nongovernmental entities from 
SAS No. 69. See footnote * to paragraph 1.01.
‡ In December 2007, FASB issued Statement No. 160, Noncontrolling Interests in Consolidated 
Financial Statements—an amendment o f ARB No. 51. The objective of FASB Statement No. 160 
is to improve comparability and transparency of consolidated financial statements by establishing 
accounting and reporting standards that require:
1. reporting of ownership interest in subsidiaries held by parties other than the parent 
be clearly identified, labeled and presented in the consolidated balance sheet within 
equity but separate from the parent's equity.
(continued)
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Opinion No. 29, Accounting for Nonmonetary Transactions, do not exempt not- 
for-profit organizations from their scope, but the transactions they contemplate 
also are covered by FASB Statement No. 116 and this guide. FASB Statement 
Nos. 116, 117, 124, and 136 and this guide provide guidance for applying the 
pronouncements to circumstances unique to not-for-profit organizations and 
not contemplated by the pronouncements and therefore should be followed to 
apply the guidance in those pronouncements to not-for-profit organizations. 
However, the guidance included in the effective provisions of pronouncements 
included in appendix C (paragraph 1.58) should be followed by all for-profit 
entities owned, whether owned all or in part, by not-for-profit entities.
1.47 Some pronouncements (listed in appendix D [paragraph 1.59] of this 
chapter), which may include guidance concerning the recognition and measure­
ment of assets, liabilities, revenues, expenses, gains and losses, and financial 
statement display, state that their provisions apply only to entities operating 
in certain industries. Such entities generally are business enterprises. An ex­
ample of such guidance is FASB Statement No. 63, Financial Reporting by 
Broadcasters. However, some not-for-profit organizations conduct activities* 7 in 
some of those industries and should apply the guidance in the pronouncements 
concerning the recognition and measurement of assets, liabilities, revenues, 
expenses, and gains and losses to the transactions unique to those industries. 
However, such not-for-profit organizations should follow the financial state­
ment display guidance in FASB Statement No. 117 and this guide, even though 
it may conflict with display that would result from applying the guidance in the 
pronouncements listed in appendix D (paragraph 1.59).
1.48 Financial reporting pronouncements that have not been superseded 
and are not included in appendixes A-D  (paragraphs 1.56-.58) of this chapter 
are listed in appendix E (paragraph 1.60) of this chapter. Not-for-profit organi­
zations should follow the effective provisions of the pronouncements listed in 
appendix E (paragraph 1.60).8
1.49 Certain other pronouncements, although they do not exempt not-for- 
profit organizations and do cover transactions conducted by not-for-profit orga­
nizations, include some provisions whose application by not-for-profit organiza­
tions may be unclear. Nevertheless, not-for-profit organizations are required to 
follow the effective provisions of those pronouncements. These provisions and 
their applicability are discussed in the following paragraphs.
Unique Considerations of Health Care Organizations
(footnote continued)
2. consolidated net income should clearly identify the portion of income attributable to 
the parent and the noncontrolling interest on the face of the income statement.
3. changes in ownership interest should be accounted for consistently.
4. when a subsidiary is deconsolidated, any retained noncontrolling equity investment 
in the former subsidiary should be measured at fair value.
5. entities should provide all appropriate disclosures to distinguish between interest of 
the parent and the interests of the noncontrolling owners.
FASB Statement No. 160 is effective for fiscal years beginning on or after December 15, 2008. Early 
adoption is prohibited. FASB Statement No. 160 should be applied prospectively as of the beginning of 
the fiscal year in which the statement is initially adopted. Presentation and disclosure requirements 
shall be applied retrospectively for all periods presented.
7 Such activities may be conducted by (a) for-profit entities owned and consolidated by not-for- 
profit organizations, (b) divisions of not-for-profit organizations, or (c) entire not-for-profit organiza­
tions.
8 See footnote 6.
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APB Opinion No. 16, Business Combinations||
1.50 Because the conditions for applying the pooling of interests method of 
accounting for a business combination generally include an exchange of common 
stock of the combining entities, not-for-profit organizations generally would not 
meet the conditions for applying that method. The AICPA Accounting Stan­
dards Executive Committee (AcSEC) believes that circumstances exist under 
which reporting on the combination of two or more not-for-profit organizations 
(or that of a not-for-profit organization with a formerly for-profit entity) by the 
pooling of interests method better reflects the substance of the transaction than 
reporting by the purchase method. Therefore, not-for-profit organizations are, 
under certain circumstances, permitted to report by the pooling of interests 
method, even though they generally do not issue common stock. Such circum­
stances include the combination of two or more entities to form a new entity 
without the exchange of consideration. See paragraph 11.38 for further guid­
ance.
1.51 An example of acceptable practice, in some circumstances, for report­
ing business combinations by not-for-profit organizations if there has been no 
exchange of consideration is to report the (a) assets, (b) liabilities, and (c) net 
asset balances of the combined entities as of the beginning of the year and dis­
close the information that would be required to be disclosed for a pooling of 
interests under APB Opinion No. 16.
Health Care Organizations
|| In June 2001, the FASB issued FASB Statement No. 141, Business Combinations, which su­
persedes several pronouncements including APB Opinion No. 16, Business Combinations. However, 
FASB Statement No. 141 does not apply to certain combinations, including a combination involving 
two or more not-for-profit organizations or the acquisition of a for-profit business entity by a not-for- 
profit organization. For those combinations, the guidance in APB Opinion No. 16 still applies. Thus, 
GAAP does not change for those types of combinations. Not-for-profit health care organizations should 
continue to follow the guidance in this guide and in APB Opinion No. 16, as amended by pronounce­
ments prior to the issuance of FASB Statement No. 141. Pronouncements that were amended by FASB 
Statement No. 141 should be applied by those entities as though that statement had not amended 
them. In addition, in applying the guidance included in APB Opinion No. 16, not-for-profit health care 
organizations should continue to apply the amendments to that opinion that were included in FASB 
Statement No. 121, Accounting for the Impairment o f Long-Lived Assets and for Long-Lived Assets 
to Be Disposed Of, even though FASB Statement No. 121 was superseded by FASB Statement No. 
144, Accounting for the Impairment or Disposal of Long-Lived Assets. (FASB Statement No. 144 did 
not carry forward those amendments to APB Opinion No. 16 because APB Opinion No. 16 had been 
superseded.)
In December 2007, FASB issued Statement No. 141 (revised 2007), Business Combinations. The 
objective of FASB Statement No. 141(R) is to improve the relevance and representative faithfulness of 
an entity’s financial statements when reporting a business combination. FASB Statement No. 141(R) 
establishes the following requirements:
1. Use the acquisition method of accounting for all business combinations.
2. Recognize and measure goodwill acquired in a business combination, or from a bargain 
purchase.
3. Determine what information to disclose to enable users of the financial statements to 
evaluate the nature and financial effects of the combination.
FASB Statement No. 141(R) defines the key terms associated with a business combination, for exam­
ple, acquiree. The statement also requires entities to record assets acquired and liabilities assumed 
as a result of a business combination at fair value, as defined by FASB Statement No. 157, Fair Value 
Measurements. The effective date of FASB Statement No. 141(R) is for fiscal years beginning on or 
after December 15, 2008, with early adoption prohibited.
Also, FASB Statement No. 142, Goodwill and Other Intangible Assets, is not applicable to good­
will and other intangible assets arising from combinations between not-for-profit organizations or 
arising from the acquisition of a for-profit business entity by a not-for-profit organization until the 
FASB completes its deliberation with respect to application of the purchase method by those entities.
AAG-HCO 1.50
17
Provisions of Certain Pronouncements Concerning Financial 
Statement Display
1.52 The following pronouncements include provisions specifying the fi­
nancial statement display of certain financial statement elements or items such 
as gains and losses, extraordinary items, translation adjustments, income tax 
expense, and prepaid or deferred income taxes:
• APB Opinion No. 9, Reporting the Results o f  Operations
• APB Opinion No. 26, Early Extinguishment o f Debt, as amended
• APB Opinion No. 30, as amended
• FASB Statement No. 52, Foreign Currency Translation, as 
amended
• FASB Statement No. 109, Accounting for Income Taxes, as 
amended
• FASB Interpretation No. 48, Accounting for Uncertainty in Income 
Taxes—an interpretation o f FASB Statement No. 109
None of the preceding pronouncements considers the net asset reporting model 
included in FASB Statement No. 117 and this guide. Therefore, preparers of 
financial statements of not-for-profit organizations should consider the report­
ing objectives of these APB opinions and FASB statements when exercising 
judgment about how to best display elements, such as in which net asset class.
GAAP Hierarchy for Governmental Organizations
1.53 AU section 411 provides that, for state or local governmental enti­
ties, officially established accounting principles consist of GASB statements 
and interpretations as well as AICPA and FASB pronouncements specifically 
made applicable to state and local governmental entities by GASB statements 
or interpretations. Appendix G (paragraph 1.62) of this chapter discusses AU 
section 411 and the hierarchy of sources of GAAP for governmental entities. 
GASB Statement No. 20 and No. 29 provide guidance on the applicability of 
FASB and AICPA pronouncements to governmental health care enterprises 
that use enterprise fund accounting and financial reporting. Footnote 1 and 
paragraph 1.17 of this chapter discusses the guidance in GASB Statement 
No. 20.
1.54 GASB Statement No. 29 provides that governmental enterprise funds 
and activities reported using enterprise fund accounting and financial reporting 
that apply the provisions of paragraph 7, as amended, of GASB Statement No. 
20 should apply only those "new" (issued after November 3 0 , 1989) FASB state­
ments and interpretations that are developed for business enterprises, rather 
than those whose provisions are limited to not-for-profit organizations or ad­
dress issues primarily concerning such organizations (such as FASB Statement 
Nos. 116, 117, 124, and 136). (See paragraph 1.17 of this chapter.)
1.55 Paragraph 33 in the "Basis for Conclusions" of GASB Statement No. 
20 also provides that AICPA pronouncements issued after November 3 0 , 1989, 
and not specifically made applicable to governmental entities should be ap­
plied using the same logic used in the application of FASB standards. That 
is, AICPA pronouncements that do not conflict with or contradict GASB pro­
nouncements should be applied on an "all or none" basis and constitute level 
"b" in the GAAP hierarchy. (See appendix G [paragraph 1.62] of this chapter.)
Unique Considerations of Health Care Organizations
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Many of the AICPA pronouncements issued after November 30, 1989 provide 
guidance on specialized industries, including this guide. However, users of this 
guide should note the provisions of SOP 94-6, Disclosure o f Certain Significant 
Risks and Uncertainties (AICPA, Technical Practice Aids, ACC sec. 10,640), 
discussed in paragraph 8.31 of this guide.
Health Care Organizations
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1.56
Appendix A— Financial Reporting Pronouncements That 
Specifically Exempt Not-for-Profit Organizations From 
Their Application
Notes regarding pronouncements listed in this appendix:
• Certain pronouncements listed in this appendix were amended by Finan­
cial Accounting Standards Board (FASB) Statement Nos. 123 (revised 
2004), Share-Based Payment, and 150, Accounting for Certain Financial 
Instruments with Characteristics o f both Liabilities and Equity. Read­
ers can find effective date information for those pronouncements in para­
graph 1.57.
• FASB Statement No. 141, Business Combinations, is listed in this ap­
pendix. Certain pronouncements listed in this appendix were amended 
by that statement and by FASB Statement No. 142, Goodwill and Other 
Intangible Assets. See paragraph 1.60 for information about applying the 
guidance in FASB Statement Nos. 141 and 142.
• Accounting Principles Board (APB) Opinion No. 18, The Equity Method o f  
Accounting for Investments in Common Stock, and FASB Statement No. 
115, Accounting for Certain Investments in Debt and Equity Securities, 
which are listed in this appendix, were amended by FASB Staff Posi­
tion (FSP) FAS 115-1 and FSP FAS 124-1, "The Meaning of Other-Than- 
Temporary Impairment and Its Application to Certain Investments," for 
reporting periods beginning after December 15, 2005.
• The FASB has released exposure drafts of proposed statements of financial 
accounting standards that would amend or replace certain pronounce­
ments that are listed in this appendix. Readers should be alert to the 
issuance of final standards.
Pronouncement Other References, i f  Any * Status o f Other References
APB Opinion No. 18, The 
Equity Method of  
Accounting for Investments 
in Common Stock, as 
amended
This guide Chapter 11 of this 
guide provides 
guidance concerning 
the equity method of 
accounting for 
investments in 
common stock
FASB Statement No. 3, 
Reporting Accounting 
Changes in Interim 
Financial Statements, as 
amended (superseded by 
FASB Statement No. 154)
None None
(continued)
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Pronouncement Other References, i f  Any * Status o f Other References
FASB Statement No. 89, None None
Financial Reporting and
Changing Prices, as
amended
Health Care Organizations
FASB Statement No. 115, 
Accounting for Certain 
Investments in Debt and 
Equity Securities, as 
amended
FASB Statement No. 
124, Accounting for 
Certain Investments 
Held by Not-for-Profit 
Organizations; 
chapter 4 of this guide
Currently effective
FASB Statement No. 128, 
Earnings per Share, as 
amended
None None
FASB Statement No. 130, 
Reporting Comprehensive 
Income, as amended
FASB Statement No. 
117
Currently effective
FASB Statement No. 131, 
Disclosures about Segments 
o f an Enterprise and
Related Information
None None
FASB Statement No. 141, 
Business Combinations, as 
amended
Chapter 1 and
Chapter 11 of this 
guide
Currently effective
FASB Statement No. 160, 
Noncontrolling Interests in 
Consolidated Financial 
Statements—an amendment 
o f ARB No. 51
None None
FASB Interpretation No.
18, Accounting for Income 
Taxes in Interim Periods, as 
amended
None None
FASB Interpretation No.
35, Criteria for Applying the 
Equity Method o f  
Accounting for Investments 
in Common Stock
See APB Opinion No. 
18
See APB Opinion No.
18
FASB Interpretation No. 46 
(revised December 2003), 
Consolidation o f  Variable 
Interest Entities, as 
amended
None None
* References in this column are provided as a guide to other sources of infor­
mation about the topic covered by the listed pronouncement.
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1.57
Appendix B— Financial Reporting Pronouncements That, 
by the Nature of Their Subject Matter, Generally Do Not 
Apply to Not-for-Profit Organizations
Notes regarding pronouncements listed in this appendix:
• Certain pronouncements listed in this appendix were replaced or super­
seded (as noted in the following paragraphs), or amended by Financial 
Accounting Standards Board (FASB) Statement No. 123(R). FASB State­
ment No. 123(R) is effective as of the beginning of the first annual report­
ing period that begins after June 15, 2005 for public entities that do not file 
as small business issuers; as of the beginning of the first annual reporting 
period that begins after December 15, 2005 for public entities that file as 
small business issuers; and as of the beginning of the first annual report­
ing period that begins after December 15, 2005 for nonpublic entities. See 
Securities and Exchange Commissions (SEC) Release No. 33-8568 for the 
SEC amendment to the compliance dates for implementing FASB State­
ment No. 123(R). Conforming changes to delete from this appendix those 
pronouncements replaced or superseded by FASB Statement No. 123(R) 
will be made in a future edition of this guide.
• FASB Statement No. 150, Accounting for Certain Financial Instruments 
with Characteristics o f both Liabilities and Equity, is listed in this ap­
pendix. FSP No. FAS 150-3, Effective Date, Disclosures, and Transition 
for Mandatorily Redeemable Financial Instruments o f  Certain Nonpublic 
Entities and Certain Mandatorily Redeemable Noncontrolling Interests 
under FASB Statement No. 150, Accounting for Certain Financial Instru­
ments with Characteristics of both Liabilities and Equity, defers in certain 
cases indefinitely the effective date for FASB Statement No. 150 for cer­
tain mandatorily redeemable financial instruments of certain nonpublic 
entities and for certain mandatorily redeemable noncontrolling interests.
• Certain pronouncements listed in this appendix were amended by FASB 
Statement No. 154, Accounting Changes and Error Corrections—a replace­
ment o f APB Opinion No. 20 and FASB Statement No. 3. FASB Statement 
No. 154 is effective for accounting changes and corrections of errors made 
in fiscal years beginning after December 15, 2005. Early adoption is per­
mitted for accounting changes and corrections of errors made in fiscal 
years beginning after FASB Statement No. 154 was issued.
• Certain pronouncements listed in this appendix were amended by FASB 
Statement No. 141. See paragraph 1.60 for information about applying 
the guidance in FASB Statement No. 141.
• The FASB has released exposure drafts of proposed statements of financial 
accounting standards that would amend or supersede pronouncements 
that are listed in this appendix. Readers should be alert to the issuance 
of final standards.
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• APB Opinion No. 14, Accounting for Convertible Debt and Debt 
Issued with Stock Purchase Warrants
• APB Opinion No. 25, Accounting for Stock Issued to Employees, as 
amended (superseded by FASB Statement No. 123(R))
• FASB Statement No. 84, Induced Conversions o f Convertible Debt
• FASB Statement No. 123 (revised 2004), Share-Based Payment 
(replaces FASB Statement No. 123, Accounting for Stock-Based 
Compensation, as amended)
• FASB Statement No. 148, Accounting for Stock-Based 
Compensation—Transition and Disclosure (superseded by 
FASB Statement No. 123(R))
• FASB Statement No. 150, Accounting for Certain Financial In­
struments with Characteristics o f both Liabilities and Equity, as 
amended
• FASB Interpretation No. 28, Accounting for Stock Appreciation 
Rights and Other Variable Stock Option or Award Plans, as 
amended (superseded by FASB Statement No. 123(R))
• FASB Interpretation No. 38, Determining the Measurement Date 
for Stock Option, Purchase, and Award Plans Involving Junior 
Stock, as amended (superseded by FASB Statement No. 123(R))
• FASB Interpretation No. 44, Accounting for Certain Transactions 
involving Stock Compensation, as amended (superseded by FASB 
Statement No. 123(R))
Health Care Organizations
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1.58
Appendix C— Financial Reporting Pronouncements 
Whose Application to Not-for-Profit Organizations 
Is Subject to Additional FASB or AICPA Guidance
Notes regarding pronouncements listed in this appendix:
• Accounting Principles Board (APB) Opinion No. 29 was amended by Fi­
nancial Accounting Standards Board (FASB) Statement Nos. 123 (revised 
2004), Share-Based Payment, and 141, Business Combinations. See para­
graph 1.57 for FASB Statement No. 123(R) effective date information 
and paragraph 1.60 for information about applying the guidance in FASB 
Statement No. 141.
• FASB Statement No. 124, Accounting for Certain Investments Held by Not- 
for-Profit Organizations, which is listed in this appendix, was amended by 
FASB Staff Position (FSP) FAS 115-1 and FSP FAS 124-1, for reporting 
periods beginning after December 15, 2005. Earlier application is permit­
ted.
• The FASB has released exposure drafts of proposed statements of financial 
accounting standards that would amend, replace, or supersede certain 
pronouncements that are listed in this appendix. Readers should be alert 
to the issuance of final standards.
Pronouncement
ARB No. 51, Consolidated Financial 
Statements, as amended
APB Opinion No. 29, Accounting for 
Nonmonetary Transactions, as amended
FASB Statement No. 94, Consolidation 
o f All Majority-owned Subsidiaries, as 
amended
FASB Statement No. 116, Accounting 
for Contributions Received and 
Contributions Made
FASB Statement No. 117, Financial 
Statements o f Not-for-Profit 
Organizations, as amended
FASB Statement No. 124, Accounting 
for Certain Investments Held by 
Not-for-Profit Organizations, as 
amended
Additional Guidance
This guide
FASB Statement No. 116 and 
chapters 5 and 10 of this guide 
provide accounting guidance for 
contributions
See ARB No. 51
FASB Statement No. 136, this 
guide and the AICPA Audit and 
Accounting Guide Not-for-Profit 
Organizations
This guide
This guide
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Pronouncement Additional Guidance
FASB Statement No. 136, Transfers o f  
Assets to a Not-for-Profit Organization 
or Charitable Trust That Raises or 
Holds Contributions for Others, as 
amended
FASB Statement No. 153, Exchanges of 
Nonmonetary Assets—an amendment o f  
APB Opinion No. 29
FASB Interpretation No. 30, Accounting 
for Involuntary Conversions o f  
Nonmonetary Assets to Monetary Assets, 
as amended
This guide and the AICPA Audit 
and Accounting Guide 
Not-for-Profit Organizations
FASB Statement No. 116 and 
chapters 5 and 10 of this guide 
provide accounting guidance for 
contributions
See APB Opinion No. 29
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Appendix D— Financial Reporting Pronouncements 
Pertaining to Specialized Industry Practices 
of Business Enterprises
Notes regarding pronouncements listed in this appendix:
• Financial Accounting Standards Board (FASB) Statement No. 156, Ac­
counting for Servicing o f Financial Assets, which is listed in this appendix, 
is effective as of the beginning of the entity's first fiscal year that begins af­
ter September 15, 2006. Earlier adoption is permitted as of the beginning 
of an entity's fiscal year, provided the entity has not yet issued financial 
statements, including interim financial statements, for any period of that 
fiscal year.
• FASB Statement No. 73 (as noted in the following paragraphs) was su­
perseded by FASB Statement No. 154, Accounting Changes and Error 
Corrections—a replacement o f APB Opinion No. 20 and FASB Statement 
No. 3. FASB Statement No. 154 also amended certain pronouncements 
listed in this appendix. FASB Statement No. 154 is effective for account­
ing changes and corrections of errors made in fiscal years beginning after 
December 15, 2005.
• Certain pronouncements listed in this appendix were amended by FASB 
Statement Nos. 141, Business Combinations, and 142, Goodwill and Other 
Intangible Assets. See paragraph 1.60 for information about applying the 
guidance in FASB Statement Nos. 141 and 142.
• The FASB has released exposure drafts of proposed statements of financial 
accounting standards that would amend certain pronouncements that are 
listed in this appendix. Readers should be alert to the issuance of final 
standards.
This appendix includes pronouncements that apply only to entities operating 
in certain industries, generally business enterprises. However, some not-for- 
profit organizations conduct activities in some of those industries and should 
apply the guidance concerning recognition and measurement of assets, liabili­
ties, revenues, expenses, and gains and losses in those pronouncements to the 
transactions unique to those industries. In addition, those not-for-profit organi­
zations should follow the financial statement display guidance in FASB State­
ment No. 117, Financial Statements o f Not-for-Profit Organizations, and this 
guide, although it may conflict with display that would result from applying 
the guidance in the pronouncements included in this appendix.
• APB Opinion No. 12, Omnibus Opinion—1967 (guidance under 
the heading "Capital Changes")
• APB Opinion No. 13, Amending Paragraph 6 o f  APB Opinion No. 
9, Application to Commercial Banks
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• FASB Statement No. 7, Accounting and Reporting by Development 
Stage Enterprises, as amended
• FASB Statement No. 19, Financial Accounting and Reporting by 
Oil and Gas Producing Companies, as amended
• FASB Statement No. 25, Suspension o f Certain Accounting Re­
quirements for Oil and Gas Producing Companies—an amend­
ment o f FASB Statement No. 19, as amended
• FASB Statement No. 35, Accounting and Reporting by Defined 
Benefit Pension Plans, as amended
• FASB Statement No. 45, Accounting for Franchise Fee Revenue
• FASB Statement No. 50, Financial Reporting in the Record and 
Music Industry
• FASB Statement No. 51, Financial Reporting by Cable Television 
Companies, as amended
• FASB Statement No. 60, Accounting and Reporting by Insurance 
Enterprises, as amended
• FASB Statement No. 61, Accounting for Title Plant, as amended
• FASB Statement No. 63, Financial Reporting by Broadcasters, as 
amended
• FASB Statement No. 65, Accounting for Certain Mortgage Bank­
ing Activities, as amended
• FASB Statement No. 67, Accounting for Costs and Initial Rental 
Operations o f Real Estate Projects, as amended
• FASB Statement No. 69, Disclosures about Oil and Gas Producing 
Activities—an amendment o f FASB Statements 19, 25 , 33, and 39, 
as amended
• FASB Statement No. 71, Accounting for the Effects o f Certain Types 
o f Regulation, as amended
• FASB Statement No. 72, Accounting for Certain Acquisitions o f  
Banking or Thrift Institutions—an amendment o f APB Opinion 
No. 17, an interpretation o f APB Opinions 16 and 17, and an 
amendment o f FASB Interpretation No. 9, as amended
• FASB Statement No. 73, Reporting a Change in Accounting for 
Railroad Track Structures—an amendment o f APB Opinion No. 
20 (superseded by FASB Statement No. 154)
• FASB Statement No. 90, Regulated Enterprises—Accounting for 
Abandonments and Disallowances o f Plant Costs—an amendment 
o f FASB Statement No. 71, as amended
• FASB Statement No. 91, Accounting for Nonrefundable Fees and 
Costs Associated with Originating or Acquiring Loans and Initial 
Direct Costs o f Leases—an amendment o f FASB Statements No. 13, 
60, and 65 and a rescission o f FASB Statement No. 17, as amended
• FASB Statement No. 92, Regulated Enterprises—Accounting for 
Phase-in Plans—an amendment o f FASB Statement No. 71
• FASB Statement No. 97, Accounting and Reporting by Insurance 
Enterprises for Certain Long-Duration Contracts and for Realized 
Gains and Losses from the Sale o f Investments, as amended
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• FASB Statement No. 101, Regulated Enterprises—Accounting for 
the Discontinuation o f Application o f  FASB Statement No. 71, as 
amended
• FASB Statement No. 110, Reporting by Defined Benefit Pension 
Plans o f Investment Contracts—an amendment o f FASB Statement 
No. 35
• FASB Statement No. 113, Accounting and Reporting for Reinsur­
ance o f Short-Duration and Long-Duration Contracts, as amended
• FASB Statement No. 120, Accounting and Reporting by Mutual 
Life Insurance Enterprises and by Insurance Enterprises for Cer­
tain Long-Duration Participating Contracts—an amendment o f  
FASB Statements 60, 97, and 113 and Interpretation No. 40
• FASB Statement No. 134, Accounting for Mortgage-Backed Secu­
rities Retained after the Securitization o f Mortgage Loans Held for 
Sale by a Mortgage Banking Enterprise—an amendment o f FASB 
Statement No. 65
• FASB Statement No. 139, Rescission o f FASB Statement No. 53 
and amendments to FASB Statements No. 63, 89, and 121
• FASB Statement No. 147, Acquisitions o f Certain Financial Insti­
tutions
• FASB Statement No. 152, Accounting for Real Estate Time- 
Sharing Transactions—an amendment o f FASB Statements No. 
66 and 67
• FASB Statement No. 156, Accounting for Servicing o f  Financial 
Assets
• FASB Interpretation No. 7, Applying FASB Statement No. 7 in 
Financial Statements o f Established Operating Enterprises
• FASB Interpretation No. 9, Applying APB Opinions No. 16 and 17 
When a Savings and Loan Association or a Similar Institution is 
Acquired in a Business Combination Accounted for by the Purchase 
Method, as amended
• FASB Interpretation No. 33, Applying FASB Statement No. 34 to 
Oil and Gas Producing Operations Accounted for by the Full Cost 
Method
• FASB Interpretation No. 36, Accounting for Exploratory Wells in 
Progress at the End o f a Period
• FASB Interpretation No. 40, Applicability o f Generally Accepted 
Accounting Principles to Mutual Life Insurance and Other Enter­
prises, as amended
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Appendix E— Financial Reporting Pronouncements 
Not Subsequently Superseded and Not Included 
in Appendixes A -D  of This Chapter
Notes regarding pronouncements listed in this appendix:
• Financial Accounting Standards Board (FASB) Statement No. 155, Ac­
counting for Certain Hybrid Financial Instruments, is effective for all 
financial instruments acquired or issued after the beginning of an en­
tity's first fiscal year that begins after September 15, 2006. FASB 
Statement No. 155 also amends certain pronouncements listed in this 
appendix.
• Certain pronouncements listed in this appendix were amended by FASB 
Statement No. 156, Accounting for Servicing o f Financial Assets. FASB 
Statement No. 156 is effective as of the beginning of the entity's first fiscal 
year that begins after September 15, 2006. Earlier adoption is permitted 
as of the beginning of an entity's fiscal year, provided the entity has not 
yet issued financial statements, including interim financial statements, 
for any period of that fiscal year.
• Certain pronouncements listed in this appendix were amended by FASB 
Statement Nos. 123(R) and 150. Readers can find effective date informa­
tion for those pronouncements in paragraph 1.57.
• FASB Statement No. 154, Accounting Changes and Error Corrections—a 
replacement o f APB Opinion No. 20 and FASB Statement No. 3, as noted in 
the following paragraphs, supersedes Accounting Principles Board (APB) 
Opinion No. 20 and FASB Interpretation No. 20, and amends certain pro­
nouncements listed in this appendix. FASB Statement No. 154 is effective 
for accounting changes and corrections of errors made in fiscal years be­
ginning after December 15, 2005. Early adoption is permitted for account­
ing changes and corrections of errors made in fiscal years beginning after 
FASB Statement No. 154 was issued. Conforming changes to reflect the 
issuance of FASB Statement No. 154 and delete APB Opinion No. 20 and 
FASB Interpretation No. 20 from this appendix will be made in a future 
edition of this guide.
• Certain pronouncements listed in this appendix were superseded or 
amended by FASB Statement Nos. 141 and 142. APB Opinion No. 16 and 
FASB Statement Nos. 10, 38, and 79 were superseded by FASB Statement 
No. 141. APB Opinion No. 17 was superseded by FASB Statement No. 142. 
This appendix, however, does not reflect those supercessions. FASB State­
ment No. 141 does not apply to certain business combinations, including 
a combination involving two or more not-for-profit organizations, or the 
acquisition of a for-profit business entity by a not-for-profit organization. 
For those combinations, pronouncements that are superseded or amended 
by FASB Statement No. 141 should be applied as though FASB Statement 
No. 141 had not superseded or amended them.
(continued)
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• The provisions of FASB Statement Nos. 141 and 142 should not be applied 
to goodwill and intangible assets arising from a combination between two 
or more not-for-profit organizations or acquired in the acquisition of a for- 
profit business entity by a not-for-profit organization until the FASB com­
pletes its project on those types of combinations and acquisitions. Thus, 
the guidance in APB Opinion Nos. 16 and 17 remains in effect for such 
assets. In addition, when applying APB Opinion Nos. 16 and 17, not-for- 
profit organizations should continue to apply the amendments to those 
opinions found in other literature even though that other literature may 
have been superseded by FASB Statement Nos. 141, 142, and 144. For 
example, when applying APB Opinion No. 17, not-for-profit organizations 
should continue to apply the amendments to that opinion found in FASB 
Statement No. 121 even though that statement was superseded by FASB 
Statement No. 144. An exposure draft of a proposed standard on combi­
nations of not-for-profit organizations is expected in 2006. Readers should 
be alert to the issuance of a final standard.
• The FASB has released exposure drafts of proposed statements of financial 
accounting standards that would amend or replace certain pronounce­
ments that are listed in this appendix. Readers should be alert to the 
issuance of final standards.
Unique Considerations of Health Care Organizations
As stated in paragraph 1.41 of this guide, not-for-profit organizations should 
follow the guidance in effective provisions of ARBs, APB opinions, and FASB 
statements and interpretations, except for specific pronouncements that ex­
plicitly exempt not-for-profit organizations and pronouncements for which this 
guide provides guidance. This appendix includes pronouncements, not subse­
quently superseded, that (a) do not exempt not-for-profit organizations from 
their application, (b) by the nature of their subject matter, apply to the kinds of 
transactions not-for-profit organizations engage in, (c) are subject to no addi­
tional FASB or AICPA guidance, and (d) do not pertain to specialized industry 
practices of business enterprises. Not-for-profit organizations should follow the 
guidance in the effective provisions of the pronouncements included in this 
appendix.
• ARB No. 43, Restatement and Revision o f Accounting Research 
Bulletins, as amended
• ARB No. 45, Long-Term Construction-Type Contracts
• ARB No. 46, Discontinuance o f Dating Earned Surplus
• APB Opinion No. 2, Accounting for the "Investment Credit," as 
amended
• APB Opinion No. 4 (amending Opinion No. 2), Accounting for the 
"Investment Credit"
• APB Opinion No. 6, Status o f Accounting Research Bulletins, as 
amended
• APB Opinion No. 9, Reporting the Results o f  Operations (para­
graph 1.52 of this guide discusses this pronouncement), as 
amended
• APB Opinion No. 10, Omnibus Opinion— 1966, as amended
• APB Opinion No. 12, Omnibus Opinion—1967 (except guidance 
under the heading, "Capital Changes"), as amended
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• APB Opinion No. 16, Business Combinations (paragraph 1.49 of 
this guide discusses this pronouncement), as amended
• APB Opinion No. 17, Intangible Assets, as amended
• APB Opinion No. 20, Accounting Changes, as amended (super­
seded by FASB Statement No. 154)
• APB Opinion No. 21, Interest on Receivables and Payables, as 
amended
• APB Opinion No. 22, Disclosure o f Accounting Policies, as amended
• APB Opinion No. 23, Accounting for Income Taxes—Special Areas, 
as amended
• APB Opinion No. 26, Early Extinguishment o f Debt (paragraph
1.52 of this guide discusses this pronouncement), as amended
• APB Opinion No. 28, Interim Financial Reporting, as amended
• APB Opinion No. 30, Reporting the Results o f  Operations— 
Reporting the Effects o f Disposal o f a Segment o f a Business, and 
Extraordinary, Unusual and Infrequently Occurring Events and 
Transactions (paragraph 1.52 of this guide discusses this pro­
nouncement), as amended
• FASB Statement No. 2, Accounting for Research and Development 
Costs, as amended
• FASB Statement No. 5, Accounting for Contingencies, as amended
• FASB Statement No. 6, Classification o f Short-Term Obligations 
Expected to Be Refinanced—(an amendment o f ARB No. 43, Chap­
ter 3A)
• FASB Statement No. 10, Extension o f "Grandfather" Provisions 
for Business Combinations—an amendment o f APB Opinion No. 
16
• FASB Statement No. 11, Accounting for Contingencies: Transition 
Method—an amendment o f FASB Statement No. 5
• FASB Statement No. 13, Accounting for Leases, as amended
• FASB Statement No. 15, Accounting by Debtors and Creditors for 
Troubled Debt Restructurings, as amended
• FASB Statement No. 16, Prior Period Adjustments, as amended
• FASB Statement No. 22, Changes in the Provisions o f Lease Agree­
ments Resulting from Refundings o f Tax-Exempt Debt—an amend­
ment o f  FASB Statement No. 13, as amended
• FASB Statement No. 23, Inception o f the Lease—an amendment 
o f FASB Statement No. 13
• FASB Statement No. 27, Classification o f Renewals or Extensions 
of Existing Sales-Type or Direct Financing Leases—an amendment 
o f FASB Statement No. 13
• FASB Statement No. 28, Accounting for Sales with Leasebacks— 
an amendment o f  FASB Statement No. 13, as amended
• FASB Statement No. 29, Determining Contingent Rentals—an 
amendment o f  FASB Statement No. 13, as amended
• FASB Statement No. 34, Capitalization o f  Interest Cost, as 
amended
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• FASB Statement No. 37, Balance Sheet Classification o f Deferred 
Income Taxes—an amendment o f APB Opinion No. 11, as amended
• FASB Statement No. 38, Accounting for Preacquisition Contingen­
cies o f Purchased Enterprises—an amendment o f APB Opinion No. 
16, as amended
• FASB Statement No. 42, Determining Materiality for Capitaliza­
tion o f Interest Cost—an amendment o f FASB Statement No. 34
• FASB Statement No. 43, Accounting for Compensated Absences, 
as amended
• FASB Statement No. 47, Disclosure o f Long-Term Obligations
• FASB Statement No. 48, Revenue Recognition When Right o f  Re­
turn Exists
• FASB Statement No. 49, Accounting for Product Financing Ar­
rangements, as amended
• FASB Statement No. 52, Foreign Currency Translation (paragraph
1.52 of this guide discusses this pronouncement), as amended
• FASB Statement No. 57, Related Party Disclosures, as amended
• FASB Statement No. 58, Capitalization o f Interest in Financial 
Statements That Include Investments Accounted for by the Equity 
Method—an amendment o f FASB Statement No. 34
• FASB Statement No. 62, Capitalization o f Interest Cost in Situa­
tions Involving Certain Tax-Exempt Borrowings and Certain Gifts 
and Grants—an amendment o f FASB Statement No. 34
• FASB Statement No. 66, Accounting for Sales o f Real Estate, as 
amended
• FASB Statement No. 68, Research and Development Arrange­
ments, as amended
• FASB Statement No. 78, Classification o f Obligations That Are 
Callable by the Creditor—an amendment o f  ARB No. 43, Chap­
ter 3A
• FASB Statement No. 79, Elimination o f  Certain Disclosures for 
Business Combinations by Nonpublic Enterprises—an amend­
ment o f APB Opinion No. 16
• FASB Statement No. 86, Accounting for the Costs o f  Computer 
Software to Be Sold, Leased, or Otherwise Marketed
• FASB Statement No. 87, Employers' Accounting for Pensions, as 
amended
• FASB Statement No. 88, Employers' Accounting for Settlements 
and Curtailments o f Defined Benefit Pension Plans and for Termi­
nation Benefits, as amended
• FASB Statement No. 93, Recognition o f Depreciation by Not-for- 
Profit Organizations, as amended
• FASB Statement No. 95, Statement o f  Cash Flows, as amended
• FASB Statement No. 98, Accounting for Leases.Sale-Leaseback 
Transactions Involving Real Estate, Sales-Type Leases o f Real Es­
tate, Definition o f the Lease Term, Initial Direct Costs o f Direct Fi­
nancing Leases—an amendment o f  FASB Statements No. 13, 66,
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and 91 and a rescission o f FASB Statement No. 26 and Technical 
Bulletin No. 79-11
• FASB Statement No. 99, Deferral o f the Effective Date o f Recogni­
tion o f  Depreciation by Not-for-Profit Organizations—an amend­
ment o f FASB Statement No. 93
• FASB Statement No. 102, Statement o f Cash Flows—Exemption o f  
Certain Enterprises and Classification o f Cash Flows from Certain 
Securities Acquired for Resale—an amendment o f FASB Statement 
No. 95, as amended
• FASB Statement No. 104, Statement o f Cash Flows—Net Report­
ing o f Certain Cash Receipts and Cash Payments and Classifica­
tion o f Cash Flows from Hedging Transactions—an amendment o f  
FASB Statement No. 95
• FASB Statement No. 106, Employers' Accounting for Postretire­
ment Benefits Other Than Pensions, as amended
• FASB Statement No. 107, Disclosures about Fair Value o f  Finan­
cial Instruments, as amended
• FASB Statement No. 109, Accounting for Income Taxes (paragraph
1.52 of this guide discusses this pronouncement), as amended
• FASB Statement No. 111, Rescission o f  FASB Statement No. 32 
and Technical Corrections
• FASB Statement No. 112, Employers' Accounting for Postemploy­
ment Benefits—an amendment o f FASB Statements No. 5 and 43, 
as amended
• FASB Statement No. 114, Accounting by Creditors for Impairment 
o f a Loan—an amendment o f FASB Statements No. 5 and 15, as 
amended
• FASB Statement No. 118, Accounting by Creditors for Impairment 
o f  a Loan—Income Recognition and Disclosures—an amendment 
o f FASB Statement No. 114
• FASB Statement No. 121, Accounting for the Impairment o f Long- 
Lived Assets and for Long-Lived Assets to Be Disposed Of, as 
amended (FASB Statement No. 121 was superseded by FASB 
Statement No. 144)
• FASB Statement No. 126, Exemption from Certain Required Dis­
closures about Financial Instruments for Certain Nonpublic Enti­
ties, as amended
• FASB Statement No. 129, Disclosure o f Information about Capital 
Structure
• FASB Statement No. 132 (revised 2003), Employers' Disclosures 
about Pensions and Other Postretirement Benefits
• FASB Statement No. 133, Accounting for Derivative Instruments 
and Hedging Activities, as amended
• FASB Statement No. 135, Rescission o f FASB Statement No. 75 
and Technical Corrections, as amended
• FASB Statement No. 137, Accounting for Derivative Instruments 
and Hedging Activities—Deferral o f  the Effective Date o f  FASB 
Statement No. 133
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• FASB Statement No. 138, Accounting for Certain Derivative In­
struments and Certain Hedging Activities
• FASB Statement No. 140, Accounting for Transfers and Servic­
ing o f Financial Assets and Extinguishments o f  Liabilities, as 
amended
• FASB Statement No. 142, Goodwill and Other Intangible Assets, 
as amended
• FASB Statement No. 143, Accounting for Asset Retirement Obli­
gations, as amended
• FASB Statement No. 144, Accounting for the Impairment or Dis­
posal o f  Long-Lived Assets, as amended
• FASB Statement No. 145, Rescission o f  FASB Statements No. 4, 
44, and 64, Amendment o f FASB Statement No. 13, and Technical 
Corrections
• FASB Statement No. 146, Accounting for Costs Associated with 
Exit or Disposal Activities
• FASB Statement No. 149, Amendment o f  Statement No. 133 on 
Derivative Instruments and Hedging Activities
• FASB Statement No. 151, Inventory Costs—an amendment o f ARB 
No. 43, Chapter 4
• FASB Statement No. 154, Accounting Changes and Error Correc­
tions
• FASB Statement No. 155, Accounting for Certain Hybrid Finan­
cial Instruments
• FASB Statement No. 157, Fair Value Measurements
• FASB Statement No. 158, Employers 'Accounting for Defined Ben­
efit Pension and Other Postretirement Plans—an amendment o f  
FASB Statements No. 87, 88, 106, and 132(R)
• FASB Statement No. 159, The Fair Value Option for Financial As­
sets and Financial Liabilities—Including an amendment o f FASB 
Statement No. 115
• FASB Interpretation No. 1, Accounting Changes Related to the 
Cost o f  Inventory
• FASB Interpretation No. 4, Applicability o f FASB Statement No. 2 
to Business Combinations Accounted for by the Purchase Method
• FASB Interpretation No. 6, Applicability o f FASB Statement No. 
2 to Computer Software, as amended
• FASB Interpretation No. 8, Classification o f a Short-Term Obliga­
tion Repaid Prior to Being Replaced by a Long-Term Security
• FASB Interpretation No. 14, Reasonable Estimation o f the Amount 
o f a Loss
• FASB Interpretation No. 19, Lessee Guarantee o f  the Residual 
Value o f Leased Property
• FASB Interpretation No. 20, Reporting Accounting Changes under 
AICPA Statements o f Position, as amended (superseded by FASB 
Statement No. 154)
• FASB Interpretation No. 21, Accounting for Leases in a Business 
Combination, as amended
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• FASB Interpretation No. 23, Leases o f Certain Property Owned by 
a Governmental Unit or Authority
• FASB Interpretation No. 24, Leases Involving Only Part o f a Build­
ing
• FASB Interpretation No. 26, Accounting for Purchase o f a Leased 
Asset by the Lessee during the Term o f the Lease
• FASB Interpretation No. 27, Accounting for a Loss on a Sublease, 
as amended
• FASB Interpretation No. 37, Accounting for Translation Adjust­
ments upon Sale o f  Part o f an Investment in a Foreign Entity
• FASB Interpretation No. 39, Offsetting o f  Amounts Related to Cer­
tain Contracts, as amended
• FASB Interpretation No. 41, Offsetting o f Amounts Related to Cer­
tain Repurchase and Reverse Repurchase Agreements
• FASB Interpretation No. 43, Real Estate Sales, as amended
• FASB Interpretation No. 45, Guarantor's Accounting and Disclo­
sure Requirements for Guarantees, Including Indirect Guarantees 
o f Indebtedness o f Others
• FASB Interpretation No. 47, Accounting for Conditional Asset Re­
tirement Obligations—an interpretation o f FASB Statement No. 
143
• FASB Interpretation No. 48, Accounting for Uncertainty in Income 
Taxes—an interpretation o f FASB Statement No. 109
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Appendix F— All Financial Reporting Pronouncements, 
Cross-Referenced by Appendix
Note regarding pronouncements listed in this appendix:
• See appendixes A-E of this chapter for effective date information for re­
cently issued pronouncements.
• Financial Accounting Standards Board (FASB) Statement Nos. 141 and 
142 supersede certain pronouncements that are listed in this appendix. 
Those supersessions are not reflected in this appendix. See paragraph 
1.60 for information about those supersessions and the applicability of 
the guidance in FASB Statement Nos. 141 and 142.
Pronouncement Appendix
ARB Nos. 1-42 Superseded
ARB No. 43 E
ARB No. 44 Superseded
ARB No. 44 (Revised) Superseded
ARB No. 45 E
ARB No. 46 E
ARB Nos. 47-50 Superseded
ARB No. 51 C
APB Opinion No. 1 Superseded
APB Opinion No. 2 E
APB Opinion No. 3 Superseded
APB Opinion No. 4 E
APB Opinion No. 5 Superseded
APB Opinion No. 6 E
APB Opinions Nos. 7-8 Superseded
APB Opinion No. 9 E
APB Opinion No. 10 E
APB Opinion No. 11 Superseded
APB Opinion No. 12 D,E
APB Opinion No. 13 D
APB Opinion No. 14 B
APB Opinion No. 15 Superseded
APB Opinion No. 16 E
APB Opinion No. 17 E
APB Opinion No. 18 A
APB Opinion No. 19 Superseded
APB Opinion No. 20 E
(continued)
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Pronouncement Appendix
APB Opinion No. 21 E
APB Opinion No. 22 E
APB Opinion No. 23 E
APB Opinion No. 24 Superseded
APB Opinion No. 25 (superseded by
FASB Statement No. 123(R)) B
APB Opinion No. 26 E
APB Opinion No. 27 Superseded
APB Opinion No. 28 A
APB Opinion No. 29 C
APB Opinion No. 30 E
APB Opinion No. 31 Superseded
FASB Statement No. 1 Superseded
FASB Statement No. 2 E
FASB Statement No. 3 (superseded by
FASB Statement No. 154) A
FASB Statement No. 4 Superseded
FASB Statement No. 5 E
FASB Statement No. 6 E
FASB Statement No. 7 D
FASB Statements No. 8 and No. 9 Superseded
FASB Statement No. 10 E
FASB Statement No. 11 E
FASB Statement No. 12 Superseded
FASB Statement No. 13 E
FASB Statement No. 14 Superseded
FASB Statement No. 15 E
FASB Statement No. 16 E
FASB Statement No. 17 Superseded
FASB Statement No. 18 Superseded
FASB Statement No. 19 D
FASB Statement No. 20 Superseded
FASB Statement No. 21 Superseded
FASB Statement No. 22 E
FASB Statement No. 23 E
FASB Statement No. 24 Superseded
FASB Statement No. 25 D
FASB Statement No. 26 Superseded
FASB Statement No. 27 E
FASB Statement No. 28 E
FASB Statement No. 29 E
FASB Statement No. 30 Superseded
FASB Statements Nos. 31-33 Superseded
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FASB Statement No. 34 E
FASB Statement No. 35 D
FASB Statement No. 36 Superseded
FASB Statement No. 37 E
FASB Statement No. 38 E
FASB Statements Nos. 39-41 Superseded
FASB Statement No. 42 E
FASB Statement No. 43 E
FASB Statement No. 44 Superseded
FASB Statement No. 45 D
FASB Statement No. 46 Superseded
FASB Statement No. 47 E
FASB Statement No. 48 E
FASB Statement No. 49 E
FASB Statement No. 50 D
FASB Statement No. 51 D
FASB Statement No. 52 E
FASB Statement No. 53 Superseded
FASB Statements Nos. 54-56 Superseded
FASB Statement No. 57 E
FASB Statement No. 58 E
FASB Statement No. 59 Superseded
FASB Statement No. 60 D
FASB Statement No. 61 D
FASB Statement No. 62 E
FASB Statement No. 63 • D
FASB Statement No. 64 Superseded
FASB Statement No. 65 D
FASB Statement No. 66 E
FASB Statement No. 67 D
FASB Statement No. 68 E
FASB Statement No. 69 D
FASB Statement No. 70 Superseded
FASB Statement No. 71 D
FASB Statement No. 72 D
FASB Statement No. 73 (superseded by
FASB Statement No. 154) D
FASB Statement Nos. 74-77 Superseded
FASB Statement No. 78 E
FASB Statement No. 79 E
FASB Statement No. 80 Superseded
FASB Statements Nos. 81-83 Superseded
(continued)
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FASB Statement No. 84 B
FASB Statement No. 85 Superseded
FASB Statement No. 86 E
FASB Statement No. 87 E
FASB Statement No. 88 E
FASB Statement No. 89 A
FASB Statement No. 90 D
FASB Statement No. 91 D
FASB Statement No. 92 D
FASB Statement No. 93 E
FASB Statement No. 94 C
FASB Statement No. 95 E
FASB Statement No. 96 Superseded
FASB Statement No. 97 D
FASB Statement No. 98 E
FASB Statement No. 99 E
FASB Statement No. 100 Superseded
FASB Statement No. 101 D
FASB Statement No. 102 E
FASB Statement No. 103 Superseded
FASB Statement No. 104 E
FASB Statement No. 105 Superseded
FASB Statement No. 106 E
FASB Statement No. 107 E
FASB Statement No. 108 Superseded
FASB Statement No. 109 E
FASB Statement No. 110 D
FASB Statement No. 111 E
FASB Statement No. 112 E
FASB Statement No. 113 D
FASB Statement No. 114 E
FASB Statement No. 115 A
FASB Statement No. 116 C
FASB Statement No. 117 C
FASB Statement No. 118 E  
FASB Statement No. 119 Superseded
FASB Statement No. 120 D
FASB Statement No. 121 E, Superseded
FASB Statement No. 122 Superseded
FASB Statement No. 123 (replaced with
FASB Statement No. 123(R)) B
FASB Statement No. 124 C
FASB Statement No. 125 Superseded
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FASB Statement No. 126 E
FASB Statement No. 127 Superseded
FASB Statement No. 128 A
FASB Statement No. 129 E
FASB Statement No. 130 A
FASB Statement No. 131 A
FASB Statement No. 132(R) E
FASB Statement No. 133 E
FASB Statement No. 134 D
FASB Statement No. 135 E
FASB Statement No. 136 C
FASB Statement No. 137 E
FASB Statement No. 138 E
FASB Statement No. 139 D
FASB Statement No. 140 E
FASB Statement No. 141 A
FASB Statement No. 142 E
FASB Statement No. 143 E
FASB Statement No. 144 E
FASB Statement No. 145 E
FASB Statement No. 146 E
FASB Statement No. 147
FASB Statement No. 148 (superseded by
D
FASB Statement No. 123(R)) B
FASB Statement No. 149 E
FASB Statement No. 150 *B
FASB Statement No. 151 E
FASB Statement No. 152 D
FASB Statement No. 153 C
FASB Statement No. 154 E
FASB Statement No. 155 E
FASB Statement No. 156 D
FASB Statement No. 157 E
FASB Statement No. 158 E
FASB Statement No. 159 E
FASB Statement No. 160 A
FASB Statement No. 161 E
FASB Interpretation No. 1 E
FASB Interpretation Nos. 2-3 Superseded
FASB Interpretation No. 4 E
FASB Interpretation No. 5 Superseded
FASB Interpretation No. 6 E
(continued)
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FASB Interpretation No. 7 
FASB Interpretation No. 8 
FASB Interpretation No. 9 
FASB Interpretation Nos. 10-13 
FASB Interpretation No. 14 
FASB Interpretation Nos. 15-17
No. 18 
No. 19
No. 20 (superseded by 
154)
No. 21 
No. 22 
No. 23 
No. 24 
No. 25 
No. 26 
No. 27
No. 28 (superseded by 
123(R))
No. 29 
No. 30 
No. 31 
No. 32 
No. 33 
No. 34 
No. 35 
No. 36 
No. 37
No. 38 (superseded by 
123(R))
No. 39 
No. 40 
No. 41 
No. 42 
No. 43
No. 44 (superseded by 
123(R))
No. 45 
No. 46(R)
No. 47 
No. 48
FASB Interpretation 
FASB Interpretation 
FASB Interpretation 
FASB Statement No. 
FASB Interpretation 
FASB Interpretation 
FASB Interpretation 
FASB Interpretation 
FASB Interpretation 
FASB Interpretation 
FASB Interpretation 
FASB Interpretation 
FASB Statement No. 
FASB Interpretation 
FASB Interpretation 
FASB Interpretation 
FASB Interpretation 
FASB Interpretation 
FASB Interpretation 
FASB Interpretation 
FASB Interpretation 
FASB Interpretation 
FASB Interpretation 
FASB Statement No. 
FASB Interpretation 
FASB Interpretation 
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FASB Statement No. 
FASB Interpretation 
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Appendix G— The Hierarchy of GAAP*
AU section 411, The Meaning o f  Present Fairly in Conformity With Generally 
Accepted Accounting Principles (AICPA, Professional Standards, vol. 1), estab­
lishes the hierarchy of generally accepted accounting principles.
For financial statements of entities other than governmental entities, the hier­
archy is summarized as follows:
• Category (a). Rule 203, Accounting Principles (AICPA, Profes­
sional Standards, vol. 2, ET sec. 203), literature consists of of­
ficially established accounting principles, which are Financial 
Accounting Standards Board (FASB) statements and interpreta­
tions, Accounting Principles Board opinions, and Accounting Re­
search Bulletins.
• Category (b). This consists of FASB Technical Bulletins and, if 
cleared by the FASB, AICPA Industry Audit and Accounting 
Guides, and AICPA Statements of Position.
• Category (c). This consists of AICPA Accounting Standards Exec­
utive Committee Practice Bulletins that have been cleared by the 
FASB and consensus positions of the FASB Emerging Issues Task 
Force.
* In May 2008, the Financial Accounting Standards Board (FASB) issued FASB Statement No. 
162, The Hierarchy o f Generally Accepted Accounting Principles, which identifies the sources of ac­
counting principles and the framework for selecting the principles used in the preparation of financial 
statements of nongovernmental entities that are presented in conformity with generally accepted ac­
counting principles (GAAP) in the United States (the GAAP hierarchy). The FASB concluded that the 
GAAP hierarchy should reside in the accounting literature established by the FASB rather than in 
the auditing literature established by the AICPA (for non-Securities and Exchange Commission [SEC] 
registrants) or the Public Company Accounting Oversight Board (PCAOB) (for SEC registrants).
FASB Statement No. 162 carries forward the GAAP hierarchy as set forth in the AICPA's State­
ments on Auditing Standards (SAS) No. 69, The Meaning of Present Fairly in Conformity With Gen­
erally Accepted Accounting Principles (AICPA, Professional Standards, vol. 1, AU sec. 411), subject 
to certain modifications that the FASB does not expect to result in changes to current practice. The 
modifications include, among other changes, the expansion of category (a) accounting principles to 
include, with one exception, all sources of accounting principles that are issued after being subject to 
the FASB's due process (including, but not limited to, FASB Staff Positions and FASB Statement 133 
Implementation Issues, which are currently not addressed in SAS No. 69.) Although certain consensus 
positions of the FASB Emerging Issues Task Force (EITF) have been issued after being subjected to 
the FASB's due process, the FASB decided to carry forward the categorization of EITF consensuses 
as presented in SAS No. 69, which is category (c).
FASB Statement No. 162 does not carry forward the exception permitted in Rule 203, Accounting 
Principles (AICPA, Professional Standards, vol. 2, ET sec. 203), of the AICPA's Code of Professional 
Conduct, that allows departures from the GAAP hierarchy if the member can demonstrate that, due 
to unusual circumstances, the financial statements would otherwise have been misleading. Therefore, 
an entity cannot represent that its financial statements are presented in accordance with GAAP if 
its selection of accounting principles departs from the GAAP hierarchy set forth in FASB Statement 
No. 162, and that departure has a material effect on its financial statements.
FASB Statement No. 162 is effective 60 days following the approval by the SEC of the conform­
ing amendments included in PCAOB Auditing Standard No. 6, Evaluating Consistency of Financial 
Statements, and conforming amendments adopted by the PCAOB on January 29, 2008. Among other 
significant provisions, the conforming amendments remove the GAAP hierarchy from the PCAOB's 
interim Auditing Standards.
In response to the FASB's release of the exposure draft of Statement No. 162 in April 2005, the 
AICPA issued an exposure draft of a proposed SAS, Amendment to Statement on Auditing Standards 
No. 69, The Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles, 
for Nongovernmental Entities, in May 2005 which deletes the GAAP hierarchy for nongovernmental 
entities from SAS No. 69. The effective dates of the AICPA, FASB, and PCAOB standards will coincide. 
For more information, please visit the FASB Web site at www.fasb.org.
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• Category (d). This consists of AICPA accounting interpreta­
tions and implementation guides (Qs and As) published by 
the FASB staff, and practices that are widely recognized and 
prevalent either generally or in the industry.
If the accounting treatment of a transaction or event is not specified by Rule 203 
literature, the auditor may consider whether the accounting treatment is spec­
ified by another source of established accounting principles. If an established 
accounting principle from one or more sources in category (b), (c), or (d) is rele­
vant to the circumstances, the auditor may be prepared to justify a conclusion 
that another treatment is generally accepted. If there is a conflict between ac­
counting principles relevant to the circumstances from one or more sources in 
category (b), (c), or (d), the auditor may follow the treatment specified by the 
source in the higher category—for example, follow category (b) treatment over 
category (c)—or be prepared to justify a conclusion that a treatment specified by 
a source in the lower category better presents the substance of the transaction 
in the circumstances.
For financial statements of state and local governmental entities,1 the hierarchy 
is summarized as follows:
• Category (a). Officially established accounting principles, con­
sists of Governmental Accounting Standards Board (GASB) 
statements and interpretations, as well as AICPA and FASB 
pronouncements specifically made applicable to state and lo­
cal governmental entities by GASB statements or interpreta­
tions. GASB statements and interpretations are periodically 
incorporated in the Codification o f Governmental Accounting 
and Financial Reporting Standards.
• Category (b). This consists of GASB Technical Bulletins and, 
if specifically made applicable to state and local governmen­
tal entities by the AICPA and cleared1 2 by the GASB, AICPA 
Industry Audit and Accounting Guides and AICPA SOPs.
• Category (c). This consists of AICPA AcSEC Practice Bulletins 
if specifically made applicable to state and local governmental 
entities and cleared3 by the GASB, as well as consensus po­
sitions of a group of accountants organized by the GASB that 
attempts to reach consensus positions on accounting issues 
applicable to state and local governmental entities.4
• Category (d). Includes implementation guides (Qs and As) 
published by the GASB staff, as well as practices that are 
widely recognized and prevalent in state and local govern­
ment.
Health Care Organizations
1 State and local governmental entities include public benefit corporations and authorities; public 
employee retirement systems; and governmental utilities, hospitals, and other health care providers,
and colleges and universities. Paragraph .14 of AU section 411, The Meaning of Present Fairly in 
Conformity With Generally Accepted Accounting Principles (AICPA, Professional Standards, vol. 1), 
establishes a hierarchy for federal governmental entities. Federal health care organizations are not 
included in the scope of this guide.
2 The auditor should assume that such pronouncements specifically made applicable to state 
and local governments have been cleared by the Governmental Accounting Standards Board (GASB) 
unless the pronouncement indicates otherwise.
3 See footnote 2.
4 As of the date of this guide, the GASB had not organized such a group.
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In the absence of a pronouncement covered by Rule 203 or another source of 
established accounting principles, the auditor of financial statements of state 
and local governmental entities may consider other accounting literature, de­
pending on its relevance in the circumstances. Other accounting literature in­
cludes, for example, GASB Concepts Statements; the pronouncements referred 
to in categories (a)-(d) above that relate to other than governmental entities 
when not specifically made applicable to state and local governmental entities 
either by the GASB or by the organization issuing them; FASB Concepts State­
ments; Federal Accounting Standards Advisory Board (FASAB) Statements, 
interpretations, Technical Bulletins, and Concepts Statements; AICPA Issues 
Papers; International Accounting Standards of the International Accounting 
Standards Committee; pronouncements of other professional associations or 
regulatory agencies; Technical Information Service Inquiries and Replies in­
cluded in AICPA Technical Practice Aids; and accounting textbooks, handbooks, 
and articles. The appropriateness of other accounting literature depends on its 
relevance to particular circumstances, the specificity of the guidance, and the 
general recognition of the issuer or author as an authority. For example, GASB 
Concepts Statements would normally be more influential than other sources in 
this category.
Unique Considerations of Health Care Organizations
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Chapter 2
General Auditing Considerations
Note: This chapter presents auditing guidance to help you implement audit­
ing standards included in both AICPA professional standards and in Public 
Company Accounting Oversight Board (PCAOB) professional standards. In 
citing the professional standards, references are made to the AICPA's Pro­
fessional Standards publication and the AICPA's PCAOB Standards and 
Related Rules publication, depending upon the applicable professional stan­
dards. Additionally, when referencing professional standards, this chapter 
cites section numbers and not the original statement number, as appro­
priate.
Auditing Guidance in the Audit and Accounting Guide 
Sta t e and Local Governments
2.01 Governmental health care entities only. This guide is not the only 
industry-specific AICPA Audit and Accounting Guide that auditors consider 
when performing an audit of a governmental health care entity. The Audit and 
Accounting Guide State and Local Governments, includes governmental health 
care entities in its scope, and the auditing guidance in that guide may also be 
considered during an audit of a governmental health care entity that is included 
in the scope of this guide.
Registered Public Accounting Firms
2.02 The PCAOB provides guidance for registered public accounting firms 
in connection with the preparation or issuance of any audit report on the fi­
nancial statements of an issuer, as defined by the Sarbanes-Oxley Act of 2002, 
and other entities when prescribed by the rules of the Securities and Exchange 
Commissions (SEC) (collectively referred to as issuers). (See the preface to this 
guide for more detailed information.)
Overview
2.03 In accordance with AU section 150, Generally Accepted Auditing Stan­
dards (AICPA, Professional Standards, vol. 1), an independent auditor plans, 
conducts, and reports the results of an audit in accordance with generally ac­
cepted auditing standards (GAAS). Auditing standards provide a measure of 
audit quality and the objectives to be achieved in an audit. This section o f the 
guide provides guidance, primarily on the application of the standards of field­
work. Specifically, this section provides guidance on the risk assessment process 
(which includes, among other things, obtaining an understanding of the entity 
and its environment, including its internal control) and general auditing con­
siderations for health care organizations.
Planning and Other Auditing Considerations
2.04 The objective of an audit o f a health care organization's financial 
statements is to express an opinion as to whether its financial statements
AAG-HCO 2.04
46
present fairly, in all material respects, the financial position, results of oper­
ations, changes in net assets, and cash flows for the specified period ended in 
conformity with generally accepted accounting principles (GAAP) or an other 
comprehensive basis of accounting. To accomplish that objective, the indepen­
dent auditor's responsibility is to plan and perform the audit to obtain rea­
sonable assurance (a high, but not absolute, level of assurance) that material 
misstatements, whether caused by error or fraud, are detected. This section 
addresses general planning considerations and other auditing considerations 
relevant to health care organizations.
Audit Planning
2.05 The first standard of field work states, "The auditor must adequately 
plan the work and must properly supervise any assistants." AU section 311, 
Planning and Supervision (AICPA, Professional Standards, vol. 1), establishes 
requirements and provides guidance on the considerations and activities appli­
cable to planning and supervision of an audit conducted in accordance with 
GAAS, including appointment o f the independent auditor; preliminary en­
gagement activities; establishing an understanding with the client; prepar­
ing a detailed, written audit plan; determining the extent of involvement of 
professionals with specialized skills; and communicating with those charged 
with governance and management. Audit planning also involves developing 
an overall audit strategy for the expected conduct, organization, and staffing 
of the audit. The nature, timing, and extent of planning vary with the size 
and complexity of the entity, and with the auditor's experience with the entity 
and understanding of the entity and its environment, including its internal 
control.
2.06 Paragraph .03 of AU section 311 (AICPA, Professional Standards, 
vol. 1) states that the auditor must plan the audit so that it is responsive to 
the assessment of the risks of material misstatement based on the auditor's 
understanding of the entity and its environment, including its internal control. 
Planning is not a discrete phase of the audit, but rather an iterative process 
that begins with engagement acceptance and continues throughout the audit as 
the auditor performs audit procedures and accumulates sufficient appropriate 
audit evidence to support the audit opinion.
Considerations for Integrated Audits
When performing an integrated audit of financial statements and in­
ternal control over financial reporting in accordance with PCAOB stan­
dards (subsequently referred to as integrated audit), paragraph 9 of 
Auditing Standard No. 5, An Audit o f Internal Control Over Financial 
Reporting That Is Integrated with An Audit o f Financial Statements 
(AICPA, PCAOB Standards and Related Rules, Rules of the Board, 
"Standards"), provides guidance regarding planning considerations in 
addition to the planning considerations discussed in AU section 311, 
Planning and Supervision (AICPA, PCAOB Standards and Related 
Rules, PCAOB Standards, As Amended).
2.07 Planning procedures usually include reviewing the independent au­
ditor's files relating to the entity and holding discussions with audit person­
nel and the personnel of the entity. Examples of these procedures include the 
following:
Health Care Organizations
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• Review correspondence files, the prior year's audit documentation, 
permanent files, financial statements, and independent auditors' 
reports.
• Review the minutes of meetings of those charged with governance.
• Review the relationship of affiliated organizations to the health 
care organization and determine the extent to which their finan­
cial information should be included in the financial statements of 
the entity. (See the related discussion in chapter 11.)
• Review the status of unsettled cost (reimbursement) reports for 
prior periods filed with third-party payors.
• Discuss matters that may affect the audit with the firm's personnel 
responsible for any nonaudit services to the entity.
• Identify situations for which accounting estimates are required 
and relevant factors that may affect those estimates.
• Inquire about current business developments affecting the entity.
• Read the current year's interim financial statements and 10-Q 
forms.
• Review periodic reports to third-party payors or other regulatory 
bodies.
• Discuss the nature, scope, and timing of the engagement with 
the entity's management, audit committee, or those charged with 
governance.
• Consider the effects of all applicable accounting and auditing pro­
nouncements, particularly recent pronouncements.
• Coordinate the assistance of entity personnel in data preparation.
• Determine the extent of involvement, if any, of consultants, spe­
cialists, and internal auditors.
• Establish the timing of the audit work.
2.08 The independent auditor may find it helpful to maintain a permanent 
file that includes copies of the following documents relating to the health care 
organization:
a. Articles of incorporation.
b. Bylaws.
c. Chart of accounts.
d. Organization chart.
e. Specific documents concerning restrictions on donor gifts and be­
quests.
f. Contracts and agreements, including leases, agreements with 
physicians, agreements with third-party payors, and agreements 
with affiliated organizations.
g. Description of internal control.
h. Loan agreements, bond indentures, and other debt instruments.
2.09 AU section 350, Audit Sampling (AICPA, Professional Standards, 
vol. 1), as amended, provides guidance to the independent auditor intending to 
use audit-sampling procedures when planning the work to be done. The AICPA 
Audit Guide Audit Sampling presents recommendations on the application of
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GAAS to audits involving the use of audit sampling methods, and guidance on 
applying audit sampling in accordance with AU section 350.
2.10 If the health care organization has an internal audit function, AU 
section 322, The Auditor's Consideration o f the Internal Audit Function in an 
Audit o f Financial Statements (AICPA, Professional Standards, vol. 1), pro­
vides guidance for the independent auditor intending to use audit-sampling 
procedures.
Considerations for Integrated Audits
Paragraphs 16-19 of Auditing Standard No. 5 provide further guidance 
on using the work of others, including relevant work performed by 
internal auditors, for an integrated audit.
Individual Practice Associations
2.11 In planning the audit of an individual practice association (IPA), the 
auditor may consider the following matters:
• The size of a typical IPA accounting department and business of­
fice often is not large enough to result in effective segregation of 
duties. However, most IPAs have an active office manager who can 
exercise a high degree of influence and control over the operations.
• Physician compensation arrangements often use incentives or 
other features with complicated methodologies and formulas.
• Contracts with managed care plans, often with capitated payment 
and risk pool settlement terms, frequently represent a significant 
amount of revenue for the IPA.
2.12 IPAs with capitated contracts accrue costs when the services are 
rendered, including cost estimates of claims incurred but not reported (IBNR). 
The IBNR accrual includes an estimate of the costs of services for which the 
IPA is responsible, including referrals outside the IPA. Risk pool settlements 
should be accrued during the contract period based on relevant factors, such as 
experience to date.
Scope of the Engagement
2.13 AU section 311 establishes requirements and provides guidance on 
the considerations and activities applicable to planning and supervision of an 
audit conducted in accordance with GAAS, including establishing a written 
understanding with the client regarding the services to be performed for each 
engagement, the objectives of the engagement, management's responsibilities, 
the auditor's responsibilities, and limitations of the engagement. If the auditor 
believes an understanding with the client has not been established, he or she 
may decline to accept or perform the engagement.
Considerations for Integrated Audits
Paragraph .06 of AU section 310, Appointment o f the Independent Audi­
tor (AICPA, PCAOB Standards and Related Rules, PCAOB Standards, 
As Amended), includes requirements related to an auditor's under­
standing when performing an integrated audit of financial statements 
and internal control over financial reporting, or an audit of the finan­
cial statements, in accordance with PCAOB standards.
Health Care Organizations
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2.14 In addition to reporting on the entity's basic financial statements, the 
independent auditor may be asked to report on the following special reports:
(a) cost-reimbursement reports; (b) cost reports related to research grants; (c) 
reports for contributors; (d) reports for local, state, or federal authorities; (e) 
reports related to bond indentures and other debt instruments; and (f) other 
special-purpose reports. The nature, timing, and extent of auditing procedures 
to be performed and the type of reports to be issued are based on the scope of 
services required by the entity.
2.15 Governmental health care entities only. Chapter 4 in the Audit and 
Accounting Guide State and Local Governments (see paragraph 2.01 in this 
chapter of the guide), discusses the need to establish an understanding with 
the client. That discussion states that the auditor considers holding a preaudit 
conference with the auditee to discuss the responsibilities of both the audi- 
tee and the auditor. That discussion also provides a listing of topics for the 
preaudit conference that have elements that are unique to or significant in a 
governmental audit.
Audit Risk
2.16 AU section 312, Audit Risk and Materiality in Conducting an Audit 
(AICPA, Professional Standards, vol. 1), states that audit risk is a function 
of the risk that the financial statements prepared by management are mate­
rially misstated and the risk that the auditor will not detect such material 
misstatement. The auditor should consider audit risk in relation to the rele­
vant assertions related to individual account balances, classes of transactions, 
and disclosures and at the overall financial statement level.
2.17 At the account balance, class of transactions, relevant assertion, or 
disclosure level, audit risk consists of (a) the risks of material misstatement 
(consisting of inherent risk and control risk) and (b) the detection risk. Para­
graph .23 of AU section 312 states that auditors should assess the risk of mate­
rial misstatement at the relevant assertion level as a basis to design and per­
form further audit procedures (tests of controls or substantive procedures). It 
is not acceptable to simply deem risk to be "at the maximum." This assessment 
may be in qualitative terms such as high, medium, and low, or in quantitative 
terms such as percentages.
2.18 In considering audit risk at the overall financial statement level, 
the auditor should consider risks of material misstatement that relate perva­
sively to the financial statements taken as a whole and potentially affect many 
relevant assertions. Risks of this nature often relate to the entity's control envi­
ronment and are not necessarily identifiable with specific relevant assertions at 
the class of transactions, account balance, or disclosure level. Such risks may 
be especially relevant to the auditor's consideration of the risks of material 
misstatement arising from fraud, for example, through management override 
of internal control.
Planning Materiality
2.19 The auditor's consideration of materiality is a matter of professional 
judgment and is influenced by the auditor's perception of the needs of users 
of financial statements. Materiality judgments are made in light of surround­
ing circumstances and necessarily involve both quantitative and qualitative 
considerations.
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2.20 In accordance with AU section 312 paragraph .27, the auditor should 
determine a materiality level for the financial statements taken as a whole 
when establishing the overall audit strategy for the audit. The auditor often 
may apply a percentage to a chosen benchmark as a step in determining mate­
riality for the financial statements taken as a whole.
Considerations for Integrated Audits
When performing an integrated audit of financial statements and in­
ternal control over financial reporting, refer to paragraph 20 of Audit­
ing Standard No. 5 regarding materiality considerations.
2.21 Governmental health care entities only. The Audit and Accounting 
Guide State and Local Governments (see paragraph 2.01 in this chapter of 
the guide) provides additional guidance on audit materiality determinations, 
including opinion units, as that term is described in State and Local Govern­
ments.
Tolerable Misstatement
2.22 The initial determination of materiality is made for the financial 
statement taken as a whole. However, the auditor should allow for the possi­
bility that some misstatements of lesser amounts than the materiality levels 
could, in the aggregate, result in a material misstatement of the financial state­
ments. To do so, the auditor should determine one or more levels of tolerable 
misstatement. AU section 312 paragraph .34 defines tolerable misstatement (or 
tolerable error) as the maximum error in a population (for example, the class 
of transactions or account balance) that the auditor is willing to accept. Such 
levels of tolerable misstatement are normally lower than the materiality levels. 
Qualitative Aspects o f Materiality
2.23 As indicated previously, judgments about materiality include both 
quantitative and qualitative information. As a result of the interaction of 
quantitative and qualitative considerations in materiality judgments, misstate­
ments o f relatively small amounts that come to the auditor's attention could 
have a material effect on the financial statements. For example, an illegal pay­
ment of an otherwise immaterial amount could be material if there is a reason­
able possibility that it could lead to a material contingent liability or a material 
loss of revenue.
2.24 Qualitative considerations also influence the auditor in reaching a 
conclusion about whether misstatements are material. Paragraph .60 of AU 
section 312 provides qualitative factors that the auditor may consider relevant 
in determining whether misstatements are material.
Use of a Specialist
2.25 AU section 336, Using the Work o f a Specialist (AICPA, Professional 
Standards, vol. 1), provides guidance to the auditor who uses the work of a spe­
cialist in performing an audit in accordance with GAAS. Guidance is provided 
on deciding when to use a specialist, the auditor's responsibilities for evaluating 
the qualifications and the work of the specialist, and using the findings of the 
specialist. The statement states the auditor should evaluate the relationship of 
the specialist to the client and states that the auditor should perform additional 
procedures if the auditor concludes that the objectivity of the specialist may be 
impaired by such a relationship.
Health Care Organizations
AAG-HCO 2.20
Use of Assertions in Obtaining Audit Evidence
2.26 Paragraphs .14—.19 of AU section 326, Audit Evidence (AICPA, Pro­
fessional Standards, vol. 1), discuss the use of assertions in obtaining audit 
evidence. In representing that the financial statements are fairly presented in 
accordance with GAAP, management implicitly or explicitly makes assertions 
regarding the recognition, measurement, and disclosure of information in the 
financial statements and related disclosures. Assertions used by the auditor 
fall into the following categories:
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Categories of Assertions
Description o f  Assertions
Classes o f  
Transactions and 
Events During the
Period
Account Balances 
at the End o f the 
Period
Presentation 
and Disclosure
Occurrence/
Existence
Transactions and 
events that have 
been recorded have 
occurred and 
pertain to the 
entity.
Assets, liabilities, 
and equity 
interests exist.
Disclosed events 
and transactions 
have occurred.
Rights and 
Obligations
The entity holds or 
controls the rights 
to assets, and 
liabilities are the 
obligations of the 
entity.
Disclosed events 
and transactions 
pertain to the 
entity.
Completeness All transactions 
and events that 
should have been 
recorded have been 
recorded.
All assets, 
liabilities, and 
equity interests 
that should have 
been recorded have 
been recorded.
All disclosures 
that should have 
been included in 
the financial 
statements have 
been included.
Accuracy/
Valuation
and
Allocation
Amounts and other 
data relating to 
recorded 
transactions and 
events have been 
recorded 
appropriately.
Assets, liabilities, 
and equity 
interests are 
included in the 
financial 
statements at 
appropriate 
amounts and any 
resulting valuation 
or allocation 
adjustments are 
recorded 
appropriately.
Financial and 
other
information is 
disclosed fairly 
and at 
appropriate 
amounts.
(continued)
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Categories of Assertions—continued
Description o f Assertions
Classes o f  
Transactions and 
Events During the
Period
Account Balances 
at the End o f  the 
Period
Presentation 
and Disclosure
Cut-off Transactions and 
events have been 
recorded in the 
correct accounting 
period.
Classification 
and Under­
standability
Transactions and 
events have been 
recorded in the 
proper accounts.
Financial 
information is 
appropriately 
presented and 
described and 
information in 
disclosures is 
expressed 
clearly.
2.27 The auditor should use relevant assertions for classes of transactions, 
account balances, and presentation and disclosures in sufficient detail to form 
a basis for the assessment of risks of material misstatement and the design 
and performance of further audit procedures. The auditor should use relevant 
assertions in assessing risks by considering the different types of potential 
misstatements that may occur, and then designing further audit procedures 
that are responsive to the assessed risks.
Understanding the Entity, Its Environment,
and Its Internal Control
2.28 AU section 314, Understanding the Entity and Its Environment and 
Assessing the Risks o f  Material Misstatement (AICPA, Professional Standards, 
vol. 1), establishes requirements and provides guidance about implementing 
the second standard of field work, as follows:
The auditor must obtain a sufficient understanding of the entity and 
its environment, including its internal control, to assess the risks of 
material misstatement of the financial statements whether due to er­
ror or fraud, and to design the nature, timing, and extent of further 
audit procedures.
2.29 Obtaining an understanding of the entity and its environment, in­
cluding its internal control, is a continuous, dynamic process of gathering, 
updating, and analyzing information throughout the audit. AU section 316, 
Consideration o f  Fraud in a Financial Statement Audit (AICPA, Professional 
Standards, vol. 1), provides standards and guidance for the auditor to consider 
throughout this process. See paragraphs 2.72-.74 for additional guidance per­
taining to AU section 316.
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Considerations for Integrated Audits
Paragraphs 14-15 of Auditing Standard No. 5 provide further guidance 
on performing an integrated audit of financial statements and internal 
control over financial reporting.
2.30 This section addresses the unique aspects of health care organi­
zations that may be helpful in developing the required understanding of the 
entity, its environment, and its internal control.
Risk Assessment Procedures
2.31 As described in AU section 326, audit procedures performed to ob­
tain an understanding of the entity and its environment, including its internal 
control, to assess the risks of material misstatement at the financial statement 
and relevant assertion levels are referred to as risk assessment procedures. AU 
section 326 paragraph .21 states that the auditor must perform risk assessment 
procedures to provide a satisfactory basis for the assessment of risks at the fi­
nancial statement and relevant assertion levels. Risk assessment procedures 
by themselves do not provide sufficient appropriate audit evidence on which to 
base the audit opinion and must be supplemented by further audit procedures 
in the form of tests of controls, when relevant or necessary, and substantive 
procedures.
2.32 In accordance with AU section 314 paragraph .06, the auditor should 
perform the following risk assessment procedures to obtain an understanding 
of the entity and its environment, including its internal control:
a. Inquiries of management and others within the entity.
b. Analytical procedures.
c. Observation and inspection.
See paragraphs .06-.13 of AU section 314 for additional guidance on risk as­
sessment procedures.
Analytical Procedures
2.33 AU section 329, Analytical Procedures (AICPA, Professional Stan­
dards, vol. 1), provides guidance on the use of analytical procedures and re­
quires their use in the planning and overall review stages of all audits. For 
planning purposes, these procedures should focus on (a) enhancing the inde­
pendent auditor's understanding of the client's business and the transactions 
and events that have occurred since the last audit date and (b) identifying ar­
eas that may represent specific risks relevant to the audit. Thus, the objective 
of the procedures is to identify such things as the existence of unusual trans­
actions and events, as well as amounts, ratios, and trends that might indicate 
matters that have financial statement and audit planning ramifications. For 
overall review purposes, these procedures may focus on considering the ade­
quacy of the evidence gathered in response to unusual or unexpected balances 
or relationships. The objective of the procedures is to assist the auditor in as­
sessing the conclusions reached and evaluating the overall financial statement 
presentation.
2.34 Analytical procedures also may be used as substantive tests to iden­
tify potential misstatements. These procedures focus on comparing actual bal­
ances with expected balances and investigating and evaluating significant dif­
ferences from the balances expected. AU section 329 paragraph .22 states that
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the auditor should document all of the following when an analytical procedure 
is used as the principal substantive test of a significant financial statement 
assertion:
a. The expectation, where that expectation is not otherwise readily 
determinable from the documentation of the work performed, and 
factors considered in its development.
b. Results of the comparison of the expectation to the recorded 
amounts or ratios developed from recorded amounts.
c. Any additional auditing procedures performed in response to signif­
icant unexpected differences arising from the analytical procedure 
and the results of such additional procedures.
Considerations for Integrated Audits
For significant risks of material misstatement, paragraph .09 of AU 
section 329, Analytical Procedures (AICPA, PCAOB Standards and 
Related Rules, PCAOB Standards, As Amended), provides that it is 
unlikely that audit evidence obtained from substantive analytical pro­
cedures alone will be sufficient.
2.35 Examples of sources of information for developing expectations in­
clude prior-period financial information, budgets, and health care financial 
and statistical ratios. Additional information is available from the Center for 
Healthcare Industry Performance Studies' Financial Analysis Service, which 
is published annually, as well as other health care industry associations.
2.36 Following are examples of analytical procedures the independent au­
ditor may find useful:
• Comparison of account balances with budget and prior-period 
amounts.
• Analysis of changes in revenues during the current period based 
on statistical data (for example, admissions, patient days, visits, 
and professional service procedure counts for laboratory, radiology, 
and surgery) and information concerning price changes.
• Comparison between periods of the number of days of revenue in 
receivables.
• Relationship between periods of the allowance for uncollectible ac­
counts to the balance of patient accounts receivable in the aggre­
gate, based on known changes in the accounts receivable's aging 
and composition by payor.
• Relationship between periods of the liability for claims IBNR to 
the related expense.
2.37 The AICPA Audit Guide Analytical Procedures provides practical 
guidance to auditors on the effective use of analytical procedures. That audit 
guide includes a discussion of AU section 329; concepts and definitions; a series 
of questions and answers; and a case study illustrating trend analysis, ratio 
analysis, reasonableness testing, and regression analysis.
Considerations for Integrated Audits
Paragraph B6 of Appendix B of Auditing Standard No. 5 provides guid­
ance on the effect of tests of controls on substantive procedures, includ­
ing analytical procedures, for an integrated audit.
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Discussion Among the Audit Team
2.38 In obtaining an understanding of the entity and its environment, 
including its internal control, AU section 314 states that there should be dis­
cussion among the audit team. In accordance with paragraph .14 of AU section 
314, the members of the audit team, including the auditor with final respon­
sibility for the audit, should discuss the susceptibility of the entity's financial 
statements to material misstatements. This discussion could be held concur­
rently with the discussion among the audit team that is specified by AU section 
316 to discuss the susceptibility of the entity’s financial statements to fraud. 
Understanding of the Entity and Its Environment
2.39 AU section 314 states the auditor must obtain an understanding of 
the entity and its environment, including its internal control. In accordance 
with AU section 314 paragraph .04, the auditor should use professional judg­
ment to determine the extent of the understanding required of the entity and 
its environment, including its internal control. The auditor's primary consid­
eration is whether the understanding that has been obtained is sufficient (1) 
to assess risks of material misstatement of the financial statements and (2) to 
design and perform further audit procedures (tests o f controls and substantive 
tests).
2.40 The auditor's understanding of the entity and its environment con­
sists of an understanding of the following aspects:
a. Industry, regulatory, and other external factors.
b. Nature of the entity.
c. Objectives and strategies and the related business risks that may 
result in a material misstatement of the financial statements.
d. Measurement and review of the entity's financial performance.
e. Internal control, which includes the selection and application of 
accounting policies (see section below for further discussion).
Refer to appendix A of AU section 314 for examples o f matters that the auditor 
may consider in obtaining an understanding of the entity and its environment 
relating to categories (a)-(d) above.
2.41 Some examples of matters that the auditor may consider in obtaining 
an understanding of the health care organization and its environment include:
• Conditions that might lead to extension or modification of audit 
tests (such as the existence of related party transactions or the 
existence of uninsured malpractice risks).
• The entity’s experience with payment denials and other matters 
subject to review by medical review organizations.
2.42 In obtaining an understanding of the health care organization and 
its environment, the independent auditor also may consider certain aspects of 
the health care organization's operations that are usually subject to higher or 
lower levels o f inherent risk.
In many health care organizations, certain accounts typically (a) will have a 
low volume of transactions, (6) will consist of transactions that are not complex, 
and (c) do not require the use o f significant accounting estimates. Accounts such 
as inventories, marketable securities, assets whose use is limited, property and 
equipment, long term debt, and equity frequently have these characteristics and
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may allow the auditor to assess inherent risk as being at a relatively low level. 
However, in certain circumstances, such as investments in complex derivative 
financial instruments, inherent risk may be higher. The auditor should use pro­
fessional judgment in evaluating the factors relevant to assessments of inherent 
risk.
2.43 Statement of Position (SOP) 00-1, Auditing Health Care Third-Party 
Revenues and Related Receivables (AICPA, Technical Practice Aids, AUD sec. 
14,360), provides guidance to auditors regarding uncertainties inherent in 
health care third-party revenue recognition. SOP 00-1 is included as appen­
dix E to this guide.
2.44 AU section 332, Auditing Derivative Instruments, Hedging Activities, 
and Investments in Securities (AICPA, Professional Standards, vol. 1), among 
other matters, provides guidance to auditors in planning and performing au­
diting procedures for assertions about derivative instruments that are made in 
an entity's financial statements, and presents examples of factors that affect 
inherent risk for assertions about derivatives. In addition, a companion Audit 
Guide, Auditing Derivative Instruments, Hedging Activities, and Investments 
in Securities, provides practical guidance for implementing AU section 332.
Considerations for Integrated Audits
Paragraph .11 of AU section 332 (AICPA, PCAOB Standards and Re­
lated Rules, PCAOB Standards, As Amended), provides guidance for 
an integrated audit if investments in derivatives and securities repre­
sents a significant account.
2.45 Auditing Interpretation No. 1, "Auditing Investments in Securities 
Where a Readily Determinable Fair Value Does Not Exist" of AU section 
332 (AICPA, Professional Standards, vol. 1, AU sec. 9332 par. .01-.04), pro­
vides guidance for auditors of nonissuers regarding the adequacy of audit evi­
dence with respect to the existence and valuation assertions in AU section 332 
(AICPA, Professional Standards, vol. 1), in confirmations received from third 
parties when auditing investments in securities where a readily determinable 
fair value does not exist, and the auditor determines auditing procedures should 
include verifying the existence and testing the measurement of the investments. 
Further guidance for auditors of nonissuers is provided in the AICPA Practice 
Aid Alternative Investments—Audit Considerations. The guidance focuses on 
the existence and valuation assertions associated with auditing investments 
for which a readily determinable fair value does not exist (collectively referred 
to in the Practice Aid as alternative investments).* Appendix 1 of that prac­
tice aid provides an example confirmation for alternative investments for use 
by practitioners. The auditing portion of that practice aid is an other auditing 
publication as defined in AU section 150. Other auditing publications have no 
authoritative status; however, they may help the auditor understand and apply 
Statements on Auditing Standards (SASs).
2.46 Because of the large monetary amounts and the complexity of deter­
mining health care service revenue and receivables, there are risks associated 
with health care service revenue recognition and the valuation of the related 
receivables. A significant portion of services usually is paid for by third par­
ties such as Medicare, Medicaid, and various health insurance carriers under
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statutory provisions or other arrangements in amounts that can be significantly 
different from, and frequently less than, the entity's established rates.
2.47 Risks are associated with recognizing the liability for costs incurred 
by providers of prepaid health care services (for example, health maintenance 
organizations) because such costs may have been incurred but not yet reported 
to the providers. It is therefore necessary to estimate the liability for those 
costs. These estimates often involve a high degree o f management judgment. 
Management generally should consider historical experience as well as the 
effects of any changes in conditions such as seasonality trends and changes in 
subscriber population and in the services and benefits provided.
2.48 Risks also are associated with contingencies for uninsured medical 
malpractice losses and obligations under continuing care contracts. A high de­
gree of management judgment and complex analyses usually are involved in 
evaluating the related financial statement assertions.
2.49 The independent auditor should understand the specific cost-finding 
or other rate-setting methods used by third-party payors to determine final 
amounts reimbursable to the health care organization. These payment meth­
ods may require that a health care organization accumulate and report vari­
ous statistical data, such as admissions, discharges, patient days, visits, beds, 
square footage, and pounds of laundry.
Understanding of Internal Control
2.50 AU section 314 paragraph .40 states that the auditor should obtain 
an understanding of the five components of internal control sufficient to assess 
the risks of material misstatement of the financial statements whether due 
to error or fraud, and to design the nature, timing, and extent of further audit 
procedures. The auditor should obtain a sufficient understanding by performing 
risk assessment procedures to
a. evaluate the design of controls relevant to an audit of financial 
statements and
b. determine whether they have been implemented.
2.51 The auditor should use such knowledge to
• identify types of potential misstatements,
• consider factors that affect the risks of material misstatement, 
and
• design tests of controls, when applicable, and substantive proce­
dures.
2.52 Obtaining an understanding of controls is different than testing the 
operating effectiveness of controls. The objective of obtaining an understand­
ing of controls is to evaluate the design of controls and determine whether they 
have been implemented for the purpose of assessing the risks of material mis­
statement. In contrast, the objective of testing the operating effectiveness of 
controls is to determine whether the controls, as designed, prevent or detect a 
material misstatement.
2.53 AU section 314 paragraph .41 defines internal control as "a process— 
effected by those charged with governance, management, and other personnel— 
designed to provide reasonable assurance about the achievement of the entity's
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objectives with regard to reliability of financial reporting, effectiveness and 
efficiency of operations, and compliance with applicable laws and regulations." 
Internal control consists of five interrelated components:
a. The control environment
b. Risk assessment
c. Information and communication systems
d. Control activities
e. Monitoring
Refer to paragraphs .40-.101 of AU section 314 for a detailed discussion of the 
internal control components.
2.54 AU section 314 also states that, in obtaining an understanding of 
internal control sufficient to assess the risks of material misstatement, the 
auditor should consider how an entity's use of IT and manual procedures may 
affect controls relevant to the audit. Information technology encompasses auto­
mated means of originating, processing, storing, and communicating informa­
tion, and includes recording devices, communication systems, computer sys­
tems, and other electronic devices. The auditor is primarily interested in the 
entity's use of IT to initiate, authorize, record, process, and report transactions 
or other financial data.
Considerations for Integrated Audits
Auditing Standard No. 5 establishes requirements that apply when an 
auditor is engaged to audit both the financial statements and manage­
ment’s assessment of the effectiveness of internal control over finan­
cial reporting in accordance with PCAOB standards. The PCAOB has 
issued staff guidance on AU section 320 (AICPA, PCAOB Standards 
and Related Rules, PCAOB Standards, As Amended), in the form of a 
questions and answers (Q&A) document, Staff Questions and Answers: 
Auditing Internal Control Over Financial Reporting. (See the preface 
to this guide for more information about management assessment of 
the effectiveness of internal control.)
Assessment of Risks of Material Misstatement and the 
Design of Further Audit Procedures
2.55 As discussed previously, risk assessment procedures allow the au­
ditor to gather the information necessary to obtain an understanding of the 
entity and its environment, including its internal control. This knowledge pro­
vides a basis for assessing the risks of material misstatement of the financial 
statements. These risk assessments are then used to design further audit proce­
dures, such as tests of controls, substantive tests, or both. This section provides 
guidance on assessing the risks of material misstatement and how to design 
further audit procedures that effectively respond to those risks.
Assessing the Risks of Material Misstatement
2.56 AU section 314 paragraph .102 states that the auditor should identify 
and assess the risks of material misstatement at the financial statement level 
and at the relevant assertion level related to classes of transactions, account 
balances, and disclosures. For this purpose, the auditor should
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a. identify risks throughout the process of obtaining an understand­
ing of the entity and its environment, including relevant controls 
that relate to the risks, and considering the classes of transactions, 
account balances, and disclosures in the financial statements.
b. relate the identified risks to what can go wrong at the relevant 
assertion level.
c. consider whether the risks are of a magnitude that could result in 
a material misstatement of the financial statements.
d. consider the likelihood that the risks could result in a material 
misstatement of the financial statements.
2.57 The auditor should use information gathered by performing risk as­
sessment procedures, including the audit evidence obtained in evaluating the 
design of controls and determining whether they have been implemented, as 
audit evidence to support the risk assessment. The auditor should use the risk 
assessment to determine the nature, timing, and extent of further audit proce­
dures to be performed.
Identification o f Significant Risks
2.58 As part of the assessment of the risks of material misstatement, the 
auditor should determine which of the risks identified are, in the auditor's judg­
ment, risks that require special audit consideration (such risks are defined as 
significant risks). One or more significant risks normally arise on most audits.
In exercising this judgment, the auditor should consider inherent risk to de­
termine whether the nature of the risk, the likely magnitude of the potential 
misstatement including the possibility that the risk may give rise to multiple 
misstatements, and the likelihood of the risk occurring are such that they re­
quire special audit consideration. Refer to paragraphs .45 and .53 o f AU section 
318, Performing Audit Procedures in Response to Assessed Risks and Evaluat­
ing the Audit Evidence Obtained (AICPA, Professional Standards, vol. 1), for 
further audit procedures pertaining to significant risks.
Designing and Performing Further Audit Procedures
2.59 AU section 318 provides guidance about implementing the third stan­
dard of field work, as follows:
The auditor must obtain sufficient appropriate audit evidence by per­
forming audit procedures to afford a reasonable basis for an opinion 
regarding the financial statements under audit.
2.60 To reduce audit risk to an acceptably low level, the auditor (1) should 
determine overall responses to address the assessed risks of material misstate­
ment at the financial statement level and (2) should design and perform fur­
ther audit procedures whose nature, timing, and extent are responsive to the 
assessed risks o f material misstatement at the relevant assertion level. The 
purpose is to provide a clear linkage between the nature, timing, and extent 
of the auditor's further audit procedures and the assessed risks. The overall 
responses and the nature, timing, and extent of the further audit procedures to 
be performed are matters for the professional judgment of the auditor.
Overall Responses
2.61 The auditor's overall responses to address the assessed risks of mate­
rial misstatement at the financial statement level may include emphasizing to
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the audit team the need to maintain professional skepticism in gathering and 
evaluating audit evidence, assigning more experienced staff or those with spe­
cialized skills or using specialists, providing more supervision, or incorporating 
additional elements of unpredictability in the selection of further audit proce­
dures to be performed. Additionally, the auditor may make general changes to 
the nature, timing, or extent of further audit procedures as an overall response, 
for example, performing substantive procedures at period end instead of at an 
interim date.
Further Audit Procedures
2.62 Further audit procedures provide important audit evidence to sup­
port an audit opinion. These procedures consist of tests of controls and substan­
tive tests. The nature, timing, and extent of the further audit procedures to be 
performed by the auditor should be based on the auditor's assessment of risks 
of material misstatement at the relevant assertion level.
2.63 In some cases, an auditor may determine that performing only sub­
stantive procedures is appropriate. However, the auditor often will determine 
that a combined audit approach using both tests of the operating effectiveness 
of controls and substantive procedures is an effective audit approach.
2.64 The auditor should perform tests of controls when the auditor’s risk 
assessment includes an expectation of the operating effectiveness of controls or 
when substantive procedures alone do not provide sufficient appropriate audit 
evidence at the relevant assertion level.
2.65 Regardless of the audit approach selected, the auditor should design 
and perform substantive procedures for all relevant assertions related to each 
material class of transactions, account balance, and disclosure.
2.66 The auditor's substantive procedures should include the following 
audit procedures related to the financial statement reporting process:
• Agreeing the financial statements, including their accompanying 
notes, to the underlying accounting records; and
• Examining material journal entries and other adjustments made 
during the course of preparing the financial statements.
The nature and extent of the auditor's examination of journal entries and other 
adjustments depend on the nature and complexity of the entity's financial re­
porting system and the associated risks of material misstatement.
2.67 The purpose of specific audit objectives and examples of control ac­
tivities in the auditing sections of the following chapters is to illustrate how 
the independent auditor might obtain an understanding of internal control, as­
sess the risks of material misstatement, and perform audit procedures. There 
is not necessarily a one-to-one relationship between audit objectives and pro­
cedures. Some procedures may relate to more than one objective. On the other 
hand, a combination of procedures may be needed to achieve a single objective. 
The auditing exhibits presented in subsequent chapters are not intended to be 
all-inclusive or to suggest that specific audit objectives, control activities, and 
audit procedures should be applied. Some of the objectives may not be relevant 
to a particular entity because of the nature of its operations or the absence of 
certain types of transactions. The absence of one or more of the illustrative con­
trols would not necessarily indicate a deficiency in internal control. The auditor 
must perform procedures that are responsive to the auditor's risk assessment.
60 Health Care Organizations
AAG-HCO 2.62
2.68 The auditing exhibits presented in subsequent chapters are arranged 
by broad audit objectives. These classifications may be useful in the evaluation 
process, but the classifications are of secondary importance. Some specific ob­
jectives may serve to achieve more than one broad objective.
2.69 Many of the illustrative control activities are premised on the exis­
tence of certain essential characteristics of internal control (for example, autho­
rization of transactions, segregation of duties, documentation, supervision and 
review, and timeliness of procedures). To avoid repetition, these characteristics 
have not been emphasized in the auditing exhibits presented in subsequent 
chapters.
Evaluating Misstatements
2.70 Based on the results of substantive procedures, the auditor may iden­
tify misstatements in accounts or notes to the financial statement. AU section 
312 paragraph .42 states that auditors must accumulate all known and likely 
misstatements identified during the audit, other than those that the auditor 
believes are trivial and communicate them to the appropriate level of manage­
ment. AU section 312 further states that auditors must consider the effects, 
both individually and in the aggregate, of misstatements (known and likely) 
that are not corrected by the entity. This consideration includes, among other 
things, the effect of misstatements related to prior periods.
2.71 For detailed guidance on evaluating audit findings and audit evi­
dence, refer to AU section 312 and AU section 326, respectively.
Consideration of Fraud in a Financial Statement Audit
2.72 AU section 316 is the primary source of authoritative guidance about 
an auditor’s responsibilities concerning the consideration of fraud in a financial 
statement audit. AU section 316 establishes standards and provides guidance 
to auditors in fulfilling their responsibility to plan and perform the audit to 
obtain reasonable assurance about whether the financial statements are free 
of material misstatement, whether caused by error or fraud, as stated in para­
graph .02 of AU section 110, Responsibilities and Functions o f  the Independent 
Auditor (AICPA, Professional Standards, vol. 1). AU section 320 paragraphs 
.24-.26 (AICPA, PCAOB Standards and Related Rules, PCAOB Standards, As 
Amended), provides guidance regarding fraud considerations when performing 
an integrated audit. See paragraph 2.83 in this chapter for a discussion of the 
guidance in AU section 333, Management Representations (AICPA, Professional 
Standards, vol. 1), regarding management representations about fraud.
2.73 There are two types o f misstatements relevant to the auditor's con­
sideration of fraud in a financial statement audit:
• Misstatements arising from fraudulent financial reporting
• Misstatements arising from misappropriation of assets (some­
times referred to as theft or defalcation)
2.74 Three conditions generally are present when fraud occurs. First, man­
agement or other employees have an incentive or are under pressure, which 
provides a reason to commit fraud. Second, circumstances exist—for example, 
the absence of controls, ineffective controls, or the ability of management to 
override controls—that provide an opportunity for a fraud to be perpetrated. 
Third, those involved are able to rationalize committing a fraudulent act.
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The Importance of Exercising Professional Skepticism
2.75 Because of the characteristics of fraud, the auditor's exercise of pro­
fessional skepticism is important when considering the risk of material mis­
statement due to fraud. Professional skepticism is an attitude that includes 
a questioning mind and a critical assessment of audit evidence. The auditor 
should conduct the engagement with a mindset that recognizes the possibil­
ity that a material misstatement due to fraud could be present, regardless 
of any past experience with the entity and regardless of the auditor's belief 
about management's honesty and integrity. Furthermore, professional skepti­
cism requires an ongoing questioning of whether the information and evidence 
obtained suggests that a material misstatement due to fraud has occurred.
Discussion Among Engagement Personnel Regarding the Risks 
of Material Misstatement Due to Fraud1
2.76 Members of the audit team should discuss the potential for material 
misstatement due to fraud in accordance with the requirements of AU section 
316 paragraphs .14—.18. The discussion among the audit team members about 
the susceptibility of the entity's financial statements to material misstatement 
due to fraud should include a consideration of the known external and internal 
factors affecting the entity that might (a) create incentives/pressures for man­
agement and others to commit fraud, (b) provide the opportunity for fraud to 
be perpetrated, and (c) indicate a culture or environment that enables manage­
ment to rationalize committing fraud. Communication among the audit team 
members about the risks of material misstatement due to fraud also should 
continue throughout the audit.
Obtaining the Information Needed to Identify the Risks
of Material Misstatement Due to Fraud
2.77 AU section 314 establishes requirements and provides guidance 
about how the auditor obtains an understanding of the entity and its envi­
ronment, including its internal control for the purpose of assessing the risks 
of material misstatement. In performing that work, information may come to 
the auditor's attention that should be considered in identifying risks of material 
misstatement due to fraud. As part of this work, the auditor should perform the 
following procedures to obtain information that is used (as described in para­
graphs .35—.42 of AU section 316), to identify the risks of material misstatement 
due to fraud:
a. Make inquiries of management and others within the entity to 
obtain their views about the risks of fraud and how they are ad­
dressed. (See AU section 316 paragraphs .20-.27.)
b. Consider any unusual or unexpected relationships that have been 
identified in performing analytical procedures in planning the au­
dit. (See AU section 316 paragraphs .28-.30.)
c. Consider whether one or more fraud risk factors exist. (See AU 
section 316 paragraphs .31-33, the appendix to AU section 316, 
and paragraph 2.79 in this chapter.)
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d. Consider other information that may be helpful in the identification 
of risks of material misstatement due to fraud. (See AU section 316 
paragraph .34.)
2.78 In planning the audit, the auditor also should perform analytical 
procedures relating to revenue with the objective of identifying unusual or un­
expected relationships involving revenue accounts that may indicate a material 
misstatement due to fraudulent financial reporting.
2.79 Considering fraud risk factors. As indicated in paragraph 2.77c in 
this chapter, the auditor may identify events or conditions that indicate in- 
centives/pressures to perpetrate fraud, opportunities to carry out the fraud, or 
attitudes/rationalizations to justify a fraudulent action. Such events or condi­
tions are referred to as fraud risk factors. Fraud risk factors do not necessarily 
indicate the existence of fraud; however, they often are present in circumstances 
where fraud exists.
2.80 AU section 316 provides fraud risk factor examples that have been 
written to apply to most enterprises. Remember that fraud risk factors are only 
one of several sources of information an auditor considers when identifying and 
assessing risk of material misstatement due to fraud.
Identifying Risks That May Result in a Material Misstatement 
Due to Fraud2
2.81 In identifying risks of material misstatement due to fraud, it is help­
ful for the auditor to consider the information that has been gathered in accor­
dance with the requirements of AU section 316 paragraph .19-.34. The auditor's 
identification o f fraud risks may be influenced by characteristics such as the 
size, complexity, and ownership attributes o f the entity. In addition, the audi­
tor should evaluate whether identified risks of material misstatement due to 
fraud can be related to specific financial-statement account balances or classes 
of transactions and related assertions, or whether they relate more pervasively 
to the financial statements as a whole. Certain accounts, classes of transactions, 
and assertions that have high inherent risk because they involve a high degree 
of management judgment and subjectivity also may present risks o f material 
misstatement due to fraud because they are susceptible to manipulation by 
management.
A Presumption That Improper Revenue Recognition Is a Fraud Risk
2.82 Material misstatements due to fraudulent financial reporting often 
result from an overstatement o f revenues (for example, through premature 
revenue recognition or recording fictitious revenues) or an understatement of 
revenues (for example, through improperly shifting revenues to a later period). 
Therefore, the auditor should ordinarily presume that there is a risk o f material 
misstatement due to fraud relating to revenue recognition (see AU section 316 
paragraph .41). 
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the auditor's consideration of fraud and assessment of risk and the auditor's procedures in response 
to those assessed risks.
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A Consideration of the Risk of Management Override of Controls
2.83 Even if specific risks of material misstatement due to fraud are not 
identified by the auditor, there is a possibility that management override of con­
trols could occur, and accordingly, the auditor should address that risk (see AU 
section 316 paragraph .57) apart from any conclusions regarding the existence 
of more specifically identifiable risks. Specifically, the procedures described in 
AU section 316 paragraph .58-.67 should be performed to further address the 
risk of management override of controls. These procedures include (1) exam­
ining journal entries and other adjustments for evidence of possible material 
misstatement due to fraud, (2) reviewing accounting estimates for biases that 
could result in material misstatement due to fraud, and (3) evaluating the busi­
ness rationale for significant unusual transactions.
Assessing the Identified Risks After Taking Into Account
an Evaluation of the Entity's Programs and Controls
That Address the Risks
2.84 AU section 316 paragraphs .4 3 - .45 provides requirements and guid­
ance concerning an entity's programs and controls that address identified risks 
of material misstatement due to fraud.
2.85 The auditor should consider whether such programs and controls 
mitigate the identified risks of material misstatement due to fraud or whether 
specific control deficiencies exacerbate the risks. After the auditor has evaluated 
whether the entity's programs and controls have been suitably designed and 
placed in operation, the auditor should assess these risks taking into account 
that evaluation. The assessment should be considered when developing the 
auditor's response to the identified risks of material misstatement due to fraud.
Responding to the Results of the Assessment3
2.86 AU section 316 paragraphs .46-.67 provide requirements and guid­
ance about an auditor's response to the results of the assessment of the risks of 
material misstatement due to fraud. The auditor responds to risks of material 
misstatement due to fraud in the following three ways:
a. A  response that has an overall effect on how the audit is 
conducted—that is, a response involving more general considera­
tions apart from the specific procedures otherwise planned (see AU 
section 316 paragraph .50).
b. A response to identified risks involving the nature, timing, and ex­
tent of the auditing procedures to be performed (see AU section 316 
paragraphs .51-.56).
c. A response involving the performance of certain procedures to fur­
ther address the risk of material misstatement due to fraud involv­
ing management override of controls, given the unpredictable ways 3
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3 Paragraph .03 of AU section 318, Performing Audit Procedures in Response to Assessed Risks 
and Evaluating the Audit Evidence Obtained (AICPA, Professional Standards, vol. 1) states that, to 
reduce audit risk to an acceptably low level, the auditor should determine overall responses to address 
the assessed risks of material misstatement at the financial statement level and should design and 
perform further audit procedures whose nature, timing, and extent are responsive to the assessed 
risks of material misstatement at the relevant assertion level. See paragraphs .04—.07 of AU section 
318. This requirement provides a link between the auditor's consideration of fraud and the auditor's 
assessment of risk and the auditor's procedures in response to those assessed risks.
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in which such override could occur (see AU section 316 paragraphs 
.57-.67 and paragraph 2.83 in this chapter).
Evaluating Audit Evidence
2.87 AU section 316 paragraphs .68-.78 provides requirements and guid­
ance for evaluating audit evidence. The auditor should evaluate whether an­
alytical procedures that were performed as substantive tests or in the overall 
review stage of the audit indicate a previously unrecognized risk of material 
misstatement due to fraud. The auditor also should consider whether responses 
to inquiries throughout the audit about analytical relationships have been 
vague or implausible, or have produced evidence that is inconsistent with other 
audit evidence accumulated during the audit.
2.88 At or near the completion of fieldwork, the auditor should evaluate 
whether the accumulated results of auditing procedures and other observa­
tions affect the assessment of the risks of material misstatement due to fraud 
made earlier in the audit. As part of this evaluation, the auditor with final 
responsibility for the audit should ascertain that there has been appropriate 
communication with the other audit team members throughout the audit re­
garding information or conditions indicative of risks of material misstatement 
due to fraud.
Responding to Misstatements That May Be the Result of Fraud
2.89 When audit test results identify misstatements in the financial state­
ments, the auditor should consider whether such misstatements may be in­
dicative of fraud. See AU section 316 paragraphs .75-.78 for requirements and 
guidance about an auditor's response to misstatements that may be the result 
of fraud. If the auditor believes that misstatements are or may be the result of 
fraud, but the effect of the misstatements is not material to the financial state­
ments, the auditor nevertheless should evaluate the implications, especially 
those dealing with the organizational position of the person(s) involved.
2.90 If the auditor believes that the misstatement is or may be the re­
sult o f fraud, and either has determined that the effect could be material to 
the financial statements or has been unable to evaluate whether the effect is 
material, the auditor should
a. attempt to obtain additional audit evidence to determine whether 
material fraud has occurred or is likely to have occurred, and, if 
so, its effect on the financial statements and the auditor's report 
thereon.4
b. consider the implications for other aspects of the audit (see AU 
section 316 paragraph .76).
c. discuss the matter and the approach for further investigation with 
an appropriate level of management that is at least one level above
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vol. 1), for guidance on auditor's reports issued in connection with audits of financial statements and for 
an integrated audit. When performing an integrated audit of financial statements and internal control 
over financial reporting, the auditor may choose to issue a combined report or separate reports on the 
company's financial statements and on internal control over financial reporting. Refer to paragraphs 
85-98 of PCAOB Auditing Standard No. 5, An Audit of Internal Control Over Financial Reporting 
That Is Integrated with An Audit o f Financial Statements (AICPA, PCAOB Standards and Related 
Rules, Rules of the Board, "Standards”), for direction on reporting on internal control over financial 
reporting.
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those involved, and with senior management, the audit committee, 
or those charged with governance.5
d. If appropriate, suggest that the client consult with legal counsel.
2.91 The auditor's consideration of the risks of material misstatement 
and the results of audit tests may indicate such a significant risk of material 
misstatement due to fraud that the auditor should consider withdrawing from 
the engagement and communicating the reasons for withdrawal to the audit 
committee or others with equivalent authority and responsibility. The auditor 
may wish to consult with legal counsel when considering withdrawal from an 
engagement.
Communicating About Possible Fraud to Management
and Those Charged With Governance
2.92 Whenever the auditor has determined that there is evidence that 
fraud may exist, that matter should be brought to the attention of an appro­
priate level of management. See AU section 316 paragraphs .79-.82 for further 
requirements and guidance about communications with management and those 
charged with governance.
Documenting the Auditor's Consideration of Fraud
2.93 AU section 316 paragraph .83 lists certain items and events the au­
ditor should document.
Practical Guidance
2.94 The AICPA Practice Aid Fraud Detection in a GAAS Audit—Revised 
Edition provides additional guidance with respect to complying with the pro­
visions of AU section 316. Moreover, this Practice Aid will assist auditors in 
understanding the requirements of AU section 316 and whether current au­
dit practices effectively incorporate these requirements. This practice aid is 
an Other auditing publication as defined in AU section 150. Other auditing 
publications have no authoritative status; however, they may help the auditor 
understand and apply SASs.
Additional Audit Considerations
Accounting Estimates
2.95 In determining the scope of audit procedures to be performed, the in­
dependent auditor may recognize that certain areas of health care organization 
operations include accounting estimates that may be material in the prepara­
tion and presentation of financial statements. SOP 94-6, Disclosure o f Certain 
Significant Risks and Uncertainties (AICPA, Technical Practice Aids, ACC sec. 
10,640),6 provides requirements and standards for entities to include in their
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5 If the auditor believes senior management may be involved, discussion of the matter directly 
with the audit committee or those charged with governance may be appropriate.
6 Statement of Position 94-6, Disclosure of Certain Significant Risks and Uncertainties (AICPA, 
Technical Practice Aids, ACC sec. 10,640), does not pertain to governmental entities, unless the entity 
has elected to follow all Financial Accounting Standards Board pronouncements under paragraph 7 of 
Governmental Accounting Standards Board Statement No. 20, Accounting and Financial Reporting 
for Proprietary Funds and Other Governmental Entities That Use Proprietary Fund Accounting. (See 
chapter 1 footnote 1.)
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financial statements information about the use of estimates in the preparation 
of financial statements. In addition, if certain specified disclosure criteria are 
met, the SOP provides guidance for entities to include disclosures about certain 
significant estimates in their financial statements. AU section 342, Auditing 
Accounting Estimates (AICPA, Professional Standards, vol. 1; AICPA, PCAOB 
Standards and Related Rules, PCAOB Standards, As Amended), provides guid­
ance on obtaining and evaluating sufficient appropriate audit evidence to sup­
port significant accounting estimates in an audit of financial statements in 
accordance with GAAS.
2.96 Although management is responsible for making estimates, the inde­
pendent auditor is responsible for evaluating the reasonableness of estimates 
and should consider appropriate procedures in planning and performing the 
audit. These procedures should include both subjective and objective factors.
2.97 The independent auditor should acquire an understanding of the 
relevance of internal control to the accumulation of data and the preparation of 
accounting estimates. Internal control should also provide for adequate review 
and approval of accounting estimates by appropriate levels of authority.
2.98 Although significant accounting estimates may affect many elements 
of a health care organization's financial statements, they most often affect the 
following:
a . The provision for third-party payor contractual adjustments and al­
lowances and the provision for estimated receivables and payables 
for final settlements with those payors.
b. The provision for uncollectible accounts.
c. Accruals for uninsured medical malpractice claims.
d. Accruals for obligations under continuing care contracts.
e. Accruals by providers of prepaid health care services for IBNR costs. 
Considerations for Integrated Audits
Paragraph .10 of AU section 342 (AICPA, PCAOB Standards and Re­
lated Rules, PCAOB Standards, As Amended), provides that for an in­
tegrated audit, auditors should obtain an understanding of how man­
agement developed estimates and to test controls over all relevant 
assertions related to the estimate.
2.99 SOP 00-1 provides guidance for auditors regarding the sufficiency of 
audit evidence supporting accounting estimates recorded for the proper valu­
ation of health care third-party revenues and related receivables. SOP 00-1 is 
included as appendix E to this guide.
Transactions Processed by Service Organizations
2.100 Health care organizations may engage outside service organizations 
to perform services that are part of the health care provider's information sys­
tem. A service organization's services are part of an entity's information system 
if they affect any of the following:
• The classes of transactions in the entity's operations that are sig­
nificant to the entity's financial statements.
• The procedures, both automated and manual, by which the entity's 
transactions are initiated, authorized, recorded, processed, and
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reported from their occurrence to their inclusion in the financial 
statements.
• The related accounting records, whether electronic or manual, 
supporting information, and specific accounts in the entity's fi­
nancial statements involved in initiating, recording, processing, 
and reporting the entity's transactions.
• How the entity's information system captures other events and 
conditions that are significant to the financial statements.
• The financial reporting process used to prepare the entity's finan­
cial statements, including significant accounting estimates and 
disclosures.
Examples of service organizations used by health care organizations include 
the following:
• Bank trust departments that invest and service assets for health 
care organizations.
• Service organizations that process payroll.
• Billing entities that prepare reimbursement claims to insurers 
and other third parties.
• Administrators of employee benefit plans who process and pay 
benefit claims and maintain participant records.
2.101 AU section 314 states that the auditor should obtain an under­
standing of the five components of internal control sufficient to assess the risks 
of material misstatement of the financial statements whether due to error or 
fraud, and to design the nature, timing, and extent of further audit proce­
dures. This understanding may encompass controls placed in operation by the 
health care organization and service organizations whose services are part of 
the health care organization’s information system. The auditor should use such 
knowledge to
• identify types of potential misstatements.
• consider factors that affect the risks of material misstatement.
• design tests of controls, when applicable.
• design substantive procedures.
2.102 AU section 324, Service Organizations (AICPA, Professional Stan­
dards, vol. 1), provides requirements and guidance for obtaining an under­
standing of internal control and assessing control risk for entities that use a 
service organization to process transactions. The AICPA Audit Guide Service 
Organizations: Applying SAS No. 70, as Amended, provides additional guidance 
for user auditors engaged to audit the financial statements of entities that use 
service organizations.
Considerations for Integrated Audits
Paragraphs B17-B27 of appendix B of Auditing Standard No. 5 provide 
guidance regarding the use of service organizations for an integrated 
audit.
2.103 The auditor o f a health care organization should determine whether 
the health care organization uses a service organization. Information about the 
nature of the services provided by the service organization and the service or­
ganization's controls over those services may be available from sources such as
Health Care Organizations
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user manuals, system overviews, technical manuals, the contract between the 
health care organization and the service organization, and reports by service 
auditors, internal auditors, or regulatory authorities on the service organiza­
tion's controls.
2.104 After considering the available information, the auditor of the health 
care organization may conclude that he or she has the means to obtain a suf­
ficient understanding of internal control to assess the risks o f material mis­
statement. If the auditor of the health care organization concludes that infor­
mation is not available to obtain a sufficient understanding to assess the risks 
of material misstatement, he or she may consider contacting the service orga­
nization, through the health care organization, to obtain specific information 
or request that a service auditor be engaged to perform procedures that will 
supply the necessary information, or the auditor o f the health care organization 
may visit the service organization and perform such procedures. If the auditor 
of the health care organization is unable to obtain sufficient appropriate audit 
evidence to achieve his or her audit objectives, the auditor of the health care 
organization should qualify his or her opinion or disclaim an opinion on the 
financial statements because of a scope limitation.
2.105 After obtaining an understanding of internal control, the auditor 
may assess control risk at the maximum level for some or all financial state­
ment assertions related to the service organization's processing because, he or 
she believes controls are unlikely to pertain to an assertion, are unlikely to be 
effective, or because evaluating their effectiveness would be inefficient. Proce­
dures to evaluate operating effectiveness include one or any combination of the 
following:
a. Performing tests o f controls over the activities o f the service orga­
nization at the health care organization.
b. Performing tests of controls at the service organization.
c. Obtaining a service auditor’s report that describes the results of 
tests of the operating effectiveness of controls performed by the 
service auditor.
Illegal Acts
2.106 The Social Security Act provides for criminal penalties for individu­
als or entities that offer, pay, solicit, or receive remuneration to induce business 
that is reimbursed under Medicare or state health care programs. The types 
of remuneration covered by the Medicare Anti-Kickback Statute include, with 
certain exceptions, kickbacks, bribes, and rebates made directly or indirectly, 
overtly or covertly, and in cash or in kind. In addition, prohibited conduct in­
cludes not only remuneration intended to induce referrals or patients but also 
remuneration intended to induce the purchasing, leasing, ordering, or arrang­
ing for any good, facility, service, or item paid for by Medicare or state health 
care programs. In addition, fraudulent activities may exist that are unrelated to 
Medicare or state programs, such as fraudulent billing and admitting practices.
2.107 The auditor's procedures will vary based on his or her assessment of 
the risks of material misstatement resulting from such illegal acts. AU section 
317, Illegal Acts by Clients (AICPA, Professional Standards, vol. 1), provides 
requirements and guidance for planning and performing the audit to provide 
reasonable assurance of detecting illegal acts having a direct and material ef­
fect on the determination of financial statement amounts. AU section 317 also
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notes that an audit in accordance with GAAS does not include audit procedures 
specifically designed to detect illegal acts that have only an indirect effect on 
the financial statements (for example, illegal acts that have a material effect as 
the result of fines or penalties that may be imposed on the entity) and provides 
guidance on the auditor's responsibilities when specific information concerning 
the possible existence of this type of illegal act comes to the auditor's attention.
2.108 Examples of laws and regulations that are generally recognized by 
auditors to have a direct and material effect on the determination of amounts 
in financial statements of health care organizations include tax laws affecting 
tax accruals and tax expense as well as Medicare and Medicaid laws directly 
affecting the amount of revenue recognized during the accounting period (such 
as those concerning the submission of bills for fictitious patients).
2.109 Health care organizations also may be affected by many other laws 
and regulations such as those related to Medicare and Medicaid fraud and 
abuse, securities trading, occupational safety and health, food and drug ad­
ministration, environmental protection, equal employment opportunities, and 
price-fixing or other antitrust violations. Generally, these laws and regula­
tions relate more to an entity's operating aspects than to its financial and 
accounting aspects, and their financial statement effect is only indirect. An 
auditor ordinarily does not have sufficient basis for recognizing possible vi­
olations of such laws and regulations. Their indirect effect is normally the 
result of the need to disclose a contingent liability because of the allegation 
or determination of illegality. For example, patients may be obtained based 
on illegal arrangements with physicians or other providers. While the direct 
effects of the services rendered may be recorded appropriately, their indirect 
effects, the possible contingent liability for violating Medicare and Medicaid 
fraud and abuse statutes, may not be appropriately disclosed. Even when vi­
olations of such laws and regulations can have consequences material to the 
financial statements, auditors may not become aware of the existence of the 
illegal act unless he or she is informed by the client, or there is evidence o f a 
governmental agency investigation or enforcement proceeding in the records, 
documents, or other information normally inspected in an audit of financial 
statements.
2.110 Whether an act is, in fact, illegal, is a determination that is nor­
mally beyond the auditor's professional competence. The auditor's training, ex­
perience, and understanding of the client and the industry may provide a basis 
for recognizing that some acts coming to the auditor's attention may be illegal. 
However, determining whether a particular client act is illegal generally would 
be based on the advice of an informed expert qualified to practice law or may 
have to await final determination by a court of law. For example, determining 
whether admitting a patient or providing a service is medically necessary or 
whether a particular procedure or device was properly approved is not within 
the auditor's professional competence.
Clinical Coding Validations
2.111 Typically, a number of clinicians (for example, the attending physi­
cian, consulting physicians, radiologists, pathologists, therapists, and nurses) 
add documentation to a patient's medical record. Provider personnel gener­
ally review the medical record and assign a code (ICD-9-CM or CPT-4 code) 
to the record. The provider prepares and submits a bill that includes, among 
other things, the assigned ICD-9-CM or CPT-4 code. The Medicare Fiscal
Health Care Organizations
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Intermediary or other third-party payor typically reviews the bill and as­
signs it a specific payment code, such as a Diagnostic Related Group (DRG) 
number. Payment is based on the DRG or other payment code assigned. The 
provider may check the payment code assigned and follow up on any discrep­
ancies identified. However, since the assignment of the payment code is made 
by the third-party payor, responsibility for correct assignment rests with that 
payor.
2.112 Errors can occur throughout this process. Physicians or other clini­
cians may not document the appropriate procedure. Coding personnel may not 
notice or interpret certain items in the medical record correctly. Accordingly, an 
incorrect code may be assigned and an erroneous amount may be paid.
2.113 An auditor ordinarily would not find it necessary to consider the pro­
cess of assigning codes in planning and performing an audit of the provider's 
financial statements. However, the auditor should be alert for indications of 
potential material misstatements of the financial statements resulting indi­
rectly from such matters. For example, the auditor may become aware that 
a retrospective review has been performed or that an investigation has been 
completed or is in process. In such circumstances, the auditor should consider 
whether performance of additional substantive audit procedures is necessary 
to reduce audit risk to an acceptable level.
Going-Concern Considerations
2.114 AU section 341, The Auditor's Consideration o f an Entity's Ability to 
Continue as a Going Concern (AICPA, Professional Standards, vol. 1), provides 
guidance to the auditor on evaluating whether there is substantial doubt about 
the entity's ability to continue as a going concern. Continuation of an entity as 
a going concern is assumed in financial reporting in the absence o f significant 
information to the contrary. Ordinarily, information that significantly contra­
dicts the going-concern assumption relates to the entity's inability to continue 
to meet its obligations as they become due without substantial disposition o f 
assets outside the ordinary course of business, restructuring of debt, externally 
forced revision of its operations, or similar actions. AU section 341 paragraph 
.02 states that the independent auditor has a responsibility to evaluate whether 
there is substantial doubt about the entity's ability to continue as a going con­
cern for a reasonable period of time, not to exceed one year beyond the date of 
the financial statements being audited. AU section 341 paragraph .18 provides 
requirements and guidance for the auditor to document certain matters if, after 
considering the identified conditions and events in the aggregate, the auditor 
believes there is substantial doubt about the ability of the entity to continue as 
a going concern for a reasonable period of time, not to exceed one year beyond 
the date of the financial statements being audited.
2.115 Noncompliance with donor-imposed restrictions should be disclosed 
if there is a reasonable possibility that a material contingent liability has been 
incurred at the date of the financial statements or there is at least a reasonable 
possibility that the noncompliance could lead to a material loss of revenue or 
could cause an entity to be unable to continue as a going concern. If the non- 
compliance results from an organization's failure to maintain an appropriate 
composition of assets in amounts needed to comply with all donor restrictions, 
the amounts and circumstances should be disclosed.
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Audit Documentation
Audits Conducted in Accordance With GAAS
2.116 AU section 339, Audit Documentation (AICPA, Professional Stan­
dards, vol. 1), provides guidance on audit documentation. The guidance states 
that the auditor must prepare audit documentation in connection with each 
engagement in sufficient detail to provide a clear understanding of the work 
performed (including the nature, timing, extent, and results of audit proce­
dures performed), the audit evidence obtained and its source, and the conclu­
sion reached. Audit documentation
a. provides the principal support for the representation in the audi­
tor's report that the auditor performed the audit in accordance with 
generally acceptable auditing standards.
b. provides that principal support for the opinion expressed regard­
ing the financial information or the assertion to the effect that an 
opinion cannot be expressed.
2.117 Audit documentation is an essential element of audit quality. Al­
though documentation alone does not guarantee audit quality, the process of 
preparing sufficient and appropriate documentation contributes to the quality 
of an audit.
2.118 Audit documentation is the record of audit procedures performed, 
relevant audit evidence obtained, and conclusions the auditor reached. Audit 
documentation, also known as working papers or workpapers, may be recorded 
on paper or on electronic or other media. When transferring or copying paper 
documentation to another media, the auditor should apply procedures to gen­
erate a copy that is faithful in form and content to the original paper document.
2.119 Audit documentation includes, for example, audit plans, analyses, 
issues memoranda, summaries of significant findings or issues, letters of con­
firmation and representation, checklists, abstracts or copies of important doc­
uments, correspondence (including e-mail) concerning significant findings or 
issues, and schedules of the work the auditor performed. Abstracts or copies of 
the entity's records (for example, significant and specific contracts and agree­
ments) should be included as part of the audit documentation if they are needed 
to enable an experienced auditor to understand the work performed and conclu­
sions reached. The audit documentation for a specific engagement is assembled 
in an audit file.
Form, Content, and Extent of Audit Documentation
2.120 The auditor should prepare audit documentation that enables an 
experienced auditor, having no previous connection to the audit, to understand 
(AU section 339 paragraph .10)
a. the nature, timing, and extent of auditing procedures performed 
to comply with SASs and applicable legal and regulatory require­
ments;
b. the results of the audit procedures performed and the audit evi­
dence obtained;
c. the conclusions reached on significant matters; and
d. that the accounting records agree or reconcile with the audited fi­
nancial statements or other audited information.
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Dating of the Auditors Report
2.121 AU section 339 paragraph .23 states that the auditor's report should 
not be dated earlier than the date on which the auditor has obtained sufficient 
appropriate audit evidence to support the opinion. Among other things, suf­
ficient appropriate audit evidence includes evidence that the audit documen­
tation has been reviewed and that the entity's financial statements, including 
disclosures, have been prepared and that management has asserted that it has 
taken responsibility for them. This ordinarily will result in a report date that 
is close to the date the auditor grants the entity permission to use the auditor’s 
report in connection with the financial statements (report release date). Delays 
in releasing the report may require the auditor to perform additional proce­
dures to comply with the requirements of AU section 560, Subsequent Events 
(AICPA, Professional Standards, vol. 1).
2.122 AU section 339 provides additional requirements and guidance re­
lated to the following:
• Form, content, and extent of audit documentation
• Significant findings and issues
• Identification of preparer and reviewer
• Documentation of specific items tested
• Documentation of departures from statements on auditing stan­
dards
• Revisions to audit documentation
Appendix A to AU section 339 lists the audit documentation requirements con­
tained in other areas of AICPA professional standards.
Audits Conducted in Accordance With PCAOB Standards
2.123 PCAOB Auditing Standard No. 3, Audit Documentation (AICPA, 
PCAOB Standards and Related Rules, Rules of the Board, "Standards"), pro­
vides general requirements for documentation preparation and retention in 
connection with any engagement conducted in accordance with auditing and 
related professional practice standards o f the PCAOB. Such engagements in­
clude audit of financial statements, an audit o f internal control over financial 
reporting, and a review of interim financial information. PCAOB Auditing Stan­
dard No. 3 provides requirements and guidance for accounting firms to retain 
for seven years documentation prepared in connection with engagements con­
ducted pursuant to the PCAOB standards.
Considerations for Integrated Audits
When performing an integrated audit, PCAOB Auditing Standard No.
5 provides requirements and guidance for documentation related to 
the audit of internal control over financial reporting in addition to 
the documentation guidance contained in PCAOB Auditing Standard 
No. 3.
Communication of Matters Related to Internal Control
2.124 AU section 325, Communicating Internal Control Related Matters 
Identified in an Audit (AICPA, Professional Standards, vol. 1), has been updated
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for the issuance of SAS No. 112, Communicating Internal Control Related Mat­
ters Identified in an Audit (AICPA, Professional Standards, vol. 1). Among other 
matters, SAS No. 112 provides the following requirements and guidance:
• Definitions of the terms control deficiency, significant deficiency, 
and material weakness used in PCAOB Auditing Standard No. 5.
• Written communication of significant deficiencies and material 
weaknesses to management and those charged with governance.
2.125 AU section 325 provides guidance on evaluating and communicating 
matters related to an entity's internal control over financial reporting identified 
during an audit of financial statements. AU section 325 provides requirements 
and guidance for control deficiencies identified during the audit that upon eval­
uation are considered significant deficiencies or material weaknesses be com­
municated in writing to management and those charged with governance as a 
part of each audit, including significant deficiencies and material weaknesses 
that were communicated to management and those charged with governance 
in previous audits, and have not yet been remediated. A control deficiency ex­
ists when the design or operation of a control does not allow management or 
employees, in the normal course of performing their assigned functions, to pre­
vent or detect misstatements on a timely basis. A significant deficiency is a 
control deficiency, or combination of control deficiencies, that adversely affects 
the entity's ability to initiate, authorize, record, process, or report financial data 
reliably in accordance with GAAP such that there is more than a remote like­
lihood that a misstatement of the entity's financial statements that is more 
than inconsequential will not be prevented or detected by the entity's internal 
control. A material weakness is a significant deficiency, or combination of signif­
icant deficiencies, that results in more than a remote likelihood that a material 
misstatement of the financial statements will not be prevented or detected by 
the entity's internal control. AU section 325 provides that the communication 
should state that it is intended solely for the information and use of manage­
ment, those charged with governance, and others within the organization and 
is not intended to be and should not be used by anyone other than these speci­
fied parties. If an entity is required to furnish such auditor communications to 
a governmental authority, specific reference to such governmental authorities 
may be made.
Communication With Those Charged With Governance
2.126 AU section 380, The Auditor's Communication With Those Charged 
With Governance (AICPA, Professional Standards, vol. 1), has been updated 
for the issuance of SAS No. 114, The Auditor's Communication With Those 
Charged With Governance (AICPA, Professional Standards, vol. 1). Para­
graph .05 of AU section 380 states the auditor must communicate with those 
charged with governance matters related to the financial statement audit that 
are, in the auditor's professional judgment, significant and relevant to the re­
sponsibilities of those charged with governance in overseeing the financial re­
porting process. The new guidance defines those charged with governance as the 
person(s) with responsibility for overseeing the strategic direction of the entity 
and obligations related to the accountability of the entity. AU section 380 is ap­
plicable to all health care organizations being audited under GAAS, regardless 
of their governance structure or size. AU section 380 states the auditor should 
communicate with those charged with governance
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• the auditor's responsibilities under GAAS.
• an overview of the planned scope and timing of the audit.
• significant finding from the audit.
While the communication can be oral, it should be in writing when, in the au­
ditor's judgment, oral communication would not be adequate. AU section 380 
also contains information on the communication process, timing of communi­
cation, and specific examples o f the types of communication. (See AU section 
380 paragraphs .23-.44 for examples of items to be communicated). AU sec­
tion 380 paragraph .40 states that the auditor should communicate with those 
charged with governance uncorrected misstatements and the effect that they 
may have on the opinion in the auditor's report, and may request their correc­
tion. AU section 380 paragraphs .40-.41 contain more information related to 
the communication of misstatements. AU section 380 also states that open and 
constructive communication about qualitative aspects of the entity’s significant 
account practices may include comment of the acceptability of significant ac­
count practices. Appendix B of AU section 380 provides guidance on the matters 
that may be included in this communication. AU section 532, Restricting the 
Use o f  an Auditor's Report (AICPA, Professional Standards, vol. 1), refers to 
reports issued under AU section 380 paragraph .40 as by-product reports, and 
states that the use of such reports should be restricted.
Management Representations
2.127 AU section 333 establishes a requirement that an auditor perform­
ing an audit in accordance with GAAS, obtain written representations from 
management for all financial statements and periods covered by the auditor's 
report. The specific written representations to be obtained depend on the cir­
cumstances of the engagement and the nature and basis o f presentation o f the 
financial statements. AU section 333 paragraph .06 lists matters ordinarily in­
cluded in management's representation letter, including representations from 
management regarding fraud. AU section 333 includes several examples as 
well. AU section 333 paragraph .16 includes an illustrative management rep­
resentation letter, AU section 333 paragraph .17 provides illustrative wording 
for additional representations that may be appropriate in certain situations, 
and AU section 333 paragraph .18 provides an illustrative updating manage­
ment representation letter.
2.128 Independent auditors of health care organizations also might obtain 
representations, if applicable, of the following:
• The health care organization is in compliance with the provisions 
of Internal Revenue Code (IRC) sec. 501(c)(3) and is exempt from 
federal income tax under IRC sec. 501(a), as evidenced by a deter­
mination letter.
• Information returns have been filed on a timely basis.
• Provision has been made, when material, for estimated retroactive 
adjustments by third-party payors under reimbursement agree­
ments.
• The health care organization is in compliance with bond inden­
tures or other debt instruments.
• Pending changes in the organizational structure, financing ar­
rangements, or other matters that could have a material effect 
on the financial statements of the entity are properly disclosed.
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• The health care organization is in compliance with contractual 
agreements, grants, and donor restrictions.
• The health care organization has maintained an appropriate com­
position of assets in amounts needed to comply with all donor re­
strictions.
• All assets and liabilities under the entity's control have been in­
cluded in the financial statements.
• The internal controls over the receipt and recording of contribu­
tions received are adequate.
• Reclassifications between net asset classes is proper.
2.129 SOP 00-1 provides the following examples of specific representations 
for receivables, cost reports filed with third parties, and contingencies related 
to health care third-party revenue recognition:
• Receivables
— Adequate consideration has been given to, and appro­
priate provision made for, estimated adjustments to rev­
enue, such as for denied claims and changes to DRG as­
signments.
— Recorded valuation allowances are necessary, appropri­
ate, and properly supported.
— All peer review organizations, fiscal intermediary, and 
third-party payor reports and information have been 
made available.
• Cost reports filed with third parties
— All required Medicare, Medicaid, and similar reports 
have been properly filed.
— Management is responsible for the accuracy and propri­
ety of all cost reports filed.
— All costs reflected on such reports are appropriate and al­
lowable under applicable reimbursement rules and regu­
lations and are patient-related and properly allocated to 
applicable payors.
— The reimbursement methodologies and principles em­
ployed are in accordance with applicable rules and regu­
lations.
— Adequate consideration has been given to, and appropri­
ate provision made for, audit adjustments by intermedi­
aries, third-party payors, or other regulatory agencies.
— All items required to be disclosed, including disputed 
costs that are being claimed to establish a basis for a 
subsequent appeal, have been fully disclosed in the cost 
report.
— Recorded third-party settlements include differences be­
tween filed (and to be filed) cost reports and calculated 
settlements, which are necessary based on historical ex­
perience or new or ambiguous regulations that may be
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subject to differing interpretations. While management 
believes the entity is entitled to all amounts claimed on 
the cost reports, management also believes the amounts 
of these differences are appropriate.
• Contingencies
— There are no violations or possible violations of laws or 
regulations, such as those related to the Medicare and 
Medicaid antifraud and abuse statutes, including but 
not limited to the Medicare and Medicaid Anti-Kickback 
Statute, Limitations on Certain Physician Referrals (the 
Stark law), and the False Claims Act, in any jurisdic­
tion, whose effects should be considered for disclosure in 
the financial statements or as a basis for recording a loss 
contingency other than those disclosed or accrued in the 
financial statements.
— Billings to third-party payors comply in all material re­
spects with applicable coding guidelines (for example, 
ICD-9-CM and CPT-4) and laws and regulations (includ­
ing those dealing with Medicare and Medicaid antifraud 
and abuse), and billings reflect only charges for goods 
and services that were medically necessary; properly ap­
proved by regulatory bodies (for example, the Food and 
Drug Administration), if  required; and properly rendered.
— There have been no communications (oral or written) 
from regulatory agencies, governmental representatives, 
employees, or others concerning investigations or allega­
tions of noncompliance with laws and regulations in any 
jurisdiction (including those related to the Medicare and 
Medicaid antifraud and abuse statutes), deficiencies in 
financial reporting practices, or other matters that could 
have a material adverse effect on the financial state­
ments.
2.130 Governmental health care entities only. Auditors o f governmental 
health care entities also should consider obtaining representations concern­
ing the information provided in management discussion and analysis, as pro­
vided in paragraph .07c of AU section 558, Required Supplementary Informa­
tion (AICPA, Professional Standards, vol. 1).
Single Audit Act and Related Audit Considerations
2.131 An independent auditor may be engaged to audit the financial state­
ments of a health care organization that expends federal awards from a gov­
ernmental agency in accordance with the Single Audit Act Amendments of 
1996 and Office o f Management and Budget (OMB) Circular A-133, Audits o f  
States, Local Governments, and Non-Profit Organizations. Federal awards may 
take the form of grants, contracts, loans, loan guarantees, property, cooperative 
agreements, interest subsidies, and insurance or direct appropriations.
2.132 OMB Circular A-133 prescribes policies, procedures, and guide­
lines to implement the Single Audit Act Amendments o f 1996 and provides 
requirements and guidance to state and local governments and not-for-profit
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organizations that expend total federal awards equal to or in excess of $500,000 
in a fiscal year to have an audit performed in accordance with the act and OMB 
Circular A-133.
2.133 Institutions covered by OMB Circular A-133 include not-for-profit 
hospitals and public hospitals and institutions of higher education, and their 
affiliated hospitals, voluntary health and welfare organizations and other 
community-based organizations.7 Medicare payments to a non-federal entity 
for providing patient care services to Medicare eligible individuals are not con­
sidered federal awards expended under OMB Circular A-133. Medicaid pay­
ments to a subrecipient for providing patient care services to Medicaid eligible 
individuals are not considered federal awards expended under OMB Circular A- 
133 unless a state requires the funds to be treated as federal awards expended 
because reimbursement is on a cost-reimbursement basis.
2.134 OMB Circular A-110 establishes standard requirements (such as 
insurance, record retention, and banking) for obtaining consistency and unifor­
mity among federal agencies in the administration of grants to and agreements 
with public and private hospitals and other entities. OMB Circular A-87, Cost 
Principles for State and Local Governments, establishes principles and stan­
dards for determining allowable costs incurred by state and local governments 
under grants, contracts, and other agreements. OMB Circular A-21, Cost Prin­
ciples for Educational Institutions, and OMB Circular A-122, Cost Principles 
for Nonprofit Organizations, establish principles and standards for determin­
ing allowable costs incurred by educational institutions and not-for-profit or­
ganizations under grants, contracts, and other agreements. Federal research 
and development awards under grants and contracts administered by hospi­
tals are exempt from OMB's cost principles circulars A-87, A-21, and A-122, 
but are subject to requirements provided in the U.S. Department of Health and 
Human Services regulations at 45 CFR Part 74, Appendix E, "Principles for De­
termining Costs Applicable to Research and Development Under Grants and 
Contracts with Hospitals."
2.135 AU section 801, Compliance Auditing Considerations in Audits o f  
Governmental Entities and Recipients o f Governmental Financial Assistance 
(AICPA, Professional Standards, vol. 1), provides general guidance for audits 
of governmental entities and entities that receive federal awards. AU section 
801 explains the requirements of the financial audit standards contained in 
Government Auditing Standards, as amended (the Yellow Book), issued by the 
Comptroller General of the United States and their relationship to GAAS. It 
also provides general guidance on testing compliance with requirements appli­
cable to federal awards. AU section 801 clarifies that the entity, rather than 
the independent auditor, is responsible for arranging for audits that meet all 
applicable requirements and provides guidance on communications the audi­
tor makes upon becoming aware that the entity may be subject to an audit 
requirement that may not be satisfied by his or her engagement.
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7 The Codification of Office of Management and Budget (OMB) Circular A-133, Audits o f States, 
Local Governments, and Non-Profit Organizations, by the U.S. Department of Health and Human 
Services (HHS) also includes audit requirements for commercial organizations (including for-profit 
hospitals) that receive federal awards under HHS programs. Generally, the organization has two 
options regarding audits: (1) a financial-related audit of a particular award in accordance with Gov­
ernment Auditing Standards, or (2) an audit that meets the requirements of OMB Circular A-133. 
See Title 45 of the Code of Federal Regulations Section 74.26(d) for further information.
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2.136 The Audit Guide Government Auditing Standards and Circular 
A-133 Audits provides guidance on the auditor's responsibilities when conduct­
ing a single audit or program-specific audit in accordance with the Single Audit 
Act Amendments of 1996 and OMB Circular A-133. It discusses the auditor's re­
sponsibility for considering internal control and for performing tests of compli­
ance with applicable laws, regulations, and program compliance requirements. 
Further, it provides reporting guidance including examples of the reports re­
quired by Government Auditing Standards and OMB Circular A-133. The Gov­
ernment Accountability Office (GAO) provided guidance to entities that are 
subject to audits conducted in accordance with both the standards issued by the 
PCAOB and Government Auditing Standards. In May 2005, the GAO posted an 
internet notice titled "Guidance on Complying with Government Auditing Stan­
dards Reporting Requirements for the Report on Internal Control for Audits 
of Certain Entities Subject to the Requirements of the Sarbanes-Oxley Act o f 
2002 and Government Auditing Standards"' at www.gao.gov/govaud/ybk01.htm.
The internet notice states that Government Auditing Standards may be used 
in conjunction with professional standards issued by other authoritative bod­
ies such as the PCAOB even though those standards are not incorporated into 
Government Auditing Standards. Further information about the internet notice 
is provided in the Audit Guide Government Auditing Standards and Circular 
A-133 Audits.
Statutory Reporting Considerations for Managed
Care Organizations
Risk-Based Capital Requirements
2.137 Many managed care organizations (MCO) that bear financial risk 
are regulated by state departments of insurance. The risk-based capital (RBC) 
formula is one of the tools used by regulators to evaluate the financial health 
of regulated entities.
2.138 The National Association of Insurance Commissioners (NAIC) for­
mula for the RBC of managed care organizations became effective in the filing 
of 1998 annual statements. Five principal risk elements to the MCO RBC for­
mula are: affiliated investment risk, asset risk, underwriting risk, credit risk, 
and general business risk. Four action levels (in order of increasingly stringent 
level of regulatory response) are: company action level, regulatory action level, 
authorized control level, and mandatory control level. At a minimum, the com­
pany action-level event requires the filing with the respective state insurance 
commissioner an RBC plan detailing conditions leading to the event and pro­
posals of corrective action. State laws vary as to whether applicable legislation 
pertaining to compliance with the RBC formula has been passed. Additional 
information can be found on the NAIC Web site at www.naic.org.
Codification of Statutory Accounting Practices for Managed 
Care Organizations
2.139 Generally speaking, regulated insurers have been required by their 
state of domicile to submit annually a set of audited financial statements that 
were prepared using that state's prescribed or permitted statutory account­
ing practices. These statutory accounting practices are considered to be an
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other comprehensive basis o f accounting under AU section 623, Special Re­
ports (AICPA, Professional Standards, vol. 1). Auditing Interpretation No. 12, 
"Evaluation of the Appropriateness of Informative Disclosures in Insurance En­
terprises' Financial Statements Prepared on a Statutory Basis," of AU section 
623 (AICPA, Professional Standards, vol. 1, AU sec. 9623 par. .60-.77; AICPA, 
PCAOB Standards and Related Rules, PCAOB Standards, As Amended, AU 
sec. 9623 par. .6 0 - .81), provide guidance in evaluating the adequacy and ap­
propriateness of informative disclosures in financial statements prepared on a 
statutory basis.
2.140 In 1999, the NAIC completed a process to codify statutory account­
ing practices for certain insurance entities (including regulated MCO), resulting 
in a revised Accounting Practices and Procedures Manual effective January 1, 
2001 (the revised manual). This manual has also been updated on an annual 
basis and a new Accounting Practices and Procedure Manual reflecting revi­
sions or additions to statutory accounting principles is published in March of 
each year. It is expected that most states will require insurers to comply with 
most, if not all, provisions of the manual. States may adopt the manual in 
whole, or in part, as an element of prescribed statutory accounting practices in 
those states. If, however, the requirements of state laws, regulations, and ad­
ministrative rules differ from guidance provided in the manual or those state 
laws, regulations, and administrative rules will take precedence. Preparers of 
financial statements and auditors should monitor the status of the adoption of 
the manual by the domiciliary state insurance regulatory authority.
2.141 Practitioners should consider whether going-concern issues exist as 
a result of the financial statement effect of adoption. This includes consideration 
of the effect on RBC.
2.142 Nine of the Statements of Statutory Accounting Principles (SSAPs) 
included in the revised manual have been specifically modified or written to 
address issues related to managed care. These include SSAPs No. 25, Account­
ing for and Disclosures about Transactions with Affiliates and Other Related 
Parties, No. 35, Guaranty Fund and Other Assessments, No. 47, Uninsured 
Plans, No. 50, Classifications and Definitions o f Insurance or Managed Care 
Contracts in Force, No. 54, Individual and Group Accident and Health Con­
tracts, No. 55, Unpaid Claims, Losses and Loss Adjustment Expenses, No. 66, 
Retrospectively Rated Contracts, No. 73, Health Care Delivery Assets-Supplies, 
Pharmaceuticals and Surgical Supplies, Durable Medical Equipment, Furni­
ture, Medical Equipment and Fixtures, and Leasehold Improvements in Health 
Care Facilities, and No. 84, Certain Health Care Receivables and Receivables 
Under Government Insured Plans. All other SSAPs will apply if applicable to 
the entity.
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Chapter 3
Cash and Cash Equivalents
Accounting and Financial Reporting
3.01 Cash and cash equivalents should include all cash and highly liq­
uid investments that are both (a) readily convertible to cash and (b) so near 
to maturity that they present insignificant risk of changes in value because 
of changes in interest rates, in accordance with paragraph 8 of Financial Ac­
counting Standards Board (FASB) Statement No. 95, Statement o f Cash Flows, 
and paragraph 9 of Governmental Accounting Standards Board (GASB) State­
ment No. 9, Reporting Cash Flows of Proprietary and Nonexpendable Trust 
Funds and Governmental Entities That Use Proprietary Fund Accounting. For 
fiduciary purposes, separate checking or savings accounts may be maintained 
for restricted donations. Such accounts, however, are not reported on a line 
separate from other cash and cash equivalents because donor restrictions gen­
erally relate to limitations on the use of net assets rather than on the use 
of specific assets.1 However, cash and claims to cash that (a) are restricted 
as to withdrawal or use for other than current operations, (b) are designated 
for expenditure in the acquisition or construction of noncurrent assets, (c) are 
required to be segregated for the liquidation of long term debts, or (d ) are re­
quired by a donor-imposed restriction that limits their use to long term pur­
poses are reported separately and are excluded from current assets. (See para­
graph 10.11.) Internally designated funds should be reported separately from 
externally designated funds either on the face of the balance sheet or in the 
notes to the financial statements. If the form of the assets is not evident from 
the description on the balance sheet, the form of the assets should be disclosed 
in the notes to the financial statements. GASB Statement No. 9, paragraph 8, 
provides that a governmental health care enterprise's statement of cash flows 
should explain the change in all cash and cash equivalents, regardless of any 
restrictions on their use. For governmental health care entities, restricted cash 
and cash equivalents should be reported when restrictions on the use of those 
assets change the nature or normal understanding of those assets, as discussed 
in GASB Statement No. 34, Basic Financial Statements—and Management's 
Discussion and Analysis—for State and Local Governments, paragraph 99. For 
example, cash and investments that can only be used to pay debt principal and 
interest would be reported as restricted cash and investments or as cash and 
investments held by trustee for debt service. The term restricted is defined by 
GASB Statement No. 34, paragraphs 34, as amended, and 99. A restriction is a 
constraint placed on the use of assets or net assets that is either externally im­
posed (such as by creditors through debt covenants) or imposed by law through 
constitutional provisions or enabling legislation.
Agency Funds
3.02 Health care organizations may receive and hold assets owned by 
others under agency relationships; for example, they may perform billing and
1 A columnar presentation that highlights the three classes of net assets (that is, permanently 
restricted, temporarily restricted, and unrestricted) is not precluded if the totals for the reporting 
entity as a whole are displayed.
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collection services for physicians. In accepting responsibility for those assets, 
an organization incurs a liability to the principal under the agency relationship 
to return the assets in the future or, if authorized, to disburse them to another 
party on behalf of the principal. Such agency funds are reported as unrestricted 
assets.
3.03 In other cases, not-for-profit health care organizations may act as 
agents, trustees, or intermediaries helping donors to make a contribution to 
another entity or individual. When acting in that capacity, those organiza­
tions do not receive a contribution when they receive the assets, nor do they 
make a contribution when they disburse the assets to the other entity or in­
dividual. Instead, they act as go-betweens, passing the assets from the donor 
through their organization to the specified entity or individual. FASB State­
ment No. 136, Transfers o f Assets to a Not-for-Profit Organization or Charitable 
Trust That Raises or Holds Contributions for Others,2 establishes standards 
for transactions in which a donor makes a contribution by transferring as­
sets to a recipient organization—a not-for-profit organization or a charitable 
trust—that accepts the assets from the donor and agrees to use the assets on 
behalf of or transfer the assets, their investment return, or both to another 
entity—the beneficiary—named by the donor.3 In general, if a donor specifies 
a beneficiary, the recipient organization should not recognize a contribution. 
(For exceptions, see the discussion of variance power at paragraph 10.05 in this 
guide and financially interrelated organizations at paragraphs 11.29-.33 in 
this guide.) Instead, as discussed in paragraph 11 of FASB Statement No. 136, 
the recipient organization should recognize its liability to the specified benefi­
ciary concurrent with its recognition of cash or other financial assets received 
from the donor. Both the asset and the liability recognized should be mea­
sured at the fair value of the assets received. If the assets received from the 
donor are donated materials, supplies, or other nonfinancial assets, the re­
cipient organization may choose either to (a) report the receipt of the assets 
as a liability to the beneficiary concurrent with recognition of the assets re­
ceived or (b) not report the transaction at all. The choice is an accounting policy 
that should be applied consistently from period to period. An entity should 
consider the need for disclosure in the notes to the financial statements pur­
suant to Accounting Principles Board Opinion No. 22, Disclosure o f Accounting 
Policies, and paragraph 11 of FASB Statement No. 136. Standards for not-for- 
profit organizations that act as agents, trustees, or intermediaries are described 
further in chapters 5 and 6 of the Audit and Accounting Guide Not-for-Profit 
Organizations.
3.04 FASB Statement No. 157, Fair Value Measurements, issued in 
September 2006, defines fair value, establishes a framework for measuring 
fair value, and expands disclosures about fair value measurements. FASB 
Statement No. 157 is effective for financial statements issued for fiscal years
Health Care Organizations
2 Governmental health care entities only. This pronouncement is not applicable to governmental 
health care enterprises. (See footnote 1 in chapter 1.)
3 Financial Accounting Standards Board (FASB) Statement No. 136, Transfers o f Assets to a 
Not-for-Profit Organization or Charitable Trust That Raises or Holds Contributions for Others, also 
establishes standards for transactions that take place in a similar manner but are not contributions 
because the transfers are revocable, repayable, or reciprocal. For example, if a resource provider trans­
fers assets to a recipient organization and names itself or its affiliate as beneficiary, that transaction 
is reciprocal even if the resource provider grants variance power. Those standards and transactions 
are discussed in paragraphs 4 .2 3 -.24, 11.21, and 11.23-.24 in this guide. This guide does not use the 
word donor in discussing those transactions because they are not contributions.
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beginning after November 15, 2007, and interim periods within those fiscal 
years. Earlier application is encouraged, provided that the reporting entity 
has not yet issued financial statements for that fiscal year, including financial 
statements for an interim period within that fiscal year.
3.05 FASB issued two FASB Staff Positions (FSPs) in February 2008 re­
lated to FASB Statement No. 157:
• FSP FAS 157-2, Effective Date o f  FASB Statement No. 157, de­
lays the effective date of FASB Statement No. 157 for nonfinan­
cial assets and nonfinancial liabilities, except for items that are 
recognized or disclosed at fair value at least once a year, to fis­
cal years beginning after November 15, 2008. The FSP is effec­
tive upon issuance and also covers interim periods within the fis­
cal years for items within the scope of this FSP. The delay is in­
tended to allow FASB and its constituents the time to consider the 
various implementation issues associated with FASB Statement 
No. 157.
• FSP FAS 157-1, Application o f  FASB Statement No. 157 to FASB 
Statement No. 13 and Other Accounting Pronouncements That Ad­
dress Fair Value Measurements for Purposes o f Lease Classifica­
tion or Measurement under Statement 13, amends FASB State­
ment No. 157 to exclude FASB Statement No. 13, Accounting for 
Leases, and other accounting pronouncements that address fair 
value measurements for purposes of lease classification or mea­
surement under FASB Statement No. 13. However, this scope ex­
ception does not apply to assets acquired and liabilities assumed in 
a business combination that are required to be measured at fair 
value under FASB Statement No. 141 (revised 2007), Business 
Combinations, regardless of whether those assets and liabilities 
are related to leases. This FSP shall be effective upon the initial 
adoption of FASB Statement No. 157.
The following paragraphs summarize FASB Statement No. 157 but are not 
intended as a substitute for the reading of the statement itself.
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Definition of Fair Value
3.06 Paragraph 5 of FASB Statement No. 157 defines fair value as "the 
price that would be received to sell an asset or paid to transfer a liability in 
an orderly transaction between market participants at the measurement date." 
That definition retains the exchange price notion in earlier definitions of fair 
value, but clarifies that the exchange price is the price in a hypothetical trans­
action at the measurement date in the market in which the reporting entity 
would transact for the asset or liability. A fair value measurement assumes 
that the transaction to sell the asset or transfer the liability occurs in the prin­
cipal market for the asset or liability or, in the absence of a principal market, 
the most advantageous market for the asset or liability. Paragraph 8 of FASB 
Statement No. 157 defines the principal market as the market in which the 
reporting entity would sell the asset or transfer the liability with the greatest 
volume and level of activity for the asset or liability.
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3.07 Paragraph 12 of FASB Statement No. 157 provides that a fair value 
measurement of an asset assumes the highest and best use of the asset by 
market participants, considering the use of the asset that is physically possible, 
legally permissible, and financially feasible at the measurement date. Highest 
and best use is determined based on the use of the asset by market participants 
that would maximize the value of the asset or the group of assets within which 
the asset would be used, even if the intended use of the asset by the reporting 
entity is different.
3.08 Paragraph 13 of FASB Statement No. 157 provides that the highest 
and best use for an asset is established by 1 of 2 valuation premises: value in- 
use or value in-exchange. The highest and best use of the asset is in-use if the 
asset would provide maximum value to market participants principally through 
its use in combination with other assets as a group (as installed or otherwise 
configured for use). For example, value in-use might be appropriate for certain 
nonfinancial assets. An asset's value in-use should be based on the price that 
would be received in a current transaction to sell the asset assuming that the 
asset would be used with other assets as a group and that those other assets 
would be available to market participants. The highest and best use of the asset 
is in-exchange if the asset would provide maximum value to market participants 
principally on a standalone basis. For example, value in-exchange might be 
appropriate for a financial asset. An asset's value in-exchange is determined 
based on the price that would be received in a current transaction to sell the 
asset standalone.
3.09 Paragraph 15 of FASB Statement No. 157 provides that a fair value 
measurement for a liability reflects its nonperformance risk (the risk that the 
obligation will not be fulfilled). Because nonperformance risk includes the re­
porting entity's credit risk, the reporting entity should consider the effect of its 
credit risk (credit standing) on the fair value of the liability in all periods in 
which the liability is measured at fair value.
3.10 Paragraph 7 of FASB Statement No. 157 provides that the hypothet­
ical transaction to sell the asset or transfer the liability is considered from the 
perspective of a market participant that holds the asset or owes the liability. 
Therefore, the definition of fair value focuses on the price that would be re­
ceived to sell the asset or paid to transfer the liability (an exit price), not the 
price that would be paid to acquire the asset or received to assume the liability 
(an entry price). Conceptually, entry prices and exit prices are different. How­
ever, paragraph 17 of FASB Statement No. 157 explains that, in many cases, 
at initial recognition a transaction price (entry price) will equal the exit price 
and, therefore, will represent the fair value of the asset or liability.
3.11 Paragraph 9 of FASB Statement No. 157 provides that the price 
should not be adjusted for transaction costs. If location is an attribute of the 
asset or liability (as might be the case for a commodity), the price in the princi­
pal (or most advantageous) market used to measure the fair value of the asset 
or liability should be adjusted for the costs, if any, that would be incurred to 
transport the asset or liability to (or from) that market.
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3.12 Paragraphs 18-20 of FASB Statement No. 157 describe the valuation 
techniques that should be used to measure fair value. Valuation techniques
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consistent with the market approach, income approach, and cost approach 
should be used to measure fair value, as follows:
• The market approach uses prices and other relevant information 
generated by market transactions involving identical or compa­
rable assets or liabilities. Valuation techniques consistent with 
the market approach include matrix pricing and often use market 
multiples derived from a set of comparables.
• The income approach uses valuation techniques to convert future 
amounts (for example, cash flows or earnings) to a single present 
amount (discounted). The measurement is based on the value indi­
cated by current market expectations about those future amounts. 
Valuation techniques consistent with the income approach include 
present value techniques, option-pricing models, and the multi­
period excess earnings method.
• The cost approach is based on the amount that currently would be 
required to replace the service capacity of an asset (often referred 
to as current replacement cost). Fair value is determined based on 
the cost to a market participant (buyer) to acquire or construct a 
substitute asset of comparable utility, adjusted for obsolescence.
3.13 Valuation techniques that are appropriate in the circumstances and 
for which sufficient data are available should be used to measure fair value. 
In some cases, a single valuation technique will be appropriate (for example, 
when valuing an asset or liability using quoted prices in an active market for 
identical assets or liabilities). In other cases, multiple valuation techniques will 
be appropriate and the respective indications of fair value should be evaluated 
and weighted, as appropriate, considering the reasonableness of the range indi­
cated by those results, examples 4—5 of appendix A of FASB Statement No. 157 
illustrate the use of multiple valuation techniques. A fair value measurement 
is the point within that range that is most representative of fair value in the 
circumstances.
3.14 Valuation techniques used to measure fair value should be consis­
tently applied. However, a change in a valuation technique or its application 
is appropriate if the change results in a measurement that is equally or more 
representative of fair value in the circumstances. Such a change would be ac­
counted for as a change in accounting estimate in accordance with the provisions 
of FASB Statement No. 154, Accounting Changes and Error Corrections—a re­
placement o f  APB Opinion No. 20 and FASB Statement No. 3.
Present Value Techniques
3.15 Appendix B of FASB Statement No. 157 provides guidance on present 
value techniques, thereby incorporating into level A generally accepted account­
ing principles (GAAP) certain guidance from FASB Concepts Statement No. 7, 
Using Cash Flow Information and Present Value in Accounting Measurements, 
making certain revisions. Appendix B neither prescribes the use of one specific 
present value technique nor limits the use of present value techniques to the 
three techniques discussed therein. It says that a fair value measurement of an 
asset or liability using present value techniques should capture the following 
elements from the perspective of market participants as of the measurement 
date: an estimate of future cash flows, expectations about possible variations 
in the amount or timing (or both) of the cash flows, the time value of money,
Cash and Cash Equivalents
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the price for bearing the uncertainty inherent in the cash flows (risk premium), 
other case-specific factors that would be considered by market participants, 
and in the case of a liability, the nonperformance risk relating to that liability, 
including the reporting entity's (obligor's) own credit risk.
3.16 Paragraph B3 of FASB Statement No. 157 provides the general prin­
ciples that govern any present value technique, as follows:
• Cash flows and discount rates should reflect assumptions that 
market participants would use in pricing the asset or liability.
• Cash flows and discount rates should consider only factors at­
tributed to the asset (or liability) being measured.
• To avoid double counting or omitting the effects of risk factors, 
discount rates should reflect assumptions that are consistent with 
those inherent in the cash flows. For example, a discount rate that 
reflects expectations about future defaults is appropriate if using 
the contractual cash flows of a loan, but is not appropriate if the 
cash flows themselves are adjusted to reflect possible defaults.
• Assumptions about cash flows and discount rates should be in­
ternally consistent. For example, nominal cash flows (that include 
the effects of inflation) should be discounted at a rate that includes 
the effects of inflation.
• Discount rates should be consistent with the underlying economic 
factors of the currency in which the cash flows are denominated.
3.17 Present value techniques differ in how they adjust for risk and in the 
type of cash flows they use. For example, the discount rate adjustment tech­
nique (also called the traditional present value technique) uses a risk-adjusted 
discount rate and contractual, promised, or most likely cash flows. In contrast, 
expected present value techniques use the probability-weighted average of all 
possible cash flows (referred to as expected cash flows). The traditional present 
value technique and 2 methods of expected present value techniques are dis­
cussed more fully in appendix B of FASB Statement No. 157.
3.18 This guide includes guidance about measuring assets (promises to 
give and beneficial interests in trusts) and liabilities (split-interest obligations) 
using traditional present value techniques. That guidance is not intended to 
suggest that the income approach is the only 1 of the 3 approaches that is ap­
propriate in the circumstances, nor is it intended to suggest that the traditional 
present value technique described in the guide is preferred over other present 
value techniques. Rather, the inclusion of that guidance in the guide merely 
reflects that prior to the issuance o f FASB Statement No. 157, present value 
techniques were specifically mentioned in FASB Statement No. 116, Account­
ing for Contributions Received and Contributions Made, and FASB Statement 
No. 136 as appropriate for measuring promises to give cash and beneficial in­
terests in trusts, and the guide had been drafted reflecting those standards. In 
conforming this guide to the standards of FASB Statement No. 157, guidance 
that previously specified the use of the traditional present value technique was 
modified to indicate that the technique was a possible technique to consider 
for fair value measurement. Further, because FASB Statement No. 157 uses 
the phrase expected cash flows in its description of the probability-weighted 
present value techniques and many standards previously used the phrase esti­
mated cash flows when describing the traditional present value technique, the 
phrases estimated cash flows, expected cash flows, and estimated expected cash
Health Care Organizations
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flows, which had been used in the guide, were all changed to the phrase future 
cash flows so as not to suggest a particular present value technique.
The Fair Value Hierarchy
3.19 FASB Statement No. 157 emphasizes that fair value is a market- 
based measurement, not an entity-specific measurement. Therefore, a fair value 
measurement should be determined based on the assumptions that market 
participants would use in pricing the asset or liability (referred to in the state­
ment as inputs). Paragraphs 21-31 establish a fair value hierarchy that distin­
guishes between (1) market participant assumptions developed based on mar­
ket data obtained from sources independent of the reporting entity (observable 
inputs) and (2) the reporting entity's own assumptions about market partici­
pant assumptions developed based on the best information available in the cir­
cumstances (unobservable inputs). Valuation techniques used to measure fair 
value should maximize the use of observable inputs and minimize the use of 
unobservable inputs.
3.20 The fair value hierarchy in FASB Statement No. 157 prioritizes the 
inputs to valuation techniques used to measure fair value into 3 broad levels. 
The 3 levels are described in the following list:
• Level 1 inputs are quoted prices (unadjusted) in active markets 
for identical assets or liabilities that the reporting entity has the 
ability to access at the measurement date. An active market is a 
market in which transactions for the asset or liability occur with 
sufficient frequency and volume to provide pricing information on 
an ongoing basis. A quoted price in an active market provides the 
most reliable evidence of fair value and should be used to measure 
fair value whenever available, except as discussed in paragraphs 
25-26 of FASB Statement No. 157.
• Level 2 inputs are inputs other than quoted prices included within 
level 1 that are observable for the asset or liability, either directly 
or indirectly. Adjustments to level 2 inputs will vary depending 
on factors specific to the asset or liability. An adjustment that is 
significant to the fair value measurement in its entirety might 
render the measurement a level 3 measurement, depending on 
the level in the fair value hierarchy within which the inputs used 
to determine the adjustment fall. Level 2 inputs include
a. quoted prices for similar assets or liabilities in active mar­
kets;
b. quoted prices for identical or similar assets or liabilities in 
markets that are not active;
c. inputs other than quoted prices that are observable for 
the asset or liability (for example, interest rates and yield 
curves observable at commonly quoted intervals, volatili­
ties, prepayment speeds, loss severities, credit risks, and 
default rates); and
d. inputs that are derived principally from or corroborated 
by observable market data by correlation or other means 
(market-corroborated inputs).
Cash and Cash Equivalents
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• Level 3 inputs are unobservable inputs for the asset or liability. 
Unobservable inputs should be used to measure fair value to the 
extent that observable inputs are not available, thereby allow­
ing for situations in which there is little, if any, market activity 
for the asset or liability at the measurement date. In develop­
ing unobservable inputs, the reporting entity need not undertake 
all possible efforts to obtain information about market partici­
pant assumptions. Unobservable inputs should reflect the report­
ing entity's own assumptions about the assumptions that market 
participants would use in pricing the asset or liability (including 
assumptions about risk). The reporting entity should not ignore 
information about market participant assumptions that is reason­
ably available without undue cost and effort.
In some cases, the inputs used to measure fair value might fall in different levels 
of the fair value hierarchy. The level in the fair value hierarchy within which 
the fair value measurement in its entirety falls should be determined based on 
the lowest level input that is significant to the fair value measurement in its 
entirety.
3.21 As discussed in paragraph 23 of FASB Statement No. 157, the avail­
ability of inputs relevant to the asset or liability and the relative reliability of 
the inputs might affect the selection of appropriate valuation techniques. How­
ever, the fair value hierarchy prioritizes the inputs to valuation techniques, 
not the valuation techniques. For example, a fair value measurement using a 
present value technique might fall within level 2 or level 3, depending on the 
inputs that are significant to the measurement in its entirety and the level in 
the fair value hierarchy within which those inputs fall.
3.22 Market participant assumptions should include assumptions about 
the effect of a restriction on the sale or use of an asset if market participants 
would consider the effect of the restriction in pricing the asset. Examples 8-9 
(paragraphs A29-A30) of FASB Statement No. 157 explain that restrictions 
that are an attribute of an asset, and therefore would transfer to a market 
participant, are the only restrictions reflected in fair value. Donor restrictions 
that are specific to the donee are reflected in the classification of net assets, not 
in the measurement of fair value.
Fair Value Option
3.23 FASB Statement No. 159, The Fair Value Option for Financial As­
sets and Financial Liabilities—Including an amendment o f FASB Statement 
No. 115, creates a fair value option under which an organization may irrevoca­
bly elect fair value as the initial and subsequent measure for many financial 
instruments and certain other items, with changes in fair value recognized 
in the statement of activities as those changes occur.* FASB Statement No. 
155, Accounting for Certain Hybrid Financial Instruments—an amendment of 
FASB Statements No. 133 and 140, similarly permits an elective fair value re­
measurement for any hybrid financial instrument that contains an embedded 
derivative, if that embedded derivative would otherwise have to be separated
Health Care Organizations
FASB Statement No. 159, The Fair Value Option for Financial Assets and Financial Liabilities— 
Including an amendment o f FASB Statement No. 115, is effective as of the beginning of the first fiscal 
year that begins after November 15, 2007. Earlier adoption is permitted if certain conditions described 
in paragraph 30 of the statement are met.
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from its debt host in conformity with FASB Statement No. 133, Accounting 
for Derivative Instruments and Hedging Activities) An election is made on a 
instrument-by-instrument basis (with certain exceptions), generally when an 
instrument is initially recognized in the financial statements.
3.24 Most financial assets and financial liabilities are eligible to be rec­
ognized using the fair value option, as are firm commitments for financial in­
struments and certain nonfinancial contracts. Specifically excluded from eli­
gibility are investments in other entities that are required to be consolidated, 
employer's and plan's obligations under postemployment, postretirement plans, 
and deferred compensation arrangements (or assets representing overfunded 
positions in those plans), financial assets and liabilities recognized under leases, 
deposit liabilities of depository institutions, and financial instruments that are, 
in whole or in part, classified by the issuer as a component of shareholder's eq­
uity. Additionally, the election cannot be made for most nonfinancial assets and 
liabilities or for current or deferred income taxes.
3.25 FASB Statement No. 159 also establishes presentation and disclosure 
requirements designed to facilitate comparisons between entities that choose 
different measurement attributes for similar types of assets and liabilities. 
Organizations should report assets and liabilities that are measured using the 
fair value option in a manner that separates those reported fair values from 
the carrying amounts of similar assets and liabilities measured using another 
measurement attribute. To accomplish that, an organization should either (a) 
report the aggregate carrying amount for both fair value and non-fair-value 
items on a single line, with the fair value amount parenthetically disclosed or 
(b) present separate lines for the fair value carrying amounts and the non-fair- 
value carrying amounts.
Disclosures‡
3.26 Paragraphs 32-35 of FASB Statement No. 157 expand the disclosures 
required for assets and liabilities measured at fair value. For assets and liabili­
ties that are measured at fair value on a recurring basis in periods subsequent 
to initial recognition or that are measured on a nonrecurring basis in periods 
subsequent to initial recognition, the statement requires the reporting entity
Cash and Cash Equivalents
t FASB Statement No. 155, Accounting for Certain Hybrid Financial Instruments—an amend­
ment of FASB Statements No. 133 and 140, is effective for all financial instruments acquired or issued 
after the beginning of the first fiscal year that begins after September 15, 2006. Early adoption is 
permitted as of the beginning of a fiscal year, provided the organization has not yet issued financial 
statements for that fiscal year.
t In February 2007, the FASB issued FASB Statement No. 159 that permits all entities, including 
not-for-profit organizations, to choose to measure eligible items at fair value at specified election dates. 
Notable eligible items include recognized financial assets and financial liabilities (except for those 
specifically prohibited), written loan commitments, and rights and obligations under a warranty that 
is not a financial instrument (because it requires or permits the insurer to provide goods or services 
rather than a cash payment) but whose terms permit the insurer to settle by paying a third party to 
provide those goods or services. Prohibited recognized financial assets and liabilities include
a. an investment in a subsidiary that the entity is required to consolidate.
b. an interest in a variable interest entity that the entity is required to consolidate.
c. employers' and plans' obligations (or assets representing net overfunded positions) for 
pension benefits, other postretirement benefits (including health care and life insur­
ance benefits), postemployment benefits, employee stock option and stock purchase 
plans, and certain other forms of deferred compensation arrangements, as defined by 
the applicable FASB pronouncements.
(continued)
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to disclose certain information that enables users of its financial statements to 
assess the inputs used to develop those measurements. For recurring fair value 
measurements using significant unobservable inputs (level 3), the reporting 
entity is required to disclose certain information to help users assess the ef­
fect of the measurements on earnings (or changes in net assets) for the period. 
Examples of potential exposure to credit risk include funds deposited with a 
single financial institution in excess of Federal Deposit Insurance Corporation 
limits and investments in obligations that are not insured or guaranteed by the 
government.
3.27 Governmental health care entities only. For governmental health care 
enterprises, GASB Statement No. 3, Deposits with Financial Institutions, In­
vestments (including Repurchase Agreements), and Reverse Repurchase Agree­
ments, as amended, requires certain disclosures about deposits, including de­
posits exposed to custodial credit risk.
Health Care Organizations
Auditing
3.28 There are no unique auditing considerations with respect to cash and 
cash equivalents recorded by health care organizations.
(footnote continued)
d. financial assets and financial liabilities recognized under leases as defined in FASB 
Statement No. 13, Accounting for Leases, excluding guarantees of a third-party lease 
obligation or a contingent obligation arising from a cancelled lease.
e. deposit liabilities, withdrawable on demand, of banks, savings and loan associations, 
credit unions, and other similar depository institutions.
f. financial instruments that are, in whole or in part, classified by the issuer as a compo­
nent of shareholder's equity (including "temporary equity"). An example is a convert­
ible debt security with a noncontingent beneficial conversion feature.
Entities shall report assets and liabilities that are measured at fair value pursuant to the fair value 
option in this statement in a manner that separates those reported fair values from the carrying 
amounts of similar assets and liabilities measured using another measurement attribute. To accom­
plish that, an entity shall either
a. present the aggregate of fair value and non-fair-value amounts in the same line item in 
the statement of financial position and parenthetically disclose the amount measured 
at fair value included in the aggregate amount, or
b. present two separate line items to display the fair value and non-fair-value carrying 
amounts.
This statement shall be effective as of the beginning of each reporting entity's first fiscal year that 
begins after November 15, 2007. This statement should not be applied retrospectively to fiscal years 
beginning prior to the effective date, except as permitted in paragraph 30 for early adoption. At the 
effective date, an entity may elect the fair value option for eligible items that exist at that date. The 
entity shall report the effect of the first remeasurement to fair value as a cumulative-effect adjustment 
to the opening balance of retained earnings. Readers can find more information pertaining to election 
dates, disclosure requirements, early adoption limitations, and the full text of this statement on the 
FASB Web site at www.fasb.org.
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Chapter 4 
Investments*
Accounting*
4.01 This chapter discusses the accounting and reporting for investments 
of health care entities other than (a) equity investments accounted for under 
the equity method or (b) investments in consolidated subsidiaries. Discussions 
pertaining to those 2 types of investments are included in chapter 11. In some 
cases, nongovernmental health care organizations may transfer assets to a not- 
for-profit organization (such as a community foundation or a financially inter­
related organization) or a trust for investment and management. Paragraphs 
4 .2 3 -.24 discuss a nongovernmental health care organization's reporting of in­
vestments held on its behalf by unrelated foundations and trusts or by related 
organizations that are not financially interrelated. Paragraphs 11 .21-.24 and 
11 .29-.33 discuss the reporting by a nongovernmental health care organization 
of investments held on its behalf by financially interrelated organizations.
4.02 The accounting for investments in equity securities that have readily 
determinable fair values† and all investments in debt securities is discussed 
in paragraphs 4.03-.13. Other types of investments that are not financial in­
struments (such as real estate or certain oil and gas interests) are reported at 
amortized cost and are subject to impairment considerations consistent with Fi­
nancial Accounting Standards Board (FASB) Statement No. 144, Accounting for 
the Impairment or Disposal o f Long-Lived Assets.1 Paragraphs 4.14-.22 discuss 
the guidance for nongovernmental entities in FASB Staff Position (FSP) FAS 
115-1 and FAS 124-1, The Meaning o f Other-Than-Temporary Impairment and 
Its Application to Certain Investments, for impairment of certain investments.
Investments in Debt Securities and Certain Equity Securities
4.03 This section discusses the accounting and reporting for investments 
in equity securities that have readily determinable fair values and all invest­
ments in debt securities held by (a) investor-owned entities, (b) not-for-profit 
organizations, and (c) governmental entities. Guidance for nongovernmental
In September 2006, Financial Accounting Standards Board (FASB) issued FASB Statement 
No. 157, Fair Value Measurements, which defines fair value, establishes a framework for measuring 
fair value in generally accepted accounting principles, and expands disclosures about fair value mea­
surements. Refer to the discussion in chapter 3.
In May 2008, FASB issued FASB Staff Position (FSP) SOP 94-3-1 and AAG HCO-1, Omnibus 
Changes to Consolidation and Equity Method Guidance for Not-for-Profit Organizations, which makes 
several changes to the guidance on consolidation and the equity method of accounting in AICPA State­
ment of Position (SOP) 94-3, Reporting o f Related Entities by Not-for-Profit Organizations (AICPA, 
Technical Practice Aids, ACC sec. 10,610), and this guide. The guidance in the FSP is effective for 
fiscal years beginning after June 15, 2008, and to interim periods therein. Refer to the FASB Web site 
at www.fasb.org.
† In February 2007, FASB issued FASB Statement No. 159, The Fair Value Option for Financial 
Assets and Financial Liabilities—Including an amendment o f FASB Statement No. 115, that permits 
all entities, including not-for-profit organizations, to choose to measure eligible items at fair value at 
specified election dates. Refer to the discussion in chapter 3.
1 Governmental health care entities only. This pronouncement is not applicable to governmental 
health care enterprises that do not apply paragraph 7 of Governmental Accounting Standards Board 
(GASB) Statement No. 20, Accounting and Financial Reporting for Proprietary Funds and Other 
Governmental Entities That Use Proprietary Fund Accounting. (See footnote 1 in chapter 1.)
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entities in FSP FAS 115-1 and FAS 124-1 for impairment of certain invest­
ments is discussed in paragraphs 4.14-.22.
Investor-Owned Entities
4.04 Investor-owned providers are subject to the accounting and reporting 
requirements of FASB Statement No. 115, Accounting for Certain Investments 
in Debt and Equity Securities. FASB Statement No. 115 defines 3 categories 
into which an enterprise classifies investments. The accounting and reporting 
differ by category. Investments in debt securities that the enterprise has the 
positive intent and ability to hold to maturity are classified as held-to-maturity 
securities and are reported at amortized cost. Debt and equity securities that 
are bought and held principally for the purpose of selling them in the near 
term are classified as trading securities and reported at fair value, with un­
realized holding gains and losses included in income. However, an enterprise 
is not precluded from classifying at acquisition a security it plans to hold for 
a longer period as a trading security. Investments in debt securities that are 
not classified as held-to-maturity or trading and equity securities that are not 
classified as trading are classified as available-for-sale securities and reported 
at fair value, with unrealized holding gains and losses excluded from income 
and reported in a separate component of other comprehensive income until 
realized, except all or a portion of the unrealized holding gain and loss of an 
available-for-sale security that is designated as being hedged in a fair value 
hedge shall be recognized in earnings during the period of the hedge.
4.05 Investor-owned entities should follow the disclosure requirements of 
FASB Statement No. 115, as amended.
Not-for-Profit Organizations
4.06 Not-for-profit organizations should report investments in equity se­
curities with readily determinable fair values and all debt securities at fair 
value on the balance sheet consistent with FASB Statement No. 124, Account­
ing for Certain Investments Held by Not-for-Profit Organizations, as amended, 
and FASB Statement No. 157, Fair Value Measurements. FASB Statement No. 
124 does not apply to investments in derivative instruments that are subject 
to the requirements of FASB Statement No. 133, Accounting for Derivative 
Instruments and Hedging Activities. FASB Statement No. 133 establishes ac­
counting and reporting standards for derivative instruments,‡ including certain 
derivative instruments embedded in other contracts and for hedging activities. 
Investment return, including realized and unrealized gains and losses, should 
be included as changes in net assets consistent with paragraphs 4.07-.10.
4.07 investment return (including realized and unrealized gains and 
losses) not restricted by donors or by law should be classified as changes in 
unrestricted net assets as follows:
Health Care Organizations
‡ FASB recently issued FASB Statement No. 161, Disclosures about Derivative Instruments and 
Hedging Activities—an amendment o f FASB Statement No. 133. The statement was issued due to the 
significant increase in the use and complexity of derivative instruments over the past several years. 
FASB believes that FASB Statement No. 133, Accounting for Derivative Instruments and Hedging 
Activities, does not provide adequate information about how derivatives and hedging activities affect 
an entity's financial position, income statement, and statement of cash flows. Accordingly, FASB 
Statement No. 161 increases disclosures about an entity's derivative and hedging activities in order 
to improve financial transparency. FASB Statement No. 161 is effective for financial statements issued 
for fiscal years and interim periods beginning after November 15, 2008. Early adoption is encouraged. 
FASB Statement No. 161 encourages, but does not require, comparative disclosures for earlier periods 
at initial adoption.
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a. Included in the performance indicator (see paragraphs 10.20-.21) 
are
• dividend, interest, and other similar investment income
• realized gains and losses
• unrealized gains and losses on trading securities2
• other than temporary impairment losses3
b. Excluded from the performance indicator are
• unrealized gains and losses on other than trading securi­
ties
4.08 Except as described in paragraphs 4.09-.10, investment return (in­
cluding realized and unrealized gains and losses) restricted by donors or by 
law, should be classified as changes in temporarily or permanently restricted 
net assets consistent with the applicable restrictions.
4.09 Gains and investment income that are limited to specific uses by 
donor-imposed restrictions may be reported as increases in unrestricted net 
assets if the restrictions are met in the same reporting period as the gains 
and income are recognized, provided that the organization has a similar policy 
for reporting contributions received, applies the policy consistently from period 
to period, and discloses its accounting policy. The classification of these gains 
and investment income in unrestricted net assets should be consistent with 
paragraph 4.07.
4.10 In the absence of donor stipulations or law to the contrary, losses on 
the investments of a donor-restricted endowment fund4 shall reduce temporar­
ily restricted net assets to the extent that donor-imposed temporary restrictions 
on net appreciation of the fund have not been met before the loss occurs. Any 
remaining loss shall reduce unrestricted net assets and shall be excluded from 
the determination of the performance indicator. If losses reduce the assets of a 
donor-restricted endowment fund below the level required by the donor stipula­
tions or law, gains that restore the fair value of the assets of the endowment fund 
to the required level shall be classified as increases in unrestricted net assets 
and shall be excluded from the determination of the performance indicator.
4.11 Not-for-profit organizations should follow the disclosure require­
ments of FASB Statement No. 124.
Governmental Entities
4.12 Governmental health care entities are subject to the accounting and 
reporting requirements of Governmental Accounting Standards Board (GASB)
2 Trading securities are defined in FASB Statement No. 115, Accounting for Certain Investments 
in Debt and Equity Securities, including any interpretations thereof.
3 Refer to FSP FAS 115-1 and FAS 124-1, The Meaning o f Other-Than-Temporary Impairment 
and Its Application to Certain Investments, when determining impairment and evaluating whether 
the impairment is other than temporary.
4 Donors that create endowment funds can require that their gifts be invested in perpetuity or 
for a specified term. Some donors may require that a portion of income, gains, or both be added to the 
gift and invested subject to similar restrictions. It is generally understood that at least the amount 
of the original gift(s) and any required accumulations are not expendable, although the value of the 
investments purchased may occasionally fall below that amount. Future appreciation of the invest­
ments generally restores the value to the required level. In states that have enacted its provisions, 
the Uniform Management of Institutional Funds Act describes historic dollar value as the amount 
that is not expendable.
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Statement No. 31, Accounting and Financial Reporting for Certain Investments 
and for External Investment Pools. Governmental health care entities should 
report investments in (a) participating interest-earning investment contracts, 
(b) external investment pools, (c) open-ended mutual funds, (d ) debt securi­
ties, and (e) equity securities, option contracts, stock warrants, and stock rights 
that have readily determinable fair values at fair value on the balance sheet. 
Governmental entities are permitted to report certain money market invest­
ments and participating interest-earning investment contracts at amortized 
cost, provided that the investment has a remaining maturity of one year or less 
at time of purchase. All investment income, including changes in the fair value 
of investments, shall be recognized as revenue in the statement of revenues, ex­
penses, and changes in net assets or equity, or both. Governmental health care 
entities are required to distinguish between operating revenues and expenses 
and nonoperating revenues and expenses. (See further discussion in para­
graph 10.24 of this guide.) Governmental health care entities should follow 
the disclosure requirements of GASB Statement No. 31. Also, GASB State­
ment No. 34, Basic Financial Statements—and Management's Discussion and 
Analysis—for State and Local Governments, paragraph 121 requires that gov­
ernmental health care entities that receive donor-restricted endowments make 
certain disclosures about their use of investment income generated by those 
endowments.
4.13 GASB Statements No. 3, Deposits with Financial Institutions, In­
vestments (Including Repurchase Agreements), and Reverse Repurchase Agree­
ments, No. 28, Accounting and Financial Reporting for Securities Lending 
Transactions, and No. 40, Deposit and Investment Risk Disclosures—an amend­
ment o f GASB Statement No. 3, and GASB Interpretation No. 3, Financial Re­
porting for Reverse Repurchase Agreements, provide guidance on investment- 
related disclosures required by governmental entities as well as accounting for 
securities lending and reverse repurchase agreements.
Impairment of Investments
4.14 FSP FAS 115-1 and FAS 124-1 provides guidance for nongovern­
mental entities about the meaning of other-than-temporary impairment and 
its application to certain debt and equity securities. FSP FAS 115-1 and FAS 
124-1 is applicable for investments in:
• debt and equity securities that are within the scope of FASB State­
ment Nos. 115 and 124 (applicable to not-for-profit health care or­
ganizations in the scope of this guide that report a performance 
indicator).
• equity securities that are not subject to the scope of FASB State­
ment Nos. 115 and 124 and not accounted for under the equity 
method pursuant to Accounting Principles Board (APB) Opinion 
No. 18, The Equity Method o f Accounting for Investments in Com­
mon Stock, and related interpretations. FSP FAS 115-1 and FAS 
124-1 refers to those equity securities as cost-method investments. 
(See FSP FAS 115-1 and 124-1 paragraph 4.)
4.15 Impairment is assessed at the individual security level, which means 
at the level and method of aggregation used by the reporting entity to measure 
realized and unrealized gains and losses on its debt and equity securities. An 
investment is impaired if the fair value of the investment is less than its cost. 
(See FSP FAS 115-1 and FAS 124-1 paragraph 7.)
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4.16 Because the fair value of a cost-method investment is not readily 
determinable, the evaluation of whether an investment is impaired should be 
determined as follows.
a. If the investor has determined the fair value of a cost-method in­
vestment (for example, for disclosure under FASB Statement No. 
107, Disclosures about Fair Value o f Financial Instruments), that 
estimate should be used to determine if the investment is impaired.
b. If the investor has not estimated the fair value of a cost-method 
investment (for example, because the investor is exempt from pro­
viding fair value disclosures under FASB Statement No. 126, Ex­
emption from Certain Required Disclosures about Financial Instru­
ments for Certain Nonpublic Entities), the investor should evaluate 
whether an event or change in circumstances has occurred in the 
reporting period that may have a significant adverse effect on the 
fair value of the investment (an impairment indicator). If an im­
pairment indicator is present, the investor should estimate the fair 
value of the investment.
In addition, if an investment was previously tested for impairment pursuant to 
the guidance in FSP FAS 115-1 and FAS 124-1, as discussed in paragraph 4.17, 
and the investor concluded that the investment was not other-than-temporarily 
impaired, the investor should continue to evaluate whether the investment is 
impaired (that is, estimate the fair value of the investment) in each subse­
quent reported period until either (a) the investment experiences a recovery 
of fair value up to (or beyond) its cost or (b) the investor recognizes an other- 
than-temporary impairment loss. (See FSP FAS 115-1 and FAS 124-1 para­
graphs 10-12.)
4.17 When the fair value of an investment is less than its cost at the bal­
ance sheet date of the reporting period for which impairment is assessed, the 
impairment is either temporary or other than temporary. (Other than tempo­
rary does not mean permanent.) An investor should apply other guidance that 
is pertinent to the determination of whether an impairment is other than tem­
porary, such as paragraph 16 of FASB Statement No. 115 (which references Se­
curities and Exchange Commission Staff Accounting Bulletin Topic 5M, Other 
Than Temporary Impairment o f Certain Investments in Debt and Equity Secu­
rities), paragraph 6 of APB Opinion No. 18, and FASB Emerging Issues Task 
Force Issue No. 99-20, "Recognition of Interest Income and Impairment on Pur­
chased and Retained Beneficial Interests in Securitized Financial Assets." In 
applying that guidance, an investor shall recognize an impairment loss when 
the impairment is deemed other than temporary even if a decision to sell has 
not been made. If an investor has decided to sell an impaired available-for-sale 
security and the investor does not expect the fair value of the security to fully 
recover prior to the expected time of sale, the security should be deemed other- 
than-temporarily impaired in the period in which the decision to sell is made. 
(See FSP FAS 115-1 and FAS 124-1 paragraphs 13-14.)
4.18 If the impairment is other than temporary, then an impairment loss 
should be recognized in earnings equal to the entire difference between the 
investment's cost and its fair value at the balance sheet date of the reporting 
period for which the assessment is made. The measurement of the impairment 
should not include partial recoveries subsequent to the balance sheet date. 
The fair value of the investment would then become the new cost basis of the
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investment and should not be adjusted for subsequent recoveries in fair value. 
(See FSP FAS 115-1 and FAS 124-1 paragraph 15.)
4.19 An investor should account for an other-than-temporarily impaired 
debt security in periods subsequent to the recognition of an other-than- 
temporary impairment loss as if the debt security had been purchased on the 
measurement date of the other-than-temporary impairment. The discount or 
reduced premium recorded for the debt security, based on the new cost basis, 
would be amortized over the remaining life of the debt security in a prospective 
manner based on the amount and timing of future cash flows. (See FSP FAS 
115-1 and FAS 124-1 paragraph 16.)
4.20 For all investments that are in an unrealized loss position for which 
other-than-temporary impairment losses have not been recognized, the investor 
should include the following information as of each date for which a statement 
of financial position is presented in its annual financial statements:
(1) The aggregate related fair value of investments with unrealized 
losses
(2) The aggregate amount of unrealized losses (that is, the amount by 
which cost exceeds fair value)
The information in (1) and (2) should be presented in tabular form, aggregated 
by each category of investment that the investor discloses in accordance with 
FASB Statement Nos. 115 and 124 and for its cost-method investments. The 
table should be segregated by those investments that have been in a continuous 
unrealized loss position for less than twelve months and those that have been 
in a continuous unrealized loss position for twelve months or longer. The ref­
erence point for determining how long an investment has been in a continuous 
unrealized loss position is the balance sheet date of the period in which the 
impairment is identified (if only annual financial statements are prepared, the 
reference point would be the annual balance sheet date of the period during 
which the impairment was identified). The continuous unrealized loss position 
ceases upon either (a) the recognition of an other-than-temporary impairment 
or (b) the recovery of fair value up to (or beyond) the cost of the investment. 
(See FSP FAS 115-1 and FAS 124-1 paragraph 17.)
4.21 In addition, for all investments that are in an unrealized loss position 
for which other-than-temporary impairment losses have not been recognized, 
the investor should explain as of the date of the most recent statement of finan­
cial position included in its annual financial statements why it concluded that 
the impairment was not other-than-temporary. (See FSP FAS 115-1 and FAS 
124-1 paragraph 17.)
4.22 As of each date for which a statement of financial position is presented 
in its annual financial statements, paragraph 18 of FSP FAS 115-1 and FAS 
124-1 requires the investor to disclose (if applicable) for cost-method invest­
ments
a. the aggregate carrying amount of all cost-method investments,
b. the aggregate carrying amount of cost-method investments that the 
investor did not evaluate for impairment, and
c. the fact that the fair value of a cost-method investment is not esti­
mated if there are no identified events or changes in circumstances 
that may have a significant adverse effect on the fair value of the 
investment, and
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(1) the investor determined, in accordance with paragraphs 
14-15 of FASB Statement No. 107 that it is not practicable 
to estimate the fair value of the investment, or
(2) the investor is exempt from estimating fair value under 
FASB Statement No. 126.
Transfers of Assets to a Not-for-Profit Organization
or Charitable Trust for Investment
4.23 If a nongovernmental health care organization transfers assets to 
a not-for-profit organization or charitable trust (called a recipient organiza­
tion) that accepts those assets and agrees to use them on behalf of or transfer 
them, their investment return, or both back to the health care organization or 
its affiliate, the transfer is reciprocal and thus is not a contribution (see para­
graphs 4 ,  17, and 18 of FASB Statement No. 136, Transfers o f  Assets to a Not-for- 
Profit Organization or Charitable Trust That Raises or Holds Contributions for 
Others).5 Examples of that type of reciprocal transfer include (a) a nongovern­
mental health care organization transfers assets to a community foundation 
to establish an endowment for the benefit of the nongovernmental health care 
organization (or its affiliate) and (b) a nongovernmental health care organiza­
tion transfers assets to a foundation it creates to hold those assets. Paragraphs 
17-18 of FASB Statement No. 136 describe 2 types of reciprocal transfers, which 
are
• an equity transaction—The nongovernmental health care orga­
nization (a) specifies itself or its affiliate as the beneficiary, (b) 
the health care organization and the recipient organization are 
financially interrelated organizations (paragraph 11.22 discusses 
financially interrelated organizations), and (c) neither the health 
care organization nor its affiliate expects payment of the trans­
ferred assets, although payment of investment return on the 
transferred assets may be expected. (All three criteria must be 
met.)
• the nongovernmental health care organization specifies itself or 
its affiliate as the beneficiary and the transfer is not an equity 
transaction. (The three criteria (a), (b), and (c) in the previous 
bullet are not met.)
4.24 If the reciprocal transaction is not an equity transaction, the non­
governmental health care organization reports an asset, in exchange for the 
assets transferred, as discussed in paragraph 17 of FASB Statement No. 136. 
(Accounting for equity transactions is discussed in paragraphs 11.21-.24 of this 
guide.) The nongovernmental health care organization should disclose the fol­
lowing information for each period for which a statement of financial position 
is presented, in accordance with paragraph 19 of FASB Statement No. 136:
• The identity of the recipient organization to which the transfer 
was made
• Whether variance power was granted to the recipient organization 
and, if so, a description of the terms of the variance power5 6
5 Governmental health care entities only. This pronouncement is not applicable to governmental 
health care enterprises. (See footnote 1 in chapter 1).
* Because of their reciprocal nature, those transfers were presumed by the FASB not to be con­
tributions received or made, even if the health care organization granted variance of power a t the 
(continued)
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• The terms under which amounts will be distributed to the health 
care organization or its affiliate
• The aggregate amount recognized in the statement of financial 
position for those transfers and whether that amount is recorded 
as an interest in the net assets of the recipient organization or as 
another asset (for example, as a beneficial interest in assets held 
by others or a refundable advance).
Health Care Organizations
Financial Statement Presentation
Entities Subject to FASB Statement No. 115, FASB Statement 
No. 124, or GASB Statement No. 31
4.25 Securities should be reported as either current or noncurrent, as 
appropriate, under the provisions of Accounting Research Bulletin No. 43, Re­
statement and Revision o f Accounting Research Bulletins, chapter 3A.7
4.26 For cash flow reporting purposes by nongovernmental entities, pur­
chases, sales, and maturities of trading securities should be classified as cash 
flows from operating activities; governmental entities should classify these 
items as investing activities. Cash flows from purchases, sales, and maturities 
of all other securities should be classified as cash flows from investing activities. 
If investments in debt securities are reported as cash equivalents in accordance 
with FASB Statement No. 95, Statement o f Cash Flows, or GASB Statement 
No. 9, Reporting Cash Flows o f Proprietary and Nonexpendable Trust Funds 
and Governmental Entities That Use Proprietary Fund Accounting, the notes 
to the financial statements should reconcile the reporting classifications used 
in the statement of financial position.
4.27 All health care organizations with investments that meet the defini­
tion of financial instruments set forth in FASB Statement No. 107 are subject to 
the disclosure requirements of FASB Statement No. 107.8 Organizations with 
derivative instruments that meet the definition of derivative instruments set 
forth in FASB Statement No. 133,‡ as amended, are subject to the disclosure
(footnote continued)
time of transfer. See paragraph 96 of FASB Statement No. 136, Transfers o f Assets to a Not-for-Profit 
Organization or Charitable Trust That Raises or Holds Contributions for Others.
7 Chapter 3A of Accounting Research Bulletin No. 43, Restatement and Revision o f Accounting 
Research Bulletins, indicates in paragraph 4 that "the term current assets is used to designate cash and 
other assets or resources commonly identified as those which are reasonably expected to be realized 
in cash or sold or consumed during the normal operating cycle o f the business." That paragraph 
further indicates that the term also comprehends "marketable securities representing the investment 
of cash available for current operations." Paragraph 5 indicates that "a one-year time period is to 
be used as a basis for the segregation of current assets in cases where there are several operating 
cycles occurring within a year." Paragraph 6 says that the "concept o f the nature of current assets 
contemplates the exclusion from that classification o f . .. cash and claims to cash which are restricted 
as to withdrawal or use for other than current operations, are designated for expenditure in the 
acquisition or construction of noncurrent assets, or are segregated for the liquidation of long-term 
debts." Cash and cash equivalents of permanent endowment funds held temporarily until suitable long 
term investment opportunities are identified are included in the classification long-term investments.
8 Disclosures about the fair value of financial instruments prescribed in FASB Statement No. 
107, Disclosures about Fair Value o f Financial Instruments, are optional for an entity that meets the 
criteria of FASB Statement No. 126, Exemption from Certain Required Disclosures about Financial 
Instruments for Certain Nonpublic Entities—an amendment o f FASB Statement No. 107, as amended.
‡ See footnote ‡ in paragraph 4.06.
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requirements in FASB Statement No. 133, as amended.9 Statement of Position 
(SOP) 02-2, Accounting for Derivative Instruments and Hedging Activities by 
Not-for-Profit Health Care Organizations and Clarification o f the Performance 
Indicator (AICPA, Technical Practice Aids, ACC sec. 10,860), requires that not- 
for-profit health care organizations that are within the scope of this guide pro­
vide disclosures that are analogous to those required by paragraph 45 of FASB 
Statement No. 133 for for-profit enterprises, including the disclosure of antici­
pated reclassifications into the performance indicator of gains and losses that 
have been excluded from that measure and reported in accumulated derivative 
gain or loss as of the reporting date. SOP 02-2 does not apply to governmental 
entities that are within the scope of this guide. SOP 02-2 is included as appen­
dix F to this guide.
4.28 Governmental health care entities are also required to disclose in­
formation about their investments in accordance with GASB Statement Nos. 
3, 28, 31, and 40; GASB Technical Bulletin No. 87-1, Applying Paragraph 68 
o f GASB Statement No. 3, No. 2003-1, Disclosure Requirements for Derivatives 
Not Reported at Fair Value on the Statement o f Net Assets, and No. 97-1, Clas­
sification o f Deposits and Investments into Custodial Credit Risk Categories for 
Certain Bank Holding Company Transactions; and GASB Interpretation No. 3. 
Among the required disclosures are the following:
• The types of investments authorized by legal or contractual pro­
visions (GASB Statement No. 3, as amended, paragraph 65)
• Investment policies related to the risks that GASB Statement No. 
40 requires to be disclosed (If a government has no investment 
policy that addresses a specific type of risk that it is exposed to, 
the disclosure should indicate that fact.) (GASB Statement No. 40 
paragraph 6)
• Significant violations during the period of legal or contractual pro­
visions for investments, and the actions taken to address such 
violations (GASB Statement No. 3 paragraph 66 and No. 38 para­
graph 9)
• The accounting methods for investments (GASB Statement No. 
31 paragraph 15)
• The credit quality ratings of investments in debt securities as de­
scribed by nationally recognized statistical rating organizations— 
rating agencies—as of the date of the financial statements (This 
disclosure does not apply to investments issued or explicitly guar­
anteed by the U.S. government, but it does apply to investments 
in external investment pools, money market funds, bond mutual 
funds, and other pooled investments of fixed-income securities. If 
a credit quality disclosure is required and the investment is un­
rated, the disclosure should indicate that fact.) (GASB Statement 
No. 40 paragraph 7)
• For investment securities, including securities underlying repur­
chase agreements, at the end of the period that are exposed to cus­
todial credit risk, the investment's type, the reported amount, and
9 Governmental health care entities only. FASB Statement Nos. 107 and 133 are not applicable 
to governmental health care enterprises that do not apply paragraph 7 of GASB Statement No. 20, 
Accounting and Financial Reporting for Proprietary Funds and Other Governmental Entities That 
Use Proprietary Fund Accounting. (See footnote 1 in chapter 1.)
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how the investments are held (This disclosure does not apply to 
investments in external investment pools and in open-end mutual 
funds or to securities underlying reverse repurchase agreements.) 
(GASB Statement No. 40 paragraph 9)
• Investments in any one issuer, by amount and issuer, that repre­
sent 5 percent or more of total investments (This disclosure does 
not apply to investments issued or explicitly guaranteed by the 
U.S. government or investments in mutual funds, external invest­
ment pools, or other pooled investments. (GASB Statement No. 40 
paragraph 11)
• Information about interest rate risk using one of the five meth­
ods listed in GASB Statement No. 40 (If a method requires an 
assumption regarding timing of cash flows, interest rate changes, 
or other factors that affect interest rate information, that assump­
tion should be disclosed. This disclosure does apply to investments 
in mutual funds, external investment pools, or other pooled invest­
ments that do not meet the definition of a 2a7-like pool.) (GASB 
Statement No. 40 paragraphs 14-15)
• The terms of investments with fair values that are highly sensitive 
to changes in interest rates to the extent investment terms are 
not considered in the interest rate risk disclosure requirements of 
GASB Statement No. 40 paragraph 15 (GASB Statement No. 40 
paragraphs 14 and 16)
• Certain information about investments in external investment 
pools (GASB Statement No. 31 paragraph 15)
4.29 The following example illustrates the accounting treatment and fi­
nancial statement presentation for other-than-trading securities of a not-for- 
profit health care organization:
Facts
Other than trading securities are purchased in year 1 at a cost of $100. At the 
end of year 1, the fair value of the securities is $300. In year 2, the securities 
are sold for $400.
Journal Entries
• Entry at the end of year 1 to adjust the recorded value o f the secu­
rities to fair value:
Valuation allowance 200
Change in net unrealized gains and losses on investments 200
• Entry at the end o f year 2 to record the sale o f the securities:
Cash 400
Health Care Organizations
Realized gain 300
Investments 100
Change in net unrealized gains and losses on 200
investments
Valuation allowance 200
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As discussed in paragraph 4.07, unrealized gains and losses on other than 
trading securities are reported in the statement of operations below the perfor­
mance indicator and realized gains and losses are reported in the statement of 
operations above the performance indicator.
Auditing
Note: This guide presents auditing guidance to help you implement auditing 
standards included in both AICPA professional standards and in Public Com­
pany Accounting Oversight Board (PCAOB) professional standards. In citing 
the professional standards, references are made to the AICPA's Professional 
Standards publication and the AICPA's PCAOB Standards and Related 
Rules publication, depending upon the applicable professional standards. 
Additionally, when referencing professional standards, this guide cites sec­
tion numbers and not the original statement number, as appropriate. For 
example, Statement on Auditing Standards (SAS) No. 54 is referred to as 
AU section 317.
4.30 Auditing objectives and procedures for investments of health care 
organizations generally are similar to those of other organizations. AU section 
332, Auditing Derivative Instruments, Hedging Activities, and Investments in 
Securities (AICPA, Professional Standards, vol. 1), among other matters, pro­
vides guidance to auditors in planning and performing auditing procedures for 
assertions about investments in securities that are made in an entity's financial 
statements. The guidance in AU section 332 (AICPA, Professional Standards, 
vol. 1), applies to all debt and equity securities. AU section 332 (AICPA, Pro­
fessional Standards, vol. 1), uses the definitions of debt security and equity 
security that are in FASB Statement No. 115, but applies to debt and equity 
securities without regard to whether they are subject to the requirements of 
FASB Statement No. 115, such as, for example, assertions about securities ac­
counted for under the equity method following the requirements of APB Opinion 
No. 18. A companion Audit Guide, Auditing Derivative Instruments, Hedging 
Activities, and Investments in Securities, provides practical guidance for imple­
menting AU section 332 (AICPA, Professional Standards, vol. 1). Paragraph .11 
of AU section 332 (AICPA, PCAOB Standards and Related Rules, PCAOB Stan­
dards, As Amended), provides guidance for an integrated audit if investments 
in derivatives and securities represents a significant account.
4.31 Auditing Interpretation No. 1, "Auditing Investments in Securities 
Where a Readily Determinable Fair Value Does Not Exist," of AU section 332, 
Auditing Derivative Instruments, Hedging Activities, and Investments in Secu­
rities (AICPA, Professional Standards, vol. 1, AU sec. 9332 par. .01-.04), pro­
vides guidance for auditors of nonissuers regarding the adequacy of audit evi­
dence with respect to the existence and valuation assertions in AU section 332 
(AICPA, Professional Standards, vol. 1), in confirmations received from third 
parties when auditing investments in securities where a readily determinable 
fair value does not exist, and the auditor determines auditing procedures in­
clude verifying the existence and testing the measurement of the investments. 
Further guidance for auditors of nonissuers is provided in the AICPA Practice 
Aid Alternative Investments—Audit Considerations. The guidance focuses on 
the existence and valuation assertions associated with auditing investments 
for which a readily determinable fair value does not exist (collectively referred
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to in the practice aid as alternative investments).|| The auditing portion of that 
practice aid is an other auditing publication as defined in AU section 150, Gen­
erally Accepted Auditing Standards (AICPA, Professional Standards, vol. 1). 
Other auditing publications have no authoritative status; however, they may 
help the auditor understand and apply SASs.
4.32 In addition, the independent auditor may need to consider the ex­
amples of specific auditing objectives, selected control activities, and auditing 
procedures that are presented in exhibit 4-1.
Health Care Organizations
|The AICPA Practice Aid Alternative Investments—Audit Considerations was issued in July
2006.
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Exhibit 4-1
Auditing Considerations*
Financial Statement 
Assertions
Existence; 
completeness; 
rights and 
obligations; and 
valuation and 
allocation
Specific Auditing 
Objectives
Marketable 
securities are 
fairly stated, 
properly 
classified, 
described, and 
disclosed.
Selected Control 
Activities
Auditing
Procedures
An independent 
trustee manages 
the investments. 
The trustee's 
reports are 
reviewed by a 
responsible 
employee.
Verify existence 
through
confirmation. Test 
the valuation of 
equity and debt 
securities not 
intended to be held 
to maturity by 
comparing the 
recorded values with 
the fair market 
values reported by 
the trustee or 
another independent 
source. For fair value 
estimates obtained 
from third-party 
sources, the auditor 
should consider the 
applicability of the 
guidance in AU 
section 336, Using 
the Work o f a 
Specialist (AICPA, 
Professional 
Standards, vol. 1), or 
AU section 324, 
Service 
Organizations 
(AICPA, Professional 
Standards, vol. 1; 
AICPA, PCAOB 
Standards and 
Related Rules, 
PCAOB Standards, 
As Amended).1
(continued)
* AU section 326, Audit Evidence (AICPA, Professional Standards, vol. 1), recategorizes asser­
tions by classes of transactions, account balances, and presentation and disclosure. This exhibit will 
be revised, as necessary, to reflect the new assertion categories in a future edition of the guide.
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Auditing Considerations—continued
Financial Statement Specific Auditing 
Assertions Objectives
Valuation and 
allocation, rights 
and obligations
Endowment 
funds are 
properly stated 
at their required 
value and 
related gains 
and losses are 
properly 
classified.
Selected Control 
Activities
Value of 
endowment 
funds are 
reviewed 
periodically to 
ensure that the 
balance is at its 
required level.
Accuracy and 
completeness
Presentation and 
disclosure
Investment 
income and gains 
or losses, or both, 
are recorded in 
accordance with 
donor
restrictions.
Securities are
properly
classified.
Review of 
investment 
transactions to 
ensure they are 
recorded in 
compliance with 
donor
restrictions.
Classification is 
monitored 
periodically and 
is based on 
management's 
intent or ability 
to dispose of 
excess funds 
that are 
available for 
operations 
within an 
operating cycle.
Auditing
_____Procedures_____
Verified that value 
of endowments are 
at required levels 
through 
confirmation. 
Review treatment 
of gains and losses 
on endowment 
funds to ensure that 
they are properly 
classified.
Test the recording 
of selected 
transactions to 
ensure amounts are 
properly classified 
in accordance with 
donor restrictions.
1 Paragraphs .35-.46 of AU section 332, Auditing Derivative Instruments, 
Hedging Activities, and Investments in Securities (AICPA, Professional 
Standards, vol. 1), and paragraphs 6.16-.38 in the companion Audit Guide 
Auditing Derivative Instruments, Hedging Activities, and Investments in 
Securities, provide guidance to auditors on audit evidence that may be used 
to support assertions about the fair value of securities. That guidance should 
be considered in the context of specific accounting requirements. AU sec­
tion 328, Auditing Fair Value Measurements and Disclosures (AICPA, Pro­
fessional Standards, vol. 1), provides additional guidance on auditing fair 
value measurements and disclosures contained in financial statements. AU 
section 328 does not address specific types of assets, liabilities, components 
of equity, transactions, or industry-specific practices.
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Chapter 5 
Receivables
5.01 Receivables may include amounts due for (a) health care services 
from patients, residents, third-party payors, and employers; (b) premiums and 
stop-loss insurance recoveries; (c) intercompany transactions; (d) promises to 
give in future periods (pledges); and (e) amounts due from employees, physi­
cians, or others. All loans, such as loans to physicians, should be evaluated 
periodically for impairment. Loans that are included in the scope of Finan­
cial Accounting Standards Board (FASB) Statement No. 114, Accounting by 
Creditors for Impairment of a Loan—an amendment o f  FASB Statements No. 5 
and 15,1 should be evaluated based on the provisions of that statement. A loan is 
impaired when, based on current information and events, it is probable that the 
provider will be unable to collect all amounts due, including principal and in­
terest, according to the contractual terms of the loan agreement. If the provider 
measures an impaired loan using a present value amount, the creditor should 
calculate that present value based on an estimate of the future cash flows of 
the impaired loan, discounted at the loan's effective interest rate.
5.02 Amounts realizable from third-party payors for health care services 
are usually less than the provider's full established rates for those services. 
The realizable amounts may be determined by (a) contractual agreement with 
others (such as Blue Cross plans, Medicare, Medicaid, or health maintenance 
organizations), (b) legislation or regulation (such as workers' compensation or 
no-fault insurance), or (c) provider policy or practice (such as courtesy discounts 
to medical staff members and employees or other administrative adjustments).
5.03 Revenue and the related receivables for health care services usually 
are recorded in the accounting records on an accrual basis at the provider's full 
established rates. The provision for contractual adjustments (that is, the differ­
ence between established rates and third-party payor payments) and discounts 
(that is, the difference between established rates and the amount collectible) 
are recognized on an accrual basis and deducted from gross service revenue to 
determine net service revenue. Contractual adjustments, discounts, and an al­
lowance for uncollectibles are recorded to report the receivables for health care 
services at net realizable value. Estimates of contractual adjustments, other 
adjustments, and the allowance for uncollectibles are reported in the period 
during which the services are provided even though the actual amounts may 
become known at a later date. This later date may be (a) when the person is 
discharged, (b) subsequent to discharge or completion of service, (c) when the 
third party is billed, or (d) when payment or partial payment is received. As 
discussed in paragraph 10.03, the provision of charity care does not qualify for 
recognition as receivables or revenue in the financial statements.
5.04 Nongovernmental health care organizations with loans and trade 
receivables should follow the recognition and measurement guidance in para­
graph .08 of Statement of Position (SOP) 01-6, Accounting by Certain Enti­
ties (Including Entities With Trade Receivables) That Lend to or Finance the
1 Governmental health care entities only. This pronouncement is not applicable to governmental 
health care enterprises that do not apply paragraph 7 o f Governmental Accounting Standards Board 
(GASB) Statement No. 20, Accounting and Financial Reporting for Proprietary Funds and Other 
Governmental Entities That Use Proprietary Fund Accounting. (See footnote 1 in chapter 1.)
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Activities o f Others (AICPA, Technical Practice Aids, ACC sec. 10,850), to the 
extent that that guidance is applicable.
Rate Setting
5.05 As part of obtaining a sufficient understanding of the entity and its 
environment, including its internal control, to assess the risk of material mis­
statement of the financial statements, whether due to error or fraud, and to 
design the nature, timing, and extent of further audit procedures, the audi­
tor should be familiar with the rate-setting environment in which the entity 
operates and the regulations and contractual agreements that determine pay­
ments to be received for health care services. Payment rates established by 
regulations or contractual agreements may be determined either prospectively 
or retrospectively.
5.06 Prospective rate setting is a method used to set payment rates in ad­
vance of the delivery of health care services. Such payment rates determine 
what third parties will pay for health care services during the rate period 
(generally one year). Prospective rate setting may result from a contractual 
agreement with a third party, such as a Blue Cross plan, or it may be man­
dated through legislation. The intent of prospective rate setting is to establish 
payment rates before the period to which they will apply and that are not sub­
ject to change. The independent auditor should be aware, however, that some 
rate-setting methods described as prospective may include provision for ret­
rospective adjustments and that some third parties pay prospective rates for 
certain services and retrospective rates for other services.
5.07 Under retrospective rate setting, third parties usually determine an 
interim payment rate and, during the rate period (generally one year), pay the 
health care organization for services rendered using that rate. After the rate 
period has ended, a final settlement is made in accordance with federal or state 
regulations or contractual agreements.
Estimated Final Settlements
5.08 Under a retrospective system, an entity may be entitled to receive 
additional payments or may be required to refund amounts received in excess 
of amounts earned under the system. Although final settlements are not made 
until a subsequent period, they are usually subject to reasonable estimations 
and are reported in the financial statements in the period in which services 
are rendered. Differences between original estimates and subsequent revisions 
(including final settlements) are included in the statement of operations in 
the period in which the revisions are made and disclosed, if material. Those 
differences are not treated as prior period adjustments unless they meet the 
criteria for prior period adjustments as set forth in FASB Statement No. 16, 
Prior Period Adjustments.2
5.09 Rate-setting methods that are described as prospective but provide 
for retrospective adjustments are accounted for as retrospective rate-setting 
systems for the services to which they apply (see paragraph 5.08).
Health Care Organizations
2 Paragraph .37 of Statement of Position (SOP) 00-1, Auditing Health Care Third-Party Revenues 
and Related Receivables (AICPA, Technical Practice Aids, AUD sec. 14,360), provides a sample dis­
closure for material differences between an original estimate and subsequent revisions. SOP 00-1 is 
included in appendix E to this guide.
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State Waiver Contingencies Under Medicare
5.10 Certain states (referred to as waiver states) have received permis­
sion to determine rates of payment for Medicare patients in accordance with 
a statewide rate-setting method different from the method used by the federal 
program. A condition for Medicare participation in a state waiver program typ­
ically requires that Medicare expenditures in that state not exceed prescribed 
limits. If Medicare expenditures exceed prescribed limits, the excess, depend­
ing on the conditions of the waiver, may be recoverable by the federal govern­
ment. FASB Statement No. 5, Accounting for Contingencies, provides guidance 
with respect to accounting for loss contingencies, such as those arising under 
state Medicare waivers. Governmental Accounting Standards Board (GASB) 
Statement No. 10, Accounting and Financial Reporting for Risk Financing and 
Related Insurance Issues, provides guidance with respect to accounting for con­
tingencies by governmental entities.
Premiums and Stop-Loss Insurance Receivables
5.11 Some health care organizations contract to provide comprehensive 
health care services for a fixed period in return for fixed periodic premiums. 
Many of those organizations may transfer a portion of their financial risks under 
the contract to another organization by purchasing stop-loss insurance. Receiv­
ables of those organizations may include uncollected premiums and amounts re­
coverable from stop-loss insurers reduced by appropriate valuation allowances. 
Chapter 13 provides guidance on applying generally accepted accounting prin­
ciples for stop-loss insurance costs of providers of prepaid health care services. 
FASB Statement No. 113, Accounting and Reporting for Reinsurance o f Short- 
Duration and Long-Duration Contracts, also provides guidance on accounting 
for reinsurance contracts. Governmental entities should comply with the pro­
visions of GASB Statement No. 10, which provides different guidance on ac­
counting for reinsurance contracts than FASB Statement No. 113.
Promises to Give in Future Periods (Pledges)
5.12 Providers involved in fund-raising campaigns frequently are the re­
cipients of promises to give3 4with payments due in future periods; pledge drives 
are a common example. FASB Statement No. 116, Accounting for Contributions 
Received and Contributions M ade,4 establishes the accounting and financial re­
porting guidance for pledges and similar promises to pay. Providers may also be 
the beneficiaries of fund-raising campaigns conducted by others. FASB State­
ment No. 136, Transfers o f Assets to a Not-for-Profit Organization or Charitable 
Trust That Raises or Holds Contributions for Others,5 establishes standards for 
transactions in which a donor makes a contribution by transferring assets to 
a recipient organization—a not-for-profit organization or a charitable trust— 
that accepts the assets from the donor and agrees to use the assets on behalf of
3 To be recognized in financial statements there must be sufficient evidence in the form of veri­
fiable documentation that a promise was made and received (Financial Accounting Standards Board 
[FASB] Statement No. 116, Accounting for Contributions Received and Contributions Made, para­
graph 6).
4 Governmental health care entities only. This pronouncement is not applicable to governmental
health care enterprises. (See footnote 1 in chapter 1.)
5 See footnote 4.
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or transfer the assets, their investment return, or both to another entity—the 
beneficiary—named by the donor.6 In general, a nongovernmental health care 
organization that is specified as a beneficiary recognizes its rights to the assets 
held by a recipient organization as an asset: either a beneficial interest or a 
receivable. (See paragraph E19 of FASB Statement No. 157, Fair Value Mea­
surements.) (For exceptions, see the discussion of variance power at paragraph 
10.05 and financially interrelated organizations at paragraphs 11.29-.33 of this 
guide.) If the beneficiary has an unconditional right to receive all or a portion 
of the specified cash flows from a charitable trust or other identifiable pool 
of assets, the beneficiary has a beneficial interest. The beneficiary recognizes 
that beneficial interest as an asset and a contribution received, measuring and 
subsequently remeasuring it at fair value,* using a valuation technique such 
as the present value of the future cash flows. If the beneficiary has uncondi­
tional rights to receive the value of the transferred assets at a future date, the 
beneficiary has a receivable that should be recognized in accordance with the 
provisions of FASB Statement No. 116 for unconditional promises to give.
5.13 A general summary of the provisions of FASB Statement No. 116 for 
promises to give is presented in the following paragraphs. Specific guidance is 
provided in chapter 5 of the AICPA Audit and Accounting Guide Not-for-Profit 
Organizations. By specifying that they will adhere to future payment dates, 
donors implicitly indicate that their gift is to support activities in each period in 
which a payment is scheduled. Therefore, in any promise to give with payments 
due in future periods, a time restriction is implicit unless the donor explicitly 
states that the gift is to support current activities or other circumstances clearly 
point to that intent.
5.14 Promises to give fall into two broad categories: conditional and uncon­
ditional. Conditional promises to give depend on the occurrence of a specified 
future and uncertain event (for example, a stipulation that the provider must 
meet a matching requirement) whose occurrence or failure of occurrence gives 
the donor the right of return of the assets or releases the donor from the obli­
gation to transfer assets in the future. Conditional promises to give are not 
recognized in financial statements until the conditions on which they depend 
are substantially met (that is, until the period in which the conditional promise 
becomes an unconditional promise). A transfer of assets in partial fulfillment of 
a conditional promise shall be accounted for as a refundable advance (that is, as 
a liability) until such time as the conditional promise becomes unconditional.7
5.15 Unconditional promises to give with payments due in future periods 
should be reported as receivables and as restricted support in the period the
Health Care Organizations
6 FASB Statement No. 136, Transfers o f Assets to a Not-for-Profit Organization or Charitable 
Trust That Raises or Holds Contributions for Others, also establishes standards for transactions that 
take place in a similar manner but are not contributions because the transfers are revocable, repayable, 
or reciprocal. Those standards and transactions are discussed in paragraphs 4.23, 4.24, 11.21, and 
11.23-.24 of this guide. This guide does not use the word donor in discussing those transactions 
because they are not contributions.
In September 2006, FASB issued FASB Statement No. 157, Fair Value Measurements, which 
defines fair value, establishes a framework for measuring fair value in generally accepted account­
ing principles, and expands disclosures about fair value measurements. See chapter 3 for further 
discussion.
7 For accounting purposes, a conditional promise to give is considered unconditional if the pos­
sibility that the condition will not be met is remote. In the case of ambiguous donor stipulations, if 
a promise contains stipulations that are not clearly unconditional (that is, if the donor's stipulations 
are ambiguous), the promise is presumed to be a conditional promise. Additional guidance on distin­
guishing conditional promises from unconditional promises is provided in FASB Statement No. 116 
paragraphs 22-23.
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promise is received (unless explicit donor stipulations or circumstances sur­
rounding the receipt of the promise make clear that the donor intended the 
promise to be used to support activities of the current period). The expiration of 
those restrictions (or the expiration of a portion of the restriction) is recognized 
as the donor makes the future payment or payments. If the promise is to be 
paid in one future payment, the related temporarily restricted net assets will 
be transferred to unrestricted net assets in the period in which the payment is 
received. If the donor sets forth a schedule of future payments, a transfer from 
temporarily restricted net assets to unrestricted net assets is made in each pe­
riod a payment is received. If other explicit donor restrictions are attached to 
the promise, such as that the gift be used for a specific purpose, the expiration 
of the restriction is recognized in the time period(s) when the donor makes the 
future payment(s) and when the stipulated purpose for which the assets were 
restricted has been fulfilled. In the period (or periods) that the restrictions ex­
pire, the temporarily restricted net assets (or the portion of the temporarily 
restricted net assets that relate to the particular payment installment) are re­
classified as unrestricted net assets and reported in the statement of operations 
as net assets released from restriction.
5.16 In the year that unconditional promises to give cash are received, 
they should be measured at the present value8 of their future cash flows. (Un­
conditional promises to give cash that are expected to be collected within one 
year of the financial statement date may be measured at their net realizable 
value.) In determining the future cash flows of unconditional promises to give 
cash, not-for-profit organizations should consider when the receivable is ex­
pected to be collected, the creditworthiness of the other parties, the organiza­
tion's past collection experience and its policies concerning the enforcement of 
promises to give, and other factors concerning the receivable's collectibility. If 
the present value of unconditional promises to give cash decreases after initial 
measurement because of decreases in future cash flows, the decrease should be 
recognized in the period(s) in which the expectation changes. Such decreases 
should be reported as expenses or losses (bad debt) in the net asset class in 
which the net assets are represented.9 Accretion of the discount element of the 
unconditional promise to give is accounted for as contribution income, which 
increases unrestricted, temporarily, or permanently restricted net assets, as 
appropriate.
5.17 With regard to pledges and other promises to pay in future periods, if 
a provider routinely conducts fund drives, an estimate of the future cash flows 
of a portfolio of short-term promises resulting from a mass fund-raising appeal 
may be made based on experience gained from similar appeals in prior years.
5.18 Chapter 5 of the Audit and Accounting Guide Not-for-Profit Organi­
zations provides further guidance regarding accounting for promises to give in 
future periods and for assets held by not-for-profit organizations or charitable 
trusts that raise or hold contributions for others.
8 FASB Statement No. 116 states that present value should be calculated using a discount rate 
commensurate with the risks involved.
9 As discussed in FASB Statement No. 116, all expenses should be reported as decreases in 
unrestricted net assets. Therefore, decreases in contributions because of changes in the estimated 
future cash flows should be reported as losses if they are decreases in temporarily restricted net 
assets or permanently restricted net assets.
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5.19 GASB Statement No. 33, Accounting and Financial Reporting for 
Nonexchange Transactions, as amended, provides guidance on accounting and 
reporting contributions to governmental health care entities. Promises of cash 
or other assets that nongovernmental entities, including individuals, voluntar­
ily make to governments may be referred to in practice as pledges, promises 
to give, promised donations, or by some other term. * Promised assets may in­
clude permanently nonexpendable additions to endowments and other trusts; 
term endowments; contributions of works of art and similar assets to capital­
ized collections; or other kinds of capital or financial assets, with or without 
purpose restrictions or time requirements. For purposes of reporting under 
GASB Statement No. 33, these are classified as voluntary nonexchange trans­
actions. Governmental health care enterprises that receive promises to give 
from nongovernmental entities to provide cash or other assets should recog­
nize receivables and revenues (net of estimated uncollectible amounts) when 
all eligibility requirements are met, provided that the promise is verifiable and 
the resources are measurable and probable of collection. Transactions that are 
not recognizable because they are not measurable should be disclosed.
5.20 As discussed in GASB Statement No. 33 paragraph 20, eligibility 
requirements comprise 1 or more of the following:
a. Required characteristics o f recipients
b. Time requirements
c. Reimbursements
d. Contingencies
Detailed guidance on the application o f eligibility requirements is provided in 
GASB Statement No. 33 paragraphs 21-26.
Financial Statement Presentation 
Accounts Receivable
5.21 Receivables are reported net of an allowance for doubtful accounts. 
Although the aggregate amount of receivables may include balances due from 
patients and third-party payors (including final settlements and appeals), the 
amounts due from third-party payors for retroactive adjustments of items such 
as final settlements or appeals shall be reported separately in the financial 
statements.
5.22 Accounts receivable of health care organizations generally are subject 
to the same financial disclosure requirements as other business organizations.* 10 1
Nongovernmental health care organizations with loans and trade receiv­
ables should follow the presentation and disclosure guidance in para­
graph .13 of SOP 01-6 to the extent that guidance is applicable. FASB Statement 
No. 107, Disclosures about Fair Value o f  Financial Instruments,11 sets forth
110 Health Care Organizations
* See footnote * in paragraph 5.12.
10 See discussion of SOP 00-1 in paragraph 5.34.
11 Governmental health care entities only. This pronouncement is not applicable to governmental 
health care enterprises that do not apply paragraph 7 of GASB Statement No. 20. (See footnote 1 in 
chapter 1.)
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disclosure requirements regarding the carrying amount of patient accounts 
receivable.†
5.23 Governmental health care entities only. GASB Statement No. 38, Cer­
tain Financial Statement Note Disclosures, paragraph 13 requires that gov­
ernmental health care entities provide details in the notes to their financial 
statements about receivable balances when significant components of those 
receivables have been obscured by aggregation.
Concentrations o f Credit Risk
5.24 FASB Statement No. 10712 provides guidance on the required disclo­
sures about significant concentrations of credit risk arising from all financial 
instruments, including trade accounts receivable? Concentration of credit risk 
frequently is an issue because most health care organizations generally tend to 
treat patients from their local or surrounding communities. Accordingly, disclo­
sure should be made of the primary geographic sources of patients. It should be 
noted that concentration of credit risk may be a significant issue in stand-alone 
financial statements issued for a member hospital of a large national multi­
hospital system but may not be an issue for financial statements prepared for 
the hospital system. When the individual facilities' financial statements are 
consolidated into statements prepared for the entire system, the credit risk is 
dispersed over a much larger base of health plans, patients, and geographies 
and, therefore, is not as concentrated. Health care organizations with signifi­
cant concentrations of credit risk should comply with the disclosure provisions 
of FASB Statement No. 107, as amended.
Off-Balance Sheet Arrangements
5.25 Off-balance-sheet risk exists when the possible accounting loss from 
a financial instrument is not reflected on the balance sheet. Health care or­
ganizations (most notably hospitals) may enter into arrangements where they 
will finance their patient accounts receivable as a cash flow management strat­
egy. Nongovernmental health care organizations should follow the presentation 
and disclosure guidance in paragraph 13 of SOP 01-6 regarding credit losses 
on off-balance-sheet instruments to the extent that guidance is applicable. 
Derivative Instruments
5.26 FASB Statement No. 133,‡ Accounting for Derivative Instruments and 
Hedging Activities, as amended, provides guidance on the required disclosures
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† In February 2007, FASB issued FASB Statement No. 159, The Fair Value Option for Financial 
Assets and Financial Liabilities—Including an amendment o f FASB Statement No. 115, that permits 
all entities, including not-for-profit organizations, to choose to measure eligible items at fair value at 
specified election dates. See discussion in chapter 3.
12 Governmental health care entities only. See footnote 11.
‡ FASB recently issued FASB Statement No. 161, Disclosures about Derivative Instruments and 
Hedging Activities—an amendment of FASB Statement No. 133. The statement was issued due to the 
significant increase in the use and complexity of derivative instruments over the past several years. 
FASB believes that FASB Statement No. 133, Accounting for Derivatives Instruments and Hedging 
Activities, does not provide adequate information about how derivatives and hedging activities affect 
an entity's financial position, income statement, and statement of cash flows. Accordingly, FASB 
Statement No. 161 increases disclosures about an entity's derivative and hedging activities in order 
to improve financial transparency. FASB Statement No. 161 is effective for financial statements issued 
for fiscal years and interim periods beginning after November 15, 2008. Early adoption is encouraged. 
FASB Statement No. 161 encourages, but does not require, comparative disclosures for earlier periods 
at initial adoption.
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by entities that hold or issue derivative instruments.13 SOP 02-2, Accounting 
for Derivative Instruments and Hedging Activities by Not-for-Profit Health Care 
Organizations and Clarification o f the Performance Indicator (AICPA, Technical 
Practice Aids, ACC sec. 10,860), requires that not-for-profit health care orga­
nizations that are within the scope of this guide provide disclosures that are 
analogous to those required by paragraph 45 of FASB Statement No. 133 for 
for-profit enterprises, including the disclosure of anticipated reclassifications 
into the performance indicator of gains and losses that have been excluded 
from that measure and reported in accumulated derivative gain or loss as of 
the reporting date. SOP 02-2 does not apply to governmental entities that are 
within the scope of this guide. SOP 02-2 is included as appendix F to this guide.
5.27 Governmental health care entities only. GASB Technical Bulletin No. 
2003-1, Disclosure Requirements for Derivatives Not Reported at Fair Value on 
the Statement o f Net Assets, applies to governmental health care enterprises.
Interfund Receivables
5.28 Interfund receivables (or payables) may exist in internal records. 
However, since general purpose financial statements of not-for-profit health 
care organizations do not classify assets and liabilities into fund groups, inter- 
fund receivables (or payables) are eliminated.
5.29 Governmental health care entities only. Such interfund balances and 
transactions are different from interfund transactions between a governmen­
tal health care enterprise fund and another fund, such as the general fund 
or a special revenue fund of a primary government, when the two funds are 
included in the same financial reporting entity. Governmental health care en­
tities that are funds or component units of another governmental entity may 
report receivables (or payables) from other funds or from the primary govern­
ment or other component units. (The term primary government is defined in 
GASB Statement No. 14, The Financial Reporting Entity.) Interfund balances 
are eliminated in the government-wide financial statements of the financial 
reporting entity, when presented.14 Discretely presented component units that 
report amounts receivable (or payable) from the primary government or from 
other component units should report those assets on a separate line from other 
receivables (payables), as discussed in GASB Statement No. 34, Basic Finan­
cial Statements—and Management's Discussion and Analysis—for State and 
Local Governments, paragraph 61. GASB Statement No. 38 paragraph 14 also 
requires disclosures about interfund balances and transfers.
Promises to Give in Future Periods (Pledges)||
5.30 Contributions receivable should be reported net of an allowance for 
uncollectible amounts. That allowance may be based on the receivable's age, 
the creditworthiness of the parties, the organization's past collection experience 
and its policies concerning the enforcement of promises to give, and other factors 
concerning the receivable's collectibility. After the date of initial measurement,
Health Care Organizations
13 Governmental health care entities only. See footnote 11.
14 If a governmental health care entity reports using multiple enterprise funds, interfund bal­
ances between those funds are eliminated in the total enterprise fund column.
|In September 2006, GASB issued GASB Statement No. 48, Sales and Pledges o f Receivables 
and Future Revenues and Intra-Entity Transfers o f Assets and Future Revenues. This statement is 
effective for financial statements with periods beginning after December 15, 2006.
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bad debt expense should be reported for the amount of promises to give that 
are expected to be uncollectible (see paragraphs 5.14 and 5.19).
5.31 Investor owned health care enterprises and not-for-profit health care 
organizations that are recipients of unconditional pledges (promises to give in 
future periods) shall disclose
a. the amounts of promises receivable in less than one year, in one to 
five years, and in more than five years.
b. the amount of the allowance for uncollectible promises receivable.
5.32 Investor owned health care enterprises and not-for-profit health care 
organizations that are recipients of conditional pledges (promises to give in 
future periods) shall disclose
a. the total of the amounts promised.
b. a description and amount for each group of promises having sim­
ilar characteristics, such as amounts of promises conditioned on 
establishing new programs, completing a new building, or raising 
matching gifts by a specified date.
Auditing
Note: This guide presents auditing guidance to help you implement auditing 
standards included in both AICPA professional standards and in Public Com­
pany Accounting Oversight Board (PCAOB) professional standards. In citing 
the professional standards, references are made to the AICPA's Professional 
Standards publication and the AICPA's PCAOB Standards and Related 
Rules publication, depending upon the applicable professional standards. 
Additionally, when referencing professional standards, this guide cites sec­
tion numbers and not the original statement number, as appropriate. For 
example, Statement on Auditing Standards (SAS) No. 54 is referred to as 
AU section 317.
5.33 In general, receivables, particularly those arising from health care 
services, are material to the financial position of health care organizations. 
Examples of specific auditing objectives, selected control activities, and auditing 
procedures that may be considered by the independent auditor as they relate to 
the major components of receivables of health care organizations are presented 
in exhibit 5-1 at the end of this chapter.
5.34 SOP 00-1, Auditing Health Care Third-Party Revenues and Related 
Receivables (AICPA, Technical Practice Aids, AUD sec. 14,360), provides guid­
ance to auditors in evaluating the reasonableness of management's estimates 
regarding the proper valuation of health care third-party revenues and receiv­
ables embodied in the financial statements.
5.35 Auditing Interpretation No. 1, "Auditing Interests in Trusts Held by 
a Third-Party Trustee and Reported at Fair Value," of AU section 328, Audit­
ing Fair Value Measurements and Disclosures (AICPA, Professional Standards, 
vol. 1, AU sec. 9328 par. .01-.04), provides guidance for auditors of nonissuers 
when the auditor determines auditing procedures should include verifying the 
existence and testing the measurement of investments held by a trust (for ex­
ample, when auditing beneficial interests reported at fair value, pursuant to
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paragraph 15 of FASB Statement No. 136; see paragraph 5.12 of this chapter).† 
That interpretation includes guidance regarding the adequacy of audit evidence 
in confirmations received from trustees with respect to the existence assertion 
and requirements for auditing fair value measurements in accordance with AU 
section 328.
Accounts Receivable Confirmations
5.36 Direct confirmation of amounts due from discharged patients and 
third-party payors may be an appropriate audit procedure for obtaining evi­
dence about the existence and accuracy of amounts due. However, many pa­
tients whose accounts are expected to be paid by a third-party payor may not 
have received bills, and many third-party payors may be unable to respond to 
confirmation requests on specific account balances. In addition, obtaining con­
firmation of receivables from patients who are not discharged may be imprac­
ticable because those patients may not know the amount of their indebtedness 
until they are discharged.
5.37 If confirmation of amounts due from patients and third-party payors 
is impracticable or determined not to be effective, AU section 330, The Confir­
mation Process (AICPA, Professional Standards, vol. 1), provides requirements 
and guidance for documenting this decision, and using alternate procedures 
such as
• performing an analytical procedure or testing the details of sub­
sequent receipts.
• reviewing third-party contracts or payment agreements.
• comparing billings with documentation in medical records.
• reviewing the results of third-party payor audits and, if available, 
peer review organization reports.
• examining or confirming interim payments with third-party 
payors.
Health Care Organizations
† See footnote † in paragraph 5.22.
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Exhibit 5-1
Auditing Considerations*
Financial Statement Specific Auditing Selected Control 
Assertions Objectives Activities
Auditing
Procedures
Receivables for Health Care Services
Existence Amounts reported 
in the financial 
statements 
represent valid 
receivables, which 
do not include 
charity care 
balances.
Charges are 
generated 
automatically 
when services 
are performed.
A medical record 
is prepared.
Procedures 
ensure that 
amounts due 
from third-party 
payors for 
individual 
accounts are 
supported 
properly.
Procedures 
ensure the 
proper recording 
of cash receipts.
Procedures 
ensure charity 
care balances 
are identified 
and excluded 
from gross 
receivables.
Review and test
subsequent
receipts.
Compare billing 
information to the 
documentation 
contained in the 
medical records.
Review the 
results of the peer 
review
organization, if 
available, and 
insurance 
company reviews 
for evidence that 
might indicate 
receivables may 
not be realized.
Trace the receipts 
applicable to 
patient accounts 
to the accounts 
receivable 
records.
Review the 
management 
policy for 
determining 
charity care. 
Review policy and 
reasonableness of 
charity care 
measurement.
(continued)
* AU section 326, Audit Evidence (AICPA, Professional Standards, vol. 1), recategorizes asser­
tions by classes of transactions, account balances, and presentation and disclosure. This exhibit will 
be revised, as necessary, to reflect the new assertion categories in a future edition of the guide.
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Financial Statement Specific Auditing 
Assertions Objectives
Completeness Amounts reported 
in the financial 
statements are 
complete and are 
calculated and 
accumulated 
properly.
Valuation and Receivables are
allocation reported in the
financial
statements at net 
realizable value.
Selected Control 
Activities
Procedures 
ensure that (a) 
detailed 
accounts 
receivable 
records are 
compared 
routinely with 
control accounts 
and third-party 
payor logs, (b) 
differences are 
investigated and 
reconciled, and 
(c) adjustments, 
if necessary, are 
made promptly.
Allowances for 
uncollectibles 
and contractual 
adjustments are 
reviewed 
periodically by 
management to 
ensure that 
receivables are 
reported at 
estimated net 
realizable value.
Write-offs and 
allowances for 
uncollectibles 
are identified 
and approved in 
accordance with 
the entity's 
established 
policy.
Auditing
Procedures
Compare detailed 
accounts
receivable records 
with control 
accounts and 
third-party payor 
logs, and 
investigate 
reconciling items.
Review 
third-party 
contracts and 
recompute patient 
receivables. 
Examine 
contracts or 
confirm interim 
third-party 
payments with 
third-party 
payors.
Review and test 
the method used 
to determine the 
allowances for 
uncollectible 
accounts.
Determine that 
patient accounts 
are classified 
appropriately by 
payor (for 
example, 
Medicare or 
self-pay) to 
evaluate 
collectibility.
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Financial Statement Specific Auditing Selected Control 
Assertions Objectives Activities
Presentation and Significant 
disclosure contractual
arrangements 
with third parties 
are disclosed.
Auditing
Procedures
Test Medicare 
logs for accuracy 
and completeness.
Test and analyze 
aged accounts 
receivable trial 
balances, 
collection trends, 
delinquent 
accounts, 
subsequent period 
write-offs and 
economic or other 
factors used to 
determine 
allowance for 
uncollectible 
accounts.
Review pledges 
and other 
receivables for 
collectibility.
Determine that 
significant 
contractual 
arrangements 
with third parties 
are disclosed.
Estimated Third-Party Settlements
Existence Amounts reported 
in the financial 
statements 
represent valid 
receivables or 
payables.
Procedures 
ensure that 
estimated 
third-party 
settlements are 
determined in 
accordance with 
the
reimbursement 
and rate-setting 
methodologies 
applicable to the 
entity.
Review
correspondence 
from significant 
third-party 
payors related to 
(a) interim 
payment rates 
applicable to 
periods for which 
final settlements 
have not been 
made and (b) the 
amount of interim 
or final
settlements made 
during the period.
(continued)
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Financial Statement 
Assertions
Completeness and 
accuracy/ 
valuation and 
allocation
Specific Auditing Selected Control 
Objectives Activities
Amounts included 
in the financial 
statements are 
accurate and 
complete.
Procedures 
ensure that 
estimated 
third-party 
settlements are 
reasonably 
calculated and 
reported.
Auditing
Procedures
Test the
reasonableness of 
settlement 
amounts, 
including specific 
and unallocated 
reserves, in light 
of the payors 
involved, the 
nature of the 
payment 
mechanism, the 
risks associated 
with future 
audits, and other 
relevant factors. 
Review
third-party payor 
audit reports and 
adjustments for 
prior years’ cost 
reports or 
settlements to 
consider whether
(а) the effect of 
such adjustments 
has been reported 
properly in the 
financial 
statements and
(b) adjustments of 
a similar nature 
apply to the 
current period.
Obtain a 
representation 
from management 
that provisions 
for estimated 
retroactive 
adjustments by 
third-party 
payors under 
reimbursement 
agreements for 
open years are 
adequate.
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Financial Statement 
Assertions
Presentation and 
disclosure
Specific Auditing Selected Control Auditing
Objectives Activities Procedures
Amounts reported 
in the financial 
statements are 
presented 
properly and all 
required 
disclosures are 
made.
Determine that 
the tentative 
nature of 
third-party 
settlement 
amounts is 
disclosed properly.
Determine that 
differences 
between original 
estimates and 
subsequent 
revisions 
(including final 
settlements) are 
included in the 
statement of 
operations in the 
period in which 
the revisions are 
made and 
disclosed, if 
material.
AAG-HCO 5.37
Property and Equipment, Supplies, and Other Assets 121
Chapter 6
Property and Equipment, Supplies, 
and Other Assets
Overview
6.01 Health care organizations use various types of property and equip­
ment. Those assets may be material to the financial position of institutional 
health care organizations, such as hospitals and nursing homes. Typical ac­
counts used to record property and equipment transactions are land, land im­
provements, buildings and improvements, leasehold improvements, equipment 
(fixed and movable), leased property and equipment, accumulated depreciation 
and amortization, and construction in progress.
6.02 Supplies usually are not material to the financial position of health 
care organizations. However, because of the volume of supply transactions, they 
may materially affect operations. Supplies typically include medical and surgi­
cal supplies; pharmaceuticals; linens, uniforms, and garments; food and other 
commodities; and housekeeping, maintenance, and office supplies.
6.03 Other assets may include prepaid expenses, deposits, and deferred 
expenses. Prepaid costs, such as amounts paid to physicians for future services 
(for example, administering a hospital department or providing community 
services that further the organization's mission) may be deferred and amortized 
over the period benefited. Such assets are classified as current or noncurrent 
as appropriate.
Accounting
6.04 Accounting for property and equipment, supplies, and other assets 
of health care organizations is similar to that used by other business organiza­
tions.
6.05 Depreciation and amortization of property and equipment are 
recorded in conformity with generally accepted accounting principles. Useful 
lives assigned to depreciable assets should be reasonable, based on the cir­
cumstances. The American Hospital Association publishes useful guidelines 
for classifications and estimated useful lives for property and equipment used 
by hospitals. Those guidelines also may be useful to other health care organiza­
tions. If there is a potential that an asset is impaired, health care organizations 
should consider the guidance in Financial Accounting Standards Board (FASB) 
Statement No. 144, Accounting for the Impairment or Disposal o f Long-Lived 
Assets.1
6.06 Governmental health care entities only. Governmental health care en­
terprises should also consider the guidance in Governmental Accounting Stan­
dards Board (GASB) Statement No. 42, Accounting and Financial Reporting 
for Impairment o f Capital Assets and for Insurance Recoveries, for impairment
1 Governmental health care entities only. This pronouncement is not applicable to governmental 
health care enterprises that do not apply paragraph 7 of Governmental Accounting Standards Board 
(GASB) Statement No. 20, Accounting and Financial Reporting for Proprietary Funds and Other 
Governmental Entities That Use Proprietary Fund Accounting. (See footnote 1 in chapter 1.)
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of capital assets, as defined in paragraph 19 of GASB Statement No. 34, Basic 
Financial Statements—and Management's Discussion and Analysis—for State 
and Local Governments.
6.07 The recognition of contribution income related to donated long-lived 
assets (or assets recognized to be acquired with donated funds) is discussed in 
chapter 10 of this guide.
6.08 FASB Statement No. 143, Accounting for Asset Retirement Obliga­
tions, provides guidance that addresses financial accounting and reporting for 
obligations associated with the retirement of tangible long-lived assets and the 
associated asset retirement costs.2 FASB Statement No. 143 applies to legal 
obligations associated with the retirement of long-lived assets that result from 
the acquisition, construction, development, and (or) normal operation of a long- 
lived asset, except for certain obligations of lessees. FASB Statement No. 143 
requires that the fair value of a liability for an asset retirement obligation be 
recognized in the period in which it is incurred if a reasonable estimate of fair 
value can be made.* Upon initial recognition of a liability for an asset retire­
ment obligation, the asset retirement costs should be capitalized by increasing 
the carrying amount of the related long-lived asset. FASB Statement No. 143 
includes disclosure requirements. FASB Interpretation No. 47, Accounting for 
Conditional Asset Retirement Obligations—an interpretation o f  FASB State­
ment No. 143, clarifies that an entity is required to recognize a liability if the 
obligation to perform the asset retirement activity is unconditional, even though 
the timing and (or) method of settlement may be uncertain.3
Financial Statement Presentation
6.09 Financial statement presentation o f property and equipment of 
health care organizations is similar to that of other business organizations. 
Property held for investment purposes should be presented as part o f invest­
ments. Donor or legal restrictions on the proceeds from the disposition o f do­
nated property and equipment (or of property and equipment purchased with 
cash restricted for acquisition of long-lived assets) are disclosed.
6.10 Financial statement presentation o f supplies and other assets of 
health care organizations is similar to that of other business organizations.
6.11 Governmental health care entities only. Capital assets for governmen­
tal health care entities that are not being depreciated, if significant, should be
Health Care Organizations
2 Governmental health care entities only. This pronouncement does not apply to governmen­
tal health care enterprises' conditional asset retirement obligations, such as asbestos removal, unless 
probable of occurrence as discussed in National Council on Governmental Accounting (NCGAS) State­
ment 4, Accounting and Financial Reporting Principles for Claims and Judgments and Compensated 
Absences, as amended, paragraphs 9 and 14. This pronouncement is not applicable to governmental 
health care enterprises that do not apply paragraph 7 of GASB Statement No. 20. (See footnote 1 in 
chapter 1.)
* In September 2006, the Financial Accounting Standards Board (FASB) issued FASB Statement 
No. 157, Fair Value Measurements, which defines fair value, establishes a framework for measuring 
fair value in generally accepted accounting principles, and expands disclosures about fair value mea­
surements. This statement applies under other accounting pronouncements that require or permit 
fair value measurements, FASB having previously concluded in those accounting pronouncements 
that fair value is the relevant measurement attribute. Accordingly, this statement does not require 
any new fair value measurements but the application of it will change current practice. Refer to the 
discussion in chapter 3.
3 Governmental health care entities only. This pronouncement does not apply to governmental 
health care enterprises. See NCGA Statement 4, as amended, paragraphs 9 and 14.
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reported separately in the statement of net assets from capital assets being de­
preciated, as discussed in GASB Statement No. 34 paragraph 20. GASB State­
ment No. 34 also establishes 2 capital-asset related-disclosure requirements for 
governmental health care entities. First, GASB Statement No. 34 paragraph 
115e requires entities to disclose their policy for capitalizing assets and for 
estimating the useful lives of those assets in their summary of significant ac­
counting policies. Second, GASB Statement No. 34 paragraphs 116-117 require 
certain information to be presented about major classes of capital assets, in­
cluding beginning and ending balances, capital acquisitions, sales or other dis­
positions, current period depreciation expense, and accumulated depreciation. 
Capital assets that are not being depreciated should be disclosed separately 
from those that are being depreciated. GASB Statement No. 42 paragraph 20 
requires disclosure of the carrying amount of impaired capital assets that are 
idle at year-end and the financial statement classification of impairment losses.
Auditing
Property and Equipment, Supplies, and Other Assets
Note: This guide presents auditing guidance to help you implement auditing 
standards included in both AICPA professional standards and in Public Com­
pany Accounting Oversight Board (PCAOB) professional standards. In citing 
the professional standards, references are made to the AICPA's Professional 
Standards publication and the AICPA's PCAOB Standards and Related 
Rules publication, depending upon the applicable professional standards. 
Additionally, when referencing professional standards, this guide cites sec­
tion numbers and not the original statement number, as appropriate. For 
example, Statement on Auditing Standards No. 54 is referred to as AU sec­
tion 317.
6.12 Auditing objectives for property and equipment, supplies, and other 
assets of health care organizations are similar to those in audits of other busi­
ness organizations. The auditor may be able to assess the risks of material 
misstatement for these accounts as being relatively low because the transac­
tions therein are generally small in number, relatively simple in nature, and do 
not involve the use of complex estimates. The auditor must obtain a sufficient 
understanding of the entity and its environment, including its internal control, 
to assess the risk of material misstatement for these accounts.
6.13 A health care organization may have access to the use of property 
and equipment under a variety of arrangements. It may (a) own property and 
equipment, (b) rent property and equipment from an independent or related or­
ganization, (c) use property and equipment provided by a related organization 
(such as a religious order) or by an unrelated organization under an affiliation 
program, or (d) use property and equipment provided by a government agency or 
unit or a government-related hospital district. The independent auditor should 
inquire into (and the financial statements should disclose) the nature of any 
relationship between the health care organization and lessors, bailors, or other 
owners of property. With respect to leases, FASB Statement No. 13, Account­
ing for Leases, as amended and interpreted, provides accounting guidance.4
4 Governmental health care entities only. For governmental health care enterprises, NCGA State­
ment No. 5, Accounting and Financial Reporting Principles for Lease Agreements of State and Local 
(continued)
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FASB Staff Position FAS 13-1, Accounting for Rental Costs Incurred during a 
Construction Period, provides guidance for rental costs associated with ground 
and building operating leases that are incurred during a construction period. 
GASB Statement No. 13, Accounting for Operating Leases with Scheduled Rent 
Increases, provides additional guidance for operating leases of governmental 
health care enterprises.
6.14 In evaluating capitalization policies, the independent auditor should 
consider whether interest has been capitalized in accordance with the provi­
sions of FASB Statement No. 34, Capitalization o f Interest Cost, and related 
amendments and FASB Statement No. 62, Capitalization o f Interest Cost in 
Situations Involving Certain Tax-Exempt Borrowings and Certain Gifts and 
Grants—an amendment o f FASB Statement No. 34.
6.15 In evaluating the entity's depreciation policies, the auditor may wish 
to refer to the American Hospital Association's Estimated Useful Lives o f Depre­
ciable Hospital Assets, which is revised periodically and sets forth plant asset 
classifications and the estimated useful lives of depreciable assets. Additionally, 
social, economic, and scientific advances in the health care industry make ob­
solescence an important factor to be considered when evaluating depreciation 
policies and methods.
6.16 FASB Statement No. 1445 requires that health care organizations 
review long-lived assets for impairment whenever events or changes in circum­
stances indicate that the carrying amount of the asset may not be recoverable. 
In considering a health care organization's application of FASB Statement No. 
144, auditors may obtain an understanding of the policies and procedures used 
by management to determine whether all impaired assets have been properly 
identified. In addition to evaluating the entity's procedures for identifying in­
dicators o f impairment, the auditor may consider information obtained during 
the audit in determining whether the health care organization has identified 
appropriate indicators o f impairment. For example, a change in the use of a 
facility from an acute-care hospital to an ambulatory surgery center may re­
quire that the asset be reviewed for impairment using the method prescribed 
by FASB Statement No. 144.
6.17 Governmental health care entities only. For governmental health care 
entities, GASB Statement No. 42 requires the evaluation of prominent events 
or changes in circumstances affecting capital assets to determine whether im­
pairment has occurred.
6.18 In obtaining sufficient appropriate audit evidence with respect to 
property and equipment, supplies, and other assets, the auditor may consider 
the examples of specific auditing objectives, selected control activities, and au­
diting procedures that are presented in exhibit 6-1.
Health Care Organizations
(footnote continued)
Governments, requires the application of FASB Statement No. 13, Accounting for Leases, for pro­
prietary activities and provides additional guidance on specific matters unique to governmental 
entities.
5 Governmental health care entities only. See footnote 1.
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Exhibit 6- 1
Auditing Considerations*
Financial Statement Specific Auditing 
Assertions Objectives
Selected Control 
Activities
Auditing
Procedures
Donated Property Equipment
Valuation and Donated property Procedures Review the
allocation and equipment is ensure that the documentation
reported at fair donation of supporting the
market value at property and determination of
the date of equipment is the fair market
donation.* known and value.1
Presentation and The receipt of
recorded and that 
documentation 
supports the 
determination of 
the fair market 
value.
Review material
disclosure donated property donated property
and equipment is and equipment
properly reported. transactions to
Property and Equipment Not Held for Use in Operations
ensure the 
propriety of the 
reporting.
Presentation and Property and Property records Determine that
disclosure equipment not segregate property held for
used for property and nonoperating
operations is equipment not purposes is
reported used for operating reported
separately. purposes. separately.
Property and Equipment Additions
Rights and The appropriate Management For material new
obligations health care regularly construction,
planning agency monitors determine
or other compliance with compliance with
regulatory agency health care health care
approvals, if planning agency planning agency
required, have regulations or other
been obtained for related to regulatory agency
property and additions of requirements.
equipment property and
additions. equipment.
(continued)
* AU section 326, Audit Evidence (AICPA, Professional Standards, vol. 1), recategorizes asser­
tions by classes of transactions, account balances, and presentation and disclosure. This exhibit will 
be revised, as necessary, to reflect the new assertion categories in a future edition of the guide.
* See footnote * in paragraph 6.08.
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Financial Statement 
Assertions
Specific Auditing 
Objectives
Existence and 
valuation and 
allocation
Recorded 
property and 
equipment are 
owned by the 
entity and are 
carried at the 
appropriate 
amounts.
Selected Control 
Activities
Additions are 
authorized in the 
capital budget.
Inventory of fixed 
assets is taken 
periodically. 
Detailed property 
records
periodically are 
reconciled to the 
recorded 
amounts.
Auditing
Procedures
Review a 
summary of 
property and 
equipment (cost 
and accumulated 
depreciation) 
including 
additions, 
deletions, and 
transfers.
1 AU section 328, Auditing Fair Value Measurements and Disclosures (AICPA, 
Professional Standards, vol. 1), provides guidance on auditing fair value 
measurements and disclosures contained in financial statements. AU section 
328 does not address specific types of assets, liabilities, components of equity, 
transactions, or industry-specific practices.
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Chapter 7
Current Liabilities, Tax Considerations, 
and Long Term Obligations
Overview
7.01 Current liabilities may include notes payable to banks; the cur­
rent portion of long term debt; accounts payable; advances from and amounts 
payable to third-party payors for estimated and final reimbursement settle­
ments; refunds to and deposits from patients and others; deferred revenue; 
accrued salaries and payroll taxes; and other accruals such as pension or profit- 
sharing contributions, compensated absences, and income and other taxes. In 
addition, there may be a current portion of estimated malpractice costs and 
risk-contract recognized losses (see chapter 8).
7.02 Long term obligations may include notes, mortgages, capital leases, 
bonds, and obligations under continuing care contracts. They also may include 
estimated malpractice cost and risk-contract recognized losses.
Accounting
7.03 Accounting for current liabilities of health care organizations is sim­
ilar to that of other business enterprises. Health care organizations are usually 
labor-intensive and provide employees with compensated absences, such as for 
holidays, vacations, and illnesses. Liabilities related to such absences are ac­
counted for in accordance with Financial Accounting Standards Board (FASB) 
Statement No. 43, Accounting for Compensated Absences. Additional guidance 
was also issued in Emerging Issues Task Force (EITF) Issue No. 06-2, "Ac­
counting for Sabbatical Leave and Other Similar Benefits Pursuant to FASB 
Statement No. 43." Governmental health care entities should follow the guid­
ance in Governmental Accounting Standards Board (GASB) Statement No. 16, 
Accounting for Compensated Absences.
7.04 Liabilities related to postretirement benefits other than pensions 
should be accounted for in accordance with FASB Statement No. 158, Employ­
ers' Accounting for Defined Benefit Pension and Other Postretirement Plans—an 
amendments o f FASB Statements No. 87, 88, 106, and 132 (R).
7.05 Governmental health care entities only. Governmental health care en­
terprises are not required to apply FASB Statement No. 158. GASB Statement 
No. 45, Accounting and Financial Reporting by Employers for Postemployment 
Benefits Other Than Pensions, provides guidance and requirements for disclo­
sures about postemployment benefits. The requirements of GASB Statement 
No. 45 are effective in 3 phases based on revenues: periods beginning after 
December 15, 2006, for phase 1 governments (total annual revenues of $100 
million or more); periods beginning after December 15, 2007, for phase 2 gov­
ernments (total annual revenues of $10 million or more but less than $100 
million); and periods beginning after December 31, 2008, for phase 3 govern­
ments (total annual revenues of less than $10 million). GASB Statement No.
47, Accounting for Termination Benefits, establishes accounting standards for 
the measurement, recognition, and disclosure of voluntary termination benefits 
and involuntary termination benefits.
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7.06 Governmental health care entities only. Governmental health care en­
terprises sometimes report government-mandated or voluntary nonexchange 
revenues, such as expenditure-driven grants. These revenues are recognized 
when all eligibility requirements have been met, as discussed in GASB State­
ment No. 33, Accounting and Financial Reporting for Nonexchange Transac­
tions. In some cases, it may become apparent after revenue has been recognized 
in the financial statements that the eligibility requirements are no longer met, 
for example, because an audit of a particular grant program determined that 
certain expenses did not meet purpose restrictions. GASB Statement No. 33 
provides that, if it is probable that the recipient must return all or part of the 
resources, a liability (or reduction of receivables) and an expense should be rec­
ognized for the amount that the resource provider (grantor) is expected to cancel 
or reclaim. (See paragraphs 5 .19-.20, 10.06, and 10.13 for further discussion of 
GASB Statement No. 33.)
Tax Considerations for Not-for-Profit Health
Care Organizations
7.07 Health care organizations that are owned and operated by a state 
or local government are exempt from federal income tax pursuant to Internal 
Revenue Code (IRC) sec. 115 and also are exempt from the federal income tax 
filing requirements. Such organizations are exempt not only from regular fed­
eral income tax but also from the tax on unrelated business income. If a health 
care entity is owned and operated by a separately constituted authority or other 
legal entity, the entity's management ordinarily should consider whether such 
authority or other legal entity is organized properly to preserve qualification 
of the tax exemption pursuant to IRC sec. 115. In some cases, state or local 
governmental entities will secure tax-exempt status as an IRC sec. 501(c)(3) 
organization. If such an exemption is secured, the entity may become subject 
to federal income tax and the related filing requirements on the same basis as 
other tax-exempt entities.
7.08 Organizations take many tax positions relative to tax laws, including 
those taken in determining whether tax is due, a refund is owed, a tax return 
needs to be filed, or the characterization of income as taxable (for example, 
unrelated business income— see paragraph 7.13) or nontaxable. A tax position 
could result in or affect the measurement of a current or deferred tax asset or 
liability in the statement of financial position. FASB Interpretation No. (FIN) 
48, Accounting for Uncertainty in Income Taxes—an interpretation o f FASB 
Statement No. 109, provides recognition and measurement guidance for a tax 
position taken or expected to be taken in a tax return. FIN 48 was effective 
for fiscal years beginning after December 15, 2006. The AICPA has prepared a 
practice guide to help in understanding the interpretation. The practice guide 
is available at http://tax.aicpa.org/Resources.
Tax-Exempt Entities
7.09 Nongovernmental not-for-profit health care organizations usually 
seek exemption from federal income tax under IRC sec. 501(a). Under IRC 
sec. 501(a), entities organized and operated exclusively for religious, charita­
ble, or educational purposes, as described in IRC sec. 501(c)(3), are exempt 
from federal income taxes. The following are additional requirements for such 
entities:
Health Care Organizations
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a. No part of the entity's net earnings, either directly or indirectly, 
inures to any private shareholder or individual.
b. No substantial part of the entity's activities consists of carry­
ing on propaganda or otherwise attempting to influence legisla­
tion. (IRC sec. 501(h) provides a limited exception to the general 
rule that public charities may not incur expenditures to influence 
legislation.)
c. The entity does not participate in, or intervene in, any political 
campaign on behalf (or in opposition to) of any candidate for public 
office.
7.10 The term charitable is used in IRC sec. 501(c)(3) in its generally 
accepted legal sense. Providing health care to the community is considered a 
charitable activity. Therefore, provided a health care entity is not organized or 
operated for the benefit of private interests (such as designated individuals, the 
founder or the founder's family, shareholders of the entity, or persons controlled 
directly or indirectly by such private interests), it generally would qualify as 
an IRC sec. 501(c)(3) organization.
7.11 The IRS has ruled that in order for a nursing home to establish its 
exemption as a public charitable organization under IRC sec. 501(c)(3), it must 
be operated to meet the primary needs of the elderly for housing, health care, 
and financial security. Operating for financial security generally means that an 
individual will be maintained in residence even if such individual can no longer 
pay residence fees.
Private Inurement
7.12 Under IRC sec. 501(c)(3) no part of the net earnings of the charitable 
organization shall inure to the benefit of any private shareholder or individ­
ual. A private shareholder or individual refers to a person or persons having a 
private or personal interest in the activities of the organization. The IRS has 
stated that physicians have a personal or private interest in the activities of a 
hospital and could be subject to the private inurement proscription.
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Unrelated Business Income Tax
7.13 Although not-for-profit organizations may be exempt from federal 
income tax, they nevertheless may be subject to tax on unrelated business 
income. The objective of the tax on unrelated business is to place such activities 
on the same basis as that of taxable entities. Unrelated business income is the 
income from any regularly carried-on trade or business, the conduct of which 
is not substantially related to the exercise or performance of the organization's 
tax-exempt purpose or function. The fact that proceeds from an activity are 
used exclusively for the entity's tax-exempt purpose does not make the activity 
substantially related to its tax-exempt purpose or function. As is the case with 
most tax-related definitions, there are qualifications and exceptions. Some of 
the more significant exclusions from this tax include
an annual specific deduction for certain limited activities.
income from activities of which substantially all the work is per­
formed by unpaid volunteers.
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• income from activities carried on for the convenience of the entity's 
patients, officers, or employees.
• dividends, interest, annuities, royalties, capital gains and losses, 
and rents from real property—with two major exceptions. The first 
exception is that income from investments that are debt-financed 
and otherwise not functionally related to the tax-exempt purpose 
is taxable. The second major exception makes taxable the interest, 
annuities, royalties, and rents received from a controlled (50 per­
cent owned) taxable corporation or partnership unless this entity 
is engaged in an activity that would have been exempt if it were 
carried on directly by the not-for-profit organization.
Financial Statement Presentation
7.14 Financial reporting and disclosure requirements for current liabil­
ities and long term obligations of health care organizations are the same as 
for other business organizations. In addition, with respect to continuing care 
retirement communities (CCRC), the method of accounting for advance fees, 
the method of calculating the obligation to provide future services and use of 
facilities, and the refund policy for refundable fees are disclosed in the finan­
cial statements. Chapter 14 describes other disclosure requirements applicable 
to CCRCs. Taxable entities have the same financial reporting and disclosure 
requirements as other commercial enterprises. Tax-exempt entities should dis­
close their tax-exempt status.
7.15 Governmental health care entities only. GASB Statement No. 34, 
Basic Financial Statements—and Management's Discussion and Analysis—for 
State and Local Governments, and GASB Statement No. 38, Certain Finan­
cial Statement Note Disclosures, provide guidance about required disclosures 
for governmental health care entities about current and long term liabilities, 
including the following:
• GASB Statement No. 38 paragraph 13 requires disclosures about 
accounts payable balances when significant components of those 
balances have been obscured by aggregation.
• GASB Statement No. 38 paragraph 12 requires disclosures about 
short-term debt activity during the year, even if no short-term 
debt is outstanding at year-end. For this purpose, short-term debt 
consists of anticipation notes, use of lines of credit, and similar 
loans. Disclosures should include a schedule of changes in short­
term debt as well as a discussion of the purposes for which short­
term debt was issued.
• GASB Statement No. 34 paragraphs 116, 119, and 120 require 
information to be presented about both long term debt, such as 
bonds payable, and about long term liabilities, such as compen­
sated absences and claims and judgments. Required disclosures 
include beginning and ending balances, increases, decreases, and 
the portions of each item that are due within 1 year.
• GASB Statement No. 38 paragraphs 10-11 require disclosure of 
debt service requirements to maturity for each of the five sub­
sequent years and in five-year increments thereafter. Principal 
and interest requirements are required to be disclosed separately.
Health Care Organizations
AAG-HCO 7.14
Similar requirements apply to obligations under capital leases and 
noncancelable operating leases.
• GASB Statement No. 38 paragraph 9 requires disclosure of actions 
taken to remedy significant violations of finance-related legal or 
contractual provisions.
Long Term Debt
7.16 Significant sums of money are required to replace and upgrade build­
ings and expand the facilities of health care organizations. As a result, health 
care organizations are dependent on external sources of funds to satisfy their 
capital needs. Many health care organizations finance acquisitions, additions, 
and renovations with long term debt.
7.17 In addition to serving as a financing source for government opera­
tions, tax-exempt debt frequently is issued by state and local governments on 
behalf of nongovernmental organizations (for example, not-for-profit organiza­
tions) to foster private-sector participation in certain desirable community ac­
tivities such as the provision of health care services. Tax-exempt bonds usually 
can be issued to obtain a higher ratio of project financing (up to 100 percent), a 
longer maturity period (up to 30 years), and a lower interest cost than taxable 
bonds. The majority of tax-exempt bonds issued by health care organizations 
are revenue bonds, which are bonds secured by a pledge of the entity's revenues. 
General obligation bonds are secured by the revenues of the issuing authority. 
Financing Authorities*
7.18 Because most providers legally cannot issue tax-exempt revenue 
bonds directly, a significant number of states have enacted legislation permit­
ting health care organizations to borrow funds for capital projects by issuing 
bonds through financing authorities. Financing authorities are authorized to 
issue tax-exempt bonds or other obligations and use the proceeds for the ben­
efit of the health care organization. To obtain project financing, a health care 
organization sometimes is required by a financing authority to enter into a 
lease arrangement, a sublease arrangement, or both. At other times, a lease or 
sublease arrangement is not required.
7.19 When a financing authority issues tax-exempt bonds or similar debt 
instruments and uses the proceeds for the benefit of a health care organization, 
the obligation is reported as a liability in the organization's balance sheet if 
the health care organization is responsible for repayment. In some cases, this 
obligation may take the form of a liability arising from a capital lease. If a 
health care organization has no obligation to make payments of principal and 
interest on the debt or capital or operating lease payments on related buildings 
or equipment, the organization should not reflect the liability on its balance 
sheet. In such circumstances, proceeds from the bond issue are reported as 
contributions from the sponsoring organization.
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* In October 2006, the Financial Accounting Standards Board (FASB) issued FASB Staff Position 
(FSP) FAS 126-1, Applicability of Certain Disclosure and Interim Reporting Requirements for Obligors 
for Conduit Debt Securities. This FSP clarifies the definition of a public entity in certain accounting 
standards to include entities that are conduit bond obligors for conduit debt securities that are traded 
in a public market.
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Assets Whose Use is Limited
7.20 Among the many provisions normally included in the bond inden­
tures of tax-exempt issues are the requirements to set aside funds annually 
from operations to ensure that bond principal, interest payments, and other 
requirements are met. The treatment of funds established under the terms of 
debt-financing instruments is discussed in paragraphs 1.30-.31.
Advance Refundings
7.21 In an advance refunding, new debt is issued for the purpose of replac­
ing an existing debt issue. Advance refundings enable providers to restructure 
their long term liabilities, take advantage of reduced interest rates, or termi­
nate restrictive bond covenants. The terms by which the debt may be satisfied 
legally and the related lien released without the debt necessarily being retired 
are spelled out in the debt instrument. Under the Tax Reform Act of 1986, bonds 
issued before January 1, 1986, may be advance refunded only twice. Bonds is­
sued on or after that date may be advance refunded only once.
7.22 The accounting, financial reporting, and disclosure requirements for 
advance refundings entered into by health care organizations other than gov­
ernmental entities are described in Accounting Principles Board (APB) Opinion 
No. 30, Reporting the Results o f Operations—Reporting the Effects o f Disposal of 
a Segment o f a Business, and Extraordinary, Unusual and Infrequently Occur­
ring Events and Transactions', FASB Statement No. 140, Accounting for Trans­
fers and Servicing o f Financial Assets and Extinguishments o f Liabilities—a 
replacement o f FASB Statement No. 125; and FIN 39, Offsetting o f Amounts Re­
lated to Certain Contracts—an interpretation of APB Opinion No. 10 and FASB 
Statement No. 105.1 Generally speaking, these entities are required to report 
any gain or loss resulting from an advance refunding as an extraordinary item 
in the financial statements of the period in which the refunding occurred only 
if the criteria in APB Opinion No. 30 for classification as an extraordinary item 
are met. The accounting, financial reporting, and disclosure requirements for 
advance refundings (and for current refundings) entered into by governmen­
tal health care entities are set forth in GASB Statement No. 23, Accounting
Health Care Organizations
1 FASB Emerging Issues Task Force (EITF) Issue No. 96-19, "Debtor's Accounting for a Mod­
ification or Exchange of Debt Instruments," addresses accounting for modifications or exchanges of 
debt instruments. EITF Issue No. 96-19 requires that (1) an exchange o f debt instruments with sub­
stantially different terms is a debt extinguishment and should be accounted for in accordance with 
paragraph 16 o f FASB Statement No. 125, Accounting for Transfers and Servicing o f Financial Assets 
and Extinguishments o f Liabilities; and (2) a substantial modification of terms should be accounted for 
like, and reported in the same manner as an extinguishment. Also, transactions involving the modifi­
cation or exchange of debt instruments can only result in gain or loss recognition by the debtor if the 
conditions for extinguishment of debt described in paragraph 16 of FASB Statement No. 125 are sat­
isfied or i f the consensus in EITF Issue No. 96-19 requires that accounting. FASB Statement No. 140, 
Accounting for Transfers and Servicing o f Financial Assets and Extinguishments o f Liabilities—a re­
placement o f FASB Statement No. 125, among other matters, replaces FASB Statement No. 125. FASB 
Statement No. 140 does not change the guidance dealing with accounting for extinguishments of lia­
bilities. EITF Consensus Opinions are category (c) generally accepted accounting principles (GAAP) 
as described in AU section 411, The Meaning o f  Present Fairly in Conformity With Generally Ac­
cepted Accounting Principles (AICPA, Professional Standards, vol. 1). Including the EITF Consensus 
Opinions within this guide, which is category (b) GAAP, does not change their position in the GAAP 
hierarchy. See footnote * to paragraph 1.62 in this guide for information about a FASB exposure draft 
of a proposed FASB statement that would supersede the hierarchy for nongovernmental entities cur­
rently presented in AU section 411 and an Accounting Standards Board exposure draft o f a proposed 
Statement on Auditing Standards that would amend AU section 411.
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and Financial Reporting for Refundings o f Debt Reported by Proprietary Activi­
ties, and No. 7, Advance Refundings Resulting in Defeasance o f  Debt. Generally 
speaking, governmental entities are required to amortize any gain or loss re­
sulting from a current or advance refunding to interest expense over the shorter 
of the life of the new bonds or the remaining life of the old bonds.
7.23 There are several types of advance refundings, including net advance 
refundings, full cash advance refundings, and crossover refundings (see the 
glossary). In a crossover refunding, because the old bonds are not defeased 
until the crossover date, no immediate gain or loss should be recognized. If 
the retirement dates of the old debt have been established, the call premium, 
unamortized premium or discount, and initial issue costs should be recognized 
systematically in the income statement over the remaining life of the old debt 
as an adjustment of the cost of borrowing related to the old debt. In addition, 
the income earned on the funds used to consummate the advance refunding and 
the interest expense on both the old and new debts should be recognized in the 
statement of operations. The funds used to consummate the advance refunding 
should be reported as an asset and both the old and new debts should be reported 
as liabilities. The assets and liabilities should not be offset.
7.24 FASB Statement No. 140 provides accounting and reporting stan­
dards for extinguishments of liabilities. Paragraph 16 of FASB Statement No.
140 says a debtor should derecognize a liability if and only if it has been ex­
tinguished. Paragraph 16 says a liability has been extinguished if either of the 
following conditions is met:
a. The debtor pays the creditor and is relieved of its obligation for 
the liability. Paying the creditor includes delivery of cash, other 
financial assets, goods, or services or reacquisition by the debtor of 
its outstanding debt securities whether the securities are canceled 
or held as so-called treasury bonds.
b. The debtor is legally released from being the primary obligor under 
the liability, either judicially or by the creditor [footnote omitted].
Paragraph 114 o f FASB Statement No. 140 provides related guidance.
7.25 Paragraph 17b of FASB Statement No. 140 requires that if an entity 
had debt that was considered to be extinguished by an in-substance defeasance 
under the provisions of FASB Statement No. 76, Extinguishment o f Debt-an 
amendment o f  APB Opinion No. 26, prior to the effective date of FASB State­
ment No. 125, Accounting for Transfers and Servicing o f  Financial Assets and 
Extinguishments o f  Liabilities, the entity should provide a general description 
of the transaction and the amount of debt that is considered extinguished at 
the end of the period so long as that debt remains outstanding.
Arbitrage Rebate Liabilities
7.26 Advance refundings involving tax-exempt debt are subject to arbi­
trage rules under the IRC sec. 103(c) and related regulations that, in general, 
prohibit the yield realized from the investment of the proceeds of the new debt 
from exceeding the yield on the debt itself. Compliance with those rules is nec­
essary for the interest on the debt to be exempt from federal income tax and, 
possibly, from state and local tax.
7.27 Whenever a provider invests tax-exempt bond proceeds and the ulti­
mate yield is higher than the interest rate on the bonds, the provider may be
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subject to an arbitrage rebate liability. The arbitrage determination is made as 
of the date of the issue; however, intentional acts undertaken after the date of 
the issue can disqualify the issue retroactively. The earnings in excess of inter­
est expense represent a liability that must be paid to the U.S. Treasury in order 
for the bonds to maintain their tax-exempt status. The arbitrage rebate liabil­
ity may be a substantial amount if the bond proceeds are not spent as quickly 
as planned. For example, this may occur if a provider encounters a delay in a 
major construction project.
Auditing
7.28 Auditing objectives and procedures for long term debt issued by 
health care organizations generally are similar to those of other organizations. 
In obtaining sufficient appropriate audit evidence with respect to current lia­
bilities, tax considerations, and long term obligations, the auditor may consider 
the examples of specific auditing objectives, selected control activities, and au­
diting procedures that are presented in exhibit 7-1.
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Exhibit 7-1
Auditing Considerations*
Financial Statement Specific Auditing Selected Control
Assertions Objectives Activities Auditing Procedures
Tax-Exempt Debt
Presentation and 
disclosure
Income Taxes
Rights and 
obligations
Amounts related 
to tax-exempt 
debt are properly 
classified in the 
financial 
statements and 
related
disclosures are 
adequate.
The not-for-profit 
organization has 
obtained a 
qualifying income 
tax exemption 
from the 
governmental 
authority.
Procedures 
ensure that the 
providers 
monitor their 
compliance with 
restrictive debt 
covenants.
Management 
monitors 
compliance with 
applicable tax 
regulations. 
Transactions are 
reviewed for 
their effect on 
tax status and 
tax liabilities.
Review the debt 
instruments for 
the presence of any 
restrictive debt 
covenants. Test 
compliance with 
restrictive debt 
covenants.
Determine that the 
not-for-profit 
organization has 
obtained a 
determination of 
its tax-exempt 
status. Inquire if 
tax returns have 
been filed on a 
timely basis.
Determine the 
status of the tax 
returns under 
examination.
Read the prior 
years' tax returns.
Read the minutes 
and the accounting 
for evidence of 
significant 
unrelated business 
activities.
Review for 
reasonableness the 
unrelated business 
income tax 
liability.
(continued)
* AU section 326, Audit Evidence (AICPA, Professional Standards, vol. 1), recategorizes assert 
tions by classes of transactions, account balances, and presentation and disclosure. This exhibit will 
be revised, as necessary, to reflect the new assertion categories in a future edition of the guide.
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Financial Statement 
Assertions
Presentation and 
disclosure
Specific Auditing Selected Control
Objectives Activities Auditing Procedures
Health Care Organizations
The entity's 
tax-exempt status 
and its tax 
contingencies are 
disclosed in the 
notes to the 
financial 
statements.
Determine that the 
entity's tax-exempt 
status is disclosed 
in the notes to the 
financial 
statements.
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Chapter 8
Commitments and Contingencies
Overview
8.01 Commitments and contingencies may include (a) losses arising from 
litigation, including malpractice and other claims; (b) contingencies related to 
risk contracting; (c) third-party payment and rate-setting programs; (d) con­
struction contract commitments; (e) the Hill-Burton Act obligation to provide 
uncompensated care; (f) commitments and guarantees that include contractual 
agreements with physicians, specialists, and others who perform services by ar­
rangement with health care organizations; and (g) commitments and contingent 
liabilities related to pension plans, operating leases, purchase commitments, 
and loan guarantees. Financial Accounting Standards Board (FASB) Statement 
No. 159, The Fair Value Option for Financial Assets and Financial Liabilities— 
Including an amendment o f  FASB Statement No. 115, permits an organiza­
tion to irrevocably elect fair value, as defined by FASB Statement No. 157, 
Fair Value Measurements, as the initial and subsequent measure for certain 
financial liabilities, with changes in fair value recognized in the statement of 
activities as those changes occur.* Liabilities that require the organization to 
provide services, rather than cash or another financial asset, to the obligee are 
outside the scope of the statement and thus may not be reported at fair value.
8.02 FASB Statement No. 5, Accounting for Contingencies, as amended, 
and interpreted by FASB Interpretation No. (FIN) 14, Reasonable Estimation o f  
the Amount o f  a Loss—an interpretation o f  FASB Statement No. 5, and FIN 45, 
Guarantor's Accounting and Disclosure Requirements for Guarantees, Includ­
ing Indirect Guarantees o f  Indebtedness o f Others—an interpretation o f FASB 
Statements No. 5, 57, and 107 and rescission o f FASB Interpretation No. 34, 
provides guidance on accounting for contingencies. As discussed in FASB Staff 
Position (FSP) FIN 45-3, Application o f FASB Interpretation No. 45 to Mini­
mum Revenue Guarantees Granted to a Business or Its Owners, the guidance 
in FIN 45 applies to a guarantee granted to a business or its owner(s) that the 
revenue of the business (or a specific portion of the business) for a specified 
period of time will be at least a specified amount (referred in the FSP as a min­
imum revenue guarantee). An example of a minimum revenue guarantee is a 
guarantee granted to a nonemployee physician by a not-for-profit health care 
facility that has recruited the physician to move to the facility's geographical 
area to establish a practice. The health care facility (the guarantor) agrees to 
make payments to the newly arrived physician (the guaranteed party) at the 
end of specific periods of time if gross revenues (gross receipts) generated by 
the physician's new practice during that period of time do not equal or exceed a 
specific dollar amount. FSP FIN 45-3 applies to minimum revenue guarantees 
granted to physicians regardless of whether the physician's practice qualifies 
as a business under Emerging Issues Task Force Issue No. 97-2, "Application 
of FASB Statement No. 94 and APB Opinion No. 16 to Physician Practice Man­
agement Entities and Certain Other Entities with Contractual Management 
Arrangements."
* In February 2007, the Financial Accounting Standards Board (FASB) issued FASB Statement 
No. 159, The Fair Value Option for Financial Assets and Financial Liabilities—Including an amend­
ment of FASB Statement No. 115. See further discussion in chapter 3.
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8.03 FASB Statement No. 60, Accounting and Reporting by Insurance En­
terprises, discusses accounting for claims costs, including estimates of costs 
relating to incurred but not reported (IBNR) claims. Governmental health care 
entities generally should consider the accounting and disclosure requirements 
of Governmental Accounting Standards Board (GASB) Statement No. 10, Ac­
counting and Financial Reporting for Risk Financing and Related Insurance 
Issues, as amended.
Health Care Organizations
Medical Malpractice Claims
8.04 The extent of risk transfer is key in determining whether a liability 
should be recognized in a provider's financial statements pertaining to mal­
practice claims. The existence of an insurance policy, by itself, is no assurance 
that the risk of financial loss is transferred.
8.05 If the entity has purchased a claims-made insurance policy (see para­
graph 8.14), there is no transfer of risk for claims not reported to the insurance 
carrier within the policy term. With regard to retrospectively rated insurance 
policies (see paragraphs 8.15-.16) and policies by captive insurance companies 
(see paragraphs 8.17—.18), the economic substance of the terms of the insur­
ance policy may more closely resemble a claims funding mechanism than an 
instrument that transfers risk of loss to an external third party. If the health 
care organization has not transferred risk to an external third party, it should 
evaluate its exposure to losses arising from malpractice claims and record a 
liability, if appropriate.
Accruing Malpractice Liabilities
8.06 The ultimate costs of malpractice claims, which include costs associ­
ated with litigating or settling claims, are accrued when the incidents that give 
rise to the claims occur. Estimated losses from asserted and unasserted claims 
are accrued either individually or on a group basis, based on the best estimates 
of the ultimate costs of the claims and the relationship of past reported incidents 
to eventual claims payments. All relevant information, including industry ex­
perience, the entity's own historical experience, the entity's existing asserted 
claims, and reported incidents, is used in estimating the expected amount of 
claims. The accrual includes an estimate of the losses that will result from un­
reported incidents, which are probable of having occurred before the end of the 
reporting period.
8.07 In estimating the probability that unreported incidents have oc­
curred, some health care organizations may develop a range of possible es­
timates of the number of unreported incidents, including zero. However, the 
greater the volume of a health care organization's operations, the greater the 
likelihood that the organization's minimum estimate of the number of probable 
unreported incidents will be greater than zero.
8.08 If it is probable that a loss has been incurred and the information 
available indicates the loss is within a range of amounts, the most likely amount 
of loss in the range is accrued. If no amount in the range is more likely than any 
other, the minimum amount in the range is accrued. The potential additional 
loss is disclosed if there is at least a reasonable possibility of a loss in excess of 
the amount accrued.
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8.09 In estimating losses from malpractice claims, a health care organiza­
tion may need to modify data drawn from industry experience so it is relevant to 
developing an estimate that is specific to the organization. Various factors (such 
as the nature of operations, size, and the provider's past experience) are con­
sidered in assessing comparability. Further, industry data that are not current 
may not be relevant.
8.10 Estimated losses are reviewed and changed, if necessary, at each re­
porting date. The amounts of the changes are recognized currently as additional 
expense or as a reduction of expense.
8.11 Accrued unpaid claims and expenses that are expected to be paid 
during the normal operating cycle (generally within one year of the date of 
the financial statements) are classified as current liabilities. All other accrued 
unpaid claims and expenses are classified as noncurrent liabilities.
8.12 A health care organization discloses its program of medical malprac­
tice insurance coverages and the basis for any related loss accruals. If the orga­
nization cannot estimate losses relating to a particular category of malpractice 
claims (for example, asserted claims, reported incidents, or unreported inci­
dents) in accordance with paragraphs 8.04-.11, the potential losses related to 
that category of claims are not accrued. However, the contingency is disclosed 
in the notes to the financial statements, as required by FASB Statement No. 5.
8.13 Health care organizations that discount accrued malpractice claims 
should disclose in the notes to the financial statements the carrying amount 
of accrued malpractice claims that are discounted in the financial statements 
and the interest rate or rates used to discount those claims. Also, the FASB 
has issued FASB Statement of Financial Accounting Concepts No. 7, Using 
Cash Flow Information and Present Value in Accounting Measurements. This 
statement provides useful discussion of general principles governing the use 
of present value, and of the objective of present value in accounting measure­
ments. Statements of Financial Accounting Concepts are not sources of estab­
lished accounting principles as described in AU section 411, The Meaning o f  
Present Fairly in Conformity With Generally Accepted Accounting Principles 
(AICPA, Professional Standards, vol. 1), and, thus, do not amend, modify, or jus­
tify a change from generally accepted accounting principles (GAAP) currently 
in effect.
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Accounting for Claims-Made Insurance Policies
and Tail Coverage
8.14 A claims-made insurance policy represents a transfer of risk within 
the policy limits to the insurance carrier for asserted claims and incidents re­
ported to the insurance carrier. The policy, however, does not represent a trans­
fer of risk for claims and incidents not reported to the insurance carrier during 
the policy period. Consequently, a health care organization that is insured under 
a claims-made insurance policy recognizes the estimated cost of those claims 
and incidents not reported to the insurance carrier, in accordance with para­
graphs 8.04—.11. This estimation is done unless the health care organization 
has bought tail coverage (see the glossary) and included the cost of the premium 
as an expense in the financial statements for that period.
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Accounting for Retrospectively Rated Premiums
8.15 A health care organization with a retrospectively rated insurance 
policy whose ultimate premium is based primarily on the health care organiza­
tion's loss experience accounts for the minimum premium as an expense over 
the period of coverage under the policy and accrues estimated losses from as­
serted and unasserted claims in excess of the minimum premium, as indicated 
in paragraphs 8.04-.11. Such estimated losses, however, are not accrued in ex­
cess of a stipulated maximum premium. If the health care organization cannot 
estimate losses from asserted or unasserted malpractice claims, as indicated 
in paragraphs 8.04-.11, the health care organization should disclose the exist­
ing contingency in the notes to the financial statements, as required by FASB 
Statement No. 5.
8.16 A health care organization insured under a retrospectively rated pol­
icy whose ultimate premium is based primarily on the experience of a group 
of health care organizations amortizes the initial premium to expense on a pro 
rata basis over the policy term. The organization also accrues additional pre­
miums or refunds on the basis of the group's experience to date, which includes 
a provision for the ultimate cost of asserted and unasserted claims before the 
financial statement date, whether reported or unreported. The health care or­
ganization discloses that (a) it is insured under a retrospectively rated policy 
and (b) premiums are accrued based on the ultimate cost o f the experience to 
date of a group of organizations. If the health care organization cannot esti­
mate losses from asserted or unasserted malpractice claims, as indicated in 
paragraphs 8.04—.11, it should disclose the existing contingency in the notes to 
the financial statements, as required by FASB Statement No. 5.
Accounting for Medical Malpractice Claims Insured 
by Captive Insurance Companies
8.17 A majority-owned captive insurance company (for example, a wholly 
owned captive) is consolidated in accordance with FASB Statement No. 94, 
Consolidation o f All Majority-owned Subsidiaries—an amendment o f  ARB 
No. 51, with related amendments o f APB Opinion No. 18 and ARB No. 43, 
Chapter 12.1,† Multiprovider captives, in which the ownership percentage is
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1 In 2003, FASB issued FASB Interpretation No. (FIN) 46, Consolidation o f Variable Interest 
Entities—an interpretation o f ARB No. 51, and FIN 46, Consolidation o f Variable Interest Entities—an 
interpretation o f ARB No. 51 (revised December 2003), to address consolidation by business enterprises 
of variable interest entities. Not-for-profit organizations are not subject to FIN 46(R), except that they 
may be related parties for purposes of applying paragraphs 16-17 of that interpretation. Also, if  a 
not-for-profit entity is used by business enterprises in a manner similar to a variable interest entity 
in an effort to circumvent the provisions of FIN 46(R), that not-for-profit entity is subject to that 
interpretation.
† In December 2007, FASB issued FASB Statement No. 160, Noncontrolling Interests in Consoli­
dated Financial Statements—an amendment of ARB No. 51. The objective of FASB Statement No. 160 
is to improve comparability and transparency of consolidated financial statements by establishing 
accounting and reporting standards that require the following:
1. Reporting of ownership interest in subsidiaries held by parties other than the parent 
should be clearly identified, labeled, and presented in the consolidated balance sheet 
within equity but separate from the parent's equity.
2. Consolidated net income should clearly identify the portion of income attributable to 
the parent and the noncontrolling interest on the face of the income statement.
3. Changes in ownership interest should be accounted for consistently.
(continued)
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50 percent or less, are accounted for in accordance with Accounting Principles 
Board (APB) Opinion No. 18, The Equity Method o f Accounting for Investments 
in Common Stock. (See chapter 11 of the guide for additional discussion of 
considerations related to consolidation and the use of the equity method.)
8.18 A health care organization insured by an unconsolidated multi­
provider captive insurance company for medical malpractice claims under a 
retrospectively rated insurance policy whose ultimate premium is based pri­
marily on the health care organization's experience up to a maximum premium, 
if any, accounts for such insurance as indicated in paragraph 8.15.
8.19 A health care organization insured by an unconsolidated multi­
provider captive insurance company for medical malpractice claims under a 
retrospectively rated policy based primarily on the experience of a group of 
health care organizations accounts for such insurance as indicated in para­
graph 8.16. However, the health care organization considers whether the 
economic substance of the multiprovider captive insurance company is suffi­
cient to relieve the health care organization from further liability. The health 
care organization should disclose that (a) it is insured under a retrospec­
tively rated policy of a multiprovider captive insurance company and (6) the 
premiums are accrued based on the captive insurance company's experience 
to date.
8.20 A health care organization that is insured by a multiprovider cap­
tive insurance company discloses in its financial statements that it is insured 
by such a company, and it should disclose its ownership percentage, if sig­
nificant, in the captive company as well as the method of accounting for its 
investment in, and the operations of, the captive company. In addition, if the 
health care organization cannot make the necessary estimates of losses from 
asserted or unasserted claims, as indicated in paragraphs 8.04-.11, the health 
care organization discloses the existing contingency in the notes to the financial 
statements, as required by FASB Statement No. 5.
Accounting for Trust Funds
8.21 In general, a trust fund, whether legally revocable or irrevocable, is 
included in the financial statements of the health care organization. A portion 
of the fund equal to the amount of assets expected to be liquidated to pay 
malpractice claims classified as current liabilities is classified as a current asset; 
the balance of the fund, if any, is classified as a noncurrent asset. Revenues 
and administrative expenses of the trust fund are included in the statement of 
operations (see chapter 10). In some circumstances, the foregoing may not be 
possible (for example, if a common trust fund exists for a group of health care 
organizations; if the health care organization is part of a common municipality 
risk-financing internal service fund; or if the legal, regulatory, or indenture
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(footnote continued)
4. When a subsidiary is deconsolidated, any retained noncontrolling equity investment 
in the former subsidiary should be measured at fair value.
5. Entities should provide all appropriate disclosures to distinguish between interest of 
the parent and the interests of the noncontrolling owners.
FASB Statement No. 160 is effective for fiscal years beginning on or after December 15, 2008. Early 
adoption is prohibited. FASB Statement No. 160 should be applied prospectively as of the beginning of 
the fiscal year in which the statement is initially adopted. Presentation and disclosure requirements 
shall be applied retrospectively for all periods presented.
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restrictions prevent the inclusion of a trust fund in a health care organization's 
financial statements). In those circumstances, the provisions of paragraphs 
8.22-.23 apply.
8.22 In general, estimated losses from asserted and unasserted claims are 
accrued and reported, as indicated in paragraphs 8.04-.13. The estimated losses 
are not based on payments to the trust fund. However, accounting for a health 
care organization that participates in a pooled fund depends on the extent 
to which the associated risks and rewards have been transferred to another 
party. An organization that transfers its risk of loss to the common trust fund 
and forfeits its rights to any excess funding should expense its contributions 
and account for its participation in the trust fund based on the type of coverage 
obtained (for example, occurrence basis, claims-made, or retrospectively rated). 
Governmental health care entities that are component units of a state or local 
government reporting entity and that participate in that entity's risk-financing 
internal service fund should report claims expenses equal to the charges from 
the internal service fund if those charges meet the requirements of paragraphs 
65-68, as amended, of GASB Statement No. 10.
8.23 The existence of the trust fund and whether it is irrevocable is dis­
closed in the financial statements.
Governmental Health Care Enterprises
8.24 Governmental health care enterprises that are component units of a 
state or local governmental reporting entity and that participate in that entity's 
risk-financing internal service fund should report claims expenses equal to the 
charges from the internal service fund if those charges meet the requirements 
o f paragraphs 65-68, as amended, of GASB Statement No. 10. A governmental 
health care enterprise that participates in a public entity risk pool with trans­
fer or pooling of risk should present its premium or required contribution as 
insurance expense, as discussed in GASB Statement No. 10, paragraphs 69, 
as amended, and 70. Enterprises participating in public entity risk pools with­
out transfer or pooling of risk should report payments to pools as deposits and 
recognize and measure claims liabilities in accordance with GASB Statement 
No. 10, paragraphs 53-58, as amended. Paragraphs 116 and 119-120 of GASB 
Statement No. 34, Basic Financial Statements—and Management's Discussion 
and Analysis—for State and Local Governments, require disclosures about long 
term liabilities (such as claims and judgments). Information to be presented in­
cludes beginning and ending balances, increases, decreases, and the portions 
of each item that are due within 1 year.
Auditing Commitments and Contingencies
8.25 Auditing objectives and procedures for commitments and contingen­
cies generally are similar to those of other organizations. In obtaining sufficient 
appropriate audit evidence with respect to commitments and contingencies, the 
auditor may consider the specific auditing objectives, selected control activities, 
and auditing procedures presented in exhibit 8-1 at the end of this chapter.
Auditing Medical Malpractice Loss Contingencies
8.26 The existence of an insurance policy, by itself, is no assurance that 
malpractice contingencies are assumed by others. The auditor should review
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the insurance contracts and determine the extent of the risk retained by the 
provider. Specific auditing procedures to consider include the following:
• Determine the type (such as occurrence basis or claims-made) and 
level (per occurrence or in the aggregate) of insurance protection 
the provider has obtained.
• Determine if the coverage actually transfers the malpractice risks. 
Is the insurance with a related party (for example, a captive in­
surance company)? Does it provide for retrospective premiums or 
similar adjustments?
Once the extent of the risk retained is understood, the auditor will be able 
to assess the risks of material misstatement which are used to determine the 
nature, extent, and timing of other auditing procedures.
8.27 If a health care organization has transferred the risk of loss to a 
financially viable third party by purchasing insurance coverage of sufficient 
limits on an occurrence basis, no additional auditing procedures are necessary. 
If the organization retains all or a portion of the risk through self-insurance 
or has purchased a claims-made policy, the independent auditor should per­
form additional auditing procedures to obtain reasonable assurance that the 
organization's accounting for medical malpractice losses is in accordance with 
GAAP.
8.28 The independent auditor should consider the extent to which the re­
newal of a claims-made policy or the purchase of tail coverage after the balance- 
sheet date prior to the issuance of the financial statements limits the entity's 
liability exposure as of the balance-sheet date. If an entity either renews a 
claims-made policy or purchases tail coverage, and the new policy covers claims 
asserted during the new policy term (regardless of when the incident occurred), 
the entity has transferred to the insurer the risk for that portion of the entity's 
claims that is expected to be reported during the new policy term (up to the new 
policy limits). Accordingly, the entity's liability for the IBNR claims transferred 
would not exceed the premium on the new policy, except for anticipated claims 
in excess of the new policy limits.
8.29 Management's intent to renew a claims-made policy is not sufficient 
to constitute a limit on IBNR claims as of the balance-sheet date unless man­
agement contractually obligates itself for renewal before the issuance date of 
the financial statements and the cost is expensed in the period covered by the 
financial statements. The requirement to renew a claims-made policy or to pur­
chase and expense tail coverage applies even if state regulations require that 
renewal of claims-made coverage be offered continually.
8.30 If the insured has the unilateral option to purchase tail coverage at a 
premium that may not exceed a stipulated maximum, and the provider intends 
to purchase that coverage, the amount of IBNR loss to be accrued may effectively 
be limited to the maximum tail-coverage premium stated in the policy. However, 
providers in these circumstances that do not intend to purchase tail coverage 
may not accrue the cost of obtaining that coverage as a substitute for the IBNR 
accrual.
Auditing Accounting Estimates
8.31 Management is responsible for making the accounting estimates that 
are included in the financial statements. Management is also responsible for
Commitments and Contingencies
AAG-HCO 8.31
providing proper disclosure of (1) the use of estimates in the preparation of 
financial statements and (2) certain significant estimates (Statement of Position 
[SOP] 94-6, Disclosure o f Certain Significant Risks and Uncertainties [AICPA, 
Technical Practice Aids, ACC sec. 10,6401 ).2,3 The auditor is responsible for 
evaluating the reasonableness of management's estimates and the adequacy of 
the related disclosures. The auditor does this using one or more of the following 
approaches:
a. Test the process used by management to develop the estimate.
b. Develop an independent expectation of the estimate to corroborate 
the reasonableness of management's estimate.
c. Review subsequent events or transactions occurring prior to com­
pletion of fieldwork.
8.32 In evaluating management's estimates of asserted and unasserted 
claims, the auditor should consider factors such as management's descrip­
tion and evaluation of asserted claims and unasserted claims arising from 
reported incidents; the lawyer's (and, if appropriate, the outside risk man­
ager's) assessment of asserted claims and reported incidents not covered by 
insurers; and the actuary's evaluations of the aggregate liability covering as­
serted claims and unasserted claims arising from reported and unreported 
incidents.
8.33 Paragraph .06 of AU section 333, Management Representations 
(AICPA, Professional Standards, vol. 1), provides requirements and guidance 
for obtaining a specific written representation from management that it has 
disclosed all liabilities and gain or loss contingencies required to be accrued or 
disclosed by FASB Statement No. 5.
8.34 In evaluating the information provided by legal counsel, it may be 
necessary to supplement the written representations with inquiries if the rep­
resentations are not clear regarding the probability of the litigation outcome or 
the potential range of loss.4
8.35 The auditor should consider the frequency of losses due to unreported 
incidents and the magnitude of prior losses and underlying causes for the IBNR 
claims. If there is a basis for an accrual, the auditor should then determine 
whether the entity's prior history supports the estimation of the number of 
claims and the probable settlement value.
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2 See paragraphs 8.41-.44.
3 Governmental health care entities only. Statement of Position (SOP) 94-6, Disclosure o f Cer­
tain Significant Risks and Uncertainties (AICPA, Technical Practice Aids, ACC sec. 10,640), does not 
pertain to governmental entities unless the entity has elected to follow all FASB pronouncements 
under paragraph 7 of Governmental Accounting Standards Board Statement No. 20, Accounting and 
Financial Reporting for Proprietary Funds and Other Governmental Entities That Use Proprietary 
Fund Accounting. (See footnote 1 in chapter 1.)
4 According to AU section 337, Inquiry o f a Client’s Lawyer Concerning Litigation, Claims, and 
Assessments (AICPA, Professional Standards, vol. 1), a letter of audit inquiry to the lawyer handling 
the claims is the auditor's primary means of obtaining corroboration of the information furnished by 
management concerning claims made and known incidents for which claims have not been made that 
are either uninsured or in excess of the insurance coverage. Audit inquiry letters generally would 
not be required with respect to reported contingencies that were not considered to have a material 
potential loss. The inability or unwillingness of counsel to evaluate asserted claims and or reported 
incidents would give rise to a modification of the auditor's opinion.
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Use of Actuaries and Actuarial Methods
8.36 An actuary may be engaged to provide or review the estimate of the 
medical malpractice loss amount or range of amounts or to assist in developing 
certain factors and assumptions used in estimating the malpractice liability. 
The decision to use an actuary may be based on a consideration of whether 
(a) the estimated claim liability is potentially material to the fair presentation 
of financial statements in conformity with GAAP and (b) special knowledge is 
required to estimate the claim liability.
8.37 AU section 336, Using the Work o f a Specialist (AICPA, Professional 
Standards, vol. 1), provides requirements and guidance if an actuary is involved 
in a substantial way in determining the amount of a provider's malpractice self- 
insurance liability. The independent auditor should consider the actuary's pro­
fessional qualifications, reputation, prior experience in estimating malpractice 
claim losses, and relationship to the client. There should be an understanding 
among the auditor, the client, and the actuary of the objectives and scope of 
the analysis and the methods and assumptions used. The independent auditor 
may consider (a) the limitations of assurances in actuarial calculations due to 
uncertainties and (b) restrictions as to the use of the actuarial reports. The 
independent auditor is responsible for determining the adequacy of the actu­
ary's report for purposes of corroborating the representations in the financial 
statements. The independent auditor should perform an appropriate test of the 
accounting data provided by the client to the actuary. Such accounting data may 
include historical claim experience, policy terms (such as coverage, expiration, 
deductibles, presence of retrospectively determined premiums, and indemnity 
limitations), exposure data (such as the number of beds, high risk medical spe­
cialties, outpatient visits, and emergency room visits), and information about 
risk management systems, personnel, and procedures.
8.38 An accrual for malpractice losses should be based on estimated ulti­
mate losses and costs associated with settling claims. Accruals should not be 
based on recommended funding amounts, which in addition to a provision for 
the actuarially determined liability also includes a provision for (a) credit for 
investment income and (b) a margin for risk of adverse deviation. The following 
are examples of factors to consider and adjustments that may be required to 
convert actuarially determined malpractice funding amounts to an appropriate 
loss accrual to be reported in the financial statements:
• The risk of adverse deviation is an additional cost factor applied 
to bring a funding requirement to a selected confidence level. This 
factor does not meet the criteria for recognition as a liability in 
accordance with FASB Statement No. 5.
• An evaluation should be made of the extent and validity of indus­
try data when the credibility factor actuarial technique is used. 
The lower the credibility factor, the greater the blending of indus­
try data. This may create an unacceptable level of industry data 
at lower confidence levels. Further, a low credibility factor may 
indicate that provider-specific data is not sufficient to support the 
claims liability estimation process.
• A review of the discounting approach used is necessary to develop 
the required disclosure. The impact on the discounting calcula­
tion of any other adjustment made to the actuarially determined
Commitments and Contingencies
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amounts (such as risk of adverse deviation or the credibility of the 
risk management system) has to be evaluated.
• A review o f the expenses included in the loss estimation process 
should be made. Such expenses include the expense of settlement 
and litigation (that is, allocated loss adjustment expenses).
8.39 Limitations on the availability of provider-specific data, lack of a suf­
ficient patient population for claims projection purposes, a very low credibility 
factor, and a variety of other factors may cause the actuary's estimate of loss to 
be of limited value in developing an estimate of the liability under GAAP.
Risks and Uncertainties
8.40 Uncertainties arise when the evidence available is insufficient for a 
reasonable estimation of the effects of the outcome of a particular future event 
on the current financial statements. Normally, the resolution of the uncertainty 
is prospective, and sufficient evidence cannot be expected to exist at the time 
of the audit. In these situations, it cannot be determined what adjustments, if 
any, to the financial statements may be appropriate. If the auditor is unable to 
obtain sufficient audit evidence to support management's assertions about the 
nature of a matter involving an uncertainty and its presentation or disclosure 
in the financial statements, the auditor should consider the need to express 
a qualified opinion or to disclaim an opinion because of a scope limitation as 
discussed in paragraph .31 of AU section 508, Reports on Audited Financial 
Statements (AICPA, Professional Standards, vol. 1).
8.41 SOP 94-6 provides requirements and guidance for entities to include 
in their financial statements information about
a. the nature of their operations.
b. use of estimates in the preparation of financial estimates.
In addition, if certain specified disclosure criteria are met, it requires entities 
to include in their financial statements disclosures about
a. certain significant estimates.
b. current vulnerability due to certain concentrations.
8.42 Paragraph .18 of SOP 94-6 gives examples o f items that may be 
based on estimates that are particularly sensitive to changes in the near term. 
Examples of similar estimates that may be included in financial statements of 
health care organizations include, but are not limited to, the following:
• Third-party revenue and related receivables
• Assets subject to impairment, for example, goodwill
• Environmental remediation-related obligations
• Litigation-related contingencies, for example, fraud and abuse ac­
tions by regulators
• Estimated risk pool settlements arising from managed care con­
tracting
• Amounts reported for long term obligations such as amount re­
ported for pensions and postemployment benefits
• Estimated net proceeds recoverable, the provisions for expected 
loss to be incurred, or both, on disposition of a business or assets
Health Care Organizations
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8.43 SOP 00-1, Auditing Health Care Third-Party Revenues and Related 
Receivables (AICPA, Technical Practice Aids, AUD sec. 14,360), provides guid­
ance to auditors regarding uncertainties inherent in health care revenue recog­
nition. Examples of risks unique to the government-contracting environment 
are presented in paragraph .07 of the SOP. Also, in the health care environment, 
it is almost always at least reasonably possible that estimates regarding third- 
party payments could change in the near term as a result of one or more future 
confirming events (for example, regulatory action reflecting local or national 
audit or enforcement initiatives). For most entities with significant third-party 
revenues, the effect of the change could be material to the financial statements. 
Where material exposure exists, the uncertainty regarding revenue realization 
is disclosed in the notes to the financial statements.5
8.44 Examples of concentrations that may meet the criteria that require 
disclosure in the financial statements of health care organizations in accordance 
with paragraph .21 of SOP 94-6 include the following:
• Concentrations in the volume of business transacted with a par­
ticular payor, supplier, lender, grantor, or contributor
• Concentrations in revenue from particular products, services, or 
fund-raising events
• Concentrations in the available sources of supply of material, la­
bor, or services, or of licenses or other rights used in the entity's 
operations
• Concentrations in the market or geographic area in which an en­
tity conducts its operations
Commitments and Contingencies
Evaluating Lawyers' Responses
8.45 Determining the outcome of pending or threatened litigation, claims 
and assessments (including unasserted claims and assessments) normally is 
beyond the auditor's professional competence. Accordingly, the auditor's eval­
uation of the need for disclosures or report modifications is based primarily 
on the opinion of the lawyer handling the matter. The American Bar Associ­
ation (ABA) has adopted a Statement o f  Policy Regarding Lawyers' Responses 
to Auditors' Requests for Information under which lawyers accept certain re­
sponsibility for responses to auditors' inquiries. However, the ABA Statement 
of Policy is not enforceable by the ABA in the same way the AICPA is able to 
enforce its standards under the accounting profession's Code of Professional 
Conduct. As a result, lawyers' responses may vary widely.
8.46 Auditing Interpretation No. 7, "Assessment of a Lawyer's Evaluation 
of the Outcome of Litigation," of AU section 337, Inquiry o f a Client's Lawyer 
Concerning Litigation, Claims, and Assessments (AICPA, Professional Stan­
dards, vol. 1, AU sec. 9337 par. .18—.23), includes the following examples of
5 A sample disclosure is provided in SOP 00-1, Auditing Health Care Third-Party Revenues and 
Related Receivables (AICPA, Technical Practice Aids, AUD sec. 14,360), that among other things 
indicates laws and regulations governing the Medicare and Medicaid programs are extremely complex 
and subject to interpretation. As a result, there is at least a reasonable possibility that recorded 
estimates will change by a material amount in the near term. SOP 00-1 is included as appendix E to 
this guide.
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evaluations of litigation, which may be considered to communicate in a suffi­
ciently clear manner a remote likelihood of an unfavorable outcome:
• "We are of the opinion that this action will not result in any liability 
to the company."
• "It is our opinion that the possible liability to the company in this 
proceeding is nominal in amount."
• "We believe the company will be able to defend this action success­
fully."
• "We believe that the plaintiff’s case against the company is with­
out merit."
• "Based on the facts known to us, after a full investigation, it is our 
opinion that no liability will be established against the company 
in these suits."
8.47 On the other hand, the lawyer may use terms, such as meritorious 
defenses, that have different meanings to different lawyers. Paragraph .22 of 
Interpretation No. 7 includes the following examples of lawyers' evaluations 
that are unclear regarding the likelihood of an unfavorable outcome:
• "This action involves unique characteristics wherein authoritative 
legal precedents do not seem to exist. We believe that the plaintiff 
will have serious problems establishing the company's liability 
under the act; nevertheless, if the plaintiff is successful, the award 
may be substantial."
• "It is our opinion that the company will be able to assert mer­
itorious defenses to this action." (The term meritorious defenses 
indicates that the company's defenses will not be summarily dis­
missed by the court; it does not necessarily indicate the lawyer's 
opinion that the company will prevail.)
• "We believe the action can be settled for less than the damages 
claimed."
• "We are unable to express an opinion as to the merits of the litiga­
tion at this time. The company believes there is absolutely no merit 
to the litigation." (If the company's lawyer, with the benefit of all 
relevant information, is unable to conclude that the likelihood of 
an unfavorable outcome is remote, it is unlikely that management 
would be able to form a judgment to that effect.)
• "In our opinion, the company has a substantial chance of prevail­
ing in this action." (A substantial chance, a reasonable opportunity, 
or similar terms indicate more uncertainty than an opinion that 
the company will prevail.)
8.48 When the lawyer's response is unclear, the auditor may request a 
conference to clarify the lawyer's opinion. AU section 508 paragraphs .29-.32 
provide requirements and guidance if the response is still unclear or the mate­
riality of the uncertainty cannot be determined.
Auditing
8.49 The independent auditor may need to consider the examples o f spe­
cific auditing objectives, selected control activities, and auditing procedures for 
commitments and contingencies that are presented in exhibit 8-1.
Health Care Organizations
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Exhibit 8-1
Auditing Considerations*
Financial Statement Specific Auditing Selected Control
Assertions Objectives Activities Auditing Procedures
Malpractice Loss Contingencies
Existence and 
occurrence, 
completeness, 
rights and 
obligations, and 
valuation and 
allocation
The liability for 
malpractice 
claims is reported 
properly in the 
balance sheet.
Insurance 
coverage is 
reviewed 
regularly, 
including the 
financial 
viability of the 
insurer.
The risk 
management 
system identifies 
and monitors 
malpractice 
incidents and 
evaluates 
associated losses.
Outside legal 
counsel and 
insurance 
carriers review 
and monitor all 
claims.
The adequacy of 
malpractice 
accruals is 
reviewed 
regularly by 
management, 
including 
information 
obtained from 
qualified 
specialists. 
Information 
supplied to 
specialists is 
reviewed for 
accuracy and 
completeness.
Review the amount 
of insurance 
coverage, the type 
of coverage 
(claims-made or 
occurrence), the 
deductible 
provisions, and so 
forth, to determine 
the level of risk 
that is retained by 
the entity.
Consider the 
financial viability 
of the insurance 
carrier.
Send letters of 
inquiry to 
malpractice 
insurance carriers 
and legal counsel 
(in accordance 
with AU section 
337, Inquiry o f a 
Client's Lawyer 
Concerning 
Litigation, Claims, 
and Assessments 
[AICPA, 
Professional 
Standards, vol. 1]).
Review and test 
the method of 
estimating 
accruals (for 
example, review 
actuarial reports 
and prior historical 
loss experience).
(continued)
* AU section 326, Audit Evidence (AICPA, Professional Standards, vol. 1), recategorizes asser­
tions by classes of transactions, account balances, and presentation and disclosure. This exhibit will 
be revised, as necessary, to reflect the new assertion categories in a future edition of the guide.
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Financial Statement Specific Auditing Selected Control
Assertions Objectives Activities
Actuarial 
assumptions are 
reviewed for 
compliance with 
GAAP.
Changes in the
risk
management 
system are 
communicated 
on a timely basis.
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Auditing Procedures
Determine that 
additional 
premiums charged 
by insurers for 
retrospectively 
related policies are 
reported as a 
liability.
Review prior 
estimates and 
historical loss 
experience.
Determine 
whether 
uncertainties 
related to medical 
malpractice claims 
need to be 
disclosed in the 
auditor's report.
Presentation and The program of 
disclosure medical
malpractice 
insurance 
coverage and the 
basis for any loss 
accruals are 
disclosed 
adequately in the 
financial 
statements.
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Chapter 9
Net Assets (Equity)
Investor-Owned Health Care Organizations
9.01 The equity accounts of investor-owned health care entities are similar 
to those of other investor-owned businesses.
Not-for-Profit Health Care Organizations
9.02 The balance sheets of not-for-profit health care organizations should 
report separate amounts for each of three classes of net assets:1 (a) permanently 
restricted net assets, (b) temporarily restricted net assets, and (c) unrestricted 
net assets. This is based on the existence or absence of donor-imposed restric­
tions.
9.03 Unrestricted net assets generally result from revenues from provid­
ing or agreeing to provide health care services, receiving unrestricted contribu­
tions and grants, or receiving dividends or interest from investing in income- 
producing assets minus expenses incurred in providing or agreeing to provide 
health care services, providing other community benefits, and performing ad­
ministrative functions. The only limits on the use of unrestricted net assets are 
the broad limits resulting from the nature of the provider's organization; the 
environment in which the organization operates; the purposes specified in its 
articles of incorporation or in its bylaws; or limits resulting from contractual 
agreements with suppliers, creditors, and others entered into in the course of 
business. Information about significant contractual limits, including the exis­
tence of restrictive debt covenants, generally is provided in the notes to the 
financial statements. Similarly, information about self-imposed limits may be 
provided either on the face of the balance sheet or in the notes to the financial 
statements. Such specifics include information about voluntary resolutions by 
the entity's governing board to designate a portion of its unrestricted net assets 
for identified purposes (for example, funded depreciation).
9.04 Information about the nature and amounts of different types of per­
manent restrictions or temporary restrictions should be provided either by re­
porting their amounts on the face of the financial statements or by including 
relevant details in the notes to the financial statements. Separate line items 
may be reported within permanently restricted net assets (or in the notes to the 
financial statements) to distinguish between permanent restrictions for hold­
ings of (a) assets, such as land or works of art, donated with stipulations that 
they be used for a specified purpose, be preserved, and not be sold, or (b) assets 
donated with stipulations that they be invested to provide a permanent source 
of income (that is, permanent endowment funds).
9.05 Similarly, separate line items may be reported within temporarily 
restricted net assets (or in the notes to the financial statements) to distinguish 
between temporary restrictions for (a) support of particular operating activi­
ties, (b) investment for a specified term, (c) use in a specified future period, or
1 Though some health care organizations may use other terms, such as equity, this guide uses
the term net assets to describe residual interest.
AAG-HCO 9 .05
152
(d) acquisition of long-lived assets. Donors' temporary restrictions may require 
that resources be used in a later period or after a specified date (time restric­
tions) or that resources be used for a specified purpose (purpose restrictions) or 
both. For example, gifts of cash and other assets with stipulations that they be 
invested to provide a source of income for a specified term and that the income 
be used for a specified purpose are restricted both as to time and purpose.
9.06 The nature of the restrictions on donor-restricted resources should 
be disclosed in the financial statements.
Governmental Health Care Organizations*
9.07 The statements of net assets/balance sheets of governmental health 
care entities should report net assets/equity in 3 components: (1) invested in 
capital assets, net of related debt; (2) restricted (distinguishing between major 
categories of restrictions), and (3) unrestricted. Either term net assets or equity 
may be used to refer to the difference between assets and liabilities. The term 
fund balance should not be reported on the face of the statement. When gov­
ernmental health care entities first apply Governmental Accounting Standards 
Boards (GASB) Statement No. 34, Basic.Financial Statements—and Manage­
ment's Discussion and Analysis—for State and Local Governments, classifying 
net assets into the 3 required categories should begin by adding together all 
previously reported fund balance amounts. Calculating each of the 3 required 
components is described in paragraphs 9.08-.10.
9.08 As discussed in GASB Statement No. 34 paragraph 33, the net asset 
component, invested in capital assets, net o f  related debt should be the sum of 
capital assets (capital assets are defined in paragraph 19 of GASB Statement 
No. 34), net of accumulated depreciation less any debt issued to finance those 
assets. Invested in capital assets, net of related debt should not include any 
restricted resources that must be used to acquire capital assets, (such as unex­
pended debt proceeds or capital grants and contributions), or debt attributable 
to significant amounts of unexpended debt proceeds. Capitalized costs of is­
suance are included with the same category as the related debt, as discussed in 
the GASB staff document Comprehensive Implementation Guide—2007 (GASB 
Q&A—2007 Edition), item 7.23.3 (see paragraph 1.11 in this guide).
9.09 The term restricted is defined by GASB Statement No. 34 para­
graph 34, as amended, and GASB Statement No. 99. A restriction is a con­
straint placed on the use of assets or net assets that is either externally imposed 
(such as by creditors through debt covenants) or imposed by law through con­
stitutional provisions or enabling legislation. Restricted net assets should be 
reported based on this definition of restricted. As discussed in paragraph 98 of 
GASB Statement No. 34, major categories of restrictions should be reported on 
the face of the statement of net assets/balance sheet, for example, net assets re­
stricted for capital acquisitions. As discussed in the GASB Q&A—2007 Edition, 
item 7.23.2 (see paragraph 1.11 in this guide), unexpended debt proceeds that 
must be used to acquire or construct capital assets and the portion of the debt 
attributable to the unexpended proceeds should be included in restricted net 
assets. When a governmental health care entity reports restricted net assets
Health Care Organizations
* This section contains guidance that is limited to governmental health care organizations that 
report as proprietary activities. This section does not apply to governmental health care organizations 
that report using governmental funds.
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arising from permanent endowments, restricted net assets should be reported 
in 2 additional components—expendable and nonexpendable, as discussed in 
paragraph 35 of GASB Statement No. 34. As discussed in the GASB Q&A— 
2007 Edition, item 7.24.13 (see paragraph 1.11 in this guide), no category of 
restricted net assets can be negative. If liabilities that relate to restricted as­
sets exceed those assets, no balance should be reported. The negative amount 
should be reported as a reduction of unrestricted net assets.
9.10 GASB Statement No. 34 paragraph 98 prohibits governmental en­
tities from reporting internal designations in the net assets section of their 
statements of net assets/balance sheets. Designations are management's plans 
for the use of resources. They should not be afforded the same status as re­
strictions. Internally designated net assets should be reported as unrestricted 
net assets and should not be displayed separately in the net assets section 
of the statement of net assets/balance sheet, as discussed in paragraph 37 of 
GASB Statement No. 34. (Designated assets, however, may be reported in the 
statement of net assets/balance sheet, as discussed in paragraph 3.01 in this 
guide.)
9.11 As discussed in paragraph 6 of GASB Statement No. 46, Net Assets 
Restricted by Enabling Legislation—an amendment o f GASB Statement No. 
34, net assets at the end of the reporting period that are restricted by enabling 
legislation should be disclosed in the notes to the financial statements.
Auditing
9.12 The independent auditor may need to consider the examples of spe­
cific auditing objectives, selected control activities, and auditing procedures 
relating to net assets (equity) that are presented in exhibit 9-1.
Net Assets (Equity)
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Exhibit 9-1
Auditing Considerations*
Financial Statement 
Assertions
Net Assets (Equity)
Rights and 
obligations
Specific Auditing 
Objectives
Selected Control 
Activities Auditing Procedures
Presentation and 
disclosure
Resources are 
used and 
accounted for in 
accordance with 
donor and grantor 
restrictions.
Management 
monitors 
compliance with 
these
restrictions.
Net assets are 
presented and 
disclosed properly 
in the financial 
statements.
Procedures 
ensure proper 
authorization, 
recording, and 
presentation.
Review the 
minutes of board 
and board 
committee 
meetings for 
evidence of donor 
restrictions.
Determine 
compliance with 
donor and grantor 
restrictions.
Test significant net 
asset transactions 
to determine that 
they are properly 
authorized and 
recorded.
* AU section 326, Audit Evidence (AICPA, Professional Standards, vol. 1), recategorizes asser­
tions by classes of transactions, account balances, and presentation and disclosure. This exhibit will 
be revised, as necessary, to reflect the new assertion categories in a future edition of the guide.
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Chapter 10
Revenue, Expenses, Gains, and Losses
Conceptual Framework for Reporting Revenue, Expenses, 
Gains, and Losses
10.01 Financial Accounting Standards Board (FASB) Statement of Fi­
nancial Accounting Concepts No. 6, Elements o f  Financial Statements—a re­
placement o f FASB Concepts Statement No. 3 (incorporating an amendment o f  
FASB Concepts Statement No. 2), provides a useful conceptual framework for 
preparers of financial statements to distinguish among elements of financial 
statements for purposes of display. Additionally, not-for-profit organizations are 
subject to the requirements of FASB Statement No. 117, Financial Statements 
o f Not-for-Profit Organizations.1 This chapter draws on the concepts contained 
in FASB Concept No. 6 and FASB Statement No. 117 in discussing revenue, 
expenses, gains, and losses with respect to health care organizations. Expenses 
are not generally netted against revenues, whereas gains and losses may be 
displayed as net amounts. The application of these concepts to the classifica­
tion of revenue, expenses, gains, and losses in the statement of operations of 
health care organizations is discussed in paragraphs 10.02-.11.
10.02 FASB Concept No. 6 paragraph 78 defines revenues as "inflows or 
other enhancements of assets of an entity or settlements of its liabilities (or 
a combination of both) from delivering or producing goods, rendering services, 
or other activities that constitute the entity's ongoing major or central opera­
tions." Similarly, paragraph 80 defines expenses as "outflows or other using up 
of assets or incurrences of liabilities (or a combination of both) from deliver­
ing or producing goods, rendering services, or carrying out other activities that 
constitute the entity's ongoing major or central operations."
Distinguishing Charity Care From Bad Debt Expense 
or Allowance
10.03 Charity care represents health care services that are provided but 
are never expected to result in cash flows. As a result, charity care does not 
qualify for recognition as receivables or revenue in the financial statements. 
Distinguishing charity care from bad-debt expense (or allowance, for govern­
mental health care entities1 2) requires the exercise of judgment. Charity care 
is provided to a patient with demonstrated inability to pay. Each organization 
establishes its own criteria for charity care consistent with its mission state­
ment and financial ability. Only the portion of a patient's account that meets 
the organization's charity care criteria is recognized as charity. Although it is 
not necessary for the entity to make this determination upon admission or reg­
istration of an individual, at some point the entity must determine that the 
individual meets the established criteria for charity care. (See paragraph 10.28 
for disclosure requirements relating to charity care.)
1 Governmental health care entities only. This pronouncement is not applicable to governmental 
health care enterprises. (See footnote 1 in chapter 1.)
2 Governmental health care entities only. See paragraph 10.27 in this chapter for a discussion 
about the reporting of allowances by governmental health care entities.
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Revenue
10.04 Revenue usually is recorded when coverage is provided to an enrollee 
or the service is provided to a patient or resident. Revenue is classified based on 
the type of service rendered or contracted to be rendered. Examples of revenue 
include
• patient service revenue, which is derived from fees charged for 
patient care. This may be based on diagnosis related group pay­
ments, resource-based relative value scales payments, per diems, 
discounts, or other fee-for-service arrangements.
• premium revenue, which is derived from capitation arrangements.
• resident service revenue, which may be related to maintenance 
fees, rental fees, or amortization of advance fees.
10.05 Some not-for-profit health care enterprises may receive relatively 
small amounts of contributions, grants, or tax support. Such amounts, whether 
temporarily restricted, permanently restricted, or unrestricted, are recognized 
as revenue or gains when they are received. Special considerations pertain­
ing to revenue recognition of promises to give in future periods (pledges) are 
discussed in chapter 5 and in paragraphs 10.08-.11 in this guide. FASB State­
ment No. 136, Transfers o f Assets to a Not-for-Profit Organization or Charitable 
Trust That Raises or Holds Contributions for Others,3 establishes standards 
for transactions in which a donor makes a contribution by transferring as­
sets to a recipient organization—a not-for-profit organization or a charitable 
trust—that accepts the assets from the donor and agrees to use the assets on 
behalf of or transfer the assets, their investment return, or both to another 
entity—the beneficiary—named by the donor.4 If a donor transfers assets to 
an agent, trustee, or intermediary (recipient organization) and specifies a non­
governmental health care organization as the ultimate recipient (the specified 
beneficiary) of the contribution or grant, that specified health care organization 
should recognize its rights to the assets held by a recipient organization as an 
asset and contribution revenue unless the recipient organization is explicitly 
granted variance power. (See paragraph E19 of FASB Statement No. 157, Fair 
Value Measurements.) Variance power is the unilateral power to redirect the use 
of the transferred assets to an entity or individual other than the specified ben­
eficiary. Explicitly grants means that the donor should explicitly refer to the 
recipient organization's ability to exercise variance power in the instrument 
that transfers the assets. Unilateral power means that the recipient organiza­
tion can override the donor's instructions without approval from the donor, the 
specified beneficiary, or any other interested party. (See paragraph 12 of FASB 
Statement No. 136.) If the recipient organization is explicitly granted variance 
power, the specified health care organization (beneficiary) should not recog­
nize its potential for future distributions from the assets held by the recipient
3 Governmental health care entities only. This pronouncement is not applicable to governmental 
health care enterprises. (See footnote 1 in chapter 1.)
4 Financial Accounting Standards Board (FASB) Statement No. 136, Transfers o f Assets to a 
Not-for-Profit Organization or Charitable Trust That Raises or Holds Contributions for Others, also 
established standards for transactions that take place in a similar manner but are not contributions 
because the transfers are revocable, repayable, or reciprocal. For example, if a resource provider trans­
fers assets to a recipient organization and names itself or its affiliate as beneficiary, that transaction 
is reciprocal even if the resource provider grants variance power. Those standards and transactions 
are discussed in paragraphs 4.14-.15, 11.21, and 11.23-.24 of this guide. This guide does not use the 
word donor in discussing those transactions because they are not contributions.
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organization. (See paragraph 16 of FASB Statement No. 136.) Those distribu­
tions, if they occur, should be recognized as contributions by the specified health 
care organization (beneficiary) when received or unconditionally promised. (See 
further discussion at paragraph 5.12 in this guide. Also, special considera­
tions pertaining to transfers between related entities are discussed in para­
graphs 10.08, 11.21-.24 and 11.29-.33 in this guide.)
10.06 Governmental health care enterprises may also receive contribu­
tions, grants, or tax support. Governmental health care enterprises classify 
these transactions into one of four classes of nonexchange transactions based 
on their principal characteristics, as discussed in Governmental Accounting 
Standards Board (GASB) Statement No. 33, Accounting and Financial Report­
ing for Nonexchange Transactions, as amended, paragraph 7. (GASB Statement 
No. 33, as amended, applies to transactions involving financial and capital re­
sources. GASB Statement No. 33, as amended, does not apply to other resources, 
such as contributed services.) Transactions that are not recognizable because 
they are not measurable should be disclosed.
10.07 Other revenue, gains, or losses are derived from services other than 
providing health care services or coverage to patients, residents, or enrollees. 
These typically include
• interest and dividends from all funds held by a trustee, malprac­
tice funds, or other miscellaneous investment activities.
• certain realized changes in market values of marketable securities 
(see chapter 4).
• fees from educational programs, which include tuition for schools 
(such as nursing) or laboratory and X-ray technology.
• rental of health care facility space.
• sales of medical and pharmaceutical supplies to employees, physi­
cians, and others.
• fees charged for transcripts for lawyers, insurance companies, and 
others.
• proceeds from sale of cafeteria meals and guest trays to employees, 
medical staff, and visitors.
• proceeds from sale of scrap, used X-ray film, and the like.
• proceeds from sales at gift shops, snack bars, newsstands, parking 
lots, vending machines, or other service facilities operated by the 
health care organization.
10.08 Interest earned and gains and losses on investments and other as­
sets (or liabilities) are reported by not-for-profit organizations as increases or 
decreases in unrestricted net assets, unless their use is temporarily or perma­
nently restricted by explicit donor stipulation or by law. Net assets released 
from restriction, such as those related to the fulfillment of time or purpose 
restrictions, should be reported separately in the financial statements or dis­
closed in the notes. Additional guidance on accounting for investments can be 
found in chapter 4. Occasionally, nongovernmental health care organizations 
may receive funds from (or transfer funds to) a not-for-profit organization or 
a charitable trust. If the not-for-profit organization is an affiliate, those trans­
fers generally are either: (a) an equity transfer, (b) an equity transaction, or (c) 
a loan or advance. Equity transfers are discussed in paragraph 11.20. Equity
Revenue, Expenses, Gains, and Losses
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transactions are discussed in paragraphs 11.21-.24. Loans and advances to re­
lated entities are discussed in paragraph 11.26. In limited circumstances, those 
transfers are contributions. The circumstances in which a distribution from a 
not-for-profit organization or charitable trust to an affiliated nongovernmental 
health care organization is a contribution are described in paragraphs 11.32- 
.33. If the not-for-profit organization or charitable trust is not an affiliate, the 
transaction is either (a) an investment transaction, (b) a refundable advance, or 
(c) a contribution. Investment transactions are discussed in paragraphs 4.23— 
.24. The transfer is a refundable advance if it is revocable or repayable. The 
transfer is a contribution only if it meets the definition of a contribution in 
FASB Statement No. 116, Accounting for Contributions Received and Contri­
butions Made; that is, it is an unconditional, voluntary, nonreciprocal transfer 
by an entity acting other than as an owner.
10.09 Contributions of noncash assets that are not long-lived assets are 
recognized as revenue or gains in the period received and as assets or a reduc­
tion of liabilities or expenses, depending on the form of the benefits received. 
(For example, a donation of supplies would be reflected as revenue or gains and 
as an increase in inventory or supply expense.) The donations are measured 
at fair value.* Donations received with no restrictions attached are reported 
as unrestricted support in the statement of operations. Donations with explicit 
donor restrictions attached (other than permanent restrictions) are reported 
as temporarily restricted support. The expiration of these restrictions is recog­
nized in the period when the time stipulated by the donor has elapsed, when the 
stipulated purpose for which the asset was restricted has been fulfilled, or both. 
When the restriction expires, the temporarily restricted net assets are reclas­
sified to unrestricted net assets and reported in the statement of operations as 
"net assets released from restriction." Donor-restricted contributions whose re­
strictions are met in the same reporting period may be reported as unrestricted 
support provided that an organization discloses its accounting policy and ap­
plies the policy consistently from period to period. Donations with explicit donor 
restrictions attached that permanently limit the health care organization's use 
of the contributed assets (for example, permanent endowments) are reported 
as increases in permanently restricted net assets.
10.10 Contributions of long-lived assets, including the use of long-lived 
assets such as land, buildings, and equipment, are reported as support or gains 
in the period received. The donation is measured at its fair value.* If the donor 
places no restrictions on the use of the asset, the contribution is reported as 
unrestricted support. Contributions of long-lived assets with explicit donor re­
strictions are reported as temporarily or permanently restricted support. The 
provider reports expirations of donor restrictions when the stipulation is ful­
filled and the assets are placed in service. At that time, temporarily restricted 
net assets are reclassified to unrestricted net assets and reported in the state­
ment of operations as "net assets released from restriction."
10.11 Donations of cash or other assets that must be used to acquire long- 
lived assets are reported as temporarily restricted support in the period re­
ceived. Expirations of donor restrictions are reported when the acquired long- 
lived assets are placed in service and donor-imposed restrictions are satisfied.
Health Care Organizations
In September 2006, FASB issued FASB Statement No. 157, Fair Value Measurements, which 
defines fair value, establishes a framework for measuring fair value in generally accepted accounting 
principles, and expands disclosures about fair value measurements. See discussion in chapter 3.
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The temporarily restricted net assets are reclassified to unrestricted net assets 
and reported in the statement of operations as "net assets released from re­
striction." For providers that prepare classified balance sheets, assets that are 
restricted by donors for acquisition of long-lived assets (such as cash or con­
tributions receivable) are not included in "cash and cash equivalents" or with 
other "contributions receivable." Rather, those assets are reported in a separate 
section, such as "assets restricted to investment in property and equipment," 
and are sequenced near the "property and equipment" section of the balance 
sheet (see paragraph 3.01).
10.12 The nature and extent of donated services received by health care or­
ganizations varies and can range from the limited participation of many people 
in fund-raising activities to active participation in the entity's service programs; 
their values usually are not recorded. Contributed services should be reported 
as contribution revenue and as assets or expenses if the services create or en­
hance a nonfinancial (that is, nonmonetary) asset (for example, property and 
equipment) or meet all of the following criteria:
a. Require specialized skills
b. Are provided by individuals with those skills (such as accounting, 
financial, construction, educational, electrical, legal, medical, and 
other services provided by accountants, investment advisers, con­
tractors, teachers, electricians, lawyers, doctors, and other profes­
sionals and craftspeople)
c. Would typically need to be purchased by the organization if they 
had not been provided by contribution
Additional guidance with regard to the accounting for and the reporting of 
donated services is provided in FASB Statement No. 116.
10.13 Contributions to governmental health care enterprises are governed 
by GASB Statement No. 33, discussed in paragraph 10.06. GASB Statement 
No. 33 applies to external transactions involving financial and capital resources. 
As discussed in GASB Statement No. 33 paragraph 14, purpose restrictions on 
nonexchange revenues (such as grants, contributions, and endowments) do not 
affect when revenues are recognized. Rather, resulting net assets should be 
reported as restricted until the resources have been used for the specified pur­
pose (see paragraph 9.08 of this guide) or for as long as the resource provider 
requires (for example, for endowments). Unlike not-for-profit health care enti­
ties, the statement of revenues, expenses, and changes in net assets/equity does 
not require disaggregation of transactions based on the types of restrictions 
that may exist (such as unrestricted, temporarily restricted, or permanently 
restricted revenues). Disaggregations such as "net assets released from restric­
tions," "changes in temporarily restricted net assets", and "changes in perma­
nently restricted net assets" should not be reported in either the statement 
of revenues, expenses, and changes in net assets/equity or in the net assets 
section of the statement of net assets/balance sheet of governmental health 
care entities. Interfund transfers are reported after "nonoperating revenues 
and expenses" in the statement of revenues, expenses, and changes in net as­
sets/equity as discussed in paragraphs 101 and 112 of GASB Statement No. 34, 
Basic Financial Statements—and Management's Discussion and Analysis—for 
State and Local Governments (see paragraph 1.21 of this guide). Intra-entity 
activity between a primary government and its component units are accounted 
for in accordance with paragraph 61 of GASB Statement No. 34.
Revenue, Expenses, Gains, and Losses
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10.14 Additional guidance regarding accounting for contributions dis­
cussed previously can be found in chapters 5 and 6 of the Audit and Accounting 
Guide Not-for-Profit Organizations, which also addresses the following:
• Permanent endowments
• Split-interest agreements
• Gifts in kind
• Contributed utilities, facilities, or use of long-lived assets
• Transfers to a not-for-profit organization or charitable trust that 
raises or holds contributions for others (refer to chapter 5 in the 
Audit and Accounting Guide Not-for-Profit Organizations under 
the heading "Agency Transactions")
10.15 Foundations, business organizations, and other types of entities may 
provide resources to health care organizations under programs referred to as 
grants, awards, or sponsorships. Those asset transfers are contributions if the 
resource providers receive no value in exchange for the assets transferred or if 
the value received by the resource provider is incidental to the potential public 
benefit from using the assets transferred. For governmental health care or­
ganizations, these transactions are referred to as nonexchange transactions, 
addressed in GASB Statement No. 33. The asset transfers are exchange or 
exchange-like transactions if the potential public benefit is secondary to the re­
source providers' potential direct benefits. For example, a research grant made 
by a foundation to a hospital would likely be a contribution if the research pro­
gram is to be planned and carried out by the hospital and the hospital has the 
right to publish the results. If, however, the grant is made by a pharmaceutical 
manufacturer that provides potential new medications to be tested in the hos­
pital's research facilities and retains the right to any patents or other results, 
the grant would likely be an exchange transaction.
10.16 For governmental health care entities, capital contributions and 
contributions to term and permanent endowments are reported as a compo­
nent of the all-inclusive statement of revenues, expenses, and changes in net 
assets/equity. Contributions of capital assets or of financial resources required 
to be used to acquire capital assets are required to be reported as revenues sep­
arately after "nonoperating revenues and expenses," in the statement of rev­
enues, expenses, and changes in net assets/equity, as illustrated in paragraph 
1.19 of this guide. Contributions to term and permanent endowments should 
be reported in the same manner as capital contributions. Capital contributions 
received from other funds of the same financial reporting entity should be re­
ported last as interfund transfers, after "nonoperating revenues and expenses" 
in the statement of revenues, expenses, and changes in net assets/equity, as 
discussed in paragraph 101 of GASB Statement No. 34 and paragraph 10.13 in 
this chapter.
10.17 Revenues from capital contributions as well as contributions to the 
principal of permanent and term endowments should be reported after "nonop­
erating revenues and expenses," as discussed in GASB Statement No. 34 para­
graph 100. Income from permanent or term endowments should be recorded 
as "nonoperating revenue," as discussed in the GASB staff document Compre­
hensive Implementation Guide—2007 (GASB Q&A—2007 Edition), item 7.74.3 
(see paragraph 1.11 in this guide).
Health Care Organizations
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Expenses
10.18 The basis and timing of the recognition of expenses for health care 
organizations generally are the same as for other business enterprises. Ex­
penses arising from nonexchange transactions (such as grants, taxes, and con­
tributions) reported by governmental health care enterprises are recognized 
based on their appropriate class of nonexchange transactions, as discussed in 
paragraph 10.06. Not-for-profit organizations report expenses as decreases in 
unrestricted net assets.
10.19 Statement of Position (SOP) 98-2, Accounting for Costs o f Activi­
ties o f  Not-for-Profit Organizations and Local Governmental Entities That In­
clude Fund Raising (AICPA, Technical Practice Aids, ACC sec. 10,730), provides 
guidance for not-for-profit and state and local governmental entities (including 
health care organizations) that conduct fund-raising activities with activities 
related to other functions, such as program activities or supporting services 
(joint activities). This SOP establishes financial accounting standards for ac­
counting for costs of joint activities, and requires financial statement disclo­
sures about the nature of the activities for which joint costs have been allocated 
and the amounts of joint costs. SOP 98-2 is included as appendix C to this guide.
Financial Statement Presentation
10.20 The statement o f operations for not-for-profit organizations should 
include a performance indicator that reports results of operations. This perfor­
mance indicator and the income from continuing operations reported by for- 
profit health care enterprises generally are consistent, except for transactions 
that clearly are not applicable to one kind of entity (for example, for-profit 
health care enterprises typically would not receive contributions, and not-for- 
profit health care organizations would not award stock compensation). That 
is, the performance indicator is analogous to income from continuing opera­
tions of a for-profit enterprise. Because of the importance of the performance 
indicator, it should be clearly labeled with a descriptive term such as revenues 
over expenses, revenues and gains over expenses and losses, earned income, or 
performance earnings. The notes to the financial statements should include a 
description of the nature and composition of the performance indicator. Not- 
for-profit organizations should report the performance indicator in a statement 
that also presents the total changes in unrestricted net assets. Other changes 
in net assets may be presented separately or in the same statement.
10.21 Health care organizations should report the following items sepa­
rately from the performance indicator:
a. Transactions with owners acting in that capacity.
b. Equity transfers involving other entities that control the reporting 
entity, are controlled by the reporting entity, or are under common 
control with the reporting entity.
c. Receipt of restricted contributions, including temporary restric­
tions (such as time or purpose) or permanent restrictions.
d. Contributions of (and assets released from donor restrictions re­
lated to) long-lived assets.
e. Items that are required to be reported in or reclassified from other 
comprehensive income, such as minimum pension liabilities in ac­
cordance with paragraph 37 of FASB Statement No. 87, Employers'
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Accounting for Pensions;† foreign currency translation adjustments 
and the effective portion of the gain or loss on derivative instru­
ments designated and qualifying as cash flow hedging instruments.
f. Items that are required to be reported separately under special­
ized not-for-profit standards. These include extraordinary items 
and the effect of discontinued operations, pursuant to the provisions 
of FASB Statement No. 117; and unrealized gains and losses on 
investments not restricted by donors or by law (except for those in­
vestments classified as trading securities) and investment returns 
restricted by donors or by law, as discussed in paragraphs 4.07- 
.10 of this guide. FASB Statement No. 154, Accounting Changes 
and Error Corrections—a replacement o f  APB Opinion No. 20 and 
FASB Statement No. 3, changed the accounting and reporting re­
quirements for changes in accounting principle. Voluntary changes 
in accounting principle are not reported as a cumulative-effect ad­
justment through the income statement of the period of change. 
Generally, FASB Statement No. 154 requires retrospective appli­
cation to prior periods' financial statements or to the beginning of 
the earliest period for which retrospective application is practica­
ble. Offsetting adjustments, if any, are made to the opening balance 
for net assets.
10.22 Classifying revenues, expenses, gains, and losses within classes of 
net assets does not preclude incorporating additional classifications within the 
performance indicator. For example, within a class or classes of changes in 
net assets, a not-for-profit organization may classify items as operating and 
nonoperating, expendable and nonexpendable, earned and unearned, recurring 
and nonrecurring, or in other ways. This guide neither requires nor precludes 
reporting such intermediate measures or subtotals. However, because terms 
such as operating income are used with different meanings, if an intermediate 
measure of operations is reported and its use is not apparent from the details 
provided on the face of the statement, a note to the financial statements should 
describe the nature of the reported measure of operations or the items excluded 
from operations.
10.23 Governmental health care entities should separately report special 
items and extraordinary items at the bottom of the statement of revenues, 
expenses, and changes in net assets or equity, or both, as illustrated in GASB 
Statement No. 34 paragraph 101. Governmental health care entities should 
report special items separately after capital contributions and contributions 
to permanent and term endowments but before extraordinary items, if any. 
GASB Statement No. 34 paragraph 56 defines a special item as a significant
Health Care Organizations
† In September 2006, FASB issued FASB Statement No. 158, Employers' Accounting for Defined 
Benefit Pension and Other Postretirement Plans—an amendment of FASB Statements No. 87, 88, 106, 
and 132(R). An employer with publicly traded equity securities shall initially apply the requirement 
to recognize the funded status of a benefit plan and the disclosure requirements as of the end of 
the fiscal year ending after December 15, 2006. An employer without publicly traded equity securities 
shall initially apply the requirement to recognize the funded status of a benefit plan and the disclosure 
requirements as of the end of the fiscal year ending after June 15, 2007. An employer without publicly 
traded equity securities shall provide the disclosures in paragraph 14 in the notes to the financial 
statements for a fiscal year ending after December 15, 2006, but before June 16, 2007, unless it 
has applied the recognition provisions of this statement in preparing those financial statements; the 
requirement to measure plan assets and benefit obligations as of the date of the employer's fiscal 
year-end statement of financial position shall be effective for fiscal years ending after December 15, 
2008.
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transaction or other event that is within the control of management and that 
is either unusual in nature or infrequent in occurrence.
10.24 Governmental health care entities are required to distinguish be­
tween operating revenues and expenses and nonoperating revenues and ex­
penses and provide an intermediate total for operating income or loss. GASB 
Statement No. 34 paragraph 102 does not establish a definition of operating. 
Rather, governments are required to establish their own policy defining oper­
ating revenues and expenses that is appropriate to the nature of the activity 
being reported. Once established, an entity's policy should be applied consis­
tently and disclosed in the notes to the financial statements. GASB Statement 
No. 34 paragraph 102 notes that a consideration for determining which rev­
enues and expenses should be reported as operating is how those transactions 
would be classified in the statement of cash flows. Using this approach, transac­
tions that are considered investing, capital and related financing, and noncap­
ital financing activities would normally not be reported as operating revenues 
and expenses. This would include investment revenues and interest expense 
as well as most nonexchange transactions, including most grants, taxes, and 
contributions.
10.25 For governmental health care entities, changes in accounting prin­
ciples, addressed in Accounting Principles Board Opinion No. 20, Accounting 
Changes, as amended, should be reported as restatements of beginning net as­
sets or equity, or both, as discussed in footnote 13 to paragraph 17 of GASB 
Statement No. 34.
10.26 For financial reporting purposes, patient service revenue is re­
ported net of provisions for contractual and other adjustments in the oper­
ating statement. Significant revenue earned under capitation arrangements is 
reported separately. The notes to the financial statements disclose the meth­
ods of revenue recognition (for example, policies related to capitation revenue, 
patient service revenue, or contributions). In addition, with regard to contrac­
tual adjustments and third-party settlements, identification and explanation 
of the estimated amounts that are payable or receivable by the entity are 
disclosed.
10.27 GASB Statement No. 34 paragraph 100 requires revenues to be 
reported by major source, net of discounts and allowances, and separately iden­
tify pledged revenues. Therefore, governmental health care entities do not re­
port bad debt expense. The amount of discounts and allowances, including the 
increase or decrease in the estimate of uncollectible accounts, should be re­
ported parenthetically on the face of the financial statements, as a separate 
line directly below the revenue amount, or in the notes, as required by GASB 
Statement No. 34 footnote 41 to paragraph 100. Paragraph 10.04 in this chap­
ter provides additional discussion on classification of revenue, and examples of 
revenue, including patient service revenue. As discussed in paragraph 10.26 in 
this chapter, patient service revenue is reported net of contractual and other 
adjustments in the operating statement.
10.28 As discussed in paragraph 10.03, patient service revenue does not 
include charity care. Management's policy for providing charity care, as well 
as the level of charity care provided, should be disclosed in the financial state­
ments. Such disclosure generally is made in the notes to the financial state­
ments and is measured based on the provider's rates, costs, units of service, or 
other statistical measure.
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10.29 Expenses may be reported on the face of the financial statements 
using either a natural classification or a functional presentation. Public compa­
nies (that is, registrants with the Securities and Exchange Commission) are re­
quired to disclose segment information in accordance with FASB Statement No. 
131, Disclosure about Segments o f an Enterprise and Related Information. Not- 
for-profit organizations that report using a natural classification of expenses 
are required to disclose expenses by functional classification. In October 2006, 
FASB issued FASB Staff Position (FSP) FAS 126-1, Applicability o f Certain 
Disclosure and Interim Reporting Requirements for Obligors for Conduit Debt 
Securities. This FSP clarifies the definition of a public entity in certain account­
ing standards to include entities that are conduit bond obligors for conduit debt 
securities that are traded in a public market.
10.30 For governmental health care entities, GASB Statement No. 34, 
as amended, paragraph 122 defines a segment as an identifiable activity (or 
grouping of activities) reported as or within an enterprise fund or an other 
stand-alone entity that
• has one or more bonds or other debt instruments outstanding with 
a revenue stream pledged in support of that debt, and
• is required by an external party (such as through a bond inden­
ture) to account separately for its assets, liabilities, revenues, and 
expenses.
GASB Statement No. 34 paragraph 122 also details the disclosure required for 
segments.
10.31 Governmental health care entities that receive restricted resources 
are required to disclose whether, when both restricted and unrestricted re­
sources are available, it is their policy to use restricted or unrestricted resources 
first, as discussed in GASB Statement No. 34 paragraph 115(h).
10.32 GASB Statement No. 34 paragraph 121 requires governmental 
health care entities that receive donor-restricted endowments to make certain 
disclosures about their policy for use of investment income generated by those 
endowments.
10.33 As noted in paragraph 10.24 of this chapter, governmental health 
care entities should disclose their policy for defining operating revenues and 
expenses.
10.34 The extent of classification and subclassification of expenses de­
pends on many factors, such as the nature and complexity of the health care or­
ganization. For example, some entities may present only 2 categories: (a) health 
services (including inpatient services, outpatient procedures, and home health 
services) and (b) general and administrative. Others may present additional 
distinctions such as physician services, research, and teaching. Functional al­
locations should be based on full cost allocations. If a not-for-profit health care 
organization includes a ratio of fund-raising expenses to amounts raised in its 
financial statements, it should disclose how that ratio is computed (See para­
graph 20 of FASB Statement No. 136).
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Auditing5
10.35 The independent auditor may need to consider the examples of spe­
cific auditing objectives, selected control activities, and auditing procedures to 
audit revenue, expenses, gains, and losses that are presented in exhibit 10-1. 8
5 Statement of Position (SOP) 00-1, Auditing Health Care Third-Party Revenues and Related 
Receivables (AICPA, Technical Practice Aids, AUD sec. 14,360), discusses matters for auditors to 
consider in testing third-party revenues and related receivables, and provides guidance to auditors 
regarding the sufficiency of evidential matter and reporting on financial statements of health care 
entities exposed to material uncertainties. SOP 00-1 is included as appendix E to this guide.
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Exhibit 10-1
Auditing Considerations*
Financial Statement Specific Auditing Selected Control 
Assertions Objectives Activities Auditing Procedures
Revenue and Gains for Health Care Services
Existence and 
occurrence, 
completeness, and 
presentation and 
disclosure
Revenue and 
gains are 
reported in the 
proper period 
using the accrual 
basis of 
accounting and 
are classified 
properly by the 
type of service 
rendered.
In the statement 
of operations, 
revenue from 
health care 
services is 
reported, net of 
contractual 
adjustments and 
other
adjustments, in 
the proper period 
and is classified 
properly.
Procedures help 
ensure that 
revenue is 
accrued as 
services are 
performed or as 
contractual 
obligations are 
satisfied.
Management 
establishes and 
monitors 
controls over the 
recognition of 
revenue.
Controls ensure 
that deductions 
from revenue are 
recorded in the 
proper period 
and are classified 
properly.
Contractual and 
other
adjustments are 
authorized, 
controlled, and 
recorded 
properly.
Charity care, 
bad-debt 
writeoffs, and 
courtesy and 
policy discounts 
are authorized, 
controlled, and 
recorded 
properly.
Perform a
walk-through of the 
revenue system.
Compare the current 
period's revenue with 
prior periods' 
revenue or budgets, 
or both, and obtain 
explanations for 
large or unusual 
variances.
Consider the 
adequacy of the 
controls over the 
revenue recognition 
process.
Review the financial 
statements to 
determine that 
revenue is reported 
net of contractual 
adjustments and 
other adjustments.
Test contractual 
adjustments, other 
adjustments, and 
bad debts to 
determine that they 
are accounted for 
both in accordance 
with the respective 
contracts and the 
entity's policy. 
Determine that 
specific and 
unallocated reserves 
appear reasonable 
and comparable to 
prior year.
* AU section 326, Audit Evidence (AICPA, Professional Standards, vol. 1), recategorizes asser­
tions by classes of transactions, account balances, and presentation and disclosure. This exhibit will 
be revised, as necessary, to reflect the new assertion categories in a future edition of the guide.
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Financial Statement 
Assertions
Specific Auditing Selected Control
Objectives Activities Auditing Procedures
Review third-party 
payor contracts and 
methods of 
payment and test 
the entity's 
computation of 
estimated 
adjustments to 
revenue as required 
under such 
contracts.
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Chapter 11
The Reporting Entity and Related 
Organizations
Overview
11.01 Networks among health care organizations, both vertical and hor­
izontal, are being formed continually and new organizational structures are 
being developed. The dynamics of change in the health care industry and their 
impact on evolving organizational structures must be considered in defining 
the reporting entity.
11.02 An integrated health care system typically consists of multiple re­
lated entities, operating both for-profit and not-for-profit organizations. A not- 
for-profit parent corporation may be the sole corporate member or, through 
other means, it may control other entities such as a not-for-profit hospital, 
a not-for-profit medical foundation that contracts with a for-profit physician 
group, or other not-for-profit providers such as a long-term care center, a sub­
stance abuse center, a surgery center, or an outpatient clinic. The system also 
may own stock in various for-profit ventures such as health maintenance or­
ganizations or insurance companies that may or may not provide patient care. 
Fund-raising typically is accomplished through a separate foundation. Foun­
dations, auxiliaries, guilds, and similar organizations frequently assist and, in 
many instances, are related to the health care organization.
Financial Reporting of Governmental Health Care Entities
11.03 The Governmental Accounting Standards Board (GASB) has issued 
GASB Statement No. 14, The Financial Reporting Entity, which addresses is­
sues related to consolidations, application of the equity method of accounting, 
and accounting for various types of joint ventures for governmental entities. 
GASB Statement No. 14 establishes standards for defining and reporting for 
the financial reporting entity and for reporting its participation in joint ven­
tures. GASB Statement No. 39, Determining Whether Certain Organizations 
Are Component Units, amended GASB Statement No. 14 to provide additional 
guidance for assessing potential component units in determining the financial 
reporting entity. GASB Statement No. 39 may require the reporting of certain 
hospital foundations in the financial statements of governmental health care 
entities, regardless of whether the foundations follow Financial Accounting 
Standards Board (FASB) or GASB standards.
Financial Reporting of Nongovernmental 
Health Care Entities*
11.04 The guidance which follows in this chapter relates to for-profit 
and not-for-profit consolidations of parent-subsidiary relationships, whether
* In December 2007, the Financial Accounting Standards Board (FASB) issued Statement No. 
141 (revised 2007), Business Combinations. The objective of FASB Statement No. 141(R) is to improve 
(continued)
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through stock ownership or other means of control. Other circumstances may 
exist in the health care industry where combined financial statements involv­
ing commonly controlled entities are more meaningful than their separate fi­
nancial statements. More specific guidance related to combined financial state­
ments can be found in Accounting Research Bulletin (ARB) No. 51, Consolidated 
Financial Statements, paragraphs 22-23.* 1 FASB Interpretation No. (FIN) 46 
(revised December 2003), Consolidation o f Variable Interest Entities—an in­
terpretation o f ARB No. 51, addresses consolidation by business enterprises of 
variable interest entities. Not-for-profit organizations are not subject to FIN 
46(R), except that they may be related parties for purposes of applying para­
graphs 16-17 of FIN 46(R). Also, if a not-for-profit entity is used by business 
enterprises in a manner similar to a variable interest entity in an effort to cir­
cumvent the provisions of FIN 46(R), that not-for-profit entity is subject to that 
interpretation.
11.05 Whether the financial statements of a reporting health care organi­
zation and those of one or more other for-profit or not-for-profit entities should 
be consolidated, whether those other entities should be reported using the eq­
uity method, and the extent of disclosure that should be required (if any) if 
consolidated financial statements are not presented, should be based on the 
nature of the relationship between the entities.
Health Care Organizations
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the relevance and representative faithfulness of an entity's financial statements when reporting a 
business combination. FASB Statement No. 141(R) establishes the following requirements:
1. Use the acquisition method of accounting for all business combinations.
2. Recognize and measure goodwill acquired in a business combination, or from a bargain 
purchase.
3. Determine what information to disclose to enable users of the financial statements to 
evaluate the nature and financial effects of the combination.
FASB Statement No. 141(R) defines the key terms associated with a business combination (for exam­
ple, acquiree). The statement also requires entities to record assets acquired and liabilities assumed 
as a result of a business combination at fair value, as defined by FASB Statement No. 157, Fair Value 
Measurements. The effective date of FASB Statement No. 141(R) is for fiscal years beginning on or 
after December 15, 2008, with early adoption prohibited.In December 2007, FASB issued Statement 
No. 160, Noncontrolling Interests in Consolidated Financial Statements—an amendment of ARB No. 
51. The objective of FASB Statement No. 160 is to improve comparability and transparency of consol­
idated financial statements by establishing accounting and reporting standards that require
1. reporting of ownership interest in subsidiaries held by parties other than the parent 
be clearly identified, labeled, and presented in the consolidated balance sheet within 
equity but separate from the parent's equity.
2. consolidated net income should clearly identify the portion of income attributable to 
the parent and the noncontrolling interest on the face of the income statement.
3. changes in ownership interest should be accounted for consistently.
4. when a subsidiary is deconsolidated, any retained noncontrolling equity investment 
in the former subsidiary should be measured at fair value.
5. entities should provide all appropriate disclosures to distinguish between interest of 
the parent and the interests of the noncontrolling owners.
FASB Statement No. 160 is effective for fiscal years beginning on or after December 15, 2008. Early 
adoption is prohibited. FASB Statement No. 160 should be applied prospectively as of the beginning of 
the fiscal year in which the statement is initially adopted. Presentation and disclosure requirements 
shall be applied retrospectively for all periods presented.
1 In some situations, debt agreements may require combined financial statements of affiliated 
entities, the assets or revenues of which serve as collateral for the related debt (sometimes called 
an obligated group). Accounting Research Bulletin (ARB) No. 51, Consolidated Financial Statements, 
applies to those situations. However, if debt or other agreements prescribe a financial presentation 
that varies from generally accepted accounting principles (GAAP) (for example, exclusion of entities 
otherwise required to be consolidated), the auditor should consider AU section 623, Special Reports 
(AICPA, Professional Standards, vol. 1), for reporting guidance.
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11.06 Health care organizations may be related to one or more other enti­
ties in numerous ways, including ownership, control, and/or economic interest.
11.07 As discussed in paragraphs 11.10—.17, the existence of various forms 
of control and economic interests result in various financial reporting. Certain 
kinds of control result in consolidation (see paragraph 11.10). Other kinds of 
control result in consolidation only if coupled with an economic interest (see 
paragraph 11.11). Still other kinds of control result in consolidation being per­
mitted but not required, if coupled with an economic interest (see paragraph 
11.12). The existence of either control or an economic interest, but not both, is 
discussed in paragraph 11.13; consolidation of variable interest entities is dis­
cussed in paragraph 11.14; disclosures concerning restrictions on distributions 
are discussed in paragraph 11.15; and reporting under the equity method of 
accounting is discussed in paragraph 11.17.
11.08 Control is the direct or indirect ability to determine the direction of 
management and policies through ownership, contract, or otherwise. However, 
the rights and powers of the controlling entity may vary depending on the legal 
structure of the controlled entity and the nature of control. The majority owner 
of a for-profit entity's voting stock or the sole corporate member of a not-for- 
profit entity may not only have the ability to determine the direction of the 
controlled entity but also have the proportionate right to (or the responsibility 
for) operating results and a residual interest in the net assets upon dissolution. 
However, in other situations, the rights of the controlling party may be more 
limited. For example, in the case of a sole general partner in a limited partner­
ship, the limited partners—and not the general partner—may be entitled to the 
net assets upon dissolution. Further, the existence of "super-majority" voting 
rights can entitle the holder to disproportionate voting powers, and could affect 
the determination of the "controlling entity." As a result, whether the financial 
statements of a controlled entity should be consolidated with the reporting en­
tity depends on the nature of control and whether an economic interest exists.2,3
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2 FASB Emerging Issues Task Force (EITF) Issue No. 97-2, "Application of FASB Statement No. 
94 and Accounting Principles Board (APB) Opinion No. 16 to Physician Practice Management Entities 
and Certain Other Entities with Contractual Management Arrangements," addresses the issue of 
consolidation and business combinations among physician practice management entities, and other 
situations in which one entity manages another under similar circumstances and arrangements. If 
a physician practice is a variable interest entity as described in FASB Interpretation No. (FIN) 46 
(revised December 2003), Consolidation o f Variable Interest Entities—an interpretation of ARB No. 51, 
that entity is subject to the requirements of that interpretation, and the consensus in EITF Issue 
No. 97-2 does not apply. Not-for-profit organizations are not subject to FIN 46(R), except that they 
may be related parties for purposes of applying paragraphs 16-17 of that interpretation. Also, if a 
not-for-profit entity is used by business enterprises in a manner similar to a variable interest entity 
in an effort to circumvent the provisions of FIN 46(R), that not-for-profit entity is subject to that 
interpretation. EITF Consensus Opinions are category (c) GAAP as described in AU section 411, The 
Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles (AICPA, 
Professional Standards, vol. 1). Including the EITF Consensus Opinions within this guide, which is 
category (b) GAAP, does not change their position in the GAAP hierarchy. See footnote * to the heading 
to paragraph 1.62 in this guide for information about a FASB exposure draft of a proposed statement 
that would supersede the hierarchy currently presented in AICPA AU section 411, and an Accounting 
Standards Board exposure draft of a proposed Statement on Auditing Standard that would amend 
AU section 411.
3 EITF Issue No. 04-5, "Determining Whether a General Partner, or the General Partners as a 
Group, Controls a Limited Partnership or Similar Entity When the Limited Partners Have Certain 
Rights," provides a framework to determine whether the general partner(s) in a limited partnership 
control the limited partnership (or a similar entity) that is not a variable interest entity under FIN 
46(R). EITF Issue No. 04-5 does not apply to a general partner that carries its investment in the limited 
partnership at fair value with changes in fair value reported in the statement of operations or financial
(continued)
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11.09 An economic interest in another entity exists if (a) the other entity 
holds or utilizes significant resources that must be used for the unrestricted 
or restricted purposes of the reporting entity—either directly or indirectly—for 
producing income or providing services or (b) the reporting entity is responsible 
for the liabilities of the other entity. The following are examples of economic 
interests:
• Other entities solicit funds in the name of, and with the expressed 
or implied approval of, the reporting entity. In addition, substan­
tially all of the funds solicited are intended by the contributor or 
are otherwise required to be transferred to the reporting entity or 
used at its discretion or direction.
• The reporting entity transfers significant resources to another 
entity whose resources are held for the benefit of the reporting 
entity.
• The reporting entity assigns certain significant functions to an­
other entity.
• The reporting entity provides or is committed to provide funds for 
another entity or the reporting entity guarantees significant debt 
of another entity.
• The reporting entity has a right to, or the responsibility for, the 
operating results of another entity. Or, upon dissolution, the re­
porting entity is entitled to the net assets, or is responsible for any 
deficit, o f another entity.
11.10 Health care organizations with a controlling financial interest in 
other entities through direct or indirect ownership of a majority voting interest4 
in those other entities should consolidate those other entities, unless control 
does not rest directly or indirectly with the majority owner or sole corpo­
rate member (for example, if the subsidiary is in legal reorganization or in
Health Care Organizations
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performance in accordance with GAAP. EITF Issue No. 04-5 applies to not-for-profit entities that are 
required to apply the consolidation guidance in ARB No. 51 and FASB Statement No. 94, Consolida­
tion of All Majority-owned Subsidiaries—an amendment o f ARB No. 51, with related amendments 
of APB Opinion No. 18 and ARB No. 43, Chapter 12, for their investments in partnership entities 
(includes not-for-profit health care organizations in the scope of this guide). FASB Staff Position (FSP) 
SOP 78-9-1, Interaction o f AICPA Statement o f Position 78-9 and EITF Issue No. 04-5, amends the 
guidance in Statement of Position (SOP) No. 78-9, Accounting for Investments in Real Estate Ventures 
(AICPA, Technical Practice Aids, ACC sec. 10,240), to be consistent with the guidance in EITF Issue 
No. 04-5, so that guidance for assessing whether a general partner or the general partners as a group 
controls a limited partnership is consistent, irrespective of the industry within which the limited 
partnership operates. EITF Issue No. 04-5 and FSP SOP 78-9-1 are effective (1) after June 29, 2005, 
for general partners of all new limited partnerships formed and for existing limited partnerships 
for which the partnership agreements are modified; and (2) no later than the beginning of the first 
reporting period in fiscal years beginning after December 15, 2005, for general partners in all other 
limited partnerships.
4 Because not-for-profit organizations may exist in various legal forms, ownership of not-for-profit 
organizations may be evidenced in various ways. Examples include corporations issuing stock, corpo­
rations issuing ownership certificates, membership corporations issuing membership certificates, joint 
ventures, and partnerships. A parent corporation typically owns stock in a for-profit entity, whereas 
a sole corporate member holds membership rights in a not-for-profit entity. As it relates to health 
care consolidations, sole corporate membership in a not-for-profit entity is considered to be equivalent 
to ownership of a majority voting interest in a for-profit entity, unless the sole corporate member's 
economic interest in the controlled entity is limited by state law or contractual agreement.
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bankruptcy).5 6,6,† In such situations consolidation is prohibited, as discussed in 
paragraph 2 of ARB No. 51, as amended.7
11.11 In the case of (a) control through a majority voting interest in 
the board of another entity by means other than ownership or sole corporate 
membership8 and (b) an economic interest in such entities, consolidation is re­
quired, unless control is likely to be temporary or does not rest with the majority 
owner. In this situation consolidation is prohibited.9
11.12 Control of a separate not-for-profit organization in which the re­
porting entity has an economic interest may take forms other than majority 
ownership or voting interest; for example, control may be through contract or 
affiliation agreement.10 1In circumstances such as these, consolidation is permit­
ted but not required, unless control is likely to be temporary.11 In this situation 
consolidation is prohibited.12 If the reporting entity controls a separate not-for- 
profit entity through a form other than majority ownership (paragraph 11.10)
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5 See footnote 2 in this chapter.
6 See footnote 3 in this chapter.
† The Accounting Standards Executive Committee issued SOP 07-1, Clarification o f the Scope 
o f the Audit and Accounting Guide Investment Companies and Accounting by Parent Companies 
and Equity Method Investors for Investments in Investment Companies (AICPA, Technical Practice 
Aids, ACC sec. 10,930), in May 2007. The purpose of SOP 07-1 is to clarify the scope of the Audit and 
Accounting Guide Investment Companies to assist preparers and auditors in determining whether the 
provisions of the guide should be applied. SOP 07-1 amends the guide by deleting paragraphs 1.01-1.06 
and replacing them with specific guidance for determining whether an entity is within the scope of 
the guide. In addition, SOP 07-1 provides guidance for determining whether the specialized industry 
accounting principles of the guide might be retained in the financial statements of a parent company 
of an investment company or an investor in an investment company that has the ability to exercise 
significant influence over the investment company and applies the equity method of accounting to 
its investment in the entity. SOP 07-1 is effective for fiscal years beginning on or after December 15, 
2007.
In February 2008, the FASB issued FSP SOP 07-1-1, Effective Date o f AICPA Statement o f 
Position 07-1, which indefinitely defers the effective date of SOP 07-1 end prohibits adoption of the 
SOP for an entity that has not early adopted the SOP before issuance of this FSP. An entity that early 
adopted SOP 07-1 before issuance of this FSP is permitted but not required to continue to apply the 
provisions of the SOP. Entities who elect to retain their adoption of the SOP must also apply it to all 
consolidated entities going forward, including those formed or acquired after the adoption of the SOP. 
An entity that did not early adopt SOP 07-1 is not permitted to adopt the SOP.
7 FASB Statement No. 144, Accounting for the Impairment or Disposal o f Long-Lived Assets, 
among other matters, amends ARB No. 51 to eliminate the exception to consolidation for a subsidiary 
for which control is likely to be temporary. This guide has been conformed to FASB Statement No. 144 
to eliminate the exception to consolidation for a temporarily controlled subsidiary in circumstances in 
which this guide requires consolidation based on a controlling financial interest (paragraph 11.10 of 
this guide). No such conforming change to this guide is appropriate in circumstances in which consol­
idation is required or permitted based on control through other than a controlling financial interest 
(paragraphs 11.11—.12 in this guide). Accordingly, this guide retains the exception to consolidation for 
a temporarily controlled subsidiary in circumstances in which consolidation is required or permitted 
based on control through other than a controlling financial interest.
8 For purposes of this guide, a majority voting interest in the board of another entity by means 
other than ownership or sole corporate membership is illustrated by the following example. Entity B 
has a five-member board, and a simple voting majority is required to approve board actions. Entity 
A will have a majority voting interest in the board of entity B if three or more of its board members, 
officers, or employees serve on (or may be appointed at entity A's discretion to) the board of entity B. 
However, if three of entity A's board members serve on the board of entity B but entity A does not have 
the ability to require that those members serve on entity B's board, entity A does not have a majority 
voting interest in the board of entity B.
9 See footnote 7 in this chapter.
10 Evidence of control may include authority to amend articles of incorporation and bylaws or 
authority to approve operating, capital, and construction budgets; capital acquisitions; strategic plans, 
goals, and objectives; and mergers or dissolutions.
11 See footnote 2 in this chapter.
12 See footnote 9 in this chapter.
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or voting interest (paragraph 11.11), has an economic interest in that other 
entity, and consolidated financial statements are not presented, the notes to 
the financial statements should include the following disclosures:
a. Identification of the other entity and the nature of its relationship 
with the reporting entity that results in control
b. Summarized financial data of the other entity, including total as­
sets, liabilities, net assets, revenue, and expenses; and resources 
that are held for the benefit of the reporting entity or that are un­
der its control
c. The disclosures set forth in FASB Statement No. 57, Related Party 
Disclosures
11.13 In some cases, one entity may have an economic interest in another 
entity without controlling it (for example, a noncontrolled entity may solicit 
funds in the name of, and with the expressed or implied approval of, the re­
porting entity and substantially all of the funds solicited are intended by the 
contributor to benefit the reporting entity). The existence of control (other than 
through ownership or sole corporate membership) or an economic interest, but 
not both, precludes consolidation but requires the disclosures set forth in FASB 
Statement No. 57, Related Party Disclosures.13
11.14 FASB Interpretation No. (FIN) 46, Consolidation o f Variable In­
terest Entities, clarifies the application of ARB No. 51 to certain entities in 
which equity investors do not have the characteristics of a controlling finan­
cial interest or do not have sufficient equity at risk for the entity to finance its 
activities without additional subordinated financial support. An entity subject 
to consolidation according to the provisions of FIN 46(R) is referred to in that 
interpretation as a variable interest entity. An entity shall be subject to consol­
idation according to the provisions of FIN 46(R) if, by design, the conditions in 
paragraph 5 of that interpretation exist. Paragraph 14 of FIN 46(R) provides 
guidance for consolidation based on variable interests. FIN 46(R) also requires 
certain disclosures. Not-for-profit organizations are not subject to FIN 46(R), 
except that they may be related parties for purposes of applying paragraphs 
16-17 of that interpretation. Also, if a not-for-profit entity is used by business 
enterprises in a manner similar to a variable interest entity in an effort to cir­
cumvent the provisions of FIN 46(R), that not-for-profit entity is subject to that 
interpretation.
11.15 If consolidated financial statements are presented and they include 
a controlled not-for-profit organization, they should disclose any restrictions 
made by entities outside of the reporting entity on distributions from the con­
trolled not-for-profit organization to the reporting entity and any resulting un­
availability of the net assets of the controlled not-for-profit organization for use 
by the reporting entity.
11.16 When consolidated financial statements are required or permitted, 
a minority interest should be provided if such interest is represented by an 
economic interest whereby the minority interest would share in the operating 
results or residual interest upon dissolution.
Health Care Organizations
13 The existence of an economic interest does not necessarily cause the entities to be related 
parties, as defined in FASB Statement No. 57, Related Party Disclosures. However, the disclosures 
required by that statement are required under this guide if an economic interest exists.
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11.17 Investments in common stock of for-profit entities in which the re­
porting entity has 50 percent or less of the voting stock in the investee should 
be reported under the equity method in conformity with Accounting Principles 
Board (APB) Opinion No. 18, The Equity Method o f  Accounting for Investments 
in Common Stock, if the guidance in that opinion requires use of the equity 
method.14,† The equity method should be followed by an investor whose in­
vestment in voting stock gives it the ability to exercise significant influence 
over operating and financial policies of an investee. Determining the ability of 
an investor to exercise significant influence is not always clear, and applying 
judgment is necessary to assess the status of each investment. However, to 
achieve a reasonable degree of uniformity, the ownership of 20 percent or more 
of the voting stock leads to a presumption that the investor can exercise signif­
icant influence and, therefore, the investment should be accounted for under 
the equity method in accordance with APB Opinion No. 18. However, this pre­
sumption can be overcome in certain instances. FIN 35, Criteria for Applying 
the Equity Method o f Accounting for Investments in Common Stock, paragraph 
4 provides examples of indications that an investor may be unable to exercise 
significant influence. Health care organizations that report investments on the 
equity method should make the financial statement disclosures required by 
APB Opinion No. 18. FASB Staff Position (FSP) APB 18-1, Accounting by an 
Investor for Its Proportionate Share o f  Accumulated Other Comprehensive In­
come o f  an Investee Accounted for under the Equity Method in Accordance with 
APB Opinion No. 18 upon a Loss o f  Significant Influence, requires that investors 
offset their proportionate share of an investee's equity adjustments for other 
comprehensive income against the carrying value of the investment at the time 
significant influence is lost. FSP APB 18-1 does not provide guidance for entities 
that have historically not recorded their proportionate share of an investee's 
equity adjustments for other comprehensive income.
11.18 This guide provides guidance concerning consolidated financial 
statements. Consolidation of a parent or subsidiary organization requires the 
presentation of a single set of amounts for the entire reporting entity. Com­
bination, as discussed in paragraphs 22-23 o f ARB No. 51, refers to financial 
statements prepared for organizations between which common control exists
The Reporting Entity and Related Organizations
14 The consensus opinion reached in EITF Issue No. 02-14, "Whether an Investor Should Apply 
the Equity Method of Accounting to Investments Other Than Common Stock," which was ratified by 
the FASB in July 2004, expands the use of the equity method of accounting described in APB Opinion 
No. 18, The Equity Method of Accounting for Investments in Common Stock, to certain investments 
that are deemed in-substance common stock (as defined in the consensus opinion). The consensus 
opinion limits the use of the equity method to
•  investm ent(s) in common stock, and
•  investm ent(s) in-substance common stock, as that type of investment is defined in the con­
sensus opinion.
EITF Issue No. 02-14 does not change the application of the equity method for
•  investments in noncorporate entities accounted for under AICPA SOP 78-9, Accounting for 
Investments in Real Estate Ventures (AICPA, Technical Practice Aids, ACC sec. 10,240).
•  investments in limited liability companies that maintain specific ownership accounts for 
each investor as discussed in EITF Issue No. 03-16, "Accounting for Investments in Limited 
Liability Companies."
•  beneficial interests in trusts as required by FASB Statement No. 136, Transfers o f Assets 
to a Not-for-Profit Organization or Charitable Trust That Raises or Holds Contributions for 
Others.
EITF Issue No. 02-14 is effective for reporting periods beginning after September 15, 2004.
† See footnote † in paragraph 11.10.
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but for which the parent-subsidiary relationship does not exist. Both consoli­
dation and combination require elimination of interorganization transactions 
and balances. Paragraph 22 of ARB No. 51 states that "there are circumstances, 
however, where combined financial statements (as distinguished from consol­
idated statements) of commonly controlled companies are likely to be more 
meaningful than their separate statements." This guide prohibits consolidated 
financial statements in certain circumstances. However, it provides no guid­
ance concerning combined financial statements of commonly controlled enti­
ties, which may be presented in certain circumstances in conformity with the 
guidance in ARB No. 51.
11.19 Paragraph 15 of FASB Statement No. 94, Consolidation o f  All 
Majority-owned Subsidiaries—an amendment o f ARB No. 51, with related 
amendments o f APB Opinion No. 18 and ARB No. 43, Chapter 12, precludes the 
use of the parent company's financial statements as the general-purpose finan­
cial statements of the primary reporting entity. Similarly, where consolidation is 
required, this guide precludes the issuance of parent company financial state­
ments as the general-purpose financial statements of the primary reporting 
entity. However, neither FASB Statement No. 94 nor this guide discuss the use 
of the parent company’s financial statements as other than the general-purpose 
financial statements for the primary reporting entity.15 Generally accepted ac­
counting principles do not preclude the issuance of financial statements for 
the subsidiary only. However, care should be taken to include all disclosures 
required by FASB Statement No. 57 and other relevant pronouncements.
Transfers
Equity Transfers
11.20 Equity transfers are similar to ownership transactions between a 
for-profit parent and its owned subsidiary (for example, additional paid-in cap­
ital or dividends).16 However, equity transfers can occur only between related 
not-for-profit entities when one controls the other or both are under common 
control. An equity transfer embodies no expectation of repayment, nor does the 
transferor receive anything of immediate economic value (such as a financial 
interest or ownership). Equity transfers are reported separately as changes in 
net assets, are excluded from the performance indicator, and do not result in 
any step-up in basis of the underlying assets transferred. (Certain transfers 
from a foundation to a related nongovernmental health care organization are 
discussed in paragraphs 11.32-.33.)
Equity Transactions
11.21 Transfers from a nongovernmental health care organization to a not- 
for-profit organization or charitable trust are equity transactions, as described 
in FASB Statement No. 136, Transfers o f Assets to a Not-for-Profit Organiza­
tion or Charitable Trust That Raises or Holds Contributions for Others, (see 
paragraphs 4 and 18), if the transfer meets all of the following criteria:
Health Care Organizations
15 Contractual agreements or regulatory provisions may require parent company only financial
statements. AU section 623 provides guidance for reporting on financial presentations to comply with
contractual agreements or regulatory provisions.
16  Governmental health care entities only. See paragraphs 1.13 and 10.13 in this guide regarding 
the reporting of transfers by governmental health care entities.
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• A nongovernmental health care organization transfers assets to 
a not-for-profit organization or charitable trust (called a recipient 
organization) that accepts those assets and agrees to use them on 
behalf of or transfer them, their investment return, or both back 
to the health care organization or its affiliate.
• The nongovernmental health care organization and the recipient 
organization are financially interrelated organizations.
• Neither the nongovernmental health care organization nor its af­
filiate expects payment of the transferred assets, although pay­
ment of investment return on the transferred assets may be ex­
pected.
11.22 Paragraph 13 of FASB Statement No. 136 provides that organiza­
tions are financially interrelated if the relationship between them has both of 
the following characteristics: (a) one organization has the ability to influence 
the operating and financial decisions of the other and (b) one organization has 
an ongoing economic interest in the net assets of the other. The ability to influ­
ence the operating and financial decisions of the other can be demonstrated in 
several ways:
a. The organizations are affiliates as defined in FASB Statement No. 
57.
b. One organization has considerable representation on the governing 
board of the other organization.
c. The charter or bylaws of one organization limits its activities to 
those that are beneficial to the other organization.
d. An agreement between the organizations allows one organization 
to actively participate in the policymaking processes of the other, 
such as setting organizational priorities, budgets, and management 
compensation.
An ongoing economic interest in the net assets of another is a residual right to 
the other organization's net assets that results from an ongoing relationship. 
The value of those rights increases or decreases as a result of the investment, 
fundraising, operating, and other activities of the other organization.17
11.23 An equity transaction differs from an equity transfer in that an 
equity transaction, as described in FASB Statement No. 136, involves a finan­
cially interrelated party either as a third party in a transfer from an entity to 
one of its affiliates or as a counterparty in a transfer from an entity to itself. 
An equity transfer, as described in the guide, is a transaction directly between 
a transferor and a transferee. In addition, an equity transaction is reciprocal; 
the health care organization or its affiliate named as the beneficiary receives 
an ongoing economic interest in the assets held by the recipient organization. 
(See paragraphs 18 and 95 of FASB Statement No. 136). An equity transfer is 
nonreciprocal; there is no expectation of repayment and the transferor does not 
receive a financial interest or ownership. (See paragraph 11.20 of this guide). 17
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17 Paragraph 104 of FASB Statement No. 136 notes that although most of the relationships de­
scribed in the definition of economic interest in the glossary of SOP 94-3, Reporting of Related Entities 
by Not-for-Profit Organizations (AICPA, Technical Practice Aids, ACC sec. 10,610), are potentially 
ongoing economic interests in the net assets of the other, some are not. (The guidance in SOP 94-3 
is incorporated in paragraph 11.09 of this guide). Only economic interests that are both ongoing and 
residual interests in the net assets meet the criterion of paragraph 13(b) of FASB Statement No. 136.
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11.24 The reporting of an equity transaction depends upon whether the 
resource provider or its affiliate is the specified beneficiary. As discussed in 
paragraph 18 of FASB Statement No. 136, if the resource provider specifies itself 
as the beneficiary, the resource provider reports an asset—interest in the net 
assets of the recipient organization (or an increase in a previously recognized 
interest),18 and the recipient organization reports an equity transaction as a 
separate line in its statement of activities. If the resource provider specifies its 
affiliate as the beneficiary, the resource provider and the recipient organization 
report an equity transaction as separate lines in their statements of activities, 
and the affiliate named as beneficiary reports an interest in the net assets of the 
recipient organization.19 The resource provider should disclose the information 
described in paragraph 4.24 of this guide for each period for which a statement 
of financial position is presented.
Other Transfers*
11.25 Other transfers may occur among related entities. If the entities 
are consolidated or combined, such transfers are eliminated in consolidation 
or combination, or both. If the entities are not consolidated or combined (for 
example, in separate subsidiaries or obligated group financial statements),20 
the method of accounting for such transfers is dictated by the substance of 
the transaction as well as the legal form. For example, certain transfers by a 
foundation to a related nongovernmental health care organization are reported 
as contributions, as discussed in paragraphs 11.32-.33. In other situations, 
payments may be made for services provided between not-for-profit entities 
under common control, which should be accounted for as revenues and expenses 
depending on the types of services provided.
11.26 A health care organization may loan or advance resources to a re­
lated entity. If repayment is reasonably assured, a receivable or payable should 
be recorded by the entities. Subsequent to the time a receivable is recorded, the 
ability of the receiving entity to repay the receivable should be considered. If 
the receivable is not to be repaid, or if the receiving entity is perceived as un­
able to repay, it may be accounted for as an equity transfer with the transferor 
reducing net assets and the transferee increasing net assets at the date such 
determination is made (see paragraph 11.20).
11.27 Transfers that result in changes in ownership interest are accounted 
for as investments in accordance with APB Opinion No. 18 and FASB Statement 
No. 94.
11.28 Assets transferred from one commonly controlled entity to another 
should be recorded by the transferee at the carrying value of the transferring 
entity. This treatment is consistent with the guidance prescribed by appendix 
D of FASB Statement No. 141, Business Combinations.‡
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18 That interest would be eliminated if the beneficiary (resource provider) and the recipient 
organization were included in consolidated financial statements. See footnote 6 to paragraph 15 of 
FASB Statement No. 136.
19 That interest would be eliminated if the beneficiary (affiliate) and the recipient organization 
were included in consolidated financial statements. See footnote 6 to paragraph 15 of FASB Statement 
No. 136.
* See footnote * in heading above paragraph 11.04.
20 See paragraph 12.12 for additional discussion regarding obligated group financial statements.
‡ FASB Statement No. 141, Business Combinations, supersedes AICPA Accounting Interpreta­
tion No. 39, Transfers and Exchanges Between Companies under Common Control, of APB Opinion
(continued)
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Related Fund-Raising Organizations
11.29 A related entity may act as an agent, trustee, or intermediary for 
contributions to the reporting entity. FASB Statement No. 136 establishes stan­
dards for transactions in which a donor makes a contribution by transferring 
assets to a recipient organization—a not-for-profit organization or a charitable 
trust—that accepts the assets from the donor and agrees to use the assets on 
behalf of or transfer the assets, their investment return, or both to another 
entity—the beneficiary—named by the donor.21,22 Paragraph 68 of FASB State­
ment No. 136 states that a donor may specify the beneficiary (a) by name, (b) 
by stating that all entities that meet a set of donor-defined criteria are benefi­
ciaries, or (c) by actions surrounding the transfer that made clear the identity 
of the beneficiary, such as by responding to a request from an organization that 
exists to raise assets for the beneficiary. Paragraphs 69-72 and appendix A of 
FASB Statement No. 136 provide examples of donor stipulations and discuss 
whether those stipulations specify a beneficiary.
11.30 If a recipient organization and a specified beneficiary are financially 
interrelated organizations (as defined in paragraph 13 of FASB Statement No. 
136 and described in paragraph 11.22 of this guide) and the recipient organiza­
tion is not a trustee, the recipient organization should recognize the fair value 
of any assets it receives from the donor that are specified by the beneficiary as a 
contribution received, rather than as a liability to the beneficiary, as discussed 
in paragraph 14 of FASB Statement No. 136. For example, a foundation that 
exists to raise, hold, and invest assets for a specified health care organization or 
for a group of affiliates of which the specified health care organization is a mem­
ber generally is financially interrelated with the organization or organizations 
it supports. A financially interrelated foundation should recognize contribution 
revenue when it receives assets from the donor.23 The specified health care or­
ganization should recognize its interest in the net assets of the foundation (the 
recipient organization) and adjust that interest for its share of the change in 
net assets of the recipient organization using a method similar to the equity 
method of accounting for investments in common stock (see paragraph 15 of 
FASB Statement No. 136).24
11.31 When measuring its interest in the recipient organization, the spec­
ified health care organization would include the net assets of the recipient or­
ganization that are restricted to use by that health care organization. If the
The Reporting Entity and Related Organizations
(footnote continued)
No. 16, Business Combinations. However, the guidance in that interpretation, used in past practice to 
account for transfers of net assets between entities under common control, is carried forward without 
reconsideration in appendix D of FASB Statement No. 141.
21 FASB Statement No. 136 also establishes standards for transactions that take place in a 
similar manner but are not contributions because the transfers are revocable, repayable, or reciprocal. 
For example, if a resource provider transfers assets to a recipient organization and names itself or 
its affiliate as beneficiary, that transaction is reciprocal even if the resource provider grants variance 
power. Those standards and transactions are discussed in paragraphs 4.23-.24, 11.21, and 11.23—.24 
of this guide. This guide does not use the word donor in discussing those transactions because they 
are not contributions.
22 Governmental health care entities only. This pronouncement is not applicable to governmental 
health care enterprises. (See footnote 1 in chapter 1.)
23 Foundations that are not providers of health care services are not covered by this guide and 
should follow the AICPA Audit and Accounting Guide Not-for-Profit Organizations.
24 That interest would be eliminated if the beneficiary and the recipient organization were in­
cluded in consolidated financial statements. See footnote 6 to paragraph 15 of FASB Statement No. 
136.
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recipient organization supports more than one beneficiary and an agreement 
with the recipient organization specifies how unrestricted gifts to the recipient 
organization should be divided between the organizations supported, the spec­
ified health care organization would also include its share of the recipient or­
ganization's unrestricted assets, computed in accordance with that agreement. 
Similarly, if a parent organization controls both the recipient organization and 
the specified health care organization and the parent directed that unrestricted 
gifts would be distributed to affiliates in accordance with a specified formula, 
each affiliate would include in its interest its share of unrestricted net assets, 
computed in accordance with that formula. (See paragraphs 41-45 of FASB 
Statement No. 136).
11.32 Distributions from a financially interrelated recipient organization 
to a nongovernmental health care organization that it supports are generally 
reported by the health care organization as a reduction of its interest in the 
recipient organization. However, if the distribution is made from net assets 
that are not includable in that interest because the health care organization 
does not have rights to them (that is, the recipient organization can determine 
to whom the assets will be distributed), the health care organization reports 
a contribution from the related recipient organization. For example, assume a 
foundation's mission is to raise contributions for two financially interrelated 
health care organizations, Hospital A and Hospital B. The foundation receives 
$10,000 in contributions from donors that do not specify which of the 2 hospitals 
should benefit from their gifts. There is no agreement between the foundation 
and Hospitals A and B that specifies how gifts to the foundation should be 
divided between the hospitals if the donor does not specify a beneficiary. Hos­
pital A would report contribution revenue for any portion of the $10,000 that it 
receives from the foundation. Likewise, Hospital B would report contribution 
revenue for any portion of the $10,000 that it receives, but neither Hospital A 
nor Hospital B would record an interest in those assets before the foundation 
either distributes them or unconditionally promises them.
11.33 As discussed in paragraphs 11-12 of FASB Statement No. 136, if the 
recipient organization and the specified health care organization are not finan­
cially interrelated organizations as defined in paragraph 13 of FASB Statement 
No. 136 (see paragraph 11.22 in this guide), and the donor specifies a beneficiary, 
the recipient organization should recognize a liability to the specified benefi­
ciary unless the recipient is explicitly granted variance power. (See discussion 
of variance power at paragraph 10.05 of this guide). If the assets received from 
the donor are donated materials, supplies, or other nonfinancial assets, the re­
cipient organization may choose either to (a) report the receipt of the assets as 
a liability to the beneficiary concurrent with recognition of the assets received 
or (b) not to report the transaction at all. The choice is an accounting policy that 
should be applied consistently from period to period and disclosed in the notes 
to the financial statements. The specified health care organization recognizes 
its rights to the assets (financial or nonfinancial) held by a recipient organiza­
tion as an asset and contribution revenue unless the recipient organization is 
explicitly granted variance power. (See further discussion at paragraphs 5.12 
and 10.05.) In contrast, if the donor does not specify a beneficiary (see further 
discussion at paragraph 11.29) and the foundation and a hospital are under 
common control, but they are not financially interrelated, the recipient orga­
nization should recognize contribution revenue when it receives the gift. The 
gift should be accounted for as contributions received by the hospital, consis­
tent with FASB Statement No. 116, Accounting for Contributions Received and
Health Care Organizations
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Contributions Made, and chapter 10 of this guide, provided that the foundation 
is acting other than as an owner.
11.34 Additional guidance regarding accounting for contributions received 
by agents, trustees, and intermediaries can be found in chapter 5 of the Audit 
and Accounting Guide Not-for-Profit Organizations.
Disclosure
11.35 Significant relationships and transactions not in the ordinary course 
of business with directors, management, medical staff, or other related parties 
(including unconsolidated related organizations) should be disclosed in accor­
dance with FASB Statement No. 57. AU section 334, Related Parties (AICPA, 
Professional Standards, vol. 1), sets forth procedures for the auditor to consider 
in determining the existence of transactions with related parties and identify­
ing them.
11.36 Hospital boards may contract with management companies to oper­
ate their facilities. Frequently, the management company will employ the ad­
ministrator as well as other key personnel. Further, services may be acquired 
from entities related to the management company.25 The auditor should eval­
uate the impact of these arrangements on the hospital's internal controls and 
disclose related party transactions as required by FASB Statement No. 57.
11.37 The reporting and disclosure requirements of the nongovernmental 
health care organization under the circumstances noted in paragraphs 11.10- 
.19 are summarized as follows:26
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Circumstances
The entity owns a majority of a 
for-profit entity's voting stock.
The entity is the sole corporate 
member of a not-for-profit entity. 
(See paragraph 11.10, footnote 4.)
The entity controls another through 
a majority voting interest in the 
board and an economic interest 
exists.
The reporting entity owns 50 
percent or less of the common voting 
stock o f an investee and can exercise 
significant influence over operating 
and financial policies.
Requirements
Consolidate unless control does not rest 
with the majority owner or the interest 
is limited by state law or contractual 
agreement.
Consolidate unless control does not rest 
with the majority owner or the sole 
corporate member's interest is limited 
by state law or contractual agreement.
Consolidate unless control is likely to be 
temporary or does not rest with the 
majority owner or the sole corporate 
member; or the interest is limited by 
state law or contractual agreement.
The investment should be accounted for 
under the equity method in accordance 
with APB Opinion No. 18.
(continued)
25 See footnote 2 in this chapter.
26 See footnote 7 in this chapter.
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Circumstances Requirements
There have been material 
transactions between the health 
care entity and the related 
organization. (This could be present 
in any of the foregoing 
circumstances.)
An entity has control over another 
not-for-profit organization or has an 
economic interest in the other, but 
not both.
The reporting entity controls a 
separate not-for-profit entity 
through a form other than majority 
ownership or voting interest and 
has an economic interest in that 
other entity.
In the notes to the financial statements 
(a) disclose the existence and nature of 
the relationship and (b) describe and 
quantify the transactions.
The entity is a variable interest 
entity subject to the provisions of 
FIN 46(R).
In the notes to the financial statements 
(a) disclose the existence and nature of 
the relationship and (b) describe and 
quantify the transactions.
Consolidation is prohibited.
Consolidation permitted but not 
required. If consolidated statements are 
not presented, the notes to the financial 
statements should disclose (a) the 
identification of the other entity and the 
nature of its relationship with the 
reporting entity, (6) summarized 
financial data of the other entity, and (c) 
the disclosures set forth in FASB 
Statement No. 57.
Apply the guidance in FIN 46(R), 
including the disclosure requirements 
in that interpretation.|
Business Combinations* 
11.38 As discussed in paragraph 11.01, the dynamics of change in the 
health care industry have resulted in increased business combinations as new 
organizational structures are being formed. FASB Statement No. 141 addresses 
financial accounting and reporting for business combinations. FASB Statement 
No. 141 prescribes the use of the purchase method for those business combi­
nations. FASB Statement No. 141, however, does not apply to certain combina­
tions, including a combination involving 2 or more not-for-profit organizations, 
or the acquisition of a for-profit business by a not-for-profit organization. For 
those combinations, the guidance in APB Opinions Nos. 16 and 17, Intangible 
Assets, still apply and provides a useful framework when evaluating similar 
transactions entered into by not-for-profit health care business organizations.#
|| For information about FIN 46(R), and the applicability of FIN 46(R)'s requirements for not-for- 
profit organizations, see paragraph 11.14 in this chapter.
* See footnote * in heading above paragraph 11.04.
# On October 9, 2006, the FASB issued an exposure draft of a proposed FASB statement, Not- 
for-Profit Organizations: Mergers and Acquisitions, which would eliminate the use of the pooling-of- 
interests method of accounting by not-for-profit organizations and would require that they apply the 
acquisition method to any merger or acquisition. The acquisition method would require a not-for- 
profit organization to identify the acquirer, recognize the identifiable assets acquired and liabilities 
assumed that compose the business or nonprofit activity acquired at their fair values as of the acqui­
sition date (with certain exceptions), and recognize either goodwill or the contribution inherent in the 
transaction. The proposed FASB Statement would amend APB Opinion Nos. 16 and 29, Accounting
(continued)
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A list of possible factors to be considered when evaluating these transactions 
in relation to APB Opinion No. 16 is summarized as follows:
The Reporting Entity and Related Organizations
Circumstances
Monetary consideration received or 
paid, change in legal title to assets 
or assumption of liabilities, or both.
Change in control (for example, 
change in sole corporate member).
Accounting and Disclosure Guidance
This is similar to a purchase under APB 
Opinion No. 16.* 27
This is similar to a pooling of interests 
transaction under APB Opinion No. 16. 
No step-up in basis.
See paragraphs 1.50-.51 for additional guidance regarding the application of 
APB Opinion No. 16 to not-for-profit organizations. Also see footnote † in the 
section "APB Opinion No. 16, Business Combinations" in chapter 1 in this guide 
regarding pronouncements that were superseded by FASB Statement No. 141, 
including APB Opinion No. 16.
Auditing
11.39 The independent auditor may need to consider the examples of 
specific auditing objectives, control activities, and auditing procedures for re­
lated party organizations, balances, and transactions that are presented in 
exhibit 11-1.
(footnote continued)
for Nonmonetary Transactions, and FASB Statement Nos. 116, Accounting for Contributions Re­
ceived and Contributions Made, and 117, Financial Statements of Not-for-Profit Organizations. 
Concurrently, the FASB also issued an exposure draft of a proposed FASB statement, Not-for-Profit 
Organizations: Goodwill and Other Intangible Assets Acquired in a Merger or Acquisition, which 
would amend FASB Statement No. 142, Goodwill and Other Intangible Assets, to provide guidance 
to not-for-profit organizations for testing goodwill for impairment and applying FASB Statement No. 
142's provisions (as amended) to identified intangible assets recognized as the result of a merger or 
acquisition. Readers should be alert to the issuance of final standards.
27 FASB Statement No. 141 supersedes AICPA Accounting Interpretation No. 39 of APB Opinion 
No. 16. Appendix D of FASB Statement No. 141 carries forward without reconsideration guidance in 
APB Opinion No. 16 and an interpretation that has been used in past practice to account for transfers 
of net assets or exchanges of shares between entities under common control. Paragraph D12 of FASB 
Statement No. 141 discusses the accounting for a transfer of assets or exchange of shares between 
entities under common control.
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Exhibit 11-1
Health Care Organizations
Auditing Considerations*
Financial Statement Specific Auditing Selected Control 
Assertions Objectives Activities Auditing Procedures
Reporting Entity and Related Organizations
Existence and The reporting
occurrence, entity is
completeness, and appropriate, 
presentation and 
disclosure
Procedures 
ensure that 
investees, 
affiliates, and 
other related 
entities are 
accounted for 
appropriately.
Relationships 
and transactions 
with related 
organizations are 
identified and 
disclosed, if 
appropriate, 
because of 
economic 
dependence of 
the entity.
Procedures 
ensure that 
conflict-of- 
interest policies, 
procedures, and 
disclosure 
requirements are 
met.
Review the articles 
of incorporation, 
bylaws, and minutes 
of directors' 
meetings, 
shareholder lists, 
and filings with 
regulatory 
authorities to 
determine the 
existence of related 
parties.
Obtain
representations from 
management as to 
whether all 
investees, affiliates, 
and related entities 
have been accounted 
for properly or 
disclosed.
Review transactions 
with investees, 
affiliates, and other 
related entities to 
determine that they 
are reported 
properly and clearly 
expressed.
Test significant 
related party 
transactions as 
follows:
• Determine 
substance.
• Examine 
documents 
(invoices, 
contracts, and 
agreements)
* AU section 326, Audit Evidence (AICPA, Professional Standards, vol. 1), recategorizes asser­
tions by classes of transactions, account balances, and presentation and disclosure. This exhibit will 
be revised, as necessary, to reflect the new assertion categories in a future edition of the guide.
AAG-HCO 11.39
Financial Statement Specific Auditing Selected Control
Assertions__________ Objectives_________ Activities Auditing Procedures
• Determine the 
basis of pricing.
• Determine the 
collectibility of 
receivables and 
advances.
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Review related party 
transactions for 
completeness by—
• Considering 
previously 
identified 
transactions or 
relationships.
• Reviewing the 
minutes of 
directors' and 
other meetings.
• Discussing 
related-party 
transactions with 
entity personnel.
• Reviewing 
unusual
• transactions.
• Reviewing the 
responses to 
related party 
(conflict-of- 
interest) 
questionnaires.
Presentation and 
disclosure
Related party 
transactions and 
organizations are 
reported 
properly.
Review the 
presentation and 
disclosure of related 
party information for 
completeness and 
understandability.
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Chapter 12
Independent Auditor's Reports
Overview
12.01 The guidance in AU section 508, Reports on Audited Financial State­
ments (AICPA, Professional Standards, vol. 1), applies to audit reports on the 
financial statements of health care organizations. Such a report may contain 
an unqualified opinion, an unqualified opinion with an explanatory paragraph, 
a qualified opinion, a disclaimer of opinion, or an adverse opinion. The facts 
and circumstances of each particular audit govern the appropriate form of the 
report.1 Guidance on the dating of the independent auditor's report is provided 
in AU section 530, Dating o f the Independent Auditor's Report (AICPA, Profes­
sional Standards, vol. 1).
Considerations for Integrated Audits
Paragraphs 86—88 of Public Company Accounting Oversight Board 
(PCAOB) Auditing Standard No. 5, An Audit o f Internal Control Over 
Financial Reporting That Is Integrated with An Audit o f  Financial 
Statements (AICPA, PCAOB Standards and Related Rules, Rules of 
the Board, "Standards"), provide further guidance on choosing to is­
sue a combined report or separate reports on the company's financial 
statements and on internal control over financial reporting.
When performing an integrated audit of financial statements and in­
ternal control over financial reporting, the auditor should date the au­
dit report no earlier than the date on which the auditor has obtained 
sufficient competent evidence to support the auditor's opinion. Refer 
to paragraph 89 of PCAOB Auditing Standard No. 5, which provides 
direction with respect to the report date in an audit of internal control 
over financial reporting.
12.02 Auditing Interpretation No. 17, "Clarification in the Audit Report 
of the Extent of Testing of Internal Control Over Financial Reporting in Accor­
dance With Generally Accepted Auditing Standards," of AU section 508 (AICPA, 
Professional Standards, vol. 1, AU sec. 9508 par. .85—.88), provides for audits 
of nonissuers an example of additional language that may be added to an audi­
tor's standard report to explain that an audit includes consideration of internal 
control over financial reporting as a basis for designing audit procedures but 
not for the purpose of expressing an opinion on the effectiveness of internal 
control over financial reporting. (See exhibit 12-1.) Auditing Interpretation 
No. 18, "Reference to PCAOB Standards in an Audit Report on a Nonissuer," 
of AU section 508 (AICPA, Professional Standards, vol. 1, AU sec. 9508 par. 
.89-.92), provides guidance on the appropriate referencing of PCAOB Auditing 
Standards in audit reports for those auditors who are engaged to perform an 
audit in accordance with PCAOB standards when auditing nonissuers.
1 Paragraph .30 of AU section 508, Reports on Audited Financial Statements (AICPA, Professional 
Standards, vol. 1), eliminates the requirement that when certain criteria are met, the auditor add 
an uncertainties explanatory paragraph to the auditor's report. AU section 508 provides guidance 
concerning emphasis paragraphs, uncertainties, and disclaimers of opinion.
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12.03 The AICPA Practice Aid Alternative Investments—Audit Consid­
erations provides reporting guidance for auditors of nonissuers with invest­
ments for which a readily determinable fair value does not exist (collectively 
referred to in the practice aid as alternative investments), including guidance 
concerning inclusion of an emphasis of matter paragraph and auditor's report 
modifications.* The auditing portion of that practice aid is an other auditing 
publication as defined in AU section 150, Generally Accepted Auditing Stan­
dards (AICPA, Professional Standards, vol. 1). Other auditing publications 
have no authoritative status; however, they may help the auditor understand 
and apply Statements on Auditing Standards.
12.04 The Audit and Accounting Guide State and Local Governments pro­
vides guidance on audit reports for state and local governments as well as on as­
sessing materiality (opinion units). (See paragraphs 2.01 and 12.10-.11 of this 
guide.) Also, chapter 16 of that guide discusses auditor association with munic­
ipal securities filings and the use of Government Auditing Standards in reports 
and references in the offering document—the official statement. Governments 
sometimes issue municipal securities to finance facilities for nongovernmental 
organizations, including not-for-profit health care organizations. Those non­
governmental organizations may be considered obligated persons with regard 
to the securities and thus also provide audited financial statements for the 
official statement.
12.05 The report examples appearing in this chapter illustrate the form 
of certain auditor's reports issued by the independent auditor in auditing the 
financial statements of a health care organization. The forms of report illus­
trated are prescribed by AICPA professional standards. The PCAOB provides 
requirements and related interpretive guidance when preparing or issuing any 
audit report on the financial statements of an issuer in accordance with the 
standards of the PCAOB. For example, PCAOB Auditing Standard No. 1, Ref­
erences in Auditors'Reports to the Standards o f the Public Company Account­
ing Oversight Board (AICPA, PCAOB Standards and Related Rules, Rules of 
the Board, "Standards"), replaces in auditors' reports the sentence "We con­
ducted our audits in accordance with auditing standards generally accepted 
in the United States of America" with the following sentence: "We conducted 
our audits in accordance with the standards of the Public Company Account­
ing Oversight Board (United States)" in a "Report of Independent Registered 
Public Accounting Firm." The Securities Exchange Commission simultaneously 
issued interpretive guidance in Release No. 33-8422 under the Securities Act 
of 1933 (Release No. 34-49708 under the Securities Exchange Act of 1934) to 
address certain implementation issues relating to the standard.
Unqualified Opinion
12.06 The independent auditor's standard report states that the financial 
statements present fairly, in all material respects, an entity's financial position, 
results of operations, changes in net assets, and cash flows in conformity with 
generally accepted accounting principles (GAAP). The opinion should include 
an identification of the United States of America as the country of origin of those 
accounting principles. This conclusion may be expressed only when the inde­
pendent auditor has formed such an opinion on the basis of an audit performed
Health Care Organizations
* The AICPA Practice Aid Alternative Investments—Audit Considerations was issued in July 
2006.
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in accordance with generally accepted auditing standards and an identification 
of the United States of America as the country of origin of those standards, or 
in accordance with the standards of the PCAOB (United States), as discussed 
in paragraph 12.05. An example of the independent auditor's standard report 
is presented in exhibit 12-1 at the end of this chapter.
Qualified Opinion
12.07 AU section 508 states that the auditor may express a qualified opin­
ion if the circumstances warrant. A qualified opinion states that except for the 
effects of the matter to which the qualification relates, the financial statements 
present fairly, in all material respects, the financial position, results of opera­
tions, and cash flows in conformity with GAAP. Such an opinion is expressed 
when
a. there is a lack of sufficient appropriate audit evidence or there are 
restrictions on the scope of the audit that have led the independent 
auditor to conclude that an unqualified opinion cannot be expressed 
and the independent auditor has concluded not to disclaim an opin­
ion (see exhibit 12-2).
b. the independent auditor believes, on the basis of the audit, that 
the financial statements contain a departure from GAAP, the effect 
of which is material, and has concluded not to express an adverse 
opinion (see exhibit 12-3).
Additional Information
12.08 AU section 551, Reporting on Information Accompanying the Basic 
Financial Statements in Auditor-Submitted Documents (AICPA, Professional 
Standards, vol. 1), contains useful guidance on reporting on additional informa­
tion. The information covered by AU section 551 is presented to accompany the 
basic financial statements in an independent auditor-submitted document and 
is not considered necessary for a fair presentation of financial position, results 
of operations, changes in net assets, and cash flows in conformity with GAAP. 
Such information includes additional details or explanations of items in, or re­
lated to, the basic financial statements, consolidating/combining information, 
historical summaries of items extracted from the basic financial statements, 
statistical data, and other material, some of which may be from sources outside 
the accounting system or outside the health care organization.
12.09 With respect to supplementary and other information, guidance is 
contained in AU section 551; AU section 550, Other Information in Documents 
Containing Audited Financial Statements; and AU section 558, Required Sup­
plementary Information (AICPA, Professional Standards, vol. 1). AU section 
550 and AU section 558 provide that an auditor may issue a report providing 
an opinion, in relation to the basic financial statements taken as a whole, on 
supplementary information and other information that has been subjected to 
the auditing procedures applied in the audit of those basic financial statements. 
AU section 551 clarifies the reporting guidance with respect to required sup­
plementary information (RSI) in an auditor-submitted document. In addition, 
AU section 552, Reporting on Condensed Financial Statements and Selected 
Financial Data (AICPA, Professional Standards, vol. 1), contains guidance on 
reporting in a client-prepared document when condensed financial statements 
or selected financial data are presented by a public entity.
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Auditor Reporting on RSI and Supplementary
Information for Governmental Health
Care Entities
12.10 GAAP specifies that certain information be presented as RSI. For 
governmental health care entities, Governmental Accounting Standards Board 
Statement No. 34, Basic Financial Statements—and Management's Discussion 
and Analysis—for State and Local Governments, paragraphs 8-11 require pre­
sentation of management's discussion and analysis (MD&A) as RSI. Govern­
mental health care entities may be required to present RSI other than MD&A, 
as established by GAAP. Governmental health care entities may voluntarily 
provide supplementary information other than RSI (known as SI). Only in­
formation required by GAAP to be presented as RSI can be considered RSI. 
The auditor may be engaged to audit either or both RSI or SI—that is, ex­
press an opinion on whether the information is fairly presented, in all material 
respects, in conformity with GAAP. Chapter 14 in the Audit and Accounting 
Guide State and Local Governments provides a discussion of reporting guid­
ance on RSI and SI. Reporting on RSI is discussed in paragraphs 14.54—.57 
and paragraphs 14.60-.64 in that guide. As discussed in paragraph 14.56 in 
that guide, AU section 558 paragraph .08 and AU section 551 paragraph .16 
state that the auditor's reporting on unaudited RSI2 should be expanded if (a) 
the information that GAAP requires to be presented in the circumstances is 
omitted; (b) the auditor has concluded that the measurement or presentation 
of the information departs materially from prescribed guidelines; (c) the audi­
tor is unable to complete the prescribed procedures; or (d ) the auditor is unable 
to remove substantial doubts about whether the information conforms to pre­
scribed guidelines. AU section 558 paragraph .08 provides example language 
for explanatory paragraphs that, except for an explanatory paragraph because 
all RSI is omitted, include a disclaimer on the information.
12.11 When an auditor-submitted document contains unaudited RSI, AU 
section 551 provides requirements and guidance for the auditor to report 
whether the information is stated fairly in all material respects in relation 
to the basic financial statements taken as a whole or disclaim such an opinion. 
In addition, AU section 550 paragraph .07 and AU section 558 paragraph .09 
permit auditors to report on unaudited RSI that accompanies financial state­
ments in client-prepared documents using the guidance in AU section 551. AU 
section 551 paragraphs .12-.14 provide example language for the auditor's re­
port. See paragraph 14.60 in the Audit and Accounting Guide State and Local 
Governments.
Special Reports
12.12 If a health care organization is required to follow reporting require­
ments of a regulatory agency, to report under a cash receipts and disbursements
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2 Unaudited required supplementary information (RSI) is information that accompanies the basic 
financial statements on which the auditor is not engaged to express an opinion whether it is fairly 
presented in conformity with generally accepted accounting principles. Unless the auditor is engaged 
to audit the RSI, this section of this guide and the Audit and Accounting Guide State and Local 
Governments refer to the information as unaudited even though generally accepted auditing standards 
require the auditor to perform specific procedures and perhaps to report on the information. See 
footnote 19 to paragraph 14.54 in the Audit and Accounting Guide State and Local Governments.
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basis of accounting, or to report on another comprehensive basis of account­
ing other than GAAP, AU section 623, Special Reports (AICPA, Professional 
Standards, vol. 1), provides requirements and guidance. AU section 623 also 
provides reporting guidance when reporting on specified elements, accounts, or 
items of a financial statement; compliance with aspects of contractual agree­
ments or regulatory requirements related to audited financial statements; fi­
nancial presentations to comply with contractual agreements or regulatory pro­
visions; and financial information presented in prescribed forms (see exhibit 
12-4). Accountants' reports on regulatory basis financial statements generally 
are prescribed by professional standards as restricted-use reports as described 
in AU section 532, Restricting the Use o f  an Auditor's Report (AICPA, Profes­
sional Standards, vol. 1). Where obligated group financial statements exclude 
entities that are required under GAAP to be consolidated in order to comply 
with loan agreements, the accountants' report should restrict the use to spec­
ified parties (see exhibit 12-4).3 Use should be restricted to the company and 
other parties to the agreement. Health care providers that receive federal fi­
nancial assistance should also refer to the Audit Guide Government Auditing 
Standards and Circular A -133 Audits.
Independent Auditor's Reports
3 Obligated group is a term used to denote a group of entities, sometimes a parent corporation 
and several of its subsidiaries, that is liable for the repayment of obligations, such as tax-exempt 
bonds.
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Unqualified Opinion—Comparative Financial Statements 
Independent Auditor's Report
To the Board of Trustees
XYZ Health Care Organization
We have audited the accompanying balance sheets of XYZ Health Care Or­
ganization as of September 30, 20X2, and 20X1, and the related statements 
of operations, changes in net assets, and cash flows for the years then ended. 
These financial statements are the responsibility of XYZ Health Care Orga­
nization's management. Our responsibility is to express an opinion on these 
financial statements based on our audits.
We conducted our audits in accordance with auditing standards generally ac­
cepted in the United States of America. These standards require that we plan 
and perform the audit to obtain reasonable assurance about whether the finan­
cial statements are free of material misstatement. [Optional: An audit includes 
consideration o f internal control over financial reporting as a basis for designing 
audit procedures that are appropriate in the circumstances, but not for the pur­
pose o f expressing an opinion on the effectiveness o f  XYZ's internal control over 
financial reporting. Accordingly, we express no such opinion.]4 An audit includes 
examining, on a test basis, evidence supporting the amounts and disclosures 
in the financial statements. An audit also includes assessing the accounting 
principles used and significant estimates made by management, as well as 
evaluating the overall financial statement presentation. We believe that our 
audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all 
material respects, the financial position of XYZ Health Care Organization as of 
September 30 , 20X2, and 20X1, and the results of its operations, changes in net 
assets, and cash flows for the years then ended in conformity with accounting 
principles generally accepted in the United States of America.
[Signature]
[Date]
Exhibit 12-1
4 This optional wording may be added to reports on the financial statement audits of health care 
organizations in accordance with Auditing Interpretation No. 17, "Clarification in the Audit Report 
of the Extent of Testing of Internal Control Over Financial Reporting in Accordance With Generally 
Accepted Auditing Standards," of AU section 508 (AICPA, Professional Standards, vol. 1, AU sec. 9508 
par. .85-.88), which provides reporting guidance for audits of nonissuers. This wording may be added 
even in a report on the financial statements in an audit conducted in accordance with Government 
Auditing Standards or U.S. Office of Management and Budget Circular A-133, Audits of States, Local 
Governments, and Non-Profit Organizations, in which the auditor reports on internal control over 
financial reporting but does not express an opinion on that internal control. See the AICPA Audit 
Guide Government Auditing Standards and Circular A-133 Audits. Auditing Interpretation No. 17 
addresses how auditors may expand this report to explain that their consideration of internal control 
was sufficient to provide the auditor sufficient understanding to plan the audit and determine the 
nature, timing and extent of tests to be performed, but was not sufficient to express an opinion on the 
effectiveness of the internal control. If this optional wording is added, the remainder of the paragraph 
should read as follows:
An audit also includes examining, on a test basis, evidence supporting the amounts and dis­
closures in the financial statements, assessing the accounting principles used and significant 
estimates made by management, as well as evaluating the overall financial statement presen­
tation. We believe that our audit provides a reasonable basis for our opinion.
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Exhibit 12-2
Qualified Opinion—Scope Limitation 
Independent Auditor's Report
To the Board of Trustees
XYZ Health Care Organization
[Include same first paragraph as the standard report—see exhibit 12-1]
Except as discussed in the following paragraph, we conducted our audits in 
accordance with auditing standards generally accepted in the United States 
o f America. Those standards require that we plan and perform the audit to 
obtain reasonable assurance about whether the financial statements are free of 
material misstatement. An audit includes examining, on a test basis, evidence 
supporting the amounts and disclosures in the financial statements. An audit 
also includes assessing the accounting principles used and significant estimates 
made by management, as well as evaluating the overall financial statement 
presentation. We believe that our audits provide a reasonable basis for our 
opinion.
We were unable to obtain audited financial statements supporting XYZ's invest­
ment in an affiliate stated at $XXX,XXX and $XXX,XXX at September 30, 20X2, 
and 20X1, respectively, or its equity in earnings of that affiliate of $XXX,XXX 
and $XXX,XXX, which is included in the statement of operations for the years 
then ended as described in Note X to the financial statements; nor were we able 
to satisfy ourselves as to the carrying value of the investment in the affiliate or 
the equity in its earnings by other auditing procedures.
In our opinion, except for the effects of such adjustments, if any, as might have 
been determined to be necessary had we been able to examine evidence regard­
ing the affiliate investment and earnings, the financial statements referred to 
in the first paragraph present fairly, in all material respects, the financial po­
sition of XYZ Health Care Organization as of September 30, 20X2, and 20X1, 
and the results of its operations, changes in net assets, and cash flows for the 
years then ended in conformity with accounting principles generally accepted 
in the United States of America.
[Signature]
[Date]
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Qualified Opinion—Departure From Generally Accepted Accounting 
Principles That Have a Material Effect on the Financial Statements 
Independent Auditor's Report
To the Board of Trustees
XYZ Health Care Organization
[Include same first and second paragraphs as the 
standard report—see exhibit 12-1]
XYZ Health Care Organization has excluded, from property and debt in the 
accompanying balance sheets, certain lease obligations that, in our opinion, 
should be capitalized to conform with accounting principles generally accepted 
in the United States of America. If these lease obligations were capitalized, 
property would be increased by $XXX,XXX and $XXX,XXX, long-term debt 
would be increased by $XXX,XXX and $XXX,XXX, and unrestricted net assets 
would be increased by $XXX,XXX and $XXX,XXX as of September 30, 20X2, 
and 20X1, respectively. In addition, earnings would be increased by $XXX,XXX 
and $XXX,XXX, respectively, for the years then ended.
In our opinion, except for the effects of not capitalizing certain lease obligations 
as discussed in the preceding paragraph, the financial statements referred to in 
the first paragraph present fairly, in all material respects, the financial position 
of XYZ Health Care Organization as of September 30 , 20X2, and 20X1, and the 
results of its operations, changes in net assets, and cash flows for the years 
then ended in conformity with accounting principles generally accepted in the 
United States of America.
[Signature]
[Date]
Exhibit 12-3
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Report on Financial Statements Prepared Pursuant to a Master Trust 
Indenture That Results in a Presentation Not in Conformity With 
Generally Accepted Accounting Principles or Other Comprehensive 
Basis of Accounting 
Independent Auditor's Report
To the Board of Directors
Sample Health Care Corporation
We have audited the accompanying special-purpose combined balance sheets 
of the Obligated Group (as defined in the Master Trust Indenture dated De­
cember X, 20X0, between Sample Health Care Corporation and Any Bank as 
Trustee) of Sample Health Care Corporation and Affiliates as of December 31, 
20X2, and 20X1, and the related special-purpose combined statements of oper­
ations, changes in net assets, and cash flows for the years then ended. These 
financial statements are the responsibility of management. Our responsibility 
is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with auditing standards generally ac­
cepted in the United States of America. Those standards require that we plan 
and perform the audit to obtain reasonable assurance about whether the fi­
nancial statements are free of material misstatement. An audit includes exam­
ining, on a test basis, evidence supporting the amounts and disclosures in the 
financial statements. An audit also includes assessing the accounting principles 
used and significant estimates made by management, as well as evaluating the 
overall financial statement presentation. We believe that our audits provide a 
reasonable basis for our opinion.
As described in Note 1, these special-purpose financial statements were pre­
pared in accordance with the accounting requirements set forth in the Master 
Trust Indenture and are not intended to be a presentation in conformity with 
generally accepted accounting principles.
In our opinion, the special-purpose financial statements of the Obligated Group 
as of and for the years ended December 31, 20X2, and 20X1, are fairly presented, 
in all material respects, on the basis of accounting described in Note 1.
This report is intended solely for the information and use of the board of direc­
tors and management of Sample Health Care Corporation, the Trustee under 
the Master Trust Indenture, and bondholders, and is not intended to be and 
should not be used by anyone other than these specified parties.
[Signature]
[Date]
Exhibit 12-4
AAG-HCO 12.12
196
Corporate Compliance Programs
12.13 Statement of Position (SOP) 99-1, Guidance to Practitioners in Con­
ducting and Reporting on an Agreed-Upon Procedures Engagement to Assist 
Management in Evaluating the Effectiveness o f Its Corporate Compliance Pro­
gram (AICPA, Technical Practice Aids, AUD sec. 14,350), provides guidance 
to practitioners in conducting and reporting on an agreed-upon procedures 
engagement performed pursuant to the AICPA Statements on Standards for 
Attestation Engagements to assist a health care provider in evaluating the 
effectiveness of its corporate compliance program consistent with the require­
ments of a Corporate Integrity Agreement entered into with the Office of the 
Inspector General of the U.S. Department of Health and Human Services. SOP 
99-1 is included as appendix D to this guide.
Health Care Organizations
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Chapter 13
Financial Accounting and Reporting by 
Providers of Prepaid Health Care Services
Overview
13.01 This chapter provides guidance on applying generally accepted ac­
counting principles to providers of prepaid health care services for the account­
ing and reporting of health care costs, contract losses (premium deficiencies), 
stop-loss insurance (reinsurance), and contract acquisition costs.
Accounting for Health Care Costs
13.02 Health care costs should be accrued as services are rendered, in­
cluding estimates of the costs of services rendered but not yet reported. Fur­
thermore, if a provider of prepaid health care services is obligated to render 
services to specific members beyond the premium period due to provisions in 
the contract or regulatory requirements, the costs of such services to be incurred 
also should be accrued currently. Costs that will be incurred after a contract is 
terminated, such as guaranteed salaries, rent, and depreciation, net of any an­
ticipated revenues, should be accrued when it is determined that a contract with 
a sponsoring employer or other group will be terminated. Financial Accounting 
Standards Board (FASB) Statement No. 146, Accounting for Costs Associated 
with Exit or Disposal Activities, provides accounting and reporting guidance for 
certain contract termination costs associated with an exit or disposal activity.1
13.03 Amounts payable to hospitals, physicians, or other health care 
providers under risk-retention, bonus, or similar programs should be accrued 
during the contract period based on relevant factors, such as experience to date.
13.04 The basis for accruing health care costs and significant business 
and contractual arrangements with hospitals, physicians, or other associated 
entities should be disclosed in the notes to the financial statements.
Accounting for Loss Contracts
13.05 A prepaid health care provider enters into contracts to provide mem­
bers with specified health care services for specified periods in return for fixed 
periodic premiums. The premium revenue is expected to cover health care costs 
and other costs over the terms of the contracts. Only in unusual circumstances 
would a provider be able to increase premiums on contracts in force to cover 
expected losses. A provider may be able to control or reduce future health care 
delivery costs to avoid anticipated losses, but the ability to avoid losses under 
existing contracts may be difficult to measure or to demonstrate. Associated 
entities such as hospitals, medical groups, and individual practice associations 
may enter into similar contracts with prepaid health care providers in which
1 Governmental health care entities only. This pronouncement is not applicable to governmental 
health care entities that do not apply paragraph 7 of Governmental Accounting Standards Board 
(GASB) Statement No. 20, Accounting and Financial Reporting for Proprietary Funds and Other 
Governmental Entities That Use Proprietary Fund Accounting. (See chapter 1 footnote 1.)
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they agree to deliver identified health care services to the providers' members 
for specified periods in return for fixed fees.
13.06 FASB Statement No. 5, Accounting for Contingencies, states that a 
loss should be accrued in financial statements when it is probable that a loss 
has been incurred and the amount of the loss can be reasonably estimated. Ac­
cordingly, losses should be recognized when it is probable that expected future 
health care costs and maintenance costs under a group of existing contracts 
will exceed anticipated future premiums and stop-loss insurance recoveries on 
those contracts. The estimated future health care costs and maintenance costs 
to be considered in determining whether a loss has been incurred should in­
clude fixed and variable, direct and allocable indirect costs. Contracts should 
be grouped in a manner consistent with the provider's method of establishing 
premium rates, for example, by community rating practices, geographical area, 
or statutory requirements, to determine whether a loss has been incurred.
Health Care Organizations
Accounting for Stop-Loss Insurance
13.07 In stop-loss insurance, prepaid health care providers or associated 
entities transfer portions of their financial risks to other companies. A provider 
typically contracts to recover health care costs in excess of stated amounts 
during the contract periods.
13.08 Stop-loss insurance premiums should be included in reported health 
care costs. Stop-loss insurance recoveries should be reported as reductions of 
related health care costs. Receivables representing amounts recoverable from 
insurers should be reported as assets, reduced by appropriate valuation al­
lowances. In addition, the nature, amounts, and effects of significant stop-loss 
insurance contracts should be disclosed.
13.09 Governmental health care entities only. For governmental health 
care entities, Governmental Accounting Standards Board Statement No. 42, 
Accounting and Financial Reporting for Impairment o f Capital Assets and for 
Insurance Recoveries, provides accounting guidance for insurance recoveries.
Accounting for Contract Acquisition Costs
13.10 Many prepaid health care providers incur costs that vary with, and 
are primarily related to, the marketing of subscriber contracts and member en­
rollment. These costs, sometimes referred to as acquisition costs, consist mainly 
of commissions paid to agents or brokers and incentive compensation based on 
new enrollments. Commissions and incentive compensation may be paid when 
the contracts are written, at later dates, or over the terms of the contracts as 
premiums are received. Some providers incur additional costs directly related 
to the acquisition of specific contracts, such as the costs of specialized brochures, 
marketing, and advertising. Providers also incur costs that are related to the 
acquisition of new members but that do not relate to specific contracts and are 
not considered acquisition costs. These costs include salaries of the marketing 
director and staff, general marketing brochures, and general advertising and 
promotion expenses.
13.11 Although there is theoretical support for deferring certain acquisi­
tion costs, acquisition costs of providers of prepaid health care services—other
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than costs of advertising—should be expensed as incurred.2 Advertising costs 
should be accounted for in conformity with the guidance in Statement of Po­
sition 93-7, Reporting on Advertising Costs (AICPA, Technical Practice Aids, 
ACC sec. 10,590).3
Prepaid Health Care Services
  2 In accordance with existing practice, as mandated by Statement of Position (SOP) 89-5, Fi­
nancial Accounting and Reporting by Providers of Prepaid Health Care Services. Although SOP 89-5 
has been superseded with the issuance of this Audit and Accounting Guide, its provisions have been 
adopted in this chapter.
3 Governmental health care entities only. This pronouncement is not applicable to governmental 
health care enterprises that do not apply paragraph 7 of GASB Statement No. 20. (See chapter 1 
footnote 1.)
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Chapter 14
Financial Accounting and Reporting by 
Continuing Care Retirement Communities 
Overview
14.01 This chapter provides guidance on applying generally accepted 
accounting principles (GAAP) to continuing care retirement communities 
(CCRCs) for refundable and nonrefundable advance fees, for obligations to pro­
vide future services and the use of facilities to current residents, and for the 
costs of acquiring initial care contracts.1
14.02 The United States has over 1,000 CCRCs. Most CCRCs are operated 
by not-for-profit organizations, and many are affiliated with religious organi­
zations.
14.03 CCRC facilities may be independent or they may be affiliated with 
other health care facilities. They usually provide less intensive care than do 
hospitals. They generally supply required continuous nursing service or appro­
priate assistance to residents who have a wide range of medical conditions and 
needs.
14.04 Some states regulate CCRCs, although most states currently do not. 
There is, however, a growing trend toward regulation in this rapidly develop­
ing industry. States that do require some form of regulation specify that the 
CCRCs be certified by a state authority, such as a department o f insurance or 
a department of social services. In addition, some states mandate that escrow 
or reserve funds be maintained for the protection of residents.
Types of Contracts
14.05 CCRCs use three basic types of contracts. They include all-inclusive 
(type A), modified (type B), and fee-for-service (type C) contracts.
Type A Contracts
14.06 An all-inclusive continuing-care contract includes residential facil­
ities, meals, and other amenities. It also provides long term nursing care for 
little or no increase in periodic fees, except to cover normal operating costs and 
inflation.
Type B Contracts
14.07 A modified continuing-care contract also includes residential facili­
ties, meals, and other amenities. However, only a specified amount of long term 
nursing care is provided for little or no increase in periodic fees, except to cover
1 Governmental health care entities only. The provisions of this chapter do not apply to gov­
ernmental health care enterprises, unless the entity has elected to follow all Financial Accounting 
Standards Board (FASB) pronouncements under paragraph 7 of Governmental Accounting Standards 
Board (GASB) Statement No. 20, Accounting and Financial Reporting for Proprietary Funds and Other 
Governmental Entities That Use Proprietary Fund Accounting. (See chapter 1 footnote 1.)
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normal operating costs and inflation. After the specified amount of nursing 
care is used, residents pay either a discounted rate or the full per diem rates 
for required nursing care.
Type C Contracts
14.08 A fee-for-service continuing-care contract includes residential facil­
ities, meals, and other amenities as well as emergency and infirmary nursing 
care. Access to long term nursing care is guaranteed, but it may be required at 
full per diem rates.
Health Care Organizations
Types of Living Accommodations
14.09 CCRCs offer different types of living accommodations to residents, 
such as single or shared apartment units or individual homes. They also pro­
vide a variety of amenities, including social, recreational, dining, and laundry 
services.
14.10 CCRCs may provide long term nursing-care services, either at the 
same location or, by agreement, with another facility. Residents are transferred 
to or from a nursing center as medical care is required. As the health of a 
resident declines, he or she may be transferred permanently to a nursing center.
Fees and Payment Methods
14.11 Continuing-care contracts contain a number of different approaches 
to providing delivery of services. Contract provisions, for example, may stipulate 
the amount of the advance fee, whether periodic fees will be required, and, if so, 
whether they can be adjusted. In addition, contracts generally do the following: 
detail the future services that will be provided to residents; explain how a 
resident will be charged for services; describe the CCRC's refund policies and 
the formula for calculating the amount of the refund, which may be simple or 
complex; and describe the obligations of the CCRC and the resident if a contract 
is terminated or a residential unit is reoccupied.
14.12 A CCRC may require several different payment methods for services 
and the use of facilities. Paragraphs 14.13-.19 discuss 3 of the most prevalent 
methods.
Advance Fee Only
14.13 Under this method, a resident pays an advance fee in return for 
future services and the use of facilities. Such services generally include CCRC 
housing-related services (for example, meals, laundry, housekeeping, and social 
services) and health care. These services usually are provided to the resident 
for the remainder of his or her life or until the contract is terminated. Addi­
tional periodic fees are not paid, regardless of how long a resident lives or if 
the resident requires more services than anticipated. Generally, the resident 
receives no ownership interest in the facility.
Advance Fee With Periodic Fees
14.14 Under this method, a resident pays an advance fee and periodic fees 
for services and the use of facilities. Such periodic fees may be fixed, or they
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may be subject to adjustment for increases in operating costs or inflation or for 
other economic reasons.
Periodic Fees Only
14.15 Under this method, a resident pays a fee at periodic intervals for 
services and the use of the facilities provided by the CCRC. Such fees may be 
either fixed or adjustable.
14.16 An advance fee may be met by transferring a resident's personal 
assets (which may include rights to future income) or by paying a lump sum of 
cash to the CCRC.
14.17 Advance fees received for future services may be refunded at the 
occurrence of some future event, such as death, withdrawal from the CCRC, 
termination of the contract, or reoccupancy of a residential unit. The amount 
of the refund generally is based on contractual provisions or statutory require­
ments.
14.18 Many continuing-care contracts are similar to annuity contracts. 
Under those contracts, the CCRC assumes the risks associated with (a) esti­
mating the amount of the advance fee and other fees to be paid by a resident and 
(b) determining whether such fees will be sufficient to cover the cost of provid­
ing a resident's required services and the use of facilities. For some contracts, 
residents may share the future costs without limit.
14.19 The CCRC has an obligation to provide future services for the length 
o f the contract or the life of the resident. In certain circumstances, this obliga­
tion continues regardless of whether advance fees or periodic fees are sufficient 
to meet the costs of providing services to a resident.
Accounting for Refundable Advance Fees
14.20 Payment of an advance fee generally is required before a resident 
acquires a right to reside in an apartment or residential unit for life. A portion 
of advance fees may be refundable by rescission within a legally set time period 
or if a certain future event occurs, such as the death or withdrawal of a resident 
or termination of the contract. Some refunds are paid only if a residential unit 
is reoccupied.
14.21 CCRC refund policies vary either by region or according to statutory 
requirements, but generally the amount of the refund is based on provisions 
specified in a contract. For example, some contracts require a refund of the 
advance fee, less a reasonable processing fee. Amounts refunded may be based 
on a fixed amount or percentage, an amount that declines to a fixed amount 
over time, an amount that declines to zero, or an amount based on the resale 
amount. Refunds may be contingent on vacating the unit, resale of the unit, or 
passage of a fixed period of time if the unit is not resold.
14.22 The estimated amount of advance fees that is expected to be re­
funded to current residents under the terms of the contracts should be ac­
counted for and reported as a liability. The estimated amount should be based 
on the individual facility's own experience or, if records are not available, on 
the experience of comparable facilities. The remaining amount of advance fees 
should be accounted for as deferred revenue within the liability section of the 
balance sheet. Adjustments to the estimated liability should be accounted for as
Continuing Care Retirement Communities
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deferred revenue and amortized together with nonrefundable advance fees as
discussed in paragraph 14.23. The gross amount of contractual refund obliga­
tions under existing contracts and the CCRC's refund policy should be disclosed
in the notes to the financial statements. Amounts refunded should be disclosed
in the statement of cash flows as a financing transaction.
14.23 The deferred revenue should be amortized to income over future 
periods based on the estimated life of the resident or on the contract term, if 
shorter. The period of amortization should be adjusted annually based on the 
actuarially determined, estimated, remaining life expectancy of each individ­
ual or on the joint and last survivor life expectancy of each pair of residents 
occupying the same unit. The straight-line method should be used to amortize 
deferred revenue except in certain circumstances when costs are expected to 
increase at a significantly higher rate than future revenues in the later years 
of residence. In those situations, deferred revenue may be amortized to income 
using a method that reflects the disproportionate ratio between the costs of the 
expected services and the expected revenues. The amortized amount should 
not exceed the amount available to the CCRC under state regulations, contract 
provisions, or management policy. Unamortized deferred revenue from nonre­
fundable advance fees should be recorded as revenue upon a resident's death or 
the termination of the contract. The method of amortization should be disclosed 
in the notes to the financial statements.
Accounting for Fees Refundable to Residents Only From 
Reoccupancy Proceeds of a Contract Holder's Unit
14.24 Some contracts between a CCRC and a resident stipulate that all 
or a portion of the advance fee may be refundable if the contract holder's unit 
is reoccupied by another person. The source of money for the payment is from 
the proceeds of the advance fees collected by the CCRC from the next resident 
of the reoccupied unit. The terms governing how the proceeds from the next 
resident are to be paid to the previous resident vary from contract to contract. 
In effect, the CCRC acts as if it were an agent for present and future residents.
14.25 The portion of the fees that will be paid to current residents or 
their designees, only to the extent of the proceeds of reoccupancy of a contract 
holder's unit, should be accounted for as deferred revenue, provided that legal 
and management policy and practice support the withholding of refunds un­
der this condition. Similar amounts received from new residents in excess of 
the amount to be paid to previous residents or their designees also should be 
deferred. The deferred revenue should be amortized to income over future pe­
riods based on the remaining useful life of the facility. The basis and method of 
amortization should be consistent with the method for calculating depreciation 
and should be disclosed in the notes to the financial statements.
Accounting for Nonrefundable Advance Fees
14.26 Under provisions of continuing-care contracts entered into by a 
CCRC and residents, nonrefundable advance fees represent payment for fu­
ture services and should be accounted for as deferred revenue. If a CCRC has 
sufficient historical experience and relevant statistical data about life expectan­
cies, it should consider that information when determining the remaining life of 
residents. A CCRC with insufficient historical experience or reliable actuarial
Health Care Organizations
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data may use relevant data of similar communities within that area, relevant 
national industry statistics, or other appropriate data. Nonrefundable advance 
fees should be amortized in the manner discussed in paragraph 14.23.
14.27 The application o f the conclusions in paragraphs 14.25-.26 is pre­
sented in exhibit 14-1 at the end of this chapter.
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Accounting for the Obligation to Provide Future Services 
and the Use of Facilities to Current Residents
14.28 A CCRC expects to provide services and the use of facilities to indi­
viduals over their remaining lives under continuing-care contract agreements. 
The nature and extent of such services depend on such variables as the individ­
ual's age, health, sex, and economic status upon entering the CCRC. Thus, the 
CCRC assumes a risk in estimating the cost of future services and the use of 
facilities. Although many CCRCs are allowed contractually to increase periodic 
fees, some contracts may restrict increases in periodic fees and require continu­
ing services without additional compensation. If the advance fees and periodic 
fees charged are insufficient to meet the costs of providing future services and 
the use of facilities, the CCRC has a liability to provide future services and the 
use of facilities that is equal to the estimated cost of providing future services 
and the use of facilities (defined as amounts that are expected to be incurred to 
provide services and the use of facilities to individuals over their remaining lives 
under continuing care contracts, including resident-care, dietary, health care, 
facility, interest, depreciation, and amortization costs) in excess of the related 
anticipated revenues. The liability is based on actuarial assumptions (such as 
mortality and morbidity rates), on estimates o f future costs and revenues, and 
on the specific CCRC's historical experience and statistical data.
14.29 The obligation to provide future services and the use of facilities to 
current residents should be calculated annually in order to determine whether 
a liability should be reported in the financial statements. The liability related 
to continuing-care contracts is the present value of future net cash flows, minus 
the balance o f unamortized deferred revenue, plus depreciation o f facilities to 
be charged related to the contracts, plus unamortized costs of acquiring the 
related initial continuing-care contracts, if applicable. The calculation should 
be made by grouping contracts by type, such as all contracts with a limit on 
annual increases in fees, contracts with unlimited fee increases, and so forth.
14.30 Cash inflows include revenue contractually committed to support 
the residents and inflows resulting from monthly fees including anticipated in­
creases in accordance with contract terms. This includes third-party payments, 
contractually or statutorily committed investment income from services related 
to CCRC activities, contributions pledged by donors to support CCRC activ­
ities, and the volume of deferred nonrefundable advance fees. Cash outflows 
are composed of operating expenses, including interest expense and excluding 
selling, and general and administrative expenses. Anticipated cost increases 
affecting these operating expenses should be considered in determining cash 
outflows. The expected inflation rate as well as other factors should be consid­
ered in determining the discount rate. In calculating the liability, the specific 
CCRC's historical experience or statistical data relating to the residents' life 
spans should be used. The life spans used should be the same as those used 
to amortize deferred revenue (see paragraph 14.23). For a new CCRC, either
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relevant data of similar communities in the area or relevant national industry 
statistics may be used if they are deemed to be representative.
14.31 A CCRC should disclose in its notes to the financial statements 
(1) the carrying amount of the liability to provide future services and the use 
of facilities related to continuing-care contracts that is presented at present 
value in the financial statements (if not separately disclosed in the balance 
sheet) and (2) the interest rate used to discount that liability. Also, the Financial 
Accounting Standards Board (FASB) has issued FASB Statement of Financial 
Accounting Concepts No. 7, Using Cash Flow Information and Present Value in 
Accounting Measurements. This concepts statement provides useful discussion 
of general principles governing the use of present value, and of the objective of 
present value in accounting measurements. Statements of Financial Account­
ing Concepts are not sources of established accounting principles as described 
in AU section 411, The Meaning of Present Fairly in Conformity With Generally 
Accepted Accounting Principles (AICPA, Professional Standards, vol. 1), and, 
thus, do not amend, modify, or justify a change from GAAP currently in effect.*
14.32 The application of the conclusions in paragraph 14.30 is presented 
in exhibit 14-2 at the end of this chapter.
Accounting for the Costs of Acquiring Initial
Continuing-Care Contracts
14.33 Advertising costs incurred in connection with acquiring initial 
continuing-care contracts should be accounted for in conformity with the guid­
ance in Statement of Position (SOP) 93-7, Reporting on Advertising Costs 
(AICPA, Technical Practice Aids, ACC sec. 10,590). Start-up costs should be 
expensed as incurred in accordance with SOP 98-5, Reporting on the Costs o f  
Start-Up Activities (AICPA, Technical Practice Aids, ACC sec. 10,750). However, 
costs of acquiring initial continuing-care contracts that are within the scope of 
FASB Statement No. 67, Accounting for Costs and Initial Rental Operations o f  
Real Estate Projects, should be expensed or capitalized in accordance with that 
statement. Capitalized costs should be amortized to expenses on a straight- 
line basis over the average expected remaining lives of the residents under the 
contract or the contract term, if shorter. The costs of acquiring continuing-care 
contracts after a CCRC is substantially occupied or 1 year following completion 
should be expensed when incurred.* 2
Financial Statements
14.34 A complete set of illustrative financial statements for a CCRC is 
included in appendix A.
Health Care Organizations
* See footnote * to paragraph 1.62 in this guide for information about a FASB exposure draft 
of a proposed statement that would supersede the hierarchy for nongovernmental entities currently 
presented in AU section 411, The Meaning o f Present Fairly in Conformity With Generally Accepted 
Accounting Principles (AICPA, Professional Standards, vol. 1), and an Accounting Standards Board 
exposure draft of a proposed Statement on Auditing Standard that would amend AU section 411. 
Readers should be alert to the issuance of final standards.
2 In accordance with existing practice, as amended by Statement of Position (SOP) 90-8, Finan­
cial Accounting and Reporting by Continuing Care Retirement Communities. Although SOP 90-8 is 
superseded with the issuance of this Audit and Accounting Guide, its provisions have been adopted 
in this chapter.
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14.35 The notes to the financial statements for each year presented should 
include
Continuing Care Retirement Communities
• a description of the CCRC and the nature of the related continuing- 
care contracts entered into by the CCRC.
• the statutory escrow or similar requirements.
• the refund policy of the CCRC and the general amount of refund 
obligation under the existing contracts.
• the interest rate used to discount the liability to provide future 
services.
Auditing
14.36 When auditing a CCRC, the independent auditor may need to con­
sider the examples of specific auditing objectives, selected control activities, 
and auditing procedures that are presented in exhibit 14-3 at the end of this 
chapter.
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Exhibit 14-1
Accounting for Refundable and Nonrefundable Advance Fees
Assumptions:
a. The unit is occupied for 20 years.
b. The facility has an estimated 30-year life.
c. The resident is admitted on the first day of the year indicated and 
dies on the last day of year indicated.
d. The estimated remaining life expectancy is taken from an appro­
priate actuarial table.
e. The cost of providing future services is expected to be incurred 
equally over the remaining life.
Example:
__________ Advance Fees__________
Refunded to
Year Year   Entry Nonrefundable Refundable the Previous
Admitted Dies Resident Age Total 25% 75% Occupant*
1 4 A 68 $100,000 $25,000 $75,000 —
5 8 B 82 120,000 30,000 90,000 $75,000
9 13 C 79 150,000 37,500 112,500 90,000
14 — D 80 130,000 32,500 97,500 97,500
* Per contact, the amount is limited to 75% of proceeds o f reoccupancy up to amount 
originally paid by previous occupant.
Amortization o f Advance Fees Refundable to Residents
$75,000/30 years = $2,500 per year for years 1-4
15,000/26 years = $577 additional or $3,077 per year for years 5-8
22,500/22 years = $1,023 additional or $4,100 per year for years 9 through next change
in occupancy
Amortization o f  nonrefundable advance fees:
Resident A
Unamortized
Deferred
Revenue
Estimated 
Remaining 
Life (in Years) Income
Year 1 $25,000 12.1 = $2,066
2 22,934 11.5 = 1,994
3 20,940 11.1 = 1,886
4 19,054 10.6 = 1,798
Unamortized deferred revenue 
recognized upon the death of the resident 17,256
Total $25,000
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Resident B
Unamortized
Deferred
Revenue
Estimated 
Remaining 
Life (in Years) Income
Year 5 $30,000 6.1 = $4,918
6 25,082 5.8 = 4,324
7 20,758 5.5 = 3,774
8 16,984 5.3 = 3,205
Unamortized deferred revenue 
recognized upon the death of the resident
Total
13,779
$30,000
Resident C
Unamortized
Deferred
Revenue
Estimated 
Remaining 
Life (in Years) Income
Year 9 $37,500 7.0 = $5,357
10 32,143 6.7 = 4,797
11 27,346 6.4 = 4, 273
12 23,073 6.1 = 3,783
13 19,290 5.8 = 3,324
Unamortized deferred revenue 
recognized upon the death o f the resident
Total
15,966
Unamortized Estimated
Deferred Remaining
Resident D Revenue Life (in Years) Income
Year 14 $32,500 6.7 = $4,851
15 27,649 6.4 = 4,321
16 23,328 6.1 = 3,824
17 19,504 5.8 = 3,363
18 16,141 5.5 = 2,935
19 13,206 5.3 = 2,492
20 10,714 5.1 = 2,100
Amortization continues until the death o f the resident.
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Exhibit 14-2
Accounting for the Obligation to Provide Future Services and the 
Use of Facilities to Current Residents
Assumptions:
a. All residents pay a $50,000 fee, which is refundable less 2 percent 
per month for the first 36 months. After that period, none of the fee 
is refundable. The CCRC opened on 1/1/X4. (See exhibit 14-1 for an 
illustration of how to compute refundable and deferred revenue.)
b. An additional periodic fee of $1,000 is payable monthly with a 5 
percent increase annually.
c. The unamortized (deferred) costs of acquiring related initial con­
tracts on 12/31/X6 are assumed to be $17,000.
d. The unamortized deferred revenue on 12/31/X6 is assumed to be 
$27,027.
Present value o f net cash flow on 12/31/X6:
Cash inflows:
Estimated 
Remaining Life
Estimated Cash Inflows
Resident on 12/31/X6 19X7 19X8 19X9 20X0
A 36 $12,000 $12,600 $13,230 —
B 22 12,000 10,500 — —
C 27 12,000 12,600 3,308 —
D 38 12,000 12,600 13,230 $2,315
Estimated cash inflows $48,000 $48,300 $29,768 $2,315
Cash outflows:
Estimated
Remaining Life 
(in Months) Estimated Cash Outflows
Resident on 12/31/X6 19X7 19X8 19X9 20X0
A 36 $10,000 $12,000 $15,000 —
B 22 15,000 11,000 — —
C 27 14,000 17,000 5,000 —
D 38 8,000 12,000 14,000 $ 4,000
Estimated cash outflows $47,000 $52,000 $34,000 $ 4.000
Recapitulation 19X7 19X8 19X9 20X0
Cash inflows $48,000 $48,300 $29,768 $ 2,315
Cash outflows (47,000) (52,000) (34,000) (4,000)
$ 1,000 $(3,700) $(4,232) $(1,685)
Present value of net cash flows discounted at 
10 percent .$(7,137)
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Depreciation o f facilities to be charged to current residents:
Original cost of facility
Cost of facility allocable to revenue-producing service 
areas
Cost of facility to be allocated to residents (including 
common areas)
Useful life
Annual depreciation using straight-line method 
Number of residents expected to occupy the facility 
Annual depreciation per resident
Monthly depreciation per resident
$17,000,000
$(2,000,000)
$15,000,000
40 years
$ 375,000
200
$ 1,875
$ 156
Estimated 
Remaining Life 
(in Months)
Resident on 12/31/X6 19X7 19X8 19X9 20X0
A 36 $1,875 $1,875 $1,875 __
B 22 1,875 1,560 —
C 27 1,875 1,875  468
D 38 1,875 1,875 1,875 $ 312
Yearly estimated depreciation
of facilities to be charged to
current residents $7,500 $7,185 $4,218 $ 312
Total estimated depreciation of the use of facilities to 
be charged to the current residents
Liability for providing future services and the use o f  facilities to current 
residents:
Present value of future net cash outflows $7,137
Minus: (27,027)
Unamortized deferred revenue on 12/31/X6
Plus:
Depreciation to be charged to current residents 19,215
Unamortized costs of acquiring initial
contracts—see assumption c above 17,000*
Liability for providing future services and the use
of facilities to current residents on 12/31/X6 $16,325
* These numbers are for illustrative purposes only and no inference has 
been made as to the recoverability of the $17,000.
AAG-HCO 14.36
212 Health Care Organizations
Exhibit 14-3
Auditing Considerations*
Financial Statement 
Assertions
Specific Auditing 
Objectives
Selected Control 
Activities
Auditing
Procedures
Continuing Care Retirement Communities
Existence, Liabilities Written Review the
completeness, and relating to documentation refundable fee
presentation and refundable fee is prepared for arrangements
disclosure. arrangements refundable fee regarding
are accounted 
for and reported 
properly.
arrangements. stipulations for 
repayments and 
determine that 
such
arrangements 
are classified 
and disclosed 
properly in the 
financial 
statements.
Liabilities are All liabilities are Compare the
accounted for classified, account
and reported described, and balances with
properly. disclosed 
properly in the 
financial 
statements.
Management 
monitors 
compliance with 
restrictive 
covenants.
the prior 
periods' balance 
and the 
amortization 
schedules.
Confirm any 
significant new 
obligations.
Deferred Revenue
Completeness, Deferred Procedures Test the
rights and revenue and the ensure that procedures
obligations, and obligation to amounts related to the
presentation and provide future received as recognition of
disclosure. services to, and advance fees are advance fees
the use of recognized in and determine
facilities by the proper that the
current period and that obligation to
residents of the obligation to provide future
CCRCs are provide future services and the
recognized and services and the use of facilities
reported use of facilities is properly
properly is reported. reported.
* AU section 326, Audit Evidence (AICPA, Professional Standards, vol. 1), recategorizes asser­
tions by classes of transactions, account balances, and presentation and disclosure. This exhibit will 
be revised, as necessary, to reflect the new assertion categories in a future edition of the guide.
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Financial Statement 
Assertions
Specific Auditing 
Objectives
Selected Control 
Activities
Auditing
Procedures
Long Term Obligations
Existence, Liabilities Written Review the
completeness, and relating to documentation refundable fee
presentation and refundable fee is prepared for arrangements
disclosure. arrangements 
are accounted 
for and reported 
properly.
refundable fee 
arrangements.
regarding 
stipulations for 
repayments and 
determine that 
such
arrangements 
are classified 
and disclosed 
properly in the 
financial 
statements.
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Appendix A
Illustrative Financial Statements
The following illustrative financial statements illustrate the applications of 
the reporting practices discussed in this guide. Specific types of health care or­
ganizations have been selected to illustrate a wide diversity of reporting prac­
tices. It is not intended that these illustrations represent either the only types 
of disclosure nor the only statement formats that would be appropriate. For ex­
ample, the reporting of revenue, expenses, gains, and losses vary depending on 
the relationship of the underlying transaction to the entity's operations. More 
or less detail should appear either in the financial statements or in the notes 
to the financial statements, depending on the circumstances.
Governmental health care entities are required to follow the accounting 
and reporting requirements of the Governmental Accounting Standards Board 
(GASB). GASB pronouncements may require governmental health care entities 
to present information beyond or different from that presented by not-for-profit 
and investor-owned entities. For example, GASB Statement No. 3, Deposits 
with Financial Institutions, Investments (including Repurchase Agreements), 
and Reverse Repurchase Agreements, and GASB Statement No. 40, Deposit 
and Investment Risk Disclosures, require governmental entities to make cer­
tain disclosures about the credit, interest rate and foreign currency risks of 
their investments. GASB Statement No. 27, Accounting for Pensions by State 
and Local Governmental Employers, requires certain accounting for and disclo­
sures about pension benefits provided to employees of governmental health care 
entities. GASB Statement No. 9, Reporting Cash Flows o f Proprietary and Non­
expendable Trust Funds and Governmental Entities That Use Proprietary Fund 
Accounting, requires governmental health care entities to present a statement 
of cash flows using a format that differs in some respects from that required 
by Financial Accounting Standards Board (FASB) Statement No. 95, State­
ment o f Cash Flows, and that requires the reporting of cash flow information 
on both restricted and unrestricted funds. GASB Statement No. 12, Disclo­
sure o f Information on Postemployment Benefits Other Than Pension Benefits 
by State and Local Governmental Employers, requires certain disclosures about 
other postemployment benefits (OPEB) provided to employees of governmen­
tal health care entities.* GASB Statement No. 12 also provides that govern­
mental health care entities are not required to change their recognition and 
measurement of OPEB to comply with FASB Statement No. 106, Accounting 
for Postretirement Benefits Other Than Pensions, or FASB Statement No. 112, 
Employer's Accounting for Postemployment Benefits. GASB Statement No. 34, 
Basic Financial Statements—and Management's Discussion and Analysis—for
* In 2004, the Governmental Accounting Standards Board (GASB) issued GASB Statement No. 
45, Accounting and Financial Reporting by Employers for Postemployment Benefits Other Than Pen­
sions, that supersedes GASB Statement No. 12, Disclosure o f Information on Postemployment Benefits 
Other Than Pension Benefits by State and Local Governmental Employers. GASB Statement No. 45 es­
tablishes standards for the measurement, recognition, and display of other postemployment (OPEB) 
benefit expenses and related liabilities (assets). The requirements of GASB Statement No. 45 are 
effective in 3 phases based on revenues: periods beginning after December 15, 2006 for phase 1 gov­
ernments (total annual revenues of $100 million or more); periods beginning after December 15,2007, 
for phase 2 governments (total annual revenues of $10 million or more but less than $100 million); 
and periods beginning after December 31, 2008, for phase 3 governments (total annual revenues of 
less than $10 million). Earlier application is encouraged. Conforming changes to reflect the issuance 
of GASB Statement No. 45 will be made in a future edition of this guide.
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State and Local Governments, as amended, establishes new financial reporting 
requirements for state and local governments, and amends or supersedes var­
ious existing GASB and National Council on Governmental Accounting state­
ments and interpretations.
Other GASB pronouncements may also have implications for governmental 
health care entities. For example, GASB Statement No. 13, Accounting for Op­
erating Leases with Scheduled Rent Increases (paragraph 6.13), may affect the 
accounting for and financial reporting of certain lease transactions. Discussed 
elsewhere in this Audit and Accounting Guide are GASB Statement No. 7, 
Advance Refundings Resulting in Defeasance o f  Debt (paragraph 7.21), GASB 
Statement No. 10, Accounting and Financial Reporting for Risk Financing and 
Related Insurance Issues, as amended (paragraphs 8.03, 8.22, and 8.24), GASB 
Statement No. 14, The Financial Reporting Entity (paragraph 11.03), GASB 
Statement No. 16, Accounting for Compensated Absences (paragraph 7.03), 
GASB Statement No. 20, Accounting and Financial Reporting for Proprietary 
Funds and Other Governmental Entities That Use Proprietary Fund Account­
ing (chapter 1 footnote 1), GASB Statement No. 23, Accounting and Financial 
Reporting for Refundings o f Debt Reported by Proprietary Activities (paragraph 
7.21), GASB Statement No. 28, Accounting and Financial Reporting for Secu­
rities Lending Transactions (paragraphs 4.13 and 4.28), GASB Statement No. 
29, The Use o f Not-for-Profit Accounting and Financial Reporting Principles by 
Governmental Entities (chapter 1 footnote 1), GASB Statement No. 30, Risk Fi­
nancing Omnibus (paragraph 8.03), GASB Statement No. 31, Accounting and 
Financial Reporting for Certain Investments and for External Investment Pools 
(paragraph 4.12), GASB Statement No. 33, Accounting and Financial Reporting 
for Nonexchange Transactions, as amended (paragraphs 5.21-.22, 7.06, 10.06, 
10.13, and 10.15), GASB Statement No. 39, Determining Whether Certain Or­
ganizations Are Component Units (paragraph 11.03), GASB Statement No. 40 
(paragraphs 3.05, 4.13, and 4.28), GASB Statement No. 42, Accounting and 
Financial Reporting for Impairment o f  Capital Assets and for Insurance Recov­
eries (paragraphs 6.06, 6.11, 6.17, and 13.09), GASB Statement No. 47, Account­
ing for Termination Benefits (paragraph 7.05), GASB Interpretation No. 3 Fi­
nancial Reporting for Reverse Repurchase Agreements (paragraph 4.13), GASB 
Interpretation No. 4, Accounting and Financial Reporting for Capitalization 
Contributions to Public Entity Risk Pools (paragraph 8.03), and GASB Techni­
cal Bulletin 2003-1, Disclosure Requirements for Derivatives Not Reported at 
Fair Value on the Statement o f Net Assets (paragraphs 4.28 and 5.27).
These illustrative financial statements are not intended to include items that 
should be accounted for under the requirements of FASB Statement No. 133†, 
Accounting for Derivative Instruments and Hedging Activities, as amended, and 
do not reflect the requirements of FASB Statement No. 133. FASB Statement 
No. 133, among other matters, amends the disclosure requirements for securi­
ties in FASB Statement No. 115, Accounting for Certain Investments in Debt
Health Care Organizations
† The Financial Accounting Standards Board (FASB) recently issued Statement No. 161, Disclo­
sures about Derivative Instruments and Hedging Activities—an amendment o f FASB Statement No. 
133. The statement was issued due to the significant increase in the use and complexity of deriva­
tive instruments over the past several years. FASB believes that Statement No. 133, Accounting for 
Derivatives, does not provide adequate information about how derivatives and hedging activities af­
fect an entity's financial position, income statement, and statement of cash flows. Accordingly, FASB 
Statement No. 161 increases disclosures about an entity's derivative and hedging activities in order to 
improve financial transparency. FASB Statement No. 161 is effective for financial statements issued 
for fiscal years and interim periods beginning after November 15, 2008. Early adoption is encouraged. 
FASB Statement No. 161 encourages, but does not require, comparative disclosures for earlier periods 
at initial adoption.
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and Equity Securities (see paragraph 534 of FASB Statement No. 133). Prac­
titioners should refer to FASB Statement No. 133, as amended, for guidance 
on reporting derivative instruments and hedging activities. In reporting disclo­
sures about investments in securities, investor-owned entities should comply 
primarily with the requirements of paragraphs 6 ,  17, and 19-22 of FASB State­
ment No. 115, as amended.
Other disclosure requirements for investments in securities may also be appli­
cable. For example, certain disclosures for investments that are in an unrealized 
loss position but for which other-than-temporary impairments have not been 
recognized are required by Emerging Issues Task Force (EITF) Issue No. 03- 
1, "The Meaning of Other-Than-Temporary Impairment and Its Application to 
Certain Investments," paragraphs 21-22, and for reporting periods beginning 
after December 15, 2005, by FASB Staff Position (FSP) FAS 115-1 and FAS 
124-1, "The Meaning of Other-Than Temporary Impairment and Its Applica­
tion to Certain Investments," paragraphs 17-18. (The disclosure requirements 
in EITF Issue No. 03-1 paragraphs 21-22 were carried forward to FSP FAS 
115-1 and FAS 124-1 paragraphs 17-18.) Early application of FSP FAS 115-1 
and 124-1 is permitted.
This appendix contains illustrative financial statements for the following 
types of health care organizations:
1. Not-for-profit hospital
2. Governmental hospital authority (includes illustrative manage­
ment's discussion and analysis)
3. Nursing home
4. Continuing care retirement community
5. Home health agency
6. Health maintenance organization
7. Ambulatory care organization
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A  NOT-FOR-PROFIT HOSPITAL
Sample Not-for-Profit Hospital 
Balance Sheets‡
December 3 1 , 20X7 and 20X6 
(in thousands)
20X7 20X6
Assets
Current assets:
Cash and cash equivalents $4,758 $5,877
Short term investments 15,836 10,740
Assets limited as to use 970 1,300
Patient accounts receivable, net of allowance 
for doubtful accounts of $2,500 in 20X7 and
$2,400 in 20X6 15,100 14,194
Other current assets 2,670 2,856
Total current assets 39,334 34,967
(continued)
‡ In February 2007, FASB issued Statement No. 159, The Fair Value Option for Financial As­
sets and Financial Liabilities—Including an amendment of FASB Statement No. 115, that permits 
all entities, including not-for-profit organizations, to choose to measure eligible items at fair value at 
specified election dates. Notable eligible items include recognized financial assets and financial liabil­
ities (except for those specifically prohibited), written loan commitments, and rights and obligations 
under a warranty that is not a financial instrument (because it requires or permits the insurer to 
provide goods or services rather than a cash payment) but whose terms permit the insurer to settle 
by paying a third party to provide those goods or services. Prohibited recognized financial assets and 
liabilities include
a. an investment in a subsidiary that the entity is required to consolidate.
b. an interest in a variable interest entity that the entity is required to consolidate.
c. employers' and plans' obligations (or assets representing net overfunded positions) for 
pension benefits, other postretirement benefits (including health care and life insur­
ance benefits), postemployment benefits, employee stock option and stock purchase 
plans, and certain other forms of deferred compensation arrangements, as defined by 
the applicable FASB pronouncements.
d. financial assets and financial liabilities recognized under leases as defined in FASB 
Statement No. 13, Accounting for Leases, excluding guarantees of a third-party lease 
obligation or a contingent obligation arising from a cancelled lease.
e. deposit liabilities, withdrawable on demand, of banks, savings and loan associations, 
credit unions, and other similar depository institutions.
f. financial instruments that are, in whole or in part, classified by the issuer as a compo­
nent of shareholder's equity (including temporary equity). An example is a convertible 
debt security with a noncontingent beneficial conversion feature.
Entities shall report assets and liabilities that are measured at fair value pursuant to the 
fair value option in this Statement in a manner that separates those reported fair values from the 
carrying amounts of similar assets and liabilities measured using another measurement attribute. To 
accomplish that, an entity shall either
a. present the aggregate of fair value and non-fair-value amounts in the same line item in 
the statement of financial position and parenthetically disclose the amount measured 
at fair value included in the aggregate amount, or
b. present two separate line items to display the fair value and non-fair-value carrying 
amounts.
(continued)
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Sample Not-for-Profit Hospital 
Balance Sheets
(continued)
December 3 1 , 20X7 and 20X6 
(in thousands)
20X7 20X6
Interest in net assets of Sample Hospital
Foundation|| 510 462
Assets limited as to use:
Internally designated for capital acquisition 12,000 12,500
Held by trustee 6,949 7,341
18,949 19,841
Less amount required to meet current
obligations (970) (1,300)
17,979 118,541
Long term investments 4,680 4,680
Long term investments restricted for capital
acquisition 320 520
Property and equipment, net 51,038 50,492
Other assets 1,185 908
Total assets $115,046 $110,570
(continued)
(footnote continued)
This statement shall be effective as of the beginning of each reporting entity's first fiscal 
year that begins after November 15, 2007. This statement should not be applied retrospectively 
to fiscal years beginning prior to the effective date, except as permitted in paragraph 30 for early 
adoption. At the effective date, an entity may elect the fair value option for eligible items that 
exist at that date. The entity shall report the effect of the first remeasurement to fair value as a 
cumulative-effect adjustment to the opening balance of retained earnings. Readers can find more 
information pertaining to election dates, disclosure requirements, early adoption limitations, and the 
full text of this statement on the FASB Web site at www.fasb.org.
In February 2006, the FASB issued FASB Statement No. 155, Accounting for Certain Hybrid 
Financial Instruments. Among other matters, FASB Statement No. 155 paragraph 4(c) amends para­
graph 16 of FASB Statement No. 133, Accounting for Derivative Instruments and Hedging Activities.
An entity that initially recognizes a hybrid financial instrument that under FASB Statement No. 133 
paragraph 12 would be required to be separated into a host contract and a derivative instrument 
may irrevocably elect to initially and subsequently measure that hybrid financial instrument in its 
entirety at fair value (with changes in fair value recognized in earnings). FASB Statement No. 155 
is effective for all financial instruments acquired or issued after the beginning of an entity's first 
fiscal year that begins after September 15, 2006. The fair value election in paragraph 4(c) may also 
be applied upon adoption of FASB Statement No. 155 for hybrid financial instruments that had been 
bifurcated under FASB Statement No. 133 paragraph 12 prior to the adoption of FASB Statement 
No. 155. Earlier adoption is permitted as of the beginning of an entity's fiscal year, provided the 
entity has not yet issued financial statements for any period for that fiscal year.
|| These illustrative financial statements include a presentation of an interest in the net assets 
of a financially interrelated foundation that is based on the particular fact pattern described in note 
11 to the illustrative financial statements and the following additional facts:
•  Sample Not-for-Profit Hospital can influence the financial decisions of Sample Hospital 
Foundation to such an extent that it can determine the timing and amount of distributions 
from the foundation. Thus, it is inappropriate for the hospital to imply a time restriction 
on amounts held by the foundation.
•  Contributions to the foundation are restricted by donors for property acquisitions. Those 
restrictions have been met by the hospital even though the net assets remain at the foun­
dation. Thus, the net assets related to the interest in the foundation are classified as unre­
stricted in the hospital's financial statements.
•  The hospital's policy is to report restricted revenues as unrestricted if the restriction is met 
in the same period as the revenues are recognized.
(continued)
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Sample Not-for-Profit Hospital 
Balance Sheets
(continued)
December 3 1 , 20X7 and 20X6 
(in thousands)
Health Care Organizations
20X7 20X6
Liabilities and Net Assets
Current liabilities:
Current portion of long term debt $1,470 $1,750
Accounts payable and accrued expenses 5,818 5,382
Estimated third-party payor settlements 2,143 1,942
Other current liabilities 1,969 2,114
Total current liabilities 11,400 11,188
Long term debt, net of current portion 23,144 24,014
Other liabilities 3,953 3,166
Total liabilities 38,497 38,368
Net assets:
Unrestricted 70,846 66,199
Temporarily restricted 2,115 2,470
Permanently restricted 3,588 3,533
Total net assets 76,549 72,202
Total liabilities and net assets $115,046 $110,570
See accompanying notes to financial statements.
(footnote continued)
Because the change in the interest in net assets of the foundation results from contributions restricted 
to property acquisitions, this presentation shows the change in that interest reported separately from 
the performance indicator, in the spirit of the guidance in paragraph 10.20 for contributions restricted 
to property acquisitions. Readers should be aware that FASB Statement No. 136, Transfers of Assets 
to a Not-for-Profit Organization or Charitable Trust That Raises or Holds Contributions for Others, is 
silent on this classification. The AICPA has released a group of technical practice aids (TPAs) (TIS 
sections 6400.36-6400.42) that addresses recognition of the interests in the net assets of financially 
interrelated organizations and the classification of the changes in those interests. TPAs are nonau­
thoritative and are not sources of established accounting principles as described in AU section 411, 
The Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles (AICPA, 
Professional Standards, vol. 1). See footnote*  to paragraph 1.01 in this guide for information about 
a proposed FASB statement that would move responsibility for the generally accepted accounting 
principles (GAAP) hierarchy for nongovernmental entities from AU section 411 to FASB literature, 
and a proposed AICPA Statement on Auditing Standard that would delete the GAAP hierarchy for 
nongovernmental entities from AU section 411.
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FORMAT A
Sample Not-for-Profit Hospital 
Statements of Operations 
Years Ended December 31 , 20X7 and 20X6 
(in thousands)
20X7 20X6
Unrestricted revenues, gains and other support:
Net patient service revenue $85,156 $78,942
Premium revenue 11,150 10,950
Other revenue 2,601 5,212
Net assets released from restrictions used for operations 300
Total revenues, gains and other support 99,207 95,104
Expenses:
Operating expenses 88,521 80,585
Depreciation and amortization 4,782 4,280
Interest 1,752 1,825
Provision for bad debts 1,000 1,300
Other 2,000 1,300
Total expenses 98,055 89,290
Operating income 1,152 5,814
Other income:
Investment income 3,900 3,025
Other expense:
Loss from extinguishment of debt (500)
Excess of revenues over expenses 4,552 8,839
Change in net unrealized gains and losses on other than
trading securities 300 375
Net assets released from restrictions used for purchase of
property and equipment 200
Change in interest in net assets of Sample Hospital
Foundation| 283 536
Transfers to parent (688) (3,051)
Increase in unrestricted net assets $4,647 $6,699
See accompanying notes to financial statements.
|| See footnote || in "Illustrative Financial Statements for a Not-for-Profit Hospital."
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FORMAT B
Sample Not-for-Profit Hospital 
Statements of Operations 
Years Ended December 31, 20X7 and 20X6 
(in thousands)
20X7 20X6
Unrestricted revenues, gains and other support:
Net patient service revenue $85,156 $78,942
Premium revenue 11,150 10,950
Other, primarily investment income 6,501 8,237
Net assets released from restrictions used for operations 300
Total revenues, gains and other support 103,107 98,129
Expenses:
Salaries and benefits 53,900 49,938
Medical supplies and drugs 26,532 22,121
Insurance 8,089 8,526
Depreciation and amortization 4,782 4,280
Interest 1,752 1,825
Allowance for bad debts 1,000 1,300
Loss from extinguishment of debt 500
Other 2,000 1,300
Total expenses 98,555 89,290
Excess of revenues, gains, and other support over expenses 4,552 8,839
Change in net unrealized gains and losses on other than
trading securities 300 375
Net assets released from restrictions used for purchase of
property and equipment 200 —
Change in interest in net assets of Sample Hospital
Foundation|| 283 536
Transfers to parent (688) (3,051)
Increase in unrestricted net assets $4,647 $6,699
See accompanying notes to financial statements.
|| See footnote || in "Illustrative Financial Statements for a Not-for-Profit Hospital."
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Sample Not-for-Profit Hospital 
Statements of Changes in Net Assets
Years Ended December 31, 20X7 and 20X6 
(in thousands)
20X7
Unrestricted net assets:
Excess of revenues over expenses $4,552
Net unrealized gains on investments, other than trading 
securities 300
Change in interest in net assets of Sample Hospital
Foundation || 283
Transfer to parent (688)
Net assets released from restrictions used for purchase 
of property and equipment 200
Increase in unrestricted net assets 4,647
Temporarily restricted net assets:
Contributions for charity care 140
Net realized and unrealized gains on investments 5
Net assets released from restrictions   (500)
Increase (decrease) in temporarily restricted net assets (355) 
Permanently restricted net assets:
Contributions for endowment funds 50
Net realized and unrealized gains on investments 5
Increase in permanently restricted net assets 55
Increase in net assets 4,347
Net assets, beginning of year 72,202
Net assets, end of year $76,549
20X6
$8,839
375
536
(3,051)
6,699
996
8
1,004
411
2
413
8,116
64,086
$72,202
See accompanying notes to financial statements.
 || See footnote  || in "Illustrative Financial Statements for a Not-for-Profit Hospital."
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Sample Not-for-Profit Hospital 
Statements of Cash Flows (Indirect Method)
Years Ended December 31, 20X7 and 20X6 
(in thousands)
Health Care Organizations
20X7 20X6
Cash flows from operating activities:
Change in net assets $ 4,347 $8,116
Adjustments to reconcile change in net assets to net cash
provided by operating activities:
Loss from extinguishment of debt 500
Depreciation and amortization 4,782 4,280
Net realized and unrealized gains on investments, other (450) (575)
than trading
Undistributed portion of change in interest in net assets
of Sample Hospital Foundation (48) (51)
Transfers to parent 688 3,051
Allowance for bad debts 1,000 1,300
Restricted contributions and investment income (290) (413)
received
(Increase) decrease in:
Patient accounts receivable (1,906) (2,036)
Trading securities 215
Other current assets 186 (2,481)
Other assets (277) (190)
Increase (decrease) in:
Accounts payable and accrued expenses 436 679
Estimated third-party payor settlements 201 305
Other current liabilities (145) (257)
Other liabilities 787 £128)
Net cash provided by operating activities 10,026 11,600
Cash flows from investing activities:
Proceeds from sale of investments 45,100 50,650
Purchase of investments (48,869) (52,800)
Capital expenditures (4,728) (5,860)
Net cash used in investing activities (8,497) (8,010)
Cash flows from financing activities:
Transfer to parent (688) (3,051)
Proceeds from restricted contributions and restricted
investment income 290 413
Payments on long term debt (24,700) (804)
Payments on capital lease obligations (150) (100)
Proceeds from issuance of long term debt 22,600 500
Net cash used in financing activities (2,648) (3,042)
Net (decrease) increase in cash and cash equivalents (1,119) 548
Cash and cash equivalents, beginning of year 5,877 5,329
Cash and cash equivalents, end of year $ 4,758 $5,877
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Sample Not-for-Profit Hospital 
Statements of Cash Flows (Indirect Method)
(continued)
Years Ended December 3 1 , 20X7 and 20X6 
(in thousands)
Supplemental disclosures of cash flow information:
The hospital entered into capital lease obligations in the amount of $600,000 
for new equipment in 20X7.
Cash paid for interest (net of amount capitalized) in 20X7 and 20X6 was 
$1,780,000 and $1,856,000, respectively.
See accompanying notes to financial statements.
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Sample Not-for-Profit Hospital 
Notes to Financial Statements#
December 31, 20X7 and 20X6
1. Description of Organization and Summary of Significant Account­
ing Policies1
Organization. The Sample Not-for-Profit Hospital (the hospital), located in 
Tulsa, Oklahoma, is a not-for-profit acute care hospital. The hospital provides 
inpatient, outpatient and emergency care services for residents of northeastern 
Oklahoma. Admitting physicians are primarily practitioners in the local area. 
The hospital was incorporated in Oklahoma in 20X1 and is affiliated with the 
Sample Health System.
Use o f  estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabilities 
and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates. *
Health Care Organizations
# In September 2006, the FASB issued FASB Statement No. 157, Fair Value Measurements, which 
defines fair value, establishes a framework for measuring fair value in GAAP, and expands disclosures 
about fair value measurements. This statement applies under other accounting pronouncements that 
require or permit fair value measurements, the FASB having previously concluded in those accounting 
pronouncements that fair value is the relevant measurement attribute. Accordingly, this statement 
does not require any new fair value measurements, but the application of it will change current 
practice.
The statement retains the exchange price notion already established within GAAP but clarifies, 
among other matters, that fair value is the price that would be received to sell the asset or paid to 
transfer the liability (for example, an exit price) and not the price that would be paid to acquire the 
asset or paid to transfer the liability (for example, an entry price). Additionally, the statement estab­
lishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair 
value into 3 broad levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical 
assets or liabilities that the reporting entity has the ability to access at the measurement date and 
shall be used to measure fair value when available, with limited exceptions. Level 2 inputs are inputs 
other than quoted prices included within level 1 that are observable for the asset or liability, either 
directly or indirectly, and may include, for example, quoted prices for similar assets or liabilities in 
active markets. Level 3 inputs are unobservable inputs for the asset or liability. Unobservable inputs 
shall be used to measure fair value to the extent that observable inputs are not available, thereby 
allowing for situations in which there is little, if any, market activity. Unobservable inputs shall be 
developed based on the best information available in the circumstances, which might include the re­
porting entity's own data.
The guidance in this statement expands disclosures about the use of fair value to measure assets 
and liabilities in interim and annual periods subsequent to initial recognition. The disclosures focus 
on the fair value hierarchy and the effect of the measurements on earnings (or changes in net assets) 
for the period. This statement encourages entities to combine the fair value information disclosed un­
der this statement with the fair value information disclosed under other accounting pronouncements, 
including FASB Statement No. 107, Disclosures about Fair Value of Financial Instruments, where 
practicable.
This statement is effective for financial statements issued for fiscal years beginning after Novem­
ber 15, 2007 and interim periods within those fiscal years. Earlier application is encouraged, provided 
that the reporting entity has not yet issued financial statements for that fiscal year, including financial 
statements for an interim period within that fiscal year. The provisions of this statement should be 
applied prospectively as of the beginning of the fiscal year in which this statement is initially applied, 
except in limited circumstances as discussed in the statement. Readers should refer to the FASB Web 
site at www.fasb.org for more information.
1 Paragraph 13 of Statement of Position (SOP) 01-6, Accounting by Certain Entities (Including 
Entities With Trade Receivables) That Lend to or Finance the Activities of Others (AICPA, Technical 
Practice Aids, ACC sec. 10,850), provides guidance on disclosures that should be included in the 
summary of significant accounting policies, including accounting policies for loans, trade receivables, 
and doubtful accounts.
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Cash and cash equivalents. Cash and cash equivalents include certain in­
vestments in highly liquid debt instruments with original maturities of three 
months or less.
The hospital routinely invests its surplus operating funds in money market 
mutual funds. These funds generally invest in highly liquid U.S. government 
and agency obligations.
Investments. Investments in equity securities with readily determinable fair 
values and all investments in debt securities are measured at fair value in the 
balance sheet. Investment income or loss (including realized gains and losses 
on investments, interest and dividends) is included in the excess of revenues 
over expenses unless the income or loss is restricted by donor or law. Unrealized 
gains and losses on investments are excluded from the excess of revenues over 
expenses unless the investments are trading securities.
Assets limited as to use. Assets limited as to use primarily include assets held 
by trustees under indenture agreements and designated assets set aside by the 
board of trustees for future capital improvements, over which the board retains 
control and may at its discretion subsequently use for other purposes. Amounts 
required to meet current liabilities of the hospital have been reclassified in the 
balance sheet at December 31, 20X7 and 20X6.
Property and equipment. Property and equipment acquisitions are recorded 
at cost. Depreciation is provided over the estimated useful life of each class of 
depreciable asset and is computed using the straight-line method. Equipment 
under capital lease obligations is amortized on the straight-line method over 
the shorter period of the lease term or the estimated useful life o f the equip­
ment. Such amortization is included in depreciation and amortization in the 
financial statements. Interest cost incurred on borrowed funds during the pe­
riod of construction of capital assets is capitalized as a component of the cost of 
acquiring those assets.
Gifts of long-lived assets such as land, buildings, or equipment are reported 
as unrestricted support, and are excluded from the excess o f revenues over 
expenses, unless explicit donor stipulations specify how the donated assets must 
be used. Gifts of long-lived assets with explicit restrictions that specify how the 
assets are to be used and gifts o f cash or other assets that must be used to 
acquire long-lived assets are reported as restricted support. Absent explicit 
donor stipulations about how long those long-lived assets must be maintained, 
expirations o f donor restrictions are reported when the donated or acquired 
long-lived assets are placed in service.
Temporarily and permanently restricted net assets. Temporarily restricted net 
assets are those whose use by the hospital has been limited by donors to a 
specific time period or purpose. Permanently restricted net assets have been 
restricted by donors to be maintained by the hospital in perpetuity.
Excess o f  revenues over expenses. The statement o f operations includes ex­
cess o f revenues over expenses. Changes in unrestricted net assets which are 
excluded from excess o f revenues over expenses, consistent with industry prac­
tice, include unrealized gains and losses on investments other than trading 
securities, permanent transfers o f assets to and from affiliates for other than 
goods and services, and contributions o f long-lived assets (including assets ac­
quired using contributions which by donor restriction were to be used for the 
purposes of acquiring such assets).
Net patient service revenue. The hospital has agreements with third-party 
payors that provide for payments to the hospital at amounts different from
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its established rates. Payment arrangements include prospectively determined 
rates per discharge, reimbursed costs, discounted charges, and per diem pay­
ments. Net patient service revenue is reported at the estimated net realizable 
amounts from patients, third-party payors, and others for services rendered, in­
cluding estimated retroactive adjustments under reimbursement agreements 
with third-party payors. Retroactive adjustments are accrued on an estimated 
basis in the period the related services are rendered and adjusted in future 
periods as final settlements are determined.
Premium revenue. The hospital has agreements with various health manage­
ment organizations (HMOs) to provide medical services to subscribing partici­
pants. Under these agreements, the hospital receives monthly capitation pay­
ments based on the number of each HMO's participants, regardless of services 
actually performed by the hospital. In addition, the HMOs make fee-for-service 
payments to the hospital for certain covered services based upon discounted fee 
schedules.
Charity care. The hospital provides care to patients who meet certain crite­
ria under its charity care policy without charge or at amounts less than its 
established rates. Because the hospital does not pursue collection of amounts 
determined to qualify as charity care, they are not reported as revenue.
Donor-restricted gifts. Unconditional promises to give cash and other assets to 
the hospital are reported at fair value at the date the promise is received. Condi­
tional promises to give and indications of intentions to give are reported at fair 
value at the date the gift is received. The gifts are reported as either temporarily 
or permanently restricted support if they are received with donor stipulations 
that limit the use of the donated assets. When a donor restriction expires, that 
is, when a stipulated time restriction ends or purpose restriction is accom­
plished, temporarily restricted net assets are reclassified as unrestricted net 
assets and reported in the statement o f operations as net assets released from 
restrictions. Donor-restricted contributions whose restrictions are met within 
the same year as received are reported as unrestricted contributions in the 
accompanying financial statements.
Estimated malpractice costs. The provision for estimated medical malpractice 
claims includes estimates of the ultimate costs for both reported claims and 
claims incurred but not reported.
Income taxes. The hospital is a not-for-profit corporation and has been rec­
ognized as tax-exempt pursuant to Section 501(c)(3) of the Internal Revenue 
Code.
2. Net Patient Service Revenue
The hospital has agreements with third-party payors that provide for pay­
ments to the hospital at amounts different from its established rates. A sum­
mary of the payment arrangements with major third-party payors follows:
• Medicare. Inpatient acute care services and outpatient services 
rendered to Medicare program beneficiaries are paid at prospec­
tively determined rates. These rates vary according to a patient 
classification system that is based on clinical, diagnostic, and other 
factors. Inpatient nonacute services and defined capital and med­
ical education costs related to Medicare beneficiaries are paid 
based on a cost reimbursement methodology. The hospital is reim­
bursed for cost reimbursable items at a tentative rate with final 
settlement determined after submission of annual cost reports by
Health Care Organizations
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the hospital and audits thereof by the Medicare fiscal intermedi­
ary. Beginning in 20X3, the hospital claimed Medicare payments 
based on an interpretation o f certain "disproportionate share" 
rules. The intermediary disagreed and declined to pay the excess 
reimbursement claimed under that interpretation. Through 1996, 
the hospital has not included the claimed excess in net patient rev­
enues pending resolution of the matter. In 20X7, the intermediary 
accepted the claims and paid the outstanding claims, including 
$950,000 applicable to 20X6 and $300,000 applicable to 20X5 and 
prior, which has been included in 20X7 net revenues.
• Medicaid. Inpatient and outpatient services rendered to Medicaid 
program beneficiaries are reimbursed under a cost reimbursement 
methodology. The hospital is reimbursed at a tentative rate with 
final settlement determined after submission of annual cost re­
ports by the hospital and audits thereof by the Medicaid fiscal 
intermediary.
Revenue from the Medicare and Medicaid programs accounted for approxi­
mately XX percent and XX percent, respectively, of the hospital's net patient 
revenue for the year ended 20X7, and XX percent and XX percent, respectively, 
of the hospital's net patient revenue, for the year ended 20X6, Laws and regu­
lations governing the Medicare and Medicaid programs are extremely complex 
and subject to interpretation. As a result, there is at least a reasonable possibil­
ity that recorded estimates will change by a material amount in the near term. 
The 20X6 net patient service revenue increased approximately $XXX due to re­
moval of allowances previously estimated that are no longer necessary as a re­
sult of final settlements and years that are no longer subject to audits, reviews, 
and investigations. The 20X7 net patient service revenue decreased approxi­
mately $XXX due to prior-year retroactive adjustments in excess of amounts 
previously estimated.
The hospital also has entered into payment agreements with certain com­
mercial insurance carriers, HMOs, and preferred provider organizations. The 
basis for payment to the hospital under these agreements includes prospec­
tively determined rates per discharge, discounts from established charges, and 
prospectively determined daily rates.
3. Investments
Assets Limited as to Use
The composition of assets limited as to use at December 31, 20X7 and 20X6, 
is set forth in the following table. Investments are stated at fair value.
20X7 20X6
Internally designated for capital acquisition: 
Cash
U.S. Treasury obligations 
Interest receivable
$ 545,000 $ 350,000
11,435,000 12,115,000
Held by trustee under indenture agreement: 
Cash and short term investments 
U.S. Treasury obligation 
Interest receivable
20,000 35,000
12,000,000 12,500,000
352,000 260,000
6,505,000 7,007,000
92,000 74,000
6,949,000 7,341,000
$18,949,000 $19,841,000
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Other Investments
Other investments, stated at fair value, at December 31, 20X7 and 20X6, 
include:
20X7 20X6
Trading:
$1,475,000U.S. Corporate Bonds $1,260,000
Other
U.S. Treasury obligations $19,266,000 $14,233,000
Interest receivable 310,000 232,000
Less:
20,836,000 15,940,000
Long term investments
Long term investments restricted for capital
4,680,000 4,680,000
acquisitions 320,000 520,000
Short term investments $15,836,000 $10,740,000
Investment income and gains for assets limited as to use, cash equivalents, 
and other investments are comprised of the following for the years ending De­
cember 31, 20X7 and 20X6:
Income:
20X7 20X6
Interest income $3,585,000 $2,725,000
Realized gains on sales of securities 150,000 200,000
Unrealized gains on trading securities 165,000 100,000
Other Changes in Unrestricted Net Assets: 
Unrealized gains on other than trading
$3,900,000 $3,025,000
securities
4. Property and Equipment
$ 300,000 $ 375.000
A summary of property and equipment at December 31, 20X7 and 20X6, fol­
lows:
20X7 20X6
Land $3,000,000 $3,000,000
Land improvements 472,000 472,000
Buildings and improvements 46,852,000 46,636,000
Equipment 29,190,000 26,260,000
Equipment under capital lease obligations 2,851,000 2,752,000
82,365,000 79,120,000
Less accumulated depreciation and amortization 34,928,000 30,661,000
47,437,000 48,459,000
Construction in progress 3,601,000 2,033,000
Property and equipment, net $51,038,000 $50,492,000
Depreciation expense for the years ended December 31, 20X7 and 20X6 
amounted to approximately $4,782,000 and $4,280,000. Accumulated amor­
tization for equipment under capital lease obligations was $689,000 and 
$453,000 at December 31 , 20X7 and 20X6, respectively. Construction contracts 
of approximately $7,885,000 exist for the remodeling of hospital facilities. At
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mated $4,625,000.
5. Long Term Debt
A summary of long term debt and capital lease obligations at December 31, 
20X7 and 20X6, follows:
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7.25 percent 20X7 Tax-Exempt Revenue Bonds, 
principal maturing in varying annual 
amounts, due November 1 , 20XX, 
collateralized by a pledge of the hospital's 
gross receipts
8.50 percent 20X2 Tax-Exempt Revenue Bonds, 
principal maturing in varying annual 
amounts, due June 1, 20XX
7.75 percent mortgage loan, principal maturing 
in varying annual amounts, due January 
20XX, collateralized by a mortgage on certain 
property and equipment
7.75 percent note payable, payable in monthly 
installments of $12,000, including interest, 
due March 20XX, unsecured
Capital lease obligations, at varying rates of 
imputed interest from 6.8 percent to 9.3 
percent collateralized by leased equipment
Less current portion
20X7
$21,479,000
2,010,000
125,000
1,000,000
24,614,000
1,470,000
$23,144,000
20X6
$22,016,000
2,127,000
671,000
950,000
25,764,000
1,750,000
$24,014,000
Under the terms of the 20X7 and 20X2 revenue bond indentures, the hospital is 
required to maintain certain deposits with a trustee. Such deposits are included 
with assets limited as to use. The revenue note indenture also places limits on 
the incurrence of additional borrowings and requires that the hospital satisfy 
certain measures of financial performance as long as the notes are outstanding.
Scheduled principal repayments on long term debt and payments on capital 
lease obligations are as follows:
Year Ending
December 31, Long Term Debt
Capital Leases 
Obligations
20X8 $ 970,000 $ 550,000
20X9 912,000 260,000
20Y0 983,000 260,000
20Y1 1,060,000 45,000
20Y2 1,143,000 —
Thereafter 18,546,000
$23,614,000
—
Less amount representing interest 
under capital leases'obligations
1,115,000
115,000
$1,000,000
AAG-HCO APP A
232
A summary of interest cost and investment income on borrowed funds held
by the trustee under the 20X7 and 20X2 revenue bond indentures during the
years ended December 31, 20X7 and 20X6, follows:
Health Care Organizations
Interest cost:
Capitalized 
Charged to operations
Total
Investment income: 
Capitalized
Credited to other revenue 
Total
20X7 20X6
$ 740,000 $ 700,000
1,752,000 1,825,000
$2,492,000 $2,525,000
$ 505,000 $ 663,000
330,000 386,000
$ 835,000 $1,049,000
6. Temporarily and Permanently Restricted Net Assets
Temporarily restricted net assets are available for the following purposes or 
periods at December 31, 20X7 and 20X6:
20X7 20X6
Health care services
Purchase of equipment $ 320,000 $ 520,000
Indigent care 840,000 950,000
Health education 350,000 400,000
For periods after December 31, 20X9 605,000 600,000
$2,115,000 $2,470,000
Permanently restricted net assets at December 31, 20X7 and 20X6, are re­
stricted to:
Investments to be held in perpetuity, the income 
from which is expendable to support health care 
services (reported as operating income)
Endowment requiring income to be added to 
original gift until fund value is $1,500,000
20X7 20X6
$2,973,000 $2,923,000
615,000 610,000
$3,588,000 $3,533,000
During 20X7, net assets were released from donor restrictions by incurring 
expenses satisfying the restricted purposes of indigent care and health care 
education in the amounts of $250,000 and $50,000, respectively.
7. Medical Malpractice Claims
The hospital purchases professional and general liability insurance to cover 
medical malpractice claims. There are known claims and incidents that may 
result in the assertion of additional claims, as well as claims from unknown 
incidents that may be asserted arising from services provided to patients. The 
hospital has employed independent actuaries to estimate the ultimate costs, 
if  any, of the settlement of such claims. Accrued malpractice losses have been
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discounted at seven percent and in management's opinion provide an adequate 
reserve for loss contingencies.
On March 15, 20X7, a patient filed a suit against the hospital for malpractice 
during care received as an inpatient. The hospital believes it has meritorious 
defenses against the suit; however, the ultimate resolution of the matter could 
result in a loss. The patient has claimed $16 million in actual damages. Under 
state law, punitive damages are determined at trial. The hospital maintains in­
surance coverage for malpractice claims. The coverage does not include punitive 
damages awards. Trial is scheduled to occur within the next year.
8. Pension Plan and Other Postretirement Benefit Plans2,3
[The following two paragraphs are encouraged but not required.]
The hospital has a defined benefit pension plan covering substantially all of its 
employees. The plan benefits are based on years of service and the employees' 
compensation during the last five years of covered employment. Contributions 
are intended to provide not only for benefits attributed to service to date but 
also for those expected to be earned in the future.
The hospital also sponsors 2 defined benefit postretirement plans that cover 
both salaried and nonsalaried employees. One plan provides medical and dental 
benefits, and the other provides for the payment of life insurance premiums. 
The postretirement health care plan is contributory, with retiree contributions 
adjusted annually; the life insurance plan is noncontributory. The accounting 
for the health care plan anticipates future cost-sharing changes to the written 
plan that are consistent with the hospital's expressed intent to increase retiree 
contributions each year to 50 percent of the excess o f the expected general 
inflation rate over 6 percent. Beginning in 20X7, the hospital adopted a funding 
policy for its postretirement health care plan similar to its funding policy for its 
life insurance plan—an amount equal to a level percentage of the employees' 
salaries is contributed to the plan annually. For 20X7, that percentage was 4.25, 
and the aggregate contribution for both plans was $34,000. The hospital uses 
a December 31 measurement date for its plans.
2 The disclosures for pensions and other postretirement benefits in this note to the illustrative 
financial statements have been modified to reflect the requirements of FASB Statement No. 132, Em­
ployers' Disclosures about Pensions and Other Postretirement Benefits (revised 2003). This note to the 
financial statements illustrates the financial statement disclosures about pension and postretirement 
benefit plans for a public entity. Readers should refer to FASB Statement No. 132(R), when consider­
ing disclosure requirements for nonpublic entities.
In September 2006, FASB issued Statement No. 158, Employers' Accounting for Defined Benefit 
Pension and Other Postretirement Plans-an amendment o f FASB Statements N a 87, 88, 106, and 
132(R). An employer with publicly traded equity securities shall initially apply the requirement to 
recognize the funded status of a benefit plan and the disclosure requirements as of the end of the 
fiscal year ending after December 15, 2006. An employer without publicly traded equity securities 
shall initially apply the requirement to recognize the funded status of a benefit plan and the disclo­
sure requirements as of the end of the fiscal year ending after June 15, 2007. An employer without 
publicly traded equity securities shall provide the disclosures in paragraph 14 in the notes to the fi­
nancial statements for a fiscal year ending after December 15, 2006, but before June 16, 2007, unless 
it has applied the recognition provisions of this statement in preparing those financial statements; 
the requirement to measure plan assets and benefit obligations as of the date of the employer's fiscal 
year-end statement of financial position shall be effective for fiscal years ending after December 15, 
2008.
3 Readers may also need to consider the accounting and disclosure requirements of FASB Staff 
Position (FSP) FAS 106-2, Accounting and Disclosure Requirements Related to the Medicare Prescrip­
tion Drug, Improvement and Modernization Act o f  2003, when an employer provides postretirement 
prescription drug coverage.
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The following table sets forth the changes in benefit obligations, changes in 
plan assets, and components of net periodic benefit cost for both the pension 
plan and the other postretirement benefit plans:
Health Care Organizations
Pension Benefits Other Benefits
20X7 20X6 20X7 20X6
Change in benefit obligation: 
Benefit obligation at beginning of
year
Service cost
Interest cost
Plan participants' contributions 
Actuarial gain 
Benefits paid
Benefit obligation at end of year 
Change in plan assets:
Fair value of plan assets at 
beginning of year
Actual return on plan assets 
Employer contribution 
Plan participants' contributions 
Benefits paid
Fair value of plan assets at end of 
year
Funded status
Unrecognized net actuarial gain 
Unrecognized prior service cost 
Unrecognized transition obligation 
Unrecognized transition asset 
Prepaid (accrued) benefit cost
$9,710 $9,700 $585 $500
905 770 14 15
700 650 50 44
34 34
(20) (7)
(375) (1,410) (66) (8)
10,920 9,710 610 585
9,800 9,610 89 40
759 810 4 4
866 790 39 19
34 34
(375) (1,410) (66) (8)
11,050 9,800 100 89
130 90 (510) (496)
(30) (40) (30) (40)
50 55 16 19
445 470
(15) (20)
$135 $85 ($79) ($47)
AAG-HCO APP A
Illustrative Financial Statements 235
The accumulated benefit obligation for the defined benefit pension plan was 
$XXX and $XXX at December 31, 20X7, and 20X6, respectively.
Pension Benefits Other Benefits
20X7 20X6 20X7 20X6
Components of net periodic benefit 
cost:
Service cost $905 $770 $14 $15
Interest cost 700 650 50 44
Expected return on plan assets (784) (769) (6) (3)
Amortization of prior service cost 5 7 3 2
Recognized net actuarial (gain) (5) (2) (15) (1)
Amortization of transition  
obligation
Amortization of transition asset (5)
(1)
25 25
Net periodic benefit cost
A dditional Inform ation 
Assum ptions
$816 $655 $71 $82
W eighted-average assumptions 
used to determ ine benefit ob li­
gations at D ecem ber 31
-
Discount rate 7.00% 7.00% 7.00% 7.00%
Rate of compensation increase 
W eighted-average assumptions
6.00% 6.00%
used to determ ine net 
p eriod ic benefit cost for 
years ended D ecem ber 31
Discount rate
Expected long term return on plan
7.00% 7.00% 7.00% 7.00%
assets 8.00% 8.00% 6.60% 6.60%
Rate of compensation increase 6.00% 6.00%
(Entity specific narrative description of the basis used to determine the overall 
expected long term rate of return on assets, as described in paragraph 5(d)(3) 
o f FASB Statement No. 132, Employers' Disclosures about Pensions and Other 
Postretirement Benefits (revised 2003), would be included here.)
Assumed health care cost
trend rates at D ecem ber 31
Health care cost trend rate 
assumed for next year 7% 7%
Rate to which the cost trend 
rate is assumed to decline 5% 5%
(the ultimate trend rate)
Year that the rate reaches the  
ultimate trend rate 20Y2 20Y2
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1-Percentage- 
Point Decrease
($11)
(67)
Assumed health care cost trend rates have a significant effect on the amounts 
reported for the health care plans. A one-percentage-point change in assumed 
health care cost trend rates would have the following effects:
1-Percentage- 
Point Increase
Effect on total of service and interest cost $13
Effect on postretirement benefit obligation 73
Health Care Organizations
Plan Assets
The composition of plan assets at December 31, 20X7, and 20X6, is as follows:
Pension Benefits Other Benefits
20X7 20X6 20X7 20X6
Asset Category XX% xx% xx% x x %
Equity securities XX XX XX XX
XX XX XX XXDebt securities XX XX XX XXReal estate
Other XX XX XX XX
Total 100% 100% 100% 100%
(Entity specific narrative description of investment policies and strategies for 
plan assets, including weighted-average target asset allocations [if used as part 
of those policies and strategies] as described in paragraph 5(d)(2) of FASB State­
ment No. 132(R), would be included here.)
Cash Flows
Contributions
The hospital expects to contribute $XXX to its pension plan and $XXX to its 
other postretirement benefit plan in 20X8.
Estimated Future Benefit Payments
The following benefit payments, which reflect expected future service, as ap­
propriate, are expected to be paid:
Pension Other
Benefits Benefits
20X8 $xxx $XXX
20X9 XXX XXX
20Y0 XXX XXX
20Y1 XXX XXX
20Y2 XXX XXX
Years 20Y3-20Y7 XXX XXX
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9. Concentrations o f  Credit Risk
The hospital grants credit without collateral to its patients, most o f whom are 
local residents and are insured under third-party payor agreements. The mix 
o f receivables from patients and third-party payors at December 3 1 , 20X7 and 
20X6, was as follows:
20X7 20X6
Medicare 51% 53%
Medicaid 17 14
Blue Cross 18 17
Other third-party payors 7 9
Patients 7
100%
  7 
100%
10. Commitments and Contingencies
Operating leases. The hospital leases various equipment and facilities under 
operating leases expiring at various dates through April 20Y2. Total rental 
expense in 20X7 and 20X6 for all operating leases was approximately $859,000 
and $770,000, respectively.
The following is a schedule by year of future minimum lease payments under 
operating leases as of December 31, 20X7, that have initial or remaining lease 
terms in excess of 1 year.
Year Ending
December 31, Amount
20X8
20X9
20Y0
20Y1
20Y2
$517,000
506,000
459,000
375,000
343,000
Litigation. The hospital is involved in litigation and regulatory investigations 
arising in the course of business. After consultation with legal counsel, manage­
ment estimates that these matters will be resolved without material adverse 
effect on the hospital's future financial position or results from operations.
Allowance for doubtful accounts. Beginning in 20X5, the hospital has pro­
vided care under an agreement with Associated HMO. The HMO currently 
owes the hospital $950,000, substantially all o f which is overdue. The hospital 
has notified the HMO that further services under the contract cannot be pro­
vided without payment on the outstanding balance. The HMO has assured the 
hospital that additional funds are being obtained in order to pay the overdue 
balance and continue service under the agreement, however, if the HMO is un­
able to make payments, additional allowances for bad debts would need to be 
accrued.
11. Related Party Transactions
During the years ended December 31, 20X7 and 20X6, the hospital con­
tributed capital to Sample Health System, an affiliate with some board mem­
bers in common with the hospital, in the amounts of $688,000 and $3,051,000, 
respectively.
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The Sample Hospital Foundation (the foundation), which is controlled by Sam­
ple Health System, was established to solicit contributions from the general 
public solely for the funding of capital acquisitions by the hospital. Funds are 
distributed to the hospital as determined by the foundation's board of directors. 
A summary of the foundation's assets, liabilities, net assets, results of opera­
tions, and changes in net assets follows. The hospital's interest in the net assets 
of the foundation is reported as a noncurrent asset in the balance sheets.
Health Care Organizations
At December 31,
20X7 20X6
Assets principally cash and cash equivalents $521,000 $472,000
Liabilities 11,000 10,000
Unrestricted net assets 510,000 462,000
Total liabilities and net assets $521,000 $472,000
Support and revenue $269,000 $535,000
Expenses
Distributions to Sample Hospital for property
acquisitions 235,000 485,000
Other 13,000 16,000
Total expenses 248,000 501,000
Excess of support and revenue over expenses 21,000 34,000
Other changes in net assets 27,000 17,000
Unrestricted net assets, beginning of year 462,000 411,000
Unrestricted net assets, end of year $510,000 $462,000
Liabilities include $10,000 payable at the end of each year to Sample Hospital. 
These amounts were paid after the end of each year.
12. Functional Expenses
The hospital provides general health care services to residents within its ge­
ographic location. Expenses related to providing these services are as follows 
(in thousands):
At December 31,
20X7 20X6
Health care services $86,000 $78,647
General and administrative 12,055 10,643
$98,055 $89,290
13. Fair Value of Financial Instruments
The following methods and assumptions were used by the hospital in estimat­
ing the fair value of its financial instruments:
Cash and cash equivalents: The carrying amount reported in the bal­
ance sheet for cash and cash equivalents approximates its fair value.
Investments: Fair values, which are the amounts reported in the bal­
ance sheet, are based on quoted market prices, if available, or esti­
mated using quoted market prices for similar securities.
Assets limited as to use: These assets consist primarily of cash and 
short term investments and interest receivable. The carrying amount 
reported in the balance sheet is fair value.
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Accounts payable and accrued expenses: The carrying amount reported 
in the balance sheet for accounts payable and accrued expenses approx­
imates its fair value.
Estimated third-party payor settlements: The carrying amount re­
ported in the balance sheet for estimated third-party payor settlements 
approximates its fair value.
Long term debt: Fair values of the hospital's revenue notes are based 
on current traded value. The fair value of the hospital's remaining long 
term debt is estimated using discounted cash flow analyses, based on 
the hospital's current incremental borrowing rates for similar types of 
borrowing arrangements.
The carrying amounts and fair values of the hospital's finan­
cial instruments at December 31, 20X7 and 20X6, are as follows 
(in thousands):
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20X7 20X6
Carrying Fair Carrying Fair
Amount Value Amount Value
Cash and cash
equivalents $4,758 $4,758 $ 5,877 $5,877
Short term investments 15,836 15,836 10,740 10,740
Assets limited as to use 18,949 18,949 19,841 19,841
Long term investments 4,680 4,680 4,680 4,680
Long term investments
restricted for capital
acquisition 320 320 520 520
Accounts payable and
accrued expenses 5,818 5,818 5,382 5,382
Estimated third-party
payor settlements 2,143 2,143 1,942 1,942
Long term debt 24,614 23,980 25,764 24,918
14. Promises to Contribute
At December 31, 20X7, the hospital had received $1,500,000 of conditional 
promises to contribute to the building of a new facility for outpatient services. 
These contributions will be recorded as temporarily restricted support when 
received. The hospital had no material outstanding unconditional promises of 
support at December 31, 20X7.
15. Charity Care
The amount of charges foregone for services and supplies furnished under 
the hospital's charity care policy aggregated approximately $4,500,000 and 
$4,100,000 in 20X7 and 20X6, respectively.
16. Subsequent Event
On February 9, 20X8, the hospital signed a contract in the amount of 
$1,050,000 for the purchase of certain real estate.
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Illustrative Management's Discussion and Analysis 
and Financial Statements
Health Care Organizations
Sample Governmental Hospital Authority 
A Component Unit of Feeling County, State of Union 
Management's Discussion and Analysis
Our discussion and analysis of Sample Hospital Authority's (authority's) fi­
nancial performance provides an overview of the authority's financial activities 
for the fiscal years ended December 31, 20X7 and 20X6. Please read it in con­
junction with the authority's financial statements, which begin on page XXX. 
Unless otherwise indicated, amounts are in thousands.
Financial Highlights
• The authority's net assets increased in each of the past 2 years 
with a $4,225 or 6.6 percent increase in 20X7 and a $9,460 or 17.4 
percent increase in 20X6.
• The authority reported increased operating losses in both 20X7 
($24,403) and 20X6 ($13,365). Losses in 20X7 increased by $11,038 
or 82.6 percent over the loss reported in 20X6. Operating losses in 
20X6 increased by $4,020 or 43.0 percent.
• Nonoperating revenues increased by $7,890 or 39.6 percent in 
20X7 compared to 20X6. Nonoperating revenues also increased 
in 20X6 by $1,139 or 6 percent compared to 20X5.
Using This Annual Report
The authority's financial statements consist of three statements—a balance 
sheet; a statement of revenues, expenses, and changes in net assets; and a 
statement of cash flows. These financial statements and related notes provide 
information about the activities of the authority, including resources held by 
the authority but restricted for specific purposes by contributors, grantors, or 
enabling legislation.
The Balance Sheet and Statement of Revenues, Expenses, 
and Changes in Net Assets
Our analysis of the authority finances begins on page XXX. One of the most 
important questions asked about the authority's finances is, "Is the authority 
as a whole better or worse off as a result of the year's activities?" The balance 
sheet and the statement of revenues, expenses, and changes in net assets report 
information about the authority's resources and its activities in a way that helps 
answer this question. These statements include all restricted and unrestricted 
assets and all liabilities using the accrual basis of accounting. All of the current 
year's revenues and expenses are taken into account regardless of when cash 
is received or paid.
These two statements report the authority's net assets and changes in them. 
You can think of the authority's net assets—the difference between assets and
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liabilities—as one way to measure the authority’s financial health, or financial 
position. Over time, increases or decreases in the authority's net assets are one 
indicator of whether its financial health is improving or deteriorating. You will 
need to consider other nonfinancial factors, however, such as changes in the 
authority's patient base and measures of the quality of service it provides to 
the community, as well as local economic factors to assess the overall health of 
the authority.
The Statement of Cash Flows
The final required statement is the statement of cash flows. The statement 
reports cash receipts, cash payments, and net changes in cash resulting from 
operations, investing, and financing activities. It provides answers to such ques­
tions as "Where did cash come from?" "What was cash used for?" and "What was 
the change in cash balance during the reporting period?"
The Authority's Net Assets
The authority's net assets are the difference between its assets and liabilities 
reported in the balance sheet on page X. The authority's net assets increased 
in each of the past 2 years by $4,225 (6.6 percent) in 20X7 and $9,460 (17.4 
percent) in 20X6, as you can see from table 1.
Table 1: Assets, Liabilities, and Net Assets
20X7 20X6 20X5
Assets:
Current assets $32,382 $30,135 $26,070
Capital assets, net 43,382  42,918 42,445
Other noncurrent assets 25,118 23,494 19,767
Total assets 100.882 96.547 88.282
Liabilities
Long term liabilities 23,033 23,102 24,349
Other 9,690 9,511 9,459
Total liabilities 32.723 32.613 33.808
Net assets:
Invested in capital assets, net of 
related debt 22,460 21,018 18,649
Restricted for debt service 1,945 2,005 2,035
Restricted expendable net assets 1,845 2,100 2,075
Restricted nonexpendable net 
assets 3,003 2,919 2,652
Unrestricted 38,906 35,892 29,063
Total net assets $68,159 $63,934 $54,474
A significant component of the change in the authority's assets is the increase 
in patient accounts receivable. Although operating revenues decreased in 20X7 
by $3,445 (5.7 percent), patient accounts receivable, net of estimated uncol­
lectible amounts, increased by $3,107 or 18.6 percent in 20X7. In addition, 
patient service revenue decreased by $2,105 in 20X6 compared to 20X5, but
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receivables increased by $2,114 or 14.5 percent. In both cases, the increase in 
accounts receivable is primarily the result of overall slowdowns by health in­
surers in making payments in attempting to cut costs by managing their cash 
flows.
Operating Results and Changes in The Authority's 
Net Assets
In 20X7, the authority's net assets increased by $4,225 or 6.6 percent, as 
shown in table 2. This increase is made up of very different components. And 
it represents a decline of 55.3 percent compared with the increase in net assets 
for 20X6 of $9,460.
Health Care Organizations
Table 2: Operating Results and Changes
Operating Revenues:
Net patient service revenues 
Premium revenues 
Other operating revenues
Total operating revenues
Operating Expenses:
Salaries and benefits 
Medical supplies and drugs 
Depreciation and amortization 
Other operating expenses
Total operating expenses 
Operating loss
Nonoperating Revenues and 
Expenses
Property taxes 
Investment income 
Noncapital grants and contributions 
Other nonoperating revenues and
expenses, net.
Total nonoperating revenues 
(expenses)
Excess of revenues over 
expenses before capital grants, 
contributions, and additions to 
permanent endowments
Grants, Contributions, and 
Endowments
Capital grants and contributions 
Additions to permanent endowments
Increase in net assets
Net assets end of year
in Net Assets
20X7 20X6 20X5
$43,305 $43,736 $45,841
9,876 13,058 12,976
3,416 3,248 2,910
56,597 60,042 61,727
46,845 43,235 40,640
12,746 7,986 6,788
4,065 3,638 3,508
17,344 18,548 20,136
81,000 73,407 71,072
(24,403) (13,365) (9,345)
23,895 15,309 14,875
5,653 5,304 5,108
170 853 510
(1,914) (1,552) (1,718)
27,804 19,914 18,775
3,401 6,549 9,430
824 2,560 1,980
351
$4,225 $9,460 $11,410
$68,159 $63,934 $4,474
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Operating Losses
The first component o f the overall change in the authority's net assets is its 
operating income (loss)—generally, the difference between net patient service 
and Premium revenues and the expenses incurred to perform those services. 
In each of the past two years, the authority has reported an operating loss. 
This is consistent with the authority's entire operating history. The authority's 
hospital operations were begun in 19XX as a municipal hospital, when it was 
agreed that a portion of its costs would be subsidized by property tax revenues, 
making the facility more affordable for the County's lower income residents. 
However, in each of the past 2 years, operating losses have increased. Losses 
in 20X7 increased by $11,038 or 82.6 percent higher than the loss reported in 
20X6. Operating losses in 20X6 increased by $4,020 or 43.0 percent.
The primary components of these increased operating losses are
• a decrease in premium revenue of $3,182 or 24.4 percent in 20X7. 
(Premium revenues in 20X6 were roughly the same as in the pre­
vious year.)
• increases in salary and benefit costs for the hospital's employees 
($3,610 or 8.4 percent in 20X7 and $2,595 or 6.4 percent in 20X6).
• increases in medical supply and drug costs o f $4,760 or 59.6 per­
cent in 20X7 and of $1,198 or 17.6 percent in 20X6.
• an increase in the level of uncompensated care provided. These are 
services provided for which there is no expectation of payment.
Premium revenues from contracts with HMOs decreased in 20X7 primarily 
because of changes in the fixed amount per individual per month (capitation 
rate) paid by the Acme Health Maintenance Group. Acme is the HMO for the 
county's largest employer, the XYZ Motor Company. The authority, (with the 
assistance of the county), negotiated a new 4 year contract with Acme in 20X6. 
Those negotiations resulted in a 15 percent reduction in capitation rates in 
20X7. Under the contract, capitation rates increase by 3 percent each year for 
the next 3 years. At the same time, the authority (with the county's approval) 
agreed to increase its property tax levy by 10 percent, as discussed in the fol­
lowing paragraphs.
Employee salary and benefits costs increased in 20X6 and again in 20X7 based 
on rates established in labor contracts negotiated in 20X5 and 20X6. Current 
labor contracts for all o f the authority's unionized employees extend until 20Y1.
The rate o f health care inflation has a direct effect on the cost of services 
provided by the authority. A component of the authority's costs are expenses 
for medical supplies and prescription drugs. In 20X5, medical supplies and 
prescription drug costs totaled $6.8 million. In 20X6, they totaled $8.0 million 
or 10.7 percent of total expenses and an increase of 17.6 percent over 20X5. And, 
in 20X7, medical supplies and prescription drug costs totaled $12.7 million, 
representing 15.6 percent of total expenses and an increase of 59.6 percent 
over 20X6. Some of the major factors contributing to the increased medical 
supply and drug costs include the introduction of new drugs that cannot be 
obtained in generic form, and changes in therapeutic mix. In addition, in 20X7, 
the company that the authority used as its major wholesale drug supplier filed 
for bankruptcy. The authority negotiated new contracts with other suppliers at 
substantially higher costs. At its August 20X7 meeting, the authority's board 
of trustees authorized management to explore other supplier options.
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The authority sometimes provides care for patients who have little or no health 
insurance or other means of repayment. As discussed, this service to the com­
munity is consistent with the goals established for the authority when it was 
established in 19XX. The level of services provided to these patients increased 
by $1,200 in 20X6 compared to 20X5. In 20X7, the costs of uncompensated care 
increased by $255. Because there is no expectation of repayment, charity care 
is not reported as patient service revenues of the authority.
Nonoperating Revenues and Expenses
Nonoperating revenues consist primarily of property taxes levied by the au­
thority and interest revenue and investment earnings. During its negotiations 
with Acme and XYZ, discussed earlier, the authority agreed—with the county's 
approval—to increase its property tax levy to county residents by 10 percent. 
County voters approved this increase in November 20X6. In addition, a 35 per­
cent increase in the sales of new homes in the county in 20X6 and 20X5 as 
well as additions of new commercial and manufacturing facilities resulted in 
an increase in the county's grand list. The grand list is calculated as of July 1 
each year and used as the basis for tax levies on January 1. As a result of both 
of these factors, nonoperating tax revenues increased by $8,586 or 56.1 percent 
in 20X7 compared to a $434 (2.9 percent) increase in 20X6.
Grants, Contributions, and Endowments
The authority receives both capital and operating grants from various state 
and federal agencies for specific programs. These are discussed in detail in note 
2 to the financial statements. Capital and operating grants received in 20X7 
from the State of Union declined due to fiscal/budgetary issues at the state 
from $3,085 in 20X6 ($2,300 capital and $785 operating) to $800 in 20X7 ($650 
capital and $150 operating). Although $1,640 in grants have been budgeted by 
the state for the authority in 20X8, it is not clear whether monies to fund these 
grants will be appropriated.
The authority received $351 in permanent endowments in 20X6 from the AIA 
Foundation. Earnings from investing the principal of this endowment must be 
used to support expenditures for Program A research. This is in contrast to an 
increase in state funding of $580 in 20X6 compared to 20X5. The authority has 
received other permanent endowments in the past. Restrictions established by 
these endowments are detailed in note 2 to the financial statements.
The Authority's Cash Flows
Changes in the authority's cash flows are consistent with changes in oper­
ating losses and nonoperating revenues and expenses, discussed earlier, with 
1 exception. Cash flows used by operating activities increased slightly more 
than operating losses in both 20X7 and 20X6 due to increases in the authority's 
patient accounts receivable, discussed earlier.
Capital Asset and Debt Administration
Capital Assets
At the end of 20X7, the authority had $43.3 million invested in capital as­
sets, net of accumulated depreciation, as detailed in note 7 to the financial 
statements. In 20X7, the authority purchased new equipment costing $4,529.
Health Care Organizations
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Of this, $510 was acquired through capital leases. Nearly the same amount—
$4,111—was spent to acquire new equipment in 20X6. Both of these amounts 
are less than 20X5, when the authority spent $7,308 for new equipment. The 
authority has recently found it more economical to lease much of its equipment. 
This allows the authority to avoid some of the costs of obsolescence caused by 
technological changes.
In August 20X5, the authority's board of trustees approved a resolution set­
ting aside $15 million of its unrestricted net assets for future expansion of the 
hospital and possible addition of a cancer care wing. The board of trustees held 
a special meeting in September 20X7 to reconsider the feasibility of the project 
and held initial meetings with several local architectural firms in January 20X8. 
No decisions have been reached as of the date of this annual report.
Debt
At year-end, the authority had $20.9 in revenue notes, mortgage loans, and 
capital lease obligations outstanding as detailed in note 8 to the financial state­
ments. Except for capital leases of $510 initiated in 20X7, the authority issued 
no new debt in 20X7 or 20X6. The authority's formal debt issuances—revenue 
notes—cannot be issued without approval of the Feeling County board of com­
missioners. The amount of debt issued is subject to limitations that apply to 
the county and its component units as a whole. There have been no changes in 
the authority's debt ratings in the past 2 years.4
Other Economic Factors
The county's largest employer, the XYZ Motor Company, has a number of 
operating plants throughout the country. In late 20X5, XYZ announced that it 
would close its plant in New City, Ohio, and move the majority of that plant's 
operations (including up to 2,000 full-time employees) to its Feeling County 
plant. Work on that move began in May 20X6. The impact of this closure on the 
authority's operations has not been determined. Management has anticipated a 
5 percent reduction in patient volumes in its budget for 20XX and has developed 
strategies to address staffing levels and other operating expenses in the event 
of a significant additional reduction in patient volumes.
Contacting The Authority's Financial Management
This financial report is designed to provide our patients, suppliers, taxpayers, 
and creditors with a general overview of the authority's finances and to show 
the authority's accountability for the money it receives. If you have questions 
about this report or need additional financial information, contact the authority 
controller's office at Sample Hospital Authority, 92 Third Street, Anytown, UN 
01000.
4 If the authority's ability to issue additional debt is significantly impacted by such debt limita­
tion, those facts should be disclosed.
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ILLUSTRATIVE FINANCIAL STATEMENTS 
FOR A  GOVERNMENTAL HOSPITAL AUTHORITY
Health Care Organizations
Sample Governmental Hospital Authority 
A Component Unit of Feeling County, State of Union
Balance Sheets5 
December 31 , 20X7 and 20X6 
(in thousands)
20X7 20X6
Assets
Current assets:
Cash and cash equivalents $7,136 $7,557
Short term investments
Patient accounts receivable, net of estimated
3,142 3,423
uncollectibles of $2,125 (20X7) and $2,040 
(20X6) 19,834 16,727
Supplies and other current assets 2,270 2,428
Total current assets 32,382 30,135
Noncurrent cash and investments:
Internally designated for capital acquisitions 15,000 15,000
Other long term investments 2,605 1,327
Held by trustee for debt service
Restricted by contributors and grantors for
1,945 2,005
capital acquisitions and research 1,124 1,078
Principal of permanent endowments 3,003 2,919
Delinquent property taxes
Capital Assets:
385 229
Land
Depreciable capital assets, net of accumulated
3,590 3,590
depreciation
Total capital assets, net of accumulated
39,792 39,328
depreciation 43,382 42,918
Other assets 1,056 936
Total assets $100,882 $96,547
(continued)
5 As discussed in paragraph 1.17 in this guide, either a balance sheet or a statement of net assets 
format may be used.
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20X7 20X6
Liabilities and Net Assets
Current liabilities:
Current maturities of long term debt $1,250 $1,488
Accounts payable and accrued expenses 4,945 4,575
Estimated third-party payor settlements 1,822 1,651
Other current liabilities 1,673 1,797
Total current liabilities 9,690 9,511
Long term debt, net of current maturities 19,672 20,412
Other long term liabilities 3,361 2,690
Total liabilities 32,723 32,613
Net Assets:6
Invested in capital assets net of related debt 22,460 21,018
Restricted:
For debt service 1,945 2,005
Expendable for capital acquisitions 733 628
Expendable for research 781 899
Expendable for specific operating activities 331 573
Nonexpendable permanent endowments 3,003 2,919
Unrestricted 38,906 35,892
Total net assets 68,159 63,934
Total liabilities and net assets $100,882 $96,547
See accompanying notes to financial statements.
6 As discussed in paragraph 1.19 in this guide, either "net assets" or "equity" may be used as the 
label for the difference between assets and liabilities.
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Sample Governmental Hospital Authority
A Component Unit of Feeling County, State of Union
Statements of Revenues, Expenses, and Changes in Net Assets7
Years Ended December 31, 20X7 and 20X6
(in thousands)
Health Care Organizations
20X7 20X6
Operating revenues:
Net patient service revenue (net of provision 
for bad debts of $859 in 20X7 and $938 in 20X6) $43,305 $43,736
Premium revenue 9,876 13,058
Other 3,416 3,248
Total operating revenues 56,597 60,042
Operating expenses:
Salaries and benefits 46,845 43,235
Medical supplies and drugs 12,746 7,986
Insurance 7,030 7,382
Other supplies 10,314 11,166
Depreciation and amortization 4,065 3,638
Total operating expenses 81,000 74,407
Operating loss (24,403) (13,365)
Nonoperating revenues (expenses):
Property taxes 23,895 15,309
Investment income 5,653 5,304
Interest expense (1,489) (1,552)
Noncapital grants and contributions 170 853
Other ( 425) —
Total nonoperating revenues (expenses) 27,804 19,914
Excess of revenues over expenses before 
capital grants, contributions, and additions •
to permanent endowments 3,401 6,549
Capital grants and contributions 824 2,560
Additions to permanent endowments 351
Increase in net assets $4,225 $9,460
Net assets beginning of the year 63,934 54,474
Net assets end of the year $68,159 $63,934
See accompanying notes to financial statements.
7 As discussed in paragraph 1.21 of this guide, GASB Statement No. 34, Basic Financial 
Statements—and Management's Discussion and Analysis—for State and Local Governments, para­
graph 101 requires proprietary funds and special purpose governments engaged only in business-type 
activities to present an operating statement that uses an "all-inclusive" format, presenting all changes 
in both restricted and unrestricted net assets and presenting a final total, "Increase (decrease) in net 
assets/equity." As discussed in paragraph 1.19 of this guide, governmental health care entities may 
use either the term net assets or equity as a label for the difference between assets and liabilities.
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Sample Governmental Hospital Authority
A Component Unit of Feeling County, State of Union
Statements of Cash Flows
Years Ended December 3 1 , 20X7 and 20X6
(in thousands)
20X7 20X6
Cash flows from operating activities:
Receipts from and on behalf o f patients $ 50,074 $ 54,680
Payments to suppliers and contractors (30,029) (26,634)
Payments to employees (46,955) (43,460)
Other receipts and payments, net 4,591 3,597
Net cash provided by operating activities (22,319) (11,817)
Cash flows from noncapital financing 
activities:
Property taxes 20,739 12,224
Noncapital grants and contributions 170 853
Contributions to permanent endowments — 351
Other ( 425) —
Net cash provided by noncapital financing
activities 20,484 13,428
Cash flows from capital and related 
financing activities:
Capital grants and contributions 824 2,560
Property taxes restricted to capital acquisitions 3,000 3,000
Principal paid on long term debt (1,488) (1,896)
Interest paid on long term debt (1,489) (1,552)
Purchase of capital assets (4,019) (4,111)
Net cash used by capital and related
financing activities (3,172) (1,999)
Cash flows from investing activities:
Interest and dividends on investments 2,737 2,124
Purchases of investments (1,045) (289)
Proceeds from sale of investments 2,327 683
Net cash provided by investing activities 4,019 2,518
Net increase (decrease) in cash and cash
equivalents (988) 2,130
(continued)
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A Component Unit of Feeling County, State of Union
Statements of Cash Flows 
(continued)
Years Ended December 31, 20X7 and 20X6 
(in thousands)
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20X7 20X6
Cash and cash equivalents, beginning of year 9,101 6,971
Cash and cash equivalents, end of year $8,113 $9,101
Reconciliation of cash and cash equivalents to 
the statement of net assets:
Cash and cash equivalents in current assets 7,136 7,557
Restricted cash and cash equivalents 977 1,544
Total cash and cash equivalents $8,113 $9,101
Reconciliation of operating income (loss) to net cash 
provided (used) by operating activities:
Operating loss ($24,403) ($13,365)
Adjustments to reconcile operating income 
to net cash flows used in operating activities: 
Depreciation and amortization 4,065 3,638
Provision for bad debts 859 938
Changes in:
Patient accounts receivable (3,966) (2,909)
Supplies and other current assets 158 100
Other assets (120) —
Accounts payable, accrued expenses, and 
other current Liabilities 246 (225)
Estimated third-party payor settlements 171 (235)
Other liabilities related to operating activities 671 241
Net cash used in operating activities ($22,319) ($11.817)
Noncash Investing, Capital, and Financing Activities:
The authority entered into capital lease obligations of $510,000 for 
new equipment in 20X7.
The authority held investments at December 31, 20X7, with a fair 
value of $XXX. During 20X7, the net increase in the fair value of 
these investments was $XXX.
See accompanying notes to financial statements.
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Sample Governmental Hospital Authority
A Component Unit of Feeling County, State of Union
Notes to Financial Statements8
December 31, 20X7 and 20X6
(in thousands)
1. Description of Reporting Entity and Summary of Significant Ac­
counting Policies
Reporting entity. The Sample Hospital Authority (the authority) is a public 
corporation. It was created on January 1, 19XX, by the board of county com­
missioners of Feeling County, State of Union, to operate, control, and manage 
all matters concerning the county's health care functions. The board of county 
commissioners appoints the board of trustee members of the authority, and 
the authority may not issue debt or levy taxes without the county's approval. 
For this reason, the authority is considered to be a component unit of Feeling 
County and is included as a discretely presented component unit in the basic 
financial statements of the county.
Use o f  estimates. The preparation of financial statements in conformity with 
GAAP requires management to make estimates and assumptions that affect the 
reported amounts of assets and liabilities and disclosure of contingent assets 
and liabilities at the date of the financial statements and the reported amounts 
of revenues and expenses during the reporting period. Actual results could 
differ from those estimates.
Enterprise fund accounting. The authority uses enterprise fund accounting. 
Revenues and expenses are recognized on the accrual basis using the economic 
resources measurement focus. Based on GASB Statement No. 20, as amended, 
the authority has elected to apply the provisions of all relevant pronouncements 
of the FASB, including those issued after November 30 , 1989, that do not conflict 
with or contradict GASB pronouncements.
Cash and cash equivalents. Cash and cash equivalents include investments 
in highly liquid debt instruments with an original maturity of three months or 
less.
Capital assets. The authority's capital assets are reported at historical cost. 
Contributed capital assets are reported at their estimated fair value at the time 
of their donation. All capital assets other than land are depreciated or amortized 
(in the case of capital leases) using the straight-line method of depreciation 
using these asset lives:
Land improvements
Buildings and building improvements 
Equipment, computers, and furniture
15-20 years 
20-40 years 
3-7 years
8 The notes to the financial statements in these illustrative financial statements generally include 
only disclosures unique to a governmental hospital. The disclosures regarding the accounting policies 
for the use of estimates and cost of borrowing in note 1 and charity care in note 5 are not unique to 
a governmental hospital. Also, the notes to the financial statements include disclosures that are not 
required.
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Costs o f borrowing. Except for capital assets acquired through gifts, contri­
butions, or capital grants, interest cost on borrowed funds during the period of 
construction of capital assets is capitalized as a component of the cost of acquir­
ing those assets. None of the authority's interest cost was capitalized in either 
20X7 or 20X6.
Property taxes. The authority received approximately 29 percent in 20X7 and 
19 percent in 20X6 of its financial support from property taxes. These funds 
were used as follows:
Used to support operations 
Levied for debt service
20X7 20X6
$20,895 $12,309
3,000 3,000
Property taxes are levied by the county on the authority's behalf on January 
1 and are intended to finance the authority's activities of the same calendar 
year. Amounts levied are based on assessed property values as of the preceding 
July 1.
Property taxes are considered delinquent on the day following each payment 
due date.
Grants and contributions. From time to time, the authority receives grants 
from Feeling County and the State of Union as well as contributions from in­
dividuals and private organizations. Revenues from grants and contributions 
(including contributions of capital assets) are recognized when all eligibility 
requirements, including time requirements are met. Grants and contributions 
may be restricted for either specific operating purposes or for capital purposes. 
Amounts that are unrestricted or that are restricted to a specific operating 
purpose are reported as nonoperating revenues. Amounts restricted to capital 
acquisitions are reported after nonoperating revenues and expenses.
Endowments. Endowments are provided to the authority on a voluntary ba­
sis by individuals and private organizations. Permanent endowments require 
that the principal or corpus of the endowment be retained in perpetuity. If a 
donor has not provided specific, instructions, Union state law permits the au­
thority's board of trustees to authorize for expenditure the net appreciation of 
the investments of endowment funds, as discussed in note 2.
Restricted resources. When the authority has both restricted and unrestricted 
resources available to finance a particular program, it is the authority's policy 
to use restricted resources before unrestricted resources.
Net assets. Net assets of the authority are classified in four components. Net 
assets invested in capital assets net o f  related debt consist of capital assets 
net of accumulated depreciation and reduced by the current balances of any 
outstanding borrowings used to finance the purchase or construction of those 
assets. Restricted expendable net assets are noncapital net assets that must be 
used for a particular purpose, as specified by creditors, grantors, or contributors 
external to the authority, including amounts deposited with trustees as required 
by revenue bond indentures, discussed in note 8. Restricted nonexpendable net 
assets equal the principal portion of permanent endowments. Unrestricted net 
assets are remaining net assets that do not meet the definition of invested in 
capital assets net o f related debt or restricted.
Operating revenues and expenses. The authority's statement of revenues, ex­
penses and changes in net assets distinguishes between operating and non­
operating revenues and expenses. Operating revenues result from exchange
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transactions associated with providing health care services—the authority's 
principal activity. Nonexchange revenues, including taxes, grants, and contri­
butions received for purposes other than capital asset acquisition, are reported 
as nonoperating revenues. Operating expenses are all expenses incurred to 
provide health care services, other than financing costs.
Compensated absences. The authority's employees earn vacation days at vary­
ing rates depending on years of service. Vacation time does not accumulate. 
Generally, any days not used at year-end expire. Employees also earn sick leave 
benefits based on varying rates depending on years o f service. Employees may 
accumulate sick leave up to a specified maximum. Employees are not paid for 
accumulated sick leave if they leave before retirement. However, employees 
who retire from the authority may convert accumulated sick leave to termi­
nation payments at varying rates, depending on the employee’s contract. The 
estimated amount o f sick leave payable as termination payments is reported 
as a noncurrent liability in both 20X7 and 20X6.
Risk management. The authority is exposed to various risks o f loss from torts; 
theft of, damage to, and destruction of assets; business interruption; errors and 
omissions; employee injuries and illnesses; natural disasters; medical malprac­
tice; and employee health, dental, and accident benefits. Commercial insurance 
coverage is purchased for claims arising from such matters. Settled claims have 
not exceeded this commercial coverage in any of the three preceding years.
Investments in debt and equity securities. Investments in debt and equity secu­
rities are reported at fair value except for short term highly liquid investments 
that have a remaining maturity at the time they are purchased of one year 
or less. These investments are carried at amortized cost. Interest, dividends, 
and gains and losses, both realized and unrealized, on investments in debt and 
equity securities are included in nonoperating revenue when earned.
2. Endowments and Restricted Net Assets
Restricted, expendable net assets are available for the following purposes:
20X7 20X6
Program A activities:
Purchase of equipment $404 $321
Research 553 683
General 46 63
Program B activities:
Purchase of equipment 235 235
Research 184 151
General 79 110
Program C activities:
General 206 400
Buildings and equipment 94 72
Research 44 65
Total expendable, restricted net assets $1,845 $2,100
Unless the contributor provides specific instructions, Union state law permits 
the authority's board of trustees to authorize for expenditure the net appreci­
ation (realized and unrealized) of the investments in its endowments. When 
administering its power to spend net appreciation, the board of trustees is re­
quired to consider the authority's "long- and short-term needs, present and
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anticipated financial requirements, expected total return on its investments, 
price-level trends, and general economic conditions." Any net appreciation that 
is spent is required to be spent for the purposes designated by the contributor.
The board of trustees chooses to spend only a portion of the investment income 
(including changes in the value of investments) each year. Under the policy es­
tablished by the board, 5 percent of the average market value of endowment 
investments at the end of the previous 3 years has been authorized for expen­
diture. The authority retains the remaining amount, if any, to be used in future 
years when the amount computed using the spending policy exceeds investment 
income. At December 31, 20X7 and 20X6, net appreciation of $864 and $953, 
respectively, is available to be spent, of which $402 and $682, respectively, is 
reported as restricted expendable net assets, and the balance is in unrestricted 
net assets.
Restricted nonexpendable net assets as of December 31, 20X7 and 20X6, rep­
resent the principal amounts of permanent endowments, restricted to invest­
ment in perpetuity. Investment earnings from the authority's permanent en­
dowments are expendable to support these programs as established by the 
contributor:
Health Care Organizations
20X7 20X6
Program A activities $ 158 $ 158
Program B activities 176 176
Program C activities 423 423
Any activities of the authority 854 854
Endowment requiring income to be added to
1,611 1,611
original gift until the fund's value is $2,125 1,392 1,308
Total restricted nonexpendable net assets 3,003 2,919
3. Designated Net Assets
Of the $40,851 and $37,897 of unrestricted net assets reported in 20X7 and 
20X6, respectively, $15,000 has been designated by the authority's board of 
trustees for capital acquisitions. Designated funds remain under the control of 
the board of trustees, which may at its discretion later use the funds for other 
purposes.
4. Deposits and Investments
State law requires collateralization of all deposits with federal depository in­
surance and other acceptable collateral in specific amounts. The authority's 
bylaws require that all bank balances be insured or collateralized by U.S. gov­
ernment securities held by the pledging financial institution's trust department 
in the name of the authority.
The authority's investments generally are reported at fair value, as discussed 
in note 1. At December 31, 20X7 and 20X6, the authority had the following 
investments and maturities, all of which were held in the authority's name by 
a custodial bank that is an agent of the authority:9
9 This illustrative note presents interest rate information using the segmented time distribution 
method. Other methods for illustrating interest rate information are described in paragraph 15 of 
GASB Statement No. 40, Deposit and Investment Risk Disclosures.
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December 31, 20X7 Investment Maturities (in Years)
Carrying Less More
Investment Type Amount Than 1 1-5 6-10 Than 10
U.S. Treasuries
Federal National
$21,7749 $xxx $xxx $xxx $xxx
Mortgage Association 
Government National
3,580 XXX XXX XXX XXX
Mortgage Association 3,5806 XXX XXX XXX XXX
Total $28,934 $x x x $xxx $xxx $xxx
December 31, 20X6 Investment Maturities (in Years)
Carrying Less More
Investment Type Amount Than 1 1-5 6-10 Than 10
U.S. Treasuries
Federal National
$20,039 $xxx $xxx $xxx $XXX
Mortgage Association 
Government National
3,365 XXX XXX XXX XXX
Mortgage Association 3,366 XXX XXX XXX XXX
Total $26,770 $x x x $xxx $xxx $x x x
Interest Rate Risk. The authority does not have a formal investment policy 
that limits investment maturities as a means of managing its exposure to fair 
value losses arising from changing interest rates.
Credit Risk. Statutes authorize the authority to invest in obligations of the 
U.S. Treasury, agencies, and instrumentalities, commercial paper rated A-1 by 
Standard & Poor's Corporation or P-1 by Moody's Commercial Paper Record, 
and bankers' acceptances. However, the authority's bylaws require that invest­
ments be made only in U.S. government obligations held by the authority's 
third-party agent. As of December 31, 20X7 and 20X6, the authority's invest­
ments in Federal National Mortgage Association were rated AAA by Standard 
and Poor's and Fitch Ratings and Aaa by Moody's Investor Services.
Concentration o f Credit Risk. The authority places no limit on the amount it 
may invest in any 1 issuer. More than 5 percent of the authority's investments 
at December 31 , 20X7 and 20X6 are invested in the Federal National Mortgage 
Association. These investments are 12.37 percent and 12.57 percent, respec­
tively, of the authority's total investments at December 31, 20X7 and 20X6.
The carrying amounts of deposits and investments are included in the author­
ity's balance sheets as follows:
Carrying amount
20X7 20X6
Deposits $ 5,021 $ 6,539
Investments 28,934 26,770
Included in the following balance sheet captions
$33,955 $33,309
Cash and cash equivalents $7,136 $7,557
Short term investments
Noncurrent cash and investments:
3,142 3,423
Other long term investments
Restricted by contributors and grantors for
2,605 1,327
capital acquisitions and research 1,124 1,078
Internally designated for capital acquisitions 15,000 15,000
Held by trustee for debt service 1,945 2,005
Principal of permanent endowments 3,003 2,919
$33,955 $33,309
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5. Charity Care
Charges excluded from revenue under the authority's charity care policy were 
$7,100 and $6,845 for 20X7 and 20X6, respectively.
6. Accounts Receivable and Payable
Patient accounts receivable and accounts payable (including accrued ex­
penses) reported as current assets and liabilities by the authority at December 
31, 20X7 and 20X6 consisted of these amounts:
Patient Accounts Receivable
Receivable from patients and their insurance carriers 
Receivable from Medicare 
Receivable from Medicaid
Total patient accounts receivable 
Less allowance for uncollectibles amounts
Patient accounts receivable, net 
Accounts Payable and Accrued Expenses
Payable to employees (including payroll taxes)
Payable to suppliers
Other
Total accounts payable and accrued expenses
20X7 20X6
$13,976 $11,868
4,286 3,002
3,697 3,897
21,959 18,767
2,125 2,040
$19,834 $16,727
20X7 20X6
$2,437 $1,970
2,481 2,591
27 14
$4,945 $4,575
7. Capital Assets
Capital asset additions, retirements, and balances for the years ended Decem­
ber 31, 20X7 and 20X6 were as follows:
Balance 
December 31, 
20X6 Additions
Retire­
ments
Balance 
December 31, 
20X7
Land10 $ 3,590 — — $ 3,590
Land improvements 645 17 — 662
Buildings and
improvements 29,265 965 (810) 29,420
Equipment 30,375 3,547 (1,860) 32,062
Totals at historical cost $ 63,875 $4,529 ($2,670) $ 65,734
Less accumulated 
depreciation for:
Land improvements (291) (65) — (356)
Buildings and
improvements (5,352) (582) 810 (5,124)
Equipment (15,314) (3,418) 1,860 (16,872)
Total accumulated
depreciation (20,957) (4,065) 2,670 (22,352)
Capital assets, net $ 42,918 $ 464 $ 0 $ 43.382
10 When present, construction-in-progress should be reported in a separate line in this sched­
ule. (See the GASB staff document Comprehensive Implementation Guide—2005, item 7.353). See 
paragraph 1.11 in this guide regarding references to GASB staff Implementation Guides. Also, GASB 
Statement No. 34 paragraph 20 requires nondepreciable capital assets to be shown separately on the 
face of the balance sheet when these balances are significant.
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Land $ 3,590
Land improvements 608
Buildings and
improvements 29,187
Equipment 26,710
Totals at historical cost $ 60,095
Less accumulated 
depreciation for:
Land improvements (309)
Buildings and
improvements (4,826)
Equipment (12,515)
Total accumulated
depreciation (17,650)
Capital assets, net $ 42,445
Balance 
December 31, 
20X5 Additions
Retire­
ments
Balance 
December 31, 
20X6
112 (75)
$ 3,590 
645
78 — 29,265
3,921
$4,111
(256)
($ 331)
30,375 
$ 63,875
(57) 75 (291)
(526)
(3,055) 256
(5,352)
(15,314)
(3,638)
$ 473
331
$ 0
(20,957)
$ 42,918
8. Long Term Debt and Other Noncurrent Liabilities 
A schedule of changes in the authority's noncurrent liabilities for 20X7 and
20X6 follows:
Balance 
December 31, 
20X6 Additions Reductions
Balance 
December 31, 
20X7
Amounts 
Due Within 
1 Year
Bonds and Notes 
Payable:
($457) $18,257Revenue notes $18,714 — $620
Mortgage loan 1,808 — (99) 1,709 99
Note payable 
Total long term
570 (464) 106 106
debt
Capital lease
21,092 (1,020) 20,072 825
obligations 
Other Liabilities: 
Compensated
808 510 (468) 850 425
absences
Net pension
2,625 662 (6) 3,281
obligation
Total other
65 15 80 See note 9
liabilities
Total
noncurrent
2,690 677 (6) 3,361
liabilities $24,590 $1,187 ($1,494) $24,283 $1,250
(continued)
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Balance 
December 31, 
20X5 Additions Reductions
Balance 
December 31, 
20X6
Amounts 
Due Within
1 Year
Bonds and Notes 
Payable:
Revenue notes 19,568 (854) 18,714 457
Mortgage loan 1,907 — (99) 1,808 99
Note payable 1,045 — (475) 570 464
Total long term 
debt 22,520 (1,428) 21,092 1,020
Capital lease 
obligations 1,276 - (468) 808 468
Other Liabilities: 
Compensated
absences 2,400 236 (11) 2,625
Net pension 
obligation 49 16  65 See note 9
Total other 
liabilities 2,449 252 (11) 2,690
Total
noncurrent
liabilities $26,245 $252 ($1,907) $24,590 $1,488
Long term debt. The terms and due dates of the authority's long term debt, 
including capital lease obligations, at December 31, 20X7 and 20X6, follow:
• 7.25 percent revenue notes, due November 1, 20Z7, collateralized 
by a pledge of the authority's gross receipts. Thus all operating and 
nonoperating revenues of the authority are similarly pledged.
• 9.25 percent mortgage loan, due January 20Y4, collateralized by 
a mortgage on property and equipment with a depreciated cost of 
$1,530 at December 31, 20X7
• 9.75 percent note payable, due March 20X8, unsecured
• Capital lease obligations, at varying rates of imputed interest from 
9.8 percent to 12.3 percent collateralized by leased equipment with 
cost of $1,275 at December 31, 20X7
Under the terms of the revenue note indenture, the authority is required to 
maintain certain deposits with a trustee. Such deposits are included with re­
stricted cash and investments in the balance sheet. The revenue note indenture 
also places limits on the incurrence of additional borrowings and requires that 
the authority satisfy certain measures of financial performance as long as the 
notes are outstanding.
Scheduled principal and interest repayments on long term debt and payments 
on capital lease obligations are as follows:
Long Term Debt Capital Lease Obligations
Year Ending December 31: Principal Interest Principal Interest
20X8 $ 825 $ 553 $ 425 $58
20X9 775 487 213 27
20Y0 836 465 212 13
20Y1 900 448
20Y2 972 432
20Y3-20Y7 5,764 1,769
20Y8-20Z2 4,824 1,492
20Z3-20Z7 5,176 1,116
Total $20,072 $6,762 $850 $98
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9. Commitments under Noncancelable Operating Leases
The authority is committed under various noncancelable operating leases, 
all of which are for equipment and computers. These expire in various years 
through 20Y9. Future minimum operating lease payments are as follows:
Year ending December 31:
20X8 $3,109
20X9 2,898
20Y0 2,795
20Y1 2,780
20Y2 2,575
20Y3-20Y7 4,215
20Y8-20Y9 1.065
Total $19,437
10. Pension Plan11
Plan description. Sample Hospital Pension Plan (SHPP) provides retirement 
and disability benefits, annual cost-of-living adjustments, and death benefits 
to plan members and beneficiaries. SHPP is affiliated with County Employees 
Pension Plan (CEPP), an agent multiple-employer pension plan administered 
by the Union Retirement System. Article 39 of the Regulations of the State 
of Union assigns the authority to establish and amend the benefit provisions 
of the plans that participate in CEPP to the respective employer entities; for 
CEPP, that authority rests with the County of Feeling, Union. The Union Retire­
ment System issues a publicly available financial report that includes financial 
statements and required supplementary information for SHPP. That report 
may be obtained by writing to Union Retirement System, State Government 
Lane, Anytown, Union 01000 or by calling 1-800-555-PLAN.
Funding policy. The contribution requirements of plan members and the au­
thority are established and may be amended by the CEPP board of trustees. 
Plan members are required to contribute 7.8 percent of their annual covered 
salary. The authority is required to contribute at an actuarially determined 
rate; the current rate for both 20X7 and 20X6 is 11.9 percent of annual covered 
payroll.
Annual pension cost and net pension obligation. The authority's annual pen­
sion cost and net pension obligation to SHPP for 20X7 and 20X6 were as follows:
20X7 20X6
Annual required contribution $  26 $  23
Interest on net pension obligation 3 2
Adjustment to annual required contribution (3) (2)
Annual pension cost 26 23
Contributions made (11) (7)
Increase (decrease) in net pension obligation 15 16
Net pension obligation beginning of year 65 49
Net pension obligation, end of year $ 80 $ 65
11 The preparer of the financial statements should consider the need for required supplementary 
information as required by GASB Statement No. 27, Accounting for Pensions by State and Local 
Governmental Employers, paragraph 22.
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The annual required contribution for the current year was determined as part of 
the December 31, 20X6, actuarial valuation using the entry age actuarial cost 
method. The actuarial assumptions included (a) 7.5 percent investment rate 
of return (net of administrative expenses) and (b) projected salary increases 
ranging from 5.5 percent to 9.5 percent per year. Both (a) and (b) included an 
inflation component of 5.5 percent. The actuarial assumptions also include a 
2 percent per year cost-of-living adjustment. The actuarial value of assets was 
determined using techniques that smooth the effects of short term volatility 
in the market value of investments over a 4 year period. The same actuarial 
assumptions were used to determine the actuarial required contributions for 
20X6. The unfunded actuarial accrued liability is being amortized as a level 
percentage of projected payroll on an open basis. The remaining amortization 
period at December 31, 20X6, was 23 years.
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Three-Year Trend Information
Fiscal Year 
Ending
Annual 
Pension 
Cost (APC)
Percentage 
o f APC 
Contributed
Net Pension 
Obligation
12/31/X5 $20 94% $49
12/31/X6 23 30 65
12/31/X7 26 42 80
11. Postretirement Plan**
In addition to the pension benefits previously described, the authority provides 
postretirement health care benefits, in accordance with the authority's bylaws, 
to all employees who retire from the authority on or after attaining age 60 with 
at least 15 years of service. Currently 250 retirees (245 in 20X6) meet these 
eligibility requirements. The authority reimburses 75 percent of the amount of 
validated claims for medical, dental, and hospitalization costs incurred by pre- 
Medicare retirees and their dependents. The authority also reimburses a fixed 
amount of $25 per month for a Medicare supplement for each retiree eligible 
for Medicare. Expenses for postretirement health care benefits are recognized 
as retirees report claims and include a provision for estimated claims incurred 
but not yet reported to the authority. Expenses of $764 were recognized for 
postretirement health care in 20X7; expenses recognized in 20X6 were $636. 
Approximately $64 of the $128 increase in expenses over the previous year was 
caused by the addition of dental benefits, effective July 1, 20X7.
** In 2004, the GASB issued GASB Statement No. 45 that would supersede or amend previous 
authoritative guidance on accounting and financial reporting for an employer's OPEB expense and 
related information, including GASB Statement No. 12. GASB Statement No. 45 requires reporting 
of the annual cost of OPEB, and the outstanding obligations and commitments related to OPEB in 
essentially the same manner as required for pensions in GASB Statement No. 27. Paragraphs 24-25 
of GASB Statement No. 45 require disclosures in the notes to the financial statements for OPEB plans. 
Conforming changes to modify these illustrative financial statements to reflect the issuance of GASB 
Statement No. 45 will be made in a future edition of this guide.
GASB issued Technical Bulletin 2006-1, Accounting and Financial Reporting by Employers and 
OPEB Plans for Payments from the Federal Government Pursuant to the Retiree Drug Subsidy Pro­
visions of Medicare Part D, in June 2006. This Technical Bulletin is effective immediately, except for 
portions of answers pertaining specifically to measurement, recognition, or required supplementary 
information requirements of GASB Statement Nos. 43, Financial Reporting for Postemployment Ben­
efit Plans Other Than Pension Plans, or 45. Those provisions should be applied simultaneously with 
the implementation of GASB Statement Nos. 43 or 45. This Technical Bulletin clarifies the applica­
tion of existing standards of accounting and financial reporting to payments that an employer or a 
defined benefit OPEB plan receives from the federal government pursuant to the retiree drug subsidy 
provisions of Medicare Part D, as established in the Medicare Prescription Drug, Improvement, and 
Modernization Act of 2003.
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Note: Although not presented in these sample illustrative financial statements, 
other disclosures required by GASB pronouncements may be applicable, includ­
ing the following:
• Short term debt (GASB Statement No. 38, Recipient Reporting for 
Certain Shared Nonexchange Revenues—an amendment o f GASB 
Statement No. 33, paragraph 12)
• Interfund balances and transfers (GASB Statement No. 38 para­
graph 14 when a governmental health care entity reports multiple 
enterprise funds or is reported as an enterprise fund of a general 
purpose government.)
• Segment information (GASB Statement No. 34, as amended, para­
graphs 122-123)
• Violations of finance-related legal or contractual provisions (GASB 
Statement No. 38 paragraph 9)
• Risk financing (Requirements for disclosures about claims and 
judgments and risk financing by governmental health care enti­
ties that retain a portion of risk for claims and judgments (in­
cluding malpractice claims and judgments) are provided in GASB 
Statement No. 10, as amended). Additionally, GASB Statement 
No. 34 paragraph 119 requires disclosure of certain information 
about the long term portion of accrued claims and judgments, if 
applicable.
Other required disclosures, which may be applicable and would be similar to 
the disclosures contained in the notes to the sample illustrative financial state­
ments for a not-for-profit hospital, are not repeated here. They include the 
following:
• Off-Balance Sheet Risk and Concentration of Credit Risk
• Fair Value of Financial Instruments
• Commitments and Contingencies
• Subsequent Events
• Net patient service revenue
• Related party transactions
• Description of Reporting Entity and Summary of Significant Ac­
counting Policies—Supplies, Net Patient Service Revenue, Charity 
Care, Premium Revenue
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A NURSING HOME
Health Care Organizations
Sample For-Profit Nursing Home, Inc. 
Balance Sheets‡
December 31, 20X5 and 20X4
20X5 20X4
Assets
Current assets:
Cash and cash equivalents $ 95,000 $ 129,000
Investments 150,000
Assets limited as to use 50,000 50,000
Patient accounts receivable, net of allowance for 
doubtful accounts of $6,700 in 20X5 and $5,300
in 20X4 162,000 152,000
Estimated third-party payor settlements 71,000 62,000
Interest receivable 7,000
Supplies 47,000 43,000
Prepaid expenses 3,000 2,000
Deferred tax asset 12,000 14,000
Total current assets 597,000 452,000
Assets limited as to use, net of amount required
for current liabilities 173,000 150,000
Property and equipment:
Land 205,000 205,000
Land improvements 37,000 32,000
Buildings 1,399,000 1,399,000
Furniture, fixtures, and equipment 228,000 189,000
1,869,000 1,825,000
Less accumulated depreciation 210,000 141,000
Property and equipment, net 1,659,000 1,684,000
Other assets 150,000 127,000
Total assets $2,579,000 $2,413,000
(continued)
‡ See footnote ‡ in "Illustrative Financial Statements for a Not-for-Profit Hospital."
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Sample For-Profit Nursing Home, Inc. 
Balance Sheets
(continued)
December 31 , 20X5 and 20X4
20X5 20X4
Liabilities and Shareholders' Equity
Current liabilities:
Current maturities of long term debt $ 50,000 $ 50,000
Accounts payable 78,000 52,000
Accrued expenses 175,000 188,000
Deposits from patients 50,000 45,000
Other current liabilities 74,000 15,000
Total current liabilities 427,000 350,000
Deferred tax liability 6,000 14,000
Long term debt, net o f current maturities 1,700,000 1,750,000
Shareholders' equity:
Common stock $20 par value; authorized
5,000 shares; issued and outstanding
70,000 70,000
3,500 shares
Retained earnings 376,000 229,000
Total shareholders' equity 446,000 299,000
Total liabilities and shareholders' equity $2,579,000 $2,413,000
See accompanying notes to financial statements.
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Statements of Income and Retained Earnings
Years Ended December 31 , 20X5 and 20X4
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20X5 20X4
Revenue:
Net patient service revenue $2,163,000 $1,949,000
Other revenue 67,000 22,000
Interest on investments held by trustee 13,000 7,000
Total revenue 2,243,000 1,978,000
Expenses:
Salaries and benefits 969,000 919,000
Medical supplies and drugs 511,000 499,000
Insurance and other 216,000 176,000
Provision for bad debts 92,000 83,000
Depreciation 69,000 57,000
Interest 164,000 172,000
Total expenses 2,021,000 1,906,000
Operating income 222,000 72,000
Nonoperating income:
Other interest income
Income before provision for income taxes
5,000
227,000 72,000
Provision for income taxes 80,000 29,000
Net income 147,000 43,000
Retained earnings, beginning of year 229,000 186,000
Retained earnings, end of year $ 376,000 $ 229.000
See accompanying notes to financial statements.
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Sample For-Profit Nursing Home, Inc.
Statements of Cash Flows
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Cash flows from operating activities: 
Cash received from residents and
third party payors $2,019,000 $1,796,000
Cash received from others 67,000 22,000
Cash paid to employees and suppliers (1,679,000) (1,495,000)
Interest and dividends received, 10,000 10,000 10,000
Interest paid (160,000) (170,000)
Taxes paid (29,000) (30,000)
Deposits received from patients 35,000 15,000
Deposits refunded to patients (30,000) (20,000)
Net cash provided by operating activities 233,000 128,000
Cash flows from investing activities:
Purchase of investments (150,000)
Proceeds from sale of property 2,000
Capital expenditures (44,000) (79,000)
Purchase of assets limited as to use (23,000)
Net cash used in investing activities (217,000) (77,000)
Cash flows from financing activities:
Repayment of long term debt (50,000) (50,000)
Net cash used in financing activities (50,000) (50,000)
Net increase (decrease) in cash and cash
equivalents (34,000) 1,000
Cash and cash equivalents, beginning of year 129,000 128,000
Cash and cash equivalents, end of year $ 95,000 $ 129.000
Reconciliation of net income to net cash provided
by operating activities:
Net income $147,000 $43,000
Adjustments to reconcile net income to net cash
provided by operating activities:
Depreciation 69,000 57,000
Provision for bad debts 92,000 83,000
Loss on sale of property — 11,000
Change in deferred income taxes (6,000) (14,000)
(Increase) decrease in:
Patient accounts receivable (102,000) (41,000)
Other current assets (21,000) (15,000)
Estimated third-party payor settlements (9,000) (10,000)
Interest receivable (7,000) (3,000)
Other assets (7,000) (10,000)
Increase (decrease) in:
Accounts payable and accrued expenses 13,000 43,000
Deposits from patients 5,000 (5,000)
Other current liabilities 59,000 (11,000)
Net cash provided by operating activities $233,000 $128,000
See accompanying notes to financial statements.
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Sample For-Profit Nursing Home, Inc.
Notes to Financial Statements#
December 31, 20X5 and 20X4
1. Description of Organization and Summary of Significant Account­
ing Policies* 12
Organization. The Sample Nursing Home, Inc. (the company) was incorpo­
rated in New State in 20X1 and operates a 128-bed nursing home in Abacus, 
New State. A summary of the company's significant accounting policies follows:
Use o f  estimates. The preparation of financial statements in conformity with 
GAAP requires management to make estimates and assumptions that affect the 
reported amounts of assets and liabilities and disclosure of contingent assets 
and liabilities at the date of the financial statements and the reported amounts 
of revenues and expenses during the reporting period. Actual results could 
differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments 
in highly liquid debt instruments with an original maturity of three months or 
less, excluding amounts whose use is limited by note indenture.
Investments. Investments in debt instruments, including assets limited as to 
use, are classified as held-to-maturity because the company has the positive 
intent and ability to hold the securities until maturity. Held-to-maturity secu­
rities are carried at cost adjusted for amortization of premiums and accretion 
of discounts.
Assets limited as to use. Assets deposited with a trustee under terms of the 
note indenture and assets set aside by the board of directors for capital im­
provements are classified as assets limited as to use. Amounts required to meet 
current liabilities have been reclassified in the balance sheet.
Property and equipment. Property and equipment are recorded at cost. De­
preciation is calculated on the straight-line method over the estimated useful 
lives of depreciable assets.
Bond issuance costs. Costs incurred in issuing the Series 20X1 bonds are being 
amortized based on the effective interest method.
Net patient service revenue. Net patient service revenue is reported at the 
estimated net realizable amounts from residents, third-party payors, and others 
for service rendered.
Revenue under third-party payor agreements is subject to audit and retroac­
tive adjustment. Provisions for estimated third-party payor settlements are 
provided in the period the related services are rendered. Differences between 
the estimated amounts accrued and interim and final settlements are reported 
in operations in the year of settlement.
Income taxes. The provisions for income taxes are based on amounts estimated 
to be currently payable and those deferred because of temporary differences 
between the financial statement and tax bases of assets and liabilities. These 
differences consist principally of bad debts and depreciation.
Health Care Organizations
# See footnote # in "Illustrative Financial Statements for a Not-for-Profit Hospital."
12 Paragraph 13 of SOP 01-6 provides guidance on disclosures that should be included in the
summary of significant accounting policies, including accounting policies for loans, trade receivables, 
and doubtful accounts.
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2. Assets Lim ited as to Use
Assets limited as to use include assets held by trustee under the Series 20X1 
note indenture agreement at December 31, 20X5 and 20X4.
20X5 20X4
U.S. Government obligations $150,000 $130,000
Cash 24,000 21,000
Accrued interest income 2,000 2,000
176,000 153,000
Internally designated by the board of 
directors for capital improvements
Certificate of deposit $45,000 $45,000
Accrued interest 2,000 2,000
47,000 47,000
$223,000 $200,000
3. Investm ents†
4. Long Term Debt
Long term debt at December 31, 20X5 and 20X4, was as follows:
9.5 percent bonds payable to the City of
Abacus, maturing $50,000 annually through 
November 1, 20YY, with a final maturity of 
$1 million on November 1 , 20YY
20X5 20X4
$1,750,000  $1,800,000
Less current maturities 50.000 50,000
$1,700,000  $1,750,000
The notes are collateralized by a first mortgage lien on all property and equip­
ment of the company and a security interest in all o f its receipts. The note in­
denture requires the maintenance of certain deposits with a trustee, which are 
included in assets limited as to use.
Future maturities of long term debt as o f December 3 1 , 20X5, follow:
Year Ending December 31, Amount
20X6 $ 50,000
20X7 50,000
20X8 50,000
20X9 50,000
20Y0 50,000
Thereafter 1,500,000
Total $1,750,000
† In reporting disclosures about investments in securities, entities should comply primarily with 
the requirements of paragraphs 6,17, and 19-22 of FASB Statement No. 115, Accounting for Certain 
Investments in Debt and Equity Securities, as amended. Other disclosure requirements may also be 
applicable.
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5. Income Taxes
The provisions for income taxes are as follows:‡ 
20X5 20X4
Current:
Federal $72,000 $15,000
State 2,000
Total current 74,000 15,000
Deferred:
Federal 6,000 13,000
State 1,000
Total deferred 6,000 14,000
Total provision for income taxes $80,000 $29,000
Deferred income taxes are provided for the temporary differences between 
the financial reporting basis and the tax basis of the company's assets and 
liabilities.
For the years ended December 31, 20X5 and 20X4, the effective tax rate ap­
proximated the statutory rate of 34 percent and 40 percent, respectively.
The net current and noncurrent components of deferred income taxes recog­
nized in the balance sheet at December 31, 20X5 and 20X4, follows:
20X5 20X4
Net current assets $12,000 $14,000
Net noncurrent liabilities 6,000 14,000
$ 6.000 $ 0
Management has determined that no valuation allowance related to deferred 
tax assets is necessary at December 31, 20X5 and 20X4, respectively.
6. Concentration in State Medicaid Program
The company has 100 of its 128 beds designated for care of patients under 
the state's Medicaid program. The current funding of that program is 90 days 
behind filed claims. The current state budget has no provision for reducing that 
lag and, while the proposed budget for 20X6 includes additional funding, there 
is no assurance that the final budget will include the needed additional funds.
7. Third Party Rate Adjustments and Revenue
Revenue from the Medicaid program accounted for approximately XX per­
cent for the year ended 20X5, and XX percent for the year ended 20X4, of the 
company's net patient revenue. Laws and regulations governing the Medicaid
‡‡ In June 2006, the FASB issued FASB Interpretation No. 48, Accounting for Uncertainty in 
Income Taxes—an interpretation of FASB Statement No. 109. This interpretation is effective for fiscal 
years beginning after December 15, 2006. The interpretation clarifies the accounting for uncertainty in 
income taxes recognized in an organization's financial statements in accordance with FASB Statement 
No. 109, Accounting for Income Taxes. This interpretation prescribes a recognition threshold and 
measurement attribute for the financial statement recognition, measurement and disclosures of a tax 
position taken or expected to be taken in a tax return. This interpretation also provides guidance 
on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and 
transition.
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program are extremely complex and subject to interpretation. As a result, there 
is at least a reasonable possibility that recorded estimates will change by a ma­
terial amount in the near term. The 20X5 net patient service revenue increased 
approximately $XXX due to removal of allowances previously estimated that 
are no longer necessary as a result of final settlements and years that are 
no longer subject to audits, reviews, and investigations. The 20X4 net patient 
service revenue decreased approximately $XXX due to prior-year retroactive 
adjustments in excess of amounts previously estimated.
8. Risks and Uncertainties Disclosures||||
9. Pension Plan||||
10. Postretirement Benefits||
11. Fair Values of Financial Instruments||
12. Concentrations of Credit Risk|||
|| The disclosures contained in these notes would be similar to the disclosures contained in the 
notes to the financial statements for the not-for-profit hospital and, therefore, are not repeated here.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A  CONTINUING CARE 
RETIREMENT COMMUNITY
Sample Not-for-Profit Continuing Care Retirement Community 
Balance Sheets†
December 31 , 20X5 and 20X4
20X5 20X4
Assets
Current assets:
Cash $ 375,000 $ 330,000
Assets limited as to use 265,000 170,000
Accounts receivable, net of allowance for 
doubtful accounts of $4,000 in 20X5 and
$5,000 in 20X4 187,000 197,000
Supplies 40,000 21,000
Prepaid expenses 115,000 73,000
Total current assets 982,000 791,000
Assets limited as to use, net of amount required
for current liabilities 1,865,000 1,583,000
Property and equipment, net 14,893,000 15,280,000
Deferred financing costs, net of accumulated 
amortization of $28,000 in 20X5 and $21,000
in 20X4 83,000 90,000
Total assets $17,823,000 $17,744,000
Liabilities and Net Assets
Liabilities:
Current maturities of long term debt $ 90,000 $ 77,000
Accounts payable 180,000 174,000
Accrued expenses 161,000 178,000
Deposits on unoccupied units 22,000 40,000
Total current liabilities 453,000 469,000
Long term debt, less current maturities 8,871,000 8,935,000
Refundable fees 59,000 144,000
Estimated obligation to provide future services,
in excess of amounts received or to be received 88,000 100,000
Deferred revenue from advance fees 6,304,000 6,585,000
Total liabilities 15,775,000 16,233,000
Net assets:
Unrestricted 1,286,000 833,000
Temporarily restricted 311,000 294,000
Permanently restricted 451,000 384,000
Total net assets 2,048,000 1,511,000
Total liabilities and net assets $17,823,000 $17,744,000
See accompanying notes to financial statements.
† See footnote † in "Illustrative Financial Statements for a Not-for-Profit Hospital."
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Sample Not-for-Profit Continuing Care Retirement Community
Statements of Operations
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Revenue, gains, and other support:
Resident services, including amortization of
advance fees of $935,000 in 20X5 
and $915,000 in 20X4 $3,946,000 $3,152,000
Patient revenue from nonresidents 249,000 275,000
Change in obligation to provide future services 12,000 (82,000)
Contributions 54,000 39,000
Net assets released from restrictions used for 
operations 24,000 50,000
Investment income 29,000 30,000
Other 75,000 68,000
Total revenue, gains, and other support 4,389,000 3,532,000
Expenses:
Salaries and benefits 1,708,000 1,250,000
Medical supplies and drugs 543,000 742,000
Insurance 291,000 311,000
Depreciation 452,000 447,000
Interest 967,000 955,000
Total expenses 3,961,000 3,705,000
Operating income (loss) 428,000 (173,000)
Net assets released from restriction—purchase 
of equipment 25,000 45,000
Increase (decrease) in unrestricted net assets $ 453.000 $ (128,000)
See accompanying notes to financial statements.
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Sample Not-for-Profit Continuing Care Retirement Community
Statements of Changes in Net Assets
Years Ended December 31 , 20X5 and 20X4
20X5 20X4
Unrestricted net assets:
Operating income (loss)
Net assets released from restriction—purchase
$ 428,000 $ (173,000)
of equipment 25,000 45,000
Increase (decrease) in unrestricted net assets 
Temporarily restricted net assets:
453,000 (128,000)
Contributions
Net assets released from restrictions used for
40,000 15,000
operations
Net assets released from restriction—purchase
(24,000) (50,000)
of equipment (25,000) (45,000)
Investment income 26,000 15,000
Increase (decrease) in temporarily restricted 
net assets 17,000 (65,000)
Permanently restricted net assets:
Contributions 67,000 52,000
Increase in permanently restricted net assets 67,000 52,000
Increase (decrease) in net assets 537,000 (141,000)
Net assets, beginning of year   1,511,000 1,652,000
Net assets, end of year $2,048,000 $1,511,000
See accompanying notes to financial statements.
AAG-HCO APP A
Illustrative Financial Statements 273
Sample Not-for-Profit Continuing Care Retirement Community
Statements of Cash Flows
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Cash flows from operating activities: 
Cash received from residents and third
party payors $ 3,252,000 $ 2,341,000
Advance fees received 654,000 857,000
Other receipts from operations 75,000 68,000
Investment income received 68,000 53,000
Contributions received 51,000 44,000
Cash paid to employees and suppliers (2,576,000) (2,040,000)
Interest paid (950,000) (945,000)
Net cash provided by operating activities 574,000 378,000
Cash flows from investing activities:
Purchase of property and equipment (65,000) (250,000)
Purchase of assets limited as to use (377,000) 229,000
Net cash used in investing activities (442,000) (21,000)
Cash flows from financing activities:
Permanently restricted funds received 67,000 52,000
Refunds of deposits and refundable fees (103,000) (52,000)
Proceeds from issuance of long term debt 26,000
Principal payments of long term debt (77,000) (307,000)
Net cash used in financing activities (87,000) (307,000)
Net increase in cash 45,000 50,000
Cash, beginning of year 330,000 280,000
Cash, end of year $ 375,000 $ 330,000
Reconciliation of change in net assets to net
cash provided by operating activities:
Change in net assets $ 537,000 $(141,000)
Adjustments to reconcile change in net assets to
net cash provided by operating activities:
Advance fees received 654,000 857,000
Restricted net assets received (67,000) (52,000)
Amortization of advance fees (935,000) (915,000)
Loss (gain) on obligation to provide future
services (12,000) 82,000
Depreciation 452,000 447,000
Amortization of deferred financing costs 7,000 34,000,
Provision for bad debts 3,000 3,000
(Increase) decrease in:
Accounts receivable 7,000 (33,000)
Other assets (61,000) (4,000)
Increase (decrease) in:
Accounts payable and accrued expenses (11,000) 100,000
Net cash provided by operating activities $ 574,000 $ 378.000
See accompanying notes to financial statements.
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Sample Not-for-Profit Continuing Care Retirement Community 
Notes to Financial Statements13,#  
December 31, 20X5 and 20X4
1. Description of Organization and Summary of Significant Account­
ing Policies##,14
Organization. The Sample Continuing Care Retirement Community (CCRC). 
The CCRC is a nonprofit organization that principally provides housing, health 
care, and other related services to residents through the operation of a retire­
ment facility containing 249 apartments and a 78-bed health care facility lo­
cated in Evergreen Park, Illinois. The CCRC was incorporated in Illinois in 
20X1. A summary of significant accounting policies follows.
Use o f estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabilities 
and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Investments. Investments, which consist of U.S. Treasury obligations, are mea­
sured at fair value in the balance sheet. Investment income (including realized 
gains and losses on investments, interest, and dividends) is included in operat­
ing income (loss) unless restricted by donor or law. Unrealized gains and losses 
on investments, if any, are excluded from operating income (loss).
Deferred financing costs. Deferred financing costs are amortized using the 
effective interest method over the term of the related financing agreement.
Advance fees. Fees paid by a resident upon entering into a continuing care con­
tract, net of the portion thereof that is refundable to the resident, are recorded 
as deferred revenue and are amortized to income using the straight-line method 
over the estimated remaining life expectancy of the resident.
Obligation to provide future services. The CCRC annually calculates the 
present value of the net cost of future services and the use of facilities to be 
provided to current residents and compares that amount with the balance of 
deferred revenue from advance fees. If the present value of the net cost of fu­
ture services and the use of facilities exceeds the deferred revenue from advance 
fees, a liability is recorded (obligation to provide future services and use of fa­
cilities) with the corresponding charge to income. The obligation is discounted 
at nine percent, based on the expected long term rate of return on government 
obligations.
Donor restrictions. The CCRC reports gifts of cash and other assets as re­
stricted support if they are received with donor stipulations that limit the use of 
the donated assets. When a donor restriction expires (that is, when a stipulated 
time restriction ends or a purpose restriction is accomplished), temporarily
Health Care Organizations
13 SOP 00-1, Auditing Health Care Third-Party Revenues and Related Receivables (AICPA, Tech­
nical Practice Aids, AUD sec. 14,360), provides auditors with guidance regarding uncertainties in 
health care revenue recognition and includes a sample disclosure in paragraph 37 of the SOP for 
material differences between an original estimate and subsequent revisions regarding third-party 
payments. SOP 00-1 is included in appendix E to this guide.
# See footnote # in "Illustrative Financial Statements for a Not-for-Profit Hospital."
## Does not include all disclosures common to all health care entities.
14 Paragraph 13 of SOP 01-6 provides guidance on disclosures that should be included in the 
summary of significant accounting policies, including accounting policies for loans, trade receivables, 
and doubtful accounts.
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restricted net assets are reclassified as unrestricted net assets and reported 
in the statement of operations as net assets released from restrictions. Donor- 
restricted contributions whose restrictions are met within the same year as 
received are reflected as unrestricted contributions in the accompanying finan­
cial statements.
The CCRC reports gifts of property and equipment (or other long-lived assets) 
as unrestricted support unless explicit donor stipulations specify how the do­
nated assets must be used. Gifts of long-lived assets with explicit restrictions 
that specify how the assets are to be used and gifts of cash or other assets that 
must be used to acquire long-lived assets are reported as restricted support. 
Absent explicit donor stipulations about how long those long-lived assets must 
be maintained, the CCRC reports expirations of donor restrictions when the 
donated or acquired long-lived assets are placed in service.
Income taxes. The CCRC has been recognized by the IRS as a not-for-profit 
corporation as described in Section 501(c)(3) of the Internal Revenue Code (IRC) 
and is exempt from federal income taxes pursuant to Section 501(a) of the IRC.
Property and equipment. Property and equipment are stated at cost. Donated 
property is recorded at its estimated fair value at the date of receipt. Deprecia­
tion is computed on the straight-line method based on the following estimated 
useful lives:
Land improvements 20 years
Buildings and improvements 40 years
Furniture and equipment 5-15 years
Operating income (loss). The statement of operations includes operating in­
come (loss). Changes in unrestricted net assets which are excluded from oper­
ating income (loss), consistent with industry practice, include unrealized gains 
and losses on investments other than trading securities, permanent transfers 
of assets to and from affiliates for other than goods and services, and contribu­
tions of long-lived assets (including assets acquired using contributions which 
by donor restriction were to be used for the purposes of acquiring such assets).
2. Property and Equipment
A summary of property and equipment at December 31, 20X5 and 20X4, fol­
lows:
20X5 20X4
Land $ 557,000 $ 557,000
Land improvements  205,000 203,000
Buildings and improvements 14,573,000 14,564,000
Furniture and equipment 752,000 698,000
16,087,000 16,022,000
Less accumulated depreciation (1,194,000) (742,000)
$14,893,000 $15,280,000
3. Temporarily Restricted Net Assets 
Temporarily restricted net assets are available for the following purposes:
20X5 20X4.
Purchase of equipment $169,000 $152,000
Charity care 142,000 142,000
$311,000 $294,000
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Net assets were released from donor restrictions by incurring expenses sat­
isfying the restricted purposes or by occurrence of other events specified by
donors:
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20X5 20X4
Charity care $24,000 $50,000
Purchase of equipment $25,000 $45,000
4. Perm anently Restricted Net Assets
Permanently restricted net assets are restricted to investment in perpetuity, 
the income from which is expendable to support:
20X5 20X4
Charity care $168,000 $168,000
Community activities 283,000 216,000
5. Long Term Debt
$451,000 $384,000
Long term debt at December 31, 20X5 and 20X4, is as follows:
20X5 20X4
10.75 percent mortgage note payable $8,901,000 $8,965,000
Notes payable to bank—unsecured 34,000 14,000
Other 26,000 33,000
8,961,000 9,012,000
Less current maturities 90,000 77,000
$8,871,000 $8,935,000
The mortgage note is payable in consecutive monthly installments of princi­
pal and interest of $85,425 to May 20XX. The note is collateralized by a first 
mortgage on property and equipment with a depreciated cost at December 31, 
20X5, of $14,893,000 and by a pledge of all operating revenue.
As required by the mortgage note agreement, the CCRC established an initial 
debt service reserve fund of $1,000,000 at April 15, 20X3. All resident fees 
received thereafter, net of resident fee refunds and debt service payments not to 
exceed $300,000 annually in the first 4 years and $200,000 annually thereafter, 
are to be added to the debt service reserve fund until the total sum of $2,050,000 
is accumulated. Since June 1, 20X4, the CCRC has been required to deliver 
to the trustee $5,500 per month to establish maintenance reserves until the 
aggregate of such payments equals a residential unit reserve and a health care 
center reserve of $240,000 and $90,000, respectively. At December 31, 20X5 and 
20X4, the trustee held investments aggregating $2,130,000 and $1,753,000, 
respectively. Such amount has been classified as assets limited as to use.
Scheduled annual principal maturities of long term debt for the next five years 
are as follows:
Year Ending December 31, Amount
20X6 $90,000
20X7 90,000
20X8 95,000
20X9 105,000
20Y0 105,000
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6. Classification of Expenses
20X5 20X4
Program activities 3,368,000 3,135,000
General and administrative 593,000 570,000
$3,961,000 $3,705,000
7. Assets Limited as to Use||
8. Risks and Uncertainties Disclosures||
9. Pension Plan||
10. Postretirement Benefits||
11. Fair Values of Financial Instruments||
12. Concentrations of Credit Risk||
13. Investments||
|| See footnote |||| in "Illustrative Financial Statements for a Nursing Home."
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Sample Not-for-Profit Home Health Agency 
Balance Sheets‡
December 31 , 20X5 and 20X4
20X5 20X4
Assets
Current assets:
Cash and cash equivalents $ 74,000 $41,000
Investments 147,000 137,000
Accounts receivable, net of allowance for 
doubtful accounts of $61,000 in 20X5 and
$30,000 in 20X4 752,000 476,000
Other receivables 27,000 22,000
Total current assets 1,000,000 676,000
Investments 100,000 100,000
Equipment:
Medical and office equipment 56,000 39,000
Vehicles 50,000 37,000
106,000 76,000
Less accumulated depreciation (45,000) (24,000)
Equipment, net 61,000 52,000
Deferred finance charges, net of accumulated 
amortization of $15,000 in 20X5 and $10,000
in 20X4 20,000 25,000
Total assets $1,181,000 $853,000
Liabilities and Net Assets
Current liabilities:
Current maturities of long term debt $ 13,000 $13,000
Accounts payable 40,000 21,000
Accrued payroll and vacation costs 496,000 352,000
Estimated third-party payor settlements 28,000 31,000
Advances from third-party payors 70,000 66,000
Total current liabilities 647,000 483,000
Long term debt, less current maturities 105,000 118,000
Total liabilities 752,000 601,000
Net assets:
Unrestricted 330,000 167,000
Temporarily restricted 9,000 5,000
Permanently restricted 90,000 80,000
Total net assets 429,000 252,000
Total liabilities and net assets $1,181,000 $853,000
See accompanying notes to financial statements.
‡ See footnote ‡ in "Illustrative Financial Statements for a Not-for-Profit Hospital."
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FORMAT A
Sample Not-for-Profit Home Health A gency 
Statements o f  Operations
Years Ended D ecem ber 3 1 , 20X5 and 20X4
20X5 20X4
Revenue, gains, and other support:
Net patient service revenue $4,042,000 $2,687,000
Contributions 5,000 22,000
Net assets released from restrictions 5,000 —
Investment income 13,000 6,000
Other revenue 27,000 32,000
Total revenue, gains, and other support 
Expenses:
4,092,000 2,747,000
Salaries and benefits 2,714,000 1,835,000
Medical supplies and drugs 1,042,000 675,000
Insurance and other 90,000 83,000
Provision for bad debts 46,000 21,000
Depreciation 21,000 15,000
Interest 16,000 19,000
Total expenses
Excess of revenue over expenses and change in
3,929,000 2,648,000
unrestricted net assets $ 163.000 $ 99.000
See accompanying notes to financial statements.
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FORMAT B
Sample Not-for-Profit Home Health Agency 
Statements of Operations
Years Ended December 31 , 20X5 and 20X4
20X5 20X4
Revenue, gains, and other support:
Net patient service revenue $4,042,000 $2,687,000
Contributions 5,000 22,000
Net assets released from restrictions 5,000 —
Other revenue 27,000 32,000
Total revenue, gains, and other support 4,079,000 2,741,000
Expenses:
Salaries and benefits 2,714,000 1,835,000
Medical supplies and drugs 1,042,000 675,000
Insurance and other 90,000 83,000
Provision for bad debts 46,000 21,000
Depreciation 21,000 15,000
Interest 16,000 19,000
Total expenses 3,929,000 2,648,000
Operating income 150,000 93,000
Other income:
Investment income 13,000 6,000
Excess of revenue over expenses and change in
unrestricted net assets $ 163.000 $ 99.000
See accompanying notes to financial statements.
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Sample Not-for-Profit Home Health Agency 
Statements of Changes in Net Assets
Years Ended December 31 , 20X5 and 20X4
20X5 20X4
Unrestricted net assets:
Excess o f revenue over expenses $163,000 $99,000
Increase in unrestricted net assets 163,000 99,000
Temporarily restricted net assets:
Contributions 9,000 5,000
Net assets released from restrictions (5,000) —
Increase in temporarily restricted net assets 4,000 5,000
Permanently restricted net assets:
Contributions 10,000 6,000
Increase in permanently restricted net assets 10,000 6,000
Increase in net assets 177,000 110,000
Net assets, beginning of year 252,000 142,000
Net assets, end of year $429,000 $252,000
See accompanying notes to financial statements.
AAG-HCO APP A
282
Sample Not-for-Profit Home Health Agency 
Statements of Cash Flows
Years Ended December 3 1 , 20X5 and 20X4
Health Care Organizations
20X5
Cash flows from operating activities:
Cash received from patients and third party
payors $3,721,000
Other receipts from operations 22,000
Cash paid to employees and suppliers (3,679,000)
Interest paid (11,000)
Nonoperating revenue 23,000
Net cash provided by operating activities 76,000
Cash flows from investing activities:
Purchase of equipment (30,000)
Purchase of investments (10,000)
Net cash used in investing activities (40,000)
Cash flows from financing activities:
Proceeds from contributions restricted for:
Endowment 10,000
Other financing activities:
Payment of long term debt (13,000)
Net cash provided by (used in) financing
activities (3,000)
Net increase in cash and cash equivalents 33,000
Cash and cash equivalents, beginning of year 41,000
Cash and cash equivalents, end of year $ 74,000
Reconciliation of change in net assets to net 
cash provided by operating activities:
Change in net assets $177,000
Adjustments to reconcile change in net assets to
net cash provided by operating activities:
Increase in permanently restricted net assets (10,000)
Provision for bad debts 46,000
Depreciation 21,000
Amortization of deferred financing charges 5,000
(Increase) decrease in:
Accounts receivable (322,000)
Other receivables (5,000)
Increase (decrease) in:
Accounts payable, accrued payroll, and 
vacation costs 163,000
Estimated third-party payor settlements 1,000
Net cash provided by operating activities $76,000
20X4
$2,542,000
32,000
(2,541,000)
(14,000)
22,000
41,000
(19,000)
(15,000)
(34,000)
6,000
6,000
13,000
28,000 
$ 41,000
$110,000
(6,000)
21,000
15,000
5,000
(150,000)
4,000
38,000
4,000
$41,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Home Health Agency
Notes to Financial Statements#
Years Ended December 31, 20X5 and 20X4
1. Description of Organization and Summary of Significant Account­
ing Policies* 15
Organization. The Sample Home Health Agency (the agency) was incorpo­
rated in 20X0 in New State as a not-for-profit corporation. The agency provides 
health and supportive services to individuals at their homes, primarily in the 
New State area.
Use o f estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabilities 
and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments 
in highly liquid debt instruments with an original maturity of three months or 
less.
Investments. Investments, which consist of U.S. Treasury obligations, are 
measured at fair value in the balance sheet. Investment income (including 
realized gains and losses on investments, interest and dividends) is included in 
excess of revenues over expenses unless restricted by donor or law. Unrealized 
gains and losses on investments, if any, are excluded from excess of revenues 
over expenses.
Equipment. Equipment is recorded at cost. Depreciation is computed using 
the straight-line method over the estimated useful lives of the assets.
Deferred financing costs. Deferred financing costs are being amortized using 
the effective interest method over the term of the related financing agreement.
Donor restrictions. The agency reports gifts of cash and other assets as re­
stricted support if they are received with donor stipulations that limit the use 
of the donated assets. When a donor restriction expires, that is, when a stipu­
lated time restriction ends or purpose restriction is accomplished, temporarily 
restricted net assets are reclassified as unrestricted net assets and reported 
in the statement of operations as net assets released from restrictions. When 
long-lived assets are placed in service, thus satisfying purpose restrictions, 
the amount is included as a change in net assets, restricted and unrestricted. 
Donor-restricted contributions whose restrictions are met within the same year 
as received are reflected as unrestricted contributions in the accompanying fi­
nancial statements.
The agency reports gifts of equipment (or other long-lived assets) as unre­
stricted support unless explicit donor stipulations specify how the donated 
assets must be used. Gifts of long-lived assets with explicit restrictions that 
specify how the assets are to be used and gifts of cash or other assets that 
must be used to acquire long-lived assets are reported as restricted support.
# See footnote # in "Illustrative Financial Statements for a Not-for-Profit Hospital."
15 Paragraph 13 of SOP 01-6 provides guidance on disclosures that should be included in the
summary of significant accounting policies, including accounting policies for loans, trade receivables, 
and doubtful accounts.
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Absent explicit donor stipulations about how long those long-lived assets must 
be maintained, the agency reports expirations of donor restrictions when the 
donated or acquired long-lived assets are placed in service.
Net patient service revenue. Net patient service revenue represents the esti­
mated net realizable amounts from patients, third-party payors, and others for 
services rendered.
Charity care. The agency has a policy of providing charity care to patients who 
are unable to pay. Such patients are identified based on financial information 
obtained from the patient and subsequent analysis. Because the agency does 
not expect payment, estimated charges for charity care are not included in 
revenue.
Income taxes. The agency has been recognized by the IRS as a not-for-profit 
corporation as described in Section 501(c)(3) of the Internal Revenue Code (IRC) 
and is exempt from federal income taxes on related income pursuant to Section 
501(a) of the IRC.
Excess o f  revenue over expenses. The statement of operations includes excess 
of revenue over expenses. Changes in unrestricted net assets which are excluded 
from excess of revenue over expenses, consistent with industry practice, include 
unrealized gains and losses on investments other than trading securities, per­
manent transfers of assets to and from affiliates for other than goods and ser­
vices, and contributions of long-lived assets (including assets acquired using 
contributions which by donor restriction were to be used for the purposes of 
acquiring such assets).
2. Temporarily Restricted Net Assets
Temporarily restricted net assets are available for the following purposes:
20X5 20X4
Charity care $ — $5,000
Purchase of equipment 9,000 —
$9,000 $5,000
Health Care Organizations
Net assets were released from donor restrictions by incurring expenses sat­
isfying the restricted purposes or by occurrence of other events specified by 
donors:
20X5 20X4
Charity care expenditures $5,000 $ —
3. Permanently Restricted Net Assets
Permanently restricted net assets are restricted in perpetuity, the income from 
which is expendable to support:
20X5 20X4
Program A activities $10,000 $ —
Any activities of the agency 80,000 80,000
$90,000 $80,000
4. Third-Party Rate Adjustments and Revenue
Approximately 38 percent in 20X5 and 37 percent in 20X4 of net patient 
service revenue was derived under federal and state third-party reimbursement
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programs. These revenues are based, in part, on cost reimbursement principles 
and are subject to audit and retroactive adjustment by the respective third- 
party fiscal intermediaries. Laws and regulations governing these programs are 
extremely complex and subject to interpretation. As a result, there is at least a 
reasonable possibility that recorded estimates will change by a material amount 
in the near term. The 20X5 net patient service revenue increased approximately 
$XXX due to removal of allowances previously estimated that are no longer 
necessary as a result o f final settlements and years that are no longer subject 
to audits, reviews, and investigations. The 20X4 net patient service revenue 
decreased approximately $XXX due to prior-year retroactive adjustments in 
excess o f amounts previously estimated.
5. Internally Designated Assets
The board of directors has designated investments aggregating $100,000 to 
be used for future major capital improvements. Those assets are classified in 
the balance sheet as long term investments.
6. Long Term Debt
Long term debt at December 31, 20X5 and 20X4, is as follows:
20X5 20X4
Note payable to bank, interest at 15 percent, 
payable in monthly installments of $2,200 per 
month, including interest, collateralized by
equipment with a depreciated cost of $42,000 $118,000 $131,000
Less current maturities 13,000 13,000
$105,000 $118,000
Scheduled maturities of long term debt at December 31, 20X5, are as follows:
Year Ending December 31, Amount
20X6 $13,000
20X7 13,000
20X8 13,000
20X9 13,000
20Y0 13,000
Thereafter 53,000
Total $118,000
7. Classification of Expenses
__________  General and
Total A B C Administrative
Expenses incurred for the 
year ended December
31 , 20X5, were for: 
Salaries and benefits $2,714,000 $1,363,000 $699,000 $363,000 $289,000
Medical supplies and 
drugs 1,042,000 511,000 246,000 285,000
Insurance and other 
Provision for bad debts
90,000
46,000
58,000
16,000 30,000
32,000
Depreciation
Interest
21,000
16,000
5,000
10,000 3,000
16,000
3,000
Total expenses $3,929,000 $1,963,000 $978,000 $648,000 $340,000
(continued)
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Program
Total
General and 
A B C  Administrative
Expenses incurred for the 
year ended December 
31 , 20X4, were for:
Salaries and benefits $1,835,000 $ 915,000 $463,000 $216,000 $241,000
Medical supplies and
drugs 675,000 335,000 211,000 129,000
Insurance and other 83,000 64,000 19,000
Provision for bad debts 21,000 21,000
Depreciation 15,000 6,000 9,000
Interest 19,000 12,000 5,000 2,000
Total expenses $2,648,000 $1,353,000 $679,000 $345,000 $271,000
(The preparer of the financial statements may wish to include a brief descrip­
tion of the types of programs.)
8. Charity Care
Charity care represented approximately 3 percent and 4 percent of visits in 
20X5 and 20X4, respectively.
9. Risks and Uncertainties Disclosures|||
10. Pension Plan|||
11. Postretirement Benefits||||
12. Fair Value of Financial Statements|||
13. Concentrations of Credit Risk|||
14. Investments||
|| See footnote || || in "Illustrative Financial Statements for a Nursing Home."
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A  
HEALTH MAINTENANCE ORGANIZATION
Illustrative Financial Statements
Sample Not-for-Profit Health Maintenance Organization 
Balance Sheets‡
June 30, 20X5 and 20X4
20X5 20X4
Assets
Current assets:
Cash and cash equivalents $2,937,000 $1,021,000
Premiums receivable, net of allowance for 
doubtful accounts of $36,000 in 20X5 and
$42,000 in 20X4 358,000 407,000
Other receivables 263,000 261,000
Supplies 190,000 184,000
Prepaid expenses 197,000 99,000
Total current assets 3,945,000 1,972,000
Property and equipment, net 5,756,000 5,626,000
State guaranty fund deposit 150,000 150,000
Debt issuance costs, net of accumulated 
amortization of $42,000 in 20X5 and $39,000
in 20X4 18,000 21,000
Total assets $9,869,000 $7,769,000
Liabilities and Net Assets
Current liabilities:
Unsecured 12 percent note payable to a bank $ - $ 44,000
Current maturities of long term debt 241,000 109,000
Accounts payable—medical services 2,245,000 1,471,000
Other accounts payable and accrued expenses 829,000 661,000
Unearned premium revenue 141,000 202,000
Total current liabilities 3,456,000 2,487,000
Long term debt, less current maturities 4,295,000 2,382,000
Total liabilities 7,751,000 4,869,000
Net assets—unrestricted 2,118,000 2,900,000
Total liabilities and net assets $9,869,000 $7,769,000
See accompanying notes to financial statements.
‡ See footnote ‡ in "Illustrative Financial Statements for a Not-for-Profit Hospital."
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Sample Not-for-Profit Health Maintenance Organization 
Statements of Operations and Changes in Net Assets
Years Ended June 30, 20X5 and 20X4
Health Care Organizations
20X5 20X4
Revenue:
Premiums earned $27,682,000 $22,500,000
Coinsurance 689,000 500,000
Interest and other income 242,000 100,000
Total revenue 28,613,000 23,100,000
Expenses:
Salaries and benefits 16,154,000 13,328,000
Medical supplies and drugs 8,507,000 5,988,000
Insurance 3,963,000 2,463,000
Provision for bad debts 19,000 20,000
Depreciation 367,000 336,000
Interest 385,000 375,000
Total expenses 29,395,000 22,510,000
Operating income (loss) (782,000) 590,000
Net assets, beginning o f year 2,900,000 2,310,000
Net assets, end of year $2,118,000 $2,900,000
See accompanying notes to financial statements.
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Statements o f  Cash Flows
Years Ended June 30, 20X5 and 20X4
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Cash flows from operating activities:
Cash received from premiums, stop-loss
20X5 20X4
insurance recoveries, and coinsurance
Cash paid to employees and to providers of
$28,969,000 $24,410,000
health care services (28,405,000) (22,818,000)
Interest and other income received 230,000 90,000
Interest paid (382,000) (372,000)
Net cash provided by operating activities 
Cash flows from investing activities:
412,000  1,310,000
Capital expenditures (497,000) (121,000)
Net cash used in investing activities
Cash flows from financing activities:
(497,000) (121,000)
Proceeds from long term debt 2,300,000 —
Principal payments on long term debt (255,000) (1,000,000)
Principal payments on note payable £44,000) —
Net cash provided by (used in) financing
activities 2,001,000 (1,000,000)
Net increase in cash and cash equivalents 1,916,000 189,000
Cash and cash equivalents, beginning of year 1,021,000 832,000
Cash and cash equivalents, end of year
Reconciliation of change in net assets to net 
cash provided by operating activities:
$2,937,000 $1,021,000
Change in net assets $(782,000) $ 590,000
Adjustments to reconcile change in net 
assets to net cash provided by operating 
activities:
Depreciation and amortization 370,000 339,000
Provision for bad debts 
(Increase) decrease in:
19,000 20,000
Premiums receivables 30,000 64,000
Other current assets
Increase (decrease) in:
230,000 (93,000)
Accounts payable—medical services
Other accounts payable and accrued
774,000 335,000
expenses (168,000) (60,000)
Unearned premium revenue (61,000) 115,000
Net cash provided by operating activities $ 412.000 $1,310,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Health Maintenance Organization 
Notes to Financial Statements16,#
June 30, 20X5 and 20X4
Health Care Organizations
1. Organization
The Sample Health Maintenance Organization (the HMO) was incorporated 
in 20X0 in New State as a not-for-profit corporation for the purpose of providing 
comprehensive health care services on a prepaid basis and for the purpose 
of establishing and operating organized health maintenance and health care 
delivery systems.
The HMO has been determined to be a qualified HMO under Title XIII of the 
Public Health Service Act.
2. Summary of Significant Accounting Policies17
Use o f  estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabilities 
and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments 
in highly liquid debt instruments with an original maturity of three months or 
less.
Supplies. Inventories of drugs and other supplies are stated at the lower of 
cost (first-in, first-out) or market.
Property and equipment. Property and equipment are recorded at cost. Main­
tenance and repairs are charged to expense, and betterments are capitalized. 
Property and equipment costing approximately $700,000 was financed by HMO 
initial development grants received in 20X1 and 20X2 from the U.S. Depart­
ment of Health and Human Services (HHS). This property will be owned by 
the HMO as long as the equipment and facilities are used for projects related 
to the objectives of the Public Health Service Act.
Depreciation is computed using the straight-line method over the estimated 
useful lives of the related assets as follows:
Building
Improvements
Data processing and laboratory 
equipment and automobiles
Medical equipment
Office equipment
40 years 
20-25 years
3-7 years 
10 years 
5-10 years
16 SOP 00-1 provides auditors with guidance regarding uncertainties in health care revenue 
recognition and includes a sample disclosure in paragraph 37 of the SOP for material differences 
between an original estimate and subsequent revisions regarding third-party payments. SOP 00-1 is 
included in appendix E to this guide.
# See footnote # in "Illustrative Financial Statements for a Not-for-Profit Hospital."
17 Paragraph 13 of SOP 01-6 provides guidance on disclosures that should be included in the 
summary of significant accounting policies, including accounting policies for loans, trade receivables, 
and doubtful accounts.
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Amortization o f  debt issuance costs. Debt issuance costs are deferred and amor­
tized using the effective interest method over the term of the related debt.
Health care service cost recognition. The HMO contracts with various health 
care providers for the provision of certain medical care services to its members. 
The HMO compensates these providers on a capitation basis. As part of a cost 
control incentive program, the HMO retains up to 20 percent of the capitation 
as a risk-sharing fund. In the event of hospital utilization in excess of bud­
get, those providers bear the risk to the extent o f 15 percent of the capitation 
fee. Operating expenses include all amounts incurred by the HMO under the 
aforementioned contracts.
The cost of other health care services provided or contracted for is accrued 
in the period in which it is provided to a member based in part on estimates, 
including an accrual for medical services provided but not reported to the HMO.
Premiums revenue. Membership contracts are on a yearly basis subject to 
cancellation by the employer group or the HMO upon 30 days written notice. 
Premiums are due monthly and are recognized as revenue during the period in 
which the HMO is obligated to provide services to members.
Reinsurance (stop-loss insurance). Reinsurance premiums are reported as 
health care costs, and reinsurance recoveries are reported as a reduction of 
related health care costs.  
Federal income tax. The HMO is exempt from federal income taxes under 
Section 501(c)(4) of the Internal Revenue Code; accordingly, no provision for 
federal income taxes has been made in the accompanying financial statements.
3. Property and Equipment
Property and equipment at June 30, 20X5 and 20X4, consists of the following:
20X5 20X4
Land $ 300,000 $ 300,000
Buildings and improvements 5,473,000 5,459,000
Furniture and equipment 1,786,000 1,303,000
7,559,000 7,062,000
Less accumulated depreciation (1,803,000) (1,436,000)
$5,756,000 $5,626,000
4. Long Term Debt
Long term debt is collateralized by assets with a depreciated cost of
$4,943,000. A summary of long term debt at June 30 , 20X5 and 20X4, follows.
20X5 20X4
HHS loan, interest at 7.5 percent, payable in 
monthly installments of $50,000, including
interest $2,020,000 $ 111,000
HHS loan, interest at 9.25 percent, payable in 
monthly installments of $10,000, including
interest 1,658,000 1,694,000
Secured equipment loans, payable in monthly
installments o f $15,000, including interest 858,000 686,000
4,536,000 2,491,000
Less current maturities 241,000 109,000
$4,295,000 $2,382,000
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Scheduled principal payments on long term debt are as follows:
Year Ending December 31,
20X6
20X7
20X8
20X9
20Y0
Amount
$ 241,000 
259,000 
280,000 
800,000
2,956,000
$4,536,000
5. State Guarantee Fund Deposit
In August 20X4, the state in which the HMO is domiciled enacted legislation 
specifically governing HMOs. Under this legislation, the corporation is required 
to maintain a deposit of $150,000 with the director of the division of insurance 
of the state.
6. Employee Retirement Plan
The HMO has a contributory defined contribution retirement plan covering 
substantially all employees. Expense determined in accordance with the plan 
formula (4 percent to 10 percent of eligible covered compensation) was $354,000 
and $275,000 for the years ended June 30, 20X5 and 20X4, respectively.
7. Stop-Loss Insurance
The HMO entered into a stop-loss insurance agreement with an insurance 
company to limit its losses on individual claims. Under the terms of this agree­
ment, the insurance company will reimburse the HMO approximately 25 per­
cent of the cost of each member's annual hospital services, in excess of a $1,000 
deductible, up to a lifetime limitation of $500,000 per member. In the event 
the HMO ceases operations, (a) plan benefits will continue for members who 
are confined in an acute care hospital on the date of insolvency until their dis­
charge, and (b) plan benefits will continue for any other member until the end 
of the contract period for which premiums have been paid.
Stop-loss insurance premiums of approximately $700,000 and $500,000 are 
included in insurance expense (note 9) in 20X5 and 20X4, respectively. Approx­
imately $600,000 and $400,000 in stop-loss insurance recoveries are deducted 
from insurance expense in 20X5 and 20X4, respectively.
Included in other receivables is approximately $50,000 recoverable from in­
surers.
8. Malpractice Claims
Malpractice claims have been asserted against the HMO by various claimants. 
The claims are in various stages of processing, and some may ultimately be 
brought to trial. In the opinion of counsel, the outcome of these actions will not 
have a significant effect on the financial position or the operating income of the 
HMO. Incidents occurring through June 30, 20X5, may result in the assertion 
of additional claims. Other claims may be asserted arising from past services 
provided. Management believes that these claims, if asserted, would be settled 
within the limits of insurance coverage.
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9. Classification of Expenses
20X5 20X4
Program activities 
General and administrative
26,921,000
2,474,000
$29,395.000
20,909,000
1,601,000
$22,510,000
10. Risks and Uncertainties Disclosures|||
11. Pension Plan||||
12. Postretirement Benefits||||
13. Fair Value of Financial Instruments||||
14. Concentrations of Credit Risk|||
|| See footnote || || in "Illustrative Financial Statements for a Nursing Home.”
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A N  
AMBULATORY CARE ORGANIZATION
Health Care Organizations
Sample Not-for-Profit Ambulatory Care, Inc. 
Balance Sheets‡
December 3 1 , 20X5 and 20X4
20X5 20X4
Assets
Current assets:
Cash $ 65,000 $ 76,000
Patient accounts receivable, net of allowance 
for doubtful accounts of $15,000 in 20X5 and
$5,000 in 20X4 290,000 278,000
Estimated retroactive
adjustments—third-party payors 19,000 32,000
Accounts receivable— other 13,000 8,000
Supplies 21,000 18,000
Prepaid expenses and deposits 5,000 9,000
Total current assets 413,000 421,000
Property and equipment, at cost:
Land 100,000 100,000
Land improvements 322,000 322,000
Buildings 682,000 682,000
Equipment 1,390,000 1,389,000
2,494,000 2,493,000
Less accumulated depreciation 217,000 100,000
Property and equipment, net 2,277,000 2,393,000
Other assets:
Advances receivable 14,000 5,000
Total assets $2,704,000 $2,819,000
Liabilities and Net Assets
Current liabilities:
Notes payable $ 138,000 $ 144,000
Accounts payable 42,000 77,000
Accrued payroll, benefits, and taxes 33,000 22,000
Estimated retroactive
adjustments—third-party payors 30,000 24,000
Financing advance from third-party payors — 1,000
Total current liabilities 243,000 268,000
Guarantee liability 10,000 10,000
Total liabilities 253,000 278,000
Net assets—unrestricted 2,451,000 2,541,000
Total liabilities and net assets $2,704,000 $2,819,000
See accompanying notes to financial statements.
‡ See footnote ‡ in "Illustrative Financial Statements for a Not-for-Profit Hospital."
AAG-HCO APP A
Illustrative Financial Statements 295
Sample Not-for-Profit Ambulatory Care, Inc. 
Statements of Operations and Changes in Net Assets
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Revenue and gains:
Net patient service revenue $ 860,000 $ 357,000
Other 29,000 15,000
Total revenue and gains 889,000 372,000
Expenses:
Salaries and benefits 485,000 243,000
Medical supplies and drugs 189,000 66,000
Insurance 154,000 98,000
Provision for bad debts 14,000 4,000
Depreciation 117,000 100,000
Interest 20,000 18,000
Total expenses 979,000 529,000
Operating loss (90,000) (157,000)
Net assets, beginning of year 2,541,000 2,698,000
Net assets, end of year $2,451,000 $2,541,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Ambulatory Care, Inc. 
Statements of Cash Flows
Years Ended December 31 , 20X5 and 20X4
Health Care Organizations
Cash flows from operating activities:
Cash received from patients and third-party
20X5 20X4
payors $866,000 $368,000
Cash received from others 21,000 6,000
Interest received 3,000 11,000
Interest paid (15,000) (16,000)
Cash paid to employees and suppliers
Net cash provided by (used in) operating
(870,000) (432,000)
activities
Cash flows from investing activities:
5,000 (63,000)
Purchase of equipment (1,000) (4,000)
Advances made to XYZ Affiliate (9,000) (5,000)
Net cash used in investing activities
Cash flows from financing activities:
(10,000) (9,000)
Proceeds from notes payable — 144,000
Payments on notes payable
Net cash provided by (used in) financing
(6,000) —
activities (6,000) 144,000
Net increase (decrease) in cash (11,000) 72,000
Cash, beginning of year 76,000 4,000
Cash, end of year
Reconciliation of change in net assets to net 
cash provided by (used in) operating 
activities:
$65,000 $76,000
Change in net assets
Adjustments to reconcile change in net assets 
to net cash provided by (used in) operating 
activities:
$ (90,000) $(157,000)
Depreciation 117,000 100,000
Provision for bad debts 
(Increase) decrease in:
14,000 4,000
Patient accounts receivable (12,000) (19,000)
Other current assets
Increase (decrease) in:
Accounts payable and accrued payroll,
1,000 (2,000)
benefits, and taxes (24,000) 10,000
Other current liabilities
Net cash provided by (used in) operating
(1,000) 1,000
activities $ 5,000 $(63,000)
See accompanying notes to financial statements.
AAG-HCO APP A
Illustrative Financial Statements 297
Sample Not-for-Profit Ambulatory Care, Inc.
Notes to Financial Statements#
December 31, 20X5 and 20X4
1. Description of Organization and Summary of Significant Account­
ing Policies* 18
Organization. Ambulatory Care, Inc. was incorporated on September 7 , 20X3, 
in New State, to operate an ambulatory care health facility to treat or prevent 
injury and disease, to provide funds or to expend funds to further the treatment 
or prevention of injury or disease, and to develop and participate in activities 
designed to promote the general health of the community.
Three area hospitals—ABC Hospital and Health Center, DEF Hospital, and 
GHI Hospital—entered into a members' agreement to develop this ambula­
tory care center. In accordance with this agreement, each hospital contributed 
capital of $947,000 to Ambulatory Care, Inc. Ambulatory Care, Inc. began op­
erations in October 20X3.
Use o f estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabilities 
and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Supplies. Supplies are stated at the lower of cost (first-in, first-out) or net 
realizable value.
Depreciation. Depreciation of property and equipment is computed on the 
straight-line method over the estimated lives of depreciable assets.
Third-party contractual adjustments. Retroactively calculated third-party 
contractual adjustments are accrued on an estimated basis in the period the re­
lated services are rendered. Net patient service revenue is adjusted as required 
in subsequent periods based on final settlements.
Net patient service revenue. Patient service revenue is reported at the esti­
mated net realizable amounts from patients, third-party payors, and others for 
services rendered.
Charity care. Ambulatory Care, Inc. has a policy of providing charity care to 
patients who are unable to pay. Such patients are identified and related charges 
are estimated, based on financial information obtained from the patient and 
subsequent analysis. Since management does not expect payment for charity 
care, the estimated charges are excluded from revenue.
Income taxes. Ambulatory Care, Inc. has been recognized by the IRS as a not- 
for-profit corporation as described in Section 501(c)(3) of the Internal Revenue 
Code (IRC) and is exempt from federal income taxes on related income pursuant 
to Section 501(a) of the IRC.
# See footnote # in "Illustrative Financial Statements for a Not-for-Profit Hospital."
18 Paragraph 13 of SOP 01-6 provides guidance on disclosures that should be included in the
summary of significant accounting policies, including accounting policies for loans, trade receivables, 
and doubtful accounts.
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2. Advances Receivable
In May 20X4, Ambulatory Care, Inc. entered into a 5 year agreement with 
XYZ Affiliates (XYZ). Under this agreement, XYZ is to provide emergency med­
ical services as well as charge and bill each patient treated at Ambulatory Care, 
Inc. Ambulatory Care, Inc. has guaranteed that XYZ will collect at least $18,000 
per month during the term of this agreement. In any month in which XYZ does 
not collect the minimum guarantee, Ambulatory Care, Inc. advances funds to 
XYZ to cover the deficiency. Such advances are to be repaid to the extent XYZ's 
net cash collections exceed the minimum guarantee amount. Management es­
timates that the advances will be fully recovered in 20X8.
3. Related-Party Transactions
During 20X3, Ambulatory Care, Inc. entered into a contract with 1 of the 
member hospitals (the managing hospital) for the management of the business 
and affairs of Ambulatory Care, Inc. Under this agreement, Ambulatory Care, 
Inc. pays $4,000 per month to the managing hospital. The agreement with the 
managing hospital was to remain in effect through December 31 , 20X5, but has 
been extended on a month-to-month basis.
In addition, during 20X4 each hospital loaned $48,000 to Ambulatory Care, 
Inc. in the form of promissory notes at an interest rate of prime rate plus 1 per­
cent (effective rates of 10 percent and 9 percent in 20X5 and 20X4, respectively). 
Of the total $144,000 liability, $48,000 is payable on demand after November 28, 
20X5, to one member hospital, with the remaining portion ($96,000) payable on 
demand after December 8 , 20X5, to the other 2 member hospitals. During 20X5, 
Ambulatory Care, Inc. paid $2,000 to each member hospital, thereby reducing 
the obligation to $138,000.
4. Revenue From Contracting Agencies
Ambulatory Care, Inc. participates as a provider of health care services to 
Blue Cross, Medicare, and County Indigent Plan patients. Reimbursement for 
covered services is based on tentative payment rates. Final reimbursement is 
determined after submission of annual cost reports and audits thereof by the 
fiscal intermediaries. Provisions for estimated reimbursement adjustments are 
reported in the financial statements in the period that the services are rendered.
Revenue from the Medicare program accounted for approximately XX percent 
for the year ended 20X5, and XX percent for the year ended 20X4, of Ambulatory 
Care, Inc.'s net patient revenue. Laws and regulations governing the Medicare 
program are extremely complex and subject to interpretation. As a result, there 
is at least a reasonable possibility that recorded estimates will change by a ma­
terial amount in the near term. The 20X5 net patient service revenue increased 
approximately $XXX due to removal of allowances previously estimated that 
are no longer necessary as a result of final settlements and years that are 
no longer subject to audits, reviews, and investigations. The 20X4 net patient 
service revenue decreased approximately $XXX due to prior-year retroactive 
adjustments in excess of amounts previously estimated.
5. Charity Care
Ambulatory Care, Inc. has a policy of providing charity care to indigent pa­
tients in emergency situations. These services, which are excluded from rev­
enues, amounted to $27,000 and $13,000 in 20X5 and 20X4, respectively, when 
measured at Ambulatory Care, Inc.'s established rates.
Health Care Organizations
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6. Classification of Expenses
_____________________________  General and
Total A  B  C Administrative
Expenses incurred for
the year ended
December 31 , 20X5, 
were for:
Salaries and benefits $485,000 $216,000 $102,000 $121,000 $46,000
Medical supplies and
drugs 189,000 98,000 43,000 48,000 —
Insurance 154,000 79,000 45,000 14,000 16,000
Provision for bad debts 14,000 9,000 — 5,000 —
Depreciation 117,000 100,000 — 17,000 —
Interest 20.000 9,000 — — 11,000
Total expenses $979,000 $511,000 $190,000 $205,000 $73,000
Total A
Program
B C
General and 
Administrative
Expenses incurred for the 
year ended December
31, 20X4, were for: 
Salaries and benefits $243,000 $111,000 $46,000 $57,000 $29,000
Medical supplies and 
drugs 66,000 31,000 15,000 20,000
—
Insurance 98,000 45,000 19,000 26,000 8,000
Provision for bad debts 4,000 — 4,000 — —
Depreciation 100,000 56,000 — 44,000 —
Interest 18,000 7,000 —  — 11,000
Total expenses $529,000 $250,000 $84,000 $147,000 $48,000
(The preparer of the financial statements may wish to include a brief descrip­
tion of the types of programs.)
7. Risks and Uncertainties Disclosures||||
8. Pension Plan|||
9. Postretirement Benefits|||
10. Fair Value of Financial Instruments||||
11. Concentrations of Credit Risk||
|| See footnote || || in "Illustrative Financial Statements for a Nursing Home."
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Appendix B
Background Information and Basis 
for Conclusions
1. This appendix provides background information and discusses the com­
ments received on the April 14, 1995, exposure draft that preceded this Audit 
and Accounting Guide (guide): Proposed Audit and Accounting Guide Health 
Care Organizations and the basis for key conclusions in this guide.
Background Information
2. In 1989, the AICPA Health Care Committee (committee) completed a 
total rewrite of the guide. Since then, conforming changes have been made 
to update the guide for newly issued technical pronouncements. In June 1993, 
the Financial Accounting Standards Board (FASB) issued FASB Statement No. 
116, Accounting for Contributions Received and Contributions Made, and FASB 
Statement No. 117, Financial Statements of Not-for-Profit Organizations. These 
statements provide broad standards and introduce new concepts for which there 
is no detailed implementation guidance. FASB Statement No. 117 permits the 
AICPA to provide more specific reporting guidance. Specifically, paragraph 3 of 
FASB Statement No. 117 states the following:
Within the parameters of the Statement, the AICPA or another ap­
propriate body, following the process described in AICPA Statement 
of Auditing Standards (SAS) No. 69, The Meaning o f  Present Fairly 
in Conformity With Generally Accepted Accounting Principles, may 
provide more specific reporting guidance for certain not-for-profit 
organizations.
The guide provides this guidance as it relates to providers of health care ser­
vices.
3. In April 1995, the committee released an exposure draft of a proposed 
Audit and Accounting Guide Health Care Organizations for public comment. 
The committees received 40 comment letters on the exposure draft. The commit­
tees redeliberated the issues based on the comments received. This appendix 
discusses the key issues in the exposure draft and comments received on those 
issues, as well as the basis for Accounting Standards Executive Committee's 
(AcSEC) conclusions on those and certain other issues.
Basis for Conclusions
FASB Statement Nos. 116 and 117
4. FASB Statement Nos. 116 and 117 allow more flexibility in financial re­
porting than currently exists within the health care industry. The most promi­
nent flexibility relates to the elimination of the requirements to present a clas­
sified balance sheet and income statement as compared to the statement of 
activities.
5. FASB Statement Nos. 116 and 117 apply to all not-for-profit enter­
prises, regardless of whether the entity is a business enterprise. The majority 
of tax-exempt health care organizations, however, operate as business enter­
prises (that is, they are essentially self-sustaining from fees charged for goods
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and services). The committee believes that the uniformity and usefulness of 
financial reporting for business enterprise organizations would be enhanced 
if the implementation guidance for FASB Statement Nos. 116 and 117 were 
consistent with the objectives of business enterprise financial reporting. The 
committee points to the provisions in FASB Statement of Financial Account­
ing Concepts No. 4, Objectives o f Financial Reporting by Nonbusiness Orga­
nizations, paragraph 8, which clearly supports the use of business enterprise 
financial reporting objectives for those organizations:
Some organizations have no ownership interest but are essentially 
self-sustaining from fees they charge for goods and services. Exam­
ples are those private nonprofit hospitals... that may receive relatively 
small amounts of contributions and grants, but finance their capital 
needs largely from the proceeds of debt issues and their operating 
needs largely from service charges rather than from private philan­
thropy or governmental grants. As a result, assessments of amounts, 
timing, and uncertainty of cash flows become the dominate interest of 
their creditors and other resource providers and profitability becomes 
an important indicator of performance. Consequently, the objectives 
of Concepts Statement 1 may be more appropriate for those organiza­
tions.
6. Based on the theoretical support provided in FASB Concept No. 4, as 
well as the FASB allowance for more specific guidance (see paragraph 2 of this 
appendix), chapter 1 of the guide defines 4 types of operating structures that are 
found within the industry: (1) not-for-profit business-oriented organizations, (2) 
investor-owned health care enterprises, (3) governmental health care organi­
zations, and (4) not-for-profit, nonbusiness-oriented organizations. This guide 
provides specific reporting guidance for not-for-profit business-oriented organi­
zations, investor-owned enterprises and governmental entities. (Not-for-profit 
nonbusiness organizations follow guidance for not-for-profit entities provided 
in the Audit and Accounting Guide Not-for-Profit Organizations.) The guide rec­
ommends that these entities provide a classified balance sheet and a statement 
o f operations. The guide also encourages natural class reporting on the face of 
the financial statements, with disclosure of functional details in the footnotes.
7. A number of respondents to the exposure draft were concerned that 
because the exposure draft of the guide did not require an entity to distinguish 
between operating activities and nonoperating activities, such distinctions were 
no longer permissible. In response to these concerns, the guide was clarified to 
incorporate paragraph 23 o f FASB Statement No. 117. This paragraph specif­
ically allows additional classifications within a statement of operations. Like 
FASB Statement No. 117, however, the guide neither requires nor precludes 
such classifications.
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Assets Whose Use is Limited
8. Several comments were received on the exposure draft requesting spe­
cific guidance to allow internally designated funds to be disclosed on the face of 
the financial statements. In response to these comments, the committee clari­
fied the guide to require cash and claims to cash that meet one of the following 
criteria to be reported separately and excluded from current assets:
a. Restricted as to withdrawal or use for other than current operations
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b. Designated for expenditure in the acquisition or construction of 
noncurrent assets
c . Required to be segregated for the liquidation of long term debts
d. Required by a donor-imposed restriction that limits their use to 
long term purposes
Consistent with comments received from a rating agency, the guide requires 
internally designated funds to be reported separately from externally desig­
nated funds either in the notes to or on the face of the financial statements. 
The committee believes this separation is beneficial due to the degree of control 
an organization maintains over internally designated funds.
Investments
9. Chapter 4, as presented in the exposure draft, was redrafted to conform 
with the provisions of FASB Statement No. 124, Accounting for Certain Invest­
ments Held by Not-for-Profit Organizations. This standard requires fair value 
accounting for marketable equity and debt securities. The majority of respon­
dents to the exposure draft favored an income recognition approach similar to 
FASB Statement No. 115, Accounting for Certain Investments in Debt and Eq­
uity Securities. They believe such an approach is essential because it would fos­
ter greater consistency among not-for-profit and for-profit entities. Accordingly, 
an approach similar to FASB Statement No. 115 (that is, the differentiation 
of trading securities versus available-for-sale securities) was incorporated into 
the guide. (FASB specifically prohibited the use of a held-to-maturity category 
by not-for-profit organizations.)1
Accounting for Donor-Imposed Restricted Contributions on 
Long-Lived Assets
10. The majority of comments received on accounting for donor-imposed 
restrictions on contributions of long-lived assets concurred with the commit­
tee's conclusion that the expiration of donor imposed restrictions on long-lived 
assets should be recognized when the asset is placed in service (rather than 
as depreciated as permitted by FASB Statement No. 116). Other respondents 
disagreed with the committee's position for various reasons. After considering 
each comment on the issue, the committee concluded that it would maintain the 
position set forth in the exposure draft. The committee believes this approach is 
easier to implement, it provides for uniformity in reporting within the industry 
and, because the donations are excluded from operating results, an appropriate 
matching of revenues and expenses occurs.
Use of a Performance Indicator
11. The guide stresses the importance of the performance indicator and, in 
an effort to ensure consistency within the industry, provides specific guidance on 
what the performance indicator should represent. This guidance is consistent 
with performance criteria historically used in the health care industry, to the 
extent allowed under the provisions of FASB Statement No. 117. Specifically,
Background Information and Basis for Conclusions
1 Financial Accounting Standards Board Statement No. 124, Accounting for Certain Investments 
Held by Not-for-Profit Organizations, as amended, permits not-for-profit organizations to designate 
debt securities as held-to-maturity with unrealized gains and losses excluded from an operating mea­
sure in the statement of activities.
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the guide states that health care organizations should report the results of their 
operations separately from2
a. transactions with owners acting in that capacity.
b. equity transfers involving other entities that control the reporting 
entity, are controlled by the reporting entity, or are under common 
control with the reporting entity.
c. receipt of restricted contributions, including temporary restrictions 
(such as time or purpose) or permanent restrictions.
d. contributions of (and assets released from donor restrictions related 
to) long-lived assets.
e. unrealized gains and losses on investments not restricted by donors 
or by law, except for those investments classified as trading securi­
ties.
f. investment returns restricted by donors or by law.
g. other items that are required by generally accepted accounting 
principles (GAAP) to be reported separately (such as extraordinary 
items, the effect of discontinued operations, or the cumulative effect 
of accounting changes).3
12. In its deliberations, FASB discussed the use of the word net income to 
describe the performance indicator of not-for-profit health care organizations. 
FASB concluded that the term net income is an inappropriate term to describe 
the performance indicator of a not-for-profit organization and that descriptive 
terms such as revenues over expenses, revenues and gains over expenses and 
losses, earned income, or performance earnings would be more appropriate. 
Accordingly, this guide requires the use of such descriptive terms instead of net 
income to describe the performance indicator of not-for-profit organizations.
Definition of a Governmental Entity
13. Subsequent to the release of the exposure draft, FASB and the Govern­
mental Accounting Standards Board agreed on the definition of a governmental 
entity. Paragraph 1.02 o f the guide incorporates that definition.
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Effective Date
14. Several comment letters were received expressing concern about the 
effective date of the guide. In response to these comments, the committee re­
vised the effective date to fiscal years beginning after June 15, 1996, with earlier 
application permitted.
2 The guidance discussed in paragraph 11 (including footnote 3 to paragraph 11) of this appendix 
has been modified by the AICPA staff to include certain conforming changes necessary due to the 
issuance of authoritative pronouncements since the guide was originally issued. See paragraph 10.21.
3 Governmental enterprises should report extraordinary items and the effect of discontinued op­
erations in the statement of operations immediately preceding net income; the cumulative effect of an 
accounting change should be reported as an adjustment to beginning fund balance in the period of the 
change. Investor-owned enterprises should report extraordinary items, the effect of discontinued oper­
ations and the cumulative effect of an accounting change in the statement of operations immediately 
preceding net income.
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Status of Audit and Accounting Guides
in the GAAP Hierarchy
15. In several instances, the guide provides more specific reporting re­
quirements than FASB Statement Nos. 116 and 117 (see paragraphs 4-6, 8, 
and 10-11). In the deliberation of the guide, the question has arisen regarding 
the status of the guide in the GAAP hierarchy, given the fact that AICPA Audit 
and Accounting Guides are level B GAAP while FASB statements are level A. 
In discussing the issue, the committee and AcSEC referred to paragraph 49 of 
FASB Statement No. 117, which states that the AICPA
may provide more specific reporting guidance for certain not-for profit 
organizations. SAS 69 requires that an entity adopt cleared AICPA 
Industry Audit and Accounting Guides, and cleared AICPA Statements 
of Position that become effective after March 15 , 1992. As used in SAS 
69, cleared means that the FASB has indicated that it does not object 
to the issuance of the proposed pronouncement.
FASB has indicated that it does not object to the more specific reporting re­
quirements contained in this guide for health care organizations.
Background Information and Basis for Conclusions
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Appendix C
Statement of Position 98-2, 
Accounting for Costs of 
Activities of Not-for-Profit 
Organizations and State and 
Local Governmental Entities 
That Include Fund Raising
March 1 1 , 1998
Amendment to
AICPA Audit and Accounting Guides 
Health Care Organizations,
Not-for-Profit Organizations, and
Audits o f State and Local Governmental Units
Issued by the Accounting 
Standards Executive Committee
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NOTE
Statements of Position on accounting issues present the conclusions 
of at least two-thirds of the Accounting Standards Executive Commit­
tee, which is the senior technical body of the Institute authorized to 
speak for the Institute in the areas of financial accounting and report­
ing. AU section 411, The Meaning o f Present Fairly in Conformity With 
Generally Accepted Accounting Principles, identifies AICPA Statements 
of Position that have been cleared by either the Financial Accounting 
Standards Board (for financial statements of nongovernmental entities) 
or the Governmental Accounting Standards Board (for financial state­
ments of state and local governmental entities), as sources of established 
accounting principles in category b of the hierarchy of generally accepted 
accounting principles that it establishes. AICPA members should con­
sider the accounting principles in this Statement of Position if a differ­
ent accounting treatment of a transaction or event is not specified by a 
pronouncement covered by Rule 203 of the AICPA Code of Professional 
Conduct. In such circumstances, the accounting treatment specified by 
this Statement of Position should be used, or the member should be pre­
pared to justify a conclusion that another treatment better presents the 
substance of the transaction in the circumstances.
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Summary
This Statement of Position (SOP) applies to all nongovernmental not-for-profit 
organizations (NPOs) and all state and local governmental entities that solicit 
contributions.
This SOP requires—
• If the criteria of purpose, audience, and content as defined in this 
SOP are met, the costs of joint activities that are identifiable with 
a particular function should be charged to that function and joint 
costs should be allocated between fund raising and the appropriate 
program or management and general function.
• If any of the criteria of purpose, audience, and content are not met, 
all costs of the activity should be reported as fund-raising costs, 
including costs that otherwise might be considered program or 
management and general costs if they had been incurred in a dif­
ferent activity, subject to the exception in the following sentence. 
Costs of goods or services provided in exchange transactions that 
are part of joint activities, such as costs of direct donor benefits 
of a special event (for example, a meal), should not be reported as 
fund raising.
• Certain financial statement disclosures if joint costs are allocated.
• Some commonly used and acceptable allocation methods are de­
scribed and illustrated although no methods are prescribed or pro­
hibited.
This SOP amends existing guidance in AICPA Audit and Accounting Guides 
Health Care Organizations, Not-for-Profit Organizations (which was issued in 
August 1996 and supersedes SOP 87-2, Accounting for Joint Costs o f Informa­
tional Materials and Activities o f Not-for-Profit Organizations That Include a 
Fund-Raising Appeal, because the provisions of SOP 87-2 are incorporated into 
the Guide), and Audits o f State and Local Governmental Units.*
This SOP is effective for financial statements for years beginning on or after 
December 1 5 , 1998. Earlier application is encouraged in fiscal years for which 
financial statements have not been issued. If comparative financial statements 
are presented, retroactive application is permitted but not required.
* The AICPA Audit and Accounting Guide State and Local Governments supersedes the 1994 
AICPA Audit and Accounting Guide Audits of State and Local Governmental Units and subsequent 
editions of that Guide with conforming changes made by the AICPA staff. The AICPA Audit and 
Accounting Guide State and Local Governments provides guidance on the application of this Statement 
of Position (SOP) to state and local governments. [Footnote added, June 2004, to reflect conforming 
changes necessary due to the issuance of the AICPA Audit and Accounting Guide State and Local 
Governments.]
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Foreword
The accounting guidance contained in this document has been cleared by the 
Financial Accounting Standards Board (FASB) and the Governmental Account­
ing Standards Board (GASB). The procedure for clearing accounting guidance 
in documents issued by the Accounting Standards Executive Committee (Ac- 
SEC) involves the FASB and the GASB reviewing and discussing in public board 
meetings (1) a prospectus for a project to develop a document, (2) a proposed 
exposure draft that has been approved by at least ten of AcSEC's fifteen mem­
bers, and (3) a proposed final document that has been approved by at least ten 
of AcSEC's fifteen members. The document is cleared if at least five of the seven 
FASB members and three of the five GASB members do not object to AcSEC 
undertaking the project, issuing the proposed exposure draft or, after consid­
ering the input received by AcSEC as a result of the issuance of the exposure 
draft, issuing the final document.†
The criteria applied by the FASB and the GASB in their review of proposed 
projects and proposed documents include the following:
1. The proposal does not conflict with current or proposed accounting 
requirements, unless it is a limited circumstance, usually in spe­
cialized industry accounting, and the proposal adequately justifies 
the departure.
2. The proposal will result in an improvement in practice.
3. The AICPA demonstrates the need for the proposal.
4. The benefits of the proposal are expected to exceed the costs of 
applying it.
In many situations, prior to clearance, the FASB and the GASB will propose 
suggestions, many of which are included in the documents.
† This document was cleared prior to July 1, 1997. In July 1997, the GASB increased to seven 
members. Documents considered by the GASB after July 1, 1997 are cleared if at least four of the 
seven GASB members do not object. [Footnote renumbered, June 2004, to reflect conforming changes 
necessary due to the issuance of the AICPA Audit and Accounting Guide State and Local Governments.]
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Introduction
.01 Some nongovernmental not-for-profit organizations (NPOs) and some 
state and local governmental entities,1 such as governmental colleges and uni­
versities and governmental health care providers, solicit support through a 
variety of fund-raising activities.1 2 These activities include direct mail, tele­
phone solicitation, door-to-door canvassing, telethons, special events, and oth­
ers. Sometimes fund-raising activities are conducted with activities related to 
other functions, such as program  activities or supporting services, such as 
m anagem ent and general activities.3 Sometimes fund-raising activities in­
clude components that would otherwise be associated with program or support­
ing services, but in fact support fund raising.
.02 External users of financial statements—including contributors, credi­
tors, accreditation agencies, and regulators—want assurance that fund-raising 
costs, as well as program costs and management and general costs, are stated 
fairly.
.03 In 1987, the AICPA issued Statement of Position (SOP) 87-2, Account­
ing for Joint Costs o f Informational Materials and Activities ofNot-for-Profit Or­
ganizations That Include a Fund-Raising Appeal. 4 SOP 87-2 required that all 
circumstances concerning informational materials and activities that include a 
fund-raising appeal be considered in accounting for jo in t costs of those mate­
rials and activities and that certain criteria be applied in determining whether 
joint costs of those materials and activities should be charged to fund raising 
or allocated to program or management and general. Those criteria include
1 This Statement of Position (SOP) uses the term entity to refer to both nongovernmental not- 
for-profit organizations (NPOs) and state and local governments.
2 Terms that appear in the Glossary [paragraph .30) are set in boldface type the first time they 
appear.
3 The functional classifications of fund raising, program, and management and general are dis­
cussed throughout this SOP for purposes of illustrating how the guidance in this SOP would be applied 
by entities that use those functional classifications. Some entities have a functional structure that 
does not include fund raising, program, or management and general, or that includes other functional 
classifications, such as m em bership developm ent. This SOP is not intended to require reporting the 
functional classifications of fund raising, program, and management and general. In circumstances in 
which entities that have a functional structure that includes other functional classifications conduct 
joint activities, all costs of those joint activities should be charged to fund raising (or the category in 
which fund raising is reported—see the following two parenthetical sentences), unless the purpose, 
audience, and content of those joint activities are appropriate for achieving those other functions. (An 
example of an entity that reports fund raising in a category other than fund raising is a state and 
local governmental entity applying the accounting and financial reporting principles in the AICPA 
Industry Audit Guide Audits o f Colleges and Universities, as amended by SOP 74-8. As discussed in 
paragraph D.5 of this SOP [paragraph .241, those entities are required to report fund raising as part 
of the "institutional support" function. See also footnote # to paragraph D.5.) [Footnote revised, June 
2004, to reflect conforming changes necessary due to the issuance of GASB Statements No. 34 and 
No. 35.J
4 In August 1996, the AICPA issued the Audit and Accounting Guide Not-for-Profit Organiza­
tions. The Guide supersedes SOP 87-2, Accounting for Joint Costs of Informational Materials and 
Activities of Not-for-Profit Organizations That Include a Fund-Raising Appeal, because the provisions 
of SOP 87-2 are incorporated into paragraphs 13.36 to 13.45 of Not-for-Profit Organizations. Not-for- 
Profit Organizations applies to all nongovernmental NPOs other than those required to follow the 
Audit and Accounting Guide Health Care Organizations. The discussion in this SOP of SOP 87-2 
refers to both SOP 87-2 and the guidance included in paragraphs 13.36 to 13.45 of Not-for-Profit Or­
ganizations. Also, SOP 87-2 was not applicable to entities that are within the scope of Governmental 
Accounting Standards Board (GASB) Statement No. 29, The Use of Not-for-Profit Accounting and 
Financial Reporting Principles by Governmental Entities.
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requiring verifiable indications of the reasons for conducting the activity, such 
as the content, audience, and action, if any, requested of the participant, as well 
as other corroborating evidence. Further, SOP 87-2 required that all joint costs 
of those materials and activities be charged to fund raising unless the appeal 
is designed to motivate its audience to action other than providing financial 
support to the organization.
.04 The provisions of SOP 87-2 have been difficult to implement and have 
been applied inconsistently in practice. (Appendix B [paragraph .22], "Back­
ground," discusses this further.)
.05 This SOP establishes financial accounting standards for accounting for 
costs of joint activities. In addition, this SOP requires financial statement 
disclosures about the nature of the activities for which joint costs have been 
allocated and the amounts of joint costs. Appendix F [paragraph .26] provides 
explanations and illustrations of some acceptable allocation methods.
Scope
.06 This SOP applies to all nongovernmental NPOs and all state and local 
governmental entities that solicit contributions.
Conclusions
Accounting for Joint Activities
.07 If the criteria of purpose, audience, and content are met, the costs of a 
joint activity that are identifiable with a particular function should be charged 
to that function and joint costs should be allocated between fund raising and 
the appropriate program or management and general function. If any of the 
criteria are not met, all costs of the joint activity should be reported as fund­
raising costs, including costs that otherwise might be considered program or 
management and general costs if they had been incurred in a different activity, 
subject to the exception in the following sentence. Costs of goods or services 
provided in exchange transactions that are part of joint activities, such as costs 
of direct donor benefits of a special event (for example, a meal), should not be 
reported as fund raising.
Purpose
.08 The purpose criterion is met if the purpose of the joint activity includes 
accomplishing program or management and general functions. (Paragraphs .09 
and .10 provide guidance that should be considered in determining whether 
the purpose criterion is met. Paragraph .09 provides guidance pertaining to 
program functions only. Paragraph .10 provides guidance pertaining to both 
program and management and general functions.)
.09 Program functions. To accomplish program functions, the activity 
should call for specific action by the audience that will help accomplish the 
entity’s mission. For purposes of applying the guidance in this SOP, the fol­
lowing are examples of activities that do and do not call for specific action by 
the audience that will help accomplish the entity's mission:
• An entity's mission includes improving individuals' physical 
health. For that entity, motivating the audience to take specific 
action that will improve their physical health is a call for spe­
cific action by the audience that will help accomplish the entity's
AAG-HCO APP C
314
mission. An example of an activity that motivates the audience to 
take specific action that will improve their physical health is send­
ing the audience a brochure that urges them to stop smoking and 
suggests specific methods, instructions, references, and resources 
that may be used to stop smoking.
• An entity's mission includes educating individuals in areas other 
than the causes, conditions, needs, or concerns that the entity's 
programs are designed to address (referred to hereafter in this 
SOP as "causes"). For that entity, educating the audience in areas 
other than causes or motivating the audience to otherwise engage 
in specific activities that will educate them in areas other than 
causes is a call for specific action by the audience that will help 
accomplish the entity's mission. Examples of entities whose mis­
sion includes educating individuals in areas other than causes are 
universities and possibly other entities. An example of an activity 
motivating individuals to engage in education in areas other than 
causes is a university inviting individuals to attend a lecture or 
class in which the individuals will learn about the solar system.
• Educating the audience about causes or motivating the audience 
to otherwise engage in specific activities that will educate them 
about causes is not a call for specific action by the audience that 
will help accomplish the entity’s mission. Such activities are con­
sidered in support of fund raising. (However, some educational 
activities that might otherwise be considered as educating the au­
dience about causes may implicitly call for specific action by the 
audience that will help accomplish the entity's mission. For ex­
ample, activities that educate the audience about environmental 
problems caused by not recycling implicitly call for that audience 
to increase recycling. If the need for and benefits of the specific 
action are clearly evident from the educational message, the mes­
sage is considered to include an implicit call for specific action by 
the audience that will help accomplish the entity's mission.)
• Asking the audience to make contributions is not a call for spe­
cific action by the audience that will help accomplish the entity's 
mission.
If the activity calls for specific action by the audience that will help accomplish 
the entity's mission, the guidance in paragraph .10 should also be considered 
in determining whether the purpose criterion is met.
.10 Program and management and general functions. The following fac­
tors should be considered, in the order in which they are listed,5 to determine 
whether the purpose criterion is met:
a. Whether compensation or fees for performing the activity are 
based on contributions raised. The purpose criterion is not met if 
a majority of compensation or fees for any party's performance of
Health Care Organizations
5 In considering the guidance in paragraph .10, the factor in paragraph .10a (the compensation or 
fees test) is the preeminent guidance. If the factor in paragraph .10a is not determinative, the factor 
in paragraph .10b (whether a similar program or management and general activity is conducted 
separately and on a similar or greater scale) should be considered. If the factor in paragraph .106 is 
not determinative, the factor in paragraph .10c (other evidence) should be considered.
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any component of the discrete joint activity varies based on contri­
butions raised for that discrete joint activity.6,7
b. Whether a similar program or management and general activity is 
conducted separately and on a similar or greater scale. The purpose 
criterion is met if either of the following two conditions is met:
(1) Condition 1:
— The program component of the joint activity calls 
for specific action by the recipient that will help 
accomplish the entity's mission and
— A similar program component is conducted with­
out the fund-raising component using the same 
medium and on a scale that is similar to or 
greater than the scale on which it is conducted 
with the fund raising.8
(2) Condition 2:
A management and general activity that is similar to the 
management and general component of the joint activity be­
ing accounted for is conducted without the fund-raising com­
ponent using the same medium and on a scale that is similar 
to or greater than the scale on which it is conducted with the 
fund raising
If the purpose criterion is met based on the factor in paragraph .10b, 
the factor in paragraph .10c should not be considered.
c. Other evidence. If the factors in paragraph .10a or .10b do not de­
termine whether the purpose criterion is met, other evidence may 
determine whether the criterion is met. All available evidence, both 
positive and negative, should be considered to determine whether, 
based on the weight of that evidence, the purpose criterion is met.
.11 The following are examples of indicators that provide evidence for 
determining whether the purpose criterion is met:
a. Evidence that the purpose criterion may be met includes—
• Measuring program results and accomplishments o f the 
activity. The facts may indicate that the purpose criterion
6 Some compensation contracts provide that compensation for performing the activity is based on 
a factor other than contributions raised, but not to exceed a specified portion of contributions raised. 
For example, a contract may provide that compensation for performing the activity is $10 per contact 
hour, but not to exceed 60 percent of contributions raised. In such circumstances, compensation is not 
considered based on amounts raised, unless the stated maximum percentage is met. In circumstances 
in which it is not yet known whether the stated maximum percentage is met, compensation is not 
considered based on amounts raised, unless it is probable that the stated maximum percentage will 
be met.
7 The compensation or fees test is a negative test in that it either (a) results in failing the purpose 
criterion or (b) is not determinative of whether the purpose criterion is met. Therefore, if the activity 
fails the purpose criterion based on this factor (the compensation or fees test), the activity fails the 
purpose criterion and the factor in paragraph .10b should not be considered. If the purpose criterion 
is not failed based on this factor, this factor is not determinative of whether the purpose criterion is 
met and the factor in paragraph .10b should be considered.
8 Determining the scale on which an activity is conducted may be a subjective determination. 
Factors to consider in determining the scale on which an activity is conducted may include dollars 
spent, the size of the audience reached, and the degree to which the characteristics of the audience 
are similar to the characteristics of the audience of the activity being evaluated.
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is met if the entity measures program results and accom­
plishments of the activity (other than measuring the ex­
tent to which the public was educated about causes).
• Medium. The facts may indicate that the purpose crite­
rion is met if the program component of the joint activ­
ity calls for specific action by the recipient that will help 
accomplish the entity's mission and if the entity conducts 
the program component without a significant fund-raising 
component in a different medium. Also, the facts may indi­
cate that the purpose criterion is met if the entity conducts 
the management and general component of the joint ac­
tivity without a significant fund-raising component in a 
different medium.
b. Evidence that the purpose criterion may not be met includes—
• Evaluation or compensation. The facts may indicate that 
the purpose criterion is not met if (a) the evaluation of 
any party's performance of any component of the discrete 
joint activity varies based on contributions raised for that 
discrete joint activity or (6) some, but less than a majority, 
of compensation or fees for any party's performance of any 
component of the discrete joint activity varies based on 
contributions raised for that discrete joint activity.
c. Evidence that the purpose criterion may be either met or not met 
includes—
• Evaluation o f measured results o f the activity. The entity 
may have a process to evaluate measured program results 
and accomplishments of the activity (other than measur­
ing the extent to which the public was educated about 
causes). If the entity has such a process, in evaluating the 
effectiveness of the joint activity, the entity may place sig­
nificantly greater weight on the activity's effectiveness in 
accomplishing program goals or may place significantly 
greater weight on the activity's effectiveness in raising 
contributions. The former may indicate that the purpose 
criterion is met. The latter may indicate that the purpose 
criterion is not met.
• Qualifications. The qualifications and duties of those per­
forming the joint activity should be considered.
— If a third party, such as a consultant or contractor, 
performs part or all of the joint activity, such as 
producing brochures or making telephone calls, 
the third party's experience and the range of ser­
vices provided to the entity should be considered 
in determining whether the third party is per­
forming fund-raising, program (other than edu­
cating the public about causes), or management 
and general activities on behalf of the entity.
— If the entity's employees perform part or all of 
the joint activity, the full range of their job du­
ties should be considered in determining whether
Health Care Organizations
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those employees are performing fund-raising, 
program (other than educating the public about 
causes), or management and general activities on 
behalf of the entity. For example, (a) employees 
who are not members of the fund-raising depart­
ment and (b) employees who are members of the 
fund-raising department but who perform non­
fund-raising activities are more likely to perform 
activities that include program or management 
and general functions than are employees who 
otherwise devote significant time to fund raising.
• Tangible evidence o f intent. Tangible evidence indicating 
the intended purpose of the joint activity should be con­
sidered. Examples of such tangible evidence include
— The entity's written mission statement, as stated 
in its fund-raising activities, bylaws, or annual 
report.
— Minutes of board of directors', committees', or 
other meetings.
— Restrictions imposed by donors (who are not re­
lated parties) on gifts intended to fund the joint 
activity.
— Long-range plans or operating policies.
— Written instructions to other entities, such as 
script writers, consultants, or list brokers, con­
cerning the purpose of the joint activity, audience 
to be targeted, or method of conducting the joint 
activity.
— Internal management memoranda.
Audience
.12 A rebuttable presumption exists that the audience criterion is not met 
if the audience includes prior donors or is otherwise selected based on its ability 
or likelihood to contribute to the entity. That presumption can be overcome if 
the audience is also selected for one or more of the reasons in paragraph .13a, 
.13b, or .13c. In determining whether that presumption is overcome, entities 
should consider the extent to which the audience is selected based on its ability 
or likelihood to contribute to the entity and contrast that with the extent to 
which it is selected for one or more of the reasons in paragraph .13a, .13b, 
or .13c. For example, if the audience's ability or likelihood to contribute is a 
significant factor in its selection and it has a need for the action related to the 
program component of the joint activity, but having that need is an insignificant 
factor in its selection, the presumption would not be overcome.
.13 In circumstances in which the audience includes no prior donors and 
is not otherwise selected based on its ability or likelihood to contribute to the 
entity, the audience criterion is met if the audience is selected for one or more 
of the following reasons:
a. The audience's need to use or reasonable potential for use of the 
specific action called for by the program component of the joint 
activity
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b. The audience's ability to take specific action to assist the entity in 
meeting the goals of the program component of the joint activity
c. The entity is required to direct the management and general compo­
nent of the joint activity to the particular audience or the audience 
has reasonable potential for use of the management and general 
component
Content
Health Care Organizations
.14 The content criterion is met if the joint activity supports program or 
management and general functions, as follows:
a. Program. The joint activity calls for specific action by the recipient 
that will help accomplish the entity's mission. If the need for and 
benefits of the action are not clearly evident, information describing 
the action and explaining the need for and benefits of the action is 
provided.
b. Management and general. The joint activity fulfills one or more 
of the entity's management and general responsibilities through a 
component of the joint activity.9
.15 Information identifying and describing the entity, causes, or how the 
contributions provided will be used is considered in support of fund raising.
Allocation Methods
.16 The cost allocation methodology used should be rational and system­
atic, it should result in an allocation of joint costs that is reasonable, and it 
should be applied consistently given similar facts and circumstances.
Incidental Activities
.17 Some fund-raising activities conducted in conjunction with program or 
management and general activities are incidental to such program or manage­
ment and general activities. For example, an entity may conduct a fund-raising 
activity by including a generic message, "Contributions to Organization X may 
be sent to [address]" on a small area of a message that would otherwise be con­
sidered a program or management and general activity based on its purpose, 
audience, and content. That fund-raising activity likely would be considered in­
cidental to the program or management and general activity being conducted. 
Similarly, entities may conduct program or management and general activities 
in conjunction with fund-raising activities that are incidental to such fund­
raising activities. For example, an entity may conduct a program activity by 
including a generic program message such as "Continue to pray for [a partic­
ular cause]" on a small area of a message that would otherwise be considered 
fund raising based on its purpose, audience, and content. That program ac­
tivity would likely be considered incidental to the fund-raising activity being 
conducted. Similarly, an entity may conduct a management and general activity 
by including a brief management and general message—"We recently changed 
our phone number. Our new number is 123-4567"—on a small area of a message 
that would otherwise be considered a program or fund-raising activity based
9 Some states or other regulatory bodies require that certain disclosures be included when solic­
iting contributions. For purposes of applying the guidance in this SOP, communications that include 
such required disclosures are considered fund-raising activities and are not considered management 
and general activities.
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on its purpose, audience, and content. That management and general activity 
would likely be considered incidental to the program or fund-raising activity 
being conducted. In circumstances in which a fund-raising, program, or man­
agement and general activity is conducted in conjunction with another activity 
and is incidental to that other activity, and the conditions in this SOP for alloca­
tion are met, joint costs are permitted but not required to be allocated and may 
therefore be charged to the functional classification related to the activity that 
is not the incidental activity. However, in circumstances in which the program 
or management and general activities are incidental to the fund-raising activi­
ties, it is unlikely that the conditions required by this SOP to permit allocation 
of joint costs would be met.
Disclosures
.18 Entities that allocate joint costs should disclose the following in the 
notes to their financial statements:
a. The types of activities for which joint costs have been incurred
b. A  statement that such costs have been allocated
c. The total amount allocated during the period and the portion allo­
cated to each functional expense category
.19 This SOP encourages, but does not require, that the amount of joint 
costs for each kind of joint activity be disclosed, if practical.
Effective Date
.20 This SOP is effective for financial statements fof years beginning on 
or after December 15, 1998. Earlier application is encouraged in fiscal years 
for which financial statements have not been issued. If comparative financial 
statements are presented, retroactive application is permitted but not required.
The provisions of this Statement of Position need not be applied to 
immaterial items.
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Appendix A
Accounting for Joint Activities10
Start
Does the activity 
include soliciting
  contributions?
No Do not apply 
the
provisions of 
the SOP.
Apply the provisions of the SOP.
PURPOSE
No
  Does the 
activity call for 
specific action?
(Par. .09)  
Yes
  Does a majority of  
compensation or fees of 
any party performing a
component of the discrete 
joint activity vary based 
on contributions raised for 
that discrete joint activity? 
  (Par. .10a)  
is the purpose 
criterion met 
based on other 
evidence? 
(Par. .10c)
No
Yes
No
No
Does the activity 
have elements of 
management and 
general functions?
Yes
No
Yes
Al  costs of the 
activity should be 
charged to fu nd 
raising, except for 
the costs of goods
or services 
provided in 
exchange
  transactions.  
  Is the program 
(including a cal  for
action) or management 
& general component 
conducted on a similar 
scale using the same 
medium without the 
fu nd-raising appeal? 
 (Par. .10b)  
All costs of the 
activity should be 
charged to fond 
raising, except for 
the costs of goods
or services 
provided in 
exchange
  transactions.
Yes
continued
A
10 Note: This flowchart summarizes certain guidance in this SOP and is not intended as a sub­
stitute for the SOP.
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A
AUDIENCE
Can the presumption that 
the audience criterion is 
not met be overcome 
because tha audience is 
selected for program or 
management and 
general reasons?
  (Pars. .12 and .13)
Yes
Is the audience prior 
donors or otherwise 
selected based on its 
ability or likelihood to 
contribute?
  (Par. .12)
No
No
All costs of the 
activity should be 
charged to fu nd 
raising, except for 
the costs of goods
and services 
provided in 
exchange
  transactions.
No
Is the audience 
selected for program 
or management and
general reasons?
.  (Par. .13)  
Y e *
CONTENT
 Does the activity 
motivate the 
audience to action 
in support of 
program goals? 
  (Par. .14a)  
No
  Does the 
content fu lfill 
management 
and general
responsibilities? 
 (Par. .14b )
No
costs of the 
activity should be 
charged to fu nd 
raising, except fo  
the costs of goods
and services 
provided in 
exchange
 transactions.  
Yes
 Costs that are  
identifiable with a 
particula r  function 
should be charged
to that function 
and joint costs 
should be
allocated.  
Yes
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Appendix B
Background
B.1. As stated in paragraph .04, the provisions of Statement of Position (SOP) 
87-2, Accounting for Joint Costs o f Informational Materials and Activities o f  
Not-for-Profit Organizations That Include a Fund-Raising Appeal, have been 
difficult to implement and applied inconsistently in practice. That difficulty has 
been due in part to the following:
• The second sentence of paragraph 1 of SOP 87-2 stated that "some 
of the costs incurred by such organizations are clearly identifiable 
with fundraising, such as the cost of fund-raising consulting ser­
vices." It is unclear whether activities that would otherwise be 
considered program activities should be characterized as program 
activities if they are performed or overseen by professional fund 
raisers. Also, it is unclear whether activities would be reported 
differently (for example, as program rather than fund raising) de­
pending on whether the fund-raising consultant is compensated 
by a predetermined fee or by some other method, such as a per­
centage of contributions raised.
• SOP 87-2 was unclear about whether allocation of costs to fund­
raising expense is required if the activity for which the costs 
were incurred would not have been undertaken without the fund­
raising component.
• SOP 87-2 defined joint costs through examples, and it is therefore 
unclear what kinds of costs were covered by SOP 87-2. For exam­
ple, it is unclear whether salaries and indirect costs can be joint 
costs.
• Some believe the guidance in SOP 87-2 was inadequate to deter­
mine whether joint activities, such as those that request contri­
butions and also list the warning signs of a disease, are designed 
to motivate their audiences to action other than to provide con­
tributions to the entity. It is unclear what attributes the targeted 
audience should possess in order to conclude that a program func­
tion is being conducted.
B.2. In 1992, the Accounting Standards Executive Committee (AcSEC) un­
dertook a project to supersede SOP 87-2, to provide clearer guidance than that 
provided by SOP 87-2, as well as to provide guidance that would improve on the 
guidance in SOP 87-2. In September 1993, AcSEC released an exposure draft 
of a proposed SOP, Accounting for Costs o f Materials and Activities o f Not-for- 
Profit Organizations and State and Local Governmental Entities That Include 
a Fund-Raising Appeal, for public comment. AcSEC received more than 300 
comment letters on the exposure draft. AcSEC redeliberated the issues based 
on the comments received.
B.3. In 1996, after redeliberating the issues based on the comments received 
and m a k in g  certain revisions to the draft SOP, AcSEC conducted a field test of 
the draft SOP. The objectives of the field test were to determine whether the 
provisions of the draft SOP were sufficiently clear and definitive to generate con­
sistent and comparable application of the SOP. Based on the field test results, 
AcSEC concluded that the provisions of the draft SOP, with certain revisions,
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application of the SOP.
B.4. Some respondents who commented on the exposure draft, as well as 
some interested parties who followed the project through its due process sub­
sequent to the exposure draft, commented that the SOP should be reexposed 
for public comment. Reasons cited include:
• Approximately three years had passed between the end of the 
comment period and AcSEC's decision to issue the SOP.
• AcSEC made significant revisions to the SOP subsequent to re­
leasing the exposure draft for comment.
Considering whether a proposed standard should be reexposed for public 
comment is inherently a subjective process. Factors that AcSEC considered 
include—
• The significance of changes made to the exposure draft and 
whether those changes result in guidance that the public did not 
have an opportunity to consider.
• Whether the scope was revised in such a way that affected entities 
did not have an opportunity to comment.
• New information about or changes in the nature of the transac­
tions being considered, practice, or other factors.
AcSEC believes that the length of time between exposure and final issuance is 
not pertinent to whether the SOP should be reexposed for public comment.
B.5. Based on consideration of the factors identified, AcSEC believes that the 
SOP should not be reexposed for public comment. AcSEC notes that although 
the SOP has been revised based on comments received on the exposure draft, 
those revisions do not change the overall model in the SOP. Those revisions 
were made primarily to clarify the SOP and improve its operationality. Further, 
AcSEC believes that the project received a high level of attention from inter­
ested parties. AcSEC provided working drafts to interested parties and those 
parties provided input throughout the process, up to and including the Finan­
cial Accounting Standard Board's and the Governmental Accounting Standards 
Board's clearance of the SOP for issuance.
B.6. Appendix C [paragraph .23] discusses the key issues in the exposure 
draft and comments received on those issues, as well as the basis for AcSEC's 
conclusions on those and certain other issues.
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Appendix C
Basis for Conclusions
C .l. This section discusses considerations that were deemed significant by 
members of the Accounting Standards Executive Committee (AcSEC) in reach­
ing the conclusions in this Statement of Position (SOP). It includes reasons for 
accepting certain views and rejecting others. Individual AcSEC members gave 
greater weight to some factors than to others.
Overall Framework
C.2. This SOP uses the model in SOP 87-2, Accounting for Joint Costs o f  
Informational Materials and Activities o f Not-for-Profit Organizations That In­
clude a Fund-Raising Appeal, as a starting point and clarifies guidance that 
was unclear, provides more detailed guidance, revises some guidance, and ex­
pands the scope of costs covered to include all costs of joint activities. The model 
established by SOP 87-2 was to account for joint costs as fund raising unless an 
entity could demonstrate that a program or management and general function 
had been conducted. SOP 87-2 used verifiable indications of the reasons for 
conducting the activity, such as content, audience, the action requested, if any, 
and other corroborating evidence as a basis for determining whether a program 
or management and general function had been conducted.
C.3. On an overall basis, the majority of respondents who commented on 
the September 1993 exposure draft of a proposed SOP, Accounting for Costs 
o f Materials and Activities o f Not-for-Profit Organizations and State and Local 
Governmental Entities That Include a Fund-Raising Appeal, opposed it, for 
various reasons, including the following:
• The guidance in SOP 87-2 is operational, results in sound financial 
reporting, and should be retained.
• The guidance in SOP 87-2 should be retained but clarified.
• The guidance proposed in the exposure draft should be revised. 
(Some commented that it overstates fund raising; others com­
mented that it understates fund raising.)
C.4. AcSEC concluded that it supports the model in the exposure draft, sub­
ject to certain revisions. AcSEC believes that this SOP provides clear, detailed 
accounting guidance that, when applied, will increase comparability of financial 
statements. Those statements will also include more meaningful disclosures 
without incurring increased costs.
C.5. Some respondents commented that the model in the exposure draft 
would adversely affect entities both financially and operationally. Various rea­
sons were given, including the following:
• It would inhibit the ability of entities, particularly small entities 
and entities that raise contributions through direct solicitations, 
to generate the necessary revenue to perform their program ser­
vices.
• Most entities would not meet the criteria in this SOP for reporting 
costs of joint activities as program or management and general, 
because they must combine their mission statements, public in­
formation and education, and fund-raising appeals due to a lack
AAG-HCO APP C
Statement of Position 98-2 325
of resources. Some noted that this may result in unsatisfactory 
ratings from public watchdog groups.
AcSEC did not find these arguments compelling. This SOP provides accounting 
guidance; it provides no guidance concerning how entities should undertake 
their activities. Also, this SOP does not prohibit allocation merely because ac­
tivities carrying out different functions are combined. In fact, this SOP provides 
guidance for reporting costs as program or management and general in circum­
stances in which those activities are combined with fund-raising. Moreover, 
actions taken by financial statement users are not the direct result of the re­
quirements of this SOP. Rather, those actions may result from more relevant 
and useful information on which to base decisions.
C.6. Some respondents commented that the exposure draft is biased toward 
reporting expenses as fund raising. AcSEC believes that determining whether 
the costs of joint activities should be classified as program, management and 
general, or fund raising sometimes is difficult, and such distinctions sometimes 
are subject to a high degree of judgment. AcSEC believes that external finan­
cial statement users focus on and have perceptions about amounts reported as 
program, management and general, and fund raising. That focus and those per­
ceptions provide incentives for entities to report expenses as program or man­
agement and general rather than fund raising. Therefore, in circumstances in 
which joint activities are conducted, a presumption exists that expenses should 
be reported as fund raising rather than as program or management and gen­
eral. The criteria in this SOP provide guidance for entities to overcome that 
presumption.
Accounting for Joint Activities
C.7. This SOP requires that if any of the criteria of purpose, audience, and 
content are not met, all costs of the activity should be reported as fund raising, 
including costs that otherwise might be considered program or management 
and general costs if they had been incurred in a different activity, subject to 
the exception in the following sentence. Costs of goods or services provided in 
exchange transactions that are part of joint activities, such as costs of direct 
donor benefits of a special event (for example, a meal), should not be reported 
as fund raising. (This SOP expands on the model established by SOP 87-2 by 
including all costs of joint activities other than costs of goods or services pro­
vided in exchange transactions, rather than merely joint costs.) AcSEC believes 
that the criteria of purpose, audience, and content are each relevant in deter­
mining whether a joint activity should be reported as fund raising, program, 
or management and general because each provides significant evidence about 
the benefits expected to be obtained by undertaking the activity.
C.8. Some respondents commented that reporting costs that otherwise might 
be considered program or management and general costs if they had been in­
curred in a different activity as fund raising is misleading and that the scope 
of the SOP should include only joint costs of joint activities. Some commented 
that reporting costs that otherwise might be considered program or manage­
ment and general costs if they had been incurred in a different activity as fund 
raising conflicts with Financial Accounting Standards Board (FASB) Statement 
of Financial Accounting Standards No. 117, Financial Statements o f  Not-for- 
Profit Organizations, which defines fund raising, program, and management 
and general and requires not-for-profit organizations (NPOs) to report infor­
mation about expenses using those functional classifications.
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C.9. AcSEC believes that the purpose for which costs other than joint costs 
are incurred may be fund raising, program, or management and general, de­
pending on the context in which they are used in the activity undertaken. For 
example, a program-related pamphlet may be sent to an audience in need of 
the program. In that context, the pamphlet is used for program purposes. How­
ever, in order to demonstrate to potential donors that the entity's programs are 
worthwhile, that same pamphlet may be sent to an audience that is likely to 
contribute, but that has no need or reasonable potential for use of the program. 
In that context, the pamphlet is used for fund raising. AcSEC believes this 
broader scope will result in more comparability and more meaningful financial 
reporting by covering all costs of activities that include fund raising and by as­
signing those costs to the function for which they are incurred, consistent with 
the guidance in Statement No. 117.
C.10. AcSEC believes that costs of goods or services provided in exchange 
transactions should not be charged to fund raising because those costs are 
incurred in exchange for revenues other than contributions.
Criteria of Purpose, Audience, and Content
Call For Action
C.11. The definition of program in FASB Statement No. 117 includes public 
education. As noted in paragraph C.6, AcSEC believes that in circumstances in 
which joint activities are conducted, a presumption exists that expenses should 
be reported as fund raising rather than as program or management and general. 
AcSEC believes that in order to overcome that presumption, it is not enough 
that (a) the purpose of the activity include educating the public about causes, 
(b) the audience has a need or reasonable potential for use of any educational 
component of the activity pertaining to causes, or (c) the audience has the 
ability to assist the entity in meeting the goals of the program component of 
the activity by becoming educated about causes. Therefore, AcSEC concluded 
that for purposes of this SOP, in order to conclude that the criteria of purpose, 
audience, and content are met program activities are required to call for specific 
action by the recipient (other than becoming educated about causes) that will 
help accomplish the entity's mission. As discussed in paragraph .09, in certain 
circumstances educational activities may call for specific action by the recipient 
that will help accomplish the entity's mission.
Purpose
C.12. AcSEC believes meeting the purpose criterion demonstrates that the 
purpose of the activity includes accomplishing program or management and 
general functions. Inherent in the notion of a joint activity is that the activity 
has elements of more than one function. Accordingly, the purpose criterion 
provides guidance for determining whether the purpose of the activity includes 
accomplishing program or management and general functions in addition to 
fund raising.
Compensation and Evaluation Tests
C.13. The exposure draft proposed that all costs of the joint activity should 
be charged to fund raising if (a) substantially all compensation or fees for per­
forming the activity are based on amounts raised or (6) the evaluation of the 
party performing the activity is based on amounts raised. Some respondents 
commented that basing the method of compensation or evaluating the perfor­
mance of the party performing the activity based on contributions raised should
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not lead to the conclusion that all costs of the activity should be charged to fund 
raising. Others commented that the method of compensation is unrelated to 
whether the purpose criterion is met. The reasons given included the following:
• It is counterintuitive to imply that those performing multipurpose 
activities that include fund raising would not be compensated or 
evaluated based on amounts raised.
• Such guidance would create a bias toward entities that use em­
ployees to raise contributions and against entities that hire pro­
fessional fund raisers and public relations firms and is therefore 
not neutral.
Some respondents gave examples of circumstances in which substantially all 
compensation is based on contributions raised and asserted that the activity 
was nevertheless a program activity. In each of those examples, AcSEC consid­
ered all the facts presented and concluded that the activity was fund raising.
C.14. AcSEC continues to support the spirit of the proposed guidance, be­
cause AcSEC believes that basing a majority of compensation on funds raised 
is persuasive evidence that the activity is a fund-raising activity. Nevertheless, 
AcSEC believes that the proposed guidance was unclear and would be difficult 
to implement, primarily because of the broad definition of "based on contri­
butions raised" included in the glossary of the exposure draft. In connection 
with that issue, AcSEC was concerned that any joint activities performed by 
a fund-raising department or by individuals whose duties include fund rais­
ing, such as executive officers of small NPOs who are employed based on their 
ability to raise contributions, would be required to be reported as fund raising 
because the compensation of the parties performing those activities is based 
on amounts raised. Also, AcSEC had concerns that it would be difficult to de­
termine whether fixed contract amounts were negotiated based on expected 
contributions. Therefore, AcSEC concluded that the compensation test should 
be revised to provide that the purpose criterion is not met if a majority of com­
pensation or fees for any party's performance of any component of the discrete 
joint activity varies based on contributions raised for that discrete joint activity. 
AcSEC believes that guidance is sound and is operational.
C.15. AcSEC believes that the guidance in paragraph .10a is not biased 
against entities that hire professional fund raisers, because it applies to the 
entity's employees as well as professional fund raisers. For example, if a ma­
jority of an employee's compensation or fees for performing a component of a 
discrete joint activity varies based on contributions raised for that discrete joint 
activity, the purpose criterion is not met.
Similar Function-Similar Medium Test
C.16. Some respondents misinterpreted the exposure draft as providing that, 
in order to meet the purpose criterion, the program or management and gen­
eral activity must be conducted without the fund-raising component, using the 
same medium and on a scale that is similar to or greater than the program or 
management and general component of the activity being accounted for. That 
was not a requirement proposed by the exposure draft. The exposure draft pro­
posed that meeting that condition would result in meeting the purpose criterion. 
Failing the criterion merely leads to consideration of other evidence, such as 
the indicators in paragraph .11. AcSEC has revised the SOP to state this more 
clearly.
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Other Evidence
C.17. The compensation test and the similar function-similar medium test 
may not always be determinative because the attributes that they consider 
may not be present. Therefore, this SOP includes indicators that should be 
considered in circumstances in which the compensation test and the similar 
function-similar medium test are not determinative. The nature of those in­
dicators is such that they may be present in varying degrees. Therefore, all 
available evidence, both positive and negative, should be considered to deter­
mine whether, based on the weight of that evidence, the purpose criterion is 
met.
Audience
C.18. The exposure draft proposed that if the audience for the materials or 
activities is selected principally on its ability or likelihood to contribute, the 
audience criterion is not met and all the costs of the activity should be charged 
to fund raising. Further, the exposure draft proposed that if the audience is 
selected principally based on its need for the program or because it can assist 
the entity in meeting its program goals other than by financial support provided 
to the entity, the audience criterion is met. Some respondents commented that 
that audience criterion is too narrow, because it is based on the principal reason 
for selecting the audience. They asserted that for some activities no principal 
reason exists for selecting an audience; entities select the audience for those 
activities for multiple reasons, such as both the audience's ability to contribute 
and its ability to help meet program goals. Some commented that for some 
activities, entities select audiences that have provided past financial support 
because, by providing financial support, those audiences have expressed an 
interest in the program.
C.19. AcSEC believes that meeting the audience criterion should demon­
strate that the audience is selected because it is a suitable audience for ac­
complishing the activity's program or management and general functions. 
Therefore, the reasons for selecting the audience should be consistent with the 
program or management and general content of the activity. However, AcSEC 
believes it is inherent in the notion of joint activities that the activity has ele­
ments of more than one function, including fund raising, and acknowledges that 
it may be difficult to determine the principal reason for selecting the audience. 
Accordingly, AcSEC concluded that if the audience includes prior donors or is 
otherwise selected based on its ability or likelihood to contribute, a rebuttable 
presumption should exist that the audience was selected to raise funds. AcSEC 
believes that the reasons for selecting the audience that can overcome that pre­
sumption, which are included in paragraph .13 of this SOP, demonstrate that 
the audience is selected because it is a suitable audience for accomplishing the 
activity's program or management and general functions based on the program 
or management and general content of the activity.
Content
C.20. AcSEC believes that meeting the content criterion demonstrates that 
the content of the activity supports program or management and general func­
tions. AcSEC believes that accounting guidance should not impose value judg­
ments about whether the entity's mission, programs, and responsibilities are 
worthwhile. Therefore, whether the content criterion is met depends on the 
relationship of the content to the entity's mission, programs, and management 
and general responsibilities.
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C.21. Paragraph .14 provides that, to meet the content criterion, program 
activities should call for specific action by the recipient that will help accom­
plish the entity's mission. The exposure draft proposed that slogans, general 
calls to prayer, and general calls to protest do not meet the content criterion; 
some respondents disagreed. AcSEC concluded that this SOP should be silent 
concerning whether slogans, general calls to prayer, and general calls to protest 
are calls to action that meet the content criterion. AcSEC believes that deter­
mining whether those items are calls to action that meet the content criterion 
requires judgments based on the particular facts and circumstances.
C.22. Some respondents commented that educating the public about causes 
without calling for specific action should satisfy the content criterion. They 
noted that this is particularly relevant for NPOs subject to Internal Revenue 
Code (IRC) Section 501(c)4, because those NPOs are involved in legislative 
reform. Also, some noted that it may be the entity's mission or goal to educate 
the public about causes. They believe that, in those cases, the NPO's program is 
to educate the public about causes without necessarily calling for specific action 
by the recipient.
C.23. As discussed in paragraph C.11, AcSEC concluded that education that 
does not motivate the audience to action is in fact done in support of fund raising. 
However, this SOP acknowledges that some educational messages motivate 
the audience to specific action, and those messages meet the content criterion. 
AcSEC believes that that provision will result in the activities of some NPOs 
subject to IRC Section 501(c)4 (and some other entities, whose mission or goal 
is to educate the public) meeting the content criterion.
C.24. Paragraph .13c provides that one way that the audience criterion is met 
is if the entity is required to direct the management and general component 
of the activity to the particular audience. Further, as discussed in paragraph
D.13, in Discussion of Conclusions, an audience that includes prior donors and 
is selected because the entity is required to send them certain information to 
comply with requirements of the Internal Revenue Service (IRS) is an example 
of an audience that is selected because the entity is required to direct the man­
agement and general component of the activity to that audience. Paragraph 
.14b provides that one way that the content criterion is met is if the activity 
fulfills one or more of the entity's management and general responsibilities 
through a component of the joint activity. However, footnote 9 to paragraph 
.146 provides that disclosures made when soliciting contributions to comply 
with requirements of states or other regulatory bodies are considered fund­
raising activities, and are not considered management and general activities. 
AcSEC considered whether it is inconsistent to conclude both that (a) activ­
ities conducted to comply with requirements of regulatory bodies concerning 
contributions that have been received are management and general activities, 
and that (6) activities conducted to comply with requirements of regulatory 
bodies concerning soliciting contributions are fund-raising activities. AcSEC 
believes that those provisions are not inconsistent. AcSEC believes there is a 
distinction between (a) requirements that must be met as a result of receiv­
ing contributions and (b) requirements that must be met in order to solicit 
contributions. AcSEC believes that activities that are undertaken as a result 
of receiving contributions are management and general activities while ac­
tivities that are undertaken in order to solicit contributions are fund-raising 
activities.
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Incidental Activities
C.25. Many entities conduct fund-raising activities in conjunction with pro­
gram or management and general activities that are incidental to such program 
or management and general activities. Similarly, entities may conduct program 
or management and general activities in conjunction with fund-raising activ­
ities that are incidental to such fund-raising activities. Such efforts may be 
a practical and efficient means for entities to conduct activities, although the 
principal purpose of the activity may be to fulfill either fund-raising, program, 
or management and general functions. The exposure draft proposed that inci­
dental activities need not be considered in applying this SOP. Some respondents 
disagreed with that guidance, while others commented that it was confusing. 
AcSEC continues to support that guidance. AcSEC believes that guidance is 
necessary to avoid requiring complex allocations in circumstances in which the 
criteria of purpose, audience, and content are met but the activity is overwhelm­
ingly either fund raising, program, or management and general.
Allocation Methods
C.26. Respondents had various comments concerning allocation methods, in­
cluding the following:
• The SOP should focus on allocation methods rather than on cir­
cumstances in which entities should allocate.
• The SOP should prescribe allocation methods.
• The approach taken in the SOP—discussing, rather than requir­
ing or prohibiting allocation methods—is sound.
• Certain allocation methods should be prohibited.
• The SOP should set maximum allocation percentages.
AcSEC believes that no particular allocation method or methods are neces­
sarily more desirable than other methods in all circumstances. Therefore, this 
SOP neither prescribes nor prohibits any particular allocation methods. AcSEC 
believes entities should apply the allocation methods that result in the most 
reasonable cost allocations for their activities. Appendix F [paragraph .26] of 
this SOP illustrates several allocation methods, any one of which may result 
in a reasonable or unreasonable allocation of costs in particular circumstances. 
The methods illustrated are not the only acceptable methods. However, AcSEC 
believes that the methods illustrated in this SOP are among those most likely 
to result in meaningful cost allocations.
C.27. Accounting Principles Board (APB) Opinion No. 20, Accounting 
Changes, states in paragraph 7 that "the term accounting principle includes 
'not only accounting principles and practices but also the methods of applying 
them.'" APB Opinion 20 also states in paragraphs 15 and 16 that
...In the preparation of financial statements there is a presumption 
that an accounting principle once adopted should not be changed in 
accounting for events and transactions of a similar type....The pre­
sumption that an entity should not change an accounting principle 
may be overcome only if the enterprise justifies the use of an alterna­
tive acceptable accounting principle [allocation method] on the basis 
that it is preferable.
A change in cost allocation methodology may be a change in accounting principle 
for entities covered by this SOP. Accordingly, paragraph .16 of this SOP provides
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that the cost allocation methodology used should be applied consistently, given 
similar facts and circumstances.
Disclosures
C.28. Respondents made various comments concerning the required and en­
couraged disclosures, including recommendations for additional disclosures and 
recommendations that certain disclosures be deleted. AcSEC was not persuaded 
that the costs of the other disclosures recommended by respondents are justified 
by their benefits. AcSEC believes that, with the exception of one disclosure, the 
disclosures prescribed by the exposure draft provide relevant information about 
the kinds of activities for which joint costs have been incurred and the man­
ner in which those costs are reported in the financial statements. In considering 
disclosures proposed by the exposure draft about the allocation method, AcSEC 
observed that there are no requirements to disclose methods of allocating other 
expenses and questioned the utility of disclosing the allocation method in this 
circumstance. AcSEC concluded that the requirement to disclose the allocation 
method should be deleted.
C.29. Paragraph .19 encourages, but does not require, certain disclosures. Ac­
SEC believes those disclosures provide useful information but that they should 
be encouraged rather than required because the costs of making them may not 
be justified by the benefits in all cases.
Effective Date
C.30. Some respondents commented that the effective date should be de­
ferred. AcSEC believes that the accounting systems required to implement this 
SOP are already in place and that implementation should be relatively straight­
forward. However, AcSEC acknowledges that some entities may change their 
operations based on the reporting that would result from this SOP. Therefore, 
AcSEC concluded that this SOP should be effective for financial statements for 
years beginning on or after December 1 5 , 1998.
Cost-Benefit
C.31. Some respondents commented that the guidance would increase record 
keeping costs. AcSEC believes that implementing this SOP will not significantly 
increase record keeping costs, which are primarily the costs of documenting rea­
sons for undertaking joint activities. Further, AcSEC believes that the costs of 
making the disclosures required by this SOP should be minimal, because enti­
ties should already have the information that is required to be disclosed. AcSEC 
believes that implementing this SOP will result in more relevant, meaningful, 
and comparable financial reporting and that the cost of implementing this SOP 
will be justified by its benefits.
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Appendix D
Discussion of Conclusions
Scope
D.1. This Statement of Position (SOP) applies only to costs of joint activities. 
It does not address allocations of costs in other circumstances.
Reporting Models and Related Requirements
D.2. Paragraph 26 of Financial Accounting Standards Board (FASB) State­
ment of Financial Accounting Standards No. 117, Financial Statements o f Not- 
for-Profit Organizations, specifies that a statement of activities or notes to the 
financial statements should provide information about expenses reported by 
their functional classification, such as major classes of program services and 
supporting activities. Paragraph 13.34 of the AICPA Audit and Accounting 
Guide Not-for-Profit Organizations provides that the financial statements of 
not-for-profit organizations (NPOs) should disclose the total fund-raising ex­
penses. [Revised, June 2004, to reflect conforming changes necessary due to 
conforming changes made to the AICPA Audit and Accounting Guide Not-for- 
Profit Organizations.]
D.3. Governmental Accounting Standards Board (GASB) Statement No. 29, 
The Use o f Not-for-Profit Accounting and Financial Reporting Principles by Gov­
ernmental Entities, provides that governmental entities should not change their 
accounting and financial reporting to apply the provisions of FASB Statements 
No. 116, Accounting for Contributions Received and Contributions Made, and 
No. 117. GASB Statement No. 29 permits governmental entities that have ap­
plied the accounting and financial reporting principles in SOP 78-10, Account­
ing Principles and Reporting Practices for Certain Nonprofit Organizations, or 
in the AICPA Industry Audit Guide Audits o f Voluntary Health and Welfare Or­
ganizations modified by all applicable FASB pronouncements issued through 
November 30, 1989, and by most applicable GASB pronouncements) to con­
tinue to do so, pending GASB pronouncements on the accounting and financial 
reporting model for governmental entities. Alternatively, those governmental 
entities are permitted to change to the current governmental financial report­
ing model.‡
D.4. GASB Statement No. 15, Governmental College and University Account­
ing and Financial Reporting Models, requires governmental colleges and uni­
versities to use one of two accounting and financial reporting models. One 
model, referred to as the "AICPA College Guide Model,” encompasses the ac­
counting and financial reporting guidance in the 1973 AICPA Industry Audit 
Guide Audits o f Colleges and Universities, as amended by SOP 74-8, Finan­
cial Accounting and Reporting by Colleges and Universities, and as modified by
‡ GASB Statement No. 34, Basic Financial Statements—and Management's Discussion and 
Analysis—for State and Local Governments, supersedes the provisions of GASB Statement No. 29, 
The Use o f Not-for-Profit Accounting and Financial Reporting Principles by Governmental Entities, 
relating to the use of the AICPA Not-for-Profit model. See GASB Statement No. 34, including para­
graph 147. The AICPA Audit and Accounting Guide State and Local Governments provides guidance 
on the application of this SOP to state and local governments. [Footnote revised, June 2004, to reflect 
conforming changes necessary due to the issuance of GASB Statement No. 34.]
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applicable FASB pronouncements issued through November 30, 1989, and all 
applicable GASB pronouncements. (The other model, referred to as the "Gov­
ernmental Model," is based on the pronouncements of the National Council on 
Governmental Accounting [NCGA] and the GASB.)|
D.5. For state and local governmental entities, some are required to report 
expenses by function using the functional classifications of program, manage­
ment and general, and fund raising. Other state and local governmental entities 
that report expenses or expenditures by function have a functional structure 
that does not include fund raising, program, or management and general. Still 
other state and local governmental entities do not report expenses or expen­
ditures by function. Examples of those various reporting requirements are as 
follows:#
• Entities applying the accounting and financial reporting prin­
ciples in the AICPA Industry Audit Guide Audits o f Voluntary 
Health and Welfare Organizations, as well as those that follow 
SOP 78-10 and that receive significant amounts of contributions 
from the public, are required to report separately the costs of the 
fund-raising, program, and management and general functions.
• Entities applying the accounting and financial reporting princi­
ples in the AICPA Industry Audit Guide Audits o f  Colleges and 
Universities, as amended by SOP 74-8, are required to report fund 
raising as part of the "institutional support" function.
D.6. As discussed in footnote 3 to paragraph .01 of this SOP, this SOP is 
not intended to require reporting the functional classifications of fund raising, 
program, and management and general. Rather, those functional classifica­
tions are discussed throughout this SOP for purposes of illustrating how the 
guidance in this SOP would be applied by entities that use those functional 
classifications. Entities that do not use the functional classifications of fund 
raising, program, and management and general should apply the guidance in 
this SOP for purposes of accounting for joint activities, using their reporting 
model. For example, some entities may conduct membership-development ac­
tivities. As discussed in the Glossary [paragraph .30] of this SOP, if there are 
no significant benefits or duties connected with membership, the substance of 
the membership-development activities may, in fact, be fund raising. In such 
circumstances, the costs of those activities should be charged to fund raising. 
To the extent that member benefits are received, membership is an exchange 
transaction. In circumstances in which membership development is in part 
soliciting revenues from exchange transactions and in part soliciting contribu­
tions and the purpose, audience, and content of the activity are appropriate for 
achieving membership development, joint costs should be allocated between 
fund raising and the exchange transaction.
|| GASB Statement No. 35, Basic Financial Statements—and Management's Discussion and 
Analysis—for Public Colleges and Universities, supersedes GASB Statement No. 15, Governmental 
College and University Accounting and Financial Reporting Models. See GASB Statements No. 34 
and No. 35. The AICPA Audit and Accounting Guide State and Local Governments provides guidance 
on the application of this SOP to governmental (public) colleges and universities. [Footnote revised, 
June 2004, to reflect conforming changes necessary due to the issuance of GASB Statement No. 35.1
# This discussion is no longer applicable. See footnotes ‡ and || in paragraphs D.3 and D.4, 
respectively. [Footnote added, June 2004, to reflect conforming changes necessary due to the issuance 
of GASB Statements No. 34 and No. 35.1
AAG-HCO APP C
334
Assigning Costs of Joint Activities
D.7. Paragraph .07 provides: "If the criteria of purpose, audience, and con­
tent are met, the costs of a joint activity that are identifiable with a particular 
function should be charged to that function and joint costs should be allocated 
between fund raising and the appropriate program or management and general 
function. If any of the criteria are not met, all costs of the joint activity should 
be reported as fund-raising costs, including costs that otherwise might be con­
sidered program or management and general costs if they had been incurred in 
a different activity...." For example, if the criteria are met, the costs of materi­
als that accomplish program goals and that are unrelated to fund raising, such 
as the costs of a program-related pamphlet included in a joint activity, should 
be charged to program, while joint costs, such as postage, should be allocated 
between fund raising and program. However, if the pamphlet is used in fund­
raising packets and the criteria are not met, the costs of the pamphlets used in 
the fund-raising packets, as well as the joint costs, should be charged to fund 
raising. (If some pamphlets are used in program activities that include no fund 
raising, the cost of the pamphlets used in those separate program activities 
that include no fund raising should be charged to program.)
Educational Activities
D.8. Some entities have missions that include educating the public (students) 
in areas other than causes. Paragraph .09 provides that, for those entities, 
educating the audience in areas other than causes or motivating the audience 
to engage in specific activities, such as attending a lecture or class, that will 
educate them in areas other than causes is considered a call for specific action 
by the recipients that will help accomplish the entity's mission. Educating the 
audience about causes or motivating the audience to engage in specific activities 
that will educate them about causes without educating them in other subjects is 
not considered a call for specific action by the audience that will help accomplish 
the entity's mission. An example of a lecture or class that will educate students 
in an area other than causes is a lecture on the nesting habits of the bald eagle, 
given by the Save the Bald Eagle Society, an NPO whose mission is to save 
the bald eagle from extinction and educate the public about the bald eagle. An 
example of a lecture or class that will address particular causes is a lecture by 
the Bald Eagle Society on the potential extinction of bald eagles and the need 
to raise contributions to prevent their extinction. For purposes of applying the 
guidance in this SOP, motivating the audience to attend a lecture on the nesting 
habits of the bald eagle is a call for specific action that will help accomplish the 
entity's mission. If the lecture merely addresses the potential extinction of bald 
eagles and the need to raise contributions to prevent their extinction, without 
addressing the nesting habits of the bald eagle, motivating the audience to 
attend the lecture is not considered a call for specific action by the recipient 
that will help accomplish the entity's mission.
D.9. AcSEC notes that most transactions in which a student attends a lecture 
or class are exchange transactions and are not joint activities. Such transactions 
are joint activities only if the activity includes fund raising.
Audience
D.10. Paragraph .12 provides that a rebuttable presumption exists that the 
audience criterion is not met if the audience includes prior donors or is other­
wise selected based on its ability or likelihood to contribute to the entity. That
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presumption can be overcome if the audience is also selected for the program 
or management and general reasons specified in paragraph .13. Further, para­
graph .12 provides that in determining whether that presumption is overcome, 
entities should consider the extent to which the audience is selected based on 
its ability or likelihood to contribute to the entity and contrast that with the 
extent to which it is selected for the reasons that may overcome that presump­
tion. Some organizations conduct joint activities that are special events, such 
as symposia, dinners, dances, and theater parties, in which the attendee re­
ceives a direct benefit (for example, a meal or theater ticket) and for which the 
admission price includes a contribution. For example, it may cost $500 to at­
tend a dinner with a fair value of $50. In that case, the audience is required to 
make a $450 contribution in order to attend. In circumstances in which the au­
dience is required to make a contribution to participate in a joint activity, such 
as attending a special event, the audience's ability or likelihood to contribute 
is a significant factor in its selection. Therefore, in circumstances in which the 
audience is required to make a contribution to participate in a joint activity, the 
extent to which the audience is selected for the program or management and 
general reasons in paragraph .13 must be overwhelmingly significant in order 
to rebut the presumption that the audience criterion is not met.
D.11. The source of the names and the characteristics of the audience should 
be considered in determining the reason for selecting the audience. Some en­
tities use lists compiled by others to reach new audiences. The source of such 
lists may indicate the purpose or purposes for which they were selected. For 
example, lists acquired from entities with similar or related programs are more 
likely to meet the audience criterion than are lists acquired from entities with 
dissimilar or unrelated programs. Also, the characteristics of those on the lists 
may indicate the purpose or purposes for which they were selected. For example, 
a list based on a consumer profile of those who buy environmentally friendly 
products may be useful to an entity whose mission addresses environmental 
concerns and could therefore indicate that the audience was selected for its 
ability to take action to assist the entity in meeting program goals. However, a 
list based on net worth would indicate that the audience was selected based on 
its ability or likelihood to contribute, unless there was a correlation between net 
worth and the program or management and general components of the activity.
D.12. Some audiences may be selected because they have an interest in or 
affinity to the program. For example, homeowners may have an interest in the 
homeless because they are sympathetic to the plight of the homeless. Never­
theless, including homeowners in the audience of a program activity to provide 
services to the homeless would not meet the audience criterion, because they 
do not have a need or reasonable potential for use of services to the homeless.
D.13. Paragraph .13c provides that the audience criterion is met if the en­
tity is required to direct the management and general component of the joint 
activity to the particular audience or the audience has reasonable potential for 
use of the management and general component. An example of a joint activ­
ity in which the audience is selected because the entity is required to direct 
the management and general component of the joint activity to the particular 
audience is an activity in which the entity sends a written acknowledgment or 
other information to comply with requirements of the Internal Revenue Service 
to prior donors and includes a request for contributions. An example o f a joint 
activity in which the audience is selected because the audience has reasonable 
potential for use of the management and general component is an activity in
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for contributions.
Content
D.14. Paragraph .14 provides that, to meet the content criterion, program 
activities should call for specific action by the recipient that will help accomplish 
the entity's mission. As discussed in the Glossary [paragraph .30], the action 
should benefit the recipient or society. Examples of actions that benefit the 
recipient (such as by improving the recipient's physical, mental, emotional, 
or spiritual health and well-being) or society (such as by addressing societal 
problems) include the following:
a. Actions that benefit the recipient:
• Stop smoking. Specific methods, instructions, references, 
and resources should be suggested.
• Do not use alcohol or drugs. Specific methods, instructions, 
references, and resources should be suggested.
b. Actions that benefit society:
• Write or call. The party to communicate with and the sub­
ject matter to be communicated should be specified.
• Complete and return the enclosed questionnaire. The re­
sults of the questionnaire should help the entity achieve 
its mission. For example, if the entity discards the ques­
tionnaire, it does not help the entity achieve its mission.
• Boycott. The particular product or company to be boy­
cotted should be specified.
D.15. Paragraph .14b provides that to meet the content criterion, manage­
ment and general functions are required to fulfill one or more of the entity's 
management and general responsibilities through a component of the joint ac­
tivity. Some states or other regulatory bodies require that certain disclosures 
be included when soliciting contributions. Paragraph .14, footnote 9, of this 
SOP provides that for purposes of applying the guidance in this SOP, commu­
nications that include such required disclosures are considered fund-raising 
activities and are not considered management and general activities. Some 
examples of such disclosures include the following:
• Information filed with the attorney general concerning this chari­
table solicitation may be obtained from the attorney general of [the 
state] by calling 123-4567. Registration with the attorney general 
does not imply endorsement.
• A copy of the registration and financial information may be ob­
tained from the Division of Consumer Services by calling toll-free, 
within [the state], 1-800-123-4567. Registration does not imply en­
dorsement, approval, or recommendation by [the state].
• Information about the cost of postage and copying, and other infor­
mation required to be filed under [the state] law, can be obtained 
by calling 123-4567.
• The organization's latest annual report can be obtained by calling 
123-4567.
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Allocation Methods
D.16. Paragraph .16 of this SOP states, "The cost allocation methodology 
used should be rational and systematic, it should result in an allocation of joint 
costs that is reasonable, and it should be applied consistently given similar facts 
and circumstances." The allocation of joint costs should be based on the degree 
to which costs were incurred for the functions to which the costs are allocated 
(that is, program, management and general, or fund raising). For purposes of 
determining whether the allocation methodology for a particular joint activity 
should be consistent with methodologies used for other particular joint activi­
ties, facts and circumstances that may be considered include factors related to 
the content and relative costs of the components of the activity. The audience 
should not be considered in determining whether the facts and circumstances 
are similar for purposes of determining whether the allocation methodology 
for a particular joint activity should be consistent with methodologies used for 
other particular joint activities.
Practicability of Measuring Joint Costs
D.17. The Glossary [paragraph .30] of this SOP includes a definition of joint 
costs. Some costs, such as utilities, rent, and insurance, commonly referred to 
as indirect costs, may be joint costs. For example, the telephone bill for a de­
partment that, among other things, prepares materials that include both fund­
raising and program components may commonly be referred to as an indirect 
cost. Such telephone bills may also be joint costs. However, for some entities, it 
is impracticable to measure and allocate the portion of the costs that are joint 
costs. Considerations about which joint costs should be measured and allocated, 
such as considerations about materiality and the costs and benefits of develop­
ing and providing the information, are the same as considerations about cost 
allocations in other circumstances.
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Appendix E
Illustrations of Applying the Criteria of Purpose, Audience, and 
Content to Determine Whether a Program or Management and 
General Activity Has Been Conducted
Illustration 1
Facts
E.1. Entity A's mission is to prevent drug abuse. Entity A's annual report 
states that one of its objectives in fulfilling that mission is to assist parents in 
preventing their children from abusing drugs.
E.2. Entity A mails informational materials to the parents of all junior high 
school students explaining the prevalence and dangers of drug abuse. The ma­
terials encourage parents to counsel children about the dangers of drug abuse 
and inform them about how to detect drug abuse. The mailing includes a re­
quest for contributions. Entity A conducts other activities informing the public 
about the dangers of drug abuse and encouraging parents to counsel their chil­
dren about drug abuse that do not include requests for contributions and that 
are conducted in different media. Entity A's executive director is involved in 
the development of the informational materials as well as the request for con­
tributions. The executive director's annual compensation includes a significant 
bonus if total annual contributions exceed a predetermined amount. 
Conclusion
E.3. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated.
E.4. The activity calls for specific action by the recipient (encouraging par­
ents to counsel children about the dangers of drug abuse and informing them 
about how to detect drug abuse) that will help accomplish the entity's mission. 
Therefore, the guidance in paragraph .10 should be considered. Neither of the 
factors in paragraph .10a or .10b is determinative of whether the purpose cri­
terion is met. (Although Entity A's executive director's annual compensation 
varies based on annual contributions, the executive director's compensation 
does not vary based on contributions raised for this discrete joint activity.) 
Therefore, other evidence, such as the indicators in paragraph .11, should be 
considered. The purpose criterion is met based on the other evidence, because
(а) the program component of this activity calls for specific action by the recipi­
ent (encouraging parents to counsel children about the dangers of drug abuse) 
that will help accomplish the entity's mission, and it otherwise conducts the 
program activity in this illustration without a request for contributions, and
(b) performing such programs helps accomplish Entity A's mission. (Note that 
had Entity A conducted the activity using the same medium on a scale that is 
similar to or greater than the scale on which it is conducted with the request 
for contributions, the purpose criterion would have been met under paragraph 
.106.)
E.5. The audience criterion is met because the audience (parents of junior 
high school students) is selected based on its need to use or reasonable potential 
for use of the action called for by the program component.
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E.6. The content criterion is met because the activity calls for specific action 
by the recipient (encouraging parents to counsel children about the dangers of 
drug abuse and informing them about how to detect drug abuse) that will help 
accomplish the entity's mission (assisting parents in preventing their children 
from abusing drugs), and it explains the need for and benefits of the action (the 
prevalence and dangers of drug abuse).
Illustration 2
Facts
E.7. Entity B's mission is to reduce the incidence of illness from ABC disease, 
which afflicts a broad segment of the population. One of Entity B's objectives 
in fulfilling that mission is to inform the public about the effects and early 
warning signs of the disease and specific action that should be taken to prevent 
the disease.
E.8. Entity B maintains a list of its prior donors and sends them donor re­
newal mailings. The mailings include messages about the effects and early 
warning signs of the disease and specific action that should be taken to pre­
vent it. That information is also sent to a similar-sized audience but without 
the request for contributions. Also, Entity B believes that recent donors are 
more likely to contribute than nondonors or donors who have not contributed 
recently. Prior donors are deleted from the mailing list if they have not con­
tributed to Entity B recently, and new donors are added to the list. There is no 
evidence of a correlation between recent contributions and participation in the 
program component of the activity. Also, the prior donors' need to use or rea­
sonable potential for use of the messages about the effects and early warning 
signs of the disease and specific action that should be taken to prevent it is an 
insignificant factor in their selection.
Conclusion
E.9. The purpose and content criteria are met. The audience criterion is not 
met.11 All costs, including those that might otherwise be considered program or 
management and general costs if they had been incurred in a different activity, 
should be charged to fund raising.
E.10. The activity calls for specific action by the recipient (action that should 
be taken to prevent ABC disease) that will help accomplish the entity's mission. 
Therefore, the guidance in paragraph .10 should be considered. The purpose 
criterion is met because (a) the program component of the activity calls for 
specific action by the recipient that will help accomplish the entity's mission 
(to reduce the incidence of illness from the disease), and (b) the program is 
also conducted using the same medium on a scale that is similar to or greater 
than the scale on which it is conducted with the request for contributions (a 
similar mailing is done without the request for contributions, to a similar-sized 
audience).
E.11. The audience criterion is not met. The rebuttable presumption that the 
audience criterion is not met because the audience includes prior donors is not
11 Paragraph .07 of this SOP provides that all costs of joint activities, except for costs of goods 
or services provided in exchange transactions that are part of joint activities, such as costs of direct 
donor benefits of a special event (for example, a meal), should be charged to fund raising if any of 
the criteria of purpose, audience, or content are not met. Accordingly, if one or more criteria are not 
met, the other criteria need not be considered. However, the illustrations in this Appendix provide 
conclusions about whether each of the criteria would be met in circumstances in which one or more 
criteria are not met in order to provide further guidance.
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overcome in this illustration. Although the audience has a need to use or rea­
sonable potential for use of the program component, that was an insignificant
factor in its selection.
E.12. The content criterion is met because the activity calls for specific action 
by the recipient (actions to prevent ABC disease) that will help accomplish the 
entity's mission (to reduce the incidence of ABC disease), and it explains the 
need for and benefits of the action (to prevent ABC disease).
Illustration 3
Facts
E.13. Entity C's mission is to reduce the incidence of illness from ABC dis­
ease, which afflicts a broad segment of the population. One of Entity C's objec­
tives in fulfilling that mission is to increase governmental funding for research 
about ABC disease.
E.14. Entity C maintains a list of its prior donors and its employees call 
them on the telephone reminding them of the effects of ABC disease, asking for 
contributions, and encouraging them to contact their elected officials to urge 
increased governmental funding for research about ABC disease. The callers 
are educated about ABC, do not otherwise perform fund-raising functions, and 
are not compensated or evaluated based on contributions raised. Entity C's 
research indicates that recent donors are likely to contact their elected officials 
about such funding while nonrecent donors are not. Prior donors are deleted 
from the calling list if they have not contributed to Entity C recently, and new 
donors are added to the list.
Conclusion
E.15. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated.
E.16. The activity calls for specific action by the recipient (contacting elected 
officials concerning funding for research about ABC disease) that will help ac­
complish the entity's mission. Therefore, the guidance in paragraph .10 should 
be considered. Neither of the factors in paragraph .10a or .10b is determina­
tive of whether the purpose criterion is met. Therefore, other evidence, such as 
the indicators in paragraph .11, should be considered. The purpose criterion 
is met based on the other evidence, because (a) the qualifications and duties 
of the personnel performing the activity indicate that it is a program activity 
(the callers are educated about ABC and do not otherwise perform fund-raising 
functions), (6) the method of compensation for performing the activity does not 
indicate that it is a fund-raising activity (the employees are not compensated 
or evaluated based on contributions raised), and (c) performing such programs 
helps accomplish Entity C's mission.
E.17. The audience criterion is met because the audience (recent donors) 
is selected based on its ability to assist Entity C in meeting the goals of the 
program component of the activity (recent donors are likely to contact their 
elected officials about such funding while nonrecent donors are not).
E.18. The content criterion is met because the activity calls for specific action 
by the recipient (contacting elected officials concerning funding for research 
about ABC disease) that will help accomplish the entity's mission (to reduce 
the incidence of ABC disease), and it explains the need for and benefits of the 
action (to prevent ABC disease).
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Illustration 4
Facts
E.19. Entity D's mission is to improve the quality of life for senior citizens.
One of Entity D's objectives included in that mission is to increase the physical 
activity of senior citizens. One of Entity D's programs to attain that objective 
is to send representatives to speak to groups about the importance of exercise 
and to conduct exercise classes.
E.20. Entity D mails a brochure on the importance of exercise that encour­
ages exercise in later years to residents over the age of sixty-five in three zip code 
areas. The last two pages of the four-page brochure include a perforated contri­
bution remittance form on which Entity D explains its program and makes an 
appeal for contributions. The content of the first two pages of the brochure is 
primarily educational; it explains how seniors can undertake a self-supervised 
exercise program and encourages them to undertake such a program. In addi­
tion, Entity D includes a second brochure on various exercise techniques that 
can be used by those undertaking an exercise program.
E.21. The brochures are distributed to educate people in this age group about 
the importance of exercising, to help them exercise properly, and to raise contri­
butions for Entity D. These objectives are documented in a letter to the public 
relations firm that developed the brochures. The audience is selected based on 
age, without regard to ability to contribute. Entity D believes that most of the 
recipients would benefit from the information about exercise.
Conclusion
E.22. The purpose, audience, and content criteria are met, and the joint 
costs should be allocated. (Note that the costs of the second brochure should 
be charged to program because all the costs of the brochure are identifiable 
with the program function.)
E.23. The activity calls for specific action by the recipient (exercising) that 
will help accomplish the entity's mission. Therefore, the guidance in paragraph 
.10 should be considered. Neither of the factors in paragraph .10a or .10b is de­
terminative of whether the purpose criterion is met. Therefore, other evidence, 
such as the indicators in paragraph .11, should be considered. The purpose cri­
terion is met based on the other evidence, because (a) performing such programs 
helps accomplish Entity D's mission, and (b) the objectives of the program are 
documented in a letter to the public relations firm that developed the brochure.
E.24. The audience criterion is met because the audience (residents over 
sixty-five in certain zip codes) is selected based on its need to use or reasonable 
potential for use of the action called for by the program component.
E.25. The content criterion is met because the activity calls for specific action 
by the recipient (exercising) that will help accomplish the entity's mission (in­
creasing the physical activity of senior citizens), and the need for and benefits 
of the action are clearly evident (explains the importance of exercising).
Illustration 5
Facts
E.26. The facts are the same as those in Illustration 4, except that Entity E 
employs a fund-raising consultant to develop the first brochure and pays that 
consultant 30 percent of contributions raised.
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Conclusion
E.27. The content and audience criteria are met. The purpose criterion is not 
met, however, because a majority of compensation or fees for the fund-raising 
consultant varies based on contributions raised for this discrete joint activity 
(the fund-raising consultant is paid 30 percent of contributions raised). All costs 
should be charged to fund raising, including the costs of the second brochure and 
any other costs that otherwise might be considered program or management 
and general costs if they had been incurred in a different activity.
Illustration 6
Facts
E.28. Entity F's mission is to protect the environment. One of Entity F's 
objectives included in that mission is to take action that will increase the portion 
of waste recycled by the public.
E.29. Entity F conducts a door-to-door canvass of a community that recycles a 
low portion of its waste. The purpose of the activity is to help increase recycling 
by educating the community about environmental problems created by not re­
cycling, and to raise contributions. Based on the information communicated by 
the canvassers, the need for and benefits of the action are clearly evident. The 
ability or likelihood of the residents to contribute is not a basis for communi­
ties selected, and all neighborhoods in the geographic area are covered if their 
recycling falls below a predetermined rate. The canvassers are selected from 
individuals who are well-informed about the organization's environmental con­
cerns and programs and who previously participated as volunteers in program 
activities such as answering environmental questions directed to the organi­
zation and developing program activities designed to influence legislators to 
take actions addressing those concerns. The canvassers have not previously 
participated in fund-raising activities.
Conclusion
E.30. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated.
E.31. The activity calls for specific action by the recipient (implicitly—to help 
increase recycling) that will help accomplish the entity's mission. Therefore, the 
guidance in paragraph .10 should be considered. Neither of the factors in para­
graph .10a or .10b is determinative of whether the purpose criterion is met. 
Therefore, other evidence, such as the indicators in paragraph .11, should be 
considered. The purpose criterion is met based on the other evidence, because 
(a) the qualifications and duties of the personnel performing the activity indi­
cate that it is a program activity (the canvassers are selected from individuals 
who are well-informed about the organization's environmental concerns and 
programs and who previously participated as volunteers in program activities 
such as answering environmental questions directed to the organization and 
developing program activities designed to influence legislators to take actions 
addressing those concerns), and (b) performing such programs helps accomplish 
Entity F's mission (to protect the environment).
E.32. The audience criterion is met because the audience (neighborhoods 
whose recycling falls below a predetermined rate) is selected based on its need 
to use or reasonable potential for use of the action called for by the program 
component.
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E.33. The content criterion is met because the activity calls for specific action 
by the recipient (implicitly—to help increase recycling) that will help accom­
plish the entity's mission (to protect the environment), and the need for and 
benefits of the action are clearly evident (increased recycling will help alleviate 
environmental problems).
Illustration 7
Facts
E.34. Entity G's mission is to provide summer camps for economically disad­
vantaged youths. Educating the families of ineligible youths about the camps 
is not one of the program objectives included in that mission.
E.35. Entity G conducts a door-to-door solicitation campaign for its camp 
programs. In the campaign, volunteers with canisters visit homes in middle- 
class neighborhoods to collect contributions. Entity G believes that people in 
those neighborhoods would not need the camp's programs but may contribute. 
The volunteers explain the camp's programs, including why the disadvantaged 
children benefit from the program, and distribute leaflets to the residents re­
gardless of whether they contribute to the camp. The leaflets describe the camp, 
its activities, who can attend, and the benefits to attendees. Requests for con­
tributions are not included in the leaflets.
Conclusion
E.36. The purpose, audience, and content criteria are not met. All costs 
should be charged to fund raising.
E.37. The activity does not include a call for specific action because it only 
educates the audience about causes (describing the camp, its activities, who 
can attend, and the benefits to attendees). Therefore, the purpose criterion is 
not met.
E.38. The audience criterion is not met, because the audience is selected 
based on its ability or likelihood to contribute, rather than based on (a) its need 
to use or reasonable potential for use of the action called for by the program 
component, or (6) its ability to take action to assist the entity in meeting the 
goals of the program component of the activity. (Entity G believes that people in 
those neighborhoods would not need the camp's programs but may contribute.)
E.39. The content criterion is not met because the activity does not call for 
specific action by the recipient. (The content educates the audience about causes 
that the program is designed to address without calling for specific action.)
Illustration 8
Facts
E.40. Entity H's mission is to educate the public about lifesaving techniques 
in order to increase the number of lives saved. One of Entity H's objectives in 
fulfilling that mission, as stated in the minutes of the board's meetings, is to 
produce and show television broadcasts including information about lifesaving 
techniques.
E.41. Entity H conducts an annual national telethon to raise contributions 
and to reach the American public with lifesaving educational messages, such 
as summary instructions concerning dealing with certain life-threatening situ­
ations. Based on the information communicated by the messages, the need for 
and benefits of the action are clearly evident. The broadcast includes segments
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describing Entity H's services. Entity H broadcasts the telethon to the entire 
country, not merely to areas selected on the basis of giving potential or prior 
fund raising results. Also, Entity H uses national television broadcasts devoted 
entirely to lifesaving educational messages to conduct program activities with­
out fund raising.
Conclusion
E.42. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated.
E.43. The activity calls for specific action by the recipient (implicitly—to save 
lives) that will help accomplish the entity's mission. Therefore, the guidance in 
paragraph .10 should be considered. The purpose criterion is met because (a) 
the program component of the activity calls for specific action by the recipient 
that will help accomplish Entity H's mission (to save lives by educating the 
public), and (b) a similar program activity is conducted without the fund rais­
ing using the same medium and on a scale that is similar to or greater than the 
scale on which it is conducted with the appeal (Entity H uses national televi­
sion broadcasts devoted entirely to lifesaving educational messages to conduct 
program activities without fund raising).
E.44. The audience criterion is met because the audience (a broad segment 
of the population) is selected based on its need to use or reasonable potential 
for use of the action called for by the program activity.
E.45. The content criterion is met because the activity calls for specific action 
by the recipient (implicitly—to save lives) that will help accomplish the entity's 
mission (to save lives by educating the public), and the need for and benefits of 
the action are clearly evident (saving lives is desirable).
Illustration 9
Facts
E.46. Entity I’s mission is to provide food, clothing, and medical care to chil­
dren in developing countries.
E.47. Entity I conducts television broadcasts in the United States that de­
scribe its programs, show the needy children, and end with appeals for con­
tributions. Entity I's operating policies and internal management memoranda 
state that these programs are designed to educate the public about the needs 
of children in developing countries and to raise contributions. The employees 
producing the programs are trained in audiovisual production and are familiar 
with Entity I's programs. Also, the executive producer is paid $25,000 for this 
activity, with a $5,000 bonus if the activity raises over $1,000,000.
Conclusion
E.48. The purpose, audience, and content criteria are not met. All costs 
should be charged to fund raising.
E.49. The activity does not include a call for specific action because it only 
educates the audience about causes (describing its programs and showing the 
needy children). Therefore, the purpose criterion is not met. (Also, note that if 
the factor in paragraph .10a were considered, it would not be determinative of 
whether the purpose criterion is met. Although the executive producer will be 
paid $5,000 if the activity raises over $1,000,000, that amount would not be a 
majority of the executive producer's total compensation for this activity, because
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$5,000 would not be a majority of the executive producer's total compensation of 
$30,000 for this activity. Also, note that if other evidence, such as the indicators 
in paragraph .11, were considered, the purpose criterion would not be met based 
on the other evidence. Although the qualifications and duties of the personnel 
performing the activity indicate that the employees producing the program are 
familiar with Entity I’s programs, the facts that some, but less than a majority, 
o f the executive producer's compensation varies based on contributions raised, 
and that the operating policies and internal management memoranda state 
that these programs are designed to educate the public about the needs of 
children in developing countries [with no call for specific action by recipients] 
and to raise contributions, indicate that the purpose is fund raising.)
E.50. The audience criterion is not met because the audience is selected based 
on its ability or likelihood to contribute, rather than based on (a) its need to 
use or reasonable potential for use o f the action called for by the program com­
ponent, or (b) its ability to take action to assist the entity in meeting the goals 
of the program component of the activity. (The audience is a broad segment of 
the population of a country that is not in need of or has no reasonable potential 
for use of the program activity.)
E.51. The content criterion is not met because the activity does not call for 
specific action by the recipient that will help accomplish the entity's mission. 
(The content educates the audience about the causes without calling for specific 
action.)
Illustration 10
Facts
E.52. Entity J is a university that distributes its annual report, which in­
cludes reports on mission accomplishments, to those who have made signif­
icant contributions over the previous year, its board of trustees, and its em­
ployees. The annual report is primarily prepared by management and general 
personnel, such as the accounting department and executive staff. The activ­
ity is coordinated by the public relations department. Internal management 
memoranda indicate that the purpose of the annual report is to report on how 
management discharged its stewardship responsibilities, including the univer­
sity's overall performance, goals, financial position, cash flows, and results of 
operations. Included in the package containing the annual report are requests 
for contributions and donor reply cards.
Conclusion
E.53. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated.
E.54. The activity has elements of management and general functions. 
Therefore, no call for specific action is required. Neither of the factors in para­
graph .10a or .10b is determinative of whether the purpose criterion is met. 
Therefore, other evidence, such as the indicators in paragraph .11, should be 
considered. The purpose criterion is met based on the other evidence, because 
(a) the employees performing the activity are not members of the fund-raising 
department and perform other non-fund-raising activities and (b) internal man­
agement memoranda indicate that the purpose of the annual report is to fulfill 
one of the university's management and general responsibilities.
E.55. The audience criterion is met because the audience is selected based 
on its reasonable potential for use of the management and general component.
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Although the activity is directed primarily at those who have previously made
significant contributions, the audience was selected based on its presumed in­
terest in Entity J's annual report (prior donors who have made significant con­
tributions are likely to have an interest in matters discussed in the annual
report).
E.56. The content criterion is met because the activity (distributing annual 
reports) fulfills one of the entity's management and general responsibilities 
(reporting concerning management's fulfillment of its stewardship function).
Illustration 11
Facts
E.57. Entity K is an NPO. In accordance with internal management mem­
oranda documenting its policies requiring it to comply with Internal Revenue 
Service (IRS) regulations, it mails prior donors who have made quid pro quo 
payments in excess of $75 documentation required by the IRS. The documen­
tation is included on a perforated piece of paper. The information above the 
perforation line pertains to the documentation required by the IRS. The infor­
mation below the perforation line includes a request for contributions and may 
be used as a donor reply card.
Conclusion
E.58. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated. (Note that the costs of the information below the perforation 
line are identifiable with fund raising and therefore should be charged to fund 
raising.)
E.59. The activity has elements of management and general functions. 
Therefore, no call for specific action is required. Neither of the factors in para­
graph .10a or .10b is determinative of whether the purpose criterion is met. 
Therefore, other evidence, such as the indicators in paragraph .11, should be 
considered. The purpose criterion is met based on the other evidence, because 
internal management memoranda indicate that the purpose of the activity is 
to fulfill one of Entity K's management and general responsibilities.
E.60. The audience criterion is met because the entity is required to direct the 
management and general component of the activity to the particular audience. 
Although the activity is directed at those who have previously contributed, the 
audience was selected based on its need for the documentation.
E.61. The content criterion is met because the activity (sending documenta­
tion required by the IRS) fulfills one of the entity's management and general 
responsibilities (complying with IRS regulations).
Illustration 12
Facts
E.62. Entity L is an animal rights organization. It mails a package of material 
to individuals included in lists rented from various environmental and other 
organizations that support causes that Entity L believes are congruent with 
its own. In addition to donor response cards and return envelopes, the package 
includes (a) materials urging recipients to contact their legislators and urge 
the legislators to support legislation to protect those rights, and (6) postcards 
addressed to legislators urging support for legislation restricting the use of 
animal testing for cosmetic products. The mail campaign is part of an overall
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strategy that includes magazine advertisements and the distribution of similar 
materials at various community events, some of which are undertaken without 
fund-raising appeals. The advertising and community events reach audiences 
similar in size and demographics to the audience reached by the mailing.
Conclusion
E.63. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated.
E.64. The activity calls for specific action by the recipient (mailing postcards 
to legislators urging support for legislation restricting the use of animal testing 
for cosmetic products) that will help accomplish the entity's mission. Therefore, 
the guidance in paragraph .10 should be considered. Neither of the factors in 
paragraph .10a or .10b is determinative of whether the purpose criterion is met. 
Therefore, other evidence, such as the indicators in paragraph .11, should be 
considered. The purpose criterion is met based on the other evidence, because (a) 
the program component of this activity calls for specific action by the recipient 
that will help accomplish the entity's mission, and it otherwise conducts the 
program activity in this illustration without a request for contributions, and 
(b) performing such programs helps accomplish Entity L's mission.
E.65. The audience criterion is met because the audience (individuals in­
cluded in lists rented from various environmental and other organizations that 
support causes that Entity L believes are congruent with its own) is selected 
based on its ability to take action to assist the entity in meeting the goals of the 
program component of the activity.
E.66. The content criterion is met because the activity calls for specific action 
by the recipient (mailing postcards to legislators urging support for legislation 
restricting the use of animal testing for cosmetic products) that will help ac­
complish the entity's mission (to protect animal rights), and the need for and 
benefits of the action are clearly evident (to protect animal rights).
Illustration 13
Facts
E.67. Entity M is a performing arts organization whose mission is to make 
the arts available to residents in its area. Entity M charges a fee for attending 
performances and sends advertisements, including subscription forms, for the 
performances to residents in its area. These advertisements include a return 
envelope with a request for contributions. Entity M evaluates the effectiveness 
of the advertising based on the number of subscriptions sold as well as contri­
butions received. In performing that evaluation, Entity M places more weight 
on the number of subscriptions sold than on the contributions received. Also, 
Entity M advertises the performances on local television and radio without a 
request for contributions but on a smaller scale than the mail advertising. 
Conclusion
E.68. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated.
E.69. The activity calls for specific action by the recipient (attending the per­
formances) that will help accomplish the entity's mission. Therefore, the guid­
ance in paragraph .10 should be considered. Neither of the factors in paragraph 
.10a or .10b is determinative of whether the purpose criterion is met. Therefore, 
other evidence, such as the indicators in paragraph .11, should be considered.
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The purpose criterion is met based on the other evidence, because (a) the en­
tity measures program results and accomplishments of the joint activity and 
in evaluating the effectiveness of the activity, the entity places significantly 
greater weight on the activity's effectiveness in accomplishing program goals 
than on the activity's effectiveness in raising contributions (Entity M evaluates 
the effectiveness of the advertising based on the number of subscriptions sold 
as well as contributions received and places more weight on the number of sub­
scriptions sold than on the contributions received), (b) it otherwise conducts the 
program activity without a request for contributions, and (c) performing such 
programs helps accomplish Entity M's mission (to make the arts available to 
residents in its area).
E.70. The audience criterion is met because the audience (a broad segment 
of the population in Entity M's area) is selected based on its need to use or 
reasonable potential for use of the action called for by the program component.
E.71. The content criterion is met because the activity calls for specific action 
by the recipient (attending the performances) that will help accomplish the 
entity's mission (making the arts available to area residents), and the need 
for and benefits of the action are clearly evident (attending the performance is 
a positive cultural experience). (Note that the purchase of subscriptions is an 
exchange transaction and, therefore, is not a contribution.)
Illustration 14
Facts
E.72. Entity N is a university whose mission is to educate the public (stu­
dents) in various academic pursuits. Entity N's political science department 
holds a special lecture series in which prominent world leaders speak about 
current events. The speakers command relatively high fees and, in order to 
cover costs and make a modest profit, the university sets a relatively expensive 
fee to attend. However, the tickets are priced at the fair value of the lecture and 
no portion of the ticket purchase price is a contribution. Entity N advertises 
the lectures by sending invitations to prior attendees and to prior donors who 
have contributed significant amounts, and by placing advertisements in local 
newspapers read by the general public. At some of the lectures, including the 
lecture being considered in this illustration, deans and other faculty members 
of Entity N solicit significant contributions from attendees. Other lectures in 
the series are conducted on a scale similar to the scale of the lecture in this 
illustration without requesting contributions. Entity N's records indicate that 
historically 75 percent of the attendees have attended prior lectures. Of the 75 
percent who have attended prior lectures, 15 percent have made prior contri­
butions to Entity N. Of the 15 percent who have made prior contributions to 
Entity N, 5 percent have made contributions in response to solicitations made at 
the events. (Therefore, one-half of one percent of attendees make contributions 
in response to solicitations made at the events. However, those contributions 
are significant.) Overall, the audience's ability or likelihood to contribute is an 
insignificant factor in its selection. Entity N evaluates the effectiveness of the 
activity based on the number of tickets sold, as well as contributions received. 
In performing that evaluation, Entity N places more weight on the number of 
tickets sold than on the contributions received.
Conclusion
E.73. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated.
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E.74. The activity calls for specific action by the recipient (attending the 
lecture) that will help accomplish the entity's mission. Therefore, the guidance 
in paragraph .10 should be considered. The purpose criterion is met because (a) 
the program component of the activity calls for specific action by the recipient 
that will help accomplish the entity's mission (educating the public [students] 
in various academic pursuits), and (b) the program is also conducted using the 
same medium on a scale that is similar to or greater than the scale on which 
it is conducted with the request for contributions (other lectures in the series 
are conducted on a scale similar to the scale of the lecture in this illustration 
without requesting contributions).
E.75. The audience criterion is met. The rebuttable presumption that the au­
dience criterion is not met because the audience includes prior donors is over­
come in this illustration because the audience (those who have shown prior 
interest in the lecture series, prior donors, a broad segment of the population 
in Entity N's area, and those attending the lecture) is also selected for its rea­
sonable potential for use of the program component (attending the lecture). 
Although the audience may make significant contributions, that was an in­
significant factor in its selection.
E.76. The content criterion is met because the activity calls for specific action 
by the recipient (attending the lecture) that will help accomplish the entity's 
mission (educating the public [students] in various academic pursuits), and the 
need for and benefits of the action are clearly evident (attending the lecture 
is a positive educational experience). (Note that the purchase of the tickets 
is an exchange transaction and, therefore, is not a contribution. As discussed 
in paragraph .07 of this SOP, costs of goods or services provided in exchange 
transactions that are part of joint activities, such as costs of direct donor benefits 
of a special event, should not be reported as fund raising.12)
Illustration 15
Facts
E.77. Entity O is a university whose mission is to educate the public (stu­
dents) in various academic pursuits. Entity O's political science department 
holds a special lecture series in which prominent world leaders speak about 
current events. Admission is priced at $250, which is above the $50 fair value 
of the lecture and, therefore, $200 of the admission price is a contribution. 
Therefore, the audience's likelihood to contribute to the entity is a significant 
factor in its selection. Entity O advertises the lectures by sending invitations to 
prior attendees and to prior donors who have contributed significant amounts, 
and by placing advertisements in local newspapers read by the general public. 
Entity O presents similar lectures that are priced at the fair value of those 
lectures.
Conclusion
E.78. The purpose and content criteria are met. The audience criterion is not 
met. All costs, including those that might otherwise be considered program or 
management and general costs if they had been incurred in a different activity,
12 Paragraphs 13.21-13.26 of the Audit and Accounting Guide Not-for-Profit Organizations pro­
vide guidance concerning reporting special events. (Footnote revised, June 2004, to reflect conforming 
changes necessary due to conforming changes made to the AICPA Audit and Accounting Guide Not- 
for-Profit Organizations.]
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except for the costs of the direct donor benefit (the lecture), should be charged 
to fund raising.
E.79. The activity calls for specific action by the recipient (attending the 
lecture) that will help accomplish the entity's mission. Therefore, the guidance 
in paragraph .10 should be considered. The purpose criterion is met because (a) 
the program component of the activity calls for specific action by the recipient 
that will help accomplish the entity's mission (educating the public [students] 
in various academic pursuits), and (b) the program is also conducted using the 
same medium on a scale that is similar to or greater than the scale on which 
it is conducted with the request for contributions (other lectures in the series 
are conducted on a scale similar to the scale of the lecture in this illustration 
without including a contribution in the admission price.)
E.80. The audience criterion is not met. The rebuttable presumption that the 
audience criterion is not met because the audience is selected based on its like­
lihood to contribute to the entity is not overcome in this illustration. The fact 
that the $250 admission price includes a $200 contribution leads to the conclu­
sion that the audience's ability or likelihood to contribute is an overwhelmingly 
significant factor in its selection, whereas there is no evidence that the extent 
to which the audience is selected for its need to use or reasonable potential for 
use of the action called for by the program component (attending the lecture) 
is overwhelmingly significant.
E.81. The content criterion is met because the activity calls for specific action 
by the recipient (attending the lecture) that will help accomplish the entity's 
mission (educating the public [students] in various academic pursuits), and the 
need for and benefits of the action are clearly evident (attending the lecture 
is a positive educational experience). (Note that the purchase of the tickets 
is an exchange transaction and, therefore, is not a contribution. As discussed 
in paragraph .07 of this SOP, costs of goods or services provided in exchange 
transactions that are part of joint activities, such as costs of direct donor benefits 
of a special event, should not be reported as fund raising.13)
Illustration 16
Facts
E.82. Entity P's mission is to reduce the incidence of illness from ABC disease, 
which primarily afflicts people over sixty-five years of age. One of Entity P's 
objectives in fulfilling that mission is to have all persons over sixty-five screened 
for ABC disease.
E.83. Entity P rents space at events attended primarily by people over sixty- 
five years of age and conducts free screening for ABC disease. Entity P's em­
ployees, who are educated about ABC disease and screening procedures and do 
not otherwise perform fund-raising functions, educate interested parties about 
the effects of ABC disease and the ease and benefits of screening for it. Entity P 
also solicits contributions at the events. The effectiveness of the activity is eval­
uated primarily based on how many screening tests are performed, and only 
minimally based on contributions raised. The employees are not compensated 
or evaluated based on contributions raised.
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vide guidance concerning reporting special events. [Footnote revised, June 2004, to reflect conforming 
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Conclusion
E.84. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated.
E.85. The activity calls for specific action by the recipient (being screened 
for ABC disease) that will help accomplish the entity's mission. Therefore, the 
guidance in paragraph .10 should be considered. Neither of the factors in para­
graph .10a or .10b is determinative of whether the purpose criterion is met. 
Therefore, other evidence, such as the indicators in paragraph .11, should be 
considered. The purpose criterion is met based on the other evidence, because 
(a) a process exists to evaluate measured program results and accomplishments 
and in evaluating the effectiveness of the joint activity, the entity places signif­
icantly greater weight on the activity's effectiveness in accomplishing program 
goals than on the activity's effectiveness in raising contributions (Entity P eval­
uates the effectiveness of the activity based on the number of screening tests 
conducted as well as contributions received and places more weight on the 
number of tests conducted than on the contributions received); (b) the quali­
fications and duties of the personnel performing the activity indicate that it 
is a program activity (the employees are educated about ABC disease and the 
testing procedures and do not otherwise perform fund-raising functions); (c) the 
method of compensation for performing the activity does not indicate that it is 
a fund-raising activity (the employees are not compensated or evaluated based 
on contributions raised); and (d) performing such programs helps accomplish 
Entity P's mission (to prevent ABC disease).
E.86. The audience criterion is met because the audience (people over sixty- 
five years of age) is selected based on its need to use or reasonable potential for 
use of the action called for by the program component.
E.87. The content criterion is met because the activity calls for specific action 
by the recipient (being screened for ABC disease) that will help accomplish the 
entity's mission (to reduce the incidence of ABC disease), and it explains the 
need for and benefits of the action (to prevent ABC disease).
Illustration 17
Facts
E.88. Entity Q's mission is to provide cultural and educational television 
programming to residents in its area. Entity Q owns a public television station 
and holds a membership drive in which it solicits new members. The drive is 
conducted by station employees and consists of solicitations that are shown 
during long breaks between the station's regularly scheduled programs. Entity 
Q's internal management memoranda state that these drives are designed to 
raise contributions. Entity Q evaluates the effectiveness of the activity based 
on the amount of contributions received. Entity Q shows the programs on a 
similar scale, without the request for contributions. The audience is members 
of the general public who watch the programs shown during the drive. Station 
member benefits are given to those who contribute and consist of tokens of 
appreciation with a nominal value.
Conclusion
E.89. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated. (Note that there would be few, if any, joint costs. Costs as­
sociated with the fund-raising activities, such as costs of airtime, would be 
separately identifiable from costs of the program activities, such as licensing
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costs for a particular television program. Also, note that because no significant 
benefits or duties are associated with membership, member dues are contribu­
tions. Therefore, the substance of the membership-development activities is, in 
fact, fund raising.)
E.90. The activity calls for specific action by the recipient (watching the tele­
vision program) that will help accomplish the entity's mission. Therefore, the 
guidance in paragraph .10 should be considered. The purpose criterion is met 
because (a) the program component of the activity calls for specific action by the 
recipient that will help accomplish the entity's mission, and (b) the program is 
also conducted using the same medium on a scale that is similar to or greater 
than the scale on which it is conducted with the request for contributions (En­
tity Q shows the television programs on a similar scale, without the request for 
contributions).
E.91. The audience criterion is met. The rebuttable presumption that the 
audience criterion is not met because the audience is selected based on its like­
lihood to contribute is overcome in this illustration because the audience (mem­
bers of the general public who watch the television programs shown during the 
drive) is also selected for its reasonable potential for use of the program com­
ponent (watching the television programs). Although the audience may make 
contributions, that was an insignificant factor in its selection.
E.92. The content criterion is met because the activity calls for specific action 
by the recipient (watching the television programs) that will help accomplish 
the entity's mission (providing cultural and educational television program­
ming to residents in its area), and the need for and benefits of the action are 
clearly evident (watching the programs is a positive cultural and educational 
experience).
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Appendix F
Illustrations of Allocation Methods
F.1. Some commonly used cost allocation methods follow.
Physical Units Method
F.2. Joint costs are allocated to materials and activities in proportion to the 
number of units of output that can be attributed to each of the materials and 
activities. Examples of units of output are lines, square inches, and physical 
content measures. This method assumes that the benefits received by the fund­
raising, program, or management and general component of the materials or ac­
tivity from the joint costs incurred are directly proportional to the lines, square 
inches, or other physical output measures attributed to each component of the 
activity. This method may result in an unreasonable allocation of joint costs if 
the units of output, for example, line counts, do not reflect the degree to which 
costs are incurred for the joint activity. Use of the physical units method may 
also result in an unreasonable allocation if the physical units cannot be clearly 
ascribed to fund raising, program, or management and general. For example, 
direct mail and telephone solicitations sometimes include content that is not 
identifiable with fund raising, program, or management and general; or the 
physical units of such content are inseparable.
Illustration
F.3. Assume a direct mail campaign is used to conduct programs of the entity 
and to solicit contributions to support the entity and its programs. Further, 
assume that the appeal meets the criteria for allocation of joint costs to more 
than one function.
F.4. The letter and reply card include a total of one hundred lines. Forty-five 
lines pertain to program because they include a call for action by the recipient 
that will help accomplish the entity's mission, while fifty-five lines pertain to 
the fund-raising appeal. Accordingly, 45 percent of the costs are allocated to 
program and 55 percent to fund-raising.
Relative Direct Cost Method
F.5. Joint costs are allocated to each of the components on the basis of their 
respective direct costs. Direct costs are those costs that are incurred in con­
nection with the multipurpose materials or activity and that are specifically 
identifiable with a function (program, fund raising, or management and gen­
eral). This method may result in an unreasonable allocation of joint costs if the 
joint costs of the materials and activity are not incurred in approximately the 
same proportion and for the same reasons as the direct costs of the materials 
and activity. For example, if a relatively costly booklet informing the reader 
about the entity's mission (including a call for action by the recipient that will 
help accomplish the entity's mission) is included with a relatively inexpensive 
fund-raising letter, the allocation of joint costs based on the cost of these pieces 
may be unreasonable, particularly if the booklet and letter weigh approximately 
the same and therefore contribute equally to the postage costs.
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Illustration
F.6. The costs of a direct mail campaign that can be specifically identified 
with program services are the costs of separate program materials and a post­
card which calls for specific action by the recipient that will help accomplish 
the entity's mission. They total $20,000. The direct costs of the fund-raising 
component of the direct mail campaign consist of the costs to develop and pro­
duce the fund-raising letter. They total $80,000. Joint costs associated with the 
direct mail campaign total $40,000 and would be allocated as follows under the 
relative direct cost method:
Program $20,000/$100,000 x $40,000 = $8,000 
Fund raising $80,000/$100,000 x $40,000 = $32,000
Stand-Alone Joint-Cost-Allocation Method
F.7. Joint costs are allocated to each component of the activity based on a ratio 
that uses estimates of costs of items included in joint costs that would have been 
incurred had the components been conducted independently. The numerator 
of the ratio is the cost (of items included in joint costs) of conducting a single 
component independently; the denominator is the cost (of items included in joint 
costs) of conducting all components independently. This method assumes that 
efforts for each component in the stand-alone situation are proportionate to the 
efforts actually undertaken in the joint cost situation. This method may result 
in an unreasonable allocation because it ignores the effect of each function, 
which is performed jointly with other functions, on other such functions. For 
example, the programmatic impact of a direct mail campaign or a telemarketing 
phone message may be significantly lessened when performed in conjunction 
with a fund-raising appeal.
Illustration
F.8. Assume that the joint costs associated with a direct mail campaign in­
cluding both program and fund-raising components are the costs of stationery, 
postage, and envelopes at a total of $100,000. The costs of stationery, postage, 
and envelopes to produce and distribute each component separately would have 
been $90,000 for the program component and $70,000 for the fund-raising com­
ponent. Under the stand-alone joint-cost-allocation method, the $100,000 in 
joint costs would be allocated as follows: $90,000/$160,000 x $100,000 = $56,250 
to program services and $70,000/$160,000 x $100,000 = $43,750 to fund raising.
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Appendix G
Illustrations of Disclosures
G.1. The disclosures discussed in paragraphs .18 and .19 are illustrated be­
low. Alternative 1 reports the required and encouraged information in narrative 
format. Alternative 2 reports that information in tabular format, as well as in­
formation concerning joint costs incurred for each kind of activity by functional 
classification, which is neither required nor encouraged, but which is not pro­
hibited.
Alternative 1
Note X. Allocation of Joint Costs
In 19XX, the organization conducted activities that included requests 
for contributions, as well as program and management and general 
components. Those activities included direct mail campaigns, special 
events, and a telethon. The costs of conducting those activities included 
a total of $310,000 of joint costs, which are not specifically attributable 
to particular components of the activities (joint costs). [Note to reader: 
The following sentence is encouraged but not required.] Joint costs for 
each kind of activity were $50,000, $150,000, and $110,000 respec­
tively. These joint costs were allocated as follows:
Fund raising $180,000
Program A 80,000
Program B 40,000
Management and general 10.000
Total $310,000
Alternative 2
Note X. Allocation of Joint Costs
In 19XX, the organization conducted activities that included appeals 
for contributions and incurred joint costs of $310,000. These activities 
included direct mail campaigns, special events, and a telethon. Joint 
costs were allocated as follows:
Special
Direct Mail Events Telethon Total
Fund raising $40,000 $50,000 $90,000 $180,000
Program A 10,000 65,000 5,000 80,000
Program B 25,000 15,000 40,000
Management and general 10,000 10,000
Total $50,000 $150,000 $110,000 $310,000
[Note to reader: Shading is used to highlight information that is neither re­
quired nor encouraged, but which is not prohibited. However, entities may prefer 
to disclose it. Disclosing the total joint costs for each kind o f activity ($50,000, 
$150,000, and $110,000) is encouraged but not required.]
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Appendix H
Contrast of Guidance in This SOP With the Guidance 
in SOP 87 -214,**
This SOP SOP 87-2
Applies to all entities that solicit con­
tributions, including state and local 
governments.
Covers all costs of joint activities. 
(Costs that otherwise might be con­
sidered program or management 
and general costs if they had been 
incurred in a different activity, ex­
cept for costs of goods or services pro­
vided in exchange transactions that 
are part of joint activities, such as 
costs of direct donor benefits of a 
special event [for example, a meal], 
should be charged to fund raising un­
less the criteria in the SOP are met.)
Criteria of purpose, audience, and 
content should all be met in order 
to charge costs of the activity to pro­
gram or management and general.
Applied to entities that follow the 
AICPA Industry Audit Guide Au­
dits o f Voluntary Health and Welfare 
Organizations or SOP 78-10. (SOP 
87-2 was not applicable to entities 
that are within the scope of Govern­
mental Accounting Standards Board 
Statement No. 29, The Use of Not-for- 
Profit Accounting and Financial Re­
porting Principles by Governmental 
Entities.)
Covers only joint costs of joint 
activities.
Unclear concerning whether all cri­
teria should be met in order to charge 
costs of the activity to program or 
management and general.
14 In August 1996, the AICPA issued the Audit and Accounting Guide Not-for-Profit Organiza­
tions, which superseded SOP 87-2, Accounting for Joint Costs of Informational Materials and Activities 
of Not-for-Profit Organizations That Include a Fund-Raising Appeal, because the guidance in SOP 87-2 
is incorporated into paragraphs 13.36 to 13.45 of the Guide. Also, Not-for-Profit Organizations super­
seded the AICPA Industry Audit Guide Audits of Voluntary Health and Welfare Organizations and 
SOP 78-10. Not-for-Profit Organizations applies to all nongovernmental not-for-profit organizations 
other than those required to follow the Audit and Accounting Guide Health Care Organizations. There­
fore, incorporating the guidance in SOP 87-2 into Not-for-Profit Organizations broadened the scope 
of the guidance previously included in SOP 87-2 to all not-for-profit organizations other than those 
required to follow Health Care Organizations. The discussion in this SOP of SOP 87-2 refers to both 
SOP 87-2 and the guidance included in paragraphs 13.36 to 13.45 of Not-for-Profit Organizations, ex­
cept that the guidance in Not-for-Profit Organizations applies to all not-for-profit organizations other 
than those required to follow Health Care Organizations.
** See footnotes ‡ and || in paragraphs D.3 and D.4, respectively. [Footnote revised, June 2004, 
to reflect conforming changes necessary due to the issuance of GASB Statements No. 34 and No. 35.]
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This SOP
Neither prescribes nor prohibits any 
allocation methods. Includes a dis­
cussion to help users determine 
whether an allocation is reasonable, 
and provides some illustrations.
Requires note disclosures about the 
types of activities for which joint 
costs have been incurred, amounts 
allocated during the period, and 
amounts allocated to each functional 
expense or expenditure category.
SOP 87-2
Neither prescribes nor prohibits any 
allocation methods. No illustrations 
are provided.
Requires less extensive note disclo­
sures: total amount allocated during 
the period and amounts allocated to 
each functional expense category.
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Appendix I
Effects on Other Guidance
I.1. For nongovernmental organizations, this Statement of Position (SOP) 
amends the AICPA Audit and Accounting Guide Health Care Organizations 
and paragraphs 13.35 to 13.44 of the AICPA Audit and Accounting Guide Not- 
for-Profit Organizations. [Revised, June 2004, to reflect conforming changes 
necessary due to conforming changes made to the AICPA Audit and Accounting 
Guide Not-for-Profit Organizations.]
I.2. Also, this SOP amends the AICPA Audit and Accounting Guide Not- 
for-Profit Organizations to clarify that costs of goods or services provided in 
exchange transactions that are part of joint activities, such as costs of direct 
donor benefits of a special event (for example, a meal), should not be reported as 
fund-raising. In particular, paragraphs 13.21, 13.23, and 13.24 of Not-for-Profit 
Organizations are amended as follows:
13.21 Some organizations conduct joint activitiesfn 9 that are spe­
cial events, including special social and educational events (such as 
symposia, dinners, dances, and theater parties) in which the attendee 
receives a direct benefit (for example, a meal or theater ticket). FASB 
Statement No. 117 requires the reporting of the gross amounts of rev­
enues and expenses from special events and other fund-raising activi­
ties that are ongoing major or central activities, but permits (but does 
not require) reporting net amounts if the receipts and related costs 
result from special events that are peripheral or incidental activities.
13.23 For example, assume that an organization has a special event 
that is an ongoing and major activity with a ticket price of $100. As­
sume that the activity does not meet the audience criterion in SOP 
98-2, Accounting for Costs o f Activities o f Not-for-Profit Organizations 
and State and Local Governmental Entities That Include Fund Rais­
ing, and, therefore, all costs of the activity, other than the direct donor 
benefits, should be reported as fund raising. The event includes a din­
ner that costs the organization $25 and that has a fair value of $30. 
(Chapter 5, "Contributions Received and Agency Transactions," of this 
Guide, discusses the appropriate reporting if the meal or other items of 
value are donated to the organization for resale.) In addition, the orga­
nization incurs other direct costs of the event in connection with pro­
moting and conducting the event, including incremental direct costs 
incurred in transactions with independent third parties and the pay­
roll and payroll-related costs for the activities of employees who are di­
rectly associated with, and devote time to, the event. Those other direct 
costs, which include (a) $5 that otherwise might be considered manage­
ment and general costs if they had been incurred in a different activity, 
and (b) fund-raising costs of $10, are unrelated to the direct benefits 
to donors and, accordingly, should not be included as costs of benefits 
to donors. In addition, the organization has the following transactions, 
which are unrelated to the special event: unrestricted contributions of 
$200, program expenses of $60, management and general expenses of 
$20, and fund-raising expenses of $20.
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13.24 Some ways in which the organization could display the results 
of the special event as part of its statement of activities are illustrated 
as follows:
Illustration 1
Changes in unrestricted net assets:
Contributions $200
Special event revenue 100
Less: Costs of direct benefits to donors (25)
Net revenues from special events  75
Contributions and net revenues 275
from special events
Other expenses:
Program 60
Management and general 20
Fund raising 35
Total other expenses 115
Increase in unrestricted net assets $160
Illustration 2
Changes in unrestricted net assets:
Revenues:
Contributions $200
Special event revenue 100
Total revenues 300
Expenses:
Program 60
Costs of direct benefits to donors 25
Management and general 20
Fund raising  35
Total expenses 140
Increase in unrestricted net assets $160
Illustration 3
Changes in unrestricted net assets:
Contributions $270
Dinner sales 30
Less: Costs of direct benefits to donors (25)
Gross profit on special events 5
Contributions and net revenues 275
from special events
Other expenses:
Program 60
Management and general 20
Fund raising 35
Total other expenses 115
Increase in unrestricted net assets $160
AAG-HCO APP C
360 Health Care Organizations
fa 9 See footnote 1.
[Revised, June 2004, to reflect conforming changes necessary due to conforming 
changes made to the AICPA Audit and Accounting Guide Not-for-Profit Orga­
nizations.]
I.3. For governmental entities that have applied the accounting and financial 
reporting principles in SOP 78-10, Accounting Principles and Reporting Prac­
tices for Certain Nonprofit Organizations, or the AICPA Industry Audit Guide 
Audits o f Voluntary Health and Welfare Organizations (modified by all appli­
cable Financial Accounting Standards Board [FASB] pronouncements issued 
through November 3 0 , 1989, and by most applicable Governmental Accounting 
Standards Board [GASB] pronouncements) in conformity with GASB State­
ment No. 29, The Use o f Not-for-Profit Accounting and Financial Reporting 
Principles by Governmental Entities, this SOP amends the principles—based 
on SOP 78-10 and Audits o f Voluntary Health and Welfare Organizations, as 
modified—that those entities apply. For governmental entities that have ap­
plied the accounting and financial reporting principles in the 1973 AICPA In­
dustry Audit Guide Audits o f Colleges and Universities, as amended by SOP 
74-8, Financial Accounting and Reporting by Colleges and Universities, and 
as modified by applicable FASB pronouncements issued through November 30, 
1989, and all applicable GASB pronouncements in conformity with GASB State­
ment No. 15, Governmental College and University Accounting and Financial 
Reporting Models, this SOP amends the principles—based on Audits o f Colleges 
and Universities, as amended and modified—that those entities apply. For other 
governmental organizations, this SOP amends the Audit and Accounting Guide 
Audits o f State and Local Governmental Units.††
† See footnotes ‡ and || in paragraphs D.3 and D.4, respectively. Also, the AICPA Audit and 
Accounting Guide State and Local Governments supersedes the 1994 AICPA Audit and Accounting 
Guide Audits o f State and Local Governmental Units and subsequent editions of that Guide with 
conforming changes made by the AICPA staff. The AICPA Audit and Accounting Guide State and 
Local Governments, provides guidance on the application of this SOP to state and local governments. 
[Footnote added, June 2004, to reflect conforming changes necessary due to the issuance of GASB 
Statements No. 34, No. 35, and the AICPA Audit and Accounting Guide Audits o f State and Local 
Governmental Units.]
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Glossary
Activities. Activities are efforts to accomplish specific objectives. Some activi­
ties include producing and distributing materials. For example, if an entity 
undertakes a mass mailing that includes a letter and a pamphlet, produc­
ing and distributing the letter and pamphlet are part of the activity. Other 
activities may include no materials, such as an annual dinner or a radio 
commercial.
Compensation or fees. Reciprocal transfers of cash or other assets in ex­
change for services performed.
Contributions. Contributions are unconditional transfers of cash or other as­
sets to an entity or a settlement or cancellation of its liabilities in a vol­
untary nonreciprocal transfer by another entity acting other than as an 
owner.
Costs of joint activities. Costs of joint activities are costs incurred for a joint 
activity. Costs of joint activities may include joint costs and costs other 
than joint costs. Costs other than joint costs are costs that are identifiable 
with a particular function, such as fund raising, program, management and 
general, and cost of sales. For example, some costs incurred for printing, 
paper, professional fees, and salaries to produce donor cards are not joint 
costs, although they may be incurred in connection with conducting joint 
activities.
Fund-raising activities. Fund-raising activities are activities undertaken to 
induce potential donors to contribute money, securities, services, materi­
als, facilities, other assets, or time. They include publicizing and conducting 
fund-raising campaigns; maintaining donor mailing lists; conducting spe­
cial fund-raising events; preparing and distributing fund-raising manuals, 
instructions, and other materials; and conducting other activities involved 
with soliciting contributions from individuals, foundations, governments, 
and others.
Help accomplish the entity's mission. Actions that help accomplish the 
entity's mission are actions that either benefit the recipient (such as by 
improving the recipient's physical, mental, emotional, or spiritual health 
and well-being) or benefit society (by addressing societal problems).
Joint activity. A joint activity is an activity that is part of the fund-raising 
function and has elements of one or more other functions, such as pro­
gram, management and general, membership development, or any other 
functional category used by the entity.
Joint costs. Joint costs are the costs of conducting joint activities that are 
not identifiable with a particular component of the activity. For example, 
the cost of postage for a letter that includes both fund-raising and program 
components is a joint cost. Joint costs may include the costs of salaries, con­
tract labor, consultants, professional fees, paper, printing, postage, event 
advertising, telephones, airtime, and facility rentals.
Management and general activities. Management and general activities 
are those that are not identifiable with a single program, fund-raising ac­
tivity, or membership-development activity but that are indispensable to
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the conduct of those activities and to an organization's existence. They 
include oversight, business management, general recordkeeping, budget­
ing, financing, soliciting revenue from exchange transactions, such as gov­
ernment contracts and related administrative activities, and all manage­
ment and administration except for direct conduct of program services or 
fund-raising activities. Disseminating information to inform the public of 
the organization's "stewardship" of contributed funds, announcements con­
cerning appointments, and the annual report, among other activities, are 
management and general activities, as are soliciting funds other than con­
tributions, including exchange transactions (whether program-related or 
not).
Medium. A medium is a means of mass communication, such as direct mail, 
direct response advertising, or television.
Membership-development activities. Membership-development activities 
include soliciting for prospective members and membership dues, member­
ship relations, and similar activities. If there are no significant benefits or 
duties connected with membership, however, the substance of membership- 
development activities may, in fact, be fund-raising.
Program activities. Program activities are the activities that result in goods 
or services being distributed to beneficiaries, customers, or members that 
fulfill the purposes or mission for which the organization exists. Those ser­
vices are the major purpose for and the major output of the organization 
and often relate to several major programs. For example, a large univer­
sity may have programs for student instruction, research, and patient care, 
among others. Similarly, a health and welfare organization may have pro­
grams for health and family services, research, disaster relief, and public 
education, among others.
Health Care Organizations
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NOTE
This Statement of Position presents the recommendations of the AICPA 
Health Care Pilot Task Force regarding the application of Statements 
on Standards for Attestation Engagements to agreed-upon procedures 
attestation engagements performed to assist a health care provider in 
evaluating the effectiveness of its corporate compliance program con­
sistent with the requirements of a Corporate Integrity Agreement en­
tered into with the Office of Inspector General of the U.S. Department of 
Health and Human Services. The Auditing Standards Board has found 
the recommendations in this Statement of Position to be consistent with 
existing standards covered by Rule 202 of the AICPA Code of Profes­
sional Conduct. AICPA members should be prepared to justify depar­
tures from the recommendations in this Statement of Position.
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Summary
This Statement of Position (SOP) provides guidance to practitioners in con­
ducting and reporting on an agreed-upon procedures engagement performed 
pursuant to the AICPA Statements on Standards for Attestation Engagements 
to assist a health care provider in evaluating the effectiveness of its corporate 
compliance program consistent with the requirements of a Corporate Integrity 
Agreement (CIA) entered into with the Office of Inspector General (OIG) of the 
U.S. Department of Health and Human Services. CIAs are specific to the entity 
involved; consequently, users of this SOP should be familiar with the specific 
requirements of the entity's CIA.
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Introduction and Background
.01 Within the past several years, the health care industry has experi­
enced a significant increase in the number and magnitude of allegations of fraud 
and abuse involving federal health care programs (for example, Medicare and 
Medicaid) and private health care insurance. These allegations have triggered 
regulatory scrutiny, litigation, significant monetary settlements, and negative 
publicity related to—among other things—coding and billing practices, patient 
referrals, cost reporting, quality of care, and clinical practices. Typically, as 
part of the global resolution of these allegations, the entity enters into a Cor­
porate Integrity Agreement (CIA) with the Office o f Inspector General (OIG) of 
the U.S. Department of Health and Human Services. Such agreements require 
that management annually report on its compliance with the terms of the CIA 
and that there be an assessment of the entity's compliance with the CIA. This 
assessment includes a billing analysis, which may be performed by an indepen­
dent review organization (such as a practitioner or consultant) or the provider 
(if permitted by the OIG), and an agreed-upon procedures engagement.
.02 This SOP provides guidance to practitioners in conducting and re­
porting on an agreed-upon procedures engagement performed pursuant to the 
American Institute of Certified Public Accountants (AICPA) Statements on 
Standards for Attestation Engagements (SSAEs) to assist an entity in eval­
uating the effectiveness of its corporate compliance program consistent with 
the requirements of a CIA.1 The terms of a CIA are unique to the entity; con­
sequently, users of this SOP need to be familiar with the actual CIA and its 
requirements.
.03 This SOP applies to agreed-upon procedures engagements to assist 
in evaluating an entity's compliance for a specified period. Such engagements 
should follow the AICPA attestation standards, including SSAE No. 1, Attesta­
tion Standards; SSAE No. 3, Compliance Attestation; and SSAE No. 4, Agreed- 
Upon Procedures Engagements. The engagement should be conducted in accor­
dance with standards established by the AICPA, including the criteria set forth 
in this SOP. However, this SOP is not intended to provide all the required crite­
ria set forth in individual CIAs, nor all the applicable standards established by 
the AICPA. Additionally, the SOP contains some guidance that may be applied 
in evaluating an organization's corporate compliance program, even though the 
program was not imposed by a CIA.
Overview of a Typical Corporate Integrity Agreement
.04 A CIA is an agreement between a health care provider and the OIG in 
conjunction with a global settlement of a fraud investigation. Such an agree­
ment typically seeks to establish a compliance program within the health care 
provider (for example, hospital, clinical lab, physician group) that will promote 
compliance with the requirements of Medicare, Medicaid, and all other federal 
health care programs.
1 The practitioner also might be engaged to assist in other areas beyond an agreed-upon pro­
cedures engagement such as providing consulting services in connection with evaluating the com­
pany's billing practices, policies, and procedures as required by the CIA or in implementing, assessing, 
and reporting on voluntarily adopted compliance programs. In addition, the practitioner may assist 
in preparing an entity's self-disclosure reports to federal health agencies related to billing errors 
and other compliance matters. Similarly, practitioners may be involved in an entity's preparation of 
government-required (but not CIA-imposed) compliance reporting (for example, contract requirements 
for Medicare part C) beyond an agreed-upon procedures engagement.
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.05 CIAs are case-specific. Their terms are tailored to address the organi­
zational and operating deficiencies related to providing and billing for health 
care services that have been identified by the OIG, the entity, or others. Detailed 
compliance requirements are imposed as a condition for continued participa­
tion in federal health care programs. A sample CIA, provided by the OIG and 
intended to identify potential requirements, is included in appendix A [para­
graph .32], "Sample Corporate Integrity Agreement." Typical agreements cover 
five years and require the entity to address the following areas:
• Appointment of a compliance officer and establishment of a compliance 
committee
• Establishment of a code of conduct
• Establishment of policies and procedures regarding the compliance 
program
• Development of an information and education program as to CIA re­
quirements, compliance program and code of conduct
• Annual assessment of billing policies, procedures, and practices
• Establishment of a confidential disclosure program
• Prohibition of employment of excluded or convicted persons
• Notification to OIG of investigation or legal proceedings
• Reporting of credible evidence of misconduct
• Notifications to OIG of new provider locations
• Provision of implementation and annual reports
• Proper notification and submission of required reports
• Granting of OIG access to documents and individuals to conduct as­
sessments
• Documentation of record retention requirements
• Awareness of disclosure criteria
• Agreement to comply with certain default provisions, penalties, and 
remedies
• Review of rights as to dispute resolution
• Review of effective and binding agreement clauses
Conditions for Engagement Performance
.06 A practitioner may perform an agreed-upon procedures engagement 
related to management's compliance with a CIA if all of the conditions specified 
in SSAE No. 4 and SSAE No. 3 are met.
.07 As discussed more fully in the SSAEs noted in paragraph .06, man­
agement's assertions as to its compliance must be capable of evaluation against 
reasonable criteria that either have been established by a recognized body or are 
stated in or attached to the practitioner's report in a sufficiently clear and com­
prehensive manner. Generally, to avoid confusion, management's assertions, 
which are based on the specific terms of its CIA, should be attached to the prac­
titioner's report. If the entity is not subject to a CIA, management may develop 
its assertions using the model CIA. A sample based on the model CIA, which 
is not meant to be all-inclusive, is included as appendix B [paragraph .33], 
"Sample Statement of Management's Assertions."
Health Care Organizations
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Establishing an Understanding With the Client
.08 The practitioner should document the understanding in the working 
papers, preferably through a written communication with the client, such as 
an engagement letter. Appendix C [paragraph .34], "Sample Engagement Let­
ter," contains a sample engagement letter that may be used for this kind of 
engagement.
Users' Responsibilities
.09 Users typically would be the management of the health care provider 
and the OIG. Management is responsible for ensuring that the entity complies 
with the requirements of the CIA. That responsibility encompasses (a) iden­
tifying applicable compliance requirements, (b) establishing and maintaining 
internal control policies and procedures to provide reasonable assurance that 
the entity complies with those requirements, (c) evaluating and monitoring the 
entity's compliance, and (d) preparing reports that satisfy legal, regulatory, or 
contractual requirements. Management's evaluation may include documenta­
tion such as accounting or statistical data, policy manuals, accounting manu­
als, narrative memoranda, procedural write-ups, flowcharts, completed ques­
tionnaires, internal auditors' reports, and other special studies or analyses. The 
form and extent of documentation will vary depending on the nature of the com­
pliance requirements and the size and complexity of the entity. Management 
may engage the practitioner to gather information to assist it in evaluating the 
entity's compliance. Regardless of the procedures performed by the practitioner, 
management must accept responsibility for its assertions and must not base 
such assertions solely on the practitioner's procedures.
.10 Specified users are responsible for the sufficiency (nature, timing, and 
extent) of the agreed-upon procedures because they best understand their own 
needs. The specified users assume the risk that such procedures might be insuf­
ficient for their purposes. In addition, the specified users assume the risk that 
they might misunderstand or otherwise inappropriately use findings properly 
reported by the practitioner.
Practitioner's Responsibilities
.11 The objective of the practitioner's agreed-upon procedures is to present 
specific findings to assist users in evaluating an entity's compliance with the 
requirements specified in the CIA. (See appendix D [paragraph .35], "Sample 
Procedures.")
.12 The practitioner's procedures generally may be as limited or extensive 
as the specified users desire, as long as the specified users agree upon the pro­
cedures performed or to be performed and take responsibility for the sufficiency 
of the agreed-upon procedures for their purposes.
.13 To satisfy the requirements that the practitioner and the specified 
users agree upon the procedures performed or to be performed and that the 
specified users take responsibility for the sufficiency of the agreed-upon pro­
cedures for their purposes, ordinarily the practitioner should communicate di­
rectly with and obtain affirmative acknowledgment from each of the specified 
users. For the purposes of these engagements, an effective way to obtain this 
agreement ordinarily is to distribute a draft of the report, detailing the proce­
dures, that is expected to be issued to the OIG with a request for any comments 
it may have.
AAG-HCO APP D
372
.14 To avoid possible misunderstandings, the practitioner should circulate 
the draft with a legend stating that these are the procedures expected to be 
performed, and unless informed otherwise, the practitioner assumes that there 
are no additional procedures that he or she is expected to perform. A legend 
such as the following might be used.
This draft is furnished solely for the purpose of indicating the form 
of report that we would expect to be able to furnish pursuant to the 
request by Management of [Provider] for our performance of limited 
procedures relating to [Provider's] compliance with the Corporate In­
tegrity Agreement with the Office of Inspector General (OIG) of the 
U.S. Department of Heath and Human Services. Based on our dis­
cussions with [Provider], it is our understanding that the procedures 
outlined in this draft report are those we are expected to follow. Un­
less informed otherwise within ninety (90) days of this transmittal, we 
shall assume that there are no additional procedures that we are ex­
pected to follow. The text of the definitive report will depend, of course, 
on the results of the procedures.
Involvement of a Specialist2
.15 The practitioner's education and experience enable him or her to be 
knowledgeable about business matters in general, but he or she is not expected 
to have the expertise of a person trained for or qualified to engage in the prac­
tice of another profession or occupation. In certain circumstances, it may be 
appropriate to involve a specialist to assist the practitioner in the performance 
of one or more procedures. The following are examples:
• An attorney might provide assistance concerning the application of 
laws, regulations, or rules to a client's situation.
• A medical specialist might provide assistance in understanding the 
characteristics of diagnosis codes documented in patient medical 
records.
.16 The practitioner and the specified users should agree to the involve­
ment of a specialist in assisting a practitioner in the performance of an agreed- 
upon procedures engagement. This agreement may be reached when obtaining 
agreement on the procedures performed or to be performed and acknowledg­
ment of responsibility for the sufficiency of the procedures, as discussed pre­
viously. The practitioner's report should describe the nature of the assistance 
provided by the specialist.
.17 A practitioner may agree to apply procedures to the report or work 
product of a specialist that does not constitute assistance by the specialist 
to the practitioner in an agreed-upon procedures engagement. For example, 
the practitioner may make reference to information contained in a report 
of a specialist in describing an agreed-upon procedure. However, it is inap­
propriate for the practitioner to agree to merely read the specialist's report 
solely to describe or repeat the findings, or to take responsibility for all or a 
portion of any procedures performed by a specialist or the specialist's work 
product.
Health Care Organizations
2 A specialist is a person (or firm) possessing special skill or knowledge in a particular field 
other than the attest function. As used herein, a specialist does not include a person employed by the 
practitioner's firm who participates in the attestation engagement.
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Internal Auditors and Other Personnel 3
.18 The agreed-upon procedures to be enumerated or referred to in the 
practitioner's report are to be performed entirely by the practitioner except 
as discussed in paragraphs .16-.18 of this SOP. However, internal auditors or 
other personnel may prepare schedules, accumulate data, perform an internal 
assessment of management's compliance, or provide other information for the 
practitioner's use in performing the agreed-upon procedures.
.19 A practitioner may agree to perform procedures on information docu­
mented in the working papers of internal auditors. For example, the practitioner 
may agree to—
• Repeat all or some of the procedures.
• Determine whether the internal auditors' working papers contain doc­
umentation of procedures performed and whether the findings docu­
mented in the working papers are presented in a report by the internal 
auditors.
.20 However, it is inappropriate for the practitioner to—
• Agree to merely read the internal auditor's report solely to describe or 
repeat its findings.
• Take responsibility for all or a portion of any procedures performed by 
internal auditors by reporting those findings as the practitioner's own.
• Report in any manner that implies shared responsibility for the pro­
cedures with the internal auditors.
Planning the Engagement
.21 Planning an agreed-upon procedures engagement involves working 
with the users to develop an overall strategy for the expected conduct and 
scope of the engagement. To develop such a strategy, practitioners should have 
adequate technical training and proficiency in the attestation standards and 
have adequate knowledge in health care regulatory matters to enable them to 
sufficiently understand the events, transactions, and practices that, in their 
judgment, have a significant effect on the presentation of the assertions. 
Working Papers
.22 The practitioner should prepare and maintain working papers in con­
nection with an engagement under the attestation standards; such working 
papers should be appropriate to the circumstances and the practitioner's needs 
on the engagement to which they apply.
.23 Concern over access to the practitioner's working papers might cause 
some clients to inquire about working paper requirements. In situations where 
the practitioner is requested to not maintain copies of certain client documen­
tation, or to not prepare and maintain documentation similar to client docu­
ments, the practitioner may refer to the Auditing Interpretation, "The Auditor's 
Consideration of the Completeness Assertion" (AICPA, Professional Standards, 
vol. 1, AU sec. 9326.06-.17), for guidance. See the Attest Interpretation, "Pro­
viding Access to or Photocopies of Working Papers to a Regulator," for guidance
3 SAS No. 65, The Auditor's Consideration o f the Internal Audit Function in an Audit o f Finan­
cial Statements (AICPA, Professional Standards, vol. 1, AU sec. 322), does not apply to agreed-upon 
procedures engagements.
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related to providing access to or photocopies of working papers to a regulator 
in connection with work performed on an attestation engagement.
Health Care Organizations
Management's Representations
.24 The practitioner should obtain written representation from manage­
ment on various matters including the following:
a. Acknowledging management's responsibility for complying with 
the CIA
b. Acknowledging management's responsibility for establishing and 
maintaining effective internal control over compliance
c. Stating that management has performed an evaluation of the en­
tity's compliance with CIA-specified requirements
d. Stating management's assertions about the entity's compliance 
with all aspects of the CIA, including the specific issues that gave 
rise to the CIA4
e. Stating that management has disclosed to the practitioner all 
known noncompliance with the CIA
f. Stating that management has made available all documentation 
relating to compliance with the CIA
g. Stating management's interpretation of any compliance require­
ments that have varying interpretations
h. Stating that management has disclosed any communication from 
regulatory agencies, internal auditors, legal counsel, and other par­
ties concerning matters regarding the design, implementation, and 
monitoring of the policies and procedures in place, including com­
munication received between the end of the reporting period and 
the date of the practitioner's report (the date of signature)
i. Stating that management has disclosed any known noncompliance 
occurring subsequent to the end of the reporting period
j. Describing any related material fraud or abuse, other fraud, abuse 
or illegal acts that, whether or not material, involve management or 
other employees who have a significant role in the entity's design, 
implementation, and monitoring of the policies and procedures in 
place upon which compliance is based
k. Stating that management has disclosed to the practitioners, orally 
or in writing, information about past noncompliance issues cov­
ered in the settlement agreement that gave rise to the CIA and the 
related corrective measures taken to support compliance in those 
areas
4 Depending on the circumstances, representations in the following areas might be appropriate.
•  Violations or possible violations of laws or regulations, such as those related to the Medicare 
and Medicaid antifraud and abuse statutes
•  Compliance of third-party billings with applicable coding guidelines (for example, ICD-9- 
CM, CPT) and laws and regulations (including medical necessity, proper approvals, and 
proper rendering of care)
•  Proper filing of all required Medicare, Medicaid, and similar reports under the applicable 
reimbursement rules and regulations (including nature of costs—allowable, patient-related, 
properly allocated, in accordance with applicable rules and regulations, properly adjusted 
to reflect prior audit adjustments) and adequacy of disclosures (including disputed costs)
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Management's refusal to furnish all appropriate written representations con­
stitutes a limitation on the scope of the engagement sufficient to require with­
drawal from the engagement.
Reporting Considerations
.25 A practitioner should present the results of applying agreed-upon pro­
cedures to the specific subject matter in the form of findings. The practitioner 
should not provide negative assurance about whether the assertion is fairly 
stated in accordance with established or stated criteria. For example, the prac­
titioner should not include a statement that "nothing came to my attention that 
caused me to believe that the assertion is not fairly stated in accordance with 
(established or stated) criteria."
.26 The practitioner should report all findings from the application of the 
agreed-upon procedures. The concept of materiality does not apply to findings 
to be reported in an agreed-upon procedures engagement unless the definition 
of materiality is agreed to by the specified users. Any agreed-upon materiality 
limits should be described in the practitioner's report.
.27 The practitioner has no obligation to perform procedures beyond the 
agreed-upon procedures. However, if noncompliance related to management's 
assertion comes to the practitioner's attention by other means, such information 
ordinarily should be included in his or her report.
.28 The practitioner may become aware of noncompliance related to man­
agement's assertion that occurs subsequent to the reporting period but before 
the date of the practitioner's report. The practitioner should consider including 
information regarding such noncompliance in his or her report. However, the 
practitioner has no responsibility to perform procedures to detect such noncom­
pliance other than obtaining management's representation about noncompli­
ance in the subsequent period.
.29 The practitioner should follow the reporting guidance in SSAE No. 4. 
A sample report is included in appendix E [paragraph .36], "Sample Report."
.30 Evaluating compliance with certain requirements may require inter­
pretation of the laws, regulations, rules, contracts, or other agreements that 
establish those requirements. In such situations, the practitioner should con­
sider whether he or she is provided with the reasonable criteria required to 
evaluate an assertion under the third general attestation standard. If these in­
terpretations are significant, the practitioner may include a paragraph stating 
the description and the source of interpretations made by the entity's manage­
ment. An example of such a paragraph, which should precede the procedures 
and findings paragraph(s), follows:
We have been informed that, under [name o f entity's] interpretation of 
[identify the compliance requirement], [explain the nature and source 
o f the relevant interpretation].
.31 The date of completion of the agreed-upon procedures should be used 
as the date of the practitioner's report.
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Appendix A
Sample Corporate Integrity Agreement
Between the Office of Inspector General
of the Department of Health and
Human Services and [ Provider]
I. Preamble
[Provider] ("[Provider]") hereby enters into this Corporate Integrity Agree­
ment ("CIA") with the Office of Inspector General ("OIG") of the United States 
Department of Health and Human Services ("HHS") to ensure compliance by its 
employees with the requirements of Medicare, Medicaid and all other Federal 
health care programs (as defined in 42 U.S.C. 1320a-7b(f)) (hereinafter collec­
tively referred to as the "Federal health care programs"). [Provider's] compli­
ance with the terms and conditions in this CIA shall constitute an element of 
[Provider's] present responsibility with regard to participation in the Federal 
health care programs. Contemporaneously with this CIA, [Provider] is entering 
into a Settlement Agreement with the United States, and this CIA is incorpo­
rated by reference into the Settlement Agreement.
II. Term of the CIA
The period of the compliance obligations assumed by [Provider] under this CIA 
shall be 5 years from the effective date of this CIA (unless otherwise specified). 
The effective date of this CIA will be the date on which the final signatory of 
this CIA executes this CIA (the "effective date").*
III. Corporate Integrity Obligations
[Provider] shall establish a compliance program that includes the following 
elements:
A. Compliance Officer
Within ninety (90) days after the effective date of this CIA, [Provider] 
shall appoint an individual to serve as Compliance Officer, who shall 
be responsible for developing and implementing policies, procedures, 
and practices designed to ensure compliance with the requirements set 
forth in this CIA and with the requirements of the Federal health care 
programs. The Compliance Officer shall be a member of senior man­
agement of [Provider], shall make regular (at least quarterly) reports 
regarding compliance matters directly to the CEO and/or to the Board 
of Directors of [Provider] and shall be authorized to report to the Board 
of Directors at any time. The Compliance Officer shall be responsible 
for monitoring the day-to-day activities engaged in by [Provider] to 
further its compliance objectives as well as any reporting obligations 
created under this CIA. In the event a new Compliance Officer is ap­
pointed during the term of this CIA, [Provider] shall notify the OIG, 
in writing, within fifteen (15) days of such a change.
* Source: Office of the Inspector General of the United States Department of Health and Human 
Services.
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[Provider] shall also appoint a Compliance Committee within ninety
(90) days after the effective date of this CIA. The Compliance Com­
mittee shall, at a minimum, include the Compliance Officer and any 
other appropriate officers as necessary to meet the requirements of this 
CIA within the provider's corporate structure (e.g., senior executives 
of each major department, such as billing, clinical, human resources, 
audit, and operations). The Compliance Officer shall chair the Com­
pliance Committee and the Committee shall support the Compliance 
Officer in fulfilling his/her responsibilities.
B. Written Standards
1. Code o f Conduct. Within ninety (90) days of the effective date of 
this CIA, [Provider] shall establish a Code of Conduct. The Code 
of Conduct shall be distributed to all employees within ninety (90) 
days of the effective date of this CIA. [Provider] shall make the 
promotion of, and adherence to, the Code of Conduct an element in 
evaluating the performance of managers, supervisors, and all other 
employees. The Code of Conduct shall, at a minimum, set forth:
a. [Provider's] commitment to full compliance with all 
statutes, regulations, and guidelines applicable to Fed­
eral health care programs, including its commitment to 
prepare and submit accurate billings consistent with Fed­
eral health care program regulations and procedures or 
instructions otherwise communicated by the Health Care 
Financing Administration ("HCFA") (or other appropriate 
regulatory agencies) and/or its agents;
b. [Provider's] requirement that all of its employees shall 
be expected to comply with all statutes, regulations, and 
guidelines applicable to Federal health care programs and 
with [Provider's] own policies and procedures (including 
the requirements of this CIA);
c. the requirement that all of [Provider's] employees shall 
be expected to report suspected violations of any statute, 
regulation, or guideline applicable to Federal health care 
programs or with [Provider's] own policies and procedures;
d. the possible consequences to both [Provider] and to any em­
ployee of failure to comply with all statutes, regulations, 
and guidelines applicable to Federal health care programs 
and with [Provider's] own policies and procedures or of fail­
ure to report such non-compliance; and
e. the right of all employees to use the confidential disclosure 
program, as well as [Provider's] commitment to confiden­
tiality and non-retaliation with respect to disclosures.
Within ninety (90) days of the effective date of the CIA, each employee 
shall certify, in writing, that he or she has received, read, understands, 
and will abide by [Provider's] Code of Conduct. New employees shall re­
ceive the Code of Conduct and shall complete the required certification
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within two (2) weeks after the commencement of their employment or 
within ninety (90) days of the effective date of the CIA, whichever is 
later.
[Provider] will annually review the Code of Conduct and will make 
any necessary revisions. These revisions shall be distributed within 
thirty (30) days of initiating such a change. Employees shall certify on 
an annual basis that they have received, read, understand and will 
abide by the Code of Conduct.
2. Policies and Procedures. Within ninety (90) days of the effective 
date of this CIA, [Provider] shall develop and initiate implemen­
tation of written Policies and Procedures regarding the operation 
of [Provider's] compliance program and its compliance with all fed­
eral and state health care statutes, regulations, and guidelines, in­
cluding the requirements of the Federal health care programs. At 
a minimum, the Policies and Procedures shall specifically address 
[insert language relevant to allegations in the case]. In addition, 
the Policies and Procedures shall include disciplinary guidelines 
and methods for employees to make disclosures or otherwise report 
on compliance issues to [Provider] management through the Con­
fidential Disclosure Program required by section III.E. [Provider] 
shall assess and update as necessary the Policies and Procedures 
at least annually and more frequently, as appropriate. A summary 
of the Policies and Procedures will be provided to OIG in the Imple­
mentation Report. The Policies and Procedures will be available to 
OIG upon request.
Within ninety (90) days of the effective date of the CIA, the relevant 
portions of the Policies and Procedures shall be distributed to all appro­
priate employees. Compliance staff or supervisors should be available 
to explain any and all policies and procedures.
C. Training and Education
1. General Training. Within ninety (90) days of the effective date of 
this CIA, [Provider] shall provide at least two (2) hours of training 
to each employee. This general training shall explain [Provider's]:
a. Corporate Integrity Agreement requirements;
b. Compliance Program (including the Policies and Proce­
dures as they pertain to general compliance issues); and
c. Code of Conduct.
These training materials shall be made available to the OIG, upon 
request.
New employees shall receive the general training described above 
within thirty (30) days of the beginning of their employment or within 
ninety (90) days after the effective date of this CIA, whichever is later. 
Each year, every employee shall receive such general training on an 
annual basis.
2. Specific Training. Within ninety (90) days of the effective date of 
this CIA, each employee who is involved directly or indirectly in 
the delivery of patient care and/or in the preparation or submission 
of claims for reimbursement for such care (including, but not limited 
to, coding and billing) for any Federal health care programs shall 
receive at least [insert number o f  training hours] hours of training
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in addition to the general training required above. This training 
shall include a discussion of:
a. the submission of accurate bills for services rendered to 
Medicare and/or Medicaid patients;
b. policies, procedures and other requirements applicable to 
the documentation of medical records;
c. the personal obligation of each individual involved in the 
billing process to ensure that such billings are accurate;
d. applicable reimbursement rules and statutes;
e. the legal sanctions for improper billings; and
f. examples of proper and improper billing practices.
These training materials shall be made available to OIG, upon re­
quest. Persons providing the training must be knowledgeable about 
the subject area.
Affected new employees shall receive this training within thirty (30) 
days of the beginning of their employment or within ninety (90) days of 
the effective date of this CIA, whichever is later. If a new employee has 
any responsibility for the delivery of patient care, the preparation or 
submission of claims and/or the assignment of procedure codes prior 
to completing this specific training, a [Provider] employee who has 
completed the substantive training shall review all of the untrained 
person's work regarding the assignment of billing codes.
Each year, every employee shall receive such specific training on an 
annual basis.
3. Certification. Each employee shall certify, in writing, that he or she 
has attended the required training. The certification shall specify 
the type of training received and the date received. The Compliance 
Officer shall retain the certifications, along with specific course ma­
terials. These shall be made available to OIG upon request.
D. Review Procedures
[Provider] shall retain an entity, such as an accounting, auditing or 
consulting firm (hereinafter "Independent Review Organization"), to 
perform review procedures to assist [Provider] in assessing the ade­
quacy of its billing and compliance practices pursuant to this CIA. This 
shall be an annual requirement and shall cover a twelve (12) month 
period. The Independent Review Organization must have expertise 
in the billing, coding, reporting and other requirements of the Federal 
health care programs from which [Provider] seeks reimbursement. The 
Independent Review Organization must be retained to conduct the as­
sessment of the first year within ninety (90) days of the effective date 
of this CIA. For purposes of complying with this review procedures 
requirement, the OIG at its discretion, may permit the [Provider] to 
utilize internal auditors to perform the review(s). In such case, the 
[Provider] will engage the Independent Review Organization to verify 
the propriety of the internal auditors' methods and accuracy of their 
results. The [Provider] will request the Independent Review Organiza­
tion to produce a report on its findings which report shall be included 
in the Annual Report to the OIG.
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The Independent Review Organization (or the [Provider], if permit­
ted by the OIG, as set forth above) will conduct two separate engage­
ments. One will be an analysis of [Provider's] billing to the Federal 
health care programs to assist the [Provider] and OIG in determin­
ing compliance with all applicable statutes, regulations, and direc- 
tives/guidance ("billing engagement"). The second engagement will 
assist the [Provider] and OIG in determining whether [Provider] is 
in compliance with this CIA ("compliance engagement").
1. Billing Engagement. The billing engagement shall consist of a re­
view of a statistically valid sample of claims for the relevant period. 
The sample size shall be determined through the use of a probe 
sample.1 At a minimum, the full sample must be within a ninety 
(90) percent confidence level and a precision of twenty-five (25) per­
cent. The probe sample must contain at least thirty (30) sample 
units and cannot be used as part of the full sample. Both the probe 
sample and the sample must be selected through random numbers. 
[Provider] shall use OIG's Office of Audit Services Statistical Sam­
pling Software, also known as "RAT-STATS", which is available 
through the Internet at www.hhs.gov/progorg/ratstat.html.
Each annual billing engagement analysis shall include the following 
components in its methodology:
a. Billing Engagement Objective: Provide a statement stat­
ing clearly the objective intended to be achieved by the 
billing engagement and the procedure or combination of 
procedures that will be applied to achieve the objective.
b. Billing Engagement Population: Identify the population, 
which is the group about which information is needed. Ex­
plain the methodology used to develop the population and 
provide the basis for this determination.
c. Sources of Data: Provide a full description of the source of 
the information upon which the billing engagement conclu­
sions will be based, including the legal or other standards 
applied, documents relied upon, payment data, and/or any 
contractual obligations.
d. Sampling Unit: Define the sampling unit, which is any of 
the designated elements that comprise the population of 
interest.
e. Sampling Frame: Identify the sampling frame, which is 
the totality of the sampling units from which the sample 
will be selected.
As part of the billing engagement:
a. Inquire of management as to the procedures and controls
affecting the billing process subject to the annual assess­
ment as specified in the CIA. Document that aspect of the 
billing process (e.g., flow of documents, processing activi­
ties), and those controls that will be tested in the sample. 
The documentation may consist of flow charts, excerpts 
from policies and procedures manuals, control question­
naires, etc.
Health Care Organizations
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b. Report the sample results, including the overall error rate 
and the nature of the errors found (e.g., no documentation, 
inadequate documentation, assignment of incorrect code).
c  Document findings related to [Provider's] procedures to 
correct inaccurate billings and codings to the Federal 
health care programs and findings regarding the steps 
[Provider] is taking to bring its operations into compliance 
or to correct problems identified by the audit.
2. Agreed-upon Procedures or Compliance Engagement. An Indepen­
dent Review Organization (or the [Provider], if permitted by the 
OIG) shall also conduct an agreed-upon procedures or compliance 
engagement, which shall assist the users in determining whether 
[Provider's] program, policies, procedures, and operations comply 
with the terms of this CIA. This engagement shall include a section 
by section analysis of the requirements of this CIA.
A complete copy of the Independent Review Organization's billing 
and agreed-upon procedures or compliance engagement shall be in­
cluded in each of [Provider's] Annual Reports to OIG.
3. Disclosure o f Overpayments and Material Deficiencies. If, as a result 
of these engagements, [Provider] or the Independent Review Orga­
nization identifies any billing, coding or other policies, procedures 
and/or practices that result in an overpayment, [Provider] shall no­
tify the payor (e.g., Medicare fiscal intermediary or carrier) within 
30 days of discovering the deficiency or overpayment and take re­
medial steps within 60 days of discovery (or such additional time 
as may be agreed to by the payor) to correct the problem, including 
preventing the deficiency from recurring. The notice to the payor 
shall include:
a. a statement that the refund is being made pursuant to this 
CIA;
b. a description of the complete circumstances surrounding 
the overpayment;
c. the methodology by which the overpayment was deter­
mined;
d. the amount of the overpayment;
e. any claim-specific information used to determine the over­
payment (e.g., beneficiary health insurance number, claim 
number, service date, and payment date);
f. the cost reporting period; and
g. the provider identification number under which the repay­
ment is being made.
If [Provider] determines an overpayment represents a material defi­
ciency, contemporaneous with [Provider's] notification to the payor as 
provided above, [Provid er] shall also notify OIG of:
a. a complete description of the material deficiency;
b. amount of overpayment due to the material deficiency;
c. [Provider's] action(s) to correct and prevent such material 
deficiency from recurring;
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d. the payor's name, address, and contact person where the 
overpayment was sent;
e. the date of the check and identification number (or elec­
tronic transaction number) on which the overpayment was 
repaid.
For purposes of this CIA, an "overpayment" shall mean the amount 
of money the provider has received in excess of the amount due and 
payable under the Federal health care programs' statutes, regulations 
or program directives, including carrier and intermediary instructions.
For purposes of this CIA, a "material deficiency" shall mean any­
thing that involves: (i) a substantial overpayment or improper pay­
ment relating to the Medicare and/or Medicaid programs; (ii) conduct 
or policies that clearly violate the Medicare and/or Medicaid statute, 
regulations or directives issued by HCFA and/or its agents; or (iii) se­
rious quality of care implications for federal health care beneficiaries 
or recipients. A material deficiency may be the result of an isolated 
event or a series of occurrences.
4. Verification/Validation. In the event that the OIG determines that 
it is necessary to conduct an independent review to determine 
whether or the extent to which [Provider] is complying with its 
obligations under this CIA, [Provider] agrees to pay for the reason­
able cost of any such review or engagement by the OIG or any of its 
designated agents.
E. Confidential Disclosure Program
Within ninety (90) days after the effective date of this CIA, [Provider] 
shall establish a Confidential Disclosure Program, which must include 
measures (e.g., a toll-free compliance telephone line) to enable em­
ployees, contractors, agents or other individuals to disclose, to the 
Compliance Officer or some other person who is not in the report­
ing individual's chain of command, any identified issues or questions 
associated with [Provider's] policies, practices or procedures with re­
spect to the Federal health care program, believed by the individual to 
be inappropriate. [Provider] shall publicize the existence of the hotline 
(e.g., e-mail to employees or post hotline number in prominent common 
areas).
The Confidential Disclosure Program shall emphasize a non- 
retribution, non-retaliation policy, and shall include a reporting mech­
anism for anonymous, confidential communication. Upon receipt of a 
complaint, the Compliance Officer (or designee) shall gather the infor­
mation in such a way as to elicit all relevant information from the in­
dividual reporting the alleged misconduct. The Compliance Officer (or 
designee) shall make a preliminary good faith inquiry into the allega­
tions set forth in every disclosure to ensure that he or she has obtained 
all of the information necessary to determine whether a further review 
should be conducted. For any disclosure that is sufficiently specific so 
that it reasonably: (1) permits a determination of the appropriateness 
of the alleged improper practice, and (2) provides an opportunity for 
taking corrective action, [Provider] shall conduct an internal review of 
the allegations set forth in such a disclosure and ensure that proper 
follow-up is conducted.
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The Compliance Officer shall maintain a confidential disclosure log, 
which shall include a record and summary of each allegation received, 
the status of the respective investigations, and any corrective action 
taken in response to the investigation.
F. Ineligible Persons
[Provider] shall not hire or engage as contractors any "Ineligible Per­
son." For purposes of this CIA, an "Ineligible Person" shall be any indi­
vidual or entity who: (i) is currently excluded, suspended, debarred or 
otherwise ineligible to participate in the Federal health care programs; 
or (ii) has been convicted of a criminal offense related to the provision 
of health care items or services and has not been reinstated in the 
Federal health care programs after a period of exclusion, suspension, 
debarment, or ineligibility.
Within ninety (90) days of the effective date of this CIA, [Provider] 
will review its list of current employees and contractors against 
the General Services Administration's List of Parties Excluded 
from Federal Programs (available through the Internet at http:// 
www.amet.gov/epls) and the HHS/OIG Cumulative Sanction Report 
(available through the Internet at http://www.dhhs.gov/progorg/oig) to 
ensure that it is not currently employing or contracting with any In­
eligible Person. Thereafter, [Provider] will review the list once semi­
annually to ensure that no current employees or contractors are or 
have become Ineligible Persons.
To prevent hiring or contracting with any Ineligible Person, [Provider] 
shall screen all prospective employees and prospective contractors 
prior to engaging their services by (i) requiring applicants to disclose 
whether they are Ineligible Persons, and (ii) reviewing the General 
Services Administration's List of Parties Excluded from Federal Pro­
grams (available through the Internet at http://www.amet.gov/epls) 
and the HHS/OIG Cumulative Sanction Report (available through the 
Internet at http://www.dhhs.gov/progorg/oig).
If [Provider] has notice that an employee or agent is charged with 
a criminal offense related to any Federal health care program, or is 
suspended or proposed for exclusion during his or her employment 
or contract with [Provider], within 10 days of receiving such notice 
[Provider] will remove such employee from responsibility for, or in­
volvement with, [Provider's] business operations related to the Fed­
eral health care programs until the resolution of such criminal action, 
suspension, or proposed exclusion. If [Provider] has notice that an em­
ployee or agent has become an Ineligible Person, [Provider] will remove 
such person from responsibility for, or involvement with, [Provider's] 
business operations related to the Federal health care programs and 
shall remove such person from any position for which the person’s 
salary or the items or services rendered, ordered, or prescribed by the 
person are paid in whole or in part, directly or indirectly, by Federal 
health care programs or otherwise with Federal funds at least until 
such time as the person is reinstated into participation in the Federal 
health care programs.
G. Notification o f  Proceedings
Within thirty (30) days of discovery, [Provider] shall notify OIG, in 
writing, of any ongoing investigation or legal proceeding conducted or
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brought by a governmental entity or its agents involving an allegation 
that [Provider] has committed a crime or has engaged in fraudulent 
activities or any other knowing misconduct. This notification shall in­
clude a description of the allegation, the identity of the investigating 
or prosecuting agency, and the status of such investigation or legal 
proceeding. [Provider] shall also provide written notice to OIG within 
thirty (30) days of the resolution of the matter, and shall provide OIG 
with a description of the findings and/or results of the proceedings, 
if any.
II. Reporting
1. Credible evidence o f misconduct. If [Provider] discovers credible evi­
dence of misconduct from any source and, after reasonable inquiry, 
has reason to believe that the misconduct may violate criminal, 
civil, or administrative law concerning [Provider's] practices re­
lating to the Federal health care programs, then [Provider] shall 
promptly report the probable violation of law to OIG. Defendants 
shall make this disclosure as soon as practicable, but, not later 
than thirty (30) days after becoming aware of the existence of the 
probable violation. The [Provider's] report to OIG shall include:
a. the findings concerning the probable violation, including 
the nature and extent of the probable violation;
b. [Provider's] actions to correct such probable violation; and
c. any further steps it plans to take to address such probable 
violation and prevent it from recurring.
To the extent the misconduct involves an overpayment, the report 
shall include the information listed in section III.D.3 regarding mate­
rial deficiencies.
2. Inappropriate Billing. If [Provider] discovers inappropriate or in­
correct billing through means other than the Independent Review 
Organization's engagement, the provider shall follow procedures in 
section III.D.3 regarding overpayments and material deficiencies.
IV. New Locations
In the event that [Provider] purchases or establishes new business units after 
the effective date of this CIA, [Provider] shall notify OIG of this fact within 
thirty (30) days of the date of purchase or establishment. This notification shall 
include the location of the new operation(s), phone number, fax number, Federal 
health care program provider number(s) (if any), and the corresponding payor(s) 
(contractor specific) that has issued each provider number. All employees at 
such locations shall be subject to the requirements in this CIA that apply to 
new employees (e.g., completing certifications and undergoing training).
V. Implementation and Annual Reports
A. Implementation Report
Within one hundred and twenty (120) days after the effective date of 
this CIA, [Provider] shall submit a written report to OIG summarizing 
the status of its implementation of the requirements of this CIA. This 
Implementation Report shall include:
1. the name, address, phone number and position description 
of the Compliance Officer required by section III.A;
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2. the names and positions of the members of the Compliance 
Committee required by section III.A;
3. a copy of [Provider's] Code of Conduct required by section
III.B.1;
4. the summary of the Policies and Procedures required by 
section III.B.2;
5. a description of the training programs required by section
III.C including a description of the targeted audiences and 
a schedule of when the training sessions were held;
6. a certification by the Compliance Officer that:
a. the Policies and Procedures required by sec­
tion III.B have been developed, are being imple­
mented, and have been distributed to all perti­
nent employees;
b. all employees have completed the Code of Conduct 
certification required by section III.B.1; and
c. all employees have completed the training and ex­
ecuted the certification required by section III.C;
7. a description of the confidential disclosure program re­
quired by section III.E;
8. the identity of the Independent Review Organization(s) 
and the proposed start and completion date of the first 
audit; and
9. a summary of personnel actions taken pursuant to section
III.F.
B. Annual Reports
[Provider] shall submit to OIG an Annual Report with respect to the 
status and findings of [Provider's] compliance activities. The Annual 
Reports shall include:
1. any change in the identity or position description of the 
Compliance Officer and/or members of the Compliance 
Committee described in section III.A;
2. a certification by the Compliance Officer that:
a. all employees have completed the annual Code of 
Conduct certification required by section III.B.1; 
and
b. all employees have completed the training and ex­
ecuted the certification required by section III.C;
3. notification of any changes or amendments to the Policies 
and Procedures required by section III.B and the reasons 
for such changes (e.g., change in contractor policy);
4. a complete copy of the report prepared pursuant to the In­
dependent Review Organization's billing and compliance 
engagement, including a copy of the methodology used;
5. [Provider's] response/corrective action plan to any issues 
raised by the Independent Review Organization;
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6. a summary of material deficiencies reported throughout 
the course of the previous twelve (12) months pursuant to
III.D.3 and III.H;
7. a report of the aggregate overpayments that have been 
returned to the Federal health care programs that were 
discovered as a direct or indirect result of implementing 
this CIA. Overpayment amounts should be broken down 
into the following categories: Medicare, Medicaid (report 
each applicable state separately) and other Federal health 
care programs;
8. a copy of the confidential disclosure log required by section
III.E;
9. a description of any personnel action (other than hiring) 
taken by [Provider] as a result of the obligations in section
III.F;
10. a summary describing any ongoing investigation or legal 
proceeding conducted or brought by a government entity 
involving an allegation that [Provider] has committed a 
crime or has engaged in fraudulent activities, which have 
been reported pursuant to section III.G. The statement 
shall include a description of the allegation, the identity of 
the investigating or prosecuting agency, and the status of 
such investigation, legal proceeding or requests for infor­
mation;
11. a corrective action plan to address the probable violations 
of law identified in section III.H; and
12. a listing of all of the [Provider's] locations (including lo­
cations and mailing addresses), the corresponding name 
under which each location is doing business, the corre­
sponding phone numbers and fax numbers, each location's 
Federal health care program provider identification num­
b e r (s) and the payor (specific contractor) that issued each 
provider identification number.
The first Annual Report shall be received by the OIG no later 
than one year and thirty (30) days after the effective date of 
this CIA. Subsequent Annual Reports shall be submitted no 
later than the anniversary date of the due date of the first 
Annual Report.
C. Certifications
The Implementation Report and Annual Reports shall include a cer­
tification by the Compliance Officer under penalty of perjury, that: (1) 
[Provider] is in compliance with all o f the requirements of this CIA, 
to the best of his or her knowledge; and (2) the Compliance Officer 
has reviewed the Report and has made reasonable inquiry regarding 
its content and believes that, upon such inquiry, the information is 
accurate and truthful.
VI. Notifications and Submission of Reports
Unless otherwise stated in writing subsequent to the effective date of this 
CIA, all notifications and reports required under this CIA shall be submitted 
to the entities listed below:
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OIG:
Civil Recoveries Branch—Compliance Unit 
Office of Counsel to the Inspector General 
Office of Inspector General
U.S. Department of Health and Human Services 
Cohen Building, Room 5527 
330 Independence Avenue, SW 
Washington, DC 20201 
Phone 202-619-2078; Fax 202-205-0604
[Provider]:
[Address and Telephone number o f  Provider's Compliance Contact]
VII. OIG Inspection, Audit and Review Rights
In addition to any other rights OIG may have by statute, regulation, or con­
tract, OIG or its duly authorized representative(s), may examine [Provider's] 
books, records, and other documents and supporting materials for the purpose of 
verifying and evaluating: (a) [Provider's] compliance with the terms of this CIA; 
and (b) [Provider's] compliance with the requirements of the Federal health care 
programs in which it participates. The documentation described above shall be 
made available by [Provider] to OIG or its duly authorized representative(s) 
at all reasonable times for inspection, audit or reproduction. Furthermore, for 
purposes of this provision, OIG or its duly authorized representative(s) may 
interview any of [Provider's] employees who consent to be interviewed at the 
employee's place of business during normal business hours or at such other 
place and time as may be mutually agreed upon between the employee and 
OIG. [Provider] agrees to assist OIG in contacting and arranging interviews 
with such employees upon OIG's request. [Provider's] employees may elect to 
be interviewed with or without a representative of [Provider] present.
VIII. Document and Record Retention
[Provider] shall maintain for inspection all documents and records relating to 
reimbursement from the Federal health care programs or to compliance with 
this CIA one year longer than the term of this CIA (or longer if otherwise 
required by law).
IX. Disclosures
Subject to HHS's Freedom of Information Act ("FOIA") procedures, set forth 
in 45 C.F.R. Part 5, the OIG shall make a reasonable effort to notify [Provider] 
prior to any release by OIG of information submitted by [Provider] pursuant 
to its obligations under this CIA and identified upon submission by [Provider] 
as trade secrets, commercial or financial information and privileged and confi­
dential under the FOIA rules. [Provider] shall refrain from identifying any in­
formation as trade secrets, commercial or financial information and privileged 
and confidential that does not meet the criteria for exemption from disclosure 
under FOIA.
X. Breach and Default Provisions
[Provider] is expected to fully and timely comply with all o f the obligations 
herein throughout the term of this CIA or other time frames herein agreed to.
A. Stipulated Penalties for Failure to Comply with Certain Obligations
As a contractual remedy, [Provider] and OIG hereby agree that failure 
to comply with certain obligations set forth in this CIA may lead to the
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imposition of the following monetary penalties (hereinafter referred to 
as "Stipulated Penalties") in accordance with the following provisions.
1. A Stipulated Penalty of $2,500 (which shall begin to accrue 
on the day after the date the obligation became due) for 
each day, beginning 120 days after the effective date of 
this CIA and concluding at the end of the term of this CIA, 
[Provider] fails to have in place any of the following:
a. a Compliance Officer;
b. a Compliance Committee;
c. a written Code of Conduct;
d. written Policies and Procedures;
e. a training program; and
f. a Confidential Disclosure Program; 
2. A Stipulated Penalty of $2,500 (which shall begin to accrue 
on the day after the date the obligation became due) for 
each day [Provider] fails to meet any of the deadlines to 
submit the Implementation Report or the Annual Reports 
to the OIG.
3. A Stipulated Penalty of $2,000 (which shall begin to ac­
crue on the date the failure to comply began) for each day 
[Provider]:
a. hires or contracts with an Ineligible Person after 
that person has been listed by a federal agency as 
excluded, debarred, suspended or otherwise in­
eligible for participation in the Medicare, Medi­
caid or any other Federal health care program (as 
defined in 42 U.S.C. 1320a7b(f)). This Stipulated 
Penalty shall not be demanded for any time period 
if [Provider] can demonstrate that it did not dis­
cover the person's exclusion or other ineligibility 
after making a reasonable inquiry (as described 
in section III.F) as to the status of the person;
b. employs or contracts with an Ineligible Person 
and that person: (i) has responsibility for, or in­
volvement with, [Provider's] business operations 
related to the Federal health care programs or (ii) 
is in a position for which the person's salary or the 
items or services rendered, ordered, or prescribed 
by the person are paid in whole or in part, directly 
or indirectly, by the Federal health care programs 
or otherwise with Federal funds (this Stipulated 
Penalty shall not be demanded for any time period 
during which [Provider] can demonstrate that it 
did not discover the person's exclusion or other in­
eligibility after making a reasonable inquiry (as 
described in III.F) as to the status of the person);
c. employs or contracts with a person who: (i) has 
been charged with a criminal offense related 
to any Federal health care program, or (ii) is 
suspended or proposed for exclusion, and that
Health Care Organizations
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person has responsibility for, or involvement with, 
[Provider's] business operations related to the 
Federal health care programs (this Stipulated 
Penalty shall not be demanded for any time pe­
riod before 10 days after [Provider] received no­
tice of the relevant matter or after the resolution 
of the matter).
4. A Stipulated Penalty of $1,500 (which shall begin to accrue 
on the date the [Provider] fails to grant access) for each 
day [Provider] fails to grant access to the information or 
documentation as required in section V of this CIA.
5. A Stipulated Penalty of $1,000 (which shall begin to accrue 
ten (10) days after the date that OIG provides notice to 
[Provider] of the failure to comply) for each day [Provider] 
fails to comply fully and adequately with any obligation of 
this CIA. In its notice to [Provider], the OIG shall state the 
specific grounds for its determination that the [Provider] 
has failed to comply fully and adequately with the CIA 
obligation(s) at issue.
B. Payment o f Stipulated Penalties
1. Demand Letter. Upon a finding that [Provider] has failed to com­
ply with any of the obligations described in section X.A and deter­
mining that Stipulated Penalties are appropriate, OIG shall notify 
[Provider] by personal service or certified mail of (a) [Providers] 
failure to comply; and (b) the OIG's exercise of its contractual right 
to demand payment of the Stipulated Penalties (this notification is 
hereinafter referred to as the "Demand Letter").
Within fifteen (15) days of the date of the Demand Letter, [Provider] 
shall either (a) cure the breach to the OIG's satisfaction and pay the 
applicable stipulated penalties, or (b) request a hearing before an HHS 
administrative law judge ("ALJ") to dispute the OIG's determination of 
noncompliance, pursuant to the agreed-upon provisions set forth below 
in section X.D. In the event [Provider] elects to request an ALJ hear­
ing, the Stipulated Penalties shall continue to accrue until [Provider] 
cures, to the OIG's satisfaction, the alleged breach in dispute. Failure 
to respond to the Demand Letter in one of these two manners within 
the allowed time period shall be considered a material breach of this 
CIA and shall be grounds for exclusion under section X.C.
2. Timely Written Requests for Extensions. [Provider] may submit a 
timely written request for an extension of time to perform any act or 
file any notification or report required by this CIA. Notwithstand­
ing any other provision in this section, if OIG grants the timely 
written request with respect to an act, notification, or report, Stip­
ulated Penalties for failure to perform the act or file the notification 
or report shall not begin to accrue until one day after [Provider] 
fails to meet the revised deadline as agreed to by the OIG-approved 
extension. Notwithstanding any other provision in this section, if 
OIG denies such a timely written request, Stipulated Penalties for 
failure to perform the act or file the notification or report shall not
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OIG's written denial of such request. A "timely written request" is 
defined as a request in writing received by OIG at least five (5) busi­
ness days prior to the date by which any act is due to be performed 
or any notification or report is due to be filed.
3. Form o f Payment. Payment of the Stipulated Penalties shall be 
made by certified or cashier's check, payable to "Secretary of the 
Department of Health and Human Services," and submitted to OIG 
at the address set forth in section VI.
4. Independence from Material Breach Determination. Except as oth­
erwise noted, these provisions for payment of Stipulated Penalties 
shall not affect or otherwise set a standard for the OIG's deter­
mination that [Provider] has materially breached this CIA, which 
decision shall be made at the OIG's discretion and governed by the 
provisions in section X.C, below.
C. Exclusion for Material Breach o f  this CIA
1. Notice o f Material Breach and Intent to Exclude. The parties 
agree that a material breach of this CIA by [Provider] consti­
tutes an independent basis for [Provider's] exclusion from partici­
pation in the Federal health care programs (as defined in 42 U.S.C. 
1320a7b(f)). Upon a determination by OIG that [Provider] has ma­
terially breached this CIA and that exclusion should be imposed, 
the OIG shall notify [Provider] by certified mail of (a) [Provider's] 
material breach; and (b) OIG's intent to exercise its contractual 
right to impose exclusion (this notification is hereinafter referred 
to as the "Notice of Material Breach and Intent to Exclude").
2. Opportunity to Cure. [Provider] shall have thirty-five (35) days from 
the date of the Notice of Material Breach and Intent to Exclude 
Letter to demonstrate to the OIG's satisfaction that:
a. [Provider] is in full compliance with this CIA;
b. the alleged material breach has been cured; or
c. the alleged material breach cannot be cured within the 
35-day period, but that: (i) [Provider] has begun to take 
action to cure the material breach, (ii) [Provider] is pur­
suing such action with due diligence, and (iii) [Provider] 
has provided to OIG a reasonable timetable for curing the 
material breach.
3. Exclusion Letter. If at the conclusion of the thirty-five (35) day pe­
riod, [Provider] fails to satisfy the requirements of section X.C.2, 
OIG may exclude [Provider] from participation in the Federal 
health care programs. OIG will notify [Provider] in writing of its 
determination to exclude [Provider] (this letter shall be referred to 
hereinafter as the "Exclusion Letter"). Subject to the Dispute Res­
olution provisions in section X.D, below, the exclusion shall go into 
effect thirty (30) days after the date of the Exclusion Letter. The 
exclusion shall have national effect and will also apply to all other 
federal procurement and non-procurement programs. If [Provider]
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is excluded under the provisions of this CIA, [Provider] may seek 
reinstatement pursuant to the provisions at 42 C.F.R. §§1001.3001- 
.3004.
4. Material Breach. A material breach of this CIA means:
a. a failure by [Provider] to report a material deficiency, take 
corrective action and pay the appropriate refunds, as pro­
vided in section III.D;
b. repeated or flagrant violations of the obligations under 
this CIA, including, but not limited to, the obligations ad­
dressed in section X.A of this CIA;
c. a failure to respond to a Demand Letter concerning the 
payment of Stipulated Penalties in accordance with section 
X.B above; or
d. a failure to retain and use an Independent Review Orga­
nization for review purposes in accordance with section
III.D.
D. Dispute Resolution
1. Review Rights. Upon the OIG's delivery to [Provider] of its Demand 
Letter or of its Exclusion Letter, and as an agreed-upon contractual 
remedy for the resolution of disputes arising under the obligation 
of this CIA, [Provider] shall be afforded certain review rights com­
parable to the ones that are provided in 42 U.S.C. §§1320a7(f) and 
42 C.F.R. §1005 as if they applied to the Stipulated Penalties or 
exclusion sought pursuant to this CIA. Specifically, the OIG's de­
termination to demand payment of Stipulated Penalties or to seek 
exclusion shall be subject to review by an ALJ and, in the event of 
an appeal, the Departmental Appeals Board ("DAB"), in a manner 
consistent with the provisions in 42 C.F.R. §§1005.2-.21. Notwith­
standing the language in 42 C.F.R. §1005.2(c), the request for a 
hearing involving stipulated penalties shall be made within fifteen 
(15) days of the date of the Demand Letter and the request for a 
hearing involving exclusion shall be made within thirty (30) days 
of the date of the Exclusion Letter.
2. Stipulated Penalties Review. Notwithstanding any provision of Ti­
tle 42 of the United States Code or Chapter 42 of the Code of Federal 
Regulations, the only issues in a proceeding for stipulated penalties 
under this CIA shall be (a) whether [Provider] was in full and timely 
compliance with the obligations of this CIA for which the OIG de­
mands payment; and (b) the period of noncompliance. [Provider] 
shall have the burden of proving its full and timely compliance 
and the steps taken to cure the noncompliance, if any. If the ALJ 
finds for the OIG with regard to a finding of a breach of this CIA 
and orders [Provider] to pay Stipulated Penalties, such Stipulated 
Penalties shall become due and payable twenty (20) days after the 
ALJ issues such a decision notwithstanding that [Provider] may 
request review of the ALJ decision by the DAB.
3. Exclusion Review. Notwithstanding any provision of Title 42 of the 
United States Code or Chapter 42 of the Code of Federal Regu­
lations, the only issues in a proceeding for exclusion based on a 
material breach of this CIA shall be (a) whether [Provider] was in
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material breach of this CIA; (b) whether such breach was contin­
uing on the date of the Exclusion Letter; and (c) the alleged ma­
terial breach cannot be cured within the 35-day period, but that
(i) [Provider] has begun to take action to cure the material breach,
(ii) [Provider] is pursuing such action with due diligence, and (iii) 
[Provider] has provided to OIG a reasonable timetable for curing 
the material breach.
For purposes of the exclusion herein, exclusion shall take effect only 
after an ALJ decision that is favorable to the OIG. [Provider's] election 
of its contractual right to appeal to the DAB shall not abrogate the 
OIG's authority to exclude [Provider] upon the issuance of the ALJ's 
decision. If the ALJ sustains the determination of the OIG and de­
termines that exclusion is authorized, such exclusion shall take effect 
twenty (20) days after the ALJ issues such a decision, notwithstanding 
that [Provider] may request review of the A U  decision by the DAB.
4. Finality o f Decision. The review by an ALJ or DAB provided for 
above shall not be considered to be an appeal right arising un­
der any statutes or regulations. Consequently, the parties to this 
CIA agree that the DAB's decision (or the A U 's decision if not ap­
pealed) shall be considered final for all purposes under this CIA and 
[Provider] agrees to waive any right it may have to appeal the de­
cision administratively, judicially or otherwise seek review by any 
court or other adjudicative forum.
XI. Effective and Binding Agreement
Consistent with the provisions in the Settlement Agreement pursuant to 
which this CIA is entered, and into which this CIA is incorporated, [Provider] 
and OIG agree as follows:
a. This CIA shall be binding on the successors, assigns and transferees 
of [Provider];
b. This CIA shall become final and binding on the date the final sig­
nature is obtained on the CIA;
c. Any modifications to this CIA shall be made with the prior written 
consent of the parties to this CIA; and
d. The undersigned [Provider] signatories represent and warrant that 
they are authorized to execute this CIA. The undersigned OIG sig­
natory represents that he is signing this CIA in his official capacity 
and that he is authorized to execute this CIA.
Health Care Organizations
On Behalf of [Provider]
Date
Date
Date
[Please identify all signatories]
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ON BEHALF OF THE OFFICE OF INSPECTOR GENERAL 
OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
Lewis Morris [Date]
Assistant Inspector General for Legal Affairs 
Office of Inspector General 
U.S. Department of Health and Human Services
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Appendix B
Sample Statement of Management's Assertions
[Date]
In connection with the Corporate Integrity Agreement (CIA) entered into with 
the Office of the Inspector General of the United States Department of Health 
and Human Services dated [date], we make the following assertions, which are 
true to the best of our knowledge and belief.
Governance
Within 90 days of the date of the CIA, we—
1. Established a Compliance Committee, which meets at least 
monthly and requires a quorum to meet.
2. Appointed to our Compliance Committee members who include at 
a minimum those individuals specified in the CIA.
3. Delegated to the Compliance Committee the authority to imple­
ment and monitor the CIA, as evidenced by the organization chart 
or the Compliance Committee's charter.
4. Appointed a compliance officer, who reports directly to the individ­
ual specified in the CIA.
We appointed a compliance officer who—
1. Has sufficient staff and resources to carry out his or her responsi­
bilities.
2. Actively participates in compliance training.
3. Has authority to conduct full and complete internal investigations 
without restriction.
4. Periodically revises the compliance program to meet changing cir­
cumstances and risks.
Billing Practices, Policies, and Procedures
Although no system of internal controls can provide absolute assurance that all 
bills comply in all respects with Medicare, Medicaid, and other federal health 
care program guidelines, we are not aware of any material weaknesses in our 
billing practices, policies, and procedures. Billings to third-party payors comply 
in all material respects with applicable coding principles and laws and regula­
tions (including those dealing with Medicare and Medicaid antifraud and abuse) 
and only reflect charges for goods and services that were medically necessary, 
properly approved by regulatory bodies (e.g., the Food and Drug Administra­
tion), if  required and properly rendered. [Insert other assertions as necessary to 
address matters covered in the CIA.] Any Medicare, Medicaid, and other fed­
eral health program billing deficiencies that we identified have been properly 
reported to the applicable payor within 60 days of discovery of the deficiency. 
Corporate Integrity Policy
1. Our policy was developed and implemented within [number] days 
of execution of the CIA.
2. The policy addresses the Company's commitment to preparation 
and submission of accurate billings consistent with the standards 
set forth in federal health care program statutes, regulations,
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procedures and guidelines or as otherwise communicated by Health 
Care Financing Administration (HCFA), its agents or any other 
agency engaged in the administration of the applicable federal 
health care program.
3. The policy addressed the specific issues that gave rise to the settle­
ment, as well as other risk areas identified by the OIG in published 
Fraud Alerts issued through [date].
4. Further details on the development and implementation of our pol­
icy were provided to the OIG in our letter dated [date].
5. Our policy was distributed to all employees, physicians and inde­
pendent contractors involved in submitting or preparing requests 
for reimbursement.
6. We have prominently displayed a copy of our policy on the Com­
pany's premises.
Information and Education Program
As discussed more fully in our letter to the OIG dated [date], we conducted an 
Information and Education Program within [number] days of the CIA. The In­
formation and Education Program requires that each officer, employee, agent 
and contractor charged with administering federal health care programs (in­
cluding, but not limited to billers, coders, nurses, physicians, medical records, 
hospital administration and other individuals directly involved in billing fed­
eral health care programs) receive at least [number] hours of training.
The training provided to employees involved in billing, coding, and/or charge 
capture consisted of instructions on submitting accurate bills, the personal 
obligations of each individual to ensure billings are accurate, the nature of 
company-imposed disciplinary actions on individuals who violate company poli­
cies and/or laws and regulations, applicable federal health care program rules, 
legal sanctions against the company for submission of false or fraudulent in­
formation, and how to report potential abuses or fraud. The training material 
addresses those issues underlying our settlement with the OIG.
The experience of the trainers is consistent with the topics presented. 
Confidential Disclosure Program 
Our Confidential Disclosure Program—
1. Was established within [number] days of the CIA.
2. Enables any employee to disclose any practices or billing procedures 
relating to federal health care programs.
3. Provides a toll-free telephone line maintained by the Company, 
which Company representatives have indicated is maintained 
twenty-four hours a day, seven days a week, for the purpose of 
making any disclosures regarding compliance with the Company's 
Compliance Program, the obligations in the CIA, and Company's 
overall compliance with federal and state standards.
4. Includes policies requiring the review of any disclosures to permit a 
determination of the appropriateness of the billing practice alleged 
to be involved and any corrective action to be taken to ensure that 
proper follow-up is conducted.
5. A detailed summary of the communications (including the number 
of disclosures by employees and the dates of such disclosures) con­
cerning billing practices reported as, and found to be, inappropriate
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under the Confidential Disclosure Program, and the results of any 
internal review and the follow-up on such disclosures are summa­
rized in Attachment [title] to our Annual Report.
Excluded Individuals or Entities
Company policy—
1. Prohibits the employment of or contracting with an individual or 
entity that is listed by a federal agency as convicted of abuse or 
excluded, suspended or otherwise ineligible for participation in fed­
eral health care programs.
2. Includes a process to make an inquiry into the status of any poten­
tial employee or independent contractor.
3. Provides for an annual review of the status of all existing employ­
ees and contractors to verify whether any individual had been sus­
pended or excluded or charged with a criminal offense relating to 
the provision of federal health care services.
We are not aware of any individuals employed in contravention of the prohibi­
tions in the CIA.
Record Retention
Our record retention policy is consistent with the requirements of the CIA. 
Signed by:
Health Care Organizations
[Chief Executive Officer]
[Chief Financial Officer]
[Corporate Compliance Officer]
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Appendix C
Sample Engagement Letter
The following is an illustration of a sample engagement letter that may be used 
for this kind of engagement.
[CPA Firm Letterhead]
[Client's Name and Address]
Dear______________ ;
This will confirm our understanding of the arrangements for our performance of 
certain agreed-upon procedures in connection with management's compliance 
with the terms of the Corporate Integrity Agreement (CIA) with the Office of 
Inspector General (OIG) of the U.S. Department of Health and Human Services 
(HHS) dated [date o f CIA] for the period ending [date].
We will perform those procedures enumerated in the attachment to this letter. 
Our responsibility is to carry out these procedures and report our findings. We 
will conduct our engagement in accordance with standards established by the 
American Institute of Certified Public Accountants. Our planned procedures 
were agreed to by management and will be communicated to the OIG for its 
review and are based on the terms specified in the CIA. The sufficiency of 
these procedures is solely the responsibility of the specified users of the report. 
Consequently, it is understood that we make no representation regarding the 
sufficiency of the procedures described in the attachment for the purpose for 
which this report has been requested or for any other purpose.
Management is responsible for the Company's compliance with all applicable 
laws, regulations, and contracts and agreements, including the CIA. Manage­
ment also is responsible for the design, implementation, and monitoring of the 
policies and procedures upon which compliance is based.
Our engagement to perform agreed-upon procedures is substantially less in 
scope than an examination, the objective of which is the expression of an opinion 
on management's compliance with the CIA. Accordingly, we will not express 
such an opinion or any other form of assurance thereon.1
Working papers that are prepared in connection with this engagement are the 
property of the independent accountant. The working papers are prepared for 
the purpose of providing the principal support for the independent accountant's
1 The independent accountant may wish to include an understanding with the client about any 
limitation or other arrangements regarding liability of the practitioner or the client in the engagement 
letter. For example, the following might be included in the letter:
Our maximum liability relating to services rendered under this letter (regardless of form 
of action, whether in contract, negligence or otherwise) shall be limited to the charges paid 
to us for the portion of the services or work products giving rise to liability. We will not 
be liable for consequential or punitive damages (including lost profits or savings) even if 
aware of their possible existence.
You will indemnify us against any damage or expense that may result from any third- 
party claim relating to our services or any use by you of any work product, and you will 
reimburse us for all expenses (including counsel fees) as incurred by us in connection with 
any such claim, except to the extent such claim (i) is finally determined to have resulted 
from our gross negligence or willful misconduct or (ii) is covered by any of the preceding 
indemnities.
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report. At the completion of our work, we expect to issue an agreed-upon pro­
cedures report in the attached form.
If, however, we are not able to complete all of the specified procedures, we will 
so advise you. At that time, we will discuss with you the form of communication, 
if any, that you desire for our findings. We will ask you to confirm your request 
in writing at that time. If you request that we delay issuance of our report until 
corrective action is taken that will result in compliance with all aspects of the 
CIA, we will do so only at your written request. Our working papers will be 
retained in accordance with our firm's working paper retention policy.
The distribution of the independent accountant's report will be restricted to the 
governing board and management of the Company and the OIG.
Our fees will be billed as work progresses and are based on the amount of time 
required at various levels of responsibility plus actual out-of-pocket expenses. 
Invoices are payable upon presentation. We will notify you immediately of any 
circumstances we encounter that could significantly affect our initial estimate 
of total fees.
We agree that to the extent required by law, we will allow the Comptroller 
General of the United States, HHS, and their duly authorized representatives 
to have access to this engagement letter and our documents and records to 
the extent necessary to verify the nature and amount of costs of the services 
provided to the Company, until the expiration of four years after we have con­
cluded providing services to the Company that are performed pursuant to this 
Engagement Letter. In the event the Comptroller General, HHS, or their duly 
authorized representatives request such records, we agree to notify the Com­
pany of such request as soon as practicable.
In the event we are requested or authorized by the Company or are required 
by government regulation, subpoena, or other legal process to produce our doc­
uments or our personnel as witnesses with respect to our engagements for the 
Company, the Company will, so long as we are not a party to the proceeding in 
which the information is sought, reimburse us for our professional time and ex­
penses, as well as the fees and expenses of our counsel, incurred in responding 
to such requests.
If this letter correctly expresses your understanding of this engagement, please 
sign the enclosed copy where indicated and return it to us. We appreciate the 
opportunity to serve you.
Sincerely,_____________________
[Partner's Signature]
[Firm Name or Firm Representative]
Accepted and agreed to:_____________
[Client Representative's Signature]
[Title] ______________________
[Date] ______________________
Health Care Organizations
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Appendix D 
Sample Procedures
Procedure
Governance
1. We read the Company's corporate minutes and organization 
chart and ascertained that, within [number] days of the date of 
the Corporate Integrity Agreement (CIA), the Company—
a. Established a Compliance Committee, which is to 
meet meets at least monthly and requires a quorum 
to meet.
b. Appointed to its Compliance Committee members who 
include, at a minimum, those individuals specified in 
the CIA.
c. Delegated to the Compliance Committee the authority 
to implement and monitor the CIA, as evidenced by 
the organization chart or the Compliance Committee's 
charter.
d. Appointed a compliance officer who reports directly to 
the individual specified in the CIA.
2. We interviewed the compliance officer and were informed that, 
in his or her opinion, the Compliance Officer—
a. Has sufficient staff and resources to carry out his or 
her responsibilities.
b. Actively participates in compliance training.
c. Has the authority to conduct full and complete inter­
nal investigations without restriction.
d. Periodically revises the compliance program to meet 
changing circumstances and risks.
3. We read the OIG notification letter as specified in the CIA and 
noted that the appropriate official signed the letter, that it was 
addressed to the OIG, that it covered items (a) through (d) in Step 
1, and that it was dated within [number of] days of the execution 
of the CIA.
Billing Practices, Policies, and Procedures
The practitioner might be engaged to provide consulting services in 
connection with the evaluation o f the company's billing practices, 
policies, and procedures. I f  so, generally no agreed-upon procedures 
would be performed relating to this area.
Alternatively, if  the procedures relating to the Company's billing 
practices, policies, and procedures are performed by others such as 
the Company's internal audit staff, the practitioner performs Steps 
4 through 9.
Findings
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4. We read the compliance work plan and noted the following:
a. The work plan's stated objectives include the deter­
mination that billings are accurate and complete, for 
services rendered that have been deemed by medical 
specialists as being necessary, and are submitted in 
accordance with federal program guidelines.
b. The work plan sampling methodology sets confidence 
levels consistent with those defined in the CIA.
c. The work plan identifies risk areas, as defined in the 
CIA (if applicable), and specifies testing procedures by 
risk area.
d. The work plan specifies that samples are taken in risk 
areas (if applicable) identified by the CIA.
e. The work plan includes testing procedures, which the 
practitioner should modify as required by the CIA, for 
the following risks areas (if applicable) identified in 
the CIA:
(1) Clinical documentation, as follows:
(i) No documentation of service
(ii) Insufficient documentation of 
service
(iii) Improper diagnosis or treat­
ment plan giving rise to the pro­
vision of a medically unneces­
sary service or treatment
(iv) Service or treatment does not 
conform medically with the doc­
umented diagnosis or treatment 
plan
(v) Services incorrectly coded
(2) Billing and coding, as follows:
(i) Noncovered or unallowable ser­
vice
(ii) Duplicate payment
(iii) DRG window error
(iv) Unbundling
(v) Utilization
(vi) Medicare credit balances
[Note to Practitioner: Modify the preceding list as required by the 
CIA.1
5. We selected [quantity] probe samples performed by the inde­
pendent review organization for the following risk areas [list risk 
areas tested]. For the probe samples selected, we noted that the—
a. Sample patient billing files were randomly selected.
b. Sample size reflected confidence levels specified in the 
CIA.
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Procedure Findings
c. Sample plan describes how missing items (if any) 
would be treated.
d. Patient billing files tested were pulled per the listing 
of random numbers and all patient billing files were 
accounted for in the working papers.
e. Work plans for the specific sample described the risk 
areas (if applicable) being tested and the testing ap- 
proach/procedures.
f. Working papers noted the completion of each work 
plan step.
g. Working papers contained a summary of findings for 
the sample.
6. We reperformed the work plan steps [list o f specific steps per­
formed] for the sample patient billing files. The reperformance of
work plan steps related to the medical review of the sample patient
billing files was performed by the following individuals [note the
professional qualifications o f individuals without listing names].
Any exceptions between our findings and the Company's are sum­
marized in the Attachment to this report.
7. We read the summary findings of all internal compliance re­
views that the Company's Internal Audit department indicated
it had performed for the Company and noted that all material
billing deficiencies [specify material threshold as defined by the
Company] noted therein were discussed in written communica­
tions addressed to the appropriate payor (for example, Medicare
Part B carrier) and were dated within 60 days from the time the
deficiency occurred.1
8. We inquired of [individual] as to whether the Company took
remedial steps within [number of] days (or such additional time as
agreed to by the payor) to correct all material billing deficiencies
noted in Step 7. We were informed that such remedial steps had
been taken.
9. By reading applicable correspondence, we noted that any ma­
terial billing deficiencies noted in Step 7 were communicated to
the OIG, including specific findings relative to the deficiency, the
Company's actions taken to correct the deficiency, and any further
steps the Company plans to take to prevent any similar deficien­
cies from recurring.
Corporate Integrity Policy
10. We read the Company's Corporate Integrity Policy and noted
the following.
a. The policy was developed and implemented within 
[number of] days of execution of the CIA.
1 The CIA provides its own legal definition of a "material deficiency." Determination of whether a 
billing or other act meets this definition is normally beyond the auditor's professional competence and 
may have to await final determination by a court of law. Accordingly, to avoid confusion, a working 
definition different from that provided in the CIA (e.g., a specified dollar threshold) may be necessary.
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b. The policy addressed the Company's commitment to 
preparation and submission of accurate billings con­
sistent with the standards set forth in federal health 
care program statutes, regulations, procedures, and 
guidelines or as otherwise communicated by HCFA, 
its agents, or any other agency engaged in the admin­
istration of the applicable federal health care program.
c. The policy addressed the specific issues that gave rise 
to the settlement, as well as other risk areas identified 
by the OIG in published Fraud Alerts issued through 
[agency].
d. Correspondence addressed to the OIG covered the de­
velopment and implementation of the policy.
e. Documentation indicating that the policy was dis­
tributed to all employees, physicians, and indepen­
dent contractors involved in submitting or preparing 
requests for reimbursement.
f. The prominent display of a copy of the policy on the 
Company's premises.
11. We selected a sample often employees (involved in submitting 
and preparing requests for reimbursement) and examined written 
confirmation in the employee's personnel file indicating receipt of 
a copy of the Corporate Integrity Policy.
Information and Education Program
12. We read the Company's Information and Education Program 
and noted the following.
a. The Information and Education Program agenda was 
dated within [number of] days of execution of the CIA.
b. Correspondence covering the development and imple­
mentation of the Information and Education Program 
was addressed to the OIG.
c. The Information and Education Program requires that 
each officer, employee, agent, and contractor charged 
with administering federal health care programs (in­
cluding, but not limited to billers, coders, nurses, 
physicians, medical records, hospital administration 
and other individuals directly involved in billing fed­
eral health care programs) receive at least [number of] 
hours of training.
13. We selected a sample of ten employees involved in billing, 
coding and/or charge capture and examined sign-in logs of the 
training classes and noted that each had signed indicating that 
they had received at least [number of] hours of training as specified 
in the Information and Education Program. We also reviewed tests 
and surveys completed by each of the ten trained employees noting 
evidence that they were completed.
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14. We inquired as to the training of individuals not present dur­
ing the regularly scheduled training programs and were informed 
that each such individual is trained either individually or in a 
separate make-up session. We inquired as to the names of in­
dividuals not initially present and selected one such individual 
and examined that individual's post-training test and survey for 
completion.
15. We read the course agenda and noted that the training pro­
vided to employees involved in billing, coding, and/or charge cap­
ture consisted of instructions on submitting accurate bills, the per­
sonal obligations of each individual to ensure billings are accurate, 
the nature of company-imposed disciplinary actions on individuals 
who violate company policies and/or laws and regulations appli­
cable to federal health care program rules, legal sanctions against 
the company for submission of false or fraudulent information, 
and how to report potential abuses or fraud. We also noted that 
the training material addressed the following issues which gave 
rise to the settlement [practitioner list].
16. We inquired of the Corporate Compliance Officer as to the 
qualifications and experience of the trainers and were informed 
that, in the Corporate Compliance Officer's opinion, they were con­
sistent with the topics presented.
17. We noted that the Company's draft Annual Report to the OIG 
dated [date] addresses certification of training.
Confidential Disclosure Program
18. We read documentation of the Company's Confidential Dis­
closure Program and noted that it—
a. Includes the printed effective date that was within 
[number of] days of execution of the CIA.
b. Consists of a confidential disclosure program enabling 
any employee to disclose any practices or billing pro­
cedures relating to federal health care programs.
c. Provides a toll-free telephone line maintained by the 
Company, which Company representatives have indi­
cated is maintained twenty-four hours a day, seven 
days a week, for the purpose of making any disclosures 
regarding compliance with the Company's Compliance 
Program, the obligations in the CIA, and Company's 
overall compliance with federal and state standards.
d. Includes policies requiring the review of any disclo­
sures to permit a determination of the appropriate­
ness of the billing practice alleged to be involved and 
any corrective action to be taken to ensure that proper 
follow-up is conducted.
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19. We made five test calls to the toll free telephone line (hotline) 
and noted the following.
a. Each call was captured in the hotline logs and reported 
with all other incoming calls.
b. Anonymity is not discouraged.
20. We noted that the Company included in its draft Annual Re­
port addressed to OIG dated [date] a detailed summary of the 
communications (including the number of disclosures by employ­
ees and the dates of such disclosures) concerning billing practices 
reported as, and found to be, inappropriate under the Confidential 
Disclosure Program, and the results of any internal review and the 
follow-up on such disclosures.
21. We observed the display of the Company's Confidential Dis­
closure Program, including notice of the availability of its hotline, 
on the Company's premises.
Excluded Individuals or Entities
22. We read the Company's written policy relating to dealing 
with excluded or convicted persons or entities and noted that the 
policy—
a. Prohibits the hiring of or contracting with an individ­
ual or entity that is listed by a federal agency as con­
victed of abuse or excluded, suspended, or otherwise 
ineligible for participation in federal health care pro­
grams.
b. Includes a process to make an inquiry into the status 
of any potential employee or independent contractor.
c. Provides for a semi-annual review of the status of all 
existing employees and contractors to verify whether 
any individual had been suspended or excluded or 
charged with a criminal offense relating to the pro­
vision of federal health care services.
23. We selected a sample of ten employees hired over the course 
o f the test period as defined in the CIA and examined support in 
the employee's personnel file documenting inquiries made into the 
status of the employee, including documentation of comparison to 
the [source specified in the CIA].
24. We performed the following procedures related to the Com­
pany's semi-annual review of employee status.
a. Read documentation of the semi-annual review as ev­
idence that a review was performed.
b. Selected and reviewed the lesser of ten or all excep­
tions and determined that such employees were re­
moved from responsibility for or involvement with 
Provider business operations related to the Federal 
health care programs.
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c. Examined a notification letter addressed to the OIG 
and dated within 30 days of the employee's removal 
from employment.
d. Inquired of [officer] as to whether he or she was aware 
of any individuals employed in contravention of the 
prohibitions in the CIA. If so, we further noted that 
[indicate specific procedures] to confirm that such sit­
uation was cured within 30 days by [indicate how sit­
uation was cured].
Annual Report
25. We read the Company's draft Annual Report dated [date] and 
determined that it included the following items, to be modified as 
appropriate, by the practitioner:
a. Compliance Program Charter and organization chart
b. Amendments to policies
c. Detailed descriptions of reviews and audits
d. Summary of hotline communications
e. Summary of annual review of employees
f. Cross-referencing to items noted in the CIA
Record Retention
26. We read the Company's record retention policy and noted that 
it was consistent with the requirements as outlined in the CIA.
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Appendix E
Sample Report
Independent Accountant's Report
[Date]
[Sample Health Care Provider]
Office of Inspector General of the U.S. Department of Health and Human Ser­
vices
We have performed the procedures enumerated in the Attachment, which were 
agreed to by Sample Health Care Provider (Company) and the Office of In­
spector General (OIG) of the U.S. Department of Health and Human Services, 
solely to assist the users in evaluating management's assertion about [name 
o f entity's] compliance with the Corporate Integrity Agreement (CIA) with the 
OIG dated [date o f  CIA] for the [period] ending [date], which is included as 
Attachment A to this report. This agreed-upon procedures engagement was 
performed in accordance with standards established by the American Institute 
of Certified Public Accountants. The sufficiency of these procedures is solely 
the responsibility of the specified users of the report. Consequently, we make 
no representation regarding the sufficiency of the procedures described in At­
tachment B either for the purpose for which this report has been requested or 
for any other purpose.
We were not engaged to and did not perform an examination, the objective of 
which would be the expression of an opinion on management's compliance with 
the CIA. Accordingly, we do not express such an opinion. Had we performed 
additional procedures, other matters might have come to our attention that 
would have been reported to you.
This report is intended solely for the information and use of the Compliance 
Committee and management of the Company and the OIG, and is not intended 
to be and should not be used by anyone other than those specified parties. 
[Include as Attachments the CIA and the summary that enumerates procedures 
and findings.]
[Signature]
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NOTE
This Statement of Position presents the recommendations of the 
AICPA Health Care Third-Party Revenue Recognition Task Force with 
regard to auditing financial statement assertions about third-party rev­
enues and related receivables of health care entities. The Auditing Stan­
dards Board has found the recommendations in this Statement of Posi­
tion to be consistent with existing standards covered by Rule 202 of the 
AICPA Code of Professional Conduct. AICPA members should be pre­
pared to justify departures from the recommendations in this Statement 
of Position.
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Summary
This Statement of Position (SOP) provides guidance to auditors regarding un­
certainties inherent in health care third-party revenue recognition. It discusses 
auditing matters to consider in testing third-party revenues and related receiv­
ables, and provides guidance regarding the sufficiency of evidential matter and 
reporting on financial statements of health care entities exposed to material 
uncertainties.
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Introduction and Background
.01 Most health care providers participate in payment programs that pay 
less than full charges for services rendered. For example, some cost-based pro­
grams retrospectively determine the final amounts reimbursable for services 
rendered to their beneficiaries based on allowable costs. With increasing fre­
quency, even non-cost-based programs (such as the Medicare Prospective Pay­
ment System) have become subject to retrospective adjustments (for example, 
billing denials and coding changes). Often, such adjustments are not known for 
a considerable period of time after the related services were rendered.
.02 The lengthy period of time between rendering services and reaching 
final settlement, compounded further by the complexities and ambiguities of 
reimbursement regulations, makes it difficult to estimate the net patient service 
revenue associated with these programs. This situation has been compounded 
due to the frequency of changes in federal program guidelines.
.03 The AICPA Audit and Accounting Guide Health Care Organizations 
(the Guide) requires that patient revenues be reported net of provisions for 
contractual and other adjustments (paragraph 10.20). As a result, patient re­
ceivables, including amounts due from third-party payors, are also reported net 
of expected contractual and other adjustments. However, amounts ultimately 
realizable will not be known until some future date, which may be several years 
after the period in which the services were rendered.
.04 This SOP provides guidance to auditors regarding uncertainties inher­
ent in health care third-party revenue recognition. It discusses auditing matters 
to consider in testing third-party revenue and related receivables, including the 
effects of settlements (both cost-based and non-cost-based third-party payment 
programs), and provides guidance regarding the sufficiency of evidential mat­
ter and reporting on financial statements of health care entities exposed to 
material uncertainties.
Scope and Applicability
.05 This SOP applies to audits of health care organizations falling within 
the scope of the Guide. Its provisions are effective for audits of periods ending 
on or after June 30, 2000. Early application of the provisions of this SOP is 
permitted.
Third-Party Revenues and Related Receivables—
Inherent Uncertainties
.06 Health care entities need to estimate amounts that ultimately will be 
realizable in order for revenues to be fairly stated in accordance with generally 
accepted accounting principles (GAAP). The basis for such estimates may range 
from relatively straightforward calculations using information that is readily 
available to highly complex judgments based on assumptions about future de­
cisions.
.07 Entities doing business with governmental payors (for example, Medi­
care and Medicaid) are subject to risks unique to the government-contracting 
environment that are hard to anticipate and quantify and that may vary from 
entity to entity. For example—
• A health care entity's revenues may be subject to adjustment as 
a result of examination by government agencies or contractors.
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The audit process and the resolution of significant related mat­
ters (including disputes based on differing interpretations of the 
regulations) often are not finalized until several years after the 
services were rendered.
• Different fiscal intermediaries (entities that contract with the fed­
eral government to assist in the administration of the Medicare 
program) may interpret governmental regulations differently.
• Differing opinions on a patient's principal medical diagnosis, in­
cluding the appropriate sequencing of codes used to submit claims 
for payment, can have a significant effect on the payment amount.1
• Otherwise valid claims may be determined to be nonallowable af­
ter the fact due to differing opinions on medical necessity.
• Claims for services rendered may be nonallowable if they are later 
determined to have been based on inappropriate referrals.1 2
• Governmental agencies may make changes in program interpreta­
tions, requirements, or "conditions of participation," some of which 
may have implications for amounts previously estimated.
.08 Such factors often result in retrospective adjustments to interim pay­
ments. Reasonable estimates of such adjustments are central to the third-party 
revenue recognition process in health care, in order to avoid recognizing rev­
enue that the provider will not ultimately realize. The delay between rendering 
services and reaching final settlement, as well as the complexities and ambi­
guities of billing and reimbursement regulations, makes it difficult to estimate 
net realizable third-party revenues.
Management's Responsibilities
.09 Management is responsible for the fair presentation of its financial 
statements in conformity with GAAP. Management also is responsible for adopt­
ing sound accounting policies and for establishing and maintaining internal 
control that will, among other things, record, process, summarize, and report 
transactions (as well as events and conditions) consistent with management's 
assertions embodied in the financial statements. Despite the inherent uncer­
tainties, management is responsible for estimating the amounts recorded in the 
financial statements and making the required disclosures in accordance with 
GAAP, based on management's analysis of existing conditions.
.10 Management's assertions regarding proper valuation of its revenues 
and receivables are embodied in the financial statements. Management is re­
sponsible for assuring that revenues are not recognized until their realization 
is reasonably assured. As a result, management makes a reasonable estimate
Health Care Organizations
1 Historically, the Health Care Financing Administration (HCFA) contracted with Peer Review 
Organizations (PROs) to validate the appropriateness of admissions and the clinical coding from 
which reimbursement was determined. Such reviews were typically performed within ninety days 
of the claim submission date. However, the government has modified its policies with respect to 
such reviews and now analyzes coding errors through other means, including in conjunction with 
investigations conducted by the Office of the Inspector General (OIG) of the U. S. Department of 
Health and Human Services.
2 Effective January 1 , 1995, the Limitation on Certain Physician Referrals law prohibited physi­
cians from referring Medicare and Medicaid patients to health care organizations with which they had 
a financial relationship for the furnishing of designated health services. Implementing regulations 
have not yet been adopted as of the date of this publication.
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of amounts that ultimately will be realized, considering—among other things— 
adjustments associated with regulatory reviews, audits, billing reviews, inves­
tigations, or other proceedings. Estimates that are significant to management's 
assertions about revenue include the provision for third-party payor contrac­
tual adjustments and allowances.
.11 Management also is responsible for preparing and certifying cost re­
ports submitted to federal and state government agencies in support of claims 
for payment for services rendered to government program beneficiaries.
The Auditor's Responsibilities
.12 The auditor’s responsibility is to express an opinion on the financial 
statements taken as a whole. In reaching this opinion, the auditor considers 
the evidence in support of recorded amounts. If amounts are not known with 
certainty, the auditor considers the reasonableness of management's estimates 
in the present circumstances. The auditor also considers the fairness of the 
presentation and adequacy of the disclosures made by management.
.13 In planning the audit, the auditor considers current industry condi­
tions, as well as specific matters affecting the entity.3 Among a number of things, 
the auditor's procedures typically include an analysis of historical results (for 
example, prior fiscal intermediary audit adjustments and comparisons with in­
dustry benchmarks and norms) that enable the auditor to better assess the risk 
of material misstatements in the current period. When there are heightened 
risks, the auditor performs more extensive tests covering the current period. 
Exhibit 5-1 of the Guide includes a number of examples of procedures that 
auditors may consider.
.14 With respect to auditing third-party revenues, in addition to the usual 
revenue recognition considerations, the auditor considers whether amounts ul­
timately realizable are or should be presently known or are uncertain because 
they are dependent on some other future, prospective actions or confirming 
events. For example, under a typical fee-for-service contract with a commer­
cial payor, if the provider has performed a service for a covered individual, the 
revenue to which the provider is entitled should be determinable at the time 
the service is rendered. On the other hand, if the service was provided under 
a cost-based government contract, the revenue ultimately collectible may not 
be known until certain future events occur (for example, a cost report has been 
submitted and finalized after desk review or audit). In this case, management 
estimates the effect of such potential future adjustments.
.15 As stated previously, management is responsible for preparing the 
estimates contained in the financial statements. The auditor evaluates the ad­
equacy of the evidence supporting those estimates, reviews the facts supporting 
management's judgments, and evaluates the judgments made based on condi­
tions existing at the time of the audit. The fact that net revenues recorded at the 
time services are rendered differ materially from amounts that ultimately are 
realized does not necessarily mean the audit was not properly planned or car­
ried out. Similarly, the fact that future events may differ materially from man­
agement's assumptions or estimates does' not necessarily mean that manage­
ment's estimates were not valid or the auditor did not follow generally accepted
3 Risk factors, including ones related to legislative and regulatory matters, are discussed annu­
ally in the AICPA Audit Risk Alert Health Care Industry Developments.
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estimates.
Evidential Matter
.16 The measurement of estimates is inherently uncertain and depends on 
the outcome of future events. Statement on Auditing Standards (SAS) No. 57, 
Auditing Accounting Estimates (AICPA, Professional Standards, vol. 1, AU sec. 
342), and SAS No. 79, Amendment to SAS No. 58, Reports on Audited Finan­
cial Statements (AICPA, Professional Standards, vol. 1, AU sec. 508) provide 
guidance to the auditor when the valuation of revenues is uncertain, pending 
the outcome of future events. In the current health care environment, conclu­
sive evidence concerning amounts ultimately realizable cannot be expected to 
exist at the time of the financial statement audit because the uncertainty as­
sociated with future program audits, administrative reviews, billing reviews, 
regulatory investigations, or other actions will not be resolved until sometime 
in the future.
.17 The fact that information related to the effects of future program au­
dits, administrative reviews, regulatory investigations, or other actions does 
not exist does not lead to a conclusion that the evidential matter supporting 
management's assertions is not sufficient to support management's estimates. 
Rather, the auditor's judgment regarding the sufficiency of the evidential mat­
ter is based on the evidential matter that is available or can reasonably be 
expected to be available in the circumstances. If, after considering the existing 
conditions and available evidence, the auditor concludes that sufficient eviden­
tial matter supports management's assertions about the valuation of revenues 
and receivables, and their presentation and disclosure in the financial state­
ments, an unqualified opinion ordinarily is appropriate.
.18 If relevant evidential matter exists that the auditor needs and is unable 
to obtain, the auditor should consider the need to express a qualified opinion or 
to disclaim an opinion because of a scope limitation. For example, if an entity 
has conducted an internal evaluation (for example, of coding or other billing 
matters) under attorney-client privilege and management and its legal counsel 
refuse to respond to the auditor's inquiries and the auditor determines the 
information is necessary, ordinarily the auditor qualifies his or her opinion for 
a scope limitation.
.19 The auditor considers the reasonableness of management's assump­
tions in light of the entity's historical experience and the auditor's knowledge 
of general industry conditions, because the accuracy of management's assump­
tions will not be known until future events occur. For certain matters, the best 
evidential matter available to the auditor (particularly as it relates to clinical 
and legal interpretations) may be the representations of management and its le­
gal counsel, as well as information obtained through reviewing correspondence 
from regulatory agencies.
.20 Pursuant to SAS No. 85, Management Representations (AICPA, Pro­
fessional Standards, vol. 1, AU sec. 333), the auditor should obtain written 
representations from management concerning the absence of violations or pos­
sible violations of laws or regulations whose effects should be considered for 
disclosure in the financial statements or as a basis for recording a loss contin­
gency. Examples of specific representations include the following:
• Receivables
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— Adequate consideration has been given to, and appro­
priate provision made for, estimated adjustments to rev­
enue, such as for denied claims and changes to diagnosis- 
related group (DRG) assignments.
— Recorded valuation allowances are necessary, appropri­
ate, and properly supported.
— All peer review organizations, fiscal intermediary, and 
third-party payor reports and information have been 
made available.
• Cost reports filed with third parties
— All required Medicare, Medicaid, and similar reports 
have been properly filed.
— Management is responsible for the accuracy and propri­
ety of all cost reports filed.
— All costs reflected on such reports are appropriate and al­
lowable under applicable reimbursement rules and regu­
lations and are patient-related and properly allocated to 
applicable payors.
— The reimbursement methodologies and principles em­
ployed are in accordance with applicable rules and regu­
lations.
— Adequate consideration has been given to, and appropri­
ate provision made for, audit adjustments by intermedi­
aries, third-party payors, or other regulatory agencies.
— All items required to be disclosed, including disputed 
costs that are being claimed to establish a basis for a 
subsequent appeal, have been fully disclosed in the cost 
report.
— Recorded third-party settlements include differences be­
tween filed (and to be filed) cost reports and calculated 
settlements, which are necessary based on historical ex­
perience or new or ambiguous regulations that may be 
subject to differing interpretations. While management 
believes the entity is entitled to all amounts claimed on 
the cost reports, management also believes the amounts 
of these differences are appropriate.
• Contingencies
— There are no violations or possible violations of laws or 
regulations, such as those related to the Medicare and 
Medicaid antifraud and abuse statutes, including but 
not limited to the Medicare and Medicaid Anti-Kickback 
Statute, Limitations on Certain Physician Referrals (the 
Stark law), and the False Claims Act, in any jurisdic­
tion, whose effects should be considered for disclosure in 
the financial statements or as a basis for recording a loss 
contingency other than those disclosed or accrued in the 
financial statements.
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— Billings to third-party payors comply in all material re­
spects with applicable coding guidelines (for example, 
ICD-9-CM and CPT-4) and laws and regulations (includ­
ing those dealing with Medicare and Medicaid antifraud 
and abuse), and billings reflect only charges for goods 
and services that were medically necessary; properly ap­
proved by regulatory bodies (for example, the Food and 
Drug Administration), if required; and properly rendered.
— There have been no communications (oral or written) 
from regulatory agencies, governmental representatives, 
employees, or others concerning investigations or allega­
tions of noncompliance with laws and regulations in any 
jurisdiction (including those related to the Medicare and 
Medicaid antifraud and abuse statutes), deficiencies in 
financial reporting practices, or other matters that could 
have a material adverse effect on the financial state­
ments.
.21 Management's refusal to furnish written representations constitutes 
a limitation on the scope of the audit sufficient to preclude an unqualified opin­
ion and is ordinarily sufficient to cause an auditor to disclaim an opinion or 
withdraw from the engagement. However, based on the nature of the repre­
sentations not obtained or the circumstances of the refusal, the auditor may 
conclude that a qualified opinion is appropriate.
Potential Departures From GAAP Related to Estimates
and Uncertainties
.22 In addition to examining the evidence in support of management's esti­
mates, the auditor determines that there has not been a departure from GAAP 
with respect to the reporting of those estimates in the financial statements. 
Such departures generally fall into one of the following categories:
• Unreasonable accounting estimates
• Inappropriate accounting principles
• Inadequate disclosure
Therefore, in order to render an opinion, the auditor's responsibility is to eval­
uate the reasonableness of management's estimates based on present circum­
stances and to determine that estimates are reported in accordance with GAAP 
and adequately disclosed.
.23 As discussed in AU section 326, Evidential Matter (AICPA, Profes­
sional Standards, vol. 1), the auditor's objective is to obtain sufficient appro­
priate audit evidence to provide him or her with a reasonable basis for form­
ing an opinion. As discussed previously, Exhibit 5-1 of the Guide provides a 
number of sample procedures that the auditor might consider in auditing an 
entity's patient revenues and accounts receivable, including those derived from 
third-party payors. For example, the Guide notes that the auditor might "test 
the reasonableness of settlement amounts, including specific and unallocated 
reserves, in light of the payors involved, the nature of the payment mech­
anism, the risks associated with future audits, and other relevant factors."4
Health Care Organizations
4 See paragraphs .25-.28.
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[Revised, September 2008, to reflect conforming changes necessary due to the 
issuance of Statement on Auditing Standards No. 105.]
Unreasonable Accounting Estimates
.24 In evaluating the reasonableness of management's estimates, the au­
ditor considers the basis for management's assumptions regarding the nature 
of future adjustments and management's calculations as to the effects of such 
adjustments.5 The auditor cannot determine with certainty whether such esti­
mates are right or wrong, because the accuracy of management's assumptions 
cannot be confirmed until future events occur.
.25 Though difficult to predict, it is reasonable for the auditor to expect 
that management has made certain assumptions (either in detail or in the 
aggregate) in developing its estimates regarding conditions likely to result in 
adjustments. The auditor gathers evidence regarding the reasonableness of the 
estimates (for example, consistency with historical experience and basis of man­
agement's underlying assumptions). In evaluating reasonableness, the auditor 
should obtain an understanding of how management developed the estimate. 
Based on that understanding, the auditor should use one or a combination of 
the following approaches:
a. Review and test the process used by management to develop the 
estimate.
b. Develop an independent expectation of the estimate to corroborate 
the reasonableness of management's estimates.
c. Review subsequent events or transactions occurring prior to com­
pletion of fieldwork (AU sec. 342.10).
.26 Since no one accounting estimate can be considered accurate with cer­
tainty, the auditor recognizes that a difference between an estimated amount 
best supported by the audit evidence and the estimated amount included in 
the financial statements may be reasonable, and such difference would not be 
considered to be a likely misstatement. However, if the auditor believes the 
estimated amount included in the financial statements is unreasonable, he or 
she should treat the difference between that estimate and the closest reason­
able estimate in the range as a likely misstatement and aggregate it with other 
likely misstatements. The auditor also should consider whether the difference 
between estimates best supported by the audit evidence and the estimates in­
cluded in the financial statements, which are individually reasonable, indicate 
a possible bias on the part of the entity's management. For example, if each 
accounting estimate included in the financial statements was individually rea­
sonable, but the effect of the difference between each estimate and the estimate 
best supported by the audit evidence was to increase income, the auditor should 
reconsider the reasonableness of the estimates taken as a whole (SAS No. 47, 
Audit Risk and Materiality in Conducting an Audit [AICPA, Professional Stan­
dards, vol. 1, AU sec. 312.36]).
.27 The auditor recognizes that approaches and estimates will vary from 
entity to entity. Some entities with significant prior experience may attempt to 
quantify the effects of individual potential intermediary or other governmental 
(for example, the Office of Inspector General and the Department of Justice) or 
private payor adjustments, basing their estimates on very detailed calculations 
and assumptions regarding potential future adjustments. Some may prepare
5 The lack of such analyses may call into question the reasonableness of recorded amounts.
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cost report6 analyses to estimate the effect of potential adjustments. Others may 
base their estimates on an analysis of potential adjustments in the aggregate, 
in light of the payors involved; the nature of the payment mechanism; the risks 
associated with future audits; and other relevant factors.
.28 Normally, the auditor considers the historical experience of the entity 
(for example, the aggregate amount of prior cost-report adjustments and previ­
ous regulatory settlements) as well as the risk of potential future adjustments. 
The fact that an entity currently is not subject to a governmental investigation 
does not mean that a recorded valuation allowance for potential billing adjust­
ments is not warranted. Nor do these emerging industry trends necessarily 
indicate that an accrual for a specific entity is warranted.
.29 In evaluating valuation allowances, the auditor may consider the en­
tity's historical experience and potential future adjustments in the aggregate. 
For example, assume that over the past few years after final cost report audits 
were completed, a hospital's adjustments averaged 3 percent to 5 percent of 
total filed reimbursable costs. Additionally, the hospital is subject to potential 
billing adjustments, including errors (for example, violations of the three-day 
window, discharge and transfer issues, and coding errors). Even though spe­
cific incidents are not known, it may be reasonable for the hospital to estimate 
and accrue a valuation allowance for such potential future retrospective adjust­
ments, both cost-based and non-cost-based. Based on this and other information 
obtained, the auditor may conclude that a valuation allowance for the year un­
der audit of 3 percent to 5 percent of reimbursable costs plus additional amounts 
for potential non-cost-based program billing errors is reasonable.
.30 Amounts that ultimately will be realized by an entity are dependent on 
a number of factors, many of which may be unknown at the time the estimate 
is first made. Further, even if two entities had exactly the same clinical and 
coding experience, amounts that each might realize could vary materially due 
to factors outside of their control (for example, differing application of payment 
rules by fiscal intermediaries, legal interpretations of courts, local enforcement 
initiatives, timeliness of reviews, and quality of documentation). As a result, be­
cause estimates are a matter of judgment and their ultimate accuracy depends 
on the outcome of future events, different entities in seemingly similar circum­
stances may develop materially different estimates. The auditor may conclude 
that both estimates are reasonable in light of the differing assumptions.
Inappropriate Accounting Principles
.31 The auditor also determines that estimates are presented in the fi­
nancial statements in accordance with GAAP. If the auditor believes that the 
accounting principles have not been applied correctly, causing the financial 
statements to be materially misstated, the auditor expresses a qualified or ad­
verse opinion.
Health Care Organizations
6 Medicare cost reimbursement is based on the application of highly complex technical rules, 
some of which are ambiguous and subject to different interpretations even among Medicare's fiscal 
intermediaries. It is not uncommon for fiscal intermediaries to reduce claims for reimbursement that 
were based on management's good faith interpretations of pertinent laws and regulations. Addition­
ally, the Provider Reimbursement Review Board (PRRB) or the courts may be required to resolve 
controversies regarding the application of certain rules. To avoid recognizing revenues before their 
realization is reasonably assured, providers estimate the effects of such potential adjustments. This 
is occasionally done by preparing a cost report based on alternative assumptions to help estimate con­
tractual allowances required by generally accepted accounting principles. The existence of reserves 
or a reserve cost report does not by itself mean that a cost report was incorrectly or fraudulently filed.
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.32 Valuation allowances are recorded so that revenues are not recognized 
until the revenues are realizable. Valuation allowances are not established 
based on the provisions of Financial Accounting Standards Board (FASB) State­
ment of Financial Accounting Standards No. 5, Accounting for Contingencies.
.33 The auditor should be alert for valuation allowances not associated 
with any particular program, issue, or time period (for example, cost-report year 
or year the service was rendered). Such a reserve may indicate measurement 
bias. The auditor also considers the possibility of bias resulting in distorted 
earnings trends over time (for example, building up specific or unallocated val­
uation allowances in profitable years and drawing them down in unprofitable 
years).
Inadequate Disclosure
.34 If the auditor concludes that a matter involving a risk or an uncer­
tainty is not adequately disclosed in the financial statements in conformity 
with GAAP, the auditor should express a qualified or adverse opinion. SOP 94- 
6, Disclosure o f Certain Significant Risks and Uncertainties [section 10,640], 
provides guidance on the information that reporting entities should disclose 
regarding risks and uncertainties existing as of the date of the financial state­
ments.
.35 In the health care environment, it is almost always at least reasonably 
possible that estimates regarding third-party payments could change in the 
near term as a result of one or more future confirming events (for example, 
regulatory actions reflecting local or national audit or enforcement initiatives). 
For most entities with significant third-party revenues, the effect of the change 
could be material to the financial statements. Where material exposure exists, 
the uncertainty regarding revenue realization is disclosed in the notes to the 
financial statements. Because representations from legal counsel are often key 
audit evidence in evaluating the reasonableness of management's estimates of 
potential future adjustments, the inability of an attorney to form an opinion 
on matters about which he or she has been consulted may be indicative of an 
uncertainty that should be specifically disclosed in the financial statements.
.36 Differences between original estimates and subsequent revisions 
might arise due to final settlements, ongoing audits and investigations, or pas­
sage of time in relation to the statute of limitations. The Guide (paragraph 
5.07) requires that these differences be included in the statement of operations 
in the period in which the revisions are made and disclosed, if material. Such 
differences are not treated as prior period adjustments unless they meet the 
criteria for prior period adjustments as set forth in FASB Statement No. 16, 
Prior Period Adjustments.
.37 Disclosures such as the following may be appropriate:
General Hospital (the Hospital) is a (not-for-profit, for-profit, or gov­
ernmental hospital or health care system) located in (City, State). The 
Hospital provides health care services primarily to residents of the 
region.
Net patient service revenue is reported at estimated net realizable 
amounts from patients, third-party payors, and others for services ren­
dered and includes estimated retroactive revenue adjustments due to 
future audits, reviews, and investigations. Retroactive adjustments 
are considered in the recognition of revenue on an estimated basis in
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the period the related services are rendered, and such amounts are 
adjusted in future periods as adjustments become known or as years 
are no longer subject to such audits, reviews, and investigations. 
Revenue from the Medicare and Medicaid programs accounted for ap­
proximately 40 percent and 10 percent, respectively, of the Hospital's 
net patient revenue for the year ended 1999. Laws and regulations 
governing the Medicare and Medicaid programs are extremely complex 
and subject to interpretation. As a result, there is at least a reasonable 
possibility that recorded estimates will change by a material amount in 
the near term. The 1999 net patient service revenue increased approxi­
mately $10,000,000 due to removal of allowances previously estimated 
that are no longer necessary as a result of final settlements and years 
that are no longer subject to audits, reviews, and investigations. The 
1998 net patient service revenue decreased approximately $8,000,000 
due to prior-year retroactive adjustments in excess of amounts previ­
ously estimated.
Health Care Organizations
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Appendix
Other Considerations Related to Government Investigations
In recent years, the federal government and many states have aggressively in­
creased enforcement efforts under Medicare and Medicaid anti-fraud and abuse 
legislation. Broadening regulatory and legal interpretations have significantly 
increased the risk of penalties for providers; for example, broad interpretations 
of "false claims" laws are exposing ordinary billing mistakes to scrutiny and 
penalty consideration. In such circumstances, evaluating the adequacy of ac­
cruals for or disclosure of the potential effects of illegal acts in the financial 
statements of health care organizations is a matter that is likely to require a 
high level of professional judgment.
As previously discussed in this SOP, the far-reaching nature of alleged fraud 
and abuse violations creates an uncertainty with respect to the valuation of 
revenues, because future allegations of illegal acts could, if proven, result in a 
subsequent reduction of revenues. In addition, management makes provisions 
in the financial statements and disclosures for any contingent liabilities asso­
ciated with fines and penalties due to violations of such laws. FASB Statement 
No. 5, Accounting for Contingencies, provides guidance in evaluating contingent 
liabilities, such as fines and penalties under applicable laws and regulations. 
Estimates of potential fines and penalties are not accrued unless their payment 
is probable and reasonably estimable.
The auditor's expertise is in accounting and auditing matters rather than oper­
ational, clinical, or legal matters. Accordingly, the auditor's procedures focus on 
areas that normally are subject to internal controls relevant to financial report­
ing. However, the further that potential illegal acts are removed from the events 
and transactions ordinarily reflected in the financial statements, the less likely 
the auditor is to become aware of the act, to recognize its possible illegality, and 
to evaluate the effect on the financial statements. For example, determining 
whether a service was medically necessary, obtained through a legally appro­
priate referral, properly performed (including using only approved devices, ren­
dered in a quality manner), adequately supervised, accurately documented and 
classified, or rendered and billed by nonsanctioned individuals typically is not 
within the auditor's professional expertise. As a result, an audit in accordance 
with generally accepted auditing standards (GAAS) is not designed to detect 
such matters.
Further, an audit conducted in accordance with GAAS does not include render­
ing an opinion or any form of assurance on an entity's compliance with laws 
and regulations.1
Nor does an audit under GAAS include providing any assurance on an entity's 
billings or cost report. In fact, cost reports typically are not prepared and sub­
mitted until after the financial statement audit has been completed.
Certain audit procedures, although not specifically designed to detect illegal 
acts, may bring possible illegal acts to an auditor's attention. When a poten­
tially illegal act is detected, the auditor's responsibilities are addressed in SAS
1 Even when auditors undertake a special engagement designed to attest to compliance with 
certain provisions of laws, regulations, contracts, and grants (for example, an audit in accordance 
with OMB Circular A-133), the auditor's procedures do not extend to testing compliance with laws 
and regulations related to Medicare and Medicaid fraud and abuse.
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No. 54, Illegal Acts by Clients (AICPA, Professional Standards, vol. 1, AU sec. 
317). Disclosure of an illegal act to parties other than the client's senior man­
agement and its audit committee or board of directors is not ordinarily part 
of the auditor's responsibility, and such disclosure would be precluded by the 
auditor's ethical or legal obligation of confidentiality, unless the matter affects 
the auditor's opinion on the financial statements.2
Health Care Organizations
2 Statement on Auditing Standards No. 54, Illegal Acts by Clients (AICPA, Professional Stan­
dards, vol. 1, AU sec. 317.23) discusses circumstances in which a duty to notify parties outside the 
client of detected illegal acts may exist.
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Appendix F
Statement of Position 02-2,
Accounting for Derivative Instruments 
and Hedging Activities by Not-for-Profit 
Health Care Organizations, and Clarification 
of the Performance Indicator*
December 27, 2002
* The Financial Accounting Standards Board (FASB) recently issued FASB Statement No. 161, 
Disclosures about Derivative Instruments and Hedging Activities—an amendment o f FASB State­
ment No. 133. The statement was issued due to the significant increase in the use and complexity 
of derivative instruments over the past several years. FASB believes that FASB Statement No. 133, 
Accounting for Derivative Instruments and Hedging Activities, does not provide adequate information 
about how derivatives and hedging activities affect an entity's financial position, income statement, 
and statement of cash flows. Accordingly, FASB Statement No. 161 increases disclosures about an 
entity's derivative and hedging activities in order to improve financial transparency. FASB Statement 
No.161 is effective for financial statements issued for fiscal years and interim periods beginning after 
November 15, 2008. Early adoption is encouraged. FASB Statement No. 161 encourages, but does not 
require, comparative disclosures for earlier periods at initial adoption. [Footnote added, September 
2008, to reflect conforming changes necessary due to the issuance of FASB Statement No. 161.]
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NOTE
Statements of Position on accounting issues present the conclusions 
of at least two-thirds of the Accounting Standards Executive Committee, 
which is the senior technical body of the Institute authorized to speak for 
the Institute in the areas of financial accounting and reporting. State­
ment on Auditing Standards No. 69, The Meaning o f  Present Fairly in 
Conformity With Generally Accepted Accounting Principles, identifies 
AICPA Statements of Position that have been cleared by the Financial 
Accounting Standards Board as sources of established accounting prin­
ciples in category b of the hierarchy of generally accepted accounting 
principles that it establishes. AICPA members should consider the ac­
counting principles in this Statement of Position if a different accounting 
treatment of a transaction or event is not specified by a pronouncement 
covered by Rule 203 of the AICPA Code of Professional Conduct. In such 
circumstances, the accounting treatment specified by the Statement of 
Position should be used, or the member should be prepared to justify a 
conclusion that another treatment better presents the substance of the 
transaction in the circumstances.
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Summary
This Statement of Position (SOP) amends the AICPA Audit and Accounting 
Guide Health Care Organizations (Guide) to address how nongovernmental 
not-for-profit health care organizations should report gains or losses on hedging 
and nonhedging derivative instruments under Financial Accounting Standards 
Board (FASB) Statement of Financial Accounting Standards No. 133, Account­
ing for Derivative Instruments and Hedging Activities, as amended. This SOP 
requires the following:
• Not-for-profit health care organizations should apply the provi­
sions of FASB Statement No. 133 (including the provisions per­
taining to cash flow hedge accounting) in the same manner as 
for-profit enterprises.
• Not-for-profit health care organizations should provide all the dis­
closures required by paragraph 45 of FASB Statement No. 133, 
including disclosures related to reclassifications into earnings of 
gains and losses that are reported in accumulated other compre­
hensive income. Although those organizations are not otherwise 
required to report changes in the components of comprehensive 
income pursuant to paragraph 26 of FASB Statement No. 130, 
Reporting Comprehensive Income, such organizations should sep­
arately disclose the beginning and ending accumulated derivative 
gain or loss that has been excluded from the performance indi­
cator (earnings measure), the related net change associated with 
current period hedging transactions, and the net amount of any re­
classifications into the performance indicator in a manner similar 
to that described in paragraph 47 of FASB Statement No. 133.
The SOP also amends the Guide to clarify that the performance indicator (earn­
ings measure) reported by not-for-profit health care organizations is analogous 
to income from continuing operations of a for-profit enterprise.
The provisions of the SOP are effective for fiscal years beginning after June 15, 
2003. Earlier application of this SOP is encouraged but is permitted only as of 
the beginning of any fiscal quarter that begins after issuance of this SOP. The 
provisions of the SOP should be applied prospectively. Not-for-profit health care 
organizations that reported derivative gains or losses in a manner inconsistent 
with the conclusions of the SOP in financial statements issued prior to adoption 
of the SOP are not permitted to reclassify those gains or losses upon adoption.
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Foreword
The accounting guidance contained in this document has been cleared by the 
Financial Accounting Standards Board (FASB). The procedure for clearing ac­
counting guidance in documents issued by the Accounting Standards Execu­
tive Committee (AcSEC) involves the FASB reviewing and discussing in pub­
lic board meetings (1) a prospectus for a project to develop a document, (2) a 
proposed exposure draft that has been approved by at least 10 of AcSEC's 15 
members, and (3) a final document that has been approved by at least 10 of Ac­
SEC's 15 members. The document is cleared if at least four of the seven FASB 
members do not object to AcSEC undertaking the project, issuing the proposed 
exposure draft or, after considering the input received by AcSEC as a result of 
the issuance of the exposure draft, issuing the final document.
The criteria applied by the FASB in its review of proposed projects and proposed 
documents include the following:
1. The proposal does not conflict with current or proposed accounting 
requirements, unless it is a limited circumstance, usually in spe­
cialized industry accounting, and the proposal adequately justifies 
the departure.
2. The proposal will result in an improvement in practice.
3. The AICPA demonstrates the need for the proposal.
4. The benefits of the proposal are expected to exceed the costs of 
applying it.
In many situations, prior to clearance, the FASB will propose suggestions, many 
of which are included in the document.
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Introduction
.01 Financial Accounting Standards Board (FASB) Statement of Finan­
cial Accounting Standards No. 133, Accounting for Derivative Instruments and 
Hedging Activities, as amended, establishes accounting and reporting stan­
dards for derivative instruments and hedging activities. If certain conditions 
are met, a derivative may be specifically designated as a hedge of the exposure 
to changes in the fair value of a recognized asset or liability or an unrecognized 
firm commitment (fair value hedge), a hedge of the exposure to variable cash 
flows of an existing recognized asset or liability or a forecasted transaction (cash 
flow hedge), or a hedge of foreign currency exposure.1
.02 The accounting for derivative gains and losses depends on the intended 
use of the derivative and the resulting designation.
• For a fair value hedge, the gain or loss on the derivative is recog­
nized in earnings in the period of change together with the offset­
ting loss or gain on the hedged item attributable to the risk being 
hedged.
• For a cash flow hedge, the effective portion of the derivative's gain 
or loss is initially reported as a component of other comprehen­
sive income (outside earnings) and subsequently reclassified into 
earnings when the forecasted transaction affects earnings. Any 
ineffective portion of the gain or loss is reported in earnings im­
mediately.
• For a derivative not designated as a hedging instrument, the gain 
or loss is recognized in earnings in the period of change.
.03 The application of FASB Statement No. 133 to entities that do not 
report earnings as a separate caption in a statement of financial performance 
(for example, a not-for-profit organization) is described in paragraph 43 of that 
Statement. Paragraph 43 indicates that such organizations shall recognize the 
gain or loss on hedging and nonhedging derivative instruments, and changes 
in the carrying amount o f the hedged item in a fair value hedge, as a change in 
net assets in the period of change. Paragraph 43 also indicates that cash flow 
hedge accounting is not available to a not-for-profit or other entity that does 
not report earnings as a separate caption in a statement of financial perfor­
mance. Consistent with the provisions of FASB Statement No. 117, Financial 
Statements o f Not-for-Profit Organizations, FASB Statement No. 133 does not 
prescribe how a not-for-profit organization should determine the components 
of an operating measure, if one is presented.
.04 Many health care entities are organized as not-for-profit organizations, 
and thus would appear to be subject to the provisions of paragraph 43 of FASB 
Statement No. 133. The thrust of the guidance in paragraph 43 appears to be di­
rected at the fact that FASB Statement No. 117 does not require not-for-profit 
entities to report earnings. However, not-for-profit health care organizations 
must report a defined measure of earnings (performance indicator) as a sepa­
rate caption in the statement of operations, based on requirements contained
1 Not-for-profit health care organizations do not frequently enter into foreign currency hedges. 
Therefore, this SOP focuses on matters pertaining to fair value and cash flow hedges.
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in paragraph 10.17 and 10.18 of the AICPA Audit and Accounting Guide Health 
Care Organizations (the Guide). Consequently, some not-for-profit health care 
organizations believed that paragraph 43 of FASB Statement No. 133 (includ­
ing its provisions related to cash flow hedge accounting) did not affect them. 
Those entities applied the provisions of FASB Statement No. 133 in the same 
manner as for-profit enterprises. Other not-for-profit health care organizations 
believed they were subject to the guidance in paragraph 43, but interpreted that 
guidance in different ways. As a result, diversity in practice arose among not- 
for-profit health care organizations with respect to their accounting for deriva­
tives.
.05 This SOP addresses how not-for-profit health care organizations 
should report gains or losses on hedging and nonhedging derivative instru­
ments under FASB Statement No. 133 and clarifies certain matters with re­
spect to the performance indicator (earnings measure) reported by such orga­
nizations.
Scope
.06 This SOP applies to not-for-profit health care organizations that are 
within the scope of the Guide. It does not apply to governmental entities that 
are within the scope of the Guide.
Conclusions
Application of FASB Statement No. 133
.07 Except as provided in paragraph .08 of this SOP, not-for-profit health 
care organizations should apply the provisions of FASB Statement No. 133 
(including the provisions pertaining to cash flow hedge accounting) in the same 
manner as for-profit enterprises. That is, the gain or loss items that affect 
a for-profit enterprise's income from continuing operations similarly should 
affect the not-for-profit health care organization's performance indicator, and 
the gain or loss items that are excluded from a for-profit enterprise's income 
from continuing operations (such as items reported in other comprehensive 
income) similarly should be excluded from the performance indicator by the 
not-for-profit health care organization.
.08 Paragraph 47 of FASB Statement No. 133 discusses requirements to 
report changes in the components of comprehensive income pursuant to para­
graph 26 of FASB Statement No. 130, Reporting Comprehensive Income. Al­
though not-for-profit health care organizations are not subject to the require­
ments of FASB Statement No. 130, this SOP requires those organizations to 
separately disclose the beginning and ending accumulated derivative gain or 
loss that has been excluded from the performance indicator (also see para­
graph .10 of this SOP), the related net change associated with current period 
hedging transactions, and the net amount of any reclassifications into the per­
formance indicator in a manner similar to that described in paragraph 47 of 
FASB Statement No. 133. Similarly, this SOP requires not-for-profit health 
care organizations to provide disclosures that are analogous to those required 
by paragraph 45 of FASB Statement No. 133 for for-profit enterprises, including 
the disclosure of anticipated reclassifications into the performance indicator of 
gains and losses that have been excluded from that measure and reported in 
accumulated derivative gain or loss as of the reporting date.
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Performance Indicator
.09 Paragraph 10.17 and 10.18 of the Guide are amended as follows. The 
following text is added after the first sentence of paragraph 10.17:
This performance indicator and the income from continuing operations 
reported by for-profit health care enterprises generally are consistent, 
except for transactions that clearly are not applicable to one kind of 
entity (for example, for-profit health care enterprises typically would 
not receive contributions, and not-for-profit health care organizations 
would not award stock compensation). That is, the performance indi­
cator is analogous to income from continuing operations of a for-profit 
enterprise.
In paragraph 10.18, item e is eliminated, item f  is renumbered e, and item g  is 
deleted and replaced with the following two subpoints:
f. Items that are required to be reported in or reclassified from other 
comprehensive income, such as gains or losses, prior service costs or 
credits, and transition assets or obligations associated with postre­
tirement benefits; foreign currency translation adjustments; and 
the effective portion of the gain or loss on derivative instruments 
designated and qualifying as cash flow hedging instruments.
g. Items that are required to be reported separately under special­
ized not-for-profit standards. These include extraordinary items, 
the effect of discontinued operations, and the cumulative effect of 
accounting changes pursuant to the provisions of FASB Statement 
No. 117; and unrealized gains and losses on investments not re­
stricted by donors or by law (except for those investments classified 
as trading securities) and investment returns restricted by donors 
or by law, as required by paragraphs 4.07 through 4.10 of this Guide.
[Revised, September 2006, to reflect conforming changes necessary due to the 
issuance of FASB Statement No. 158.]
Effective Date and Transition
.10 The provisions of this SOP are effective for fiscal years beginning after 
June 15, 2003. Earlier application of this SOP is encouraged but is permitted 
only as of the beginning of any fiscal quarter that begins after issuance of this 
SOP. This SOP should be applied prospectively for all contracts existing on 
the initial date of application of this SOP and for transactions after that date. 
Derivative gains or losses reported in a manner inconsistent with the provisions 
of this SOP in financial statements for periods prior to the initial date of applica­
tion of this SOP should not be reclassified upon adoption. Any derivative gains 
and losses excluded from the performance indicator in the financial statements 
issued for periods ended before the initial date of application of this SOP that 
did not meet the cash flow hedging criteria of FASB Statement No. 133 should 
not be reclassified and included as a component of the performance indicator in 
any period subsequent to the initial date of application of this SOP. In addition, 
the derivative gains and losses referred to in the preceding sentence should 
not be included in the disclosure of the accumulated derivative gain or loss (as 
described in paragraph .08 of this SOP). However, to the extent that derivative 
gains or losses on cash flow hedges qualifying under FASB Statement No. 133 
had been reported in a manner consistent with the provisions of this SOP in 
financial statements for periods prior to the initial date of application of this
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SOP, such amounts should be included in that disclosure and should be reclas­
sified and included in the performance indicator when the hedged transaction 
affects the performance indicator. When the financial statements of the year of 
adoption are presented separately or included in comparative financial state­
ments, the notes to the financial statements should disclose (a) the fact that 
this SOP has been adopted and the effective date of adoption, and (b) the nature 
of any differences in accounting principles or financial statement presentation 
applicable to the financial statements presented that resulted from adoption of 
the SOP. Disclosure of pro forma amounts is not required.
.11 Entities initially applying hedge accounting upon adoption of this SOP 
are reminded that all the hedge accounting criteria in FASB Statement No. 
133 must be met for the entire period to which hedge accounting is being ap­
plied. Derivative instruments should not be retroactively designated as hedges 
if appropriate contemporaneous documentation of the election and periodic as­
sessment of effectiveness2 did not occur in conformity with FASB Statement 
No. 133.
The provisions of this SOP need not be applied 
to immaterial items.
Background
.12 Issues surrounding the reporting of derivatives by not-for-profit health 
care organizations and the resulting diversity in practice were brought to the 
attention of the planning subcommittee of the AICPA's Accounting Standards 
Executive Committee (AcSEC) in December 2000. Specifically, questions had 
been raised about whether the guidance in paragraph 43 of FASB Statement 
No. 133, Accounting for Derivative Instruments and Hedging Activities, as 
amended, applied to not-for-profit health care organizations that are required 
under industry-specific generally accepted accounting principles (GAAP) to re­
port a performance indicator.
.13 The planning subcommittee discussed the paragraph 43 issue and 
concluded that, because not-for-profit health care organizations are required 
to report a standardized performance indicator that is considered analogous 
to income from continuing operations reported by for-profit enterprises, they 
should apply the provisions of FASB Statement No. 133 in the same manner 
as do for-profit enterprises. Because that conclusion was not considered contro­
versial, the planning subcommittee directed the AICPA staff to draft clarifying 
guidance in the form of a proposed AICPA Technical Practice Aid (TPA).
.14 The planning subcommittee also discussed a footnote that had been 
added as a conforming change to paragraph 10.18 of the Guide in May 2000. 
That footnote contained the following statement:
Not-for-profit health care organizations that have early-adopted 
FASB Statement No. 133, Accounting for Derivative Instruments and
2 FASB Statement No. 133, Accounting for Derivative Instruments and Hedging Activities, as 
amended, establishes the general requirement that, to use hedge accounting, an entity should assess 
a hedge's effectiveness at the time it enters into a hedge and at least every three months thereafter, 
unless the hedge qualifies for use of the short-cut method. The requirement to assess hedge effective­
ness at least every three months applies to entities that issue financial statements only on an annual 
basis as well as to entities that issue quarterly financial statements.
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Hedging Activities, should also report unrealized gains and losses on 
derivatives that do not qualify as a fair value hedge under FASB State­
ment No. 133, except for the effect of changes in interest accruals, 
separate from the performance indicator.
In light of the planning subcommittee's conclusion that the provisions of FASB 
Statement No. 133 should be applied to not-for-profit health care organizations 
in the same manner as for-profit enterprises, it was decided that the May 2000 
conforming change should be deleted from future editions of the Guide.
.15 In January 2001, the planning subcommittee discussed a letter re­
ceived by AcSEC's Chair from The Bond Market Association (TBMA). The letter 
indicated TBMA's awareness of the planning subcommittee's discussions and 
expressed concern that the proposed guidance would be issued in the form of 
a nonauthoritative TPA. TBMA was concerned that not-for-profit health care 
organizations and their independent auditors would not be aware of such guid­
ance, resulting in the inconsistent application of derivative accounting among 
organizations in the sector. TBMA also wanted to ensure that all affected parties 
would have an opportunity to review and comment on the proposed guidance, 
because it could represent a significant change in reporting for some not-for- 
profit health care organizations.
.16 In March 2001, after further discussing the draft TPA and considering 
input received from various sources, the planning subcommittee and AcSEC 
decided that an SOP should be issued to amend the Guide to address these 
issues. Although the planning subcommittee and AcSEC did not disagree with 
the conclusions in the draft TPA, it was concluded that an SOP subject to due 
process would be the most appropriate vehicle for communicating the guid­
ance. AcSEC issued an exposure draft of a proposed SOP on June 14, 2002 and 
received four comment letters.
Views on the Issue
.17 Some believed that because not-for-profit health care organizations 
are required by the AICPA Audit and Accounting Guide Health Care Organi­
zations to report a performance indicator that is analogous to income from con­
tinuing operations of a for-profit enterprise, they should apply the provisions of 
FASB Statement No. 133 (including the cash flow hedge accounting provisions) 
in the same manner as for-profit enterprises. That is, the gain or loss items that 
under FASB Statement No. 133 would affect a for-profit enterprise's earnings 
similarly should affect the not-for-profit health care organization's performance 
indicator, and the gain or loss items that under FASB Statement No. 133 are 
reported in other comprehensive income by the for-profit enterprise similarly 
should be excluded from the performance indicator by the not-for-profit health 
care organization. They interpreted paragraph 43 of FASB Statement No. 133 
as applying only to organizations that are not required to report an earnings 
measure.
.18 Others believed that paragraph 43 precludes the use of cash flow hedge 
accounting by not-for-profit health care organizations because the FASB has not 
defined the performance indicator to be used by those organizations. They cited 
the following sentence in paragraph 501 of FASB Statement No. 133 as support 
for their position:
For this Statement to permit a not-for-profit entity, for example, to 
apply cash flow hedge accounting, the Board would first have to define
Health Care Organizations
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a subcomponent of the total change in net assets during a period that 
would be analogous to earnings for a business enterprise.
They believed that the definition of performance indicator used by not-for-profit 
health care organizations does not qualify as earnings for FASB Statement No. 
133 purposes because it was promulgated by AcSEC, rather than the FASB. 
Opponents of that view pointed to paragraph 49 of FASB Statement No. 117, 
Financial Statements o f Not-for-Profit Organizations, which allows AICPA in­
dustry Audit and Accounting Guides to provide implementing guidance with 
respect to that Statement that, if cleared by the FASB, should be adopted by 
users of those guides. The FASB did not object to the definition of performance 
indicator promulgated in the Guide.
.19 Others acknowledged that not-for-profit health care organizations re­
port a performance indicator that is analogous to income from continuing opera­
tions of a for-profit enterprise, but believed that the cash flow hedge accounting 
prohibitions in paragraph 43 should apply because the concept of other com­
prehensive income is limited to for-profit enterprises that are subject to FASB 
Statement No. 130, Reporting Comprehensive Income. Opponents of that view 
responded that not-for-profit health care organizations employ other compre­
hensive income reporting concepts in their statement of operations and their 
definition of a performance indicator. They pointed to the fact that among the ex­
clusions from the performance indicator listed in paragraph 10.18 of the Guide 
are the items that for-profit organizations are required to include in other com­
prehensive income under FASB Statement No. 130 (foreign currency items, 
gains or losses, prior service costs or credits, and transition assets or obliga­
tions associated with postretirement benefits, and unrealized gains and losses 
on certain investments in debt and equity securities). Further, they pointed to 
paragraphs 500 and 501 of FASB Statement No. 133, which indicate that the 
total change in net assets of a not-for-profit organization is analogous to the to­
tal comprehensive income of a for-profit enterprise. [Revised, September 2006, 
to reflect conforming changes necessary due to the issuance of FASB Statement 
No. 158.]
.20 Still others believed that, although not-for-profit health care organi­
zations conceptually are capable of applying the mechanics of cash flow hedge 
accounting in their financial statements, they are precluded from doing so be­
cause the list in paragraph 10.18 of the Guide of items to be excluded from the 
performance indicator does not explicitly include "the effective portion of the 
gain or loss on derivative instruments designated and qualifying as cash flow 
hedging instruments." They believed that all transactions except those explic­
itly listed in paragraph 10.18 should be included in the performance indicator.
.21 Among those who believed that paragraph 43 prohibits not-for-profit 
health care organizations from applying cash flow hedge accounting, some be­
lieved that all hedging and nonhedging derivative gains and losses should be 
included in the performance indicator. Others interpreted paragraph 43 as re­
quiring all hedging and nonhedging derivative gains and losses to be excluded 
from the performance indicator and reported in "other changes in net assets." 
Still others employed a hybrid approach to reporting derivative gains and losses 
based on guidance provided in a conforming change (that subsequently was 
rescinded)3 contained in a footnote to paragraph 10.18 of the May 2000 edition 
of the Guide.
3 See paragraph .14 of this SOP.
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Basis for Conclusions
Scope
Other Not-for-Profit Organizations
.22 AcSEC discussed whether the scope of the SOP should extend to other 
types of not-for-profit organizations (that is, not-for-profit organizations other 
than health care organizations) in situations in which those organizations vol­
untarily choose to provide a performance indicator. Those organizations are 
subject to the AICPA Audit and Accounting Guide Not-for-Profit Organizations, 
rather than the Audit and Accounting Guide Health Care Organizations. Ac­
SEC chose not to address similar issues for those organizations in the context 
of this SOP because, unlike health care organizations, other types of not-for- 
profit organizations are not subject to a standardized or prescribed performance 
measure.
Governmental Health Care Enterprises
.23 Because the concept of reporting "other comprehensive income" con­
flicts with the reporting requirements of Governmental Accounting Standards 
Board (GASB) Statement No. 34, Basic Financial Statements—and Manage­
ment's Discussion and Analysis—for State and Local Governments, cash flow 
hedge accounting is not available to governmental health care enterprises that 
are within the scope of the Guide. Therefore, governmental health care en­
terprises are excluded from the scope of the SOP. FASB Statement No. 133 
applies to governmental enterprises only to the extent that provisions in that 
Statement do not conflict with the provisions of GASB pronouncements (see 
paragraph 94 of GASB Statement No. 34).
Reporting a Separate Component of Equity
.24 Pursuant to paragraph 26 of FASB Statement No. 130, for-profit enti­
ties report accumulated other comprehensive income as a component of equity 
that is displayed separately from retained earnings and additional paid-in cap­
ital in a statement of financial position. When FASB Statement No. 130 was 
issued, the FASB considered whether not-for-profit organizations should also be 
included within the scope of that Statement. The FASB decided to exclude those 
organizations, noting that not-for-profit organizations' financial statements al­
ready were displaying the equivalent of comprehensive income as a result of 
the requirements of FASB Statement No. 117. Thus, not-for-profit organiza­
tions are not required to report accumulated other comprehensive income as a 
separate component of equity.
.25 AcSEC discussed whether the absence of a requirement to report ac­
cumulated other comprehensive income as a separate component of equity was 
a significant enough difference to preclude not-for-profit health care organiza­
tions from being able to use cash flow hedge accounting under FASB Statement 
No. 133. AcSEC determined that the concept of reporting accumulated other 
comprehensive income as a separate component of equity is unique to for-profit 
enterprises that report retained earnings and additional paid-in capital and 
that, further, the concept primarily appears to be a carryforward of the report­
ing practices followed by such entities before the issuance of FASB Statement 
No. 130. Moreover, AcSEC was concerned that such reporting may conflict with 
the provisions of FASB Statement No. 117 requiring not-for-profit organiza­
tions to report three classes of net assets (unrestricted, temporarily restricted,
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and permanently restricted). Therefore, AcSEC concluded that the absence of 
a requirement to report a separate component of equity in the balance sheet 
of not-for-profit health care organizations should not preclude those organi­
zations from using comprehensive income reporting for qualifying gains and 
losses on cash flow hedges. Although accumulated other comprehensive income 
will inherently be carried forward in a not-for-profit health care organization's 
net assets, there is no compelling need for it to be reported separately in the 
balance sheet.
Income Statement Classification of Derivative Gains and Losses
.26 Although FASB Statement No. 133 provides comprehensive disclosure 
guidance for derivatives, it does not explicitly address or prescribe the income 
statement classification for derivative gains and losses that are included in 
earnings.
.27 Paragraph 45 of FASB Statement No. 133 requires an entity to disclose 
where in the income statement it has chosen to report the net gain or loss on 
fair value and cash flow hedges (and the related hedged transaction or item), 
but the paragraph does not specify where or in what captions such gains and 
losses should be displayed. That allows for flexibility in reporting based on an 
entity's economic rationale for entering into the hedge. For derivatives that are 
not designated as hedges, FASB Statement No. 133 does not require disclosure 
of where gains and losses are reported in the income statement, nor does it 
specify where within the income statement those gains and losses should be 
reported. AcSEC decided not to provide more specific guidance regarding in­
come statement classification in this SOP because it did not want to prescribe 
more restrictive guidance for not-for-profit health care organizations than that 
applicable to other organizations subject to FASB Statement No. 133.
Definition of Performance Indicator
.28 The term performance indicator was introduced in 1996 when the 
AICPA issued the Audit and Accounting Guide Health Care Organizations.4 
The 1996 revision of the industry Guide was necessitated largely by the is­
suance of FASB Statements No. 116, Accounting for Contributions Received 
and Contributions Made, and No. 117, which (among other things) changed the 
financial statement display requirements for not-for-profit organizations. The 
1995 exposure draft of the Guide had referred to the earnings measure using 
terms such as net income and operating income. The FASB subsequently ob­
jected to that terminology, deeming it inappropriate for describing an earnings 
measure of a not-for-profit organization. Accordingly, the final Guide used the 
generic term performance indicator to denote the earnings measure.
.29 Paragraph 1.04 of the Guide states, in part:
The financial reporting for not-for-profit, business-oriented organiza­
tions and investor-owned health care enterprises generally is consis­
tent except for transactions that clearly are not applicable. For exam­
ple, not-for-profit business organizations would have nothing to report 
for shareholders' equity. On the other hand, investor-owned health care 
enterprises typically would not have anything to report for contribu­
tions.
4 Health Care Organizations replaced the AICPA Industry Audit Guide Audits o f Providers of 
Health Care Services.
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Consequently, in developing the definition of performance indicator (paragraph 
10.17 and 10.18 of the Guide), AcSEC intended that the linkage between the 
new performance indicator measure and the earnings measure previously re­
ported by not-for-profit health care organizations be preserved to the greatest 
extent possible, due to its importance to users of health care organizations' fi­
nancial statements. The phrase "other items that are required by GAAP to be 
reported separately" was included in paragraph 10.18g of the Guide to enable 
the performance indicator to remain "evergreen," that is, to permit it to be up­
dated by conforming changes to incorporate the issuance of future accounting 
standards.
.30 Subsequent to issuance of the Guide, AcSEC determined that the provi­
sions of paragraph 10.17 and 10.18 were not being interpreted by some readers 
of the Guide in the manner intended by AcSEC. In addition, when new account­
ing standards have been issued, some readers of the Guide have been uncertain 
how to apply them with respect to the performance indicator. Consequently, 
paragraph .09 of this SOP revises the definition of performance indicator to 
state explicitly that the performance indicator should be regarded as the func­
tional equivalent of income from continuing operations of a for-profit enterprise. 
Additionally, this SOP amends paragraph 10.18 of the Guide to clarify that the 
reference to "other items that are required by GAAP to be reported separately" 
refers to GAAP applicable to for-profit enterprises (for example, items that are 
required under existing accounting standards to be reported in other compre­
hensive[5] income as well as GAAP specific to not-for-profit organizations, and 
that additional items may result from issuance of future accounting standards. 
Transition
.31 Paragraph 515 of FASB Statement No. 133 states, in part:
Because hedge accounting is based on an entity's intent at the time a 
hedging relationship is established, the Board decided that retroactive 
application of the provisions of this Statement was not appropriate.
Similarly, Derivatives Implementation Group (DIG) Issue No. K5, Transition 
Provisions for Applying the Guidance in Statement 133 Implementation Issues, 
indicates that when an entity has applied "the recognition and measurement of 
derivatives differently than required by subsequently issued cleared implemen­
tation guidance, [the entity] should account for the effects of initially complying 
with that implementation guidance prospectively for all existing contracts and 
future transactions, as of the effective date for that guidance." Consequently, 
AcSEC determined that the effects of initially complying with the guidance in 
this SOP should also be accounted for prospectively.
.32 AcSEC also considered whether to allow an alternative for retroactive 
application of this SOP. Although this SOP does not change the "recognition 
and measurement of derivatives," it may change an entity's accounting policy 
and thus may affect certain actions taken by an entity. For example, based on 
their interpretation of authoritative literature, certain health care entities may 
have had economic hedges that they did not designate as cash flow hedges be­
cause they did not believe that cash flow hedging derivatives were accounted for
Health Care Organizations
[5] [Footnote deleted, September 2006, to reflect conforming changes necessary due to the issuance 
of FASB Statement No. 158.J
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differently from non-hedging derivatives. AcSEC recognized that the historical 
actions undertaken to document, designate, or assess effectiveness by entities 
that, in prior periods, had adopted accounting policies inconsistent with those 
set forth in this SOP may have differed had this SOP been effective during 
those prior periods. In recognition of this fact, and because hedging relation­
ships cannot be documented retroactively under FASB Statement No. 133, Ac­
SEC decided that retroactive application of the provisions of this SOP was not 
appropriate.
.33 Because the effect of an entity's hedging activities on its financial 
statements in the initial year of adoption of this SOP may not be comparable 
to the preceding year, AcSEC discussed whether pro forma disclosures in the 
year of adoption would address concerns related to consistency and compara­
bility of financial information. Disclosure of the pro forma effects of retroactive 
application of hedge accounting for prior periods (in a manner similar to the re­
quirements of paragraph 19(d) of Accounting Principles Board Opinion No. 20, 
Accounting Changes) was considered and rejected for the same reasons that 
AcSEC rejected retroactive restatement as a transition option, as described in 
paragraph .32. The exposure draft solicited comments on an alternative pro 
forma measure that would require entities to disclose the effect on their perfor­
mance indicator for the year of adoption of continuing to apply their prior year's 
reporting practices, if such practices differed from those required by the SOP. 
One commenter stated that such a requirement was inappropriate and would 
not provide users of the financial statements with meaningful comparative in­
formation. For example, for an entity that prior to adoption of the SOP believed 
that paragraph 43 of Statement No. 133 prohibited cash flow hedge account­
ing but that upon adoption of the SOP adopted cash flow hedge accounting, 
the information derived from disclosing what the performance indicator would 
have been had the entity continued to not take advantage of hedge account­
ing has little (if any) meaning for users of financial statements. Similarly, for 
an entity that prior to adoption of the SOP was excluding gains and losses 
from the performance indicator in a manner other than that allowed by this 
SOP, disclosing what the performance indicator would have been had the en­
tity continued to exclude those derivative gains/losses from the performance 
indicator subsequent to its adoption of the SOP does not provide meaningful 
information and, further, results in comparing a performance indicator derived 
in accordance with GAAP with a measure that is no longer considered to be 
in accordance with GAAP. Therefore, although acknowledging that the use­
fulness of financial information about an entity increases if that information 
can be compared with similar information in prior periods, AcSEC concluded 
that the potential usefulness of that information is diminished or eliminated 
if the information has no comparative value. Additionally, AcSEC considered 
this SOP's guidance as similar in nature to the guidance provided in Statement 
No. 133 and DIG Issue No. K5. Neither Statement No. 133 nor Issue No. K5 
requires disclosure of any pro forma information. Consequently, AcSEC con­
cluded that pro forma disclosures of any type would not be appropriate for the 
year of adoption of this SOP. However, when the financial statements of the 
year of adoption are presented separately or included in comparative financial 
statements, the entity should disclose in the notes to the financial statements 
(a) the fact that the SOP has been adopted and the effective date of adoption 
(for example, beginning of a year or beginning of a quarter), and (b) the nature 
of any differences in accounting principles or financial statement presentation 
applicable to the financial statements presented that resulted from adoption 
of the SOP (for example, "The effective portion of unrealized gains and losses
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on cash flow hedges, which prior to adoption of SOP 02-2 were included in the 
performance indicator, are now reported below the performance indicator").
.34 The exposure draft would have required entities to adopt the SOP 
as of the beginning of a fiscal year. Several respondents to the exposure draft 
objected to precluding entities from early adopting this SOP, based on their un­
derstanding that a number of entities had already been applying the provisions 
of FASB Statement No. 133 pertaining to cash flow hedge accounting prior to 
issuance of the exposure draft. They also were concerned about allowing di­
versity in practice to continue over the extended period that would result from 
requiring adoption as of the beginning of a fiscal year. AcSEC concluded that in 
the interest of remedying diversity in practice as quickly as possible, entities 
should be allowed to early adopt the SOP.
.35 AcSEC observed that some not-for-profit health care organizations 
may have employed a methodology that excluded derivative gains and losses 
from the performance indicator until those gains or losses were realized. Upon 
realization, those organizations would have recognized the derivative's gain 
or loss in the performance indicator. Consistent with its decision to require 
prospective application of this SOP, AcSEC decided that upon initial applica­
tion of this SOP, any prior gains or losses on derivative instruments recognized 
by those not-for-profit health care organizations that had been excluded from 
the performance indicator in years before adoption and that did not meet the 
hedging criteria of FASB Statement No. 133 (including the requirements of 
contemporaneous documentation and testing of effectiveness) should not sub­
sequently be reclassified and included as a component of the performance in­
dicator. Rather, any such derivative gains and losses should be permanently 
excluded from the performance indicator.
.36 AcSEC did agree, however, that to the extent that a not-for-profit 
health care organization had reported derivative gains or losses in a manner 
consistent with the provisions of this SOP (including compliance with the doc­
umentation and designation requirements of FASB Statement No. 133) in fi­
nancial statements for periods prior to the initial application of this SOP, such 
amounts should be reclassified and included in the performance indicator when 
the hedged item affects the performance indicator.
.37 For entities that initially apply hedge accounting upon adoption of this 
SOP or thereafter, paragraph .11 states that all the hedge accounting criteria 
in FASB Statement No. 133 must be met for the entire period to which hedge 
accounting is being applied in order for hedge accounting to be used. AcSEC 
noted that when an organization designates an existing derivative as a hedg­
ing instrument upon adoption of the SOP or thereafter, the fair value of the 
derivative instrument typically will not be zero at the inception of the hedg­
ing relationship. Because paragraph 68(b) of FASB Statement No. 133 requires 
that the fair value of the hedging instrument at the inception of the hedging 
relationship be zero in order for the short-cut method to be used, application 
of the short-cut method will not be possible and hedge ineffectiveness for cash 
flow hedges must be measured under either the hypothetical derivative method 
or the change in fair value method as described in DIG Issue No. G7, Cash Flow 
Hedges: Measuring the Ineffectiveness o f  a Cash Flow Hedge under Paragraph 
30(b) When the Shortcut Method is Not Applied. For cash flow hedging relation­
ships that were designated and accounted for pursuant to the hedge accounting 
criteria in FASB Statement No. 133 prior to the adoption of this SOP, the adop­
tion of this SOP will not affect how hedge effectiveness is assessed or hedge 
ineffectiveness is measured for such relationships.
Health Care Organizations
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Appendix G
Information Sources
Further information on matters addressed in this guide is available through 
various publications and services listed in the table that follows. Many non­
government and some government publications and services involve a charge 
or membership requirement.
Fax services allow users to follow voice cues and request that selected docu­
ments be sent by fax machine. Some fax services require the user to call from 
the handset of the fax machine, others allow the user to call from any phone. 
Most fax services offer an index document, which lists titles and other informa­
tion describing available documents.
Recorded announcements allow users to listen to announcements about a vari­
ety of recent or scheduled actions or meetings.
All telephone numbers listed are voice lines, unless otherwise designated as fax 
(f) or data (d) lines.
AAG-HCO APP G
446 Health Care Organizations
In
fo
rm
at
io
n 
So
ur
ce
s
A
va
ila
bl
e 
Pu
bl
ic
at
io
ns
C
om
pa
ra
tiv
e 
Pe
rf
or
m
an
ce
 o
f U
.S
. 
H
os
pi
ta
ls
: T
he
 S
ou
rc
eb
oo
k
Pr
of
ile
 o
f U
.S
. H
os
pi
ta
ls
G
ui
de
 to
 th
e M
an
ag
ed
 C
ar
e 
In
du
st
ry
G
ui
de
 to
 th
e N
ur
si
ng
 H
om
e I
nd
us
tr
y
Co
nt
in
ui
ng
 C
ar
e R
et
ir
em
en
t C
om
m
un
iti
es
: A
n 
In
du
st
ry
 in
 A
ct
io
n
A
lm
an
ac
 o
f H
os
pi
ta
l F
in
an
ci
al
 &
 O
pe
ra
tin
g 
In
di
ca
to
rs
H
os
pi
ta
l S
ta
tis
tic
s
N
at
io
na
l H
os
pi
ta
l P
an
el
 S
ur
ve
y 
Re
po
rt
H
M
O
 In
du
st
ry
 P
ro
fil
e
C
om
pe
tit
iv
e 
Ed
ge
 In
du
st
ry
 R
ep
or
t f
or
 H
M
O
s
So
ci
oe
co
no
m
ic
s o
f t
he
 M
ed
ic
al
 P
ra
ct
ic
e
Co
st
 S
ur
ve
y
A
ca
de
m
ic
 P
ra
ct
ic
e 
M
an
ag
em
en
t S
ur
ve
y
H
ea
lth
 C
ar
e 
F
in
an
ci
al
 M
an
ag
em
en
t (
m
on
th
ly
 p
ub
lic
at
io
n)
 Is
su
e
A
na
ly
si
s 
98
-1
, C
om
pl
ia
nc
e 
w
ith
 L
aw
s a
nd
 R
eg
ul
at
io
ns
 fo
r H
ea
lth
Ca
re
 O
rg
an
iz
at
io
ns
Fa
x 
Se
rv
ic
es
Fa
x-
on
-D
em
an
d 
(3
12
) 4
22
-2
02
0
Fa
x-
on
-D
em
an
d 
(2
02
) 3
31
-7
48
7
Fa
x-
on
-D
em
an
d 
(6
12
) 8
54
-5
69
8
In
fo
rm
at
io
n-
on
-R
eq
ue
st
 
Fa
x 
Li
ne
 
(8
00
) 6
21
-8
33
5
Fa
x-
on
-D
em
an
d 
(8
00
) F
A
X
-4
M
ED
G
en
er
al
 In
fo
rm
at
io
n
O
rd
er
 D
ep
ar
tm
en
t
30
0 
Ea
st
 L
om
ba
rd
 S
tr
ee
t
Ba
lti
m
or
e,
 M
D
 2
12
00
A
ttn
: C
us
to
m
er
 S
er
vi
ce
(8
00
) 5
68
-3
28
2_
__
__
__
__
__
__
__
__
__
__
__
__
_
O
rd
er
 D
ep
ar
tm
en
t 
A
A
H
SA
 P
ub
lic
at
io
ns
,
D
ep
t. 
51
19
W
as
hi
ng
to
n,
 D
C
 2
00
61
-5
11
9
(3
01
) 4
90
-0
67
7_
__
__
__
__
__
__
__
__
__
__
__
__
__
O
rd
er
 D
ep
ar
tm
en
t
15
50
 O
ld
 H
en
de
rs
on
 R
oa
d,
 S
ui
te
 S
27
7
C
ol
um
bu
s, 
O
H
 4
32
20
-3
62
6
(8
00
) 8
59
-2
44
7_
__
__
__
__
__
__
__
__
__
__
__
__
__
O
rd
er
 D
ep
ar
tm
en
t
P.
O
. B
ox
 9
26
83
C
hi
ca
go
, I
L 
90
67
3-
26
83
(8
00
) A
H
A
-2
62
6_
__
__
__
__
__
__
__
__
__
__
__
__
O
rd
er
 D
ep
ar
tm
en
t 
11
29
 2
0t
h 
St
re
et
, N
W
,
Su
ite
 6
00
W
as
hi
ng
to
n,
 D
C
 2
00
36
(2
02
) 7
78
-3
20
0_
__
__
__
__
__
__
__
__
__
__
__
__
_
O
rd
er
 D
ep
ar
tm
en
t
29
01
 M
et
ro
 D
ri
ve
, F
ou
rt
h 
Fl
oo
r
M
in
ne
ap
ol
is,
 M
N
 5
54
25
(6
12
) 8
58
-9
29
1_
__
__
__
__
__
__
__
__
__
__
__
__
_
O
rd
er
 D
ep
ar
tm
en
t 
51
5 
N.
 S
ta
te
 S
tr
ee
t 
C
hi
ca
go
, I
L 
60
61
0
(8
00
) 6
21
-8
33
5_
__
__
__
__
__
__
__
__
__
__
__
__
_
O
rd
er
 D
ep
ar
tm
en
t 
D
en
ve
r,
 C
O
 8
02
56
-0
44
4
(3
03
) 3
97
-7
88
8_
__
__
__
__
__
__
__
__
__
__
__
__
_
O
rd
er
 D
ep
ar
tm
en
t
Tw
o 
W
es
tb
ro
ok
 C
or
po
ra
te
 C
en
te
r,
 S
ui
te
 7
00
 
W
es
tc
he
st
er
, I
L 
60
15
4 
(2
02
) 2
96
-2
92
0
O
rg
an
iz
at
io
n
H
ea
lth
 C
ar
e 
In
ve
st
m
en
t 
A
na
ly
st
s, 
In
c.
 (H
CI
A)
A
m
er
ic
an
 A
ss
oc
ia
tio
n 
of
 
H
om
es
 a
nd
 S
er
vi
ce
s f
or
 
th
e 
A
gi
ng
 (A
AH
SA
)
C
en
te
r 
fo
r 
H
ea
lth
 C
ar
e 
In
du
st
ry
 P
er
fo
rm
an
ce
 
St
ud
ie
s (
C
H
IP
S)
A
m
er
ic
an
 H
os
pi
ta
l 
A
ss
oc
ia
tio
n 
(A
H
A)
G
ro
up
 H
ea
lth
 A
ss
oc
ia
tio
n 
of
 A
m
er
ic
a,
 In
c.
 (G
H
AA
)
In
te
rs
tu
dy
 P
ub
lic
at
io
ns
A
m
er
ic
an
 M
ed
ic
al
 
A
ss
oc
ia
tio
n 
(A
M
A)
M
ed
ic
al
 G
ro
up
 
M
an
ag
em
en
t A
ss
oc
ia
tio
n
H
ea
lth
 C
ar
e 
Fi
na
nc
ia
l 
M
an
ag
em
en
t A
ss
oc
ia
tio
n 
(H
FM
A)
AAG-HCO APP G
Information Sources 447
R
ec
or
de
d 
A
nn
ou
nc
em
en
ts
Ac
tio
n 
A
le
rt
 T
el
ep
ho
ne
 L
in
e 
(2
03
) 8
47
-0
70
0 
(e
xt
. 4
44
)
W
eb
 S
ite
 A
dd
re
ss
w
w
w
.a
ic
pa
.o
rg
w
w
w
.f
as
b
.o
rg
w
w
w
.g
as
b.
or
g
w
w
w
.g
ao
.g
ov
w
w
w
.g
po
.g
ov
w
w
w
.g
po
ac
ce
ss
.g
ov
w
w
w
.s
ec
.g
ov
w
w
w
.o
m
b.
go
v
Fa
x 
Se
rv
ic
es
24
 H
ou
r F
ax
 H
ot
lin
e 
(8
00
) 3
62
-5
06
6
G
en
er
al
 In
fo
rm
at
io
n
O
rd
er
 D
ep
ar
tm
en
t 
22
0 
Le
ig
h 
Fa
rm
 R
d.
D
ur
ha
m
, N
C
 2
77
07
-8
11
0 
(8
88
) 7
77
-7
07
7
If
 ou
ts
id
e 
of
 th
e 
U
.S
., 
ca
ll 
(9
19
) 4
02
-2
31
7
O
rd
er
 D
ep
ar
tm
en
t 
40
1 
M
er
ri
tt 
7 
P.
O
. B
ox
 5
11
6 
N
or
w
al
k,
 C
T 
06
85
6-
51
16
 
(2
03
) 8
47
-0
70
0,
 e
xt
. 1
0 
(8
00
) 7
48
-0
65
9
O
rd
er
 D
ep
ar
tm
en
t 
40
1 
M
er
ri
tt 
7 
P.
O
. B
ox
 5
11
6 
N
or
w
al
k,
 C
T 
06
85
6-
51
16
 
(2
03
) 8
47
-0
70
0 
ex
t. 
10
 
(8
00
) 7
48
-0
65
9
44
1 
G
 S
tr
ee
t, 
N
W
 
W
as
hi
ng
to
n,
 D
C
 2
05
48
 
G
AO
 P
ub
lic
at
io
ns
73
2 
N
. C
ap
ito
l S
tr
ee
t, 
N
W
 
W
as
hi
ng
to
n,
 D
C
 2
04
01
10
0 
F 
St
re
et
, N
E 
W
as
hi
ng
to
n,
 D
C
 2
05
49
 
Pu
bl
ic
at
io
ns
 U
ni
t 
(2
02
) 5
51
-4
04
0 
SE
C
 P
ub
lic
 R
ef
er
en
ce
 
(2
02
) 5
51
-8
09
0 
In
fo
rm
at
io
n 
Li
ne
 
(2
02
) 9
42
-8
08
8,
 e
xt
. 4
 
TT
Y 
(2
02
) 5
51
-6
02
0
72
5 
17
th
 S
tr
ee
t N
W
 
W
as
hi
ng
to
n,
 D
C
 2
05
03
 
(2
02
) 3
95
-3
08
0
O
rg
an
iz
at
io
n
A
m
er
ic
an
 In
st
itu
te
 o
f 
C
er
tif
ie
d 
Pu
bl
ic
 
A
cc
ou
nt
an
ts
Fi
na
nc
ia
l A
cc
ou
nt
in
g 
St
an
da
rd
s B
oa
rd
G
ov
er
nm
en
ta
l 
A
cc
ou
nt
in
g 
St
an
da
rd
s 
Bo
ar
d
U
.S
. G
ov
er
nm
en
t 
A
cc
ou
nt
ab
ili
ty
 O
ffi
ce
U
.S
. G
ov
er
nm
en
t 
Pr
in
tin
g 
O
ffi
ce
U
.S
. S
ec
ur
iti
es
 a
nd
 
E
xc
ha
ng
e 
C
om
m
is
si
on
U
.S
. O
ffi
ce
 o
f 
M
an
ag
em
en
t a
nd
 
B
ud
ge
t
AAG-HCO APP G
References to AICPA Technical Practice Aids 449
Appendix H
References to AICPA Technical Practice Aids
The following nonauthoritative questions and answers, commonly referred 
to as Technical Practice Aids (TPAs), have been prepared by AICPA staff and are 
included in AICPA Technical Practice Aids. The TPAs have not been approved, 
disapproved, or otherwise acted upon by the Accounting Standards Executive 
Committee or any other senior technical committee of the AICPA. They are 
not sources of established accounting principles as described in AU section 
411, The Meaning o f  Present Fairly in Conformity With Generally Accepted 
Accounting Principles (AICPA, Professional Standards, vol. 1), nor are they 
sources of authoritative generally accepted auditing standards. Staff believes 
the TPAs listed below may be useful and relevant for users of this guide. Other 
TPAs, as well as consensus positions of the Financial Accounting Standards 
Board's Emerging Issues Task Force, may also be useful and relevant to users 
of this guide depending on the facts and circumstances.
TPA Reference No. Title
6400.04 Hospital as Collecting Agent for Physicians
6400.12 General Obligation Bonds Issued for Current Use by 
City Owned Hospital
6400.16 Disclosure Required in Consolidated or Combined 
Financial Statements
6400.17 Elimination of Profit on Intercompany Sales
6400.19 Offsetting of Limited Use Assets
6400.20 Format of Combined or Consolidated Financial 
Statements
6400.25 Accounting for Transfer of Assets From
Not-for-Profit to For-Profit Entities
6400.26 Transfer of Assets From Subsidiary For-Profit Entity 
to Not-for-Profit Stockholder Parent
6400.28 Valuation of Assets Transferred Between Related 
Entities Under Common Control
6400.29 Timing of Recording Transfers Between Related 
Entities
6400.30 Accounting for Transactions Involving Medicaid 
Voluntary Contribution or Taxation Programs
6400.32 Use of Pooling-of-interests Method
6400.33 Accounting for a Joint Operating Agreement
6400.34 Accounting for Computer Systems Costs Incurred in 
Connection With the Health Insurance Portability 
and Accountability Act of 1996 (HIPAA)
(continued)
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TPA Reference No. Title
6400.35 Note to TIS Section 6400.36 to
6400.42—Implementation of FASB Statement
No. 136—Classification of a Beneficiary's Interest in 
the Net Assets of a Financially Interrelated 
Fund-Raising Foundation (in the Beneficiary's 
Financial Statements)
6400.36 Application of FASB Statement
No. 136—Classification of a Beneficiary's Interest in 
the Net Assets of a Financially Interrelated 
Fund-Raising Foundation (The beneficiary can 
influence the operating and financial decisions of the 
foundation to such an extent that the beneficiary can 
determine the timing and amount of distributions 
from the foundation.)
6400.37 Application of FASB Statement
No. 136—Classification of a Beneficiary's Interest in 
the Net Assets of a Financially Interrelated 
Fund-Raising Foundation (The beneficiary cannot 
influence the operating and financial decisions of the 
foundation to such an extent that the beneficiary can 
determine the timing and amount of distributions 
from the foundation.)
6400.38 Application of FASB Statement
No. 136—Classification of a Beneficiary's Interest in 
the Net Assets of a Financially Interrelated 
Fund-Raising Foundation—Does Common Control 
Lead to the Conclusion That the Beneficiary Can 
Determine the Timing and Amount of Distributions 
from the Recipient?
6400.39 Application of FASB Statement
No. 136—Classification of a Beneficiary's Interest in 
the Net Assets of a Financially Interrelated 
Fund-Raising Foundation (More Than One
Beneficiary—Some Contributions Are Designated)
6400.40 Application of FASB Statement
No. 136—Classification of a Beneficiary's Interest in 
the Net Assets of a Financially Interrelated 
Fund-Raising Foundation (The beneficiary makes an 
expenditure that meets a purpose restriction on net 
assets held for its benefit by the recipient 
organization—The beneficiary can influence the 
operating and financial decisions of the recipient to 
such an extent that the beneficiary can determine 
the timing and amount of distributions from the 
recipient.)
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TPA Reference No. Title
6400.41 Application of FASB Statement
No. 136—Classification of a Beneficiary's Interest in 
the Net Assets of a Financially Interrelated 
Fund-Raising Foundation (The beneficiary makes an 
expenditure that is consistent with a purpose 
restriction on net assets held for its benefit by the 
recipient organization—The beneficiary cannot 
influence the operating and financial decisions of the 
recipient to such an extent that the beneficiary can 
determine the timing and amount of distributions 
from the recipient.)
6400.42 Application of FASB Statement
No. 136—Classification of a Beneficiary's Interest in 
the Net Assets of a Financially Interrelated 
Fund-Raising Foundation (Recipient
Organization)—Accounting for Unrealized Gains 
and Losses on Investments Held by the Foundation
6400.43 Application of FASB Statement
No. 136—Classification of Distributions From a 
Financially Interrelated Fund-Raising Foundation 
(Recipient Organization) to a Health Care
Beneficiary
6400.44 Other-Than-Temporary Impairment Losses on 
Investments by Not-for-Profit Health Care 
Organizations
6400.45 Applicability of FASB Interpretation
No. 45—Accounting and Disclosure Requirements 
for Guarantees, Including Indirect Guarantees of 
Indebtedness of Others
6400.46 Applicability of FASB Interpretation
No. 45— Guarantor's Accounting and Disclosure 
Requirements for Guarantees, Including Indirect 
Guarantees of Indebtedness of Others—Mortgage 
Guarantees
9110.15 Reporting on Medicaid/Medicare Cost Reports
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Major Existing Differences Between AICPA 
Standards and PCAOB Standards
At the time of this writing, the following major differences existed between 
AICPA standards and final Public Company Accounting Oversight Board 
(PCAOB) standards approved by the Securities and Exchange Commission 
(SEC):
• Risk assessment standards. In March 2006, the Auditing Stan­
dards Board issued 8 Statements on Auditing Standards (SASs), 
Nos. 104-111, collectively referred to as the risk assessment stan­
dards. These standards are applicable to nonissuers and are ef­
fective for audits of financial statements for periods beginning on 
or after December 15, 2006. These standards provide extensive 
guidance concerning the auditor's assessment of the risks of ma­
terial misstatement in a financial statement audit and the design 
and performance of audit procedures whose nature, timing, and 
extent are responsive to the assessed risks. Additionally, the SASs 
establish standards and provide guidance on planning and super­
vision, the nature of audit evidence, and evaluating whether the 
audit evidence obtained affords a reasonable basis for an opinion 
regarding the financial statements under audit. SAS Nos. 104-111 
make significant changes to numerous AU sections in the audit­
ing literature. These standards and their changes do not apply to 
audits conducted in accordance with PCAOB standards.
• Audit o f  internal control. In connection with the requirement of 
Section 404(b) of the Sarbanes-Oxley Act of 2002 that an issuer's 
independent auditor attest to and report on management's as­
sessment of the effectiveness of internal control, PCAOB Audit­
ing Standard No. 5, An Audit o f Internal Control Over Financial 
Reporting That is Integrated With an Audit o f Financial State­
ments (AICPA, PCAOB Standards and Related Rules, Rules of 
the Board, "Standards"), establishes requirements and provides 
direction that apply when an auditor is engaged to audit the in­
ternal control over financial reporting and to perform that audit 
in conjunction with the audit of an issuer's financial statements. 
There were also several conforming amendments to PCAOB Au­
diting Standards resulting from the adoption of PCAOB Auditing 
Standard No. 5.
• Independence matters. Rule 3600T, requires compliance with 
Standard Nos. 1, 2, and 3, and Interpretations 99-1, 00-1, and 
00-2 of the Independence Standards Board. Also, to the extent 
that a provision of the SEC's independence rules or policies are 
more restrictive—or less restrictive—than the PCAOB's interim 
independence standards, a registered public accounting firm shall 
comply with the more restrictive requirement.
• Independence matters. The PCAOB has adopted ethics and in­
dependence rules concerning independence, tax services, and
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contingent fees. See PCAOB Rules 3501, 3502, 3520, 3521, 3522, 
3523, and 3524.
• Audit committee preapproval o f nonaudit services. Rule 3525 re­
quires registered public accounting firms who are performing a 
nonaudit service related to internal control over financial report­
ing to (1) describe, to the audit committee of the issuer the scope 
of the service, (2) discuss with the audit committee the potential 
effects of the service on independence, and (3) document the sub­
stance of these discussions.
• Concurring partner. Rule 3400T requires the establishment of 
policies and procedures for a concurring review (generally the SEC 
Practice Section [SECPS] membership rule).1
• Communication o f  firm policy. Rule 3400T requires registered 
firms to communicate through a written statement to all profes­
sional firm personnel the broad principles that influence the firm's 
quality control and operating policies and procedures on, at a min­
imum, matters that relate to the recommendation and approval 
of accounting principles, present and potential client relationships 
and the types of services provided, and inform professional firm 
personnel periodically that compliance with those principles is 
mandatory (generally the SECPS membership rule).
• Affiliated firms. Rule 3400T requires registered firms that are part 
of an international association to seek adoption of policies and 
procedures by the international organization or individual foreign 
associated firms consistent with PCAOB standards.
• Partner rotation. Rule 3600T requires compliance with the SEC's 
independence rules, which include partner rotation.
• Continuing professional education requirements. Rule 3400T re­
quires registered accounting firms to ensure that all o f their pro­
fessionals participate in at least 20 hours of qualifying continuing 
professional education every year (generally the SECPS member­
ship rule).
Please note that in the time since publication, these differences might have 
been eliminated and others might have arisen.
Health Care Organizations
1 Firms that were not members of the AICPA's Securities and Exchange Commission Practice 
Section as of April 16, 2003, do not have to comply with this requirement.
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Appendix J
Comparison of Key Provisions of the Risk 
Assessment Standards to Previous Standards
This appendix discusses the key provisions of each of the risk assessment re­
lated Statements on Auditing Standards (SASs) and provides a summary of how 
each of the SASs differs, if at all, from the previous AICPA generally accepted 
auditing standards.
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SAS No. 104, Amendment to Statement on Auditing 
Standards No. 1, Codification of Auditing Standards 
and Procedures ("Due Professional Care in the 
Performance of Work")
Health Care Organizations
Key Provisions
How the SAS Differs From Previous 
Standards
• SAS No. 104 defines reasonable 
assurance as a "high level of as­
surance."
• SAS No. 104 clarifies the meaning of 
reasonable assurance.
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SAS No. 105, Amendment to Statement 
on Auditing Standards No. 95, Generally 
Accepted Auditing Standards
Comparison of Key Provisions of the Risk Assessment
Key Provisions
How the SAS Differs From Previous 
Standards
• SAS No. 105 expands the scope 
of the understanding that the 
auditor must obtain in the sec­
ond standard of field work from 
"internal control" to "the entity 
and its environment, including 
its internal control."
• The quality and depth of the 
understanding to be obtained 
is emphasized by amending its 
purpose from "planning the au­
dit" to "assessing the risks of 
material misstatement of the 
financial statements whether 
due to error or fraud and to 
design the nature, timing, and 
extent of further audit proce­
dures."
• Previous guidance considered the 
understanding of the entity to be 
a part of audit planning, and em­
phasized that the understanding of 
internal control also was primarily 
part of audit planning.
• By stating that the purpose of your 
understanding of the entity and its 
internal control is part of assess­
ing the risks of material misstate­
ment, SAS No. 105 essentially con­
siders this understanding to provide 
audit evidence that ultimately sup­
ports your opinion on the financial 
statements.
• SAS No. 105 emphasizes the link 
between understanding the entity, 
assessing risks, and the design of fur­
ther audit procedures. It is antici­
pated that "generic" audit programs 
will not be an appropriate response 
for all engagements because risks 
vary between entities.
• The term further audit procedures, 
which consists of test of controls and 
substantive tests, replaces the term 
tests to be performed in recognition 
that risk assessment procedures are 
also performed.
• The term audit evidence replaces the 
term evidential matter.
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SAS No. 106, Audit Evidence
Key Provisions
How the SA S Differs From Previous 
Standards
• SAS No. 106 defines audit ev­
idence as "all the information 
used by the auditor in arriving 
at the conclusions on which the 
audit opinion is based."
• Previous guidance did not define 
audit evidence.
• SAS No. 106 also describes basic 
concepts of audit evidence.
• The term sufficient, appropriate au­
dit evidence, defined in SAS No. 
106, replaces the term sufficient, 
competent evidence.
• SAS No. 106 recategorizes asser­
tions by classes of transactions, 
account balances, and presen­
tation and disclosure; expands 
the guidance related to presen­
tation and disclosure; and de­
scribes how the auditor uses rele­
vant assertions to assess risk and 
design audit procedures.
• SAS No. 106 recategorizes asser­
tions to add clarity.
• Assertion relating to presentation 
and disclosure has been expanded 
and includes a new assertion that 
information in disclosures should 
be "expressed clearly" (understand- 
ability).
• SAS No. 106 defines relevant as­
sertions as those assertions that 
have a meaningful bearing on 
whether the account is fairly 
stated.
• The term relevant assertions is new, 
and it is used repeatedly through­
out SAS No. 106.
• SAS No. 106 provides additional 
guidance on the reliability of var­
ious kinds of audit evidence.
• The previous standard included a 
discussion of the competence of ev­
idential matter and how different 
types of audit evidence may provide 
more or less valid evidence. SAS 
No. 106 expands on this guidance.
• SAS No. 106 identifies risk as­
sessment procedures as audit 
procedures performed on all au­
dits to obtain an understand­
ing of the entity and its envi­
ronment, including its internal 
control, to assess the risks of 
material misstatement at the fi­
nancial statement and relevant 
assertion levels.
• SAS No. 106 introduces the con­
cept of risk assessment procedures, 
which are necessary to provide a 
basis for assessing the risks of ma­
terial misstatement. The results of 
risk assessment procedures, along 
with the results of further audit 
procedures, provide audit evidence 
that ultimately supports the audi­
tor's opinion on the financial state­
ments.
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Key Provisions
How the SAS Differs From Previous 
Standards
• SAS No. 106 provides that ev­
idence obtained by performing 
risk assessment procedures, as 
well as that obtained by per­
forming tests of controls and 
substantive procedures, is part 
of the evidence the auditor ob­
tains to draw reasonable con­
clusions on which to base the 
audit opinion, although such ev­
idence is not sufficient in and of 
itself to support the audit opin­
ion.
• SAS No. 106 describes the types 
of audit procedures that the 
auditor may use alone or in 
combination as risk assessment 
procedures, tests of controls, 
or substantive procedures, de­
pending on the context in which 
they are applied by the auditor.
• Risk assessment procedures include
— inquiries of management and 
others within the entity,
— analytical procedures, and
— observation and inspection.
• SAS No. 106 includes guidance 
on the uses and limitations of 
inquiry as an audit procedure.
• Inquiry alone is not sufficient to eval­
uate the design of internal control 
and to determine whether it has 
been implemented.
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SAS No. 107, Audit Risk and Materiality 
in Conducting an Audit
Health Care Organizations
Key Provisions
How the SAS Differs From Previous 
Standards
• The auditor must consider au­
dit risk and must determine 
a materiality level for the fi­
nancial statements taken as a 
whole for the purpose of
1. determining the extent 
and nature of risk as­
sessment procedures.
2. identifying and assess­
ing the risk of material 
misstatement.
3. determining the nature, 
timing, and extent of fur­
ther audit procedures.
4. evaluating whether the 
financial statements ta­
ken as a whole are pre­
sented fairly, in con­
formity with generally 
accepted accounting pri­
nciples.
• Previous guidance said that audi­
tors "should consider" audit risk and 
materiality for certain specified pur­
poses. SAS No. 107 states that the 
auditor "must" consider.
• New guidance explicitly states that 
audit risk and materiality are used 
to identify and assess the risk of ma­
terial misstatement.
• Combined assessment of inher­
ent and control risks is termed 
the risk o f material misstate­
ment.
• SAS No. 107 consistently uses the 
term risk o f material misstatement, 
which often is described as a com­
bined assessment of inherent and 
control risk. However, auditors may 
make separate assessment of inher­
ent risk and control risks.
• The auditor should assess the 
risk of material misstatement 
as a basis for further audit pro­
cedures. Although that risk as­
sessment is a judgment rather 
than a precise measurement of 
risk, the auditor should have an 
appropriate basis for that as­
sessment.
• Assessed risks and the basis 
for those assessments should be 
documented.
• SAS No. 107 states that the auditor 
should have and document an appro­
priate basis for the audit approach.
• These two provisions of the risk as­
sessment standards effectively elim­
inate the ability of the auditor to as­
sess control risk "at the maximum" 
without having a basis for that as­
sessment. In other words, you can no 
longer "default" to maximum control 
risk.
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Key Provisions
How the SAS Differs From Previous 
Standards
• The auditor must accumulate 
all known and likely misstate­
ments identified during the au­
dit, other than those that the 
auditor believes are trivial, and 
communicate them to the ap­
propriate level of management.
• SAS No. 107 provides additional 
guidance on communicating mis­
statements to management.
• The concept of not accumulat­
ing misstatements below a certain 
threshold is included in the previous 
standards, but SAS No. 107 provides 
additional specific guidance on how 
to determine this threshold.
• The auditor should request 
management to respond appro­
priately when misstatements 
(known or likely) are identified 
during the audit.
• SAS No. 107 provides specific guid­
ance regarding the appropriate 
auditor's responses to the types of 
misstatements (known or likely) 
identified by the auditor.
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SAS No. 108, Planning and Supervision
Key Provisions
How the SAS Differs From Previous 
Standards
SAS No. 108 provides guidance 
on
• appointment of the indepen­
dent auditor.
• establishing an understanding 
with the client.
• preliminary engagement activ­
ities.
• the overall audit strategy.
• the audit plan.
• determining the extent of in­
volvement of professionals pos­
sessing specialized skills.
• using a professional possessing 
IT skills to understand the ef­
fect of IT on the audit.
• additional considerations in ini­
tial audit engagements.
• supervision of assistants.
• Much of the guidance provided in 
SAS No. 108 has been consolidated 
from several existing standards.
• However, SAS No. 108 provides new 
guidance on preliminary engage­
ment activities, including the devel­
opment of an overall audit strategy 
and an audit plan.
— The overall audit strategy is 
what previously was commonly 
referred to as the audit ap­
proach. It is a broad ap­
proach to how the audit will 
be conducted, considering fac­
tors such as the scope of the 
engagement, deadlines for per­
forming the audit and issuing 
the report, and recent financial 
reporting developments.
— The audit plan is more de­
tailed than the audit strategy 
and is commonly referred to as 
the audit program. The audit 
plan describes in detail the na­
ture, timing, and extent of risk 
assessment and further audit 
procedures you perform in an 
audit.
• SAS No. 108 states that you should 
establish a written understanding 
with your auditee regarding the ser­
vices to be performed for each en­
gagement.
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SAS No. 109, Understanding the Entity 
and Its Environment and Assessing the Risks 
of Material Misstatement
Comparison of Key Provisions of the Risk Assessment
Key Provisions
How the SA S Differs From Previous
Standards
• SAS No. 109 describes audit 
procedures that the auditor 
should perform to obtain the 
understanding of the entity 
and its environment, includ­
ing its internal control.
• The auditor should perform risk as­
sessment procedures to gather infor­
mation and gain an understanding of 
the entity and its environment. These 
procedures include inquiries, observa­
tion, inspection, and analytical proce­
dures. Previous standards did not de­
scribe the procedures that should be 
performed to gain an understanding of 
the client.
• Information about the entity may be 
provided by a variety of sources, includ­
ing knowledge about the entity gath­
ered in previous audits (provided cer­
tain conditions are met) and the results 
of auditee acceptance and continuance 
procedures.
• SAS No. 109 also directs the auditor 
to perform a variety of risk assessment 
procedures, and it describes the limita­
tions of inquiry.
• The audit team should dis­
cuss the susceptibility of the 
entity's financial statements 
to material misstatement.
• Previous standards did not require a 
"brainstorming" session to discuss the 
risks o f material misstatements. SAS 
No. 109 requires such a brainstorming 
session, which is similar to (and may 
be performed together with) the brain­
storming session to discuss fraud.
• The purpose of obtaining 
an understanding of the en­
tity and its environment, in­
cluding its internal control, 
is to identify and assess 
the risks of material mis­
statement and design and 
perform further audit pro­
cedures responsive to the 
assessed risks.
• SAS No. 109 directly links the under­
standing of the entity and its inter­
nal control with the assessment of risk 
and design of further audit procedures. 
Thus, the understanding of the entity 
and its environment, including its in­
ternal control, provides the audit ev­
idence necessary to support the audi­
tor's assessment of risk.
(continued)
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Key Provisions
How the SAS Differs From Previous
Standards
• SAS No. 109 states the au­
ditor should assess the risks 
of material misstatement at 
both the financial statement 
and relevant assertion levels.
• The previous standard included the 
concept of assessing risk at the finan­
cial statement level, but SAS No. 109 
provides expanded and more explicit 
guidance.
• SAS No. 109 also directs the auditor 
to determine how risks at the financial 
statement level may result in risks at 
the assertion level.
• SAS No. 109 provides direc­
tions on how to evaluate the 
design of the entity's con­
trols and determine whether 
the controls are adequate and 
have been implemented.
• Under the previous standard, the pri­
mary purpose of gaining an under­
standing of internal control was to plan 
the audit. Under SAS No. 109, your un­
derstanding of internal control is used 
to assess risks. Thus, the understand­
ing of internal control provides audit 
evidence that ultimately supports the 
auditor's opinion on the financial state­
ments.
• The previous standard directs the au­
ditor to obtain an understanding of in­
ternal control as part of obtaining an 
understanding of the entity and its en­
vironment. SAS No. 109 requires audi­
tors to evaluate the design of controls 
and determine whether they have been 
implemented. Evaluating the design of 
a control involves considering whether 
the control, individually or in combina­
tion with other controls, is capable of 
effectively preventing or detecting and 
correcting material misstatements. It 
is anticipated that this phase of the au­
dit will require more work than simply 
gaining understanding of internal con­
trol.
• SAS No. 109 directs the au­
ditor to consider whether any 
of the assessed risks are sig­
nificant risks that require 
special audit consideration 
or risks for which substan­
tive procedures alone do not 
provide sufficient appropri­
ate audit evidence.
• Previous standard did not include the 
concept of significant risks.
• Significant risks exist on most engage­
ments.
• The auditor should gain an under­
standing of internal control and also 
perform substantive procedures for all 
identified significant risks. Substan­
tive analytical procedures alone are not 
sufficient to test significant risks.
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Key Provisions
How the SAS Differs From Previous
Standards
• SAS No. 109 provides exten­
sive guidance on the matters 
that should be documented.
• The guidance provided by SAS No. 109 
relating to documentation is signifi­
cantly greater than that provided by 
previous standards.
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SAS No. 110, Performing Audit Procedures 
in Response to Assessed Risks and Evaluating 
the Audit Evidence Obtained
Health Care Organizations
Key Provisions
How the SAS Differs From Previous
Standards
• SAS No. 110 provides guid­
ance on determining over­
all responses to address the 
risks of material misstate­
ment at the financial state­
ment level and the nature of 
those responses.
• The concept of addressing the risks of 
material misstatement at the financial 
statement level and developing an ap­
propriate overall response is similar to 
the requirement in previous standards 
relating to the consideration of audit 
risk at the financial statement level. 
However, that guidance was placed in 
the context of audit planning. SAS No. 
110 "repositions" your consideration of 
risk at the financial statement level so 
you make this assessment as a result 
of and in conjunction with your perfor­
mance of risk assessment procedures. In 
some cases, this assessment may not be 
able to be made during audit planning.
• SAS No. 110 requires you to consider 
how your assessment of risks at the fi­
nancial statement level affects individ­
ual financial statement assertions, so 
you may design and perform tailored fur­
ther audit procedures (substantive tests 
or tests of controls).
• The list of possible overall responses to 
the risks of material misstatement at 
the financial statement level also has 
been expanded.
• Further audit procedures, 
which may include tests of 
controls, or substantive pro­
cedures should be respon­
sive to the assessed risks 
of material misstatement at 
the relevant assertion level.
• Although the previous standards in­
cluded the concept that audit procedures 
should be responsive to assessed risks, 
this idea was embedded in the discus­
sion of the audit risk model. The SASs 
repeatedly emphasize the need to pro­
vide a clear linkage between your under­
standing of the entity, your risk assess­
ments, and the design of further audit 
procedures.
• SAS No. 110 requires you to document 
the linkage between assessed risks and 
further audit procedures, which was not 
a requirement under the previous stan­
dards.
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Key Provisions
How the SAS Differs From Previous
Standards
• SAS No. 110 provides guid­
ance on matters the audi­
tor should consider in deter­
mining the nature, timing, 
and extent of such audit pro­
cedures.
• The new guidance on determining the 
nature, timing, and extent of tests of 
controls and substantive tests has been 
expanded greatly and addresses issues 
that previously were not included in the 
authoritative literature.
• SAS No. 110 states that the nature of 
further audit procedures is of most im­
portance in responding to your assessed 
risks of material misstatement. That is, 
increasing the extent of your audit pro­
cedures will not compensate for proce­
dures that do not address the specifically 
identified risks of misstatement.
• SAS No. 110 states that you should 
perform certain substantive procedures 
on all engagements. These procedures 
include
— performing substantive tests for 
all relevant assertions related to 
each material class of transac­
tions, account balance, and disclo­
sure regardless of the assessment 
of the risks of material misstate­
ments.
— agreeing the financial statements, 
including their accompanying 
notes, to the underlying account­
ing records.
— examining material journal en­
tries and other adjustments made 
during the course of preparing the 
financial statements. 
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SAS No. 111, Amendment to Statement on Auditing 
Standards No. 39, Audit Sampling
Health Care Organizations
Key Provisions
How the SAS Differs From Previous 
Standards
• SAS No. 111 provides guidance 
relating to the auditor's judg­
ment about establishing tolera­
ble misstatement for a specific 
audit procedure and on the ap­
plication of sampling to tests of 
controls.
• SAS No. 111 provides enhanced 
guidance on tolerable misstatement. 
In general, tolerable misstatement 
in an account should be less than ma­
teriality to allow for aggregation in 
final assessment.
• Ordinarily sample sizes for nonsta­
tistical samples are comparable to 
sample sizes for an efficient and ef­
fectively designed statistical sample 
with the same sampling parameters.
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Appendix K
Schedule of Changes Made to the Text 
From the Previous Edition
As of May 1 , 2008
This schedule of changes identifies areas in the text and footnotes of this guide 
that have changed since the previous edition. Entries in the table of this ap­
pendix reflect current numbering, lettering (including that in appendix names), 
and character designations that resulted from the renumbering or reordering 
that occurred in the updating of this guide.
Terms Used to Define Professional Requirements
The 2008 editions of the AICPA Audit and Accounting Guides, including this 
guide, have been updated to conform with AU section 120, Defining Profes­
sional Requirements in Statements on Auditing Standards, AT section 20, 
Defining Professional Requirements in Statements on Standards for Attesta­
tion Engagements, and AR section 20, Defining Professional Requirements 
in Statements on Standards for Accounting and Review Services (AICPA, 
Professional Standards), in which professional requirements are categorized 
as either unconditional requirements or presumptively mandatory require­
ments, each of which is associated with specific wording such as must or is 
required or should. These standards distinguish professional requirements 
set forth in the standards from explanatory material contained in the stan­
dards, the latter of which requires only the auditor's, practitioner's, or ac­
countant's "attention and understanding." Whether the auditor, practitioner, 
or accountant performs the suggested procedures or actions in the engage­
ment (as stated in the explanatory material) depends on the exercise of pro­
fessional judgment in the circumstances consistent with the objective of the 
standard.
Because interpretive publications (including AICPA Audit and Accounting 
Guides, for example) are recommendations, the publications cannot estab­
lish requirements. Paragraph .06 of AU Section 150, Generally Accepted Au­
diting Standards (AICPA, Professional Standards, vol. 1), states, "The au­
ditor should be aware of and consider interpretive publications applicable 
to his or her audit. If the auditor does not apply the auditing guidance in­
cluded in an interpretive publication, the auditor should be prepared to explain 
how he or she complied with the SAS provisions addressed by such auditing 
guidance."
An interpretive publication, such as this guide, should state the requirement of 
the standard and then give recommendations on the application of the require­
ment in the specific circumstances. The terms must, is required, or should may 
be used in an interpretive publication only when it is clear that the require­
ment originated in a standard. Otherwise, the user may be uncertain whether a 
requirement or a recommendation is intended. The following conventions were 
used to conform the AICPA Audit and Accounting Guides to these standards, 
which define professional requirements:
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• Terms to replace the use of must, should, and is required consist 
only of those explanatory material terms included in AU section 
120, AT section 20, and AR section 20: could, may, and might, and 
these variations of those terms: could consider, may consider, and 
might consider.
• When referring guide users to interpretive publications (which 
consist of interpretations of the Statement on Auditing Standards 
(SASs), appendixes to the SASs, auditing guidance in AICPA Audit 
and Accounting Guides, and AICPA auditing Statements of Posi­
tion) or to nonauthoritative knowledge sources, if an auditor can 
perform an adequate risk assessment without the recommended 
knowledge, explanatory material terms are used; if not, should or 
should consider are used.
• Specific auditing procedures generally are explanatory in nature 
(the standards generally do not include specific audit procedures). 
As such, explanatory material terms (could, may, might, could con­
sider, may consider, or might consider) are used, unless the specific 
audit procedure is the established way or only way of achieving a 
generally accepted auditing standard objective for this industry, 
in which case should is used.
• If the recommendation is that the auditor consult or familiar­
ize himself or herself with other sources of information, such 
as Securities and Exchange Commission (SEC) regulations, in­
come tax laws, and industry developments including regulatory, 
economic, and legislative developments, then the following con­
siderations were used in developing which terms to use in the 
guides:
— If the purpose of the recommendation is for the auditor, 
practitioner, or accountant to develop the required under­
standing of the entity and its environment for risk assess­
ment purposes, and an auditor can perform an adequate 
risk assessment without the recommended knowledge, 
explanatory material terms are used within the recom­
mendation; if not, should or must is used depending upon 
the associated standard requirement.
— If the purpose of the recommendation is for the auditor, 
practitioner, or accountant to perform the engagement in 
accordance with AICPA professional standards, and the 
knowledge is available only from the source cited (such as 
SEC regulations or income tax law), then should is used. 
If the knowledge is available from other sources as well, 
explanatory material terms are used.
• The guides contain guidance for management which includes best 
practices for the industry. Because the recommendations are best 
practices, the terms ordinarily should or generally should are 
used.
Health Care Organizations
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Reference Change
Notice to Readers and 
Preface
Updated.
Footnote * in paragraph 
1.01
Revised for clarification.
Footnote † in paragraph 
1.09
Added.
Paragraphs 1.16 and 
1.23-.24
Revised to reflect the issuance of the updated 
GASB Comprehensive Implementation Guide.
Footnote ‡ in paragraph 
1.46
Added.
Footnote || in heading 
before paragraph 1.50
Revised to reflect the issuance o f FASB State­
ment Nos. 141(R) and 160.
Paragraph 1.52 Revised to reflect the issuance of FASB Interpre­
tation No. 48.
Paragraphs 1.56 and 
1.59-.60
Revised to reflect the issuance of recent authori­
tative pronouncements, release of proposed guid­
ance, and FASB project developments.
Footnote * in heading 
before paragraph 1.62
Revised to reflect the issuance of FASB State­
ment No. 162.
Note before paragraph 
2.01
Revised.
Paragraphs 2.01-.02, 
2.06, and 2.09-.10
Revised to reflect the appropriate use of terms 
used to define the professional requirements of 
auditors, practitioners, and accountants in AU 
section 120, AT section 20, and AR section 20 of 
AICPA Professional Standards.
Paragraph 2.10 Revised to reflect the issuance of PCAOB Audit­
ing Standard No. 5.
Paragraph 2.13 Revised to define professional requirements.
Paragraph 2.17 Revised for clarification.
Paragraph 2.20 Revised to reflect the issuance of PCAOB Audit­
ing Standard No. 5.
Paragraphs 2.25 and
2.29
Revised to define professional requirements.
Paragraph 2.29 Revised to reflect the issuance of PCAOB Audit­
ing Standard No. 5.
Paragraphs 2.33-.34 Revised to define professional requirements.
Paragraph 2.37 Revised to reflect the issuance of PCAOB Audit­
ing Standard No. 5.
Paragraphs 2.39, 
2.41-.42, 2.47, and 
2.51-.52
Revised to define professional requirements.
(continued)
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Reference Change
Paragraph 2.54 Revised to reflect the issuance of PCAOB Audit­
ing Standard No. 5.
Paragraphs 2.57 and
2.60
Revised to define professional requirements.
Footnote 2 in the 
heading before 
paragraph 2.81
Revised to define professional requirements.
Paragraph 2.84 Revised to define professional requirements.
Footnote 3 in heading 
before paragraph 2.86
Revised to define professional requirements.
Paragraph 2.88 Revised to define professional requirements.
Footnote 4 in 
paragraph 2.90
Revised to reflect the issuance of PCAOB Audit­
ing Standard No. 5.
Paragraphs 2.93, 2.95, 
2.98, and 2.101-.102
Revised to define professional requirements.
Paragraph 2.102 Revised to reflect the issuance of PCAOB Audit­
ing Standard No. 5.
Paragraphs 2.107 and 
2.114
Revised to define professional requirements.
Paragraph 2.119 Revised for clarification.
Paragraphs 2.122-.123 Revised to define professional requirements.
Paragraph 2.123 Revised to reflect the issuance of PCAOB Audit­
ing Standard No. 5.
Paragraph 2.124 Revised to define professional requirements; re­
vised to reflect the issuance of PCAOB Auditing 
Standard No. 5.
Paragraphs 2.125-.126 Revised to define professional requirements.
Paragraph 2.127 Revised for clarification.
Paragraph 2.132 Revised to define professional requirements.
Former footnotes * and 
† before paragraph 3.01
Deleted.
Paragraphs 3.04-.25 Added to reflect the issuance of FASB Statement 
Nos. 157 and 159.
Paragraph 3.26 Revised to reflect the issuance of FASB State­
ment No. 157.
Footnote * in heading 
before paragraph 4.01
Revised to reflect the issuance of FASB State­
ment No. 157.
Footnote † in paragraph 
4.02
Revised to reflect the issuance of FASB State­
ment No. 159.
Paragraph 4.06 Revised to reflect the issuance of FASB State­
ment No. 157.
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Reference Change
Footnote ‡ in paragraph 
4.06
Added to reflect the issuance of FASB Statement 
No. 161.
Paragraph 4.19 Revised for clarification.
Paragraph 4.31 Revised to define professional requirements.
Paragraph 5.01 Revised for clarification.
Paragraph 5.12 and 
footnote *
Revised to reflect the issuance of FASB State­
ment No. 157.
Paragraphs 5.12 and
5.16
Revised for clarification.
Footnote † in paragraph 
5.24
Revised to reflect the issuance of FASB State­
ment No. 159.
Footnote ‡ in paragraph 
5.26
Added to reflect the issuance of FASB Statement 
No. 161.
Paragraph 5.37 Revised to define professional requirements.
Footnote * in paragraph 
6.08
Revised to reflect the issuance of FASB State­
ment No. 157.
Paragraph 6.12 Revised to define professional requirements.
Former footnote † in 
paragraph 6.13
Deleted.
Paragraph 6.16 Revised to define professional requirements.
Paragraph 7.04 Revised to reflect the issuance of FASB State­
ment No. 158.
Paragraph 7.05 Revised to reflect the issuance of GASB State­
ment No. 45.
Former footnote † in 
paragraph 7.05
Deleted.
Paragraph 7.07 Revised to define professional requirements.
Former footnote ‡ in 
paragraph 7.08
Deleted.
Paragraph 7.08 Revised to reflect the issuance of FASB Interpre­
tation No. 48.
Footnote * in paragraph 
8.01
Revised to reflect the issuance of FASB State­
ment No. 159.
Paragraph 8.03 Revised to define professional requirements.
Footnote † in paragraph 
8.17
Revised to reflect the issuance of FASB State­
ment No. 160.
Paragraphs 8.33, 
8.36-.37, 8.41, and 8.48
Revised to define professional requirements.
Paragraphs 9.07 and
9.09
Revised to reflect the issuance of the updated 
GASB Comprehensive Implementation Guide.
(continued)
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Paragraph 10.05 Revised to reflect the issuance of FASB State­
ment No. 157.
Footnote * in paragraph 
10.09
Revised to reflect the issuance of FASB State­
ment No. 157.
Paragraph 10.17 Revised to reflect the issuance of the updated 
GASB Comprehensive Implementation Guide.
Paragraph 10.21 Revised to define professional requirements.
Footnote * in heading 
before paragraph 11.04
Revised to reflect the issuance of FASB State­
ment Nos. 141(R) and 160.
Footnote † in paragraph 
11.10
Revised to reflect the issuance of AICPA SOP 07- 
1 and FASB FSP SOP 07-1-1.
Paragraph 12.01 Revised for clarification; revised to reflect the is­
suance of PCAOB Auditing Standard No. 5; re­
vised to define professional requirements.
Paragraphs 12.05,
12.07, and 12.10-.12
Revised to define professional requirements.
Appendix A Revised to define professional requirements.
Appendix I Updated.
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Glossary
acquisition costs. Marketing costs that are (a) directly related to the acquisi­
tion of specific subscriber contracts and member enrollment and (b) incre­
mental to general marketing activities.
acute care. Inpatient general routine care provided to patients who are in 
a phase of illness that does not require the concentrated and continuous 
observation and treatment provided in intensive-care units.
advance fee. A payment required to be made by a continuing care retirement 
community (CCRC) resident prior to, or at the time of, admission to the 
CCRC for future services and the use of facilities specified in a contract 
that remains in effect for as long as the resident resides in the CCRC.
advance refunding. A transaction in which refunding debt is issued to pay 
the refunded debt at a specified future date(s), with the proceeds placed in 
trust or otherwise restricted to pay the refunded debt.
affiliate. A party that, directly or indirectly through one or more intermedi­
aries, controls, is controlled by, or is under common control with an enter­
prise. (Financial Accounting Standards Board Statement No. 57, Related 
Party Disclosures, paragraph 24(a))
agent. An entity that acts for and on behalf of another. A recipient organization 
acts as an agent for and on behalf of a donor if it receives assets from 
the donor and agrees to use those assets on behalf of or transfer those 
assets, the return on investment of those assets, or both to a specified 
beneficiary. A recipient organization acts as an agent for and on behalf of 
a beneficiary if it agrees to solicit assets from potential donors specifically 
for the beneficiary's use and to distribute those assets to the beneficiary. 
A recipient organization also acts as an agent if a beneficiary can compel 
the organization to make distributions on its behalf. (Financial Accounting 
Standards Board Statement No. 136, Transfers o f  Assets to a Not-for-Profit 
Organization or Charitable Trust That Raises or Holds Contributions for 
Others, paragraph 10)
allocated loss adjustment expense (ALAE). Claim expense that can be as­
signed to individual claims (for example, attorney's fees, claim adjusting 
service fees, or court costs).
ambulatory care organization. A partnership, association, corporation, or 
other legal entity organized to deliver health care services to patients that 
come or are brought to a health care facility for a purpose other than admis­
sion as an inpatient (for example, emergency room services, clinic services, 
or outpatient surgery).
ancillary services. Services performed for diagnostic or therapeutic purposes. 
Ancillary services generally are those special services for which charges in 
addition to routine charges customarily are made (for example, laboratory, 
radiology, surgical, or other services).
anticipated revenues. Amounts including third-party payments (for exam­
ple, those from Blue Cross), contractually or statutorily committed invest­
ment income from sources related to the activities of a continuing care 
retirement community (CCRC), contributions pledged by donors to sup­
port CCRC activities, periodic fees expected to be collected, or the balance 
of deferred nonrefundable advance fees.
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asserted claim. A claim made against a health care organization by or on 
behalf of a patient alleging improper professional service.
assets limited as to use. Assets that are segregated and limited either by 
the board or management (for example, designated for expenditure in the 
acquisition of property and equipment or for the liquidation of long term 
debt) or by outside third parties other than a donor or grantor (for example, 
funds under bond agreements or malpractice arrangements) as to how the 
assets may be used.
associated entity. An individual practice association, hospital, medical group, 
or similar health care organization that contracts with a prepaid health 
care provider to provide health care services.
bad-debt expense. The current period charge for actual or expected doubtful 
accounts resulting from the extension of credit.
capitation fee. A fixed amount per individual that is paid periodically (usu­
ally monthly) to a provider as compensation for providing comprehensive 
health care services for the period. The fee is set by contract between a 
prepaid health care plan and the provider. These contracts are generally 
with medical groups, independent practice associations (IPAs), hospitals, 
and other similar providers. Capitation fees may be determined actuarially 
or negotiated based on expected costs to be incurred.
charity care. Health care services that never were expected to result in cash 
inflows. Charity care results from a provider's policy to provide health care 
services free of charge to individuals who meet certain financial criteria.
claims-made insurance policy. A policy that covers only malpractice claims 
reported to the insurance carrier during the policy term, regardless of the 
date of the incident giving rise to the claim.
clinic. A freestanding facility or part of another health care organization used 
for diagnosis and treatment of outpatients.
commercial paper. Short term, unsecured promissory notes that represent 
a flexible and low-cost form of short term financing. Taxable commercial 
paper is sold on a discount basis, rather than on an interest-bearing basis, 
with the discount determined by the maturity of the notes, the creditwor­
thiness of the issuer or its credit support, and general market demand. The 
primary risk is the variable interest rate exposure. Issuance often requires 
some form of credit enhancement or liquidity support.
comprehensive medical plan (CMP). A health plan option that may be 
available to Medicare beneficiaries and provides a more limited range of 
services than health maintenance organizations but includes physician ser­
vices, laboratory, radiology, emergency, preventive, and inpatient services. 
A CMP assumes the financial risk for the provision of services and for 
out-of-area coverage.
conditional promise to give. A promise to give that depends on the occur­
rence of a specified future or uncertain event to bind the promisor.
continuing-care contract. An agreement between a resident and a CCRC 
specifying the services and facilities to be provided by the CCRC to a res­
ident over an established period of time (usually the remaining life of the 
resident).
Health Care Organizations
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continuing care retirement community (CCRC). A legal entity sponsor­
ing or guaranteeing residential facilities, meals, and health care services 
for a community of retired persons who may reside in apartments, other 
living units, or in some cases a nursing center. (Also referred to as a resi­
dential care facility or a life-care retirement community.)
contract period. The period (typically one year) for which premium rates are 
fixed by contract.
contractual adjustments. The differences between revenue at established 
rates and the amounts realizable from third-party payors under contrac­
tual agreements.
contribution. An unconditional transfer of cash or other assets to an entity or 
a settlement or cancellation of its liabilities in a voluntary nonreciprocal 
transfer by another entity acting other than as an owner.
costs of acquiring initial continuing-care contracts. Costs incurred to 
originate a contract that result from and are essential to the acquisition 
of the initial contracts and are incurred through the date of substantial 
occupancy but no later than one year from the date of completion of con­
struction.
These costs include
• the costs of processing the contract, such as evaluating the 
prospective resident's financial condition; evaluating and record­
ing guarantees, collateral, and other security arrangements; ne­
gotiating contract terms; preparing and processing contract docu­
ments; and closing the transaction.
• the costs from activities in connection with soliciting potential 
initial residents (such as model units and their furnishings, sales 
brochures, semipermanent signs, tours, grand openings, and sales 
salaries). These costs do not include advertising, interest, admin­
istrative costs, rent, depreciation, or any other occupancy or equip­
ment costs.
• the portion of an employee's compensation and benefits that re­
lates to the initial contract acquisitions.
courtesy and policy discounts. The differences between revenue recorded at 
established rates and amounts realizable for services provided to specific 
individuals such as employees, medical staff, and clergy.
credibility. A measure of the statistical significance of a provider's own data, 
dependent on its stability and volume in relation to the stability and volume 
of the industry data. Actuaries use credibility to blend an estimate from 
a provider's own experience with a broader estimate based on the experi­
ence of similar institutions. A provider's own experience may be assigned a 
credibility weight less than 100 percent due to year-to-year volatility. Such 
volatility is often a function of the size of the provider. Large providers 
generally have less volatility than small providers. In such an instance, a 
broader and more stable body of experience of similar providers would be 
used to supplement the specific provider's experience.
credit enhancement. Typically, a bank letter of credit that guarantees in­
vestors will receive principal and interest in the event of an issuer default.
A line of credit provides liquidity support to an issuer but does not pro­
vide a guarantee of the repayment of principal and interest in the event of
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issuer default. The liquidity support provides a loan to issuers in the event 
the issuer is unable to place large amounts of maturing commercial paper 
with investors.
crossover refunding (also called a delayed defeasance). A type of advance 
refunding in which the old debt is not immediately replaced. The proceeds 
from the new debt, additional cash deposits (if any), and the income earned 
on the related investments are sufficient to pay the principal and any call 
premium of the old debt and the interest on the new debt until the date 
of crossover. Until the crossover, the proceeds from the new debt serve as 
collateral for that debt. The old debt is serviced by the entity until the date 
of crossover, at which time the proceeds from the new debt are used to retire 
the old debt and the entity becomes obligated to service the new debt. The 
old debt remains as a liability on the issuer's books until the crossover, 
when it is called in accordance with the call provisions of its indenture.
deductions from  revenue. Reductions in gross revenue arising from contrac­
tual adjustments, courtesy and policy discounts, or other adjustments and 
deductions.
defeasance. Legal satisfaction of refunded debt without the debt necessarily 
being retired.
developm ent factor. A computed factor used to project future changes in 
estimated losses from the date of the occurrence of the incident to the date- 
of-claim payment resulting from inflation, claimed cost growth, industry 
trends, and court awards. The development factor can be applied to in­
curred losses, paid losses, claim counts, and average values.
diagnosis-related group (DRG). A patient classification scheme that cate­
gorizes patients who are related medically with respect to primary and 
secondary diagnosis, age, or complications.
donor-im posed condition . A donor stipulation that specifies a future and 
uncertain event whose occurrence or failure to occur gives the promisor 
a right of return of the assets it has transferred or releases the promisor 
from its obligation to transfer its assets.
donor-im posed restriction. A donor stipulation that specifies the use for a 
contributed asset that is more specific than broad limits resulting from the 
nature of the organization, the environment in which it operates, and the 
purposes specified in its articles of incorporation or bylaws of comparable 
documents for an unincorporated association. A restriction on an organi­
zation's use of the asset contributed may be temporary or permanent.
endow m ent fund. An established fund of cash, securities, or other assets used 
to provide income for the maintenance of a not-for-profit organization. The 
use of the assets of the fund may be permanently restricted, temporarily 
restricted, or unrestricted. Endowment funds generally are established by 
donor-restricted gifts and bequests to provide a permanent endowment (to 
provide a permanent source of income) or a term endowment (to provide 
income for a specific period). The principal of a permanent endowment 
must be maintained permanently, that is, not used up, expended, or oth­
erwise exhausted—and is classified as permanently restricted net assets. 
The principal of a term endowment must be maintained for a specified 
term and is classified as temporarily restricted net assets. An organiza­
tion's governing board may earmark a portion of its unrestricted net assets
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as a board-designated endowment (sometimes called funds functioning as 
endowment or quasi-endowment funds) to be invested to provide income for 
a long but unspecified period. The principal of a board-designated endow­
ment, which results from an internal designation, is not donor restricted 
and is classified as unrestricted net assets.
enrollee. An individual who is a subscriber or an eligible dependent of a sub­
scriber in a prepaid health care plan.
estimated costs of future services. Amounts that are expected to be incurred 
to provide services and the use of facilities to individuals over their remain­
ing lives under continuing-care contracts. Examples include resident care, 
dietary, health care, facility, general and administrative, interest, depreci­
ation, and amortization costs.
exposure. The amount of potential claim risk. The basis for reflecting differ­
ences in the claim potential among providers' bases for charging insurance 
premiums or allocating member contributions to a captive. Exposure bases 
for hospital professional liability include number of occupied beds, outpa­
tient visits, emergency room visits, and number of residents by specialty.
floating rate note (FRN). A debt instrument that allows issuers to borrow at 
a floating short term rate with a long term stated maturity without some 
of the risks traditionally associated with commercial paper. The investor 
is subject to principal risk to the degree the issuer's credit deteriorates or 
investor demand for FRNs decreases. Most health care issuers of FRNs 
require credit enhancement and a bank liquidity facility in conjunction 
with an FRN program.
functional classification. A method of grouping expenses according to the 
purpose for which costs are incurred. The primary functional classifications 
are program services and supporting activities.
fund. A self-contained accounting entity set up to account for a specific activity 
or project.
gross service revenues. All revenues from the provision of health care ser­
vices excluding charity care.
health care services. Services provided to individuals related to the diagnosis 
or treatment of physical or mental illness.
health maintenance organization (HMO). A generic group of medical care 
entities organized to provide defined health care services to members in 
return for fixed, periodic premiums (usually paid monthly) that are paid 
in advance.
home health agency. An agency organized to provide health and supportive 
services in a person's home. These services may include nursing, nutri­
tional, and therapeutic aid (such as physical therapy and dialysis) and the 
rental, as well as sale of medical equipment.
increased limit factor. The relationship between losses limited to a per- 
occurrence limit at which the provider's own experience is meaningful to 
losses limited to the provider's total retained limit per occurrence.
incremental costs. Costs that vary with and are directly attributable to 
changes in business, such as an additional employer or health maintenance 
organization (HMO) contract. Fixed costs such as building depreciation or
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general overhead that do not change with the addition or loss of a contract 
are not incremental costs.
incurred but not reported  (IBNR) costs. Costs associated with health care 
services incurred during a financial reporting period but not reported to 
the health care organization until after the financial reporting date.
indenture. An agreement between two or more persons specifying the recip­
rocal rights and duties of the parties under a contract (such as a lease, 
mortgage, or contract between bondholders and the issuer of the bond).
individual practice  association (IPA). A partnership, association, corpora­
tion, or other legal entity organized to provide or arrange for the delivery 
of health care services to members of a prepaid health care plan and non­
member patients. In return, the IPA receives either a capitation fee or a 
specified fee for services rendered.
inpatient. Under most circumstances, a patient who is provided with room, 
board, and general nursing service and is expected to remain in the health 
care facility at least overnight and occupy a bed.
in-substance defeasance. A form of advance refunding in which the debtor 
places into an irrevocable trust an amount of assets estimated to be suf­
ficient to satisfy all future principal and interest payments of a specific 
obligation. In such cases, the debt is not considered extinguished because 
the debtor is not legally released from being the primary obligor.
integrated delivery system. A provider or group of providers that is orga­
nized to deliver and finance acute and preventive health care services. An 
integrated delivery system generally will provide (or arrange to provide) a 
complete continuum of health care services (inpatient acute care, ambula­
tory care, outpatient surgery, home health care, including long term care) 
to an enrolled population, generally for fixed prepaid fees called premiums.
interest rate swaps. An agreement to exchange interest payments without 
actually exchanging the underlying principal. The two parties each agree 
to make interest payments based on the calculation formula for the other's 
debt. Swaps can be used for a variety of purposes, such as to reduce the 
overall cost of borrowing, lock in forward rates, reduce interest rate risk, 
or adjust the ratio of variable and fixed-rate debt liabilities. Interest rate 
swaps do not change the amount or type of debt outstanding, but they do 
affect the issuer's debt portfolio and risk profile.
intermediary. An entity that acts as a facilitator for the transfer of assets 
between a potential donor and a potential beneficiary (donee) but is nei­
ther an agent or trustee nor a donee and donor as contemplated by Finan­
cial Accounting Standards Board Statement (FASB) No. 116, Accounting 
for Contributions Received and Contributions Made. (FASB Statement No. 
136, Transfers o f Assets to a Not-for-Profit Organization or Charitable Trust 
That Raises or Holds Contributions for Others, paragraph 8)
interm ediate care facility  (ICF). A facility that provides care to individuals 
whose mental or physical conditions require services that are above the 
level of room and board and that can be made available only through insti­
tutional facilities. The care provided at an ICF does not require hospitals 
or skilled nursing facilities.
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maintenance costs. Costs associated with maintaining enrollment records 
and processing premium collections and payments.
margin for risk of adverse deviation. Actuarially determined estimate of 
the additional funding requirement to obtain a specific confidence level 
that losses will not exceed the amount paid into the self-insurance fund. 
Margins are determined using statistical simulation techniques.
medical group. An association of physicians and other licensed health care 
professionals organized on a group basis to practice medicine.
medium-term notes. An intermediate-term security offered on a continuous 
basis providing flexibility for an issuer to vary the amount o f outstanding 
notes as its funding requirements change. The broad range of possible 
maturities enables an issuer to borrow at the most attractive yield at the 
time of each issuance. They can be issued domestically or abroad.
member. An individual who is enrolled as a subscriber or as an eligible depen­
dent of a subscriber in a prepaid health care plan.
multiprovider captive. An insurance company owned by two or more health 
care organizations that underwrites malpractice insurance for its owners.
natural classification. A method of classifying expenditures according to the 
nature of the expense such as salaries and wages, employee benefits, sup­
plies, and purchased services.
net advance refunding. A type of advance refunding in which the proceeds 
from the new debt, additional cash deposits (if any) and the income earned 
on the related investments are sufficient to pay the interest, principal, and 
call premium on the old debt. After the advance refunding, the old debt is 
serviced by the investments in trust and the new debt is serviced by the 
entity.
net service revenue. Gross service revenue less provisions for contractual 
adjustments with third-party payors.
nonexchange transaction. An external transaction in which a government 
gives (or receives) value without directly receiving (or giving) equal value 
in exchange.
nonfinancial assets. Nonmonetary assets such as inventories or property, 
plant, and equipment.
not-for-profit organization. An entity that possesses the following charac­
teristics that distinguish it from a business enterprise: (a) contributions of 
significant amounts of resources from resource providers that do not expect 
commensurate or proportionate pecuniary return, (b) operating purposes 
other than to provide goods or services at a profit, and (c) absence of own­
ership interests like those of business enterprises. Not-for-profit organiza­
tions possess these characteristics in varying degrees.
nursing center. A facility that provides nursing care to residents with a vari­
ety of needs or medical conditions. A nursing center may be a component 
of a continuing care retirement community. (Also called a health center, 
skilled-nursing facility, intermediate-care facility, continuing-care facility, 
or basic-care home.)
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occurrence-basis policy. A policy that covers claims resulting from incidents 
that occur during the policy term, regardless of when the claims are re­
ported to the insurance carrier.
outliers. In referring to the Medicare Prospective Payment System, additional 
payments that are made for cases that either have unusually long lengths 
of stay or have charges in excess of the cost outlier threshold.
outpatient. A patient who is not confined overnight in a health care institution.
peer review organization (PRO). Under federal statutory provision, PROs 
are required in each state to monitor hospital activity under the prospec­
tive payment system. Each hospital must contract with a PRO, which will 
review (a) the validity of diagnostic information, which establishes the 
diagnosis-related group; (b) the appropriateness of admissions; (c) the ap­
propriateness of care to outliers; and (d) the adequacy of care provided.
periodic fees. Amounts paid to a continuing care retirement community by a 
resident at periodic intervals for continuing-care services. Such fees may 
be fixed or adjustable. (Also called maintenance fees or monthly fees.)
periodic interim payment (PIP). A plan under which the health care organi­
zation receives cash payments from a third-party payor (usually Medicare) 
in constant amounts periodically.
permanent restriction. A donor-imposed restriction that stipulates that re­
sources be maintained permanently but permits the organization to use 
up or expend part or all of the income (or other economic benefits) derived 
from the donated assets.
permanently restricted net assets. The part of the net assets of a not-for- 
profit organization resulting from (a) contributions and other inflows of 
assets whose use by the organization is limited by donor-imposed stipu­
lations that neither expire by the passage of time nor can be fulfilled or 
otherwise removed by the actions of the organization, (b) other asset en­
hancements and diminishments subject to the same kind of stipulations, 
and (c) reclassification from (or to) other classes of net assets as a conse­
quence of donor-imposed stipulations.
premium. The consideration paid for providing contract coverage. (Also called 
a subscriber fee.)
premium period. The period to which a premium payment applies (generally 
one month) that entitles a member to health care services according to the 
contract provisions.
prepaid health care plan. A plan in which the provider is compensated in 
advance by the sponsoring organization. The sponsoring organization pays 
or compensates the provider based on either a fixed sum or a per-enrollee 
amount. Prepaid health care plans include health maintenance organiza­
tions, preferred provider organizations, eye care plans, dental care plans, 
and similar plans. Under such plans, the financial risk of delivering the 
health care is transferred to the provider of services.
prepaid health care services. Any form of health care service provided to a 
member in exchange for a scheduled payment (or payments) established 
before care is provided, regardless of the level of service subsequently pro­
vided.
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prevailing charge. A charge that falls within the range of charges most fre­
quently used in a locality for a particular service or procedure.
primary care. Care that is rendered in an ambulatory fashion, such as in an 
emergency room, an outpatient clinic, or other outpatient department.
prospective payment system (PPS). Medicare payment made at a prede­
termined, specific rate for each Medicare discharge, based on the patient's 
diagnosis. Each discharge is classified according to a series of diagnosis- 
related groups. See also diagnosis-related group.
provider. A person or entity that undertakes to provide health care services.
providers of prepaid health care services (prepaid health care 
providers). Organizations that provide or arrange for the delivery of 
health care services in accordance with the terms and provisions of a pre­
paid health care plan. Providers assume the financial risk of the cost of 
delivering health care services in excess of preestablished fixed premiums. 
However, some or all of the financial risk may be contractually transferred 
to other providers (affiliated entities) or by purchasing stop-loss insurance. 
Other providers of prepaid health care services may include comprehen­
sive medical plans, physicians groups (for example, independent practice 
associations), and hospitals.
refundable advance fees. The portion of an advance fee that is payable to a 
resident of a continuing care retirement community or the resident's estate.
refunded debt. Debt for which payment at a specified future date has been 
provided by the issuance of refunding debt.
refunding debt. Debt issued to provide funds to pay for refunded debt at a 
specified future date.
reported incident. An occurrence identified by a health care organization as 
one in which improper professional service may be alleged at a future time 
that would result in a malpractice claim.
retrospectively rated insurance policy. An insurance policy with a pre­
mium that is adjustable based on the experience of the insured health care 
organization or group of health care organizations during the policy term.
risk contract. A contract between a provider of health care services and a 
prepaid health care plan that exposes the provider to the uncertainty of 
financial gain or loss by obligating the provider to provide specified health 
care services to enrollees of the plan for a negotiated price, which may be an 
amount per case, service, or day. The price may vary based on the volume 
of services furnished during the contract period.
secondary care. Care that is rendered to inpatients in hospitals that offer 
short term, acute-care services of either a general or a specialized nature.
self-insurance. That portion of risk or loss assumed by a health care organi­
zation. There is no external insurance coverage.
skilled nursing facilities (SNF). These facilities provide services on a daily, 
inpatient basis. The services provided by an SNF are ordered by a physician 
and require the skilled services of technical or professional personnel.
stop-loss (or reinsurance) insurance. A contract in which a company agrees 
to indemnify providers for certain health care costs incurred by members.
Glossary 483
AAG-HCO GLO
484
subscriber. The person who is responsible for the payment of premiums or 
whose employment is the basis for eligibility for membership in a prepaid 
health care plan.
tail coverage. Insurance designed to cover malpractice claims incurred before, 
but reported after, cancellation or expiration of a claims-made insurance 
policy.
taxable variable rate demand notes. Issuers may call the notes on any 
monthly interest payment date, which provides issuers the opportunity to 
refinance short term obligations with long term bonds if market conditions 
make this alternative attractive.
temporarily restricted net assets. The part of the net assets of a not-for- 
profit organization resulting (a) from contributions and other inflows of 
assets whose use by the organization is limited by donor-imposed stipu­
lations that either expire with the passage of time or can be fulfilled and 
removed by actions of the organization pursuant to those stipulations, (b) 
from other asset enhancements and diminishments subject to the same 
kinds of stipulations, or (c) from reclassification to (or from) other classes 
of net assets as a consequence of donor-imposed stipulations, their expira­
tion by passage of time, or their fulfillment and removal by actions of the 
organization pursuant to those stipulations.
tertiary care. Care that is rendered in hospitals that possess the personnel, 
equipment, and expertise to handle complex cases.
third-party payor. Any agency (such as Blue Cross, Medicare, or commercial 
insurance companies) that contracts with health care organizations and 
patients to pay for the care of covered patients.
trend factor. A factor used in actuarial methodology to adjust ultimate losses 
from historical experience periods to the loss cost levels of the projection 
period, due to the impact of economic, jurisdictional, and social changes 
affecting hospital professional liability loss costs.
trust fund. A fund established with an outside entity to be used for a specific 
purpose, such as to pay malpractice claims and related expenses as they 
arise.
trustee. An entity that has a duty to hold and manage assets for the benefit 
of a specified beneficiary in accordance with a charitable trust agreement. 
(Financial Accounting Standards Board Statement No. 136, Transfers o f  
Assets to a Not-for-Profit Organization or Charitable Trust That Raises or 
Holds Contributions for Others, paragraph 9)
ultimate cost. Total claims payments, including costs associated with litigat­
ing or setting claims.
unasserted claim. A medical malpractice claim that has not been asserted 
formally against a health care provider by or on behalf of a patient alleging 
improper professional service. It may relate to either reported incidents or 
to unreported incidents.
unreported incident. An occurrence in which improper professional service 
may have been administered by a health care provider, which may result 
in a malpractice claim of which the provider is not yet aware.
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unrestricted net assets. The part of net assets of a not-for-profit organization 
that is neither permanently restricted nor temporarily restricted by donor- 
imposed stipulations.
voluntary health and welfare organizations. Organizations formed for the 
purpose of performing voluntary services for various segments of society. 
They are tax-exempt (organized for the benefit of the public), supported by 
the public, and operated on a not-for-profit basis. Most voluntary health 
and welfare organizations concentrate their efforts and expend their re­
sources in an attempt to solve health and welfare problems of society and, 
in many cases, those of specific individuals. As a group, voluntary health 
and welfare organizations include not-for-profit organizations that derive 
their revenue primarily from voluntary contributions from the general pub­
lic to be used for general or specific purposes connected with health, welfare, 
or community services.
wholly owned captive. An insurance company subsidiary of a health care 
organization that provides malpractice insurance primarily to its parent 
corporation.
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AICPA RESOURCE:
Accounting & Auditing Literature
The AICPA has created a unique online research tool by 
combining the power and speed of the Web with comprehensive 
accounting and auditing standards. AICPA RESOURCE includes 
the AICPA, FASB and GASB libraries. You’ll find subscriptions to 
these titles:
• AICPA Professional Standards
• AICPA Technical Practice Aids
• AlCPA’s Accounting Trends & Techniques
• AICPA Audit and Accounting Guides
• AICPA Audit Risk Alerts
• AICPA Financial Statement Preparation Manual
• AICPA Audit & Accounting Manual
• FASB Original Pronouncements
• FASB Current Text
• EITF Abstracts
• FASB Implementation Guides
• FASB’s Comprehensive Topical Index
• GASB Original Pronouncements
• Codification of Governmental Accounting and Financial 
Reporting Standards
• GASB Implementation Guides
• GASB’s Comprehensive Topical Index
Search for pertinent information from both databases by keyword 
and get the results ranked by relevancy. Print out important 
AICPA RESOURCE segments and integrate the literature into 
your engagements and financial statements. Available from 
anywhere you have Internet access, this comprehensive 
reference library is packed with the A & A guidance you need — 
and use — the most. All libraries are updated with the latest 
standards and conforming changes.
AICPA, FASB and GASB Libraries, No. WGLBY12 
AICPA and FASB Libraries, No. WFLBY12 
AICPA Library, No. WALBY12
Log onto www.cpa2biz.com/AICPAresource for 
subscription details.
For additional Audit and Accounting Guides log onto the AICPA Store 
at www.cpa2bi2.com -  or to automatically receive an annual update 
immediately upon its release -  call 1-888-777-7077.
Additional Publications
Audit and Accounting Guides -  2008 Industry Guides
With conforming changes as of March 1, 2008.
• Common Interest Realty Associations (012578)
• Construction Contractors (012588)
• Depository and Lending Institutions: Banks and Savings 
Institutions, Credit Unions, Finance Companies, and Mortgage 
Companies (012738)
• Employee Benefit Plans (012598)
• Federal Government Contractors (012608)
• Life & Health Insurance Entities (012638)
• Not-for-Profit Organizations (012648)
• State and Local Governments (012668)
With conforming changes as of May 1, 2007.
• Agricultural Producers and Agricultural Cooperatives (012687)
• Brokers and Dealers in Securities (012707)
• Casinos (2006) (012716)
• Entities With Oil and Gas Producing Activities (012657)
• Government Auditing Standards and Circular A-133 Audits 
(012747)
• Health Care Organizations (012617)
• Investment Companies (012627)
• Property and Liability Insurance Cos. (012677)
Audit and Accounting Guides -  2008 General Guides
• Analytical Procedures (012558)
• Auditing Derivative Instruments, Hedging Activities, and 
Investments in Securities (2007) (012527)
• Auditing Revenue in Certain Industries (012518)
• Personal Financial Statements (2007) (012757)
• Prospective Financial Information (012728)
• Service Organizations: Applying SAS No. 70, as Amended 
(012778)
To order log on to the AICPA Store at www.cpa2blz.com 
Call AICPA at 1-888-777-7077 or fax to 1-800-362-5066

